TW548272B - Benzimidazole derivatives - Google Patents

Benzimidazole derivatives Download PDF

Info

Publication number
TW548272B
TW548272B TW86100149A TW86100149A TW548272B TW 548272 B TW548272 B TW 548272B TW 86100149 A TW86100149 A TW 86100149A TW 86100149 A TW86100149 A TW 86100149A TW 548272 B TW548272 B TW 548272B
Authority
TW
Taiwan
Prior art keywords
group
compound
lower alkyl
benzimidazole
aryl
Prior art date
Application number
TW86100149A
Other languages
Chinese (zh)
Inventor
Noritsugu Yamasaki
Takafumi Imoto
Yoshiyuki Murai
Takahiro Hiramura
Teruo Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW548272B publication Critical patent/TW548272B/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

Novel benzimidazole derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof wherein R3 represents carboxy, esterified carboxy, carboxamide, amino, amido or sulfonyl. Because of having hyopglycemic or PDE5 inhibitory effects, these compounds or salts thereof are useful as remedies for impaired glucose tolerance, diabetes, complications of diabetes, insulin resistant syndrome, hyperlipidemia, atherosclerosis, cardiovascular diseases, hyperglycemia, hypertension, angina pectoris, pulmonary hypertension, congestive heart failure, glomerular diseases, tubular interstitial diseases, renal failure, angiostenosis, peripheral vascular disease, apoplexy, chronic reversible obstructive diseases, allergic rhinitis, urticaria, glaucoma, diseases characterized by abnormality in intestinal motility, sexual impotence, nephritis, cancerous cachexia, or post-PCTA reconstriction.

Description

好沪部中^i?:^-^m,t*;/i灸合竹扣卬繁 548272 A7 、發明説明(]:) 本發明係有關於新穎的苯並啼唾衍生物,特別是有 關於具有血糖降低活性或PDE5抑制作用之新穎的苯並 味唾街生物或醫藥上可容許之其等的鹽類。又本發明係 有關於❹上述笨並咪。顿生物或其等之 成分之醫藥。 本么明係、提供-種新穎的笨並味唾衍生物 可容許之其等的鹽類;同時提供—種醫藥製劑,使用上 述苯生物或其等之鹽類作為有效成分,以用來 預防治療耐糖能失調、糖尿病(第u型糖尿病)、糖尿病 合併症(糖尿病性腎病、糖尿病性神經失調、糖尿病性網 膜症等)、膜島素抗性症候群(騰島素受體異常症、 R〇bS〇n_Mendenha11 症候群、Leprechaunism、 K〇bberiing_Dunnigan 症候群、Seip 症候群、症 候群、Cushing症候群、前端巨大症等)、高脂血症、動 脈粥樣硬化症、心血管疾病(狹心症、心不全等)、高血糖 症(例如附加上攝食失調等異常糖代謝之特徵者)、或高血 壓症、或狹心症、高血壓、肺高也壓 '充血性心不^、 腎小球疾病(例如糖尿病性腎小球硬化症等)、尿細管間質 性疾病(例如基於FK506、環孢子素等所引起的腎: 腎不全、動Μ樣硬化、血管狹窄(例如經皮性動脈形成 手術後者)、末猶血管疾病、腦溢血、慢性可逆性閉塞性 疾病(例如支氣管炎、氣喘(慢性氣喘、過敏性氣喘^ 敏性鼻炎m青純、㈣為料祕異常 病(例如過敏症腸症候群)、陽萎⑽如器官㈣n = (請先閱讀背面之注意事項再填寫本頁) 、ax 線 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公4 ) 548272 A7 五、發明説明(2 ) — 一·~ -- (麴先閱讀背面之注意事項再填寫本頁 陽萎等)糖尿病合併症(例如糖尿病壞疽、糖尿病關節 症糖尿病性月小球硬化症、糖尿病性皮膚異常、糖尿 :性神經異常、糖尿病性白内障、糖尿病性網膜症等)、 腎炎、惡性癌、或PCTA後的再狹窄等。 本發明者等係,提供一種醫藥製劑,使用下式⑴〜(IV) 及(VIII)〜(XIV)所代表之苯並咪唑衍生物或醫藥上可容 許之其等的鹽類作為有效成分,以用來預防治療耐糖能 2調、糖尿病(第Η型糖尿病)、糖尿病合併症(糖尿病性 腎病、糖尿病性神經失調、糖尿病性網膜症等)、胰島素 抗性症候群(胰島素受體異常症、Robson-Mendenhall症候 群、Leprechaunism、Kobbeding-Dunnigan 症候群、Seip 、-口 症候群、LaWrence症候群、Cushing症候群、前端巨大症 等)、高脂血症、動脈粥樣硬化症、心血管疾病(狹心症、 、不全等)、鬲血糖症(例如附加上攝食失調等異常糖代謝 之特徵者)、或高血壓症、或狹心症、高血壓、肺高血壓、 充血1*生〜不全、腎小球疾病(例如糖尿病性腎小球硬化症 等)、尿細管間質性疾病(例如基於FK506、環孢子素等所 引起的腎藏病)、腎不全、動脈粥樣硬化、血管狹窄(例如 經皮性動脈形成手術後者)、末稍血管疾病、腦溢血、慢 性可逆性閉塞性疾病(例如支氣管炎、氣喘(慢性氣喘、= 敏性氣喘))、過敏性鼻炎、蓴麻疹、青光眼、特徵為腸^ 動性異常之疾病(例如過敏症腸症候群)、陽萎(例如器官 性陽萎、精神性陽萎等)、糖尿病合併症(例如糖尿病壞 症、糖尿病關節症、糖尿病性腎小球硬化症、糖尿病性 本紙張尺度咖巾_家縣(CNS) M規格(2igx297公髮 548272 A7 五、發明説明(3 ) 皮膚異常、糖尿病性神經異常 病性網膜症等)、腎炎、惡性癌 n (R4) 、糖尿病性白内障、糖尿 或PCTA後的再狹窄等。沪 i?: ^-^ M, t *; / i moxibustion combined with bamboo buckle 卬 548272 A7, description of the invention () :) The present invention relates to novel benzodiazepine derivatives, especially Concerning novel benzoic salivary or pharmaceutically acceptable salts having blood sugar lowering activity or PDE5 inhibitory effect. The present invention relates to the above-mentioned stupid microphone. Pharmaceuticals or their ingredients. Benmemin is a new type of salt that can be tolerated by the stupid sialo derivative; at the same time, it provides a medicinal preparation using the above-mentioned benzene bio or its salt as an active ingredient for prevention Treatment of glucose tolerance disorders, diabetes mellitus (type u diabetes), diabetic comorbidities (diabetic nephropathy, diabetic neurological disorder, diabetic omentum, etc.), membranin resistance syndrome (tonguelin receptor abnormalities, R? bS〇n_Mendenha11 Syndrome, Leprechaunism, K〇bberiing_Dunnigan Syndrome, Seip Syndrome, Syndrome, Cushing Syndrome, Acromegaly, etc.), Hyperlipidemia, Atherosclerosis, Cardiovascular Diseases (Asthma, Insufficiency, etc.), High Glycemia (for example, those with abnormal glucose metabolism and other characteristics of eating disorders), or hypertension, or asthma, high blood pressure, and high lung pressure also include congestive heart failure, glomerular disease (such as diabetic kidney Glomerular sclerosis, etc.), urinary tubulointerstitial diseases (for example, kidneys based on FK506, cyclosporine, etc .: renal insufficiency, arterial sclerosis, vascular stenosis ( Such as percutaneous arterial formation surgery), terminal vascular disease, cerebral hemorrhage, chronic reversible occlusive disease (such as bronchitis, asthma (chronic asthma, allergic asthma) ^ allergic rhinitis m Qingchun, ㈣ is a material abnormality disease (Such as allergic bowel syndrome), impotence, such as organs n = (Please read the precautions on the back before filling out this page), the paper size of the ax line applies Chinese National Standard (CNS) A4 specification (210X 297 male 4) 548272 A7 V. Description of the invention (2) — 1 · ~-(麴 Read the precautions on the back before filling out impotence on this page, etc.) Diabetes comorbidities (such as diabetic gangrene, diabetic joint disease, diabetic lumen sclerosis, diabetes Skin abnormalities, diabetic: neurological abnormalities, diabetic cataracts, diabetic omentosis, etc.), nephritis, malignant cancer, or restenosis after PCTA, etc. The present inventors and others provide a pharmaceutical preparation using the following formula ⑴ ~ The benzimidazole derivatives represented by (IV) and (VIII) to (XIV) or their pharmaceutically acceptable salts are used as effective ingredients for the prevention and treatment of glucose tolerance. Diabetes (Type 2 diabetes), Diabetes comorbidities (Diabetic nephropathy, Diabetic neurological disorder, Diabetic retinopathy, etc.), Insulin resistance syndrome (Insulin receptor abnormality, Robson-Mendenhall syndrome, Leprechaunism, Kobbeding-Dunnigan syndrome , Seip,-Mouth syndrome, LaWrence syndrome, Cushing syndrome, megacephaly, etc.), Hyperlipidemia, Atherosclerosis, Cardiovascular disease (stenosis, insufficiency, etc.), 鬲 Glycemia (for example, attached to Those who have abnormal glucose metabolism such as eating disorders), or hypertension, or angina, hypertension, pulmonary hypertension, congestion, insufficiency, glomerular disease (such as diabetic glomerulosclerosis, etc.) , Urinary tubulointerstitial disease (such as kidney disease caused by FK506, cyclosporine, etc.), renal insufficiency, atherosclerosis, vascular stenosis (such as the latter in percutaneous arterial surgery), terminal vascular disease, Cerebral hemorrhage, chronic reversible occlusive disease (eg bronchitis, asthma (chronic asthma, = allergic asthma)), allergic Rhinitis, measles, glaucoma, diseases characterized by abnormal bowel movements (such as allergic bowel syndrome), impotence (such as organ impotence, mental impotence, etc.), comorbidities of diabetes (such as diabetic necrosis, diabetes Arthritis, diabetic glomerulosclerosis, diabetic paper-sized coffee towel Etc.), nephritis, malignant cancer (R4), diabetic cataract, diabetes, restenosis after PCTA, etc.

0) 好沪部中次ii:^-而乃ν-,消费合作扣印繁 式(I)中’ R!為氫原子、芳磺醯基 低級烷基係,可使用擇自由_素原子 基、齒低級烷基、低級烷氧基、頌基 基、芳基低級烷基、芳基低級烷氧基 基、芳磺醯基低級烷基、芳磺醯基胺基、氰芳基及雜環 基所構成群中之一個或二個基取代之,亦可使用芳基或 雜環基取代之。 R2為氫原子、低級環烷基、羥基、低級烷氧基、魏 基、低級烧硫基、胺基、低級烧胺基、羧基、芳基、或 低級烧基;該低級烧基可使用_素原子、低級烧氧基、 氰基、氣羰基、芳基、或雜環基取代之。 R3為叛基、經醋化之緩基、醯胺化之魏基、胺基、 醯胺基、或磺醯基;該胺基及該醯胺基可使用醯基或石黃 醢基取代之;該項醯基為與ώ素原子、胺基或酿胺基相 結合者。又,R*3可介由低級伸烧基或低級稀撐基而與母 核相結合。 R4為中性之取代基。 η代表0〜3之整數。 或低級烧基;該 鹵芳基、低級烧 胺基、氰基、芳 鹵芳基低級烷氧 -----------私衣^^ I (請先閲讀背面之注意事項再填寫本頁;一 、^1 -線 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) A70) Haohubu Zhongji ii: ^-而 乃 ν-, in the consumer cooperation formula (I), 'R! Is a hydrogen atom, arylsulfonyl-lower alkyl group, and a free_prime atom group can be used , Lower alkyl, lower alkoxy, succinyl, aryl lower alkyl, aryl lower alkoxy, arylsulfonyl lower alkyl, arylsulfonylamino, cyanoaryl, and heterocyclic One or two radicals in the group formed by the radical may be substituted with aryl or heterocyclic radical. R2 is a hydrogen atom, a lower cycloalkyl group, a hydroxyl group, a lower alkoxy group, a weyl group, a lower sulfur group, an amine group, a lower alkyl group, a carboxyl group, an aryl group, or a lower alkyl group; the lower alkyl group can be used_ Element atom, lower alkoxy, cyano, carbonyl, aryl, or heterocyclyl. R3 is a tertiary group, an acetate-retarded group, an amidated weanyl group, an amino group, an amidino group, or a sulfonyl group; the amine group and the amidino group may be replaced by a fluorenyl group or a lutein group; the The term hydrazone is a combination with a free atom, an amine group or an amino group. In addition, R * 3 may be combined with the mother nucleus via a low-level sintered base or a low-level dilute support. R4 is a neutral substituent. η represents an integer from 0 to 3. Or lower alkynyl; the haloaryl, lower amine, cyano, and arylhaloaryl lower alkoxy ----------- private clothing ^^ I (Please read the precautions on the back first Fill in this page; 1. ^ 1-Threaded Paper Size Applicable to China National Standard (CNS) Α4 Specification (210X297 mm) A7

548272 一—---〜 ____________ __B7 Α、發明説明(4 ) n (R:)548272 I ----- ~ ____________ __B7 Α, description of the invention (4) n (R :)

(ID 式(II)中’ R6為芳基低級烧基,可使用擇自由鹵素 原子、鹵芳基、低級烷基、鹵低級烷基、低級烷氧基、 峭基、胺基、氰基、芳基、氰芳基、芳基低級烷氧基、 芳磺醯基低級烷基、芳磺醯基胺基、芳基低級烷基及雜 環基所構成群中之一個或二個基取代之。 R7為低級烷基或低級環烷基。 r8為氨基曱醯基;該氨基曱醯基係,可使用經芳基 或雜環基取代之低級烷基、芳基、雜環基、及 9\g〆 〇< ''Ο Ola) (式(Ila)中,R9為碳數到8為止之烷基、_低級烷基、芳 基低級烷基、羥基低級烷基、三低級烷基甲矽烷基低級 烷基、低級烷氧基低級烷基、低級烷硫基低級烷基、雜 環基、或芳基;該芳基可使用鹵素原子、低級烧基、_ 低級烷基、低級烷氧基或硝基取代之。)取代之;又r8 可介由低級伸烷基或低級烯撐基而與母核相結合。 為可被ii素取代之烴基。 η代表0〜3之整數。 ______ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) ' 一 (請先閱讀背面之注意事項再填寫本頁(In formula (II), 'R6 is an aryl lower alkyl group, and a free halogen atom, a halogen aryl group, a lower alkyl group, a halogen lower alkyl group, a lower alkoxy group, an azido group, an amine group, a cyano group, One or two of the groups consisting of aryl, cyanoaryl, aryl-lower alkoxy, arylsulfonyl-lower alkyl, arylsulfonylamino, aryl-lower alkyl and heterocyclic groups R7 is lower alkyl or lower cycloalkyl. R8 is aminofluorenyl; the aminofluorenyl is a lower alkyl, aryl, heterocyclyl, and 9 substituted with aryl or heterocyclic group. \ g〆〇 < '' Ο Ola) (In the formula (Ila), R9 is an alkyl group with a carbon number of up to 8, lower alkyl, aryl lower alkyl, hydroxy lower alkyl, tri-lower alkyl Silyl lower alkyl, lower alkoxy lower alkyl, lower alkylthio lower alkyl, heterocyclic group, or aryl group; the aryl group may use a halogen atom, lower alkyl group, lower alkyl group, lower alkyl group Or nitro.) R8 can be combined with the mother core through lower alkylene or lower alkenylene. It is a hydrocarbyl group which can be substituted with ii. η represents an integer from 0 to 3. ______ This paper size applies the Chinese National Standard (CNS) Α4 specification (210X 297 mm) '1 (Please read the precautions on the back before filling this page

、1T, 1T

RR

548272 Α7 — Β7 發明说明( n (R4,) (Ml) 式(III)中,R6為芳基低級烷基,可使用擇自由鹵素 原子、低級烷基、齒低級烷基、低級烷氧基、硝基、胺 基、氰基、芳基、i芳基、氰芳基、芳基低級烷氧基、 芳磺醯基低級烷基、芳磺醯基胺基、芳基低級烷基及雜 環基所構成群中之一個或二個基取代之。 r7為低級烷基或低級環烷基。548272 Α7 — B7 Description of the invention (n (R4,) (Ml) In formula (III), R6 is an aryl lower alkyl group, and a halogen atom, a lower alkyl group, a lower alkyl group, a lower alkoxy group, Nitro, amine, cyano, aryl, iaryl, cyanaryl, aryl lower alkoxy, arylsulfonyl lower alkyl, arylsulfonylamino, aryl lower alkyl, and heterocyclic ring R7 is a lower alkyl group or a lower cycloalkyl group.

Ru 為式(Ilia) (請先閱讀背面之注意事項再填寫本頁)Ru is Ilia (Please read the notes on the back before filling this page)

R 2\ 、y'° (Ilia) 線·一 (式(Ilia)中,R12為碳數到8為止之烷基、鹵低級烷基、 芳基低級烧基、羥基低級烧基、三低級烧基甲矽烧基低 級烷基、低級烷氧基低級烷基、低級烷硫基低級烷基、 雜環基、或芳基;該芳基可使用_素原子、低級烷基、 鹵低級烷基、低級烷氧基或硝基取代之。)所代表的取代 基;又Ri!可介由低級伸烷基或低級烯撐基而與母核相結 合。 尺4’為可被函素取代之烴基。 η代表0〜3之整數。 本紙張尺度適ffl中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 發明7;見明 (FV)R 2 \, y '° (Ilia) line · One (In formula (Ilia), R12 is an alkyl group having up to 8 carbon atoms, halogen lower alkyl group, aryl lower alkyl group, hydroxy lower alkyl group, triple lower alkyl group Methylsilyl lower alkyl, lower alkoxy lower alkyl, lower alkylthio lower alkyl, heterocyclic group, or aryl group; the aryl group can use a prime atom, a lower alkyl group, a halogenated lower alkyl group , Lower alkoxy or nitro.) And Ri! Can be combined with the mother core through lower alkylene or lower alkenylene. Chi 4 'is a hydrocarbyl group which may be substituted by a functional element. η represents an integer from 0 to 3. The size of this paper is suitable for China National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 Invention 7; see Ming (FV)

(IV) 式(IV)中,Ri3為芳基低級烧基,可使用擇自由鹵素 原子、低級烷基、ii低級烷基、低級烷氧基、硝基、胺 基、氰基、芳基、函芳基、乳方基、方基低級烧基、芳 石黃酿基低級烧基、芳確醯基胺基及雜環基所構成群中之 一個或二個基取代之。 Rl4為低級烷基。 R15 為式(IVa) (iVa) (式(IVa)中R16為低級烷基或芳基)所代表的取代基 KV為可被鹵素取代之烴基。 η代表0〜3之整數。(IV) In the formula (IV), Ri3 is an aryl lower alkyl group, and a halogen atom, a lower alkyl group, a ii lower alkyl group, a lower alkoxy group, a nitro group, an amine group, a cyano group, an aryl group, One or two of the groups consisting of a aryl group, a lacto square group, a square lower group, a lower aromatic group, a lower aromatic group, a arylamino group, and a heterocyclic group are substituted. Rl4 is lower alkyl. R15 is a substituent represented by the formula (IVa) (iVa) (where R16 in the formula (IVa) is a lower alkyl group or an aryl group) KV is a hydrocarbon group which may be substituted with a halogen. η represents an integer from 0 to 3.

R 2 6 n (R/) (詳先閱讀背面之注意事項再镇荇本頁j - 、11R 2 6 n (R /) (Read the precautions on the back first for details, then check this page j-、 11

R (VIII) 式(VIII)中,I為氫原子、芳磺醯基、或低級烷基; 該低級燒基係,可使用擇自由鹵素原子、齒芳基、低級 本紙張尺度遙州中國國家標準(CNS ) Α4規格(210Χ 297公釐) A7 548272 __________ B7 五、發明説明(7 ) 烧基、鹵低級烷基、低級烷氧基、硝基、胺基、氰基、 芳基、芳基低級烧基、芳基低級烧氧基、齒芳基低級烧 氧基、芳磺醯基低級烷基、芳磺醯基胺基、氰芳基及雜 環基所構成群中之一個或二個基取代之,亦可使用芳基 或雜環基取代之。 R2為氫原子、低級環烧基、經基、羥基低級烧基、 低級烧氧基、魏基、低級烧硫基、胺基、低級烧胺基、 羧基、芳基、或低級烷基;該低級烷基可使用_素原子、 低級烷氧基、氰基、鹵羰基、芳基、或雜環基取代之。 R25為碳數到8為止之烷基、低級環烷基、函低級烷 基、三低級烷基甲矽烷基低級烷基、低級烷氧基低級烷 基、低級烧硫基低級烧基、芳基、雜環基、芳基低級烧 基、或羥基低級烷基;該芳基可使用鹵素原子、低級烷 基、鹵低級烷基、低級烷氧基或硝基取代之。 R26為氫原子或低級烷基;當該R25及r26皆為低級 烧基時’可互相結合而形成環。 Y為幾基或低級伸烧基。 A代表單純的結合或低級伸烧基或低級稀撐基。 尺4’代表可被齒素取代之烴基。 η代表〇〜3之整數。 (辞先閱讀背面之注意事項再填寫本頁R (VIII) In the formula (VIII), I is a hydrogen atom, an arylsulfonyl group, or a lower alkyl group; the lower alkyl group may use a halogen atom, a aryl group, or a lower paper. Standard (CNS) A4 specification (210 × 297 mm) A7 548272 __________ B7 V. Description of the invention (7) Alkenyl, halogenated lower alkyl, lower alkoxy, nitro, amine, cyano, aryl, aryl One or two of the group consisting of lower alkyl, aryl lower alkyl, aryl lower alkyl, arylsulfonyl lower alkyl, arylsulfonylamino, cyanoaryl and heterocyclic group It may be substituted by an aryl group or an aryl group or a heterocyclic group. R2 is a hydrogen atom, a lower cyclic alkyl group, a mesityl group, a hydroxy lower alkyl group, a lower alkyl group, a weyl group, a lower alkyl group, an amine group, a lower alkyl group, a carboxyl group, an aryl group, or a lower alkyl group; The lower alkyl group may be substituted with a prime atom, a lower alkoxy group, a cyano group, a halocarbonyl group, an aryl group, or a heterocyclic group. R25 is alkyl, lower cycloalkyl, lower alkyl, tri-lower alkylsilyl lower alkyl, lower alkoxy lower alkyl, lower sulfur thio lower alkyl, aryl , Heterocyclyl, aryl lower alkyl, or hydroxy lower alkyl; the aryl may be substituted with a halogen atom, lower alkyl, halogen lower alkyl, lower alkoxy, or nitro. R26 is a hydrogen atom or a lower alkyl group; when both R25 and r26 are a lower alkyl group, they may be bonded to each other to form a ring. Y is a few bases or a lower elongation base. A represents a simple bond or a low-level sintered base or a low-level dilute support. Chi 4 'represents a hydrocarbyl group which may be substituted by dentin. η represents an integer of 0 to 3. (Review the notes on the back before filling out this page

、1T 線1T line

本紙张尺度遍州中國國家標準(CNS ) Α4規格(210Χ 297公釐) 548272 A7 B7 五、發明説明 (¾先閱讀背面之注意事項再填寫本頁} 式(IX)中’ R”為碳數到7為止之烷基、鹵低級烷基、 芳基磺醯基、芳基低級烷基、雜環低級烷基、齒雜環低 級烧基;該芳基低級烷基的芳香環可使用擇自鹵素原 子、低級烷基、鹵低級烷基、氰芳基、胺基、低級烷氧 基、硝基、氰基、芳基、齒芳基、芳基磺醯基低級烷基、 芳基磺醯基胺基、芳基低級烷氧基、芳基低級烷基、雜 環基、芳氧基、芳基羰基、芳基羰基胺基、或經一個或 二個鹵素原子取代之芳基低級烷氧基中之一個或二個取 代之。 R28為氫原子、碳數到7為止之烷基、鹵低級烷基、 低級烷氧基低級烷基、低級環烷基、芳基、芳基低級烷 基、低級烷基胺基、低級烷氧基、低級烷硫基、羥基、 巯基、胺基或羧基。 R25為碳數到8為止之烷基、鹵低級烷基、三低級烷 基甲矽烧基低級烷基、低級烷氧基低級烷基、低級烷硫 基低級烷基、芳基、雜環基、芳基低級烷基、或羥基低 級烷基;該芳基可使用ii素原子、低級烷基、鹵低級烷 基、低級烧氧基或硝基取代之。 R26為氫原子或低級烷基;當該r25及r26皆為低級 烷基時,可互相結合而形成環。 Y為艘基或低級伸烧基。 A代表單純之結合或低級伸烷基或低級烯撐基。 R29為氫原子或低級烧基。 本紙张尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) 548272 A7 B7 η (FV)The size of this paper is covered by the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 548272 A7 B7 V. Description of the invention (¾Read the precautions on the back before filling this page} In formula (IX), 'R' is the carbon number Alkyl, halo-lower alkyl, arylsulfonyl, aryl-lower alkyl, heterocyclic-lower alkyl, and heterocyclic-lower alkyl groups up to 7; the aromatic ring of the aryl-lower alkyl can be selected from Halogen atom, lower alkyl, halogen lower alkyl, cyanoaryl, amine, lower alkoxy, nitro, cyano, aryl, dentaryl, arylsulfonyl lower alkyl, arylsulfonyl Arylamino, aryl lower alkoxy, aryl lower alkyl, heterocyclyl, aryloxy, arylcarbonyl, arylcarbonylamino, or aryl lower alkoxy substituted with one or two halogen atoms One or two of these groups are substituted. R28 is a hydrogen atom, an alkyl group having up to 7 carbon atoms, a halogen lower alkyl group, a lower alkoxy lower alkyl group, a lower cycloalkyl group, an aryl group, an aryl lower alkyl group , Lower alkylamino, lower alkoxy, lower alkylthio, hydroxyl, thiol, amine, or carboxyl. R25 is carbon Alkyl, halogen lower alkyl, tri-lower alkylsilyl lower alkyl, lower alkoxy lower alkyl, lower alkylthio lower alkyl, aryl, heterocyclic, aryl Lower alkyl, or hydroxy lower alkyl; the aryl may be substituted with a ii element atom, a lower alkyl, a halogen lower alkyl, a lower alkyloxy or a nitro group. R26 is a hydrogen atom or a lower alkyl; when the r25 When both r26 are lower alkyl groups, they can be combined with each other to form a ring. Y is a naphthyl group or a lower alkylene group. A represents a simple bond or a lower alkylene group or a lower alkenyl group. R29 is a hydrogen atom or a lower alkylene group The paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) 548272 A7 B7 η (FV)

R 33 -A-R 33 -A-

R 32 30 (X)R 32 30 (X)

R 式(X)中,R3〇為氫原子、低級烷基、可經由式(Xa) Ρ31~θ^ (Xa) 所表不者(式(Xa)中為氫原子、氰芳基、胺基、低級 烷氧基、硝基、氰基、芳基、鹵芳基、芳基磺醯基低級 烷基、芳基磺醯基胺基、芳基低級烷氧基、芳基低級烧 基、雜環基、或芳氧基。)取代之芳基低級烷基、可使用 一個或一個鹵素原子取代之芳基低級烧氧基、芳基確酿 基、雜環低級烷基、芳基羰基胺基、芳基羰基、芳基烯 撐基、或低級伸烷基二氧芳基;該芳基低級烷基之烷基 部分可再使用低級烷基取代之。 R32為氫原子、低級烧基、i低級烷基、低級環烷基、 芳基、芳基低級烷基、低級烷基胺基、低級烷氧基、低 級烧硫基、低級烧氧基低級烧基或雜環低級院基。 為羧基、低級烷氧基羰基、(2-氰基芳基)氧基魏 基、或以式(Xb) (讀先閱讀背面之注意事項再填寫本頁) 、\呑R In the formula (X), R30 is a hydrogen atom, a lower alkyl group, and can be represented by the formula (Xa) P31 ~ θ ^ (Xa) (in the formula (Xa), a hydrogen atom, a cyanoaryl group, and an amine group , Lower alkoxy, nitro, cyano, aryl, haloaryl, arylsulfonyl lower alkyl, arylsulfonylamino, aryl lower alkoxy, aryl lower alkyl, hetero Cyclic group, or aryloxy group.) Substituted aryl lower alkyl group, aryl lower alkyl group which may be substituted with one or one halogen atom, aryl group, heterocyclic lower alkyl group, arylcarbonylamino group , Arylcarbonyl, arylalkenyl, or lower alkylene dioxyaryl; the alkyl portion of the aryl lower alkyl may be replaced with a lower alkyl. R32 is a hydrogen atom, a lower alkyl group, a i-lower alkyl group, a lower cycloalkyl group, an aryl group, an aryl lower alkyl group, a lower alkylamino group, a lower alkoxy group, a lower sulfur group, a lower alkyl group, or a lower alkyl group. Or lower heterocyclic radical. Carboxyl, lower alkoxycarbonyl, (2-cyanoaryl) oxyweiyl, or formula (Xb) (read the precautions on the back before filling in this page), \ 呑

R 34 Υ一 (Xb) (式(Xb)中γ為羰基或低級伸烷基,Rw為可使用經取 尺度適則家標$ ( CNS ) A4規格(21GX 297公楚 548272 A7 五、發明説明(丨〇 ) —'—~ ' —— 代的芳基、或雜環基取代之低級燒基、芳基、或 所代表之取代基。 ’衣土。 --.-------— (讀先閱讀背面之注意事項再填寫本頁) A為單純之結合或低級伸烷基或低級烯撐基。 R4’為可使用鹵素取代之烴基。I,亦包含烷基、* 烧基、快基及此等之經齒素取代者。 方 R4’可為飽和或不飽和者,鏈狀或非鏈狀皆可,視狀 況之不同亦可為分枝者。當其為㈣素取代者時,齒素 之種類及數目沒有任何的限制。n代表0〜3之整數。因 此,可結合!個、2個或3個之R4,,又不結合仏,亦可。 又,其結合位置係,對於其他取代基而言為鄰位、間位、 對位皆可。但是,f R3。4氫時n=〇,亦即並未結合I,。 R^A<XfR35 (X〇 ^37 式(XI)中’ R35為氫原子、芳基、低級院氧基低級烧 基、低級烷基或芳基低級烷基。 好沪部中次«.^-XJh.T消费合竹私印欠 R36為羧基、低級烷氧基羰基、雜環低級烷基胺基、 或雜環低級烷基氨基甲醯基。 R37及R38分別為獨立之氫原子、鹵素原子、低級烷 基、鹵低級烷基、芳基、芳基低級烷基、或芳基低級烷 氧基。 A代表單純的結合或低級伸烷基或低級烯撐基;當 R35為低級烷基時,A代表低級伸烷基或低級烯撐基。 本紙張尺度適《中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7R 34 Υ 一 (Xb) (In formula (Xb), γ is a carbonyl group or a lower alkylene group, and Rw is a standard that can be used with appropriate standards. $ (CNS) A4 specification (21GX 297 Gong Chu 548272 A7) V. Description of the invention (丨 〇) —'— ~ '—— Substituted aryl or heterocyclic group substituted lower alkyl, aryl, or represented substituent.' Clay. --------- — (Read the precautions on the back before filling this page) A is a simple bond or a lower alkylene or a lower alkenyl group. R4 'is a hydrocarbon group that can be substituted with halogen. I, also includes alkyl and * alkyl groups , Fast-based, and the like substituted by halides. The square R4 'may be saturated or unsaturated, and may be chained or unchained. Depending on the situation, it may be branched. When it is substituted by halogen In this case, there are no restrictions on the type and number of teeth. N represents an integer from 0 to 3. Therefore, it can be combined! One, two, or three R4 can be combined without 仏, and it can be combined. The position system is ortho, meta, and para positions for other substituents. However, f R3. N = 0 at 4 hydrogen, that is, I is not bound. R ^ A < XfR35 (X〇 ^ Equation 37 (XI ) 'R35 is a hydrogen atom, an aryl group, a lower alkyloxy lower alkynyl group, a lower alkyl group, or an aryl lower alkyl group. Haohu Zhongzhong «. ^-XJh.T Consumption Hezhu Private Seal R36 is a carboxyl group , Lower alkoxycarbonyl, heterocyclic lower alkylamino, or heterocyclic lower alkylcarbamoyl. R37 and R38 are independent hydrogen, halogen, lower alkyl, halogen lower alkyl, and aryl, respectively. , Aryl lower alkyl, or aryl lower alkoxy. A represents simple bonding or lower alkylene or lower alkenyl; when R35 is lower alkyl, A represents lower alkylene or lower alkenyl The size of this paper is suitable for "China National Standard (CNS) A4 Specification (210X297mm) 548272 A7 B7

五、發明説明(1 1 R '4 0,5. Description of the invention (1 1 R '4 0,

Γ^νΛI V-R (XII) 39Γ ^ νΛI V-R (XII) 39

R 3 8 R- 式(XII)中’ R”及R38分別為獨立之氫原子、鹵素原 子、低級烷基、i低級烷基 '芳基、芳基低級烷基、或 芳基低級烷氧基。 R39為低級烷基。 尺4〇為氫原子、低級烧氧基幾基、低級烧醯基、低級 鍵烧績酿基、或氨基曱醯基。R 3 8 R- In formula (XII), 'R' and R38 are independent hydrogen atom, halogen atom, lower alkyl group, i-lower alkyl 'aryl group, aryl lower alkyl group, or aryl lower alkoxy group R39 is a lower alkyl group. Rule 40 is a hydrogen atom, a lower alkyloxy group, a lower alkyl group, a lower bond alkyl group, or an amino group.

3Θ (XIII) 式(XIII)中’ R37及R38分別為獨立之氫原子、齒素 原子、低級烷基、_低級烷基、芳基、芳基低級烷基、 或芳基低級烷氧基。 R7為低級烷基或低級環烷基 R, ' ? 93Θ (XIII) In the formula (XIII), R37 and R38 are each independently a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkyl group, an aryl group, an aryl lower alkyl group, or an aryl lower alkoxy group. R7 is lower alkyl or lower cycloalkyl R, '? 9

(讀先閱讀背面之注意事項再填寫本頁) 、\二口 548272 A7 五、發明説明(12 ) 式(XIV)中,R„及R38分別為獨立之氫原子、鹵素 原子、低級烷基、鹵低級烷基、芳基、芳基低級烷基、 或芳基低級烧氧基。 R7為低級烷基或低級環烷基。 Rq為2-喊啶基氨基甲醯基、羧基-丨―吡咯烷基羰 基、N-甲基-N-(2-比啶基曱基)氨基甲醯基、b哌啶基羰 基、[2-N-氧)-吨σ定基甲基]氨基甲酿基、‘(二甲基胺基) 苄基氨基曱醯基、胡椒基氨基甲醯基、Ν-曱基-Ν·(孓吡啶 基)氨基甲醯基、硫代嗎琳代羰基、鹵石黃醯基、胺基磺醯 基、醯基胺基磺醯基、低級烷氧基羰基、或羧基。 R29為氫原子或低級烷基;當R41為低級烷基羰基或 羧基時,R29為低級烷基。 又’本發明係提供出以上述式(VIII)〜(XIV)所代表之 新穎的笨並咪唑衍生物及其鹽類。 依據本發明所提供出之笨並咪唑衍生物可基於以下 所示之反應式(a)〜⑴以製造出。 (誚先閱讀背面之注意事項再填寫本頁 、11 線 本紙張尺度適/A中國國家標车(CNS ) A4規格(21〇χ 297公釐) A7 548272 B7 五、發明説明(丨3 ) 3a wX ^^NHCOR.a ⑴ D r^VN〇2 R3a~i T -1 ^^NCOR2a Λ , Hta (2) D ^VNH2 W_. (3) ^ . -—R3a^^ ,N 、)~ 'N (4) R〗a SO:'。2 — ^^NHCOR2b (5) D r^VN〇2 3t7~£]C ~~" ^^nh2 (6) 々N〇2 -(7) ⑻ '—/ b y---- --.------- ¾先閱讀背面之注意事項再填寫本頁.(Read the precautions on the back before filling this page), \ 二 口 548272 A7 V. Description of the invention (12) In formula (XIV), R 'and R38 are independent hydrogen atom, halogen atom, lower alkyl, Halo-lower alkyl, aryl, aryl-lower alkyl, or aryl-lower alkyl. R7 is lower-alkyl or lower-cycloalkyl. Rq is 2-methylpyridylcarbamoyl, carboxyl --- pyrrole Alkylcarbonyl, N-methyl-N- (2-pyridinylfluorenyl) carbamoyl, bpiperidinylcarbonyl, [2-N-oxy) -t-stilbylmethyl] carbamoyl, '(Dimethylamino) benzylaminofluorenyl, piperonylcarbamoyl, N-fluorenyl-N · (fluorenylpyridinyl) carbamoyl, thiomorphinylcarbonyl, halostone fluorenyl, Aminosulfonyl, sulfenylaminosulfonyl, lower alkoxycarbonyl, or carboxyl. R29 is a hydrogen atom or lower alkyl; when R41 is a lower alkylcarbonyl or carboxyl, R29 is a lower alkyl. 'The present invention provides novel benzimidazole derivatives and salts thereof represented by the above formulae (VIII) to (XIV). The benzimidazole derivatives provided according to the present invention may be It is manufactured by the following reaction formulas (a) to ⑴. (诮 Read the precautions on the back before filling in this page. The size of the 11-line paper is suitable / A China National Standard Car (CNS) A4 Specification (21〇χ (297 mm) A7 548272 B7 V. Description of the invention (丨 3) 3a wX ^^ NHCOR.a ⑴ D r ^ VN〇2 R3a ~ i T -1 ^^ NCOR2a Λ, Hta (2) D ^ VNH2 W_. ( 3) ^. -—R3a ^^, N) ~ 'N (4) R〗 a SO:'. 2 — ^ NHCOR2b (5) D r ^ VN〇2 3t7 ~ £] C ~~ " ^ ^ nh2 (6) 々N〇2-(7) ⑻ '-/ b y ---- --.------- ¾ Read the precautions on the back before filling in this page.

Rid NH ^3dRid NH ^ 3d

NO. NH,NO. NH,

、1T 線 NHCOR^ ^3d NHCOR^ ^3d, 1T line NHCOR ^ ^ 3d NHCOR ^ ^ 3d

NHCOR^ (14) (15) (16) (d) R3 (17) Rld 本紙张尺度適/彳]中國國家標率(CNS ) A4規格(210X 297公釐) 548272 A7 五、發明説明(14 r-〇c no2 nh2 ο: νη7 ΝΗ, r3 (18) (19)NHCOR ^ (14) (15) (16) (d) R3 (17) Rld The size of this paper is suitable / 彳] Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 V. Description of the invention (14 r -〇c no2 nh2 ο: νη7 ΝΗ, r3 (18) (19)

Ν ο:^ (20) Η (e) (21)〜 R-〇C (22) NO· 2 NHCOR2f f~ nh2 NHC〇R2f R3f (23)R3f"〇C^f (25) 'Ru 反應式中Rla〜Rif係擇自 Η (24) ⑴Ν ο: ^ (20) Η (e) (21) ~ R-〇C (22) NO · 2 NHCOR2f f ~ nh2 NHC〇R2f R3f (23) R3f " 〇C ^ f (25) 'Ru Rla ~ Rif is selected from Η (24) ⑴

R22 N R23 ' R 23 27、汉3〇、或式 前述《RmR,R22 N R23 'R 23 27, Han 30, or the formula "RmR,

R 38 (讀先閱讀背面之注意事項再填寫本頁)R 38 (Read the precautions on the back before filling in this page)

、1T R. 好淤部中^棺^-^’,Μ ν;消於合^ (式中R37及R38代表相同於前述者)所 一代表擇自前述之R2、R7、Ri4、r:、= R35、或R39中者。取代基Rh〜R3f為擇自式 32, 1T R. ^ ^ ^-^ ', Μ ν in the good sedimentary part; disappear in the combination ^ (where R37 and R38 represent the same as above), one of the representatives selected from the aforementioned R2, R7, Ri4, r :, = R35 or R39. The substituents Rh ~ R3f are optional from formula 32

R 2 5R 2 5

R I 2 6 (式中,Rw、R26、γ及A代表相同於前述者)所代表 的 線 本紙张尺度適W中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五 、發明説明(15 ) ~ 取代基、前述 R3、R8、Rll、Ri5、Ri9、r24、錢33、AR%、 NHR40、CN、或Rq中者。又,R3a〜R3f可與既定之取代 基互相變換之。例如,反應式(幻或⑺)所示之酯類化合物 (26)可、艾換成酸化合物(27)或鹵素化酸化合物(28),而夢 由胺類或磺胺類之作用亦可製造出目的物之苯並咪唑。 亦可進行反應式⑴或⑴或(k)或⑴或(m)或(η)所示般之衍 生物化。此等R3a〜R3f之變換可依據反應式(a)〜⑴中之任 -製程進行之,而依㈣中Rla〜Rif及4〜^之安定性 或何者較易單離出生成物等以決定選用何種製程。RI 2 6 (where Rw, R26, γ, and A represent the same as the aforementioned). The paper size of the thread paper is suitable for the Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 5. Description of the invention (15) ~ Substituent, the aforementioned R3, R8, Rll, Ri5, Ri9, r24, Qian 33, AR%, NHR40, CN, or Rq. In addition, R3a to R3f can be interchanged with a predetermined substituent. For example, the ester compound (26) shown in the reaction formula (phantom or hydrazone) can be replaced with an acid compound (27) or a halogenated acid compound (28), and the dream can also be produced by the action of amines or sulfonamides. The object of interest is benzimidazole. Derivatives such as those shown in the reaction formulas ⑴ or ⑴ or (k) or ⑴ or (m) or (η) may also be performed. These transformations of R3a ~ R3f can be performed according to any of the reaction formulas (a) ~ ⑴, and depending on the stability of Rla ~ Rif and 4 ~ ^ in the formula, or which is easier to separate the product, etc., to determine What process is used.

Rg〇2〇-- I <2a-f <x ----------ΜΦΙ (誚先閱讀背面之注意事項再填寫本頁)Rg〇2〇-- I < 2a-f < x ---------- ΜΦΙ (诮 Please read the notes on the back before filling this page)

Ria~f (9) (26) (27) (反應式中1代表低級烷基,Ru〜〖及Rhf代表相 所述者) 、則 H〇2C- (27) \ Ria -1 义2a~fRia ~ f (9) (26) (27) (In the reaction formula, 1 represents a lower alkyl group, and Ru ~ and Rhf represent the phase described above), then H〇2C- (27) \ Ria -1 -1 2a ~ f

Z 〇C — I (反應式中Z,代表氣原子或溴原子 同於前所述者) (28)Z 〇C — I (Z in the reaction formula, which represents a gas atom or a bromine atom, as described above) (28)

R (h) 、11 線R (h), line 11

R la ^及R^〜f代表相 h2n 〇R la ^ and R ^ ~ f represent phases h2n 〇

(29) (反應式中R la〜f <2a〜f NC-(29) (R la ~ f < 2a ~ f NC-

-N-N

Ri (') 2a〜f (30) 代表相同於前所述者) a〜f 本紙张尺度剌+ _家料(CNS ) A4規格(210X 297公楚 548272 A7 ---------—-----------B7 五、發明説明(16 ) h〇2cRi (') 2a ~ f (30) represents the same as the previous one) a ~ f Paper size 剌 + _Home materials (CNS) A4 specifications (210X 297 Gongchu 548272 A7 --------- —----------- B7 V. Description of the invention (16) h〇2c

^~R2a 〜f (27)^ ~ R2a ~ f (27)

V-R23M Ria 〜f (j)V-R23M Ria ~ f (j)

Ria 〜fRia ~ f

:2a-f Ria〜f: 2a-f Ria ~ f

:2a 〜f Ria 〜f (32) (33) (反應式中Rla〜laf代表相同於前所述者) 反應式(a)中,令式⑴之化合物與氫化鈉、二異丙醯胺化 鋰、碳酸氫鋰、碳酸鋰、氫氧化鋰、碳酸氫鈉、碳酸鈉、 氫氧化鈉、碳酸氫鉀、碳酸鉀、氫氧化鉀等鹼及R^z(z 為氣原子、溴原子、甲苯磺醯基氧基、甲磺醯基氧基)所 代表的化合物反應,以製造出式(2)之化合物。式(2)之化 合物係’藉由1)在酸性條件下使用還原鐵或鋅等以進行 還原、或2)在氫環境氣體下使用鈀、鉑、釕、鎳等過渡 金屬觸媒以進行還原、或3)在蟻酸存在下使用纪、翻、 釕、鎳等過渡金屬觸媒以進行還原、或4)使用亞硫酸氫 鈉以進行還原等方法,以變換成式(3)之化合物。由於依 據方法1)式(3)之化合物在反應中會產生環化而直接得出 式(4)之化^物,故較常使用之。又在1)〜4)之任一條件下 皆會生成部分的式(4)之化合物。式(3)化合物係藉由醋 酸、對甲苯磺酸、鹽酸、硫酸、磷酸等羧酸、磺酸或無 機酸以製造出式(4)之化合物。 反應式(b)中,式(5)之化合物係經由碳酸氫鋰、碳酸 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) (翱先閱讀背面之注意事項再填寫本頁) 、-5口 548272 A7 -______ B7 五、發明説明(17 ) f詞先閱讀背面之注意事JI再填寫本頁j 丁 、=0 鋰、氫氧化鋰、碳酸氫鈉、碳酸鈉、氫氧化鈉、碳酸氫 卸故酸钟、氫氧化_專驗’或醋酸、對甲苯項酸、鹽 酸、硫酸、磷酸等羧酸、磺酸或無機酸之加水分解或加 溶劑分解以製造出式(6)所代表的化合物。令式(6)之化合 物與氫化鈉、二異丙醯胺化鋰、碳酸氫鋰、碳酸鋰、氫 氧化鋰、碳酸氫鈉、碳酸鈉、氫氧化鈉、碳酸氫鉀、碳 酸鉀、氫氧化鉀等鹼及RlbZ(Z為氯原子、溴原子、甲苯 磺醯基氧基、曱磺醯基氧基)所代表的化合物反應,以製 造出式(7)之化合物。式(7)之化合物係,藉由丨)在酸性條 件下使用還原鐵或鋅等以進.行還原、或2)在氫環境氣體 下使用鈀、鉑、釕、鎳等過渡金屬觸媒以進行還原、或 3)在犧酸存在下使用纪、鉑、釕、鎳等過渡金屬觸媒以 進行還原、或4)使用亞硫酸氫鈉以進行還原等方法,以 k換成式(8)之化合物。使用與式(8)的化合物相對應之羧 酸或酸氯化物或酸溴化物或酸酐以製造出式(9)之化合 物。 反應式(c)中,使用式(10)的化合物與r1cnh2所代表 之化合物以製造出式(11)之化合物。由式(11)之化合物變 換成式(13)之化合物係相同於反應式(…中之由式(乃之化 合物變換成式(9)之化合物者。 反應式(d)中,式(14)之化合物係,藉由丨)在酸性條 件下使用還原鐵或鋅等以進行還原、或2)在氮環境氣體 下使用鈀、鉑、釕、鎳等過渡金屬觸媒以進行還原等方 法’以製造出式(15)的化合物。令式(15)的化合物 548272 A7 3e Β7 五、發明説明(18 ) 氫鐘、碳酸Μ、氫氧化鋰、碳酸氫鈉、碳酸鈉、氫氧化 鈉、碳酸氫鉀、碳酸鉀、氫氧化鉀等鹼及RidZ(z為氯原 子、溴原子、曱苯磺醯基氧基、曱磺醯基氧基)所代表的 化合物反應,以製造出式(16)之化合物。式〇6)化合物係 藉由醋酸、對甲苯磺酸、鹽酸、硫酸、磷酸等緩酸、石备 酸或無機酸以製造出式(17)之化合物。 反應式(e)中,式(18)之化合物係,藉由丨)在酸性條 件下使用還原鐵或鋅等以進行還原、或2)在氫環境氣體 下使用鈀、鉑、釕、鎳等過渡金屬觸媒以進行還原、或 3)在蟻酸存在下使用鈀、鉑、釕、鎳等過渡金屬觸媒以 進行還原、或4)使用亞硫酸氫納以進行還原等方法,以 變換成式(19)之化合物。使用與式(19)的化合物相對應之 魏或酸氣化物或酸漠化物或酸酐以製造出式之化 合物。令式(20)的化合物與氫氧化鈉、二異丙醯胺化鋰、 碳酸氫鋰、碳酸鋰、氫氧化鋰、碳酸氫鈉、碳酸鈉、氫 氧化鈉、碳酸氫鉀、碳酸鉀、氫氧化鉀等鹼及U(z為 氣原子、溴原子、甲苯磺醯基氧基、甲磺醯基氧基)所代 表的化合物反應,以製造出式(21)之化合物。 基於此等方法,所得出之式(21)的化合物一般為R 的取代位置5位及6位之混合物,或4位及7位之混合 物,藉由再結晶、柱色譜分離、薄層色譜分離、高速液 體色譜分離等方法可將其精製之。 反應式(f)中,式(22)之化合物係,藉由”在酸性條 件下使用還原鐵或鋅等以進行還原、或2)在氫環境氣體 (¾先閱讀背面之注意事項再填寫本頁): 2a to f Ria to f (32) (33) (In the reaction formula, Rla to laf are the same as those described above.) In reaction formula (a), the compound of the formula (I) is aminated with sodium hydride and diisopropylhydrazone. Lithium, lithium bicarbonate, lithium carbonate, lithium hydroxide, sodium bicarbonate, sodium carbonate, sodium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide and other bases and R ^ z (z is a gas atom, bromine atom, toluene A compound represented by sulfonyloxy, methanesulfonyloxy) is reacted to produce a compound of formula (2). The compound of formula (2) is' reduced by 1) using reduced iron or zinc under acidic conditions, or 2) using a transition metal catalyst such as palladium, platinum, ruthenium, or nickel under a hydrogen atmosphere to perform reduction Or, 3) using a transition metal catalyst such as Krypton, Nitrogen, Ruthenium, Nickel in the presence of formic acid for reduction, or 4) using sodium bisulfite for reduction, etc., to transform into a compound of formula (3). Since the compound of formula (3) according to method 1) can be cyclized in the reaction and the compound of formula (4) is directly obtained, it is more commonly used. Under any of the conditions 1) to 4), a part of the compound of the formula (4) is formed. The compound of formula (3) is a compound of formula (4) produced by carboxylic acid, sulfonic acid or inorganic acid such as acetic acid, p-toluenesulfonic acid, hydrochloric acid, sulfuric acid, phosphoric acid and the like. In the reaction formula (b), the compound of the formula (5) passes the lithium bicarbonate and carbonic acid paper standard of China State Standard (CNS) A4 (210X297 mm) (翱 Please read the precautions on the back before filling this page ), -5 mouth 548272 A7 -______ B7 V. Description of the invention (17) Read the note f on the back JI before filling in this page j Ding, = 0 lithium, lithium hydroxide, sodium bicarbonate, sodium carbonate, hydroxide Sodium, bicarbonate, acid clock, hydroxide_special test 'or acetic acid, p-toluene acid, hydrochloric acid, sulfuric acid, phosphoric acid and other carboxylic acids, sulfonic acids or inorganic acids are hydrolyzed or hydrolyzed to produce the formula (6 ). Let the compound of formula (6) and sodium hydride, lithium diisopropylamidide, lithium bicarbonate, lithium carbonate, lithium hydroxide, sodium bicarbonate, sodium carbonate, sodium hydroxide, potassium bicarbonate, potassium carbonate, hydroxide A base such as potassium is reacted with a compound represented by RlbZ (Z is a chlorine atom, a bromine atom, a tosylsulfonyloxy group, a sulfonylsulfenyloxy group) to produce a compound of formula (7). The compound of formula (7) is reduced by using iron or zinc under acidic conditions, or 2) using a transition metal catalyst such as palladium, platinum, ruthenium, or nickel under a hydrogen atmosphere to Perform reduction, or 3) use transition metal catalysts such as Krypton, platinum, ruthenium, nickel in the presence of sacrificial acid for reduction, or 4) use sodium bisulfite for reduction, etc., and replace k with formula (8) Of compounds. A carboxylic acid or an acid chloride or an acid bromide or an acid anhydride corresponding to the compound of the formula (8) is used to produce a compound of the formula (9). In the reaction formula (c), a compound represented by the formula (10) and a compound represented by r1cnh2 are used to produce a compound represented by the formula (11). The conversion from the compound of the formula (11) to the compound of the formula (13) is the same as that in the reaction formula (..., the conversion of the compound from the formula (that is, the conversion of the compound into the compound of the formula (9). In the reaction formula (d), the formula (14) ) Compounds are reduced by 丨) using reduced iron or zinc under acidic conditions, or 2) using a transition metal catalyst such as palladium, platinum, ruthenium, or nickel under a nitrogen atmosphere to reduce To produce a compound of formula (15). Let the compound of formula (15) 548272 A7 3e B7 V. Description of the invention (18) hydrogen clock, carbonic acid M, lithium hydroxide, sodium bicarbonate, sodium carbonate, sodium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide, etc. A base and a compound represented by RidZ (z is a chlorine atom, a bromine atom, an xylbenzenesulfonyloxy group, an xylsulfonyloxy group) are reacted to produce a compound of formula (16). Compound of formula (6): A compound of formula (17) is produced by using a slow acid, a carboxylic acid or an inorganic acid such as acetic acid, p-toluenesulfonic acid, hydrochloric acid, sulfuric acid, or phosphoric acid. In the reaction formula (e), the compound of the formula (18) is reduced by using reduced iron or zinc under acidic conditions, or 2) using palladium, platinum, ruthenium, nickel, etc. under a hydrogen atmosphere. Transition metal catalyst for reduction, or 3) the use of palladium, platinum, ruthenium, nickel and other transition metal catalysts for reduction in the presence of formic acid, or 4) the use of sodium bisulfite for reduction and other methods to transform into the formula (19) The compound. The compound corresponding to the compound of formula (19) is used to produce a compound of formula or acid gas or acid desert or acid anhydride. Let the compound of formula (20) and sodium hydroxide, lithium diisopropylamidide, lithium bicarbonate, lithium carbonate, lithium hydroxide, sodium bicarbonate, sodium carbonate, sodium hydroxide, potassium bicarbonate, potassium carbonate, hydrogen A base such as potassium oxide and a compound represented by U (z is a gas atom, a bromine atom, a tosylsulfonyloxy group, a methanesulfonyloxy group) are reacted to produce a compound of the formula (21). Based on these methods, the compound of formula (21) obtained is generally a mixture of positions 5 and 6 at the substitution position of R, or a mixture of positions 4 and 7 and is separated by recrystallization, column chromatography, and thin layer chromatography. , High-speed liquid chromatography separation and other methods can be refined. In the reaction formula (f), the compound of the formula (22) is “reduced by using reduced iron or zinc under acidic conditions, or 2) under a hydrogen atmosphere (¾ read the precautions on the back before filling in this page)

、1T 公 A7 548272 五、發明説明(丨9 ) 下使用鈀、鉑、釕、鎳等過渡金屬觸媒以進行還原、或 3)在犧酸存在下使用把、翻、釕、鎳等過渡金屬觸媒以 進行還原、或4)使用亞硫酸氫鈉以進行還原等方法,以 變換成式(23)之化合物。由於依據方法丨丨式口”之化合物 在反應中會產生環化而直接得出式(24)之化合物,故較常 使用之。又在1)〜4)之任一條件下皆會生成部分的式(24) 之化合物。式(23)化合物係藉由醋酸、對甲笨磺酸、鹽酸、 硫酸、磷酸等羧酸、磺酸或無機酸以製造出式(24)之化合 物。式(24)之化合物係依據反應式(e)中由式(2〇)變換至式 (21)之方法而變換成式(25)之苯並咪唑化合物。基於此方 法’所彳于出之式(25)的化合物一般為RSf的取代位置5位 及6位之混合物,或4位及7位之混合物,藉由再結晶、 柱色譜分離、薄層色譜分離、高速液體色譜分離等方法 可將其精製之。 反應式(g)中,式(26)之化合物可藉由氫氧化鋰、氫 氧化鈉、氫氧化鉀等鹼之加水分解而製造出式(27)的化合 物。令式(27)的化合物與羰基二咪唑反應之後,在驗存在 下再與胺類或績醯胺類反應,以製造出苯並咪σ坐衍生 物。 反應式(h)中,式(27)的化合物係藉由氣化亞硫醯、 亞硫醯溴、三氯化填、五氣化鱗或經基氯化碟等以變換 成式(28)所代表的酸齒化物。令式(28)之化合物與胺類或 磺醯胺類反應,以製造出苯並咪唑衍生物。 反應式⑴中,令式(29)的化合物與四氣化鈦反應以製 -----____ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁j P. 、-=t> 548272 A7 B7 五、發明説明(20 ) 造出式(30)所代表的化合物。 反應式⑴中,在以第3 丁醇作為代表之醇類存在 下,令式(27)的化合物與以二笨基磷醯迭氮作為代表之迭 氮類反應,以製造出式(31)之化合物。使用酸以分解式(31) 的化合物以得出式(32)的化合物。令式(32)的化合物與 R4〇Z(Z代表氣原子或溴原子)所代表的化合物反應以製 造出式(33)的化合物。 &1T male A7 548272 V. Explanation of the invention (丨 9) Use of transition metal catalysts such as palladium, platinum, ruthenium, nickel for reduction, or 3) Use of transition metals such as barium, ruthenium, ruthenium, nickel in the presence of sacrificial acid A catalyst is used for reduction, or 4) sodium bisulfite is used for reduction to convert the compound into a compound of formula (23). Because the compound according to the method 丨 formula "will be cyclized in the reaction and the compound of formula (24) is directly obtained, it is more commonly used. It will be partially generated under any of the conditions 1) ~ 4). A compound of formula (24). A compound of formula (23) is a compound of formula (24) produced by carboxylic acid, sulfonic acid, or inorganic acid such as acetic acid, p-toluenesulfonic acid, hydrochloric acid, sulfuric acid, phosphoric acid, or the like. The compound of 24) is converted into the benzimidazole compound of formula (25) according to the method of converting formula (20) to formula (21) in reaction formula (e). Based on this method, the formula (from The compound of 25) is generally a mixture of the 5th and 6th positions of the RSf substitution position, or a mixture of the 4th and 7th positions. It can be separated by recrystallization, column chromatography, thin layer chromatography, high-speed liquid chromatography and other methods. Purified. In the reaction formula (g), the compound of the formula (26) can be hydrolyzed by the base of lithium hydroxide, sodium hydroxide, potassium hydroxide and the like to produce a compound of the formula (27). Let the formula (27) After reacting with carbonyldiimidazole, it can react with amines or amines in the presence of In order to produce a benzimid sigma derivative. In the reaction formula (h), the compound of the formula (27) is obtained by vaporizing thionine, thionine bromide, trichloride, pentagasine scale or The basic chloride is converted into an acid dentate represented by the formula (28). The compound of the formula (28) is reacted with amines or sulfonamides to produce a benzimidazole derivative. In the reaction formula, The compound of formula (29) is reacted with titanium tetraoxide to make -----____ This paper size is in accordance with China National Standard (CNS) A4 specification (210X297 mm) (Read the precautions on the back before filling in this paper Page j P.,-= t > 548272 A7 B7 V. Description of the invention (20) The compound represented by formula (30) is produced. In the reaction formula ⑴, in the presence of an alcohol represented by a third butanol, let A compound of formula (27) is reacted with azides represented by dibenzylphosphonium azide to produce a compound of formula (31). An acid is used to decompose the compound of formula (31) to give formula (32) A compound of formula (32) is reacted with a compound represented by R40Z (Z represents a gas atom or a bromine atom) to produce formula (33) Compound &

Rg〇2C~Rg〇2C ~

(26) <2a 〜f(26) < 2a to f

泊〜f (邡先閲讀背面之注意事項再填寫本頁) zH2COcn> <2a 〜f (35)Park ~ f (邡 Please read the notes on the back before filling in this page) zH2COcn > < 2a ~ f (35)

Ria 〜f (反應式中Rg Ru〜f、R2a〜f代表相同於前所述者,Z代表 氯原子、溴原子、曱苯磺醯基氧基或甲磺醯基氧基)" Γ^ν^Ν zh2c (35) H〇2C-Ria ~ f (Rg Ru ~ f, R2a ~ f in the reaction formula are the same as those mentioned above, and Z represents a chlorine atom, a bromine atom, a benzenesulfonyloxy group or a methanesulfonyloxy group) " Γ ^ ν ^ Ν zh2c (35) H〇2C-

RR

-N <2a - f 、可 nch2c4 i 》 (36) 線 (I) (37)-N < 2a-f, but nch2c4 i》 (36) line (I) (37)

Ria-f (反應式中Ru〜f、f、z代表相同於前所述者) 24 本紙張尺度過/fl巾_家榡準(CNS )八4規加/撕公髮) 548272 A7 B7 五、發明説明6i h〇h2cRia-f (Ru ~ f, f, z in the reaction formula are the same as those mentioned above) 24 paper size over / fl towel _ Jia 榡 quan (CNS) 8 4 gauge plus / tear public hair) 548272 A7 B7 5 And invention description 6i h〇h2c

RgCK^^ 〇RgCK ^^ 〇

Cl3 <2a-fCl3 < 2a-f

Ria~fRia ~ f

Ria〜f (38)Ria ~ f (38)

2d -f Ria- f (40) (m) (39) (反應式中R 1 a〜f ^^2 a〜f Rg代表相同於前所述者)2d -f Ria- f (40) (m) (39) (In the reaction formula, R 1 a ~ f ^^ 2 a ~ f Rg represents the same as the above)

N ^-R N Ria~f 2a -f (π) 豸先閱讀背面之注意事項再填寫本頁 訂 (反應式中R la〜f Λ R2a〜f Λ Rg代表相同於前所述者) 線 反應式(k)中,式(26)的化合物經還原後會變換成式 (34)的化合物。接著,藉由亞硫醯基氯、亞硫醯基溴、羥 基氯化磷、羥基溴化磷、三氯化磷、五氯化磷、曱磺醯 基氣、或甲苯磺醯等以變換成式(35)所代表的化合物。 反應式(λ)中,令式(35)的化合物與氰化鈉或氰化舒 反應以製造出式(36)的化合物。式(3 6)的化合物會經由氫 氧化經、氫氧化納、或氫氧化鉀的加水分解以製造出式 (37)的羧酸。 反應式(m)中,令氧化式(34)所得出之式(38)的化合 物與烷基(三笨基磷醯替笨胺)反應以得出式(39)的化合 物。式(39)之化合物可藉由氫氧化鋰、氫氧化鈉、或氫氧 化鉀加水分解而製造出式(40)之羧酸。令式(35)、(37)或 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 548272 A7 B7 五、發明说明) (40)的化合物與胺類输胺類反應,以製造出苯紗坐 化合物。 反應式⑻中,式(39)的化合物會在氫環境氣氛下或 蟻酸的存在下經由把、翻、舒等過渡金屬觸媒之還原而 製造出式(41)的化合物。 又,式(1,) (n (式中Ru〜f、Rh〜f、R3a〜f代表相同於前所述者;代表 擇自岫述R4、FU、R29中者)所代表的化合物係,藉由使 用各個作為反應式(a)〜(f)中的起始原料之N ^ -RN Ria ~ f 2a -f (π) 阅读 Read the precautions on the back before filling in this page. In (k), the compound of formula (26) is converted into a compound of formula (34) after reduction. Next, it is converted into thionyl chloride, thionyl bromide, phosphorus hydroxychloride, phosphorus hydroxybromide, phosphorus trichloride, phosphorus pentachloride, sulfonylsulfonyl gas, or tosylsulfonium, etc. A compound represented by formula (35). In the reaction formula (λ), a compound of the formula (35) is reacted with sodium cyanide or cyanamide to produce a compound of the formula (36). The compound of the formula (36) is hydrolyzed by hydrogenation, sodium hydroxide, or potassium hydroxide to produce a carboxylic acid of the formula (37). In the reaction formula (m), the compound of the formula (38) obtained by oxidizing the formula (34) is reacted with an alkyl group (tribenzylphosphonium benzidine) to obtain a compound of the formula (39). The compound of formula (39) can be hydrolyzed by lithium hydroxide, sodium hydroxide, or potassium hydroxide to produce a carboxylic acid of formula (40). Order the compound of formula (35), (37) or this paper to fit the Chinese National Standard (CNS) A4 size (210X 297 mm) 548272 A7 B7 5. Description of the invention) (40) The compound reacts with amines and amines To make benzene yarn sitting compounds. In the reaction formula (I), the compound of the formula (39) is produced by reducing a transition metal catalyst such as, tumbling, or Shu in a hydrogen atmosphere or in the presence of formic acid to produce a compound of the formula (41). In addition, the compound represented by formula (1,) (n (where Ru ~ f, Rh ~ f, R3a ~ f represents the same as above; represents one selected from the description of R4, FU, and R29), By using each as a starting material in the reaction formulae (a) to (f),

R3a~^X n〇2 NHCOR13 (2,) (式中Rla、Rn、代表相同於前所述者;代表擇 前述R4、R4’、R29中者) 4b trR3a ~ ^ X n〇2 NHCOR13 (2,) (where Rla, Rn, are the same as those mentioned above; on behalf of the one selected from the aforementioned R4, R4 ’, R29) 4b tr

NO 2NO 2

R (3,) NHCOR2b (式中Rlb、Ra、尺仏代表相同於前所述者;R4b代表擇 前述R4、R4’、R29中者) R3R (3,) NHCOR2b (where Rlb, Ra, and ruler are the same as those mentioned above; R4b represents the one selected from the aforementioned R4, R4 ’, and R29) R3

NO F 2 (4,) JJl. 本紙張尺度適/1]中國國家標隼(CNS ) A4規格(210x297公釐) 548272 五、發明说明匕3 所述者;代表擇自 (式中Rlc、R2c、R3c代表相同於 前述R4、RV、R29中者)NO F 2 (4,) JJl. The size of this paper is / 1] Chinese national standard (CNS) A4 size (210x297 mm) 548272 V. Description of the invention Dagger 3; representative selected from (where Rlc, R2c And R3c are the same as those of R4, RV, and R29)

Md ^3dMd ^ 3d

NO, (5,) NHCOR. (式中Rid、R2d、R3d代表相 前述R4、R4’、R29中者) 同於 前所述者;代表擇NO, (5,) NHCOR. (Where Rid, R2d, R3d represents the phase of the aforementioned R4, R4 ', R29) is the same as the above;

N〇2 (6Ί nh2 (式中Rle、R2e、R3e代表相同於前所述者 前述R4、R4’、R29中者) 代表擇 (讀先閲讀背面之注意事項再填寫本頁j .¾^N〇2 (6Ί nh2 (where Rle, R2e, and R3e are the same as those mentioned above, and R4, R4 ’, and R29) are representative of choice (read the precautions on the back before filling in this page.

R 4f \^NHC〇R2f cn (^中^^代表相同於前所述者心代表 鈾述R4、R4’、R29中者) 所代表的化合物以製造出。 上述各反應之任一中間體係,視需要可採用通常合 成時所使用之精製法,亦即再結晶、柱色譜分離、薄ς 色瑨分離、高速液體色譜分離等方法精製之。反應的最 終生成物之本發明的化合物係,視需要可採用通常的有 機化合物精製法,亦即再結晶、柱色譜分離、薄層色譜 分離、高速液體色譜分離等方法精製之。又化合物的/則 本紙張尺度4/种®國家縣(CNS ) Λ4規格(21()>< 297公髮) —訂------線W--- A7 548272 五、發明説明(24 ) ^- 定係可藉由NMR光譜分析、質譜分析、IR光譜分析、 元素分析、融點測定等方法進行之。 本說明書之以上及以下所記載之本發明所包含的範 圍内之各種定義係,藉由以下之較佳例以詳細說明之。 低級之用語在沒有特別的限定時代表碳原子數為 1〜6。適於作為低級烷基者可舉曱基、乙基、正丙基、異 丙基、正丁基、異丁基、第2 丁基、第3 丁基、正戊基、 異戍基、第2戊基、第3戊基、曱基丁基、正己基、^ 甲基戊基、2-甲基戊基、3_甲基戊基、‘曱基戍基、丨·乙 基丁基、2-乙基丁基、二甲基丁基、2,孓二曱基丁基、 3,3-二甲基丁基、1-乙基_1β甲基丙基等直鏈狀或分枝狀的 烧基為例,且以碳數1〜3者為較佳。 碳數7為止的烷基可為甲基、乙基、正丙基、異丙 基、正丁基、異丁基、第2 丁基、第3 丁基、正戊基、 異戊基、第2戊基、第3戊基、2-甲基丁基、正己基、^ 甲基戊基、2-曱基戊基、3-曱基戊基、4-甲基戊基、1-乙 基丁基、2-乙基丁基、3 -乙基丁基、1,1_二曱基丁基、2,2_ 二甲基丁基、3,3-二甲基丁基、1-乙基-丨_甲基丙基、正庚 基、1-甲基己基、2-曱基己基、3-甲基己基、4-甲基己基、 5 -甲基己基' 1-乙基戊基、2 -乙基戊基、3 -乙基戊基、4_ 乙基戊基、1,1-二甲基戊基、2,2-二曱基戊基、3,3-二曱 基戊基、4,4-一曱基戊基、1-丙基丁基等直鏈狀或分枝狀 的烧基為例。 碳數8為止的烷基可為甲基、乙基、正丙基、異丙 ________ Μ _ 本紙乐尺度遙州中國國家標準(CNS ) Α4規格(210X297公釐) ----------Μ9! (讀先閱讀背面之注意事項再填寫本頁} 、11 線 A7 548272 五、發明説明(25 ) 基、正丁基、異丁基、第2 丁基、第3 丁基、正戊基、 異戊基、第2戊基、第3戊基、2-甲基丁基、正己基、;^ 曱基戊基、2-甲基戊基、3-曱基戍基、4-曱基戊基、1-乙 基丁基、2-乙基丁基、3-乙基丁基、1,1-二曱基丁基、2,2_ 一曱基丁基、3,3-二甲基丁基、1-乙基-1-甲基丙基、正庚 基、1-甲基己基、2-曱基己基、3-曱基己基、4-曱基己基、 5-甲基己基、1-乙基戊基、2-乙基戊基、3-乙基戍基、4_ 乙基戊基、1,1-二曱基戍基、2,2-二曱基戊基、3,3-二曱 基戊基、4,4-二甲基戊基、1-丙基丁基、正辛基、^曱基 庚基、2-甲基庚基、3-甲基庚基、4-曱基庚基、5-曱基庚 基、6-曱基庚基、1-乙基己基、2_乙基己基、3_乙基己基、 4-乙基己基、5-乙基己基、1,1_二甲基己基、2,2•二甲基 己基、3,3-二甲基己基、4,4-二曱基己基、5,5_二甲基己 基、1-丙基戊基、2-丙基戊基等直鏈狀或分枝狀的烷基 例。 低級烷撐可為甲撐、乙撐、丙撐、丁撐、戊撐及 己撐等碳數6以下之烷撐;而以碳數卜3者為較佳:低 級烯撐可為乙烯撐、卜丙烯撐、2_丙烯撐、卜丁烯撐· 2-丁稀擇、3-丁烯撐μ戊烯撐、2姻擇、3·戊烯‘、 4_戊烯撐、1-己烯撐、2·己烯撐、3_己烯撐、4_己烯卜 ^己稀撐等碳數6以下之稀撐;而以碳數Μ者^較 例.:·=:舉氟原子、氣原子、漠原子、峨原子為 Η,而較佳者為氟原子、氣原子、溴原子。 本纸張尺度㈣中210x3^ (誚先閱讀背面之注意事項再填寫本頁) 訂 548272 A7 -------------— 五、發明説明(26 ) ~^ — ---—~— i低級烷基可為經氟原子、氣原子、漠原子或碰 f子取代之碳數U止的直鏈狀或分枝狀的烧基;較 二者為經亂原子' 氯原子、溴原子取代之碳數8為止 ’更佳者為碳數1〜3之直鏈狀或分枝狀的烷基。可 舉,化甲基、二氟化甲基、三氣化甲基、氣化甲基、 一氯化甲& _氯化甲基、溴化甲基、二溴化甲基、 三溴化甲基、b氟化乙基、I·氣化乙基、1-溴化乙基、 2-氟化乙基、2-氣化乙基、2_溴化乙基、a二氟化乙 基、1,2-二氯化乙基、二溴化乙基、2,2,2_三氣化乙 基、七氟化乙基、1·氣化丙基、卜氯化丙基、卜漠化丙 基、2-乱化丙基、2_氯化丙基、2_漠化丙基、3_氣化丙 基、3-氯化丙基、3-溴化丙基、丨,2_二氟化丙基、丨,^ 一氯化丙基、1,2-二溴化丙基、2,3-二氟化丙基、2,3_ 一氯化丙基、2,3-二溴化丙基、3,3,3_三氟化丙基、 2,2,3,3,3-五氟化丙基、2-氟化丁基、2-氣化丁基、2_ 溴化丁基、4-氟化丁基、4-氯化丁基、4-溴化丁基、4,4,4_ 二氟化丁基、2,2,3,3,4,4,4-七氟化丁基、全氟化丁基、 2-氟化戊基、2-氣化戊基、2-漠化戊基、5-氟化戊基、 5- 氣化戊基、5-溴化戊基、全氟化戊基、2-氟化己基、 2-氣化己基、2-溴化己基、6-氟化己基、6-氣化己基、 6- 溴化己基、全氟彳匕己基、2-氟化庚基、2-氣化庚基、 2->臭化庚基、7-氟化庚基、7-氯化庚基、7_漠化庚基、 全氟化庚基等為例。 低級烧氧基為峡數至6為止之直鍵狀或分枝狀的统 --_ 本纸張尺度適州中國國家標準(CNS ) A4規格(21 OX 29*7公釐) (讀先閱讀背面之注意事項再填寫本頁)The compound represented by R 4f \ ^ NHC〇R2f cn (^ 中 ^^ represents the same as the former represents R4, R4 ', and R29) is manufactured. Any intermediate system of each of the above reactions can be purified by the refining method commonly used in synthesis, that is, recrystallization, column chromatography separation, thin color separation, high-speed liquid chromatography separation, etc. if necessary. The compound system of the present invention, which is the final product of the reaction, can be purified by ordinary organic compound purification methods, that is, recrystallization, column chromatography separation, thin layer chromatography separation, high-speed liquid chromatography separation, etc., if necessary. And the compound / the paper size 4 / species ® national counties (CNS) Λ4 specifications (21 () > < 297 issued) — order ------ line W --- A7 548272 V. Description of the invention (24) The ^-system can be performed by methods such as NMR spectrum analysis, mass spectrum analysis, IR spectrum analysis, elemental analysis, and melting point determination. Various definitions within the scope of the present invention described above and below in this specification are explained in detail by the following preferred examples. The term "lower level" means that the number of carbon atoms is from 1 to 6 when it is not particularly limited. Suitable examples of lower alkyl include fluorenyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl, third butyl, n-pentyl, isofluorenyl, and 2-pentyl, 3rd-pentyl, fluorenylbutyl, n-hexyl, methylpentyl, 2-methylpentyl, 3-methylpentyl, 'fluorenylmethyl, ethylethyl, Linear or branched, such as 2-ethylbutyl, dimethylbutyl, 2, fluorenedifluorenylbutyl, 3,3-dimethylbutyl, 1-ethyl_1βmethylpropyl As an example, it is preferable to use a carbon number of 1 to 3. The alkyl group having 7 carbon atoms may be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl, third butyl, n-pentyl, isopentyl, or 2-pentyl, 3-pentyl, 2-methylbutyl, n-hexyl, ^ methylpentyl, 2-fluorenylpentyl, 3-fluorenylpentyl, 4-methylpentyl, 1-ethyl Butyl, 2-ethylbutyl, 3-ethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl -丨 -methylpropyl, n-heptyl, 1-methylhexyl, 2-fluorenylhexyl, 3-methylhexyl, 4-methylhexyl, 5-methylhexyl '1-ethylpentyl, 2 -Ethylpentyl, 3-ethylpentyl, 4-ethylpentyl, 1,1-dimethylpentyl, 2,2-diamidylpentyl, 3,3-diamidylpentyl, 4 As an example, a linear or branched alkynyl group such as 4,4-fluorenylpentyl and 1-propylbutyl. Alkyl groups up to 8 carbons can be methyl, ethyl, n-propyl, isopropyl ________ Μ _ This paper is a standard of Yaozhou China National Standard (CNS) A4 (210X297 mm) ------- --- M9! (Read the precautions on the back and then fill out this page} 、 11 line A7 548272 V. Description of the invention (25), n-butyl, isobutyl, second butyl, third butyl, N-pentyl, iso-pentyl, second-pentyl, third-pentyl, 2-methylbutyl, n-hexyl, ^ fluorenylpentyl, 2-methylpentyl, 3-fluorenylfluorenyl, 4 -Fluorenylpentyl, 1-ethylbutyl, 2-ethylbutyl, 3-ethylbutyl, 1,1-difluorenylbutyl, 2,2-monofluorenylbutyl, 3,3- Dimethylbutyl, 1-ethyl-1-methylpropyl, n-heptyl, 1-methylhexyl, 2-fluorenylhexyl, 3-fluorenylhexyl, 4-fluorenylhexyl, 5-methyl Hexyl, 1-ethylpentyl, 2-ethylpentyl, 3-ethylfluorenyl, 4-ethylpentyl, 1,1-difluorenylfluorenyl, 2,2-difluorenylpentyl, 3 , 3-Difluorenylpentyl, 4,4-dimethylpentyl, 1-propylbutyl, n-octyl, fluorenylheptyl, 2-methylheptyl, 3-methylheptyl, 4-fluorenylheptyl, 5-fluorenylheptyl, 6- Fluorenylheptyl, 1-ethylhexyl, 2-ethylhexyl, 3-ethylhexyl, 4-ethylhexyl, 5-ethylhexyl, 1,1-dimethylhexyl, 2,2 • dimethyl Hexyl, 3,3-dimethylhexyl, 4,4-diamidylhexyl, 5,5-dimethylhexyl, 1-propylpentyl, 2-propylpentyl, etc. Examples of lower alkyl groups are lower alkylenes such as methyl, ethylene, propylene, butylene, pentyl, and hexamethylene, and alkylenes having a carbon number of 6 or less; those with a carbon number of 3 are preferred: lower alkylenes Vinyl, propylene, 2-propylene, butylene, 2-butylene, 3-butylene, μpentene, 2-marine, 3.pentene ', 4-pentene Supporting, 1-hexene, 2 · hexene, 3_hexene, 4_hexene, etc. ^ Thin carbons with a carbon number of 6 or less; and those with a carbon number M ^ are more examples .: =: Take the fluorine atom, gas atom, desert atom, and atom atom as Η, and the preferred ones are fluorine atom, gas atom, bromine atom. This paper size is 210x3 ^ (诮 Please read the precautions on the back before filling in this Page) Order 548272 A7 -------------— V. Description of the invention (26) ~ ^ — ---— ~ — i Lower alkyl can be via fluorine atom, gas Straight-chain or branched alkynyl radicals of carbon number U substituted with ions, molybdenum atoms, or atoms; compared with the two, which are replaced by random atoms 'chlorine and bromine atoms with carbon number 8 up to' Linear or branched alkyl groups having 1 to 3 carbon atoms. Examples include methylated, difluorinated, trimethylated, vaporized methyl, methyl chloride & _chlorinated Methyl, methyl bromide, methyl dibromide, methyl tribromide, b-fluorinated ethyl, i-gasified ethyl, 1-brominated ethyl, 2-fluorinated ethyl, 2-gas Ethyl, 2-bromoethyl, a difluorinated ethyl, 1,2-dichlorinated ethyl, ethyl dibromide, 2,2,2-trifluoroethyl, ethyl heptafluoride Base, 1 · gasified propyl, chloropropyl, propylamine propyl, 2-methylated propyl, 2-chloropropyl, 2-methylated propyl, 3-methylated propyl, 3 -Chloropropyl, 3-bromopropyl, 1,2,2-difluoropropyl, 丨, ^ monochloropropyl, 1,2-dibromopropyl, 2,3-difluoropropyl Group, 2,3-monochloropropyl, 2,3-dibromopropyl, 3,3,3-trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, 2 -Fluorinated butyl, 2-gasified butyl, 2-bromobutyl, 4-fluorinated butyl Methyl, 4-chlorobutyl, 4-bromobutyl, 4,4,4-difluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, perfluorinated Butyl, 2-fluorinated pentyl, 2-gasified pentyl, 2-desertified pentyl, 5-fluorinated pentyl, 5-gasified pentyl, 5-bromopentyl, perfluorinated pentyl , 2-hexyl fluoride, 2-hexyl hexyl, 2-bromohexyl, 6-hexyl fluoride, 6-hexyl hexyl, 6-hexyl bromide, perfluorohexyl, 2-fluoroheptyl, Examples include 2-gasified heptyl, 2- > odorized heptyl, 7-fluorinated heptyl, 7-chlorinated heptyl, 7-desertified heptyl, perfluorinated heptyl, and the like. Low-grade oxyhydroxide is a straight-bonded or branched system up to the number of isthmuses up to 6 --- This paper size is suitable for China National Standard (CNS) A4 size (21 OX 29 * 7 mm) (read first read (Notes on the back then fill out this page)

、1T 線 A7 548272 五、發明説明(27 ) " ~' 氧基可舉甲氧基、乙氧基、正丙氧基、異丙氧基、正 丁氧基、異丁氧基、帛2丁氧基、第3丁氧基、正戊氧 基、異戊氧基、第2戊氧基、第3戊氧基、甲基丁氧 基、正己氧基、異己氧基、第3己氧基、第2己氧基、 甲基戊氧基、3-甲基戊氧基、丨_乙基丁氧基、2_乙基 丁氧基、ι,ι-二甲基丁氧基、2,2-二甲基丁氧基、 一甲基丁氧基、1-乙基甲基丙氧基等為例。較佳者為 甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異 丁氧基1 2 丁氧基、第3 丁氧基;且以碳數卜3為較 佳。 低級%烷基為碳數3〜7之環烷基;較佳者可舉環丙 基、環丁基、環戊基、環己基、環庚基為例;更佳者為 碳數1〜4者,可舉環丙基、環丁基為例。 低級烷氧基低級烷基為,經碳數至8為止之直鏈狀 或分枝狀烷氧基取代之碳數至8為止之直鏈狀或分枝狀 的烷基。可舉甲氧基甲基、甲氧基乙基、甲氧基丙基、 甲氧基丁基、甲氧基戊基、甲氧基己基、甲氧基庚基、 甲氧基辛基、乙氧基甲基、乙氧基乙基、乙氧基丁基、 乙氧基戊基、乙氧基己基、乙氧基庚基、乙氧基辛基、 丙氧基甲基、丙氧基乙基、丙氧基丙基、丙氧基丁基、 丙氧基戊基、異丙氧基甲基、異丙氧基乙基、異丙氧基 丙基、異丙氧基丁基、異丙氧基戊基、丁氧基甲基、丁 氧基乙基、丁氧基丙基、丁氧基丁基、異丁氧基甲基、 異丁氧基乙基、異丁氧基丙基、異丁氧基丁基、丁 本纸張尺度適州中國國家標準(CNS ) Α4規格(υ〇χ 297公釐) (誚先閱讀背面之注意事項再填寫本頁), 1T line A7 548272 V. Description of the invention (27) " ~ 'oxy can be methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, fluorene 2 Butoxy, third butoxy, n-pentyloxy, isopentyloxy, second pentyloxy, third pentyloxy, methylbutoxy, n-hexyloxy, isohexyloxy, third hexyloxy Methyl, 2hexyloxy, methylpentyloxy, 3-methylpentyloxy, _ethylbutoxy, 2-ethylbutoxy, ι, ι-dimethylbutoxy, 2 As examples, 2-dimethylbutoxy, monomethylbutoxy, 1-ethylmethylpropoxy and the like. Preferred are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy 1 2 butoxy, third butoxy; and carbon number 3 is Better. The lower% alkyl group is a cycloalkyl group having 3 to 7 carbon atoms; the preferred ones include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cycloheptyl as examples; more preferred is 1 to 4 carbon atoms Examples include cyclopropyl and cyclobutyl. The lower alkoxy lower alkyl group is a straight or branched alkyl group having a carbon number of 8 to 8 substituted by a linear or branched alkoxy group. Examples include methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, methoxyheptyl, methoxyoctyl, and ethyl. Oxymethyl, ethoxyethyl, ethoxybutyl, ethoxypentyl, ethoxyhexyl, ethoxyheptyl, ethoxyoctyl, propoxymethyl, propoxyethyl Group, propoxypropyl, propoxybutyl, propoxypentyl, isopropoxymethyl, isopropoxyethyl, isopropoxypropyl, isopropoxybutyl, isopropyl Oxypentyl, butoxymethyl, butoxyethyl, butoxypropyl, butoxybutyl, isobutoxymethyl, isobutoxyethyl, isobutoxypropyl, Isobutoxybutyl and butyl paper sizes Applicable to China National Standard (CNS) Α4 size (υ〇χ 297mm) (诮 Please read the notes on the back before filling in this page)

、1T 線 548272 A7 B7 五、發明説明(28 ) 氧基曱基、第2 丁氧基乙基、第2 丁氧基丙基、第2 丁 氧基丁基、第3 丁氧基曱基、第3 丁氧基乙基、第3 丁 氧基丙基、第3 丁氧基丁基、戊氧基甲基、戊氧基乙基、 戊氧基丙基、戊氧基丁基、己氧基曱基、己氧基乙基、 己氧基丙基等為例;較佳為碳數1〜2之烷氧基與碳數1〜2 之烧基相結合者。 三低級烷基甲矽烷基低級烷基可為三甲基曱石夕烷 基、二乙基曱石夕烧基、三丙基甲石夕烧基等與前述之低級 烧基相結合者。 低級烷基胺基為碳數至6為止之直鏈狀或分枝狀的 烧基胺基。可舉曱胺基、乙胺基、正丙胺基、異丙胺基、 正丁胺基、異丁胺基、第2 丁胺基、第3 丁胺基、正戊 胺基、異戊胺基、第2戊胺基、第3戊胺基、2-曱基丁 胺基、正己胺基、1-曱基戊胺基、2-曱基戊胺基、3-曱基 戊胺基、4-甲基戊胺基、1-乙基丁胺基、2-乙基丁胺基、 3 -乙基丁胺基、1,1-二曱基丁胺基、2,2-二曱基丁胺基、 3,3-二甲基丁胺基、1-乙基-1-曱基丙胺基等為例。較佳者 為碳數1〜4者,可舉曱胺基、乙胺基、正丙胺基、異丙 胺基、正丁胺基、異丁胺基、第2 丁胺基、第3 丁胺基 為例。 低級烧硫基為碳數至6為止之直鏈狀或分枝狀的烧 硫基。可舉甲硫基、乙硫基、正丙硫基、異丙硫基、正 丁硫基、異丁硫基、弟2 丁硫基、第3 丁硫基、正戊石荒 基、異戊硫基、第2戊硫基、第3戊硫基、2-甲基丁硫 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) (掮先閱讀背面之注意事項再填寫本頁) ·%!1T line 548272 A7 B7 V. Description of the invention (28) oxyfluorenyl group, 2butoxyethyl group, 2butoxypropyl group, 2butoxybutyl group, 3butoxyoxy group, Third butoxyethyl, third butoxypropyl, third butoxybutyl, pentoxymethyl, pentoxyethyl, pentoxypropyl, pentoxybutyl, hexyloxy Examples are fluorenyl, hexyloxyethyl, hexyloxypropyl, and the like; preferably, an alkoxy group having 1 to 2 carbon atoms and a calcining group having 1 to 2 carbon atoms are combined. The tri-lower alkylsilyl lower alkyl group may be a combination of a trimethyl vermiculyl group, a diethyl vermiculyl group, a tripropylmethacyl group, or the like with the aforementioned lower alkyl group. The lower alkylamino group is a linear or branched alkylamino group having up to 6 carbon atoms. Examples include amido, ethylamine, n-propylamine, isopropylamine, n-butylamine, isobutylamine, second butylamine, third butylamine, n-pentylamine, isoamylamine, 2-pentylamino, 3-pentylamino, 2-fluorenylbutylamino, n-hexylamino, 1-fluorenylpentamine, 2-fluorenylpentamine, 3-fluorenylpentamine, 4- Methylpentylamino, 1-ethylbutylamino, 2-ethylbutylamino, 3-ethylbutylamino, 1,1-diamidinobutylamine, 2,2-diamidinobutylamine As an example, a methyl group, a 3,3-dimethylbutylamino group, a 1-ethyl-1-amidinopropylamino group, and the like. Preferred are those having 1 to 4 carbon atoms, and examples thereof include amido, ethylamine, n-propylamine, isopropylamine, n-butylamine, isobutylamine, second butylamino, and third butylamino As an example. The lower sulfur burning group is a linear or branched sulfur burning group having up to 6 carbon atoms. Examples include methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, di-2-butylthio, third butylthio, n-pentylthio, isopentylthio , 2th pentylthio, 3th pentylthio, 2-methylbutylthio This paper is compliant with China National Standard (CNS) A4 (210X 297 mm) (掮 Please read the notes on the back before filling in this page )%!

、1T 548272 A7 B7 五、發明説明(29 ) 基、正己硫基、異己硫基、第3己硫基、第2己硫基、 2-甲基戊硫基、3-甲基戊硫基、1-乙基丁硫基、2-乙基 丁硫基、1,1-二甲基丁硫基、2,2-二曱基丁硫基、3,3-二甲基丁硫基、1-乙基-1-曱基丙硫基等為例。較佳者為 碳數1〜4者,可舉甲硫基、乙硫基、正丙硫基、異丙硫 基、正丁硫基、異丁硫基、第2 丁硫基、第3 丁硫基為 例。 低級烷硫基低級烷基為,經前述之既定的碳數6為 止的直鏈狀或分枝狀烷硫基取代之前述既定的碳數6為 止的直鏈狀或分枝狀烧基。 低級烷氧基羰基為烷基部分的碳數至6為止 之直鏈狀或分枝狀的低級烷氧基羰基。可舉曱氧基 羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、 正丁氧基羰基、異丁氧基羰基、第2 丁氧基羰基、 第3 丁氧基羰基、正戊氧基羰基、異戊氧基羰基、 第2戊氧基羰基、第3戊氧基羰基、2-曱基丁氧基 羰基、正己氧基羰基、異己氧基羰基、第3己氧基 羰基、第2己氧基羰基、2-甲基戊氧基羰基、3-甲基戍氧基戴基、1-乙基丁氧基獄基、2 -乙基丁氧 基羰基、1,1-二曱基丁氧基羰基、2,2-二甲基丁氧 基羰基、3,3-二甲基丁氧基羰基、1-乙基-1-甲基丙 氧基羰基等為例。更佳者為與碳數1〜4之烷氧基相 結合之羰基,可舉甲氧基羰基、乙氧基羰基、正丙 氧基羰基、異丙氧基羰基、正丁氧基羰基、異 本紙張尺度適州中國國家標隼(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁)1T 548272 A7 B7 V. Description of the invention (29) group, n-hexylthio group, isohexylthio group, third hexylthio group, second hexylthio group, 2-methylpentylthio group, 3-methylpentylthio group, 1-ethylbutylthio, 2-ethylbutylthio, 1,1-dimethylbutylthio, 2,2-diamidinobutylthio, 3,3-dimethylbutylthio, 1 -Ethyl-1-amidinopropylthio and the like. The preferred number is 1 to 4 carbon atoms, and examples include methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, second butylthio, and third butyl. An example is sulfur. The lower alkylthio-lower alkyl group is a straight-chain or branched alkynyl group substituted by the aforementioned linear or branched alkylthio group having a carbon number of 6 or less. The lower alkoxycarbonyl group is a linear or branched lower alkoxycarbonyl group having 6 to 6 carbon atoms in the alkyl portion. Examples include fluorenyloxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, second butoxycarbonyl, third butoxycarbonyl, N-pentyloxycarbonyl, iso-pentyloxycarbonyl, 2nd-pentyloxycarbonyl, 3rd-pentyloxycarbonyl, 2-fluorenylbutoxycarbonyl, n-hexyloxycarbonyl, iso-hexyloxycarbonyl, 3hexyloxy Carbonyl, 2hexyloxycarbonyl, 2-methylpentyloxycarbonyl, 3-methylfluorenyloxy, 1-ethylbutoxyhexyl, 2-ethylbutoxycarbonyl, 1,1 Dioxobutoxycarbonyl, 2,2-dimethylbutoxycarbonyl, 3,3-dimethylbutoxycarbonyl, 1-ethyl-1-methylpropoxycarbonyl, and the like are exemplified. More preferably, it is a carbonyl group combined with an alkoxy group having 1 to 4 carbon atoms, and examples thereof include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an isopropoxycarbonyl group, an n-butoxycarbonyl group, and an isopropyl group. Paper size China National Standard (CNS) A4 size (210X 297 mm) (Read the precautions on the back before filling this page)

、1T 線 548272 Μ Β7 氧基羰基、第3 丁氧基羰基等為 五、發明説明(3〇 ) 丁氧基幾基、第2 例0 低級烷基羰基為烷基部分之碳數至6為止之 直鏈狀或分枝狀的烷基羰基。可舉甲基羰基、乙基 羰基、正丙基羰基、異丙基羰基、正丁基羰基、異 丁基板基、第2 丁基羰基、第3 丁基羰基、正戊基 碳基、異戊基羰基、第2戊基羰基、第3戊基羰基、 2-甲基丁基羰基、正己基羰基、異己基羰基、第3 己基羰基、第2己基羰基、2-甲基戊基羰基、3_曱 基戊基羰基、丨_乙基丁基羰基、2-乙基丁基羰基、 二甲基丁基羰基、2,2-二甲基丁基羰基、3,3_二 甲基丁基羰基、1-乙基_丨_甲基丙基羰基等為例。更 佳者為與碳數1〜4之烷基相結合之羰基,可舉甲基 羰基、乙基羰基、正丙基羰基、異丙基羰基、正丁 基羰基、異丁基羰基、第2 丁基羰基、第3 丁基羰 基等為例。 低級鏈烷磺醯基為烷基部分碳數至6為止之直鏈 狀或分枝狀的鏈烷磺醯基。可舉甲磺醯基、乙績醯基、 1-丙磺醯基、2-丙磺醯基、1-丁磺醯基、2-丁磺醯基、 一甲墓乙石黃醯基、1-(2-甲基丙)石黃醮基、戍石黃酿 基、2-戊磺醯基、3-戊磺醯基、1-(3-甲基丁)磺醯基、 一曱基丙績醯基、1-己績醯基、2 -己石黃酿基、3 -己 磺酿基、1-(2-甲基戊)磺醯基、1-(3-甲基戊)磺醯基、 1-(4 -曱基戊)績酿基、2 -乙基丁石黃酿基、3 -乙基丁石黃酿 __________Μ____ 本紙張尺度適丨彳]中國國家標率(CNS ) Α4規格(210X 297公釐) 548272 Λ7 B7 五、發明説明(31 ) 基、1,1-二甲基丁磺醯基、2,2-二甲基丁磺醯基、3,3-二 曱基丁磺醯基、1 -乙基-1 -曱基丙石黃醯基等為例。而以碳 數1〜4之烷基磺醯基為較佳。 芳基係,在本說明書中為碳數6〜1〇者,例如包含苯 基、萘基等;當為單純之萘基時係包含丨_萘基、萘基。 又,在其苯環上或萘環上具有前述之鹵素原子、低級烧 基、氰基、硝基、三氟化甲基等取代基亦可。 芳基磺醯基係包含在笨基磺醯基、曱苯磺醯基、萘 磺醯基等之磺醯基上結合有前述芳基者。 芳基低級烧基係包含苄基、丨_笨乙基、2_苯乙基、 苯丙基、苯丁基、苯戊基、苯己基、萘甲基、萘乙基、 萘丙基、萘丁基、萘戊基、萘己基;φ即代表前述低級 烷基上結合有芳基者。 芳基低級烷氧基係包含苄氧基、丨_笨乙氧基、2_笨 乙氧基、苯丙氧基、苯丁氧基、笨戊氧基、苯己氧基、 奈甲氧基、萘乙氧基、萘丙氧基、萘丁氧基、茶戊氧基; 又其笨環上及萘環上具有取代基者亦可。 芳磺醯基低級烷基為笨磺醯基曱基、曱苯磺醯基曱 基、萘磺醯基曱基等;亦即代表前述低級烷基上結合有 前述芳磺醯基者。 芳%醯基胺基包含笨磺醯基胺基、甲笨磺醯基胺 基、萘磺醯基胺基等前述胺基上結合有前述芳碏醯 者。 ,、土 芳氧基包含苯氧基、i•萘氧基、2_萘氧基等氧原子 本紙張尺度制巾國國家標準(CNSO A4規格(2?〇^97^7 (讀先閱讀背面之注意事項再填寫本頁) 、-口 548272 A7 五、發明説明(32 ) 上結合有前述芳基者。 方羰基包含笨羰基、萘羰基等羰基上結合有前述芳 基者。 芳石反^胺基包含笨碳醯胺基、萘碳醯胺基等胺基上 結合有前述芳羰基者。 芳基低級烯撐基包含苯乙烯基、萘乙烯基等經前述 芳基取代之碳數6以下的烯撐基。 雜環基可舉如後所述者為例,具體而言包含吡啶 基、喳淋基、異喳淋基、噻唑基、噻二唑基、苯並呋喃 基、二笨並呋喃基、噻萘基、1H-1,2,3-三唑基、ι,2,4-三 坐基四哇基、°夫喃基、雀嗯基…比洛基、味α坐基、嘴 啶基、吲哚基、苯並咪唑基等;此等亦包含_異喳啉基、 甲基異喹啉基般之經前述之鹵素原子、低級烷基取代 雜環低級烧基代表例如。比ϋ定曱基等般之經前述雜環 基取代之前述低級烷基;函雜環低級烷基代表前述雜環 低級烷基之雜環經齒素取代者。 雜環低級烧胺基代表例如α比嘴甲胺基等般之經由前 述雜環低級烷基取代之胺基;雜環低級烷基氨基甲醯基 代表例如吡啶甲基氨基甲醯基等般之經前述雜環低級烧 基取代之氨基甲醯基。 又,單純之吡啶基包含2-吡啶基、3-吡啶基及4-叶匕 咬基,其結合位置並無限定。同樣地其他雜環基之結合 位置亦無限定。 本紙張尺度適州中國國家標準(CNS ) A4規格(210X29*7公釐) (讀先閱讀背面之注意事項再硪寫本頁) 訂 線 548272 A7 — -------------- B7 五、發明説明(33 ) ~ ~一~—-一 低級院撐二氧¥基包含甲撑二氧¥基、乙擇 基、及丙撐二氧苄基等。 下 適當之「雜環基」代表至少具有"固氧原子、硫原 子、鼠原子等雜原子之飽和或不飽和的單環或多環雜環 基。 更佳之例可舉下述之雜環基為例·· 一具有1〜5個氮原子之7〜12環、較佳為9或1〇環之不 飽和縮合雜環基(較佳為二環基);例如為吲哚基、異吲哚 基、2哚粃基、笨並咪唑基 '喳啉基、異喳啉基、異唑 基、苯亚二唑基、四唑吡啶基、四唑噠粃基(例如四唑 [l,5-b]噠批基等)、二羥三唑噠粃基等; 一具有1〜3個硫原子之7〜12環、較佳為9或1〇環之不 飽和縮σ雜%基(較佳為二環基)或其8,§_二氧化物·,例如 二,萘基(例如4Η-1,3·二錢基、萘基等)、笨並 省笨基或其S,S-二氧化物(例如苯並[a]隹苯基或其s,s-二 氧化物、笨並[b]噻苯基或其s,s-二氧化物等)等; 具有1〜4個氮原子之3〜8環、較佳為5或6環之不飽 和單雜環基,例如°比略基、0比洛咐基、味唾基、σ比tr坐基、 ^比唆基及其N-環氧化物、喂咬基、σ比唾基、咪σ坐基、三 °坐基(例如 4Η-1,2,4·三唑、1Η-1,2,3-三唑、2Η-1,2,3-三唑 等)、四唑(例如1Η-四唑、2Η四唑等)、二羥基三粃基(例 如4’5 —私基-1,2,4-三批基、2,5-二經基-ΐ,2,4-三批基等) 等; 具有1〜4個氮原子之3〜8環、較佳為5或6環之飽和單 尺度過w中隼(CNS) Λ4規格(21〇χ2ϋ釐) (讀先閲讀背面之注意事項再填寫本頁 ^vi. 、-口 548272 A7 _____________________ B7 五、發明説明(34 ) " 雜環基,例如丙撐亞胺基、吡咯烷基、咪唑烷基、吡啶 烷基、吡唑烷基、哌粃烷基等; —具有1〜2個氧原子及1〜3個氮原子之7〜12環、較佳為 9或10環之不飽和縮合雜環基(較佳為二環基),例如苯 並噁唑基、苯並噁二唑基等; —具有1〜2個氧原子及1〜3個氮原子之3〜8環、較佳為5 或6環之不飽和單雜環基,例如嗔σ坐基、異0惡^坐基、0惡 二嗤基(例如1,2,4-噁二唑、H4-噁二唑、ι,2,5-噁二唑等) 等; —具有1〜2個氧原子及1〜3個氮原子之3〜8環、較佳為5 或6環之飽和單雜環基,例如嗎啉基等; —具有1〜2個硫原子及^個氮原子之7〜12環、較佳為 9或10環之不飽和縮合雜環基(較佳為二環基),例如苯 並喧。坐基、苯並喧二。坐基等; —具有1〜2個硫原子及1〜3個氮原子之3〜8環、較佳為5 或6環之不飽和單雜環基,例如噻唑基、i,2-噻唑基、噻 唾基 '噻二唑基(例如1,2,4-噻二唑、1,3,4-噻二唑、1,2,5· 噻二唑、1,2,3-噻二唑等)等; —具有1〜2個硫原子及1〜3個氮原子之3〜8環、較佳為5 或6環之飽和單雜環基,例如噻唑烷基等; 一具有1個硫原子之3〜8環、較佳為5或6環之不飽和 單雜環基,例如噻嗯基等。 適當之「經酯化之羧基」可舉下述者為例。 經酯化之鲮基的酯化部分的適當例為低級炊基酯 ------- ______ 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) (許先閱讀背面之注意事項再填寫本頁 、-0 Α7 548272 五、發明説明(35 ) (例如曱基酯、乙基酯、丙基酯、異丙基酯、丁基酯、異 丁基酯、第3 丁基酯、戊基酯、己基酯等),此低級烷基 酉曰可具有至少1個適當的取代基,其例為例如低級烷醯 氧(低級)烷基酯[例如乙醯氧基甲基酯、丙醯氧基甲基 酯、丁醯氧基曱基酯、戊醯氧基曱基酯、三曱基乙醯氧 基曱基酯、己醯氧基曱基酯、(或2-)乙醯氧基乙基酯、 或2-、或3)乙醯氧基丙基酯、1-(或2…或3、或4) 乙醯氧基丁基酯、1-(或2_)丙醯氧基乙基酯、卜(或2一、 或3-)丙醯氧基丙基酯、丨兴或丁醯氧基乙基酯、^(或 2-)異丁醯氧基乙基酯、丨_(或2-)三甲基乙醯氧基乙基酯、 1-(或2-)己酿氧基乙基酯、異丁醯氧基曱基酯、2_乙基丁 醯氧基曱基酯、3,3-二甲基丁醯氧基甲基酯、1-(或2_)戊 氧基乙基酯等]、低級鏈烧磺酿基(低級)烧基酯(例如2_ 醯基乙基酯等)、單(或二或三)_低級烷基酯(例如2_蛾乙 基酯、2,2,2·三氣乙基酯等);低級烷氧基碳醯氧基(低級) 烧基自曰[例如曱氧基碳醯氧基甲基g旨、乙氧基碳醯氧基曱 基酯、丙氧基碳醯氧基曱基酯、第3 丁氧基碳醯氧基甲 基δ曰1-(或2-)甲氧基碳酿氧基乙基g旨、b(或2_)乙氧 基碳醯氧基乙基酯、1_(或2-)丙氧基碳醯氧基乙基酯 等]、駄_撐(低級)烧基g旨、或(5-低級烷基氧基 二。惡茂基-4-基)(低級)烷基酯[例如(5-曱基-孓氧基4,3_ 二σ惡茂基-4-基)甲基酯、(5-乙基-2-氧基-1,3-二噁茂基_ 4-基)甲基酯、(5 -丙基-2-氧基-1,3-二鳴茂基-4-基)乙基醋 等];低級鏈烯基酯(例如乙烯基酯、烯丙基酯等);低級 本紙張尺度適ΪΪΓΐ’關家料(CNS ) A4規格(210 X297公楚) (讀先閱讀背面之注意事項再填寫本頁) .¾鲁·, 1T line 548272 Μ B7 oxycarbonyl group, 3th butoxycarbonyl group, etc. are five, description of the invention (3〇) butoxyl group, the second example 0 lower alkylcarbonyl group as the carbon number of the alkyl part to 6 A linear or branched alkylcarbonyl group. Examples include methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, n-butylcarbonyl, isobutyl substrate, second butylcarbonyl, third butylcarbonyl, n-pentyl carbon, and isopentyl. Carbonyl, 2nd pentylcarbonyl, 3rd pentylcarbonyl, 2-methylbutylcarbonyl, n-hexylcarbonyl, isohexylcarbonyl, 3hexylcarbonyl, 2hexylcarbonyl, 2-methylpentylcarbonyl, 3 _Methylpentylcarbonyl, 丨 _ethylbutylcarbonyl, 2-ethylbutylcarbonyl, dimethylbutylcarbonyl, 2,2-dimethylbutylcarbonyl, 3,3-dimethylbutyl Examples are carbonyl, 1-ethyl-methylpropylcarbonyl, and the like. More preferably, it is a carbonyl group combined with an alkyl group having 1 to 4 carbon atoms. Examples of the carbonyl group include methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, n-butylcarbonyl, isobutylcarbonyl, and Examples are butylcarbonyl, third butylcarbonyl, and the like. The lower alkanesulfonyl group is a linear or branched alkanesulfonyl group having up to 6 carbon atoms in the alkyl portion. Examples include methylsulfenyl, ethylsulfenyl, 1-propanesulfenyl, 2-propanesulfenyl, 1-butanesulfonyl, 2-butanesulfenyl, acetomethylsulfanyl, 1- ( 2-methylpropanylsulfanyl, arsenite, 2-pentylsulfanyl, 3-pentylsulfanyl, 1- (3-methylbutyl) sulfonyl, monomethylpropanyl Base, 1-hexylsulfenyl, 2-hexylsulfenyl, 3-hexylsulfenyl, 1- (2-methylpentyl) sulfonyl, 1- (3-methylpentyl) sulfonyl, 1- (4 -Phenylpentyl) chitosan, 2-ethylbutanite yellow, 3-ethylbutanite __________ Μ ____ This paper is suitable size 丨 彳] China National Standards (CNS) Α4 Specification ( 210X 297 mm) 548272 Λ7 B7 V. Description of the invention (31) group, 1,1-dimethylbutanesulfonyl, 2,2-dimethylbutanesulfonyl, 3,3-dimethylbutanesulfonyl Examples are fluorenyl, 1-ethyl-1 -fluorenylpropanthanthenyl, and the like. An alkylsulfonyl group having 1 to 4 carbon atoms is more preferred. The aryl group is 6 to 10 carbon atoms in this specification, and includes, for example, a phenyl group, a naphthyl group, and the like; when it is a simple naphthyl group, it includes a naphthyl group and a naphthyl group. The benzene ring or naphthalene ring may have the aforementioned substituents such as a halogen atom, a lower alkyl group, a cyano group, a nitro group, and a trifluoromethyl group. The arylsulfonyl group includes those in which the aforementioned aryl group is bonded to a sulfonyl group such as a benzylsulfonyl group, a benzylsulfonyl group, a naphthalenesulfonyl group, and the like. Lower aryl radicals include benzyl, phenyl, 2-phenylethyl, phenylpropyl, phenylbutyl, phenpentyl, phenylhexyl, naphthylmethyl, naphthylethyl, naphthylpropyl, naphthalene Butyl, naphthylpentyl and naphthylhexyl; φ represents those having an aryl group bonded to the aforementioned lower alkyl group. The aryl lower alkoxy system includes benzyloxy, Benzeneoxy, 2-Benzethoxy, phenylpropoxy, phenylbutoxy, pentyloxy, phenylhexyloxy, and naphthyloxy , Naphthylethoxy, naphthylpropoxy, naphthylbutoxy, and teapentyloxy; those with substituents on the stupid ring and on the naphthalene ring may also be used. Aromatic sulfonyl fluorenyl lower alkyl is benzylsulfonyl fluorenyl, fluorenylsulfonyl fluorenyl fluorenyl, naphthalenesulfonyl fluorenyl fluorenyl, and the like; that is, those in which the aforementioned arylsulfonyl group is bonded to the aforementioned lower alkyl. The aryl% fluorenylamino group includes a sulfonylamino group, a benzylsulfonylamino group, a naphthalenesulfonylamino group, and the like, and the arylfluorene is bonded to the amine group. , And aryloxy groups include oxygen atoms such as phenoxy, i • naphthyloxy, and 2-naphthyloxy. This paper is the national standard for making paper towels (CNSO A4 specification (2? 〇 ^ 97 ^ 7) (Notes on this page, please fill in this page again),-548272 A7 V. The description of the invention (32) has the aforementioned aryl group. The square carbonyl group includes a benzyl carbonyl group, a naphthalene carbonyl group, etc., and the aforementioned aryl group is combined. The amine group includes those having an arylcarbonyl group bonded to an amine group such as a carbamoylamine group and a naphthylcarbamidine group. The aryl lower alkenyl group includes a styryl group, a naphthylvinyl group and the like having a carbon number of 6 or less substituted by the aryl group. The heterocyclic group may be exemplified as described below, and specifically includes pyridyl, fluorenyl, isofluorenyl, thiazolyl, thiadiazolyl, benzofuryl, and dibenzo Furyl, thianaphthyl, 1H-1,2,3-triazolyl, ι, 2,4-trisyltetrawalyl, ° furanyl, thienyl ... Bilyl, odorant alpha, Methylpyridyl, indolyl, benzimidazolyl, etc .; these also include _isofluorinyl, methylisoquinolyl, and the like, which are substituted by the aforementioned halogen atom and lower alkyl heterocyclic ring Represents, for example, the aforementioned lower alkyl group substituted with the aforementioned heterocyclic group, such as fluorenyl, or the like; and the lower heterocyclic alkyl group represents the heterocyclic lower alkyl group substituted with dentin. Heterocyclic lower amine The group represents, for example, an amine group substituted by the aforementioned heterocyclic lower alkyl group such as α-methylamino; the heterocyclic lower alkylaminomethyl group represents the lower heterocyclic group such as pyridylaminomethylamino group Carbyl-substituted carbamoyl groups. Also, simple pyridyl groups include 2-pyridyl, 3-pyridyl, and 4-leafyl groups, and the bonding positions are not limited. Similarly, the bonding positions of other heterocyclic groups are also Unlimited. This paper is compliant with the China National Standard (CNS) A4 size (210X29 * 7mm) (read the precautions on the back before copying this page). 548272 A7 — -------- ------ B7 V. Description of the invention (33) ~~~~~ -A low-grade acryloxy group includes methylenedioxy group, ethynyl group, propylene dioxybenzyl group, etc. A suitable `` heterocyclyl '' represents a saturated or unsaturated atom having at least " solid oxygen atom, sulfur atom, rat atom and other heteroatoms A monocyclic or polycyclic heterocyclic group. A more preferred example is the following heterocyclic group. An unsaturation of 7 to 12 rings, preferably 9 or 10 rings, having 1 to 5 nitrogen atoms. Condensed heterocyclic group (preferably bicyclic group); for example, indolyl, isoindolyl, 2-indolyl, benzimidazolyl'fluorinyl, isofluorinyl, isoxazolyl, benzylidene An oxazolyl group, a tetrazolidine group, a tetrazolidine group (such as a tetrazol [l, 5-b] pyridyl group, etc.), a dihydroxytriazolidine group, etc .; one having 7 to 3 sulfur atoms 12-ring, preferably 9 or 10-ring unsaturated sigma condensing hetero% group (preferably bicyclic group) or 8, §_dioxide ·, such as dinaphthyl (such as 4Η-1, 3 Diphenyl, naphthyl, etc.), Benzobenzyl or its S, S-dioxide (eg benzo [a] pyrene or its s, s-dioxide, Benzo [b] thio Phenyl or its s, s-dioxide, etc.), etc .; unsaturated monocyclic heterocyclic groups having 3 to 8 rings, preferably 5 or 6 rings, having 1 to 4 nitrogen atoms, such as Billowy base, sialyl, sigma tr base, sigma base and its N-epoxide, feed group, sigma salyl group, sigma sigma base, three ° Sitting group (eg 4Η-1,2,4 · triazole, 1Η-1,2,3-triazole, 2Η-1,2,3-triazole, etc.), tetrazole (eg 1Η-tetrazole, 2Η Tetrazole, etc.), dihydroxytrimethyl (for example, 4'5-privyl-1,2,4-triplet, 2,5-diaphthyl-fluorene, 2,4-triplet, etc.); Saturated single-scale over 1 to 4 nitrogen atoms with 3 to 8 rings, preferably 5 or 6 rings. Medium 隼 (CNS) Λ4 specification (21〇χ 2 mm) (Read the precautions on the back before filling in this. Page ^ vi., -Port 548272 A7 _____________________ B7 V. Description of the invention (34) " Heterocyclic group, such as propyleneimino, pyrrolidinyl, imidazolidinyl, pyridinyl, pyrazinyl, piperidine Alkyl groups, etc.-Unsaturated condensed heterocyclic groups (preferably bicyclic groups) having 7 to 12 rings, preferably 9 or 10 rings, having 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as benzene Oxazolyl, benzoxadiazolyl, etc .;-unsaturated monocyclic heterocyclic groups having 3 to 8 rings, preferably 5 or 6 rings, having 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as嗔 σ sitting group, iso-0 oxa sitting group, 0 oxadiazo group (such as 1,2,4-oxadiazole, H4-oxadiazole, ι 2,5-oxadiazole, etc.) etc .;-saturated monocyclic heterocyclic groups having 3 to 8 rings, preferably 5 or 6 rings, having 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as morpholinyl Etc .;-An unsaturated condensed heterocyclic group (preferably a bicyclic group) having 7 to 12 rings, preferably 9 or 10 rings, having 1 to 2 sulfur atoms and ^ nitrogen atoms, such as benzoquinone. Sitting on the base, benzo noisy. Groups, etc .;-Unsaturated monocyclic groups having 3 to 8 rings, preferably 5 or 6 rings, having 1 to 2 sulfur atoms and 1 to 3 nitrogen atoms, such as thiazolyl, i, 2-thiazolyl , Thiasalyl'thiadiazolyl (eg 1,2,4-thiadiazole, 1,3,4-thiadiazole, 1,2,5 · thiadiazole, 1,2,3-thiadiazole Etc.);-saturated monocyclic heterocyclic groups having 3 to 8 rings, preferably 5 or 6 rings, having 1 to 2 sulfur atoms and 1 to 3 nitrogen atoms, such as thiazolidinyl, etc .; one having 1 sulfur An unsaturated monocyclic heterocyclic group having 3 to 8 rings, preferably 5 or 6 rings, such as thionyl and the like. The appropriate "esterified carboxyl group" may be exemplified by the following. A suitable example of the esterified part of the esterified fluorene group is low-grade ceryl ester ------- ______ This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) For the matters needing attention, fill in this page again, -0 Α7 548272 V. Description of the invention (35) (such as fluorenyl ester, ethyl ester, propyl ester, isopropyl ester, butyl ester, isobutyl ester, third butyl ester Esters, pentyl esters, hexyl esters, etc.), this lower alkyl group may have at least one suitable substituent, examples of which are, for example, lower alkyloxy (lower) alkyl esters [such as ethoxymethyl Esters, propionyloxymethyl esters, butyryloxymethyl esters, pentyloxymethyl esters, trimethylethylacetoxymethyl esters, hexamethylethoxymethyl esters, (or 2-) Acetyloxyethyl ester, or 2-, or 3) Acetyloxypropyl ester, 1- (or 2 ... or 3, or 4) Acetyloxybutyl ester, 1- (or 2_) propyl Ethyloxyethyl ester, Ethyl (or 2-, or 3-) Propyloxypropyl ester, Ethyl or Butyloxyethyl ester, ^ (or 2-) Isobutylethoxyethyl ester丨 _ (or 2-) trimethylacetoxyethyl ester, 1- (or 2-) hexyloxyethyl ester Isobutyl fluorenyl ethoxylate, 2-ethyl butyl fluorenyl ethoxylate, 3,3-dimethyl butyl fluorenyl ethoxylate, 1- (or 2_) pentyl oxyethyl ester, etc.] , Lower chain burned sulfonyl (lower) alkyl esters (such as 2- fluorenyl ethyl ester, etc.), mono (or di or tri) _ lower alkyl esters (such as 2- moth ethyl ester, 2, 2, 2 · Three gas ethyl ester, etc.); Lower alkoxycarbamyloxy (lower) alkyl groups [eg, alkoxycarbamyloxymethyl g, ethoxycarbamyloxybenzyl ester, propyl Oxycarbamyloxymethyl ester, 3rd butoxycarbamyloxymethyl δ 1- (or 2-) methoxycarbyloxyethyl g, b (or 2_) ethoxy Carbofluorenyl ethyl ester, 1- (or 2-) propoxy carbofluorenyl ethyl ester, etc.], fluorenyl (lower) alkyl, or (5-lower alkyloxy di. (Cyclo-4-yl) (lower) alkyl esters [e.g. (5-fluorenyl-fluorenyl 4,3_bisσoxocenyl-4-yl) methyl ester, 1,3-dioxocenyl-4-yl) methyl ester, (5-propyl-2-oxy-1,3-diomarocenyl-4-yl) ethyl vinegar, etc.]; lower alkenyl esters (Eg vinyl ester, allyl ester, etc.); low This paper scale suitable ΪΪΓΐ 'Kwan material (CNS) A4 size (210 X297 public Chu) (read to read the back of the precautions to fill out this page) .¾ Lou

、1T 線 548272 A7 五、發明説明(36) 炔基酯(例如乙炔基酯、丙炔基酯等);可至少具有1個適 當的取代基之芳基(低級)烷基酯(例如苄基酯、‘甲氧基 ¥基醋、4-硝基节基自旨、苯乙基醋、三笨甲基醋、苯二 聯甲苯酯、雙(甲氧基笨基)曱基酯、3,‘二曱氧基苄基 酉曰、4-羥基-3,5-二第3 丁基苄基酯等);可具有至少}個 適當的取代基之芳基酯(例如苯基酯、‘氯苯基酯、甲苯 基醋、帛3 丁基苯基醋、三甲笨基醋、三甲苯基醋、異 丙苯基酯等);酿酮基酯等為例。 經由如此般定義出之酯化部分保護之經酯化的羧基 之較佳例可舉低級烷氧基及苯基(或硝笨基)(C1_C4)烷氧 基羧基為例;最佳者可舉甲氧基羧基、乙氧基羧基及苄 氧基羧基為例。 適當之「經醯胺化的羧基」可舉以下者為例。 氨基曱醯基、 單或一低級烧基氨基甲酿基(低級燒基可舉前述者為 例)[例如曱基氨基甲醯基、二甲基氨基曱醯基、異丙基氨 基甲醯基、正丁基氨基甲醯基、第3 丁基氨基甲醯基、 N-曱基-N-(吡啶曱基)氨基曱醯基等]、 芳基低級烷基氨基甲醯基(芳基及低級烷基可舉前述者 為例)[例如苄基氨基甲醯基、3,4_甲撐基二氧基节基氨基 甲醯基、二胺基苄基氨基曱醯基、笨乙基氨基甲醯基]、 碳數3〜7之環低級烷基氨基甲醯基(環低級烷基可舉前所 述者為例)[例如環丙基氨基曱醯基、環丁基氨基曱醯基、 環戊基氨基甲醯基、環己基氨基甲醯基等]、 " ·_ 4 η 本紙張尺度適中囤國家標準(CNS ) A4規格(210X297^釐) ' -- (讀先閱讀背面之注意事項再填寫本頁) 、*=<» 線 548272 Α7 Β7 五、發明説明(37 ) 芳基氨基曱醯基(芳基可舉前所述者為例)[例如苯基氨基 甲醯基、萘基氨基甲醯基等]、 雜環氨基甲醯基(雜環可舉前所述者為例[例如噻唑基氨 基甲醯基、噻二唑基氨基曱醯基、说啶基氨基甲醯基、 三唑基氨基甲醯基、四唑基氨基曱醯基、N-甲基-Ν-α比啶 基氨基曱醯基、嗎啉基氨基甲醯基等]、 雜環低級烷基氨基甲醯基(雜環低級烷基可舉前述者為 例)[例如為嗎啉乙基氨基甲醯基〃比啶甲基氨基甲醯基、 曱撐基二氧苄基氨基甲醯基等] 由氮原子構成含氮雜環的一員之Ν-二取代氨基甲醯基 (例如嗎啉羰基、噻嗎啉羰基、1-全氫吖庚基羰基、1,1-二氧基噻唑啉羰基、1-哌啶基羰基、1-哌粃基羰基、4-(2-羥乙基)-1-哌粃基羰基、4-甲基-1-哌粃基羰基、羧基吡咯 烷基羰基等)、 經取代之磺醯氨基甲醯基等。 又該經取代之磺醯氨基甲醯基之取代基可舉前述之 碳數8為止的烧基、齒低級烧基、芳基低級烧基、經基 低級烷基、三低級烷基低級烷基、低級烷氧基低級烷基、 低級烷硫基低級烷基、雜環基、或芳基等為例;該芳基 係可使用前述之i素原子、低級烷基、i低級烷基、低 級烷氧基或硝基等取代之。具體而言,可舉萘磺醯基氨 基曱醯基、苯磺醯基氨基甲醯基、硝基苯磺醯基氨基曱 醯基、三ii笨磺醯基氨基甲醯基、低級烷氧基苯磺醯基 氨基曱醯基、鹵苯磺醯基氨基曱醯基、單或雙低級烷基 本紙張尺度適Λ中國國家標率(CNS ) Λ4規格(210X29*7公釐) --------------IT------^ wew— (讀先閱讀背面之注意事項再填寫本頁) 548272 A7 B7 發明説明(38) 苯磺醯基氨基甲醯基、碳數1〜8之烷基磺醯基氨基甲醯 基(第3 丁基磺醯基氨基曱醯基、丁基磺醯基氨基甲醯 基、丙基磺醯基氨基甲醯基、異丙基磺醯基氨基曱醯基、 甲基磺醯基氨基甲醯基、辛基磺醯基氨基曱醯基、戊基 磺醯基氨基曱醯基、異戊基磺醯基氨基曱醯基、己基磺 醯基氨基曱醯基等)、三鹵(低級)烷基磺醯基氨基曱醯 基、苯基(低級)烷基磺醯基氨基甲醯基、三低級烷基磺醯 基氨基甲醯基、低級烷硫基低級烷基磺醯基氨基曱醯 基、低級烷氧基(低級)烷基磺醯基氨基甲醯基、喳啉基磺 醯基氨基甲醯基等為例。 適當之「醯基」為脂肪族醯基、芳香族醯基、雜環 醯基、及經芳香族基或雜環基取代之脂肪族醯基;可舉 衍生自羧酸、碳酸、磺酸、氨基甲酸等之醯基為例。 此脂肪族醯基為飽和或不飽和之非環狀或環狀 者,例如可舉低級烷醯基(例如曱醯基、乙醯基、丙醯基、 丁醯基、異丁醯基、戊醯基、異戊醯基、三曱基乙醯基、 己醯基等)等之烷醯基、低級烷基磺醯基(例如甲醯基、 乙基磺醯基、丙基磺醯基、異丙基磺醯基、丁基磺醯 基、異丁基磺醯基、戊基磺醯基、己基磺醯基等)等之 烧基績醯基、氨基曱醯基、N-烧基氨基甲醯基(例如甲 基氨基甲醯基、乙基氨基甲醯基等)、低級烷氧基羰基 (例如甲氧基獄基、乙氧基幾基、丙氧基幾基、丁氧基 羰基、第3 丁氧基羰基等)等烷氧基羰基、低級烯氧基 羰基(例如乙烯氧基羰基、丙烯氧基羰基等)等烯氧 本紙張尺度適州中國國家標苹(CNS ) A4規格(210X29*7公釐) --------------IT------^1#— (讀先閱讀背面之注意事項再填寫本頁) 548272 A7 __________ B7 五、發明説明(39 ) 基羰基、低級烯醯基(例如丙烯醯基、甲基丙烯醯基、 巴丑醯基等)等之烯醯基、環(低級)烷羰基(例如環丙烷 叛基、%戊烷羰基、環己烷羰基等)等之環烷羰基等為 例。 芳香私醯基可舉C6-C 10芳酿基(例如苯醯基、曱苯 酉知基、一曱苯醯基等)、N-(C6-C丨〇)芳基氨基甲醯基、(例 如N-笨基氨基甲醯基、N_曱笨基氨基曱醯基、N_萘基氨 基甲醯基等)、C6-C10芳烴磺醯基(例如笨磺醯基、對甲 苯磺醯基等)等為例。 雜壞醯基可舉雜環羰基;雜環(低級)烷醯基(例如雜 環乙醯基、雜環丙醯基、雜環丁醯基、雜環戊醯基、雜 ί衣己醯基等);雜環(低級)烯醯基(例如雜環丙烯醯基、雜 環丁烯醯基、雜環戊烯醯基、雜環己烯醯基等);雜環乙 醛醯基、亞磺醯基、磺醯基等為例。 經芳香族基取代之脂肪族酿基可舉苯基(低級)烧氧 基羰基(例如苯氧基羰基、苯乙氧基羰基等)等之芳烷氧基 羰基等為例)。 此等之醯基係,可進一步使用丨個或丨個以上之適 當的取代基、例如硝基等取代之,如此般具有取代基之 較佳醯基可舉硝基芳烷氧基羰基(例如硝基苄氧基羰基 等)等為例。 本發明之苯並咪唑衍生物之較佳的鹽類為,無毒性 之w藥上可容許之常用的鹽類’可舉鈉、卸等的鹼金屬 鹽、鈣、鎂等的鹼土金屬鹽、銨鹽等無機鹼之鹽、及三 本紙張尺度追州中國國家標隼(CMS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)1T line 548272 A7 V. Description of the invention (36) Alkynyl esters (such as ethynyl esters, propynyl esters, etc.); aryl (lower) alkyl esters (such as benzyl) which may have at least one suitable substituent Esters, 'methoxybenzyl vinegar, 4-nitrobenzyl motif, phenethyl vinegar, tribenzyl methyl vinegar, phenyl dixylyl ester, bis (methoxybenzyl) fluorenyl ester, 3, 'Dimethoxybenzyl, 4-hydroxy-3,5-di-3rd-butylbenzyl ester, etc.); aryl esters (e.g., phenyl esters,' chloro Phenyl ester, tolyl vinegar, tributyl butyl vinegar, trimethylbenzyl vinegar, tricresyl vinegar, cumyl ester, etc.); keto esters, etc. are examples. Preferred examples of the esterified carboxyl group protected by the esterification moiety so defined are the lower alkoxy and phenyl (or nitrobenzyl) (C1_C4) alkoxycarboxyl groups; the best are Examples are methoxycarboxyl, ethoxycarboxyl, and benzyloxycarboxyl. Examples of suitable "fluorenated carboxyl groups" include the following. Aminoamido, mono- or mono-lower alkylcarbamoyl (lower alkyl may be exemplified by the foregoing) [e.g. amidocarbamoyl, dimethylaminocarbamoyl, isopropylcarbamoyl , N-butylcarbamoyl, 3rd butylcarbamoyl, N-fluorenyl-N- (pyridinyl) aminofluorenyl, etc.], aryl lower alkylcarbamoyl (aryl and Lower alkyl can be exemplified by the foregoing) [e.g. benzylaminomethylamino, 3,4-methyldioxybenzylaminomethylamino, diaminobenzylaminomethyl, phenylethylamino Formamyl], cyclic lower alkylaminoformamyl having 3 to 7 carbon atoms (cyclic lower alkyl can be exemplified as the former) [eg, cyclopropylaminofluorenyl, cyclobutylaminofluorenyl , Cyclopentylcarbamyl, cyclohexylcarbamyl, etc.], " · 4 η This paper has a medium size national standard (CNS) A4 specification (210X297 ^ cent) '-(Read the first read on the back Note: Please fill in this page again), * = < »line 548272 Α7 Β7 V. Description of the invention (37) Arylaminofluorenyl (Aryl can use the former as an example) [eg phenylamino Fluorenyl, naphthylcarbamoyl, etc.], heterocyclic aminocarbamoyl (the heterocycle may be exemplified by the former [for example, thiazolylaminocarbamoyl, thiadiazolylaminofluorenyl, pyridyl Carbamate, triazolylacarbamoyl, tetrazolylamidoamino, N-methyl-N-α than pyridylaminoamidino, morpholinylcarbamoyl, etc.], heterocyclic lower Alkylaminocarbamyl (heterocyclic lower alkyl can be exemplified as the foregoing) [for example, morpholinylethylaminomethylamidino, pyridylmethylaminomethylamidino, fluorenyldioxybenzylcarbamoyl Etc.] N-disubstituted carbamoyl groups (such as morpholine carbonyl, thiamorpholine carbonyl, 1-perhydroazepine carbonyl, 1,1-dioxythiazole) that are members of a nitrogen-containing heterocyclic ring composed of a nitrogen atom Phenylcarbonyl, 1-piperidinylcarbonyl, 1-piperidinylcarbonyl, 4- (2-hydroxyethyl) -1-piperidinylcarbonyl, 4-methyl-1-piperidinylcarbonyl, carboxypyrrolidinyl Carbonyl, etc.), substituted sulfocarbamoylamino, etc. The substituents of the substituted sulfocarbamoylamino can be exemplified by the aforementioned alkynyl groups up to 8 carbons, lower alkynyl, and aryl alkynyl. Basic, Economic Basic Alkyl, tri-lower alkyl, lower alkyl, lower alkoxy lower alkyl, lower alkylthio lower alkyl, heterocyclyl, or aryl are examples; the aryl system can use the aforementioned i prime atom, Lower alkyl, i-lower alkyl, lower alkoxy or nitro, etc. Specifically, naphthylsulfonylaminofluorenyl, benzenesulfonylcarbamoyl, nitrobenzenesulfonyl Aminofluorenyl, triphenylsulfonylaminocarbamyl, lower alkoxybenzenesulfonylaminofluorenyl, halobenzenesulfonylaminofluorenyl, single or double lower alkyl This paper is suitable for China National Standard Rate (CNS) Λ4 specification (210X29 * 7 mm) -------------- IT ------ ^ wew— (Read the precautions on the back before filling in this Page) 548272 A7 B7 Description of the invention (38) benzenesulfonylaminocarbamyl group, alkylsulfonylcarbamylamino group with 1 to 8 carbon atoms (third butylsulfonylaminocarbamyl group, butylsulfonyl Fluorenylcarbamyl, propylsulfonylcarbamyl, isopropylsulfonylaminocarbamyl, methylsulfonylaminocarbamyl, octylsulfonylaminocarbamyl, pentyl Sulfonamide Fluorenyl, isopentylsulfonylaminofluorenyl, hexylsulfonylaminofluorenyl, etc.), trihalo (lower) alkylsulfonylaminofluorenyl, phenyl (lower) alkylsulfonium Aminocarbamoyl, tri-lower alkylsulfonylaminocarbamyl, lower alkylthio lower alkylsulfonylaminocarbamyl, lower alkoxy (lower) alkylsulfonylaminocarbamyl, An example is a fluorinylsulfonylcarbamoyl group. Suitable "fluorenyl" are aliphatic fluorenyl, aromatic fluorenyl, heterocyclic fluorenyl, and aliphatic fluorenyl substituted with aromatic or heterocyclic groups; for example, derived from carboxylic acid, carbonic acid, sulfonic acid, An example is a fluorenyl group such as urethane. The aliphatic fluorenyl group is a saturated or unsaturated non-cyclic or cyclic, for example, a lower alkyl fluorenyl group (for example, fluorenyl, ethyl fluorenyl, propyl fluorenyl, butyl fluorenyl, isobutyl fluorenyl, pentamyl, isopropyl Alkyl, lower alkylsulfonyl (such as methylamyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, etc.) Fluorenyl, butylsulfonyl, isobutylsulfonyl, pentylsulfonyl, hexylsulfonyl, etc.), alkyl, aminofluorenyl, N-carbylcarbamoyl ( (Such as methylaminomethyl, ethylaminomethyl, etc.), lower alkoxycarbonyl (such as methoxyhexyl, ethoxyquinyl, propoxyquinyl, butoxycarbonyl, third butyl) Alkoxycarbonyl, etc.), such as alkoxycarbonyl, lower alkenyloxycarbonyl (such as ethyleneoxycarbonyl, propyleneoxycarbonyl, etc.), etc. Paper size suitable for China National Standard Apple (CNS) A4 specifications (210X29 * 7 (Mm) -------------- IT ------ ^ 1 # — (Read the precautions on the back before filling this page) 548272 A7 __________ B7 V. Description of the invention ( 39) Alkyl carbonyl, lower alkenyl (such as propenyl, methacryl, methyl, etc.), alkenyl, cyclic (lower) alkylcarbonyl (eg, cyclopropanyl,% pentanecarbonyl, ring Hexanecarbonyl, etc.) are examples. Examples of aromatic private groups include C6-C10 aromatic groups (such as phenylfluorenyl, benzophenone, monophenylphenyl, etc.), N- (C6-C 丨 〇) arylcarbamoyl, ( For example, N-benzylcarbamoyl, N-benzylaminofluorenyl, N-naphthylcarbamoyl, etc.), C6-C10 aromatic hydrocarbon sulfonyl (such as benzylsulfonyl, p-toluenesulfonyl) Etc.) as an example. Hetero bad fluorenyl may be heterocyclic carbonyl; heterocyclic (lower) alkyl fluorenyl (such as heterocyclic fluorenyl, heterocyclic fluorenyl, heterocyclopentyl, heterocyclopentyl, etc.) ; Heterocyclic (lower) alkenyl (such as heterocyclopropenyl, heterocyclobutenyl, heterocyclopentenyl, heterocyclohexenyl, etc.); heterocyclic acetaldehyde, sulfenyl As examples. Examples of the aliphatic alcohol group substituted with an aromatic group include aralkyloxycarbonyl groups such as phenyl (lower) alkoxycarbonyl groups (such as phenoxycarbonyl, phenethoxycarbonyl, etc.). These fluorenyl groups can be further substituted with one or more appropriate substituents, such as nitro, and the like. A preferred fluorenyl group having such a substituent is nitroaralkoxycarbonyl (for example Nitrobenzyloxycarbonyl, etc.) as an example. The preferred salts of the benzimidazole derivatives of the present invention are non-toxic commonly used salts such as alkali metal salts such as sodium and sodium, alkaline earth metal salts such as calcium and magnesium, Salts of inorganic bases such as ammonium salts, and three paper sizes Chase China National Standard (CMS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

、1T 線 548272 A7 B7 五、發明説明(40 ) 一'一 乙基胺、吡啶、甲基吡啶、乙醇胺、三乙醇胺、二環己 基胺、N,N,-二节基乙稀胺等之有機胺鹽、及鹽酸、淳化 氫酸、硫酸、磷酸等之無機酸鹽、及蟻酸、醋酸、三氟 醋酸' 馬來酸、酒石酸等之有機碳酸鹽、及甲績酸、笨 石頁酸、對甲苯績酸等之項酸加成鹽、及精氨酸、天冬氨 酸、谷氨酸等驗性或酸性氨基酸之驗性的鹽類或酸加成 鹽為例。 本發明的化合物為具有1個以上不對稱中心者,因 此存在有其等之鏡像體或非對映異構物。再者,化學式 中含有烯撐基之部分化合物係,存在有正反異構物。在 各個情況下,本發明係包含其等之混合物及各個異構 物。 本發明之化合物亦可形成互變異構物之形態本發 明係包含其等之混合物及各個異構物。 本發明之化合物及其鹽類可形成溶媒合物之形態, 此亦包含於本發明的範圍β。所形成之溶媒合物較:者 為水合物及乙醇合物。 本發明之具體的化合物係,以式(ΙΧ)所代表之苯並 咪唑衍生物可舉6_苯磺醯基氨基甲醯基_丨_(孓氯代苄基 2-甲基苯並咪唑、苯磺醯基氨基甲醯基_丨_(聯苯-‘甲 基)-2-乙基笨並咪唑、5_苯磺醯基氨基甲醯基氯代苄 基)-2^甲基笨並咪唑、5_(4_氯苯磺醯基氨基甲醯基卜丨-^ 氯代苄基)-2-甲基笨並咪唑、丨_(孓氯代苄基)_2_甲基_5_(2_ 萘磺醯基氨基ψ醯基)苯並咪唑、1_(2_氯代苄基 本纸張尺M/时關⑺0X29^7--~~—--— (讀先閱讀背面之注意事項再填寫本頁)1T line 548272 A7 B7 V. Description of the invention (40) Organics such as mono-ethylamine, pyridine, methylpyridine, ethanolamine, triethanolamine, dicyclohexylamine, N, N, -diethylene glycol, etc. Amine salts, and inorganic acid salts of hydrochloric acid, hydrogenated acid, sulfuric acid, phosphoric acid, etc., and organic carbonates of formic acid, acetic acid, trifluoroacetic acid ', maleic acid, tartaric acid, etc. Examples include paratoluene acids and other acid addition salts, and experimental or acidic amino acids such as arginine, aspartic acid, and glutamic acid. The compounds of the present invention are those having one or more asymmetric centers, and therefore exist as mirror images or diastereomers. In addition, some compounds containing an alkenyl group in the chemical formula have positive and negative isomers. In each case, the present invention includes mixtures thereof and each isomer. The compounds of the present invention may also be in the form of tautomers. The present invention includes mixtures thereof and each isomer. The compounds of the present invention and their salts can form a solvent, and this is also included in the scope β of the present invention. The formed solvents are: hydrate and ethanolate. In the specific compound system of the present invention, the benzimidazole derivative represented by the formula (IX) may be 6-benzenesulfonylaminocarbamyl_ 丨 ((chlorochlorobenzyl 2-methylbenzimidazole, Benzenesulfonylaminocarbamyl _ 丨 _ (biphenyl-'methyl) -2-ethylbenzimidazole, 5-benzenesulfonylaminocarbamyl chlorobenzyl) -2 ^ methylbenzyl Imidazole, 5_ (4-chlorobenzenesulfonylcarbamoylmethyl) 丨-^ chlorobenzyl) -2-methylbenzimidazole, 丨 ((chlorochlorobenzyl) _2_methyl_5_ (2_ Naphthylsulfonylamino ψ 醯 yl) benzimidazole, 1_ (2_chlorobenzyl basic paper ruler M / time off 0X29 ^ 7-- ~~ ----— (Read the precautions on the back before filling in this page)

'IT 548272 A7 B7 五、發明説明(41 ) 曱石簧醯基氨基曱酿基-2-曱基苯並咪吐、6-(1-丁績醯基氨 基甲醯基)-1-(2_氣代苄基)_2_曱基苯並咪唑、卜卜2-氣代苄 基)-2-甲基-6-(1-辛磺醯基氨基曱醯基)苯並咪唑、-氣 代苄基)-2-甲基-6-(2-丙磺醯基氨基甲醯基)苯並咪唑、^ (聯苯-4-甲基)-6-(1-丁磺醯基氨基甲醯基)-2_甲基笨並咪 唑、6-(1-丁磺醯基氨基曱醯基>1-(2,4•二氣代苄基)_孓曱 基苯並咪唑、1-(聯笨-4-甲基)-6-(1-丁磺醯基氨基甲醯 基)-2-乙基苯並咪唑、6-苯磺醯基氨基甲醯基_;[_(聯笨-4_ 甲基)-2-三氟甲基笨並咪唑、5_苯磺醯基氨基曱醯基 (聯笨-4-甲基)-2-三氟甲基苯並咪唑、6_苯磺醯基氨基曱 醯基-2-環丙基-1-(2-氟代苄基)苯並咪唑、n-笨磺醯基-3_ [1_(2_氣代苄基)-2-甲基苯並咪唑基]丙烯醯胺、N-苯磺 醯基-2-[l-(2-氣代苄基)_2_甲基笨並咪唑_6_基]乙醯胺、 1-(2_氣代苄基)_2_曱基_6_(2_萘磺醯基氨基曱醯基)笨並 咪唑、1-(2-氯代苄基)_2_曱基萘磺醯基氨基甲醯基) 苯並啼唾、6-(4-氯代笨石黃醯基氨基甲醯基氣代苄 基)-2-曱基笨並咪唑、6-(3-氣代苯磺醯基氨基甲醯基)-1-(2-氯代苄基)-2_甲基笨並咪唑、5-苯磺醯基氨基甲醯基_ 2_苄基-1-(2_氣代苄基)苯並咪唑、6_苯磺醯基氨基甲醯基 -2-苄基-1-(2_氯代苄基)笨並咪唑、6-苯磺醯基氨基甲 Si&基-1-(聯笨-4-甲基)-2-曱基笨並味唾、ι_(2-氣代节 基)-2-曱基-6-三氟代曱石黃醯基氨基甲酿基苯並味嗤、6-笨磺醯基氨基曱醯基_b(2,4-二氣代苄基)_2-曱基苯並 。米唾、氯代苄基)-6-(4-曱氧笨磺醯基氨基 本紙張尺度適W中國國家標隼(CNS ) A4規格(210X297公釐) (誚先閲讀背面之注意事項再填寫本頁 •扯^·· 丁 、\\" A7 548272 五、發明説明(42 ) 甲醯基)-2_甲基笨並味嗤、卜(2-氣代节基)-2-甲基冬(α 甲苯石《基氨基甲酿基)苯並咪唆、^氯代¥基)4· A5-—甲基苯石黃Si基氨基甲酿基)々·甲基笨並㈣、 (讀先閱讀背面之>1意事項再填寫本頁j 線 麫沪部t^i?^->p;BJT消货合竹·^印來 氣代¥基)-2-曱基邻-硝基苯石黃酿基氨基甲酿基)苯並味 。坐、W2-氯㈣基峰甲基冬[4_(三氟代甲基)苯俩基氨 基甲酿基]笨並㈣、6·(2·氯代笨德基氨基甲酸基)+ (2:氯代¥基)-2-甲基笨並㈣、^笨伽基氨基甲酿基· 2苄基小(2,4-一氣代节基)笨並蜂。坐、^笨磺酿基氨基甲 醯基-2-节基-W2,4-二氯代节基)笨並味唾、^笨伽基氨 基甲醯基聯笨冰甲基)_2,基苯並坐、6·苯磺絲 氨基甲醯基小(聯苯-4-甲基)冬疏基苯並咪σ坐、6•苯磺醯 基氨基甲醯基-1-(聯笨-4_甲基)-2_甲氧基笨並咪唑、心笨 磺醯基氨基甲醯基-丨-(聯苯-4_甲基)_2_羧基苯並咪唑、 笨磺醯基氨基甲醯基-;U(聯苯_4_甲基)_2-曱胺基苯並咪 唑、2-胺基-6-苯磺醯基氨基甲醯基―丨―(聯笨_4_甲基)苯並 咪哇、6_笨石黃醯基氨基甲醯基(聯苯_4_甲基)_2_正丙基 笨並咪唑、6-苯磺醯基氨基甲醯基(聯笨_4_甲基)_2_ 正丁基苯並咪唑、6-笨磺醯基氨基甲醯基(聯苯_‘甲 基)-2-氣代甲基苯並咪唑、6_苯磺醯基氨基甲醯基_丨_(聯 苯-4-甲基)-2-甲氧基甲基苯並咪唑、笨績醯基氨基甲 &L基-1-(聯笨-4-甲基)-2-異丙基苯並咪唑、笨磺醯基氨 基甲醯基-1-(聯苯-4-甲基)-2-甲硫基苯並咪唑、6-苯磺醯 基氨基甲醯基-1-(聯笨-4_甲基)_2_乙硫基笨並咪唑、6_ 苯磺醯基氨基甲醯基-1-(聯笨甲基)正丙硫基 本紙張尺度通州中國國家標準(CNS ) A4規格(210X 297公釐) Μ 548272 s__________________Β7_ 五、發明説明(43 ) 本並ϋ米哇、6-笨績醯基氨基曱酿基_ 1 _(聯笨曱基)一2 正己硫基苯並咪唑、6-苯磺醯基氨基曱醯基(聯笨 曱基)笨並咪唑、6-苯磺醯基氨基曱醯基4兴2,仁二氟代苄 基)-2-曱基苯並咪唑、6_苯磺醯基氨基甲醯基聯笨 甲基)-2-笨基苯並咪唑、6-苯磺醯基氨基甲醯基曱基— 1-(2-硝基苄基)笨並咪唑、6-苯磺醯基氨基甲醯基曱基 -1-苄基苯並咪唑、6-苯磺醯基氨基甲醯基_2_甲基-;u(‘ 硝基苄基)笨並咪唑、6-苯磺醯基氨基曱醯基-“(‘苄氧 苄基)-2-曱基苯並咪唑、6_苯磺醯胺基甲基-1-(2—氯代苄 基)-2-曱基苯並咪唑、N_笨磺醯基代苄基)_厶 曱基苯並咪唑-6-基]丙醯胺、6-笨磺醯基氨基甲醯基_2_ 曱基-l-[4-(l,2,3-噻二唑-4-基)苄基]笨並咪唑、氯代 苄基)-2-曱基-6-(8-喳啉磺醯基氨基甲醯基)苯並咪唑、 6-(4-第3 丁基苯石黃醯基氨基曱醯基卜丨^^氣代苄基)_孓 曱基苯並咪唑、6-苯石黃醯基氨基曱醯基_2_曱基-ΐ_[4·(三 氟代曱基)苄基]苯並咪唑、5-磺醯基氨基曱醯基甲基 苯並咪唑、1-(聯苯_4-甲基)-6-(1-丁磺醯基氨基曱醯基)_ 2_曱氧曱基笨並咪唑、1_(4_苄氧苄基)丁磺醯基氨 基曱醯基)-2-曱氧曱基笨並咪唑、丁磺醯基氨基曱 醯基)-1-(2,4-二環苄基)_2_曱氧曱基笨並咪唑)、ι_(孓環 节基)-2-曱基-6-(1_丙磺醯基氨基曱醯基)苯並咪唑、6_ 乙石黃si基氨基曱醯基_1-(2_環苄基曱基苯並咪唑、6_ (丙磺基_丨-羰基)-1-(2_氯代苄基)_2_曱基苯並咪唑、6_笨磺 醯基氨基曱醯基-1-(聯笨-4-甲基)-2-環丙基笨並咪唑、;[_ --- ~—____47 _ 本纸张尺度適ffl中國國家標準(CNS)A4規格( 210X 297公釐) (邡先閱讀背面之注意事項再填寫本頁〕 .私^·. 訂 -線 548272 A7 B7 五、發明説明(44) (2-氯代苄基)-2-甲基-6-(1-戊磺醯基氨基甲醯基)苯並咪 唑、1-(2-氯代苄基)-2-甲基-6-[(3-甲基丁)磺醯基氨基甲 醯基]苯並咪唑、1-(2-氣代苄基己磺醯基氨基甲醯 基)-2-甲基笨並咪唑、7-(1-丁石黃醯基氨基甲醯基) 二氣代苄基)_2_甲基苯並咪唑、1_(2_氣代苄基)_2_甲基_ 6-[1-[3-(二甲酸基)丙]績醯基氨基甲酿基]笨並味哇、‘ (1-丁磺醯基氨基甲醯基‘二氣代苄基甲基苯 並咪唑、1-(4-苄氧苄基丁績醯基氨基甲醯基)_孓 甲基苯並咪唑、6-(1-丁磺醯基氨基甲醯基)-1-[(2,_氰基 聯苯-4-基)甲基]-2-甲基笨並咪唑、6兴丨_乙磺醯基氨基曱 醯基)_1-[(2’-氟代聯笨-4-基)甲基]-2-甲基笨並咪唑、6_ (1- 丁石頁基氨基甲酸基)-l-[(3 -氣代聯苯基)甲基] 甲基笨並味嗤、1-(2-氣代卞基)_6_ [(2-甲氧基乙)石黃酿基 氨基甲醯基]-2-曱基笨並咪唑、氯代苄基)-6-(1-己碏 基氣基甲醯基)-2-甲基苯並。米。坐、ι_(2,4_二氣代节 基)-2-曱基(1-戍石頁基氣基甲酿基)苯並。米0坐、ι_(聯笨 4-曱基)-2-乙基-6[1-[3-(甲硫基)丙]磺醯基氨基曱醯基] 苯並咪唑、1-(4-聯笨曱基)-2-乙基-6-(1-戊磺醯基氨基甲 醯基)笨並咪唑、6-(1-丁磺醯基氨基曱醯基)-1-(2,4_二氯 代苄基)-2-乙基笨並咪唑、1-(4-聯苯曱基)_2-乙基 曱基)丁石頁酿基氣基曱酿基]笨並味σ坐、5-(1-丁石黃酿基气 基曱S&基)-1-(2,4-一氣代卞基)-2-曱基苯並咪α全、(4·聯 笨曱基)-5-(1-丁磺醯基氨基曱醯基乙基笨並咪唑、^ (4-聯笨曱基)-2-乙基-6-(2-曱氧基乙磺醯基氨基曱醯基) (詐先閱讀背面之注意事項再填寫本頁 、-口'IT 548272 A7 B7 V. Description of the invention (41) Vermiculite, fluorenylamino, ammonium-2-fluorenylbenzimidazole, 6- (1-butanylaminocarbamyl) -1- (2_qi Benzyl) _2_fluorenylbenzimidazole, bu 2-oxobenzyl) -2-methyl-6- (1-octanesulfonylaminofluorenyl) benzimidazole, -oxobenzyl ) -2-methyl-6- (2-propanesulfonylcarbamoamido) benzimidazole, ^ (biphenyl-4-methyl) -6- (1-butanesulfonylcarbamoamido) -2_methylbenzimidazole, 6- (1-butanesulfonylaminofluorenyl) > 1- (2,4 • digasobenzyl) _fluorenylbenzimidazole, 1- (bibenzyl -4-methyl) -6- (1-butanesulfonylaminocarbamyl) -2-ethylbenzimidazole, 6-benzenesulfonylaminocarbamyl_; [_ (联 笨 -4_ 甲Group) -2-trifluoromethylbenzimidazole, 5-benzenesulfenylaminofluorenyl (biben-4-methyl) -2-trifluoromethylbenzimidazole, 6_benzenesulfonylamino Fluorenyl-2-cyclopropyl-1- (2-fluorobenzyl) benzimidazole, n-benzylsulfenyl-3_ [1_ (2_fluorobenzyl) -2-methylbenzimidazole Propyl] acrylamidonium, N-benzenesulfonamido-2- [l- (2-gaso-benzyl) _2_methylbenzimidazole_6_yl] acetamidoamine, 1- (2_ Benzyl) _2_fluorenyl_6_ (2-naphthalenesulfonylaminofluorenyl) benzimidazole, 1- (2-chlorobenzyl) _2_fluorenylnaphthalenesulfonylaminocarbamyl) benzene Benzalane, 6- (4-chlorobenzite, fluorenylcarbamoylcarbamoyl, carbamoyl benzyl) -2-fluorenylbenzimidazole, 6- (3-fluorobenzenesulfonylcarbamoylmethyl) -1 -(2-chlorobenzyl) -2-methylbenzimidazole, 5-benzenesulfonylcarbamoamidinyl_ 2-benzyl-1- (2-fluorobenzyl) benzimidazole, 6_ Phenylsulfonylcarbamoyl-2-benzyl-1- (2-chlorobenzyl) benzimidazole, 6-benzenesulfonylcarbamoyl Si & yl-1- (biben-4-methyl ) -2-Amidinobenzyl, ι_ (2-Azobenzyl) -2-amidino-6-trifluoroarsenoxanthenylaminomethyl benzobenzine, 6-benzylsulfonylamino Fluorenyl_b (2,4-dioxobenzyl) _2-fluorenylbenzo. Misal, chlorobenzyl) -6- (4-Hydroxybenzylsulfonylamino) This paper is suitable for Chinese National Standard (CNS) A4 (210X297 mm) (诮 Please read the notes on the back before filling This page • Ding, Ding, \\ " A7 548272 V. Description of the invention (42) Formamyl) -2_methylbenzyl miso, Bu (2-Azoyl) -2-methyl Winter (α-Toluene "methylcarbamyl" benzimidazolam, ^ chlorinated ¥ 4) A · -methylbenzite yellow Si-methylcarbamyl) 々 · methylbenzene, (read First read the > 1 notice on the back and then fill out this page. Benzyl yellow yellow carbamoyl) benzo. Sit, W2-chlorofluorenyl peak methyl winter [4_ (trifluoromethyl) benzylcarbamyl] benzopyrene, 6. (2 · chlorochlorobenzylcarbamate) + (2: Chloroyl group) -2-methylbenzyl, benzobenzylcarbamoyl, 2benzyl small (2,4-monokistilbyl) benzyl. Benzene, sulfonylaminocarbamoyl-2-benzyl-W2,4-dichlorobenzyl) benzobenzyl, benzobenzylcarbamoylmethylbenzylmethyl) _2, phenylbenzene Side-by-side, 6 · benzenesulfonylaminocarbamyl small (biphenyl-4-methyl) benzylbenzimidyl sigma, 6 • benzenesulfonylaminocarbamyl-1- (biben-4_ (Methyl) -2_methoxybenzimidazole, benzylsulfenylcarbamoyl- 丨-(biphenyl-4_methyl) _2_carboxybenzimidazole, benzsulfenylcarbamoyl- ; U (biphenyl_4_methyl) _2-fluorenylaminobenzimidazole, 2-amino-6-benzenesulfonylcarbamoylamino —— 丨 (biben_4_methyl) benzimidyl Wow, 6_benzylxanthenylcarbamyl (biphenyl_4_methyl) _2_n-propylbenzimidazole, 6-benzenesulfonylcarbamoyl (biben_4_methyl) _2_ Butyl benzimidazole, 6-benzylsulfonylaminocarbamyl (biphenyl_'methyl) -2-oxomethylbenzimidazole, 6_benzylsulfonylcarbamoyl_ 丨 _ (bi Benzyl-4-methyl) -2-methoxymethyl benzimidazole, Benzylcarbamoyl & L-based-1- (bibenzyl-4-methyl) -2-isopropylbenzimidazole Benzylsulfonylcarbamoamidin-1- (biphenyl-4-methyl) -2- Methylthiobenzimidazole, 6-benzenesulfonylaminocarbamyl-1- (bibenzyl-4_methyl) _2_ethylthiobenzimidazole, 6_benzenesulfonylaminocarbamyl-1- (Methylbenzyl) N-propyl sulfide basic paper size Tongzhou Chinese National Standard (CNS) A4 specification (210X 297mm) Μ 548272 s__________________B7_ V. Description of the invention (43) Benzowa, 6-benzylamino Benzyl group _ 1 _ (bibenzylidene)-2 n-hexylthiobenzimidazole, 6-benzenesulfenylaminofluorenyl (benzylidene) benzimidazole, 6-benzenesulfonylaminofluorene Hydrazine, 2-diphenyl benzyl) -2-fluorenylbenzimidazole, 6-benzenesulfonylcarbamoylbibenzylmethyl) -2-benzylbenzimidazole, 6-benzenesulfonyl Aminocarbamoyl fluorenyl — 1- (2-nitrobenzyl) benzimidazole, 6-benzenesulfonylaminocarbamylfluorenyl-1-benzylbenzimidazole, 6-benzenesulfonylamino Formamidine_2_methyl-; u ('nitrobenzyl) benzimidazole, 6-benzenesulfonamidoaminofluorenyl-"(' benzyloxybenzyl) -2-fluorenylbenzimidazole, 6_benzenesulfonamidomethyl-1- (2-chlorobenzyl) -2-fluorenylbenzimidazole, N_benzylsulfenylbenzyl) _ Fluorenylbenzimidazole-6-yl] propanamide, 6-benzylsulfonylcarbamoamidinyl_2_fluorenyl-l- [4- (l, 2,3-thiadiazol-4-yl) benzyl Yl] benzimidazole, chlorobenzyl) -2-fluorenyl-6- (8-fluorinylsulfonamidocarbamoyl) benzimidazole, 6- (4- 3rd-butylbenzoxanthenylaminofluorene Fluorenyl group ^^ Benzyl benzyl) _fluorenyl benzimidazole, 6-benzoxanthan fluorenylaminofluorenyl_2_fluorenyl-fluorenyl_ [4 · (trifluorofluorenyl) benzyl] benzo Imidazole, 5-sulfoamidomethylamidomethyl benzimidazole, 1- (biphenyl_4-methyl) -6- (1-butanesulfonylaminoamido) _ 2_oxofluorenyl Benzimidazole, 1- (4-benzyloxybenzyl) butanesulfonylaminofluorenyl) -2-benzyloxybenzylbenzimidazole, butansulfonylaminofluorenyl) -1- (2,4- Bicyclobenzyl) _2_oxofluorenylbenzimidazole), ι_ (fluorenyl link group) -2-fluorenyl-6- (1_propanesulfonylaminofluorenyl) benzimidazole, 6_ethylstone Yellow si-aminoaminofluorenyl_1- (2-cyclobenzylfluorenylbenzimidazole, 6_ (propanesulfonyl- 丨 -carbonyl) -1- (2-chlorobenzyl) _2_fluorenylbenzimidazole 6-benzylsulfonylaminofluorenyl-1- (bibenz-4-methyl) -2-cyclopropylbenzimidazole 、; [_ --- ~ —____ 47 _ This paper is suitable for ffl Chinese National Standard (CNS) A4 specification (210X 297 mm) (邡 Please read the precautions on the back before filling this page] .Private ^ ·. Order- Line 548272 A7 B7 V. Description of the invention (44) (2-chlorobenzyl) -2-methyl-6- (1-pentylsulfonylaminomethylamidino) benzimidazole, 1- (2-chloro Benzyl) -2-methyl-6-[(3-methylbutyl) sulfonamidocarbamoyl] benzimidazole, 1- (2-fluorobenzylhexylsulfonylcarbamoamido)- 2-methylbenzimidazole, 7- (1-butanxanthenylcarbamoyl) di-gaso-benzyl) _2_methylbenzimidazole, 1_ (2-_o-benzyl) _2_methyl_ 6 -[1- [3- (Dicarboxylate) propyl] carbamylcarbamyl] benzyl, wow, '(1-butanesulfonylaminocarbamyl', dioxobenzylmethylbenzimidazole , 1- (4-benzyloxybenzylbutanylaminocarbamyl) _fluorenylmethylbenzimidazole, 6- (1-butanesulfonylaminocarbamyl) -1-[(2, _cyanohydrazine Phenyl-4-yl) methyl] -2-methylbenzimidazole, 6-X-Ethylsulfonylaminofluorenyl) _1-[(2'-fluorobibenzyl-4-yl) methyl] 2-methylbenzimidazole, 6_ (1-butacil Formic acid group) -l-[(3-Gaminated biphenyl) methyl] methylbenzyl miso, 1- (2-gasofluorenyl) _6_ [(2-methoxyethyl) stone yellow Carbamidyl] -2-fluorenylbenzimidazole, chlorobenzyl) -6- (1-hexylfluorenylmethylformyl) -2-methylbenzo. Meter. Sit, ι_ (2,4_ dikisordinyl) -2-benzoyl (1-pentanylpyridylaminomethyl) benzo. Mi 0, ι_ (bibenzyl-4-fluorenyl) -2-ethyl-6 [1- [3- (methylthio) propyl] sulfonylaminofluorenyl] benzimidazole, 1- (4- Bibenzylidene) -2-ethyl-6- (1-pentylsulfonylaminocarbamyl) benzimidazole, 6- (1-butanesulfonylaminofluorenyl) -1- (2,4 _Dichlorobenzyl) -2-ethylbenzimidazole, 1- (4-biphenylfluorenyl) _2-ethylfluorenyl) butyl stilbene base gas-based sulfonyl group] stupid flavor σ sitting, 5- (1-Butane yellow fermented sulfonyl group S & yl) -1- (2,4-monogasofluorenyl) -2-fluorenylbenzimid alpha all, (4 · bibenzyl)- 5- (1-Butylsulfonylaminofluorenylethylbenzimidazole, ^ (4-bibenzylfluorenyl) -2-ethyl-6- (2-fluorenylethoxysulfonylaminofluorenyl) ) (Read the precautions on the back before filling in this page,-mouth

i -1 !- I I - 1 -- · 線 本紙張尺度適W中國國家標率(CNS ) A4規格(210X29*7公釐) 48272 A7 B7 好浐部中戎打^-^Jh V-,消贽合Μ··;;卬到水 潑^明元明( I 並味 / ^ — ^ 6-(i,丁磺醯基氨基甲醯基)-2-乙基-l-[4-(4- 1 下氣)节基]笨並咪唑、6-(1-丁磺醯基氨基甲醯基)_ [4 (3,4·二氯代苄氧)苄基]_2-乙基苯並咪唑、6-(1-丁磺 、,土風基甲醯基hi·[第2(2,4_二氣代苯乙基)]_2-甲基苯 JE. υή^ 〇4λ \ ί: r λ 丁磺醯基氨基甲醯基)-1-[4-(2-吡啶基)苄 :甲基苯並咪唑、6-(1-丁磺醯基氨基甲醯基)-卜(2,4-氯代¥基)-2,心二甲基苯並咪唑、6_(1-丁磺醯基氨基甲 SE. :¾ ^ w 甘 Υ基-1-(4-苯氧苄基)苯並咪唑、6-(丁績醯基氨 土甲醯基)-2-甲基^-(2-吡啶甲基)苯並咪唑、1-[(4-苯醯 胺)T基)]-6-(1- 丁磺醯基氨基甲醯基)_2_甲基苯並咪 =二心ο-丁磺醯基氨基曱醯基)_2-曱基-[4_(2_苯乙)苄基] 笨亚咪唑、笨醯)苄基]_6_(1_ 丁磺醯基氨基甲醯 基)_孓甲基苯並咪唑、6_(丨_丁磺醯基氨基曱醯基)_2_甲基 [(2本乙雄)卞基]苯並咪ϋ坐、1-(二笨吹喃-2-甲基)-6_ (丁 κ醯基氨基甲醯基)_2_甲基苯並咪唑、6_(卜丁磺醯 土氨基甲醯基)-1_(2,4-二氣代苄基)-2-羥基笨並咪唑、6_ (1-丁磺醯基氨基甲醯基)_2_甲基-W2-喳啉甲基)苯並咪 唑、及6-(1_丁磺醯基氨基甲醯基)-2-甲基-1_[3_(4_溴代異 喳啉)甲基]笨並咪唑等為例。 式(X)所代表者係,具體而言可舉1-(2-氰苄基)6_ 乙氧羰基-2-正丙基笨並咪唑、6_乙氧羰基_2_正丙基_ 1-(2-吡啶甲基)笨並咪唑、心乙氧羰基甲基_2_正丙 基笨並咪唑、1-正丁基乙氧羰基_2_正丙基笨並咪 唑、1-(聯笨-4-甲基)_6_乙氧羰基-2•甲基笨並、卜 本紙張尺度適州中國國冬標準(CNS ) Α4規格(210X 29*7公釐) --------- 許先閱讀背面之注意事項再填寫本頁)i -1!-II-1-· The size of the paper is suitable for China National Standard (CNS) A4 size (210X29 * 7mm) 48272 A7 B7 Μ 合 M ·· ;; 卬 卬 水水 ^^ 元 元 明 (I and taste / ^ — ^ 6- (i, butanesulfonylcarbamoyl) -2-ethyl-l- [4- (4 -1 down gas) benzyl] benzimidazole, 6- (1-butanesulfonylcarbamoyl) _ [4 (3,4 · dichlorobenzyloxy) benzyl] _2-ethylbenzimidazole , 6- (1-Butylsulfonium ,, ethoxymethylmethyl} hi [[2 (2,4_digasophenethyl)] _ 2-methylbenzene JE. Υή ^ 〇4λ \ ί: r λ Butylsulfonylaminocarbamyl) -1- [4- (2-pyridyl) benzyl: methylbenzimidazole, 6- (1-butylsulfonylaminocarbamyl) -Bu (2,4- Chloro ¥ yl) -2, cardiac dimethyl benzimidazole, 6- (1-butanesulfonylcarbamyl SE.: ¾ ^ w glycinyl-1- (4-phenoxybenzyl) benzimidazole, 6- (Butylpyridinylaminocarbamyl) -2-methyl ^-(2-pyridylmethyl) benzimidazole, 1-[(4-phenylamidine) T group)]-6- (1-butyl Sulfofluorenylaminomethylsulfonyl) _2_methylbenzimidyl = 2-heart ο-butanesulfonylaminofluorenyl) _2-fluorenyl- [4_ (2_phenylethyl) benzyl] benzimidazole , Stupid) benzyl] _6_ (1_ butylsulfonylaminomethylfluorenyl) _fluorenylmethylbenzimidazole, 6_ (丨 _butylsulfonylaminoaminofluorenyl) _2_methyl [(2benethandro) Fluorenyl] benzimidazoline, 1- (dibenzyl-2-methyl) -6_ (butylκamidocarbamoyl) _2_methylbenzimidazole, 6_ (bubusulfenylamino) (Methylamidino) -1_ (2,4-dioxobenzyl) -2-hydroxybenzimidazole, 6_ (1-butanesulfonylaminomethylamidino) _2_methyl-W2-pyridinomethyl) Examples are benzimidazole and 6- (1-butanesulfonylcarbamoyl) -2-methyl-1_ [3- (4-bromoisofluorinyl) methyl] benzimidazole. The formula (X) represents, specifically, 1- (2-cyanobenzyl) 6_ethoxycarbonyl-2-n-propylbenzimidazole, 6_ethoxycarbonyl_2_n-propyl_ 1 -(2-pyridylmethyl) benzimidazole, cardioethoxycarbonylmethyl_2-n-propylbenzimidazole, 1-n-butylethoxycarbonyl_2_n-propylbenzimidazole, 1- (bi Benthyl-4-methyl) _6_ethoxycarbonyl-2 • methylbenzyl, paper size Shizhou China National Winter Standard (CNS) A4 specification (210X 29 * 7 mm) ------- -Xu first read the notes on the back before filling out this page)

、1T 線 548272 A7 B7 五、發明説明(46) 乙氧羰基-1-(2-甲氧苄基)_2_甲基笨並咪唑、心乙氧羰基 甲氧苄基)-2-甲基苯並咪唑、1β[2-(苯磺醯甲基)苄 基]-6-乙氧羰基-2-甲基苯並咪唑、1-(2_氰苄基)_6_(2_氰 卡氧羰基)-2-甲基笨並咪唑、Ν(聯苯_孓甲基)_6_乙氧羰 基甲基苯並咪唑、6-乙氧羰基-2-甲基萘甲基) 苯並味唑:W聯苯-4-甲基)_6_乙氧羰基_2_乙基τ苯並1米 唑、6-乙氧羰基-2-正丙基-1-異丙基笨並咪唑、2_苄基— 6-乙氧羰基-1-甲基苯並咪唑、6_羧基甲基_2_正丙基 笨亚咪唑、6-羧基-2-正丙基-1-異丙基笨並咪唑、“正丁 基-6-羧基-2-正丙基笨並咪唑、6_羧基甲基硝苄 基)苯並咪唑、b(聯苯_‘甲基)_6_羧基_2_甲基苯並咪 坐6-魏基-1-(2 •甲氧节基)·2-甲基笨並味。坐、緩基— 1-(4-甲氧苄基)-2-曱基苯並咪唑、6_羧基_2-甲基-(苯磺醯甲基)苄基]笨並咪唑、6-羧基-i-(2_氰苄基)-2_ 甲基苯並咪唑、6-羧基-1-(聯笨甲基)_孓甲基苯並咪 唑、6-羧基-2-甲基-1-(2-萘甲基)苯並咪唑、^(聯苯_4_ 甲基)-6-羧基-2-乙基苯並咪唑、5_羧基-2_甲基-:[_(2_硝 苄基)笨並咪唑、1_(聯笨_4_甲基)_6_羧基_2_三氟代甲基 笨並咪唑、1-(聯苯_4-曱基)_5_羧基三氟代甲基笨並 咪唑、5-乙氧羰基-2_甲基苯並咪唑、2_苄基_5_乙氧羰基 苯並咪唑、6-乙氧羰基_2_甲基“-(I硝苄基)笨並咪 唑、5 -乙氧羰基-2-曱基-1-(2-硝苄基)苯並咪唑、弘乙 氧羰基-2-三氟代甲基苯並咪唑、ι_(聯苯-4_甲基) 乙氧羰基-2-三氟代甲基苯並咪唑、1气聯苯甲基^ 本紙掁尺度適州中國國家標率(〇、5)八4規格(210\297公釐) 1 (請先閱讀背面之注意事項再填寫本頁) 、1Τ -線 548272 A7 ___________________ ___B7 五、發明説明(47) 5- 乙氧羰基-2-二氟代曱基笨並咪唑、ι_曱基_2_正丙基_ 6- [(2-吡啶甲基)氨基曱醯基]笨並咪唑、2_正丙基異丙 基-6-[(2-吡啶曱基)氨基曱醯基]笨並咪唑、卜正丁基-2_ 正丙基-6-[(2-吡啶曱基)氨基曱醯基]笨並咪唑、2_苄基_ 1- 甲基-6-[(2-吡啶曱基)氨基曱醯基]笨並咪唑、1-(2_曱氧 苄基)-2-甲基-6-[(2-吡啶曱基)氨基曱醯基]苯並咪唑、1β (4-曱氧苄基)-2-曱基-6-[(2-吡啶甲基)氨基甲醯基]苯並 咪唑、1-[2-(苯磺醯曱基)苄基]_2_甲基_6_[(2_吡啶甲基) 氨基甲醯基]笨並咪唑、丨气孓氧苄基兴2_曱基_6_[(2_吡啶 曱基)氨基曱酿基]笨並味η坐、ι_(聯笨曱基曱基-6-[(2-。比咬曱基)氨基曱醯基]笨並。米。坐、2_曱基萘曱 基)-6-[(2-咕啶曱基)氨基甲醯基]笨並咪唑、丨_(聯笨_4_ 曱基)-2_乙基-6-[(2-吡啶曱基)氨基甲醯基]苯並咪唑、2_ 曱基-1-(2-硝苄基)-6-[(2-吡啶曱基)氨基曱醯基]苯並咪 唑、2-曱基-1-(2-硝苄基)-5_[(2-吡啶曱基)氨基曱醯基]苯 並味唾、1-(聯笨_4_甲基)·2_甲基-6-[(2“比啶曱基)氨基甲 醯基]笨並咪唑、1_(4_苄氧苄基)-2-曱基-6-[(2-吡啶甲基) 氨基曱醯基]笨並咪唑、2-甲基-1-(3,4-甲二氧苄基)-6-[(2-咐啶曱基)氨基曱醯基]笨並咪唑、2_曱基-6_[(2 —。比啶 甲基)氨基甲醯基]-l-[4-(l,2,3-噻二唑-4-基)苄基]苯並咪 唾、2-曱基-5-[(2-吡啶甲基)氨基甲醯基]笨並咪唑、丨_苯 磺醯基-2-甲基-6-[(2-吡啶曱基)氨基甲醯基]笨並咪唑、^ 苯磺醯基-2-曱基-5-[(2-吡啶曱基)氨基甲醯基]苯並咪唑、 2- 甲基-1-(4-硝苄基)-6-[(2-吡啶甲基)氨基曱醯基]苯並咪 本紙張尺度適州 ( CNS ) ( 210X 297/>4 ) ' (請先閱讀背面之注意事項再填寫本頁)1T line 548272 A7 B7 V. Description of the invention (46) Ethoxycarbonyl-1- (2-methoxybenzyl) _2_methylbenzimidazole, cardioethoxycarbonylmethoxybenzyl) -2-methylbenzene Benzimidazole, 1β [2- (benzenesulfonylmethyl) benzyl] -6-ethoxycarbonyl-2-methylbenzimidazole, 1- (2_cyanobenzyl) _6_ (2_cyanocarboxycarbonyl) 2-methylbenzimidazole, N (biphenyl_fluorenylmethyl) _6_ethoxycarbonylmethylbenzimidazole, 6-ethoxycarbonyl-2-methylnaphthylmethyl) benzimidazole: W Benzene-4-methyl) _6_ethoxycarbonyl_2_ethylτbenzo1mazole, 6-ethoxycarbonyl-2-n-propyl-1-isopropylbenzimidazole, 2-benzyl— 6-ethoxycarbonyl-1-methylbenzimidazole, 6-carboxymethyl_2_n-propylbenzimidazole, 6-carboxy-2-n-propyl-1-isopropylbenzimidazole, "n Butyl-6-carboxy-2-n-propylbenzimidazole, 6-carboxymethylnitrobenzyl) benzimidazole, b (biphenyl_'methyl) _6_carboxy_2_methylbenzimidazole 6-Weiji-1- (2 • methoxybenzyl) · 2-methylbenzyl. Sit, slow — 1- (4-methoxybenzyl) -2-fluorenylbenzimidazole, 6_ Carboxy_2-methyl- (benzenesulfonylmethyl) benzyl] benzimidazole, 6-carboxy-i- (2-cyanobenzyl -2_ methylbenzimidazole, 6-carboxy-1- (bibenzylmethyl) _fluorenylmethylbenzimidazole, 6-carboxy-2-methyl-1- (2-naphthylmethyl) benzimidazole, ^ (Biphenyl_4_methyl) -6-carboxy-2-ethylbenzimidazole, 5-carboxy-2_methyl-: [_ (2_nitrobenzyl) benzimidazole, 1_ (biben_ 4_methyl) _6_carboxy_2_trifluoromethylbenzimidazole, 1- (biphenyl_4-fluorenyl) _5_carboxytrifluoromethylbenzimidazole, 5-ethoxycarbonyl-2 _Methylbenzimidazole, 2-benzyl_5_ethoxycarbonylbenzimidazole, 6-ethoxycarbonyl_2_methyl "-(I-nitrobenzyl) benzimidazole, 5-ethoxycarbonyl-2 -Fluorenyl-1- (2-nitrobenzyl) benzimidazole, ethoxycarbonyl-2-trifluoromethylbenzimidazole, ι_ (biphenyl-4-methyl) ethoxycarbonyl-2-tris Fluoromethyl benzimidazole, 1 gas dibenzyl ^ This paper is a standard Shizhou China national standard (0, 5) 8 4 specifications (210 \ 297 mm) 1 (Please read the precautions on the back before filling This page), 1T -line 548272 A7 ___________________ ___B7 V. Description of the invention (47) 5-ethoxycarbonyl-2-difluorofluorenylbenzimidazole, ι_fluorenyl_2_n-propyl_ 6- [( 2-pyridylmethyl) aminofluorene Yl] benzimidazole, 2-n-propylisopropyl-6-[(2-pyridinyl) aminofluorenyl] benzimidazole, n-butyl-2-n-propyl-6-[(2-pyridinyl) Yl) aminofluorenyl] benzimidazole, 2-benzyl_ 1-methyl-6-[(2-pyridinyl) aminofluorenyl] benzimidazole, 1- (2-fluorenyloxybenzyl) 2-methyl-6-[(2-pyridinyl) aminofluorenyl] benzimidazole, 1β (4-fluorenylbenzyl) -2-fluorenyl-6-[(2-pyridylmethyl) Carbamidyl] benzimidazole, 1- [2- (benzenesulfonyl) benzyl] _2_methyl_6 _ [(2_pyridylmethyl) carbamoyl] benzimidazole, Oxybenzyl 2-hexyl-6-[(2_pyridinyl) aminoamino]], and ^ (bibenzylidene-6-[(2-. Than bitenyl) aminoamino]]. Meter. Perylene, 2-Methenylnaphthyl) -6-[(2-cumidinyl) carbamoyl] benzimidazole, 丨 _ (biben_4_fluorenyl) -2_ethyl-6- [ (2-Pyridinyl) carbamoyl] benzimidazole, 2-fluorenyl-1- (2-nitrobenzyl) -6-[(2-pyridinyl) aminopyridyl] benzimidazole, 2 -Fluorenyl-1- (2-nitrobenzyl) -5 _ [(2-pyridylfluorenyl) aminofluorenyl] benzoxyl, 1- (bibenzyl_4_methyl) · 2-methyl- 6-[(2 "pyridinyl) carbamoyl] benzimidazole, 1- (4-benzyloxybenzyl) -2-fluorenyl-6-[(2-pyridylmethyl) aminomethyl] Benzimidazole, 2-methyl-1- (3,4-methyldioxybenzyl) -6-[(2-methylpyridinyl) aminoamido] Benzimidazole, 2_amido-6_ [ (2--pyridylmethyl) carbamoyl] -l- [4- (l, 2,3-thiadiazol-4-yl) benzyl] benzimidyl, 2-fluorenyl-5- [(2-Pyridinylmethyl) carbamoyl] benzimidazole, benzenesulfonyl-2-methyl-6-[(2-pyridinyl) carbamoyl] benzimidazole, ^ benzene Sulfonyl-2-fluorenyl-5-[(2-pyridinyl) carbamoyl] benzimidazole, 2-methyl-1- (4-nitrobenzyl) -6-[(2-pyridine Methyl) aminofluorenyl] benzimidyl paper ruler Fitness States (CNS) (210X 297 / > 4) '(Please read the notes and then fill in the back of this page)

、1T 線 548272 A7 B7 五、發明説明(48) 唾、2-曱基小(4-硝苄基)-5-[(2_吡啶甲基)氨基甲醯基]苯 並味。坐、2-曱基-1-(2-笨甲基比啶甲基)氨基曱醯 基]笨並咪唑、2-曱基-1-(2-笨曱基)·5-[(2-α比啶甲基)氨基 甲醯基]苯並咪唑、1-(4_胺苄基)_2_甲基-6_[(2_吡啶甲基) 氨基甲醯基]苯並咪唑、1-(4-胺苄基)-2-甲基-5-[(2-吡啶 曱基)氨基甲醯基]苯並咪唑、1-[4-(苯石黃醯胺基)苄基]_2_ 甲基-6-[(2^比啶甲基)氨基甲醯基]苯並咪唑、κ(聯苯_4_ 甲基)_2·曱基-6-[(2-吡啶甲基)氨基甲醯基]苯並咪唑、2-苄基-6-羧基-1-甲基苯並咪唑、4_乙氧羰基_2_曱基笨並咪 σ坐、1-(4-卞氧卞基)-6-乙氧幾基-2 -曱基笨並。米哇、ι_(4_ 苄氧苄基)_6_羧基曱基笨並咪唑、6_乙氧羰基_1-[(2,_ 氰基聯苯-4-基)甲基]-2-甲基苯並味唾、6-羧基-1-[(2,_氰 基聯苯-4-基)甲基]-2-甲基苯並咪唑、6_乙氧羰基_1-[(2,_ 氟代聯笨-4-基)甲基]-2-甲基笨並味唾、6-緩基-i-[(2,_氟 代聯笨-4-基)曱基]-2-曱基苯並咪唾、6-乙氧幾基_;[_[(% 氟代聯本-4-基)曱基]-2-曱基苯並味σ坐、6-叛基》_1_[(3_氟 代聯苯-4-基)甲基]-2-曱基苯並η米吐、1-(4_聯笨甲基)-5_ 乙氧幾基-2-乙基苯並味唾、1-(4-聯苯曱基)緩基_2_ 乙基笨並咪唑、6-乙氧羰基-2-乙基-l-[4-(4-l代辛氧基) 节基]笨並咪唑、6_羧基乙基氟代苄氧基)节 基]笨並咪唑、1-[4-(3,4-二氯苄氧基)苄基乙氧羰基 -2_乙基本並口米嗤、6_叛基_1_[4_(3,4·二氣节氧基)节 基]-2-乙基苯並咪唑、聯苯曱基)_6_(正丁基 氣基曱酿基)-2 -乙基笨並味嗤、1_(4_聯笨甲夷) (¾先閱讀背面之注意事項再镇寫本頁} 訂 本紙張尺度適中囤國家標準(CNS ) A4規格(210X29*7公釐) 548272 Α7 Β7 五、發明説明(49) 2乙基-6-(省唾-2-氨基甲驢基)苯並味唾、1_(4_聯苯甲 基)-2-乙基-6-(2-吐啶氨基甲醯基)苯並咪唑、丨吖第2(2,4_ 二氣苯乙基)]—6-乙氧羰基-2-甲基苯並咪唑、6_羧基“_ [第2(2,4-一氣笨乙基)]-2-甲基苯並17米唾、1-(4_聯笨甲 土)2乙基6(本氛基甲^基)苯並味。坐、ι_(4_聯笨甲 基)-2-乙基-6-(l,3,4-噻二唑基_2_氨基甲醯基)苯並咪 唑、1-(4-聯苯甲基)-2-乙基-6-(四唑-5-氨基甲醯基)苯並 咪唑、1-(4-聯苯甲基)_2_乙基_6_〇,3,冬三唑氨基甲醯 基)苯並咪唑、1-(4-聯苯甲基)_2-乙基-6-(1,3,4_三唑_2_氨 基甲醯基)苯並咪唑、i-G-聯苯甲基)乙基-6-(3_σ比啶氨 基甲醯基)苯並咪唑、丨兴扣聯苯甲基)_孓乙基(‘吡啶氨 基甲醯基)苯並咪唑、丨-^仁二氯代苄基)-2,4_二曱基_6_ 曱氧羰基苯並咪唑、6-羧基-1-(2,4-二氯代苄基)-2,4-二甲 基苯並咪唑、6-乙氧羰基甲基“-(扣苯氧苄基)笨並 咪唑、6-羧基-2-甲基-1-(4-苯氧苄基)笨並咪唑、心乙 氧羰基-2-曱基-1-(2-。比啶甲基)笨並咪唑、6_羧基 甲基-1-(2-。比淀曱基)笨並咪嗤、6-乙氧羰基_2_甲基_ 1_(4-硝苄基)苯並咪唑、1-(4_胺苄基乙氧羰基_2_ 曱基笨並咪唑、1-[(4-笨醯胺基)苄基]_6_乙氧羰基-2一 甲基笨並咪唑、1-[(4-笨醯胺基)苄基卜6_羧基-2_甲基 笨並咪唑、6-乙氧羰基-2-曱基_1-[4-(2-笨乙烯基)苄基] 笨並咪唑、6-乙氧羰基-2-甲基_1-[4-(2-笨乙基)苄基] 苯並咪唑、6_羧基-2-曱基-1-[4-(2-笨乙基)苄基]苯並 口米°坐、1-[(4_本醯基)午基]-6-乙氧幾基-曱基笨並咪 本紙張尺度適/1]中國國家標隼(CNS ) Λ4規格(210X 297公釐) I t. I ! I HI I I - i- = I (邡先閱讀背面之注意事項再填寫本頁j 丁 、\=口 線一 kl 548272 五、發明説明(50) '~- 唾、W(4-笨臨基抒基]冬缓基_2_甲基笨並味咬、 _2_甲基-[4-(2-苯乙烯基)苄基]笨並味 ^ 〇 ^ ^ 卜(一本亚σ比喃 _ 土)-6-乙氧幾基-2-曱基笨並味0坐、卜叛基^仁 口比喃.2-甲基)-2-甲基苯並口米唾、6•乙氧幾基_2_甲基 喳啉甲基)苯並味唑、6_緩基_2_曱基小(2_β查啉甲基)笨並 咪唑、1-(2,4-二氣代节基)-2_經基_6_乙氧幾基笨並咪 唾、6-乙氧幾基-2-甲基小[3_(4_漠代異㈣)甲基]苯並味 唾、及6省基_2•甲基_[3·(4_漠代異咳琳)甲基]苯並味哇 等為例。 式(XI)所代表的化合物之笨並咪唑衍生物之具體 例可舉1·(2-氣代节基)_6-乙氧幾基丄笨基笨並㈣、2_ 苄基羧基氣代苄基)笨並咪唑、h苄基_6_羧基_ 1-(2-氯代苄基)笨並咪唑、2_苄基羧基]_(2,4_二氯^ ¥基)苯並咪嗤、24基·6遗基小(2,4二氯代¥基)苯並 咪唑、2-苄基氣代苄基)_6_乙氧羰基笨並咪唑、1 苄基氯代苄基)-5-乙氧羰基笨並咪唑、孓苄基 (2,4_二氯代苄基)_6_乙氧羰基苯並咪唑、孓苄基_1_(2,各 二氣代苄基)-5-乙氧羰基笨並咪唑、1_(2_氯代苄基)_2_ 甲基苯並咪唑-6-醋酸、丨气、氣代苄基>孓甲基苯並咪唑 -6-甲基丙烯酸、丨-(2-氣代苄基甲基苯並咪唑_6_丙 烯酸、1-(2-氯代苄基)_6-[2_(σ比啶甲基)氨基甲醯基]苯 並咪唑、1-(聯苯-4-甲基)_6_乙氧羰基-2-甲氧甲基笨並 咪唑、1-(聯苯-4-甲基)_6_羧基甲氧甲基笨並咪唑、 1-(4-苄氧苄基)-6-乙氧羰基_2_甲氧甲基苯並咪唑、^ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公屋) (許先閱讀背面之注意事項再填寫本頁 、\:口 54 548272 A7 B7 五、發明説明(51 (4今氧苄基)领基-2_甲氧甲基苯並口米心 二# 代苄基)-6-乙氧羰基_2·甲氧甲基苯並咪唑、及 氣 (翱先閱讀背面之注意事項再填寫本頁) 1 -(2,4-二氯代节基)-2-甲氧f基苯並味嗤等為例。土 #式(ΧΠ)所代表的苯並Μ衍生物之具體例可舉6· 第^ 丁乳碳基小(2-氣代节基)-2正了基苯並味唾、1 氣代·"績叫2·正丙基苯並味哇、6_乙酿胺小 (2-虱代卞基)-2-正丙基苯並咪唑、胺基氯代苄 f 正丙基苯並咪唑、丨^氯代苄基)-2-正丙基·6-脲基 苯亚咪°坐、6·第3 T氧幾基胺基-1-(2-氯代节基)·2-甲美 苯並味唑、6-胺基-Η2-氣代节基)_2_甲基笨並咪唾、及 6-(1-丁磺醯胺基)-1-(2-氯代苄基)_孓甲基苯並咪唑等為 例。 式(XIII)所代表的苯並味唾衍生物之具體例可舉 1-(2-氯代苄基)-6-氰基-2-環丙基笨並咪唑、及1-(2_氯 代苄基)-6-氰基-2-正丙基苯並咪唑等為例。式(VI)所代 表的苯並咪唑衍生物之具體例可舉1-(2_氯代苄基) (4-二曱胺基苯甲基羰基)_2_正丙基苯並咪唑、1气2•氯 代苄基)-2-正丙基-6-硫代嗎啉羰基笨並咪唑、丨_(孓氯 代苄基)-2-環丙基-6-(2-吡啶羰基)笨並咪唑、6_(2_羧基 -1*-比略燒羰基)-1-(2-氣代苄基)-2-正丙基苯並咪唑、 卜(2-氣代苄基)-6-[N-曱基-N-(吡啶曱基)羰基卜2-正丙 基笨並味唑、1-(2-氯代苄基)_6_胡椒羰基_2-正丙基笨 並味嗤、1-(2-氣代苄基)-6-(均哌啶基羰基)_2_正丙基笨 並味啤、1-(2-氣代节基)-6-[N-曱基-N-(2“比啶)魏基]-2-正 本紙張尺度选爪中SI國家標準(CNS)A4規格(210X29^7公釐) ----- 548272 A7 ^ ^-------- B7 五、發明説明(52) —' -- 丙基苯並咪唑、2_正丁基-1-(2_氟代苄基)_6_[n_甲基_ (2比疋甲基)幾基]苯並咪嗤、2_環丙基_ι_(2_氟代苄 基>6-(胡椒羰基)苯並咪唑、2_[[1-(2_氯代苄基乙基 笨並咪唑-6-基]碳醯胺基甲基]吡啶氧化物、及^ (2,4-一氣代苄基甲基-6_(2•吡啶羰基)苯並咪唑等 為例。 又以下所列舉出之新穎的苯並咪唑衍生物亦包 含於本發明之_中,料·· W2-溴代节基)冬乙氧羰 基-2-正丙基苯並。米,坐、6_乙氧幾基小(2·氣代节基 正=基苯並咪唑、6_乙氧羰基氟代苄基)_2_正丙 基苯並咪唑、6_乙氧羰基-1-(3-氟代苄基)-2-正丙基苯 並咪唑、1-(2,6-二氯代苄基)_6_乙氧羰基正丙基苯並 咪唑、1-(3-甲苄基)_6_乙氧羰基_2_正丙基苯並咪唑、2_ 裒丙基6乙氧^基_1_(2_氟代节基)苯並咪。坐、ι_(2_氣 代苄基)_2-環丁基-6-乙氧羰基苯並咪唑、丨_(2_氣代苄 基)-6-乙氧羰基_2_正戊基苯並咪唑、5_羧基_丨_(2•氣代 苄基)_2_正丙基苯並咪唑、6_羧基_丨_(3_甲苄基)_2_正丙 基苯並咪唑、2-正丁基-7·羧基-1·(2-氣代苄基)苯並咪 唑、6-羧基-丨_(2-氟代苄基)_2_環丙基苯並咪唑、1正丁 基-6-羧基-丨气孓氟代苄基)苯並咪唑、丨兴孓氯代苄基)_6_ 氯代羰基-2-環丙基苯並咪唑、丨气孓氣代苄基)_6_嗎啉 氨基甲醯基-2-正丙基苯並咪唑、2_正丁基-1-(2_氯代苄 基)冬[(2“比啶甲基)氨基曱醯基]苯並味唑、2_正丁基_ 5_氨基甲醯基-1-(2_氣代苄基)笨並咪唑、1-(2_氯代苄基)_ 本紙張尺度適用中國國家標準(CNS ) (21〇><297公羡)1T line 548272 A7 B7 V. Description of the invention (48) Saliva, 2-fluorenyl small (4-nitrobenzyl) -5-[(2-pyridylmethyl) carbamoyl] benzo. Perylene, 2-fluorenyl-1- (2-benzylmethylpyridinylmethyl) aminofluorenyl] benzimidazole, 2-fluorenyl-1- (2-benzylmethyl) · 5-[(2- α-pyridylmethyl) carbamoyl] benzimidazole, 1- (4-aminobenzyl) _2_methyl-6 _ [(2-pyridylmethyl) carbamoyl] benzimidazole, 1- ( 4-aminobenzyl) -2-methyl-5-[(2-pyridinyl) carbamoyl] benzimidazole, 1- [4- (benzoxanthinylamino) benzyl] _2_methyl -6-[(2 ^ pyridinylmethyl) carbamoyl] benzimidazole, κ (biphenyl_4-methyl) _2 · fluorenyl-6-[(2-pyridylmethyl) carbamoyl] Benzimidazole, 2-benzyl-6-carboxy-1-methylbenzimidazole, 4-ethoxycarbonyl_2_fluorenylbenzimidazine, 1- (4-fluorenyloxy) -6- Ethoxy-2-yl is fluorenyl. Miwa, ι_ (4_benzyloxybenzyl) _6_carboxyfluorenylbenzimidazole, 6_ethoxycarbonyl_1-[(2, _cyanobiphenyl-4-yl) methyl] -2-methyl Benzo saliva, 6-carboxy-1-[(2, _cyanobiphenyl-4-yl) methyl] -2-methylbenzimidazole, 6_ethoxycarbonyl_1-[(2, _ Fluorobibenzyl-4-yl) methyl] -2-methylbenzylidene, 6-branyl-i-[(2, _fluorobibenzyl-4-yl) fluorenyl] -2- 曱Benzyl benzimidazolam, 6-ethoxyquinyl _; [_ [(% Fluorobiben-4-yl) fluorenyl] -2-fluorenylbenzo sigma, 6-tertyl "_1 _ [( 3-Fluorobiphenyl-4-yl) methyl] -2-fluorenylbentamethine, 1- (4-bibenzylmethyl) -5_ethoxyquinyl-2-ethylbenzoxyl , 1- (4-biphenylfluorenyl) sulfanyl_2_ethylbenzimidazole, 6-ethoxycarbonyl-2-ethyl-l- [4- (4-l-octyloxy) benzyl] benzyl Benzimidazole, 6-carboxyethylfluorobenzyloxy) benzyl] benzimidazole, 1- [4- (3,4-dichlorobenzyloxy) benzylethoxycarbonyl-2_ethylbenzyl Thallium, 6-tetyl_1_ [4_ (3,4 · di-aminobenzyloxy) benzyl] -2-ethylbenzimidazole, biphenylfluorenyl) _6_ (n-butylaminofluorenyl)- 2 -Ethyl Benzo and Miso, 1_ (4_ 联 笨 甲 奕) (¾Read the back first Please pay attention to writing this page again} The national standard of the paper size (CNS) A4 (210X29 * 7 mm) 548272 Α7 Β7 V. Description of the invention (49) 2 ethyl-6- (provincial saliva-2 -Carbamoyl) benzoyl saliva, 1_ (4_biphenylmethyl) -2-ethyl-6- (2-turidineaminomethylamidino) benzimidazole, azine 2 (2,4_ Digas phenethyl)]-6-ethoxycarbonyl-2-methylbenzimidazole, 6-carboxy "_ [2 (2,4-monogas ethyl)]-2-methylbenzo 17 m Saliva, 1- (4-bibenzylidene) 2 ethyl 6 (benzylmethyl) benzo. Sit, ι_ (4-bibenzylidene) -2-ethyl-6- (l, 3,4-thiadiazolyl-2-aminocarbamyl) benzimidazole, 1- (4-biphenylmethyl) -2-ethyl-6- (tetrazol-5-aminomethylfluorenyl) benzene Benzimidazole, 1- (4-biphenylmethyl) _2_ethyl_6_〇, 3, Dongtriazolecarbamoyl) benzimidazole, 1- (4-biphenylmethyl) _2-ethyl -6- (1,3,4_triazole_2_aminomethylfluorenyl) benzimidazole, iG-biphenylmethyl) ethyl-6- (3_σbipyridylcarbamoyl) benzimidazole, 丨Xing biphenylmethyl) _ ethyl ('pyridylaminomethyl) benzimidazole, 丨-^ dichlorobenzyl)- 2,4_difluorenyl_6_fluorenyloxybenzimidazole, 6-carboxy-1- (2,4-dichlorobenzyl) -2,4-dimethylbenzimidazole, 6-ethoxycarbonyl Methyl "-(benzophenoxybenzyl) benzimidazole, 6-carboxy-2-methyl-1- (4-phenoxybenzyl) benzimidazole, cardioethoxycarbonyl-2-fluorenyl-1- (2-. Bipyridylmethyl) benzimidazole, 6-carboxymethyl-1- (2-.pyridyl) benzimidazole, 6-ethoxycarbonyl_2_methyl_1_ (4-nitrobenzyl) Benzimidazole, 1- (4-aminobenzylethoxycarbonyl_2_fluorenylbenzimidazole, 1-[(4-benzylamino) benzyl] _6_ethoxycarbonyl-2-methylbenzimidazole , 1-[(4-benzylamino) benzyl 6-carboxy-2_methylbenzimidazole, 6-ethoxycarbonyl-2-fluorenyl_1- [4- (2-benzylvinyl) Benzyl] benzimidazole, 6-ethoxycarbonyl-2-methyl_1- [4- (2-benzylethyl) benzyl] benzimidazole, 6-carboxy-2-fluorenyl-1- [4 -(2-benzylethyl) benzyl] benzobenzyl, 1-[(4_benzyl) pentyl] -6-ethoxyquinyl-benzylbenzyl, paper scale suitable / 1 ] Chinese National Standard (CNS) Λ4 specification (210X 297 mm) I t. I! I HI II-i- = I 548272 V. Description of the invention (50) '~-salivary, W (4-benzylyl), winter slow _2_methylbenzyl, and _2_methyl- [4- (2-styryl) ) Benzyl] stupid ^ 〇 ^ ^ Bu (a sub-sigma sigma _ soil) -6-ethoxyquinyl-2-fluorenyl stupid and scented ^ Renopican. 2-methyl) -2-methylbenzoacetone, 6 • ethoxyquinyl_2_methylpyridinylmethyl) benzozazole, 6_stilbyl_2_ Fluorenyl small (2-βchalinelinemethyl) benzimidazole, 1- (2,4-di-oxobenzyl) -2_ meridyl_6_ethoxyquinylbenzimidazole, 6-ethoxyquinyl -2-methyl-small [3_ (4_mo-isoisopyrene) methyl] benzoyl salivate, and 6 provinces_2 • methyl_ [3 · (4_mo-isoisocyline) methyl] benzene A specific example of a benzimidazole derivative of the compound represented by the formula (XI) is 1 · (2-Azobenzyl) _6-ethoxyquinyl, benzyl, and 2_ Benzyl carboxyl gas benzyl) benzimidazole, h benzyl_6_carboxyl 1- (2-chlorobenzyl) benzimidazole, 2_benzylcarboxyl] _ (2,4_dichloro ^ ¥ Group) benzimidazole, 24 groups, 6-membered group small (2,4 dichloro substituted group) benzimidazole, 2-benzyl azobenzyl) _6_ethoxycarbonylbenzimidazole, 1 benzyl chloride Benzyl) -5-ethoxycarbonylbenzimidazole, fluorenylbenzyl (2,4-dichlorobenzyl) _6_ethoxycarbonylbenzimidazole, fluorenylbenzyl_1_ (2, each dioxobenzyl ) -5-ethoxycarbonylbenzimidazole, 1_ (2-chlorobenzyl) _2_methylbenzimidazole-6-acetate Acid, gas, benzyl group > fluorenylmethyl benzimidazole-6-methacrylic acid, 丨-(2-gaso benzylmethylbenzimidazole-6-acrylic acid, 1- (2-chloro Benzyl) _6- [2_ (σ than pyridylmethyl) carbamoyl] benzimidazole, 1- (biphenyl-4-methyl) _6_ethoxycarbonyl-2-methoxymethylbenzimidazole, 1- (biphenyl-4-methyl) _6_carboxymethoxymethylbenzimidazole, 1- (4-benzyloxybenzyl) -6-ethoxycarbonyl_2_methoxymethylbenzimidazole, ^ This paper is suitable for China National Standard (CNS) A4 size (210X297 public housing) (may read the precautions on the back before filling in this page, \: 口 54 548272 A7 B7 V. Description of the invention (51 (4 this oxybenzyl ) Lingji-2_methoxymethylbenzyl Mixin II # benzyl) -6-ethoxycarbonyl_2 · methoxymethylbenzimidazole, and qi (翱 Please read the notes on the back before filling (This page) 1-(2,4-Dichlorobenzyl) -2-methoxyf-based benzo miso, etc. as an example. Specific examples of the benzo-M derivative represented by the soil formula (χΠ) can be mentioned as follows: 6th butyl milk carbon-based small (2- oxobenzyl) -2 n-phenyl benzoyl saliva, 1 oxo. " The result is called 2 · n-propylbenzyl, w_6 ethyl ethyl amine small (2-benzylidene) -2-n-propylbenzimidazole, amine chlorobenzyl f n-propylbenzimidazole , 丨 ^ chlorobenzyl) -2-n-propyl · 6-ureidobenzimidyl °, 6 · 3rd T oxoylamino-1- (2-chlorobenzyl) · 2-form US benzimidazole, 6-amino-fluorenyl 2-azabenzyl) _2_methylbenzimidazoline, and 6- (1-butanesulfonylamino) -1- (2-chlorobenzyl) _Methylbenzimidazole and the like. Specific examples of the benzoyl salivary derivative represented by the formula (XIII) include 1- (2-chlorobenzyl) -6-cyano-2-cyclopropylbenzimidazole, and 1- (2-chloro Benzyl) -6-cyano-2-n-propylbenzimidazole and the like. Specific examples of the benzimidazole derivative represented by the formula (VI) include 1- (2-chlorobenzyl) (4-diamidinobenzylcarbonyl) _2-n-propylbenzimidazole, and 2 • chlorobenzyl) -2-n-propyl-6-thiomorpholine carbonyl benzimidazole, 丨 ((chlorochlorobenzyl) -2-cyclopropyl-6- (2-pyridylcarbonyl) benzyl Benzimidazole, 6- (2-carboxy-1 * -pyridyl carbonyl) -1- (2-gaso-benzyl) -2-n-propylbenzimidazole, di (2-gaso-benzyl) -6- [N-fluorenyl-N- (pyridinyl) carbonylcarbonyl 2-n-propylbenzazole, 1- (2-chlorobenzyl) _6_piperidylcarbonyl-2-n-propylbenzyl miso, 1- (2-Azobenzyl) -6- (Hypiperidinylcarbonyl) _2-n-propylbenzyl, 1- (2-Azobenzyl) -6- [N-fluorenyl-N -(2 "Bipyridine) Weiji] -2-The original paper size selection claw SI national standard (CNS) A4 specification (210X29 ^ 7 mm) ----- 548272 A7 ^ ^ ------- -B7 V. Explanation of the invention (52) — '--propylbenzimidazole, 2-n-butyl-1- (2-fluorobenzyl) _6_ [n_methyl_ (2 than fluorenylmethyl) Phenyl] benzimidazole, 2-cyclopropyl_ι_ (2-fluorobenzyl) > 6- (piperidylcarbonyl) benzimidazole, 2-[[1- (2-chlorobenzylethyl) Benzimidazole-6-yl] carbamidomethyl] pyridine oxide, and (2,4-monogaso benzylmethyl-6- (2 • pyridylcarbonyl) benzimidazole, etc. are exemplified. Also listed below The novel benzimidazole derivative is also included in the present invention, and the material is W2-bromobenzyl) ethoxycarbonyl-2-n-propylbenzo. M, ze, 6_ethoxy Small groups (2 · Azobenzyl n- = benzimidazole, 6-ethoxycarbonylfluorobenzyl) _2-n-propylbenzimidazole, 6_ethoxycarbonyl-1- (3-fluorobenzyl ) -2-n-propylbenzimidazole, 1- (2,6-dichlorobenzyl) -6-ethoxycarbonyl-n-propylbenzimidazole, 1- (3-methylbenzyl) _6_ethoxycarbonyl _2_n-propylbenzimidazole, 2_fluorenyl6ethoxy ^ yl_1_ (2_fluorobenzyl) benzimid., Ι_ (2_fluorobenzyl) _2-cyclobutyl- 6-ethoxycarbonyl benzimidazole, 丨 _ (2_oxobenzyl) -6-ethoxycarbonyl_2_n-pentylbenzimidazole, 5_carboxy_ 丨 _ (2 • oxobenzyl) _2 _N-propylbenzimidazole, 6_carboxy_ 丨 _ (3_methylbenzyl) _2_n-propylbenzimidazole, 2-n-butyl-7 · carboxy-1 · (2-air benzyl) Benzimidazole, 6-carboxyl- 丨 _ (2-fluorobenzyl) _2_cyclopropane Benzimidazole, 1-n-butyl-6-carboxy- 丨 pneumidofluorobenzyl) benzimidazole, 丨 fluorenylchlorobenzyl) _6_ chlorocarbonyl-2-cyclopropylbenzimidazole, gas孓 Gas benzyl) _6_morpholinecarbamidinyl-2-n-propylbenzimidazole, 2-n-butyl-1- (2-chlorobenzyl) dong [(2 "pyridylmethyl) Aminofluorenyl] benzazole, 2-n-butyl-5aminocarbamyl-1- (2_fluorobenzyl) benzimidazole, 1- (2_chlorobenzyl) _ This paper Standards apply Chinese National Standards (CNS) (21〇 > < 297 public envy)

訂 A7 548272 _________B7 _ 五、發明説明(53) (請先閱讀背面之注意事項再填寫本頁} 經M·部中央樣卒Λ只工消贽合作扣印梦 2-環丙基-6-嗎淋戴基笨並咪哇、1_(2_氯代苄基)-2-環丙 基-6-[(2-β比咬曱基)氨基甲酿基]苯並咪α坐、ι_(2-氯代节 基)-2-環丁基-6-[(2-吨唆甲基)氨基甲醯基]苯並u米唾、 1-(2-氣代苄基)-2-正丙基-5-[(2-吡啶曱基)氨基甲醯基] 苯並咪唑、1-(2-氣代苄基)-6-苯氨基曱醯基-2-正丙基 笨並咪唑、1-(2-氣代苄基)-2-正丙基-6-[(4-吡啶曱基) 氨基甲醯基]苯並咪唑、1-(2-氯代苄基)-2-正丙基-6-[(3-°比咬曱基)氨基曱醯基]苯並咪。坐、1_(3_曱苄基)-2-正丙 基-6-[(2-°比唆甲基)氨基甲酿基]苯並味σ坐、1_(2_氯代节 基)-2-乙基·6-[(2-邱b啶曱基)氨基曱醯基]笨並咪唑、2-正丁基-1·(2-氯代苄基)-7-[(2-吡啶曱基)氨基甲醯基]苯 並咪4、1-(2-氣代苄基)-6-乙氧羰基_2_甲基苯並咪 唾、1-(3 -氣代卞基)-6-乙氧幾基-2-正丙基苯並味tr坐、1_ 午基-6-乙氧幾基正丙基笨並味α坐、1_(‘氣代节基)_ 6-乙氧幾基-2-正丙基苯並味。坐、6-乙氧幾基_2_曱基_ 1-[2-(二氣代曱基)卞基]苯並咪^坐、6_乙氧魏基_2_曱基 -1-[4_(三氟代曱基)苄基]苯並咪唑、1_(3,4·二氯代节 基)-6-乙氧羰基-2-甲基苯並咪唑、6-乙氧幾基_2_甲基-1-(2-曱苄基)苯並咪唑、K4-第3 丁苄基乙氧緩i基 _2_甲基苯並咪唑、1_(2_氯代苄基)巧_乙氧羰基甲基 苯並咪唑、i_(2,6-二氯代苄基)_6_乙氧羰基_2_曱基笨並 咪唑、1-(2,4-二氣代苄基)-6-乙氧羰基_2-甲基笨並咪 唑、6-羧基-K4-氣代苄基)_2-正丙基苯並咪唑、6•羧基 -l-(2,6-二氣代苄基)-2-甲基笨並咪唑、6-羧基_2_曱基 本紙張尺度刺巾關家標準(CNS ) A4規格(21G X297^ ) ' -------_ 548272 A7 B7 五、發明説明(54) [2-(三氟代甲基)苄基]笨並咪唑、心羧基_2_甲基-丨-^^二 氟代甲基)苄基]苯並咪唾、6_魏基-1_(3,4_二氣代苄基)_2_ 甲基本並米σ坐、1-卞基-6-魏基-2-正丙基笨並σ米哇、6_幾 基-1-(3-氣代节基)-2-正丙基苯並味唾、&緩基_ι_(24-二 氯代苄基)_2_甲基苯並咪唑、1_(4_第;3 丁苄基)_6_羧基-2-甲基苯並咪唑、6-羧基-2-甲基-1-(2-甲苄基)苯並味 唑、1-苄基-6-羧基-2-甲基苯並咪唑、5-羧基氣代 苄基)_2_甲基苯並咪唑、6_羧基氯代苄基)_2_甲基笨 並口米σ坐、1-(2,4-一氯代卞基)-2-甲基-6-[(2-。比咬曱基)氨 基曱醯基]笨並咪唑、1-(2-氯代苄基)-2-曱基-6_[(孓吡啶 曱基)氨基曱醯基]苯並咪唑、1-(3-氣代苄基)_2_正丙基_ 6-[(2·-比啶曱基)氨基曱醯基]苯並咪唑、丨_吡基_2_正丙基 -6-[(2-。比咬曱基)氨基曱醯基]笨並味β坐、1_(4_氣代节 基)-2-丙基-6-[(2-。比啶甲基)氨基甲醯基]笨並咪唑、^ (2,6-二氯代苄基)-2-甲基-6-[(2-吡啶甲基)氨基甲醯基] 苯並咪唑、2-曱基-6-[(2-α比啶曱基)氨基曱醯基(三 氟代甲基)卞基]苯並味σ坐、2-曱基-6-[(2-处咬曱基)氨基 曱醯基]_1-[4-(三氟代甲基)苄基]苯並咪唑、1-(3,4_二氣 代苄基)-2-甲基-6-[(2-吐咬曱基)氨基甲酿基]笨並口米 σ坐、2-曱基小(2-曱苄基)-6-[(2-邱t咬曱基)氨基曱酸基]苯 並味哇、1_节基_2·曱基-6-[(2-°比唆曱基)氨基曱酿基]笨 並咪唑、1-(4-第3 丁苄基)-2-曱基-6-[(2-吡啶甲基)氨基 曱酿基]笨並咪唑、6-氨基曱醯基-1-(2,4-二氣代苄基)_2_ 曱基笨並咪唑、1-(2,4-二氟代苄基)-2-甲基-6-[(2-吡啶甲基) 本紙張尺度過州中國國家標準(CNS ) Λ4規格(210X 297公釐) (誚先閱讀背面之注意事項再填寫本頁 ^^1. 、\呑 線一 548272 ΚΊ Β7 五、發明説明(55) — 氨基甲醯基]苯並咪唑、1-(2,4_二氟代苄基曱基_5_ [(2-α比咬曱基)氨基曱酿基]苯並σ米嗤、二氟代节 基>7-乙氧羰基-2-曱基笨並咪唑、7_羰基q_(2,4_二氣代 苄基)_2_曱基苯並咪唑、1_(2,4_二氣代苄基)_‘乙氧羰基 -2-曱基笨並咪唑、4_羧基_1-(2,4_二氣代苄基)_2_甲基笨 並咪唑、1-(2,4-二氣代苄基>5-乙氧羰基甲基苯並 唑、5-羧基-^2,4-二氯代苄基)_2_甲基苯並咪唑、及&(正 丁基氨基曱醯基)-1-(2,4-二氯代苄基曱基苯並咪 〇 以上所述之本發明的笨並咪唑衍生物及其等之作 為醫藥可容許的鹽類係,基於其也糖效果活性,例如對 於耐糖能失調、冑尿病(第η型糖尿病)、糖尿病合併症 (,尿病性腎病、糖尿病㈣經失調、糖尿病性網膜症 寺)、胰島素抗性症候群(胰島素受體異常症、R〇bs〇心Order A7 548272 _________B7 _ V. Description of the invention (53) (Please read the precautions on the back before filling out this page} After the central sample of the M department, 工 only eliminates the cooperation and stamps the dream 2-cyclopropyl-6-? Lymphylbenzimidazole, 1_ (2-chlorobenzyl) -2-cyclopropyl-6-[(2-β specific sulfanyl) carbamoyl] benzyl alpha, ι_ (2 -Chlorobenzyl) -2-cyclobutyl-6-[(2-ton fluorenylmethyl) aminomethylfluorenyl] benzoumisaline, 1- (2-fluorobenzyl) -2-n-propyl 5--5-((2-pyridinyl) carbamoyl) benzimidazole, 1- (2-airobenzyl) -6-benzaminofluorenyl-2-n-propylbenzimidazole, 1 -(2-Aminobenzyl) -2-n-propyl-6-[(4-pyridinyl) carbamoyl] benzimidazole, 1- (2-chlorobenzyl) -2-n-propyl -6-[(3- ° specific fluorenyl) aminofluorenyl] benzimidyl. 1- (3_fluorenylbenzyl) -2-n-propyl-6-[(2- ° specific fluorenyl Carbamoyl) benzoyl sigma, 1_ (2-chlorobenzyl) -2-ethyl · 6-[(2-Qiudinyl) aminoamido] benzimidazole, 2 -N-butyl-1 · (2-chlorobenzyl) -7-[(2-pyridinyl) carbamoyl] benzimidene 4,1- (2-fluorobenzyl) -6-ethyl Oxycarbonyl_2 _Methylbenzimidyl salivate, 1- (3 -airofluorenyl) -6-ethoxyquinyl-2-n-propylbenzoxyl, 1-amyl-6-ethoxyn-n-propyl Stupid and scented α, 1 _ ('Azobenzyl) _ 6-ethoxyquinyl-2-n-propylbenzo. Scent, 6-ethoxyquinyl_2_fluorenyl_ 1- [2- (Dioxofluorenyl) fluorenyl] benzimidyl, 6_ethoxyweiyl_2_fluorenyl-1- [4_ (trifluorofluorenyl) benzyl] benzimidazole, 1_ (3, 4 · Dichlorobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole, 6-ethoxyquinyl-2-methyl-1- (2-fluorenylbenzyl) benzimidazole, K4- 3rd Benzyl ethoxyl group 2_methylbenzimidazole, 1_ (2-chlorobenzyl) quinone_ethoxycarbonylmethylbenzimidazole, i_ (2,6-dichlorobenzyl) _6 _Ethoxycarbonyl_2_fluorenylbenzimidazole, 1- (2,4-dioxobenzyl) -6-ethoxycarbonyl_2-methylbenzimidazole, 6-carboxy-K4-oxobenzyl Group) _2-n-propylbenzimidazole, 6 • carboxy-l- (2,6-digaso-benzyl) -2-methylbenzimidazole, 6-carboxy_2_ 曱 Basic paper scale Home Standard (CNS) A4 Specification (21G X297 ^) '-------_ 548272 A7 B7 V. Description of the Invention (54) [2- (trifluoromethyl) benzyl] benzimidium , Heart carboxy_2_methyl- 丨-^^ difluoromethyl) benzyl] benzimidal, 6_weiyl-1_ (3,4_digasobenzyl) _2_methylbenzamizineσ Sat, 1-fluorenyl-6-weiyl-2-n-propylbenzyl sigma miwa, 6-Ichizyl-1- (3-oxobenzyl) -2-n-propylbenzo sial, & Branyl_ι_ (24-dichlorobenzyl) _2_methylbenzimidazole, 1_ (4_th; 3 butylbenzyl) _6_carboxy-2-methylbenzimidazole, 6-carboxy-2-methyl 1- (2-methylbenzyl) benzimidazole, 1-benzyl-6-carboxy-2-methylbenzimidazole, 5-carboxy air-benzyl) -2-methylbenzimidazole, 6 _Carboxylchlorobenzyl) _2_methylbenzyl, 1- (2,4-monochlorofluorenyl) -2-methyl-6-[(2-. Specific sulfonyl) aminofluorenyl] benzimidazole, 1- (2-chlorobenzyl) -2-fluorenyl-6 _ [(fluorenylpyridinyl) aminofluorenyl] benzimidazole, 1- ( 3-Aromatic benzyl) _2_n-propyl_ 6-[(2 · -pyridinyl) aminopyridyl] benzimidazole, 丨 _pyridyl_2_n-propyl-6-[(2 -. Than stilbene) amino stilbyl] stupid β-single, 1- (4- azabenzyl) -2-propyl-6-[(2-. Pyridylmethyl) carbamoyl] Benzimidazole, ^ (2,6-dichlorobenzyl) -2-methyl-6-[(2-pyridylmethyl) carbamoyl] benzimidazole, 2-fluorenyl-6-[( 2- [alpha] pyridinyl) aminoamino (trifluoromethyl) fluorenyl] benzo sigma, 2-fluorenyl-6-[(2-position fluorenyl) aminofluorenyl] _1 -[4- (trifluoromethyl) benzyl] benzimidazole, 1- (3,4-dioxobenzyl) -2-methyl-6-[(2-tetramethylpyridyl) carbamate Brewing group] Stupid glutamate rice sigma, 2-fluorenyl small (2-fluorenylbenzyl) -6-[(2-Quet fluorenyl) aminophosphonic acid group] benzo flavor wow, 1_septyl_ 2 · fluorenyl-6-[(2- ° specific fluorenyl) aminofluorenyl] benzimidazole, 1- (4-third butylbenzyl) -2-fluorenyl-6-[(2-pyridylmethyl ) Aminopyrene] Benzimidazole, 6-Ammonia Fluorenyl-1- (2,4-difluorobenzyl) _2_ fluorenylbenzimidazole, 1- (2,4-difluorobenzyl) -2-methyl-6-[(2-pyridine Methyl) This paper has passed the Chinese National Standard (CNS) standard Λ4 specification (210X 297 mm) (诮 Please read the notes on the back before filling in this page ^^ 1. \ 、 线 一 548272 ΚΊ Β7 V. Description of the invention (55) —carbamoyl] benzimidazole, 1- (2,4-difluorobenzylfluorenyl_5_ [(2-α than fluorenyl) aminofluorenyl]] benzoσmidine, Difluorobenzyl > 7-ethoxycarbonyl-2-fluorenylbenzimidazole, 7_carbonyl q_ (2,4_digaso benzyl) _2_fluorenylbenzimidazole, 1_ (2,4_ Dioxobenzyl) _ 'ethoxycarbonyl-2-fluorenylbenzimidazole, 4-carboxyl-1- (2,4_dioxobenzyl) _2_methylbenzimidazole, 1- (2, 4-dioxobenzyl > 5-ethoxycarbonylmethylbenzoxazole, 5-carboxy- ^ 2,4-dichlorobenzyl) -2-methylbenzimidazole, and & (n-butyl Aminofluorenyl) -1- (2,4-dichlorobenzylfluorenylbenzyl) Benzoimidazole derivatives of the present invention as described above and their pharmaceutically acceptable salts are based on It is also sugar effect active, for example Impaired glucose tolerance, diarrhea (n-type diabetes), diabetic comorbidities (urinary nephropathy, diabetic dysmenorrhea, diabetic omentum), insulin resistance syndrome (insulin receptor abnormalities, Robs) 〇 Heart

Mendenhall ^ # , leprechaunism^ Kobberling-Dunnigan 症候=、Seip症候群、Lawrence症候群、“也叩症候 群二前端巨大症等)、高脂血症、動脈粥樣硬化症、心 =管疾病(狹心症、心不全等)、高▲糖症(例如附加上攝 ⑤失調等異常糖代謝之特徵者)、或高血壓症等具有預 防及治療之功用;再者基於其cGMP-PDE(特別是PDE_ P制作用平,骨筋弛緩作用、氣管擴張作用、血管擴 平π筋細胞抑制作用、過敏抑制作用等,對於 狹心症、高血壓、肺高血壓、充血性心不全、腎小球疾 :(例如糖尿病性腎小球硬化症等)、尿細管間質性疾 (讀先閱讀背面之注意事項再填寫本頁 裝·· 、1ΤMendenhall ^ #, leprechaunism ^ Kobberling-Dunnigan Syndrome =, Seip Syndrome, Lawrence Syndrome, "Second-end megacephaly syndrome, etc.), Hyperlipidemia, Atherosclerosis, Heart = Duct Disease (Arrhythmia, Arrhythmia) Etc.), high ▲ glycemia (such as those with abnormal glucose metabolism characteristics such as ⑤ imbalance), or hypertension and other preventive and therapeutic functions; based on its cGMP-PDE (especially PDE_ P production level , Bone tendon relaxation, tracheal dilation, vasodilation, π tendon cell inhibition, allergic inhibition, etc., for stenosis, hypertension, pulmonary hypertension, congestive heart failure, glomerular disease: (such as diabetic Globular sclerosis, etc.), Urinary tubulointerstitial disease (Read the precautions on the back before filling out this page ... 1T

π (RJπ (RJ

(式(I)中’ Ri為氫原子、芳磺醯基、或低級烷基 級烧基係, 548272 五、發明説明(56) 病(例如基於FK506、環孢子素等 不全、動脈粥樣硬化、血管狹窄所^起的腎藏病)、腎 術後者)、太耥A其广广 ?如 '經皮性動脈形成手 T後者)末稍血官疾病、腦溢血、慢性可 病(例如支氣管炎、氣喘(慢性氣喘 '過土,疾 性鼻炎、蓴麻療、青光眼、特徵為腸運動性昱而」)、過敏 (例如過敏症腸症料)、陽萎(例 蒌7疾病 := 尿:;併細如糖尿:糖尿:: 跃 洋糖尿病性網膜症等)、 :二f;癌、或PCTA後的再狹窄等各種疾病的預防 及治療相當有效。 又本發明者等發現出,本發明者等在特開平5_ 22000唬么報中所揭不出之用來作為c_GMp磷酸二酯 酶抑㈣之笨並W衍生物亦顯示出前述般之活性,亦 即此等笨並咪唑衍生物可作為相同於前述化合物般之 有效的治療劑或預防劑。 亦即本發明亦包含下式⑴所代表之苯並咪唑衍生物 或以其等的鹽類作為有效成分之醫藥上可容許的藥劑, (I) 該低 本紙張尺度適削,關家標準(CNS ) Μ規格(21〇>< 297公釐 (誚先閱讀背面之注意事項再填寫本頁) 、-口 548272 A7 -------------------B7^ 五、發明説明(57) — ~— ---- 可使用擇自由_素原子、鹵芳基、低級燒基、i低級烧 基'低級燒氧基、石肖基、胺基、氰基、芳基、芳基低級 烧基、芳基低⑽氧基、㈣基低㈣氧基、芳績酿基 低級烧基、芳雜基胺基、氰芳基及雜環基所構成群中 之一個或二個基取代4,亦可使用芳&或雜環基取代 之。 尺2為氫原子、低級環烷基、羥基、低級烷氧基、 锍基、低級烷硫基、胺基、低級烷胺基、羧基、芳基、 或低級燒基;該低級院基可使用鹵素原子、低級二氧 基、氰基、氣羰基、芳基、或雜環基取代之。 R3為羧基、經酯化之羧基、醯胺化之羧基、胺基、 醯胺基、或磺醯基;該胺基及該醯胺基可使用醯基或磺 醯基取代之;該磺醯基為與_素原子、胺基或醯胺基相 結合者。又,I可介由低級伸烷基或低級烯撐基而與母 核相結合。 R#為中性之取代基。R4可為鹵素原子、或院基、 芳烷基、炔基、低級烷氧基或此等之經_素取代者。當 R4為L基時,其為飽和或不飽和、鏈狀或環狀皆可,看 情形亦可為分枝狀者。當其為_素原子或經_素取代 時,可使用任何一種鹵素,且數量不拘。 η代表0〜3之整數。因此,可結合1個、2個或3個 之R4,又不結合&亦可。又,其結合位置係,對於其他 取代基而言為鄰位、間位、對位皆可。);其為可作為耐 糖能失調、糖尿病(第II型糖尿病)、糖尿病合併症(糖尿 % 尺度遙财¥國^7^7^規格(2ι〇χ297|^ '~— ---------扯,丨 (諳先閱讀背面之注意事項再填寫本頁j 、=口 線 548272 6JL. A7 五、發明説明(58) 病性腎病、糖尿病性 胰島素抗性症候群w =㈣病性網膜症等)、(In the formula (I), 'Ri is a hydrogen atom, arylsulfonyl group, or a lower alkyl-based alkyl group, 548272. V. Description of the invention (56) Disease (such as based on FK506, insufficiency such as cyclosporine, atherosclerosis , Kidney disease caused by vascular stenosis), those after renal surgery), is it too wide? Such as 'percutaneous arterial formation, the latter) terminal hemorrhagic disease, cerebral hemorrhage, chronic diseases (such as bronchitis, asthma (chronic asthma'), soil rhinitis, ramie therapy, glaucoma, characterized by intestinal motility "Yu Er"), allergies (such as allergic intestinal material), impotence (eg 疾病 7 disease: = urine :; and as fine as diabetes: diabetes: diabetes mellitus omental disease, etc.),: two f; cancer, It is quite effective in the prevention and treatment of various diseases such as restenosis after PCTA and the like. The inventors have found that the inventors cannot disclose it as a c_GMp phosphodiesterase in Unexamined Japanese Patent Publication No. 5-22000. Inhibitory benzobenzazole derivatives also exhibit the aforementioned activity, that is, these benzoimidazole derivatives can be used as effective therapeutic or preventive agents as the aforementioned compounds. That is, the present invention also includes the following formula: The representative benzimidazole derivative or a pharmaceutically acceptable medicament with the salts thereof as an active ingredient, (I) The low paper size is suitable for cutting, and the family standard (CNS) M specification (21〇 > < 297 mm (诮 Read the precautions on the back before (Write this page), -port 548272 A7 ------------------- B7 ^ V. Description of the invention (57) — ~ — ---- You can use optional free _ prime Atom, haloaryl, lower alkynyl, i-lower alkynyl 'lower alkynyl, schottyl, amine, cyano, aryl, aryl lower alkynyl, arylloweroxy, fluorenylloweroxy , One or two groups in the group consisting of lower aromatic group, lower alkynyl group, arylheteroamino group, cyanoaryl group and heterocyclic group may be substituted by 4, or aryl & or heterocyclic group may be substituted. Is a hydrogen atom, a lower cycloalkyl group, a hydroxyl group, a lower alkoxy group, a fluorenyl group, a lower alkylthio group, an amine group, a lower alkylamino group, a carboxyl group, an aryl group, or a lower alkyl group; a halogen atom may be used for the lower academic group , Lower dioxy, cyano, carbonyl, aryl, or heterocyclyl. R3 is carboxyl, esterified carboxyl, amidated carboxyl, amine, amidino, or sulfonyl; The amine group and the sulfonyl group may be substituted with a fluorenyl group or a sulfonyl group; the sulfonyl group is a combination with a hydrogen atom, an amine group, or a sulfonyl group. Also, I may be through a lower alkylene group or Lower alkenyl group Binding. R # is a neutral substituent. R4 may be a halogen atom, or a phenyl group, an aralkyl group, an alkynyl group, a lower alkoxy group, or the like. When R4 is an L group, it It can be saturated or unsaturated, chain or cyclic, and it can also be branched. When it is a prime atom or substituted with a prime, any kind of halogen can be used, and the number is not limited. Η represents 0 An integer of ~ 3. Therefore, one, two, or three R4 can be combined without &. The binding position is ortho, meta, and para for other substituents. Both can be.); It can be used as glucose tolerance disorders, diabetes (type II diabetes), diabetes comorbidities (diabetes% scale remote wealth ¥ 国 ^ 7 ^ 7 ^ specifications (2ι〇χ297 | ^ '~ --- --- ------ Pull, 丨 (谙 Please read the notes on the back before filling in this page j 、 = 口 口 548548 6JL. A7 V. Description of the invention (58) Sick nephropathy, diabetic insulin resistance syndrome w = ㈣ Diseased omentum, etc.),

Me H , n 、群(胰島素受體異常症、Robson-Me H, n, group (insulin receptor abnormality, Robson-

Mendenhall 症候 n · LePrechaumsm > Kobberling-Mendenhall syndrome nLePrechaumsm > Kobberling-

Dunnigan 症候群、s g P症候群、Lawrence症候群、 Cushing症候群、前經 々 ^ 石#介、广、、1 - ;正寺)、高脂血症、動脈粥樣 疾病(狹心症、心不全等)' 高血糖症(例 如附加上攝食矣纲蝥、 調寺”吊糖代謝之特徵者)、或高血壓 ’正5〜症、高血壓、#高血壓、充血性心不全 小球疾病(例如糖尿病性腎小球硬化症等)、尿細管間質 性疾病」例如基於FK5〇6、環孢子素等所引起的腎藏 病)、腎不全、動脈粥樣硬化、血管狹窄(例如經皮性動 脈形成手術後者)、末稍血管疾病、腦溢血、慢性可逆 性閉塞性疾病(例如支氣管炎、氣喘(慢性氣喘、過敏性 氣喘)上、過敏性鼻炎、蓴麻疹、青光眼、特徵為腸運動 性異常之疾病(例如過敏症腸症候群)、陽萎(例如器官性 陽萎精神性陽萎等)、糖尿病合併症(例如糖尿病壞 疽、糖尿病關節症、糖尿病性腎小球硬化症、糖尿病性 皮膚異常、糖尿病性神經異常、糖尿病性白内障、糖尿 病性網膜症等)、腎炎、惡性癌、或pc丁A後的再狹窄 等的預防、治療劑使用之醫藥製劑。 式(I)所代表的苯並咪。坐衍生物之具體例可舉丁 基-1-(2-氣代苄基)-6-乙氧羰基苯並咪唑、1气4_溴_2_氟 代苄基)-2-丁基-6-乙氧羰基苯並咪。坐、2-丁基-1_(2 ‘ 一 氯代苄基)-6-乙氧羰基笨並咪唑、2-丁基-6-乙氧碳酿 本纸張尺度適州中國國家標率(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁) 、=口 •丨線 48272 A7 B7 發明説明(59) — 基1-(4-甲氧碳基节基)笨並味σ坐、丁基冬乙氧幾基-W2'氟代节基)苯並味σ坐、2_丁基·卜乙氧幾基小&三氟 代曱¥基)苯並咪唾、W2-氣代¥基)冬乙氧幾基士乙 基笨並咪唑、i-(2-氣代苄基)_6_乙氧羰基丙基苯並咪 坐、1-(2-氯代苄基)-2-環丙基-6-乙氧羰基苯並咪唑、 1- (2-氣代苄基)-6_乙氧羰基_2_異丙基苯並咪唑、2_丁基 4-(2-氣代苄基)-5-乙氧羰基苯並咪唑、2…丁基―丨气孓氯 代苄基)-7-乙氧羰基苯並咪唑、丨气孓氣代苄基)_5_乙氧 羰基-2-丙基苯並咪唑、2_丁基_1-(2_氯代苄基)_6_羧基笨 並咪唑、2-丁基-6-羧基-1-(4-羧基苄基)苯並咪唑、6_羧 基-1-(2-氯代苄基)-2-乙基苯並咪唑、6-羧基-1β(2-氯代 卞基)-2-丙基苯並咪唑、6-羧基氣代苄基)_2_環丙 基苯並咪唑、2-丁基-5-羧基-1-(2-氣代苄基)咪唑、2-丁 基-1-(2-氣代苄基)-6·二甲基氨基曱醯基笨並咪唑、6_ (苄基氨基曱醯基)-2-丁基-i^2-氯代苄基)苯並咪唑、2_ 丁基1 (2-氣代卞基)-6-嗎淋幾基苯並味。坐、2 -丁基- 6· 氨基曱醯基-(2-氣代苄基)苯並咪唑、2-丁基氯代 卞基)-6-(4-曱基派批)魏基苯並^米α坐、2_ 丁基氣代 卞基)-6-(曱基氣基曱醯基)苯並味σ坐、^氨基曱隨基 (2-氣代苄基)-2-乙基笨並咪唑、6-氨基曱醯基氣代 苄基)_2_丙基笨並咪唑、6_氨基甲醯基氣代苄基)_ 2- 環丙基笨並咪唑、2_ 丁基氨基曱醯基-κ(2_氯代苄 基)笨並咪唑、2-丁基-1-(2-氣代苄基)_6_(異丙基羰基) 笨並咪唑、1-(2-氣代苄基)-6-氯代甲醯基_2_丙基笨 (請先閱讀背面之注意事項再填寫本頁jDunnigan Syndrome, sg P Syndrome, Lawrence Syndrome, Cushing Syndrome, Anterior Meridian ^ 石 # 介 , 广 ,, 1-; 正 寺), Hyperlipidemia, Atherosclerosis (Arrhythmia, Arrhythmia, etc.) 'High Glycemic disease (for example, those with the characteristics of glucose metabolism in the form of ingestion 矣 矣, Tiao Temple), or high blood pressure '+5, disease, hypertension, #hypertension, congestive heart failure (such as diabetic glomerulopathy) Bulbar sclerosis, etc.), urinary tubulointerstitial diseases "such as renal disease due to FK506, cyclosporine, etc.), renal insufficiency, atherosclerosis, vascular stenosis (e.g., percutaneous arterial surgery ), Peripheral vascular disease, cerebral hemorrhage, chronic reversible occlusive disease (such as bronchitis, asthma (chronic asthma, allergic asthma), allergic rhinitis, measles, glaucoma, diseases characterized by abnormal bowel movements (such as Allergic bowel syndrome), impotence (such as organic impotence, mental impotence, etc.), diabetic comorbidities (such as diabetic gangrene, diabetic joint disease, diabetic glomerular stiffness Disease, diabetic skin abnormalities, diabetic neurological abnormalities, diabetic cataracts, diabetic retinopathy, etc.), nephritis, malignant cancer, or restenosis after PCA, etc., pharmaceutical preparations for use as a therapeutic agent. Formula (I The specific examples of benzimide represented by) are butyl-1- (2-gaso-benzyl) -6-ethoxycarbonylbenzimidazole, 1-gas 4-bromo_2_fluorobenzyl ) -2-butyl-6-ethoxycarbonylbenzimidyl. Sat, 2-butyl-1_ (2 'monochlorobenzyl) -6-ethoxycarbonylbenzimidazole, 2-butyl-6-ethoxycarbon brewing paper scale Shizhou China National Standard (CNS ) A4 specification (210X 297mm) (read the precautions on the back before filling this page), = 口 • 丨 line 48272 A7 B7 invention description (59) — 1- (4-methoxycarbon-based base) Stupid sigma, butyl winter ethoxyl-W2'fluorobenzyl) benzo-sigma sigma, 2-butyl · buthoxyxyl small & trifluorofluorenyl (benzyl) benzimidyl Salivary, W2-Atomyl radicals) Ethoxybenzyl ethylbenzimidazole, i- (2-Atomylbenzyl) _6_ethoxycarbonylpropylbenzimidazole, 1- (2-chloro Benzyl) -2-cyclopropyl-6-ethoxycarbonylbenzimidazole, 1- (2-Gasoxybenzyl) -6_ethoxycarbonyl-2-isopropylbenzimidazole, 2-butyl 4 -(2-Atomylbenzyl) -5-ethoxycarbonylbenzimidazole, 2 ... butyl- 丨 Azobenzylchlorobenzyl) -7-Ethoxycarbonylbenzimidazole, 丨 Atomobiumbenzyl) _5_ethoxycarbonyl-2-propylbenzimidazole, 2-butyl_1- (2-chlorobenzyl) _6_carboxybenzimidazole, 2-butyl-6-carboxy-1- (4- Carboxybenzyl) benzimidazole, 6_carboxy-1- (2-chlorobenzyl) -2-ethylbenzimidazole, 6-carboxy-1β (2-chlorofluorenyl) -2-propylbenzimidazole, 6-carboxybenzyl) _2_ ring Propyl benzimidazole, 2-butyl-5-carboxy-1- (2-fluorobenzyl) imidazole, 2-butyl-1- (2-fluorobenzyl) -6 · dimethylaminofluorene Fluorenylbenzimidazole, 6- (benzylaminofluorenyl) -2-butyl-i ^ 2-chlorobenzyl) benzimidazole, 2-butyl 1 (2-oxofluorenyl) -6-? Pour a few bases of benzo. Perylene, 2-Butyl-6 · aminofluorenyl- (2-fluorobenzyl) benzimidazole, 2-butylchlorofluorenyl) -6- (4-fluorenyl group) Weidylbenzo ^ Αα, 2-butylamino substituted fluorenyl) -6- (fluorenylaminofluorenyl) benzo, σα, ^ aminopyridinyl (2-aminobenzyl) -2-ethylbenzyl Benzimidazole, 6-aminofluorenylaminobenzyl) _2-propylbenzimidazole, 6-aminobenzylaminobenzyl) _ 2-cyclopropylbenzimidazole, 2-butylaminobenzyl -κ (2-chlorobenzyl) benzimidazole, 2-butyl-1- (2-gaso-benzyl) -6_ (isopropylcarbonyl) benzimidazole, 1- (2-gaso-benzyl) -6-Chloroformyl-2_propylbenzyl (Please read the precautions on the back before filling in this page j

、1T 線 本紙張尺度過Λ中國國家標隼(CNS ) A4規格(210X 297公楚) 548272 Α7 Β7 五、發明説明(60) (請先閱讀背面之注意事項再填寫本頁 並咪唑、1-(2_氯代苄基)-6-(甲基氨基甲醯基)-2-丙基笨 並咪唑、1-(2-氣代苄基)_6-(乙基氨基甲醯基)_2_丙基笨 並咪唑、1-(2-氣代苄基)_6_(異丙基氨基甲醯基丙基 苯並咪唑、1气2_氣代苄基)_6_(哌啶羰基)_2_丙基苯並咪 唑、氣代苄基)-卜(嗎啉羰基)-2-丙基笨並咪唑、1-(2_ 氯代¥基)-6-(2-嗎啉乙基氨基甲醯基卜2-丙基苯並咪 唑、1-(2-氣代苄基)_6-[4_(2-羥基乙基)哌粃基]羰基_2_丙 基苯並咪唑、1-(2_氯代苄基)-2-丙基-6-(2-吡啶甲基)氨基 甲醯基笨並咪唑、及1-(2-氯代苄基)-2-丙基-6-[4-(4-苯基 -1,2,3,6-四氫吨啶4_基)丁基]氨基甲醯基笨並咪唑等為 例。1. The paper size of the 1T line paper has passed the Chinese National Standard (CNS) A4 specification (210X 297 Gongchu) 548272 Α7 Β7 5. Invention Description (60) (Please read the precautions on the back before filling in this page and imidazole, (2-chlorobenzyl) -6- (methylaminomethylmethyl) -2-propylbenzimidazole, 1- (2-aminobenzyl) _6- (ethylaminomethylmethyl) _2_ Propyl benzimidazole, 1- (2-gaso-benzyl) _6_ (isopropylcarbamoylpropylbenzimidazole, 1-gaso 2-benzyl) _6_ (piperidinecarbonyl) _2_propyl Benzimidazole, oxobenzyl) -bu (morpholinecarbonyl) -2-propylbenzimidazole, 1- (2-chlorochloro) -6- (2-morpholineethylcarbamoyl) b 2 -Propylbenzimidazole, 1- (2-fluorobenzyl) _6- [4_ (2-hydroxyethyl) piperidinyl] carbonyl-2-propylbenzimidazole, 1- (2-chlorobenzyl ) -2-propyl-6- (2-pyridylmethyl) carbamoylbenzimidazole and 1- (2-chlorobenzyl) -2-propyl-6- [4- (4- Phenyl-1,2,3,6-tetrahydrotantidine 4-yl) butyl] carbamoylbenzimidazole and the like are taken as examples.

、1T 線 ^本^明之本並味σ坐衍生物用在治療上時,可令其 此合適於經口服用或外用之有機、無機固狀體或液體賦 形劑般之醫藥上可容許的擔體,藉此以形成以前述衍生 物作為有效成分之常用的醫藥製劑。醫藥製劑可為錠 劑、顆粒、粉劑、或膠囊等般之固狀體,又亦可為溶液、 懣’蜀液、糖漿、乳液、檸檬水等般之液狀。 視必要上述製劑中亦可含有助劑、安定劑、濕潤劑 及其他通常所使用的添加劑如乳糖、檸檬酸、酒石酸、 硬月曰馱、硬脂酸鎂、白土、蔗糖、殿粉、滑石、明膠、 寒天、果膠、落花生油、撖欖油、可可油、乙烯醇等。 雖然前述衍生物的使用量係隨著患者的年齡、條件 及疾病的種類、狀態、所使用之前述衍生物的種類而變化 之,但一般之經口服用時,為量每天 本祕尺 -——— 548272 A7 B7 五、發明説明(61) 次;筋脈或靜脈注射時為0.1〜10mg/kg的量每天1〜4次。 【圖面之簡單說明】 圖1係顯示化合物(42)〜化合物(47)之化學式圖。 圖2係顯示化合物(48)〜化合物(53)之化學式圖。 圖3係顯示化合物(54)〜化合物(59)之化學式圖。 圖4係顯示化合物(60)〜化合物(65)之化學式圖。 圖5係顯示化合物(66)〜化合物(71)之化學式圖。 圖6係顯示化合物(72)〜化合物(77)之化學式圖。 圖7係顯示化合物(78)〜化合物(83)之化學式圖。 圖8係顯示化合物(84)〜化合物(89)之化學式圖。 圖9係顯示化合物(90)〜化合物(95)之化學式圖。 圖10係顯示化合物(96)〜化合物(101)之化學式圖。 圖11係顯示化合物(102)〜化合物(107)之化學式圖。 圖12係顯示化合物(108)〜化合物(113)之化學式圖。 圖13係顯示化合物(114)〜化合物(119)之化學式圖。 圖14係顯示化合物(120)〜化合物(125)之化學式圖。 圖15係顯示化合物(126)〜化合物(131)之化學式圖。 圖16係顯示化合物(132)〜化合物(137)之化學式圖。 圖17係顯示化合物(138)〜化合物(143)之化學式圖。 圖18係顯示化合物(144)〜化合物(149)之化學式圖。 圖19係顯示化合物(150)〜化合物(155)之化學式圖。 圖20係顯示化合物(156)〜化合物(161)之化學式圖。 圖21係顯示化合物(162)〜化合物(167)之化學式圖。 圖22係顯示化合物(168)〜化合物(173)之化學式圖。 _65_ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁) 、訂 548272 A7 B7 五、發明説明(62) 圖23係顯示化合物(174)〜化合物(179)之化學式圖。 圖24係顯示化合物(180)〜化合物(185)之化學式圖。 圖25係顯示化合物(186)〜化合物(191)之化學式圖。 圖26係顯示化合物(192)〜化合物(197)之化學式圖。 圖27係顯示化合物(198)〜化合物(203)之化學式圖。 圖28係顯示化合物(204)〜化合物(209)之化學式圖。 圖29係顯示化合物(210)〜化合物(215)之化學式圖。 圖30係顯示化合物(216)〜化合物(221)之化學式圖。 圖31係顯示化合物(222)〜化合物(227)之化學式圖。 圖32係顯示化合物(228)〜化合物(233)之化學式圖。 圖33係顯示化合物(234)〜化合物(239)之化學式圖。 圖34係顯示化合物(240)〜化合物(245)之化學式圖。 圖35係顯示化合物(246)〜化合物(251)之化學式圖。 圖36係顯示化合物(252)〜化合物(257)之化學式圖。 圖37係顯示化合物(258)〜化合物(263)之化學式圖。 圖38係顯示化合物(264)〜化合物(269)之化學式圖。 圖39係顯示化合物(270)〜化合物(275)之化學式圖。 圖40係顯示化合物(276)〜化合物(281)之化學式圖。 圖41係顯示化合物(282)〜化合物(287)之化學式圖。 圖42係顯示化合物(288)〜化合物(293)之化學式圖。 圖43係顯示化合物(294)〜化合物(299)之化學式圖。 圖44係顯示化合物(300)〜化合物(305)之化學式圖。 圖45係顯示化合物(306)〜化合物(311)之化學式圖。 圖46係顯示化合物(312)〜化合物(316)之化學式圖。 _66 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁) 、1Τ Φ. 548272 A7 B7 五、發明説明(63) (讀先閱讀背面之注意事項再填寫本頁) 圖47係顯示化合物(317)〜化合物(322)之化學式圖。 圖48係顯示化合物(323)〜化合物(328)之化學式圖。 圖49係顯示化合物(329)〜化合物(334)之化學式圖。 圖50係顯示化合物(335)〜化合物(340)之化學式圖。 圖51係顯示化合物(341)〜化合物(346)之化學式圖。 圖52係顯示化合物(347)〜化合物(352)之化學式圖。 圖53係顯示化合物(353)〜化合物(358)之化學式圖。 圖54係顯示化合物(359)〜化合物(364)之化學式圖。 圖55係顯示化合物(365)〜化合物(370)之化學式圖。 圖56係顯示化合物(371)〜化合物(376)之化學式圖。 圖57係顯示化合物(377)〜化合物(382)之化學式圖。 圖58係顯示化合物(383)〜化合物(386)之化學式圖。 【實施本發明之最佳形態】 以下藉由實施例以具體地說明本發明,但本發明並 非以此等實施例為限。 <製造例1;3-[Ν-(2-溴代苄基)丁醯胺基]-4-硝基安 息香酸乙酯的製造> 在氮氣環境氣體中、室溫下分成數次而將氫化鈉 (100mg、60%油中懸濁液)添加入3-丁醯胺基-4-硝基安息 香酸乙酯(247mg)之N,N-二曱基甲醯胺(10ml)溶液中。在 室溫下攪拌前述反應懸濁液1小時,在10分内慢慢地 將2-溴代苄基溴化物(244mg)之N,N-二曱基曱醯胺(2ml) 溶液滴入。在室溫下攪拌前述反應混合物1小時後,將 其注入冰水中。使用二氣曱烷萃取所析出之油狀物質, __67_ 本紙張尺度適中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7_____ 五、發明说明(64) (讀先閱讀背面之注意事項再填寫本頁) 經水洗、乾燥有機溶劑層後,進行減壓濃縮。使用凝膠 滲透色譜法以將殘渣展開,以25%醋酸乙酯/正己烷洗提 而得出黃色油狀的3-[N-(2-溴代苄基)丁醯胺基]-4-硝基 安息香酸乙酯(540mg)。 [化合物的物性] ^-NMR (CDCh, δ) : 0.87 (3Η, t5 J=8Hz)3 1.48 (3H5 t3 J=8Hz), 1.68 (2 H, sextet, J二8Hz)3 2.03 (2H3 t, J二8Hz), 4.30-4.46 (2H,瓜),4.70 (1H, d, J=15Hz), 5·40 (1H, d, J二15Hz), 7·08_7·34 (2H, in), 7.43 (1H, dd3 J=l, 8 Hz), 7.58 (1H, dd, J二1, 8Hz), 7.66 (1H, d, J二1Hz), 7.96 (1H, d, J二8Hz 8 •16 (1H, dd, J=l, 8Hz)。 <製造例2;3-[N-(2-氯代苄基)苯醯胺基]-4-硝基安 息香酸乙酯的製造> 使用3-苯醯胺基-4-硝基安息香酸乙酯(450mg)及2-氯代苄基溴化物(243mg)並藉由相同於製造例1之方法 以得出黃色結晶的3-[N-(2-氯代苄基)苯醯胺基]-4-硝基 安息香酸乙酯(480g)。 [化合物的物性] lH-NMR (CDCla, δ) : 1.35 (3Η, t3 J=8Hz) 5 4.35 (2H, q3 J-8Hz), 4.76 (1 H,bd,J=15Hz),5.82 (1H,bd,J=15Hz),7.10-8.00 (12H,m)。 即:111一 113°C〇 <製造例3;3-[N-(2-氟代苄基)丁醯胺基]-4-硝基安 息香酸乙酯的製造> 使用3-丁醯胺基-4-硝基安息香酸乙酯(3〇〇mg)及2-氟代苄基溴化物(243mg)並藉由相同於製造例1之方法以 ____—-ω----- 本紙張尺度適用中酬家標準(〔奶)八4規格(21(^ 297公釐) 548272 Α7 Β7 五、發明説明(65) 得出黃色油狀的3-[N-(2-氟代苄基)丁醯胺基l·4-硝基安 息香酸乙酯(394g)。 [化合物的物性] Ή-NMR (CDC13, 6) : 0.85 (3H, t, J^SHz), 1.40 (3H, t, J=8Hz), 1.65 (2H, sextet, J=8Hz), 1.98 (2H, t, J=8Hz), 4.30-4.45 (2H, m)3 4.60 (1H, d5 J= 10Hz), 5·25 (1H, d, J二10Hz), 6·88 (2H, t, J二8Hz), 7.08 (2H, dd, J=5, 8Hz ),7·24 (1H, dt, J=l, 8Hz), 7.41 (1H, dt, J=l, 8Hz), 7·69 (1H, d, J二1Hz) ,7.96 (1H, d, J:8Hz), 8·15 (1H, dd, J=l, 8Hz)。 <製造例4;3-[N-(4-氟代苄基)丁醯胺基]-4-硝基安 息香酸乙酯的製造> 使用3-丁醯胺基-4-硝基安息香酸乙酯(300mg)及4-氟代苄基溴化物(243mg)並藉由相同於製造例1之方法 以得出黃色油狀的3-[N-(4-氟代苄基)苯醯胺基]-4-硝基 安息香酸乙酯(400g)。 [化合物的物性] !H-NMR (CDCh, δ) : 0.86 (3Η, t, J-8Hz), 1.37 (3H, t, J-8Hz), 1.56-1.76 (2H,m),1.96-2.04 (2H,m),4·32-4·46 (2H,m),4.40 (1H,d,J=MHz),5· 23(1H, d, J二14Hz), 6·95 (2H, t, J二8Hz), 7.10 (2H, dd, J二5, 8Hz), 7.47 (1 H, d3 J=lHz), 7.95 (1H, d, J=8Hz), 8.16 (1H, dd, J=l, 8Hz)〇 <製造例5;3-[N-(2-氰基苄基)丁醯胺基]-4-硝基安 息香酸乙S旨的製造> 將碳酸鈣(296mg)加入3-丁醯胺基-4-硝基安息香酸 乙酯(200mg)與2-氰基苄基溴化物(154mg)之N,N-二曱基 曱醯胺溶液中,在20°C下攪拌3小時。使用醋酸乙酯及 ________μ- 本紙張尺度適用中國國家標率(CNS ) Α4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁)1T line ^ ^ ^ ^ the original and sigma sigma derivative when used in therapy, can make it suitable for oral or external use of organic, inorganic solids or liquid excipients as pharmaceutically acceptable A carrier, thereby forming a commonly used pharmaceutical preparation containing the aforementioned derivative as an active ingredient. The pharmaceutical preparations can be solids such as tablets, granules, powders, or capsules, and can also be liquids such as solutions, cornice's solution, syrup, emulsion, lemonade, and the like. If necessary, the above preparations may also contain auxiliaries, stabilizers, wetting agents and other commonly used additives such as lactose, citric acid, tartaric acid, stearic acid, magnesium stearate, white clay, sucrose, temple powder, talc, Gelatin, cold weather, pectin, groundnut oil, olive oil, cocoa butter, vinyl alcohol, etc. Although the amount of the aforementioned derivative varies with the patient's age, conditions, and the type and state of the disease, as well as the type of the aforementioned derivative, the amount of the derivative used is generally daily when taken orally- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————— for the scales for injection is 0.1 to 10 mg / kg once a day. [Brief Description of Drawings] FIG. 1 is a diagram showing chemical formulas of compound (42) to compound (47). FIG. 2 is a diagram showing chemical formulas of compound (48) to compound (53). FIG. 3 is a diagram showing chemical formulas of compound (54) to compound (59). FIG. 4 is a diagram showing chemical formulas of compound (60) to compound (65). FIG. 5 is a diagram showing chemical formulas of compound (66) to compound (71). FIG. 6 is a diagram showing chemical formulas of compound (72) to compound (77). FIG. 7 is a diagram showing chemical formulas of compound (78) to compound (83). FIG. 8 is a diagram showing chemical formulas of compound (84) to compound (89). FIG. 9 is a diagram showing chemical formulas of compound (90) to compound (95). FIG. 10 is a diagram showing chemical formulas of compound (96) to compound (101). FIG. 11 is a diagram showing chemical formulas of compound (102) to compound (107). FIG. 12 is a diagram showing chemical formulas of compound (108) to compound (113). FIG. 13 is a diagram showing chemical formulas of compound (114) to compound (119). FIG. 14 is a diagram showing chemical formulas of compound (120) to compound (125). FIG. 15 is a diagram showing chemical formulas of compound (126) to compound (131). FIG. 16 is a diagram showing chemical formulas of compound (132) to compound (137). FIG. 17 is a diagram showing chemical formulas of compound (138) to compound (143). FIG. 18 is a diagram showing a chemical formula of a compound (144) to a compound (149). FIG. 19 is a diagram showing chemical formulas of compound (150) to compound (155). FIG. 20 is a diagram showing chemical formulas of compound (156) to compound (161). FIG. 21 is a diagram showing chemical formulas of compound (162) to compound (167). FIG. 22 is a diagram showing chemical formulas of compound (168) to compound (173). _65_ The size of this paper is China State Standard (CNS) A4 (210X 297 mm) (read the precautions on the back before filling out this page), order 548272 A7 B7 5. Description of the invention (62) Figure 23 shows the compounds (174) ~ Chemical formula of compound (179). FIG. 24 is a diagram showing chemical formulas of compound (180) to compound (185). FIG. 25 is a diagram showing chemical formulas of compound (186) to compound (191). FIG. 26 is a diagram showing chemical formulas of compound (192) to compound (197). FIG. 27 is a diagram showing chemical formulas of compound (198) to compound (203). FIG. 28 is a diagram showing chemical formulas of compound (204) to compound (209). FIG. 29 is a diagram showing chemical formulas of compound (210) to compound (215). FIG. 30 is a diagram showing chemical formulas of compound (216) to compound (221). FIG. 31 is a diagram showing chemical formulas of compound (222) to compound (227). FIG. 32 is a diagram showing chemical formulas of compound (228) to compound (233). FIG. 33 is a diagram showing chemical formulas of compound (234) to compound (239). FIG. 34 is a diagram showing chemical formulas of compound (240) to compound (245). FIG. 35 is a diagram showing chemical formulas of compound (246) to compound (251). FIG. 36 is a diagram showing chemical formulas of compound (252) to compound (257). FIG. 37 is a diagram showing chemical formulas of compound (258) to compound (263). FIG. 38 is a diagram showing chemical formulas of compound (264) to compound (269). FIG. 39 is a diagram showing chemical formulas of compound (270) to compound (275). FIG. 40 is a diagram showing chemical formulas of compound (276) to compound (281). FIG. 41 is a diagram showing chemical formulas of compound (282) to compound (287). FIG. 42 is a diagram showing chemical formulas of compound (288) to compound (293). FIG. 43 is a diagram showing chemical formulas of compound (294) to compound (299). FIG. 44 is a diagram showing chemical formulas of compound (300) to compound (305). FIG. 45 is a diagram showing chemical formulas of compound (306) to compound (311). Fig. 46 is a diagram showing chemical formulae of compound (312) to compound (316). _66 This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) (read the precautions on the back before reading this page), 1T Φ. 548272 A7 B7 V. Description of the invention (63) (Read the back on read (Please fill in this page again for precautions) Figure 47 shows the chemical formulas of compound (317) to compound (322). FIG. 48 is a diagram showing the chemical formula of compound (323) to compound (328). FIG. 49 is a diagram showing chemical formulas of compound (329) to compound (334). FIG. 50 is a diagram showing chemical formulas of compound (335) to compound (340). FIG. 51 is a diagram showing chemical formulas of compound (341) to compound (346). FIG. 52 is a diagram showing chemical formulas of compound (347) to compound (352). Fig. 53 is a diagram showing chemical formulas of compound (353) to compound (358). Fig. 54 is a diagram showing chemical formulas of compound (359) to compound (364). Fig. 55 is a diagram showing chemical formulas of compound (365) to compound (370). FIG. 56 is a diagram showing chemical formulas of compound (371) to compound (376). FIG. 57 is a diagram showing chemical formulas of compound (377) to compound (382). FIG. 58 is a diagram showing chemical formulas of compound (383) to compound (386). [Best Mode for Carrying Out the Invention] The present invention will be specifically described below with reference to the examples, but the present invention is not limited to these examples. < Production Example 1; Production of 3- [N- (2-bromobenzyl) butylamidino] -4-nitrobenzoate ethyl ester > Sodium hydride (100 mg, 60% suspension in oil) was added to a solution of ethyl 3-butylamido-4-nitrobenzoate (247 mg) in N, N-dimethylformamide (10 ml) . The reaction suspension was stirred at room temperature for 1 hour, and a solution of 2-bromobenzyl bromide (244 mg) in N, N-diamidinofluorene (2 ml) was slowly added dropwise over 10 minutes. After the aforementioned reaction mixture was stirred at room temperature for 1 hour, it was poured into ice water. Extraction of the oily substance with dioxane, __67_ This paper is in accordance with the Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7_____ V. Description of the invention (64) (Read the precautions on the back before reading Fill out this page again) After washing with water and drying the organic solvent layer, it was concentrated under reduced pressure. The residue was developed by gel permeation chromatography, and was extracted with 25% ethyl acetate / n-hexane to give 3- [N- (2-bromobenzyl) butylamido] -4- as a yellow oil. Ethyl nitrobenzoate (540 mg). [Physical properties of compounds] ^ -NMR (CDCh, δ): 0.87 (3Η, t5 J = 8Hz) 3 1.48 (3H5 t3 J = 8Hz), 1.68 (2 H, sextet, J 2 8Hz) 3 2.03 (2H3 t, J2 8Hz), 4.30-4.46 (2H, melons), 4.70 (1H, d, J = 15Hz), 5.40 (1H, d, J2 15Hz), 7.08_7 · 34 (2H, in), 7.43 (1H, dd3 J = 1, 8 Hz), 7.58 (1H, dd, J2 1, 8Hz), 7.66 (1H, d, J2 1Hz), 7.96 (1H, d, J2 8Hz 8 • 16 (1H , Dd, J = 1, 8 Hz). ≪ Production Example 2; Production of 3- [N- (2-chlorobenzyl) phenylamidino] -4-nitrobenzoate > Using 3- Ethyl benzamino-4-nitrobenzoate (450 mg) and 2-chlorobenzyl bromide (243 mg) and 3- [N- ( 2-Chlorobenzyl) phenylamino] -4-nitrobenzoate (480g). [Physical properties of the compound] lH-NMR (CDCla, δ): 1.35 (335, t3 J = 8Hz) 5 4.35 (2H, q3 J-8Hz), 4.76 (1 H, bd, J = 15Hz), 5.82 (1H, bd, J = 15Hz), 7.10-8.00 (12H, m). That is: 111-113 ° C. ; Production Example 3; Preparation of 3- [N- (2-fluorobenzyl) butanamido] -4-nitrobenzoate Production> Ethyl 3-butylamido-4-nitrobenzoate (300 mg) and 2-fluorobenzyl bromide (243 mg) were used in the same manner as in Production Example 1 with ____ —-Ω ----- This paper size applies the middle-paid family standard ([Milk) 8 4 size (21 (^ 297 mm) 548272 Α7 Β7 V. Description of the invention (65) The yellow oily 3- [ N- (2-Fluorobenzyl) butylammonium l-4-nitrobenzoate (394g). [Physical properties of the compound] Ή-NMR (CDC13, 6): 0.85 (3H, t, J ^ SHz), 1.40 (3H, t, J = 8Hz), 1.65 (2H, sextet, J = 8Hz), 1.98 (2H, t, J = 8Hz), 4.30-4.45 (2H, m) 3 4.60 (1H, d5 J = 10Hz), 5.25 (1H, d, J = 10Hz), 6.88 (2H, t, J = 8Hz), 7.08 (2H, dd, J = 5, 8Hz), 7.24 (1H, dt, J = 1, 8Hz), 7.41 (1H, dt, J = 1, 8Hz), 7.69 (1H, d, J = 1Hz), 7.96 (1H, d, J: 8Hz), 8 · 15 ( 1H, dd, J = 1, 8Hz). < Production Example 4; Production of 3- [N- (4-fluorobenzyl) butylamidino] -4-nitrobenzoate ethyl ester > Using 3-butylamido-4-nitrobenzoate Acid ethyl ester (300 mg) and 4-fluorobenzyl bromide (243 mg) and 3- [N- (4-fluorobenzyl) benzene hydrazone as a yellow oil was obtained by the same method as in Production Example 1. Amino] -4-nitrobenzoate (400 g). [Physical properties of compound]! H-NMR (CDCh, δ): 0.86 (3Η, t, J-8Hz), 1.37 (3H, t, J-8Hz), 1.56-1.76 (2H, m), 1.96-2.04 ( 2H, m), 4 · 32-4 · 46 (2H, m), 4.40 (1H, d, J = MHz), 5.23 (1H, d, J = 14Hz), 6.95 (2H, t, J2 8Hz), 7.10 (2H, dd, J2 5, 8Hz), 7.47 (1 H, d3 J = lHz), 7.95 (1H, d, J = 8Hz), 8.16 (1H, dd, J = l, 8Hz) < Production Example 5; Production of 3- [N- (2-cyanobenzyl) butyramidinyl] -4-nitrobenzoate ethyl ester > Calcium carbonate (296 mg) was added to 3- In a solution of butylammonio-4-nitrobenzoate ethyl ester (200 mg) and 2-cyanobenzyl bromide (154 mg) in N, N-diamidinofluorenylamine, stir at 20 ° C for 3 hours . Use of ethyl acetate and ________ μ- This paper size applies to China National Standards (CNS) Α4 size (210X 297 mm) (read the precautions on the back before filling this page)

、1T 548272 A7 ---------------- B7__ 五、發明説明(66) 水以使得前述之反應混合物分層,以水及食鹽水洗淨有 機層後’使用硫酸鎂乾燥之。經餾除溶劑後,可得出黃 (請先閱讀背面之注意事項再填寫本頁) 色油狀的3-[N-(2-氰基苄基)丁醯胺基]-4-硝基安息香酸 乙酉旨(330mg)。 [化合物的物性] Η 賺(CDCh,(5) : 〇·86 (3H,t,J:8Hz),1·49 (3H,t,J:8Hz),1·67 (2H, sextet, J二8Hz), 2·02 (2H, t, J二8Hz), 4.28-4.52 (2H, m), 4.90 (1H, d, J: 15Hz), 5·28 (1H, d, J二15Hz), 7.40 (1H, t, J二8Hz), 7·61 (1H, dt, J二1, 8Hz ),7·70 (1H, d, J:lHz), 7·74 (1H, dd, J:l, 8Hz), 8.02 (1H, d, J:l〇Hz), 8 •22 (1H, dd, J=l, 10Hz)。 <製造例6> 藉由相同於製造例5之方法以製造出下述之化合 物。 <製造例6_ 1 ;3·[Ν-(3_ I代节基)丁醯胺基]_4·硝基安 息香酸乙酯> [化合物的物性] 黄色油状。 lH_NMR (CDCh,6) : 〇·86 (3Η,t,J:7.5Hz),L35 (3Η,t,J=7.5Hz) 1 68 (2H,ffl),2·00 (2H,t,J二7.5Hz),4·36 (1H,d,J=15Hz),4·40 (2H m) 5 31 (1H,d,J:15Hz),6·85-7·28 (4H,m),7.60 (1H,d,7.97 (1H d J二10Hz), 8.16 (1H, dd, J=l〇,1.5Hz)。 <製造例6-2;4-硝基-3-[N-(2-吡啶甲基>正丁醯胺 基]-安息香酸乙酯> 此化合物係直接使用在後述之製程中。 ________74—_-__ _本紙張尺中國國家標準((:奶)八4規格(21〇'乂 297公釐) ^ 548272 經浐部中戎榀枣而以5消贽合竹ii卬繁 A7 --------------------E___ 五、發明説明(67) [化合物的物性] 黄色油状。 <製造例6_3;3_[N_2,6_二氯代苄基)丁醯胺基]_4-硝 基安息香酸乙酯> [化合物的物性] 旧-臟(CDCh,6) ·· 〇·89 (3H,t,J:7.5Hz),1.38 (3H,t,J二7·5Ηζ),1·7〇 (2Η, m), 2·03 (2Η, t, J:7.5Hz), 4.36 (2Η, m), 4.96 (1Η, d, J=13.5Hz), 5. 70(1H, d, J二13.5Hz), 7.10-7.28 (3H, m), 7·49 (1H, d, J=1.5Hz), 8.03 (1H, d,J=7_5Hz),8·14 (1H,dd,J=:7.5 及 1.5Hz)c mp : 85 —89°C。 <製造例6-4;3-[N-(3-甲基苄基)丙醯胺基]-4-硝基安 息香酸乙酯> 此化合物係直接使用在後述之製程中。 [化合物的物性] 黄色油状。 <製造例6_5;3-[N-(2-氟代苄基)環丙烷醯基胺基]-4-硝基安息香酸乙酯> [化合物的物性] 黄色油状。 W-NMR (CDCh,6) : 0.60-0.71 (2H,m),0.99-1.14 (3H,m), 1·38 (3H, t, J=7.5Hz)3 4.37 (2H, m), 4.62 (1H, d, J=12Hz), 5.30 (1H, d, J=12Hz), 6.92 (1H,t,J:7.5Hz),7.10 (1H,t,J:7.5Hz),7.26 (1H,m), 7.42 (1H,t。J=7 • 5Hz),7.80 (1H,s),7.99 (1H,d,J:7.5Hz),8.14 (1H,dd,J:7.5 及 2Hz )〇 本紙張尺度適州中國國家標準(CNS ) A4規格(2丨0X 297公釐) (請先閱讀背面之注意事項再填寫本頁)1T 548272 A7 ---------------- B7__ 5. Description of the invention (66) Water is used to separate the aforementioned reaction mixture, and the organic layer is washed with water and brine. Dry over magnesium sulfate. After distilling off the solvent, you can get yellow (please read the precautions on the back before filling in this page) 3- [N- (2-cyanobenzyl) butylamidino] -4-nitro Acetyl Benzoate (330mg). [Physical properties of compound] Η Earn (CDCh, (5): 0.86 (3H, t, J: 8Hz), 1.49 (3H, t, J: 8Hz), 1.67 (2H, sextet, J2 8Hz), 2.02 (2H, t, J 8Hz), 4.28-4.52 (2H, m), 4.90 (1H, d, J: 15Hz), 5.28 (1H, d, J 2 15Hz), 7.40 (1H, t, J = 8Hz), 7.61 (1H, dt, J = 1, 8Hz), 7.70 (1H, d, J: 1Hz), 7.74 (1H, dd, J: 1, 8Hz), 8.02 (1H, d, J: 10Hz), 8 • 22 (1H, dd, J = 1, 10Hz). ≪ Manufacturing example 6 > ≪ Production Example 6-1; 3 · [N- (3-I-generation benzyl) butyramido] -4 · nitronitrobenzoate > [physical properties of the compound] yellow oil. LH-NMR (CDCh, 6): 0.86 (3Η, t, J: 7.5Hz), L35 (3Η, t, J = 7.5Hz) 1 68 (2H, ffl), 2.00 (2H, t, J = 7.5Hz), 4.36 (1H, d, J = 15Hz), 4.40 (2H m) 5 31 (1H, d, J: 15Hz), 6.85-7 · 28 (4H, m), 7.60 (1H, d , 7.97 (1H d J = 10Hz), 8.16 (1H, dd, J = 10, 1.5Hz). ≪ Production Example 6-2; 4-nitro-3- [N- (2-pyridylmethyl) >; N-butylamine [Base] -Ethyl Benzoate > This compound is used directly in the process described below. ________ 74 —_-__ _ This paper rule is a Chinese national standard ((: milk) 8 4 size (21〇'297 mm) ^ 548272 In the Ministry of Economics, the jujube and the jujube are replaced by 5 and combined with bamboo ii. A7 -------------------- E___ V. Description of the invention (67) [Compound of Physical properties] Yellow oil. ≪ Production Example 6_3; 3_ [N_2,6_dichlorobenzyl) butanamido] _4-nitrobenzoate ethyl ester > [Physical properties of compound] Old-dirty (CDCh, 6 ) 〇 89 (3H, t, J: 7.5 Hz), 1.38 (3H, t, J 2 7. 5Ηζ), 1.70 (2Η, m), 2.03 (2Η, t, J: 7.5Hz), 4.36 (2Η, m), 4.96 (1Η, d, J = 13.5Hz), 5.70 (1H, d, J = 13.5Hz), 7.10-7.28 (3H, m), 7.49 ( 1H, d, J = 1.5Hz), 8.03 (1H, d, J = 7_5Hz), 8.14 (1H, dd, J =: 7.5 and 1.5Hz) c mp: 85 —89 ° C. < Production Example 6-4; 3- [N- (3-methylbenzyl) propanamido] -4-nitrobenzoate ethyl ester > This compound was used directly in the production process described below. [Physical properties of the compound] Yellow oil. < Production Example 6-5; 3- [N- (2-fluorobenzyl) cyclopropanefluorenylamino] -4-nitrobenzoate ethyl ester > [Physical properties of compound] A yellow oily substance. W-NMR (CDCh, 6): 0.60-0.71 (2H, m), 0.91-1.14 (3H, m), 1.38 (3H, t, J = 7.5Hz) 3 4.37 (2H, m), 4.62 ( 1H, d, J = 12Hz), 5.30 (1H, d, J = 12Hz), 6.92 (1H, t, J: 7.5Hz), 7.10 (1H, t, J: 7.5Hz), 7.26 (1H, m) , 7.42 (1H, t. J = 7 • 5Hz), 7.80 (1H, s), 7.99 (1H, d, J: 7.5Hz), 8.14 (1H, dd, J: 7.5 and 2Hz) State Chinese National Standard (CNS) A4 Specification (2 丨 0X 297 mm) (Please read the precautions on the back before filling this page)

、1T ΛΨ. 548272 A7 __________________B7 五、發明説明(68) " <製造例6-6;3-[N-(2-氯代节基)環丁烷醯基胺基]_4_ 硝基安息香酸乙酯> [化合物的物性] (讀先閲讀背面之注意事項再填寫本頁) ^-NMR (CDCh, d) ; K37 (3H, t3 J=7.5Hz), L68-L87 (4H3 m), 2.Z2-2.58 (2H,m),2.75-2.94 ( 1H,m),4.23-4.46 (2H,m),4·63 UH,d,J:15Hz),5.、 1T ΛΨ. 548272 A7 __________________B7 V. Description of the invention (68) " < Production example 6-6; 3- [N- (2-Chlorobenzyl) cyclobutanefluorenylamino] _4_ Nitrobenzoic acid Ethyl esters> [Physical properties of compounds] (Read the precautions on the back before filling this page) ^ -NMR (CDCh, d); K37 (3H, t3 J = 7.5Hz), L68-L87 (4H3 m), 2.Z2-2.58 (2H, m), 2.75-2.94 (1H, m), 4.23-4.46 (2H, m), 4.63 UH, d, J: 15Hz), 5.

45 (1H5 d5 J=15Hz), 7.14-7.24 (3H5 m)5 7.35-7.45 (1H) m)3 7.56 (1H3 d, J 二2Hz), 7·97 (1H3 d, J:9Hz), 8·13 (1H, dd, J:9, 2Hz)。 <製造例6-7;3-環丁烷醯基胺基_4_硝基安息香酸乙 酯> [化合物的物性] 醜(cdci3,6) : 143 (3H,t,j:7.5Hz),186一219 ⑽,瓜), (4H, m), 3.20-3.41 (1H, m), 4·43 (2H, q, J:7.5Hz), 7·80 (1H, dd, J=10, 2Hz)3 8.26 (1H5 d5 J-lOHz), 9.45 (1H5 d5 J-2Hz)〇 即:94-960C〇 <製1^例7;3-乙醯胺基-4-硝’基苯並醯胺的製造> 在氮氣環境氣體中、冰浴下將氣化乙二醯(3.9lml) 滴入3-乙醯胺基_4_硝基安息香酸(7.〇〇g)的二氣曱烧 (5〇ml)溶液中,在冰浴下攪拌!小時,在室溫下攪拌2 小時半。經餾除反應溶劑後,將其溶解於四氫吡喃(5〇ml) 中,在氮氣環境氣體中、冰浴下滴入氨水(28〇/〇)中。經攪 拌反應液1小時後,加入水及醋酸,過濾出所析出的固 體(ca.8g)。濾液經分層後,將有機層以水洗淨、並藉由 石’IL &L鎮乾燥後’進行減壓以除去溶劑,如此以得出殘潰。 藉由使用熱醋酸乙g旨以洗淨並過濾所析出之固體及殘洁 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 ___________B7 五、發明説明(69) 以得出3-乙醯胺基-4-硝基苯並醯胺(4.94g)。 [化合物的物性] 4-醒(DMS0-d6,ά) : 2·08 (3H,s),7·68 (1H,br s)3 7·78 (1H,dd,J二9, 2Hz), 7.94-8.05 (2H, m), 8.23 (1H, brs)〇45 (1H5 d5 J = 15Hz), 7.14-7.24 (3H5 m) 5 7.35-7.45 (1H) m) 3 7.56 (1H3 d, J 2 2Hz), 7.97 (1H3 d, J: 9Hz), 8 · 13 (1H, dd, J: 9, 2Hz). < Production Example 6-7; 3-cyclobutanefluorenylamino-4_nitrobenzoate ethyl ester > [Physical properties of compound] (cdci3,6): 143 (3H, t, j: 7.5Hz ), 186-219 ⑽, melon), (4H, m), 3.20-3.41 (1H, m), 4.43 (2H, q, J: 7.5Hz), 7.80 (1H, dd, J = 10 , 2Hz) 3 8.26 (1H5 d5 J-10Hz), 9.45 (1H5 d5 J-2Hz) 〇 That is: 94-960C < Preparation 1 ^ Example 7; 3-acetamido-4-nitro'ylbenzo Production of hydrazine > The gaseous ethylenedioxane (3.9lml) was dripped into a gas of 3-acetamido-4-nitrobenzoic acid (7.00g) in a nitrogen atmosphere under an ice bath In a simmered (50 ml) solution, stir in an ice bath! For 2 hours, stir at room temperature for 2 and a half hours. After distilling off the reaction solvent, it was dissolved in tetrahydropyran (50 ml), and dropped into ammonia water (28/0) in a nitrogen bath under an ice atmosphere. After the reaction solution was stirred for 1 hour, water and acetic acid were added, and the precipitated solid (ca. 8 g) was filtered off. After the filtrate was separated into layers, the organic layer was washed with water, and the solvent was removed under reduced pressure by using the stone 'IL & L after drying', so as to obtain a residue. By using hot ethyl acetate, the purpose is to wash and filter the precipitated solids and residues. The size of this paper applies Chinese National Standard (CNS) A4 specifications (210X 297 mm) 548272 A7 ___________B7 V. Description of Invention (69) 3-Ethylamido-4-nitrobenzofluorenamine (4.94 g) was obtained. [Physical properties of the compound] 4-wake (DMS0-d6, ά): 2.08 (3H, s), 7.68 (1H, br s) 3 7.78 (1H, dd, J 2: 9, 2Hz), 7.94-8.05 (2H, m), 8.23 (1H, brs).

Mass (FAB) : Z24〇 <製造例8;3-[N-(2-氯代苄基)乙醯胺基]_4_硝基苯 並醯胺的製造> 藉由相同於製造例7之方法以製造出3-[N-(2-氯代 苄基)乙醯胺基]-4·硝基苯並醯胺。 [化合物的物性] W-臟(DMS0-d6,(5) : 1·86 (3H,s),4·64 (1H, d,J=15Hz),5·06 (1H, d, J二15Hz),7·22-7·40 (4H,m),7·73 (1H,br s)5 7·84 (1H,d,J=2Hz),8.03 ( 1H, dd, J:9, 2Hz), 8.14 (1H, d, J:9Hz), 8.22 (1H, br s)〇 <製造例9;3-[N_(2-氣代苄基)乙醯胺基]-4-硝基苯 並硝醯的製造> 在氮氣環境氣體中、冰浴下將1,4-二噁烷(3〇ml)滴 入四氣化鈦(1.70ml)之二氯甲烷溶液(4ml)中,接著再滴 入3-[N-(2-氯代苄基)乙醯胺基]_4_硝基苯並醯胺(2.7〇g) 之丨,4-二σ惡烧(65ml)溶液。經擾拌15分後,加入三乙胺 (3.14g),在冰浴下攪拌2小時。反應完成後,進行減壓 以除去 >谷劑’將水及醋酸加入殘渣中。經分層後,將有 機層以水洗淨、並藉由硫酸鎮乾燥後,再進行減壓以除 去溶劑。使用柱色譜[2〇〇ml、正己烧-醋酸乙酯(4-1)]以精 製殘渣,而得出3-[N-(2-氣代苄基)乙醯胺基]-4-硝基笨 本^则’關家縣1 CNS ) A4規格(21Qx 297=襲) ~ " (讀先閱讀背面之注意事項再填寫本頁) 、11 Φ. 548272 Α7 Β7 五、發明説明(70 ) 並硝醯(1.21g)。 [化合物的物性] (許先閱讀背面之注意事項再填寫本頁) 1眶(CDC13,6) : 1·92 (3H,s),4·61 (1H,d,J二 15Ηζ),5·40 (1H,d,J二 15Hz), 7·18_7·50 (5H, m), 7·80 (1H, dd, J=9, 2Hz)3 801 (1H, d, J=9Hz)。 Mass (FAB) : 300。Mass (FAB): Z24〇 < Production Example 8; Production of 3- [N- (2-chlorobenzyl) acetamidinyl] _4-nitrobenzopyramine > This method is used to produce 3- [N- (2-chlorobenzyl) acetamidinyl] -4 · nitrobenzopyramine. [Physical properties of compound] W-dirty (DMS0-d6, (5): 1.86 (3H, s), 4.64 (1H, d, J = 15Hz), 5.06 (1H, d, J-2 15Hz) ), 7.22-7 · 40 (4H, m), 7.73 (1H, br s) 5 7.84 (1H, d, J = 2Hz), 8.03 (1H, dd, J: 9, 2Hz) , 8.14 (1H, d, J: 9Hz), 8.22 (1H, br s) 〇 < Production Example 9; 3- [N_ (2-Azobenzyl) acetamidinyl] -4-nitrobenzo Production of nitrate> In a nitrogen atmosphere, 1,4-dioxane (30 ml) was dropped into a dichloromethane solution (4 ml) of titanium tetragas (1.70 ml), and then A solution of 3- [N- (2-chlorobenzyl) acetamidinyl] _4-nitrobenzopyramine (2.70 g) was added dropwise to a solution of 4-bisσ oxalate (65 ml). After 15 minutes, triethylamine (3.14 g) was added, and the mixture was stirred in an ice bath for 2 hours. After the reaction was completed, the pressure was reduced to remove > cereals'. Water and acetic acid were added to the residue. After layering, the organic The layer was washed with water and dried with sulfuric acid, and then the pressure was reduced to remove the solvent. The column chromatography [200 ml, n-hexane-ethyl acetate (4-1)] was used to purify the residue to obtain 3- [N- (2-Atomylbenzyl) acetamidinyl] -4-nitro This ^ rule 'Guanjia County 1 CNS) A4 specifications (21Qx 297 = attack) ~ " (Read the precautions on the back before filling in this page), 11 Φ. 548272 Α7 Β7 V. Description of the invention (70) Tritium (1.21g). [Physical properties of compound] (Xu first read the precautions on the back and then fill out this page) 1 orbital (CDC13, 6): 1.92 (3H, s), 4.61 (1H, d, J 2 15Ηζ), 5. · 40 (1H, d, J = 15Hz), 7 · 18_7 · 50 (5H, m), 7 · 80 (1H, dd, J = 9, 2Hz) 3 801 (1H, d, J = 9Hz). Mass (FAB): 300.

IR (Nujol) : 2250cm lQ <製造例l0;3-[N-(2-氣代苄基)胺基]-4-硝基苯並硝 醯的製造> 將35%的鹽酸(lml)加入代苄基)乙醯胺 基]-4-硝基苯並醯胺(85〇11^的Μ—二噁烷(1〇ml)溶液 中,加熱迴流4天。經餾除反應液體後,在水及三氯甲 烧的混合液中進行分層。有機層經水洗淨後,使用硫酸 鎂乾燥之,再進行減壓以除去溶劑。使用柱色譜[5〇ml、 三氯甲烧]精製殘渣而得出3-[N-(2-氯代苄基)胺基]_4-硝 基苯並梢酿(230mg)。 [化合物的物性] !Η-NMR (CDCh,(5) : 4.65 (2H,d,J:6Hz),6.93 (1H,dd,J:9,2Hz),7.10 (1H,d,J=2Hz),7.25-7.40 (3H,m),7·40-7.54 (1H,m),8·30 (1H,d,J:9Hz ),8.45 (1H, br s)〇 Mass (FAB) : 258。 IR (Nujol) : 2220cm'l〇 <製造例11;4-胺基-3-[N-(2-氯代苄基)胺基]苯並硝 醯的製造> 將10%碳化鈀(50mg)加入3_[Ν·(2-氯代苄基)胺基]_4_ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 548272 經浐部中决桴^-^h T,消费合竹扣印$ A7 B7 五、發明説明(71) 硝基苯並硝醯(261mg)、甲醇(15ml)、1,4-二噁烷(3ml)的 混合溶液中,在氫環境氣體中、3氣壓下進行接觸還原。 反應完成後,以石夕藻土過濾反應液,並進行減壓以除去 濾液。使用醚洗淨、過濾所得的固體,而得出4_胺基_ 3-[N-(2 -氯代卞基)胺基]苯並頌酿(196mg)。 [化合物的物性] ^-NMR (DMS0-d6, δ) : 4.39 (2H5 d3 J=5Hz), 5.57 (1H, t5 J-5Hz), 5.69 (2 H, s), 6.46 (1H, d, J二2Hz), 6.61 (1H, d, J:9Hz), 6.88 (1H, dd, J=9, 2Hz) ,7·25- 7·41 (3H, m), 7·44-7·54 (1H, m)〇 <實施例1; 1 -(2-溴代苄基)_6-乙氧羰基_2-正丙基苯 並咪唑(42)的合成> 將3·[Ν-(2-溴代苄基)丁醯胺基]-4-硝基安息香酸乙 醋(390mg)與還原鐵(21〇mg)加入醋酸(iml)與乙醇(2mi) 之混合液中以形成懸濁液,令此懸濁液迴流1小時同時 激烈地攪拌之。反應完成後將其冷卻,經矽藻土過濾 後,進行減壓以濃縮濾液。將醋酸乙酯及碳酸氫鈉水溶 液加入殘渣中以形成分層。經乾燥有機溶劑層後,對溶 液進行減壓蒸餾以得出褐色殘渣。使用柱色譜精製此殘 渣而得出1-(2-溴代苄基)_6」乙氧羰基-2-正丙基苯並咪唑 (42)(160mg) ° [化合物(42)的物性] H-NMR (CDCla, δ) : 1.04 (3H, t, J-8Hz), 1.40 (3H, t, J=8Hz), 1.78-1.98 (2H, m), 2·34 (2H, t, J=8Hz), 4·38 (2H, q, J:8Hz), 5·45 (2H, s), 6.65 ( 1H, t, J-8Hz), 7.00 (in, tj J=8Hz), 7.13 (1H, t5 J=8Hz), 7.28 (1H3 t, J, (誚先閱讀背面之注意事項再填寫本頁) 、-口 Φ.IR (Nujol): 2250cm lQ < Production Example 10; Production of 3- [N- (2-Gas-benzyl) amino] -4-nitrobenzonitrazine > 35% hydrochloric acid (lml) A solution of benzyl) acetamido] -4-nitrobenzofluorenamine (850.11 M in dioxane (10 ml) was added and heated under reflux for 4 days. After the reaction liquid was distilled off, The layers were separated in a mixed solution of water and chloroform. The organic layer was washed with water, dried over magnesium sulfate, and then depressurized to remove the solvent. Column chromatography [50 ml, chloroform] The residue was purified to obtain 3- [N- (2-chlorobenzyl) amino] 4-nitrobenzopyrene (230 mg). [Physical properties of the compound]! -NMR (CDCh, (5): 4.65 (2H, d, J: 6Hz), 6.93 (1H, dd, J: 9, 2Hz), 7.10 (1H, d, J = 2Hz), 7.25-7.40 (3H, m), 7.40-7.54 (1H , M), 8.30 (1H, d, J: 9Hz), 8.45 (1H, br s), Mass (FAB): 258. IR (Nujol): 2220cm'l0 < Production Example 11; 4-amine Of 3-methyl-3- [N- (2-chlorobenzyl) amino] benzonitrazine> 10% palladium carbide (50 mg) was added to 3_ [N · (2-chlorobenzyl) amino] _4_ This paper size applies Chinese National Standard (CNS) Α4 regulations (210 × 297 mm) 548272 In the Ministry of Economic Affairs ^-^ h T, Consumption Hezhuzhuan $ A7 B7 V. Description of the invention (71) Nitrobenzonitrate (261mg), methanol (15ml), 1 In a mixed solution of 4,4-dioxane (3 ml), contact reduction was performed in a hydrogen atmosphere at 3 atmospheres. After the reaction was completed, the reaction solution was filtered through celite and the pressure was reduced to remove the filtrate. Ether was used. The obtained solid was washed and filtered to obtain 4-amino_3- [N- (2-chlorofluorenyl) amino] benzophenone (196 mg). [Physical properties of the compound] ^ -NMR (DMS0 -d6, δ): 4.39 (2H5 d3 J = 5Hz), 5.57 (1H, t5 J-5Hz), 5.69 (2 H, s), 6.46 (1H, d, J = 2Hz), 6.61 (1H, d, J: 9Hz), 6.88 (1H, dd, J = 9, 2Hz), 7.25-7.41 (3H, m), 7.44-7.54 (1H, m) 〇 < Example 1; Synthesis of 1- (2-bromobenzyl) _6-ethoxycarbonyl_2-n-propylbenzimidazole (42) > 3 · [N- (2-bromobenzyl) butanamido] Ethyl-4-nitrobenzoate (390 mg) and reduced iron (21 mg) were added to a mixed solution of acetic acid (iml) and ethanol (2mi) to form a suspension. The suspension was refluxed for 1 hour. Stir it vigorously. After the reaction was completed, it was cooled, filtered through celite, and then subjected to reduced pressure to concentrate the filtrate. Ethyl acetate and an aqueous solution of sodium bicarbonate were added to the residue to form a layer. After the organic solvent layer was dried, the solution was distilled under reduced pressure to obtain a brown residue. This residue was purified by column chromatography to give 1- (2-bromobenzyl) _6 ″ ethoxycarbonyl-2-n-propylbenzimidazole (42) (160mg) ° [Physical properties of compound (42)] H- NMR (CDCla, δ): 1.04 (3H, t, J-8Hz), 1.40 (3H, t, J = 8Hz), 1.78-1.98 (2H, m), 2.34 (2H, t, J = 8Hz) , 4.38 (2H, q, J: 8Hz), 5.45 (2H, s), 6.65 (1H, t, J-8Hz), 7.00 (in, tj J = 8Hz), 7.13 (1H, t5 J = 8Hz), 7.28 (1H3 t, J, (诮 Please read the precautions on the back before filling in this page),-口 Φ.

經浐部中决柊消贽合竹杉印繁 548272 A7 ------------------—.,__ ____B7 五、發明説明(72) 8Ηζ), 7·78 (1H, d, J二ΙΟΗζ), 7·99 (1H, d, J=1〇Hz), 8〇2 (1H, s)。 mp : 134—135°C〇 <貫施例2,1-(2-氰基苄基)_6_乙氧羰基_2_正丙基苯 並咪唑(43)的合成> 使用3-[N-(2-氰基苄基)丁醯胺基]_4_硝基安息香酸 乙酯(390mg)亚藉由相同於實施例之方法以得出無色結 晶的1-(2-氰基苄基)_6_乙氧羰基_2_正丙基苯並咪唑 (43) (160mg) 〇 [化合物(43)的物性] ΙΝΜβ (CDC13,(5) : 1,〇4 (3H,t5 J:8Hz),1.40 (3H,t,J:8Hz),1.88 (2 H, sextet, J:8Hz), 2.80 (2H, t, J:8Hz), 4·38 (2H, q, J二8Hz), 5·62 (2H, s )5 6.57-6.63 (1H3 m)3 7.38-7.50 (ZH5 m)3 7.78 (1H, dd3 J-l, 8Hz)3 7.79 ( 1H, d, J:8Hz), 7·94 (1H, d, J:1Hz)3 8,03 (1H, dd5 J:l3 8Hz)。 mp : 132-134〇C〇 <實施例3; 1-(2-氣代苄基)-6-乙氧羰基-2-苯基苯並 咪唑(44)的合成> 使用3-[N-(2-氯代苄基)苯醯胺基]-4-硝基安息香酸 乙酯(460mg)並藉由相同於實施例之方法以得出黃色結 晶的1-(2-氯代苄基)-6-乙氧羰基-2-笨基苯並咪唑 (44) (220mg) ° [化合物(44)的物性] 'H-NMR (CDCh, δ) : 1.40 (3Η, t, J-8Hz), 4.38 (2H, q, J=8Hz), 5.56 (2H, s), 6·72 (H, dd, J=l, 8Hz), 7.18 (1H, dt, J:l, 8Hz), 7.30 (1H, dt, J二1 ,8Hz), 7.45-7.55 (4H, m), 7.64 (1H, d3 J^lHz), 7.68 (1H, d, J^lHz), 7.9 ---------------- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (誚先閱讀背面之注意事項再填寫本頁) 、\呑 %! 548272 A7 B7 五、發明説明(73) ◦ (1H, d, J:10Hz), 7·95 (1H, s), 8·08 (1H, dd, J:l3 8Hz)。 mp : 140-142°C〇 <實施例4;6-乙氧羰基-1-(2-氟代苄基)-2-正丙基苯 並咪唑(45)的合成> 使用3-[N-(2-氟代卞基)丁酿胺基]-4-石肖基安息香酸 乙酯(390mg)並藉由相同於實施例之方法以得出無色結 晶的6-乙氧幾基-1-(2-氟代节基)-2-正丙基苯並味唾 (45)(160mg) 〇 [化合物(45)的物性] 1 醜(CDC13,6) : 1.04 (3H,t,J:8Hz),1.40 (3H,t3 J:8HZ),u—u (2H,m),2.34 (2H,t,J=8Hz),4.38 (2H3 q,ιϋΗζ),5·45 (2H,s) 6 65 ( 1H, t, J二8Hz), 7.00 1H, t, J二8Hz), 7·13 (1H, t, J=8Hz), 7.28 (1H, t, J二8 Hz), 7·78 (1H, d, J二10Hz), 7.99 (1H, d, J=10Hz), 8.02 (1H, s)。 mp : 134— 1350C〇 <實施例5;6-乙氧羰基-1 -(4-氟代苄基)_2_正丙基苯 並咪唑(46)的合成> 使用3-[N-(4-氟代苄基)丁醯胺基]-4-硝基安息香酸 乙酯(400mg)並藉由相同於實施例之方法以得出無色結 晶的6-乙氧裁基-1 -(4-氟代节基)-2-正丙基笨並咪峻 (45)(160mg) 〇 [化合物(46)的物性] 1醒(CDCU d): 1.04 (3H,t,J:8Hz),1.40 (3H,t3 J:8Hz)5 i 88 (2H sextet, J-8Hz), 2.82 (2H, t, J-8Hz), 4.38 (2H, q, J~8Hz) 5 3§ s)The decision of the Ministry of Economic Affairs and the elimination of the combination of bamboo fir and India 548272 A7 ----------------------., __ ____B7 V. Description of the invention (72) 8Ηζ), 7 · 78 (1H, d, J Ι 10Ηζ), 7.99 (1H, d, J = 10 Hz), 80 (1H, s). mp: 134-135 ° C. < Example 2 Synthesis of 1,1- (2-cyanobenzyl) -6-ethoxycarbonyl-2-n-propylbenzimidazole (43) > Use 3- [ N- (2-cyanobenzyl) butyramidinyl] -4-nitrobenzoate (390mg). Substantially the same method as in the example to give 1- (2-cyanobenzyl) as colorless crystals. ) _6_Ethoxycarbonyl_2_n-propylbenzimidazole (43) (160mg) 〇 [Physical properties of compound (43)] INMβ (CDC13, (5): 1, 4 (3H, t5 J: 8Hz) , 1.40 (3H, t, J: 8Hz), 1.88 (2 H, sextet, J: 8Hz), 2.80 (2H, t, J: 8Hz), 4.38 (2H, q, J 2 8Hz), 5. · 62 (2H, s) 5 6.57-6.63 (1H3 m) 3 7.38-7.50 (ZH5 m) 3 7.78 (1H, dd3 Jl, 8Hz) 3 7.79 (1H, d, J: 8Hz), 7.94 (1H, d, J: 1 Hz) 3 8,03 (1H, dd5 J: 13 8 Hz). mp: 132-134 ° C < Example 3; 1- (2-Azobenzyl) -6-ethoxycarbonyl Synthesis of 2-phenylbenzimidazole (44) > Using 3- [N- (2-chlorobenzyl) phenylamidino] -4-nitrobenzoate ethyl ester (460 mg) The method used in the examples to give 1- (2-chlorobenzyl) -6-ethoxycarbonyl-2-benzylbenzimid as yellow crystals (44) (220mg) ° [Physical properties of compound (44)] 'H-NMR (CDCh, δ): 1.40 (3Η, t, J-8Hz), 4.38 (2H, q, J = 8Hz), 5.56 (2H , s), 6.72 (H, dd, J = 1, 8Hz), 7.18 (1H, dt, J: 1, 8Hz), 7.30 (1H, dt, J = 1, 8Hz), 7.45-7.55 (4H , m), 7.64 (1H, d3 J ^ lHz), 7.68 (1H, d, J ^ lHz), 7.9 ---------------- This paper size applies to Chinese national standards ( CNS) A4 specification (210X 297mm) (诮 Please read the notes on the back before filling this page), \ 呑%! 548272 A7 B7 V. Description of the invention (73) ◦ (1H, d, J: 10Hz), 7 · 95 (1H, s), 8.08 (1H, dd, J: 13 8Hz). mp: 140-142 ° C. < Example 4; Synthesis of 6-ethoxycarbonyl-1- (2-fluorobenzyl) -2-n-propylbenzimidazole (45) > Using 3- [ N- (2-Fluorofluorenyl) butyramine] -4-Ethylshinoyl ethyl benzoate (390 mg) and the same method as in the example to give 6-ethoxyquinyl-1- (2-Fluorobenzyl) -2-n-propylbenzoxyl salivary (45) (160mg) 〇 [Physical properties of compound (45)] 1 (CDC13, 6): 1.04 (3H, t, J: 8Hz ), 1.40 (3H, t3 J: 8HZ), u-u (2H, m), 2.34 (2H, t, J = 8Hz), 4.38 (2H3 q, ιϋΗζ), 5.45 (2H, s) 6 65 (1H, t, J = 8Hz), 7.00 1H, t, J = 8Hz), 7.13 (1H, t, J = 8Hz), 7.28 (1H, t, J = 8Hz), 7.78 (1H , D, J = 10Hz), 7.99 (1H, d, J = 10Hz), 8.02 (1H, s). mp: 134-1350C. < Example 5; Synthesis of 6-ethoxycarbonyl-1-(4-fluorobenzyl) _2-n-propylbenzimidazole (46) > Use 3- [N- ( 4-Fluorobenzyl) butylammonio] -4-nitrobenzoate (400 mg) and the same method as in the example was used to give 6-ethoxyl-1-(4 as colorless crystals) -Fluorobenzyl) -2-n-propylbenzimidazole (45) (160mg) 〇 [Physical properties of compound (46)] 1 (CDCU d): 1.04 (3H, t, J: 8Hz), 1.40 (3H, t3 J: 8Hz) 5 i 88 (2H sextet, J-8Hz), 2.82 (2H, t, J-8Hz), 4.38 (2H, q, J ~ 8Hz) 5 3§ s)

?·00 (4H, d,J:7Hz),7·77 (1H, d,J=8Hz),7·98 (1H,d,J:1HZ),8 00 (1H 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) (誚先閱讀背面之注意事項再填寫本頁)· 00 (4H, d, J: 7Hz), 7.77 (1H, d, J = 8Hz), 7.98 (1H, d, J: 1HZ), 8 00 (1H) Standard (CNS) A4 specification (210X 297 mm) (诮 Please read the precautions on the back before filling this page)

、1T 548272 A7 ____________________B7 五、發明説明(74) 1 ,dd, J=l, 8Hz)〇 mp : 134—1350C0 <實施例6> 使用相同於實施例i之方法以合成出以下的化合 物。 <貫施例6-1 ;6-乙氧羰基-2-正丙基吡啶甲基) 苯並咪唑(47)> [化合物(47)的物性] Ή-ΝΜ (CDCls,6) : 1·03 (3H,t,^7·5Ηζ),h39 (3H,七,㈣淑),ι 89 (2H5 m)3 Z.86 (2H5 t5 J,7.5Hz)3 4.38 (2H3 q3 J,7.5Hz), 5.50 (2H, s), 6.7 2 (1H, d, J:7.5Hz), 7.24 (1H, m), 7.58 (1H, dt, J:7.5,1.5Hz), 7.79 (1H, d, J:7.5Hz), 7·96-8·02 (2H, m), 8·60 (1H, d, J:4Hz)。 inp : 84 —85°C。 <實施例6-2;6-乙氧羰基-1-(3-氟代苄基)_2-正丙基 苯並啼唾(48)> [化合物(4 8)的物性] INMR (CDCh,d) : 1·〇4 (3H,t,J二7·5Ηζ),1·39 (3H,t,1.90 (2H,m),2.81(2H,t,J:7.5Hz)54.39(2H,q,J=7.5HZ),5.39(2H,s),6.7 0-6.84 (2H,m),7.00 (m,dt,J:8.5 及 1.5Hz),7.78 (1H】d,J=8.5Hz), 7·96 (1H, s), 8·00 (1H, d, J:8.5Hz)。 mp : M2 — 146°C。 <貫施例6_3;l-(2,6_二氣代卡基)_6·乙氧緩基_2-正 丙基苯並味唾(49)> [化合物(49)的物性] 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 、-5'<> 548272 A7 ____________________B7五、發明説明(75) (CDCla, ά) : 1.03 (3Η, t5 J=7.5Hz), 1.38 (3H5 t3 h88 (2H,m),2·93 (2H,t,J:7.5Hz),4·34 (2H,q,j:7.5Hz),5 61 (2H,s) w 6 (1H,d,J=7.5Hz),7.39 (2H,d,J=7.5Hz),7 68 (ih,d,>7·5Ηζ),7^· 1H, d, J-1.5Hz), 7.91 (2H5 d, J=7.5Hz)〇 mp : 153- 156°C〇 <實施例6-4;1-(3-甲基节基)+乙氧幾基_2_正丙 (誚先閱讀背面之注意事項再填寫本頁) 基 本並味唾(5 0) [化合物(50)的物性] 無色固体。 1 麵(CDCl3,㈨:(3H,t,㈣·5Ηζ),141 (3H,七,㈣·5Hz)【的 (2H, m), 2.29 (3H, s), 2.82 (2H, t, J=7.5Hz)3 4.38 (2H, q, J=7.5Hz) 5 3 5 (2H, s), 6.79-6.86 (2H, ffi), 7.09 (1H, d5 J=7.5Hz), 7.20 (1H, t, J=7.5H Z),7·76 (1H,d,J:7.5Hz)3 7·95-8·02 (2H,m)。 . <實施例6-5;2-環丙基-6-乙氧羰基_H2_氟代苄基) 苯並咪唑(51)> [化合物(51)的物性] H-NME (CDCh, δ) : 1.1〇 (2Η, m)3 1.27 (2H, m), 1.40 (3H, t5 J=7.5Hz), 1·95 (1H,m),4·37 (2H,q,J二7·5Ηζ),5.56 (2H,s),6·77 (1H,t,J二7.5Hz) ,7.03 (1H,t,J:7.5Hz),7.13 (1H,t,J:7.5Hz),7.29 (1H,ιη),7·69 (1H, d, J:7.5Hz), 7.96 (1H, d, J=7.5Hz), 8.02 (1H, d, J=2Hz)。 mp : 122- 126〇C〇 <實施例6-6; 1-(2-氣代苄基)-6-氰基-2-環丙基苯並 咪唑(52)> [化合物(52)的物性] > 79 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 、-=" 548272 A7 B7 五、發明説明(76 ) 'H-NKR (CDCh5 δ) : 1.04-1.24 (ZH, m)3 1.24-1.39 (2H5 m)5 1.83-2.01 (1H ,m), 5.58 (2H, s)5 6·54 (1H, d5 J二9Hz), 7.16 (1H, td, J:9, 2Hz), 7.22-7 (請先閱讀背面之注意事項再填寫本頁) •38 (1H, m), 7·43-7·56 (3H, m), 7.74 (1H, dd, J:9, 2Hz)。1T 548272 A7 ____________________ B7 V. Description of the invention (74) 1, dd, J = 1, 8 Hz) mp: 134-1350C0 < Example 6 > The same method as in Example i was used to synthesize the following compounds. < Example 6-1; 6-ethoxycarbonyl-2-n-propylpyridylmethyl) benzimidazole (47) > [physical properties of compound (47)] Ή-NM (CDCls, 6): 1 · 03 (3H, t, ^ 7 · 5Ηζ), h39 (3H, seven, ㈣shu), ι 89 (2H5 m) 3 Z.86 (2H5 t5 J, 7.5Hz) 3 4.38 (2H3 q3 J, 7.5Hz ), 5.50 (2H, s), 6.7 2 (1H, d, J: 7.5Hz), 7.24 (1H, m), 7.58 (1H, dt, J: 7.5, 1.5Hz), 7.79 (1H, d, J : 7.5Hz), 7.96-8 · 02 (2H, m), 8.60 (1H, d, J: 4Hz). inp: 84 —85 ° C. < Example 6-2; 6-ethoxycarbonyl-1- (3-fluorobenzyl) _2-n-propylbenzothiazol (48) > [physical properties of compound (4 8)] INMR (CDCh , D): 1.04 (3H, t, J 2 7. 5Ηζ), 1.39 (3H, t, 1.90 (2H, m), 2.81 (2H, t, J: 7.5Hz) 54.39 (2H, q, J = 7.5HZ), 5.39 (2H, s), 6.7 0-6.84 (2H, m), 7.00 (m, dt, J: 8.5 and 1.5Hz), 7.78 (1H) d, J = 8.5Hz) , 7.96 (1H, s), 8.00 (1H, d, J: 8.5Hz). Mp: M2-146 ° C. ≪ Executive Example 6_3; l- (2,6_ two gas generation card Group) _6 · ethoxysulfanyl-2-n-propylbenzobenzo salivary (49) > [physical properties of compound (49)] This paper is in accordance with China National Standard (CNS) A4 size (210X297 mm) ( Please read the precautions on the back before filling this page), -5 '< > 548272 A7 ____________________ B7 V. Invention Description (75) (CDCla, ά): 1.03 (3Η, t5 J = 7.5Hz), 1.38 (3H5 t3 h88 (2H, m), 2.93 (2H, t, J: 7.5Hz), 4.34 (2H, q, j: 7.5Hz), 5 61 (2H, s) w 6 (1H, d, J = 7.5Hz), 7.39 (2H, d, J = 7.5Hz), 7 68 (ih, d, > 7.5Ηζ), 7 ^ · 1H, d, J-1.5Hz), 7.91 (2H5 d, J = 7.5Hz) mp: 153-156 ° C. < Example 6-4; 1- (3-methylbenzyl) + ethoxyquinyl_2_n-propyl (诮 Please read the precautions on the back before filling this page) Basic And taste saliva (50) [physical properties of compound (50)] colorless solid. 1 side (CDCl3, ㈨: (3H, t, ㈣ · 5Ηζ), 141 (3H, seven, ㈣ · 5Hz) [2H, m), 2.29 (3H, s), 2.82 (2H, t, J = 7.5Hz) 3 4.38 (2H, q, J = 7.5Hz) 5 3 5 (2H, s), 6.79-6.86 (2H, ffi) , 7.09 (1H, d5 J = 7.5Hz), 7.20 (1H, t, J = 7.5HZ), 7.76 (1H, d, J: 7.5Hz) 3 7.95-8 · 02 (2H, m) . < Example 6-5; 2-cyclopropyl-6-ethoxycarbonyl_H2_fluorobenzyl) benzimidazole (51) > [physical properties of compound (51)] H-NME (CDCh, δ): 1.1〇 (2Η, m) 3 1.27 (2H, m), 1.40 (3H, t5 J = 7.5Hz), 1.95 (1H, m), 4.37 (2H, q, J 2 7 · 5Ηζ), 5.56 (2H, s), 6.77 (1H, t, J, 7.5Hz), 7.03 (1H, t, J: 7.5Hz), 7.13 (1H, t, J: 7.5Hz), 7.29 ( 1H, ιη), 7.69 (1H, d, J: 7.5Hz), 7.96 (1H, d, J = 7.5Hz), 8.02 (1H, d, J = 2Hz). mp: 122-126 ° C < Example 6-6; 1- (2-Gas benzyl) -6-cyano-2-cyclopropylbenzimidazole (52) > [Compound (52) Physical properties] > 79 This paper is sized to China National Standard (CNS) A4 (210X297 mm),-= " 548272 A7 B7 V. Description of the invention (76) 'H-NKR (CDCh5 δ): 1.04- 1.24 (ZH, m) 3 1.24-1.39 (2H5 m) 5 1.83-2.01 (1H, m), 5.58 (2H, s) 5 6.54 (1H, d5 J to 2Hz), 7.16 (1H, td, J : 9, 2Hz), 7.22-7 (Please read the precautions on the back before filling this page) • 38 (1H, m), 7.43-7 · 56 (3H, m), 7.74 (1H, dd, J : 9, 2Hz).

Mass (FAB) : 308 (M+l)〇 IR (Nujol) : 2210cm l〇 <實施例6-7; 1-(2-氯代苄基)-2-環丁基-6-乙氧羰基 苯並咪唑(53)> [化合物(53)的物性] ^-NMR (CDCh, δ) : 1.38 (3Η, t3 J=7.5Hz), 1.90-2.21 (2H5 m)5 2.Z1-2.24 (2H3 m)5 2.46-2.70 (2H3 m)3 3.52-3,73 (1H, m), 4.37 (2H3 q3 J=7.5Hz)3 5 •39 (2H, s), 6.34 (1H, dd3 J=9, 2Hz), 7·06 (1H, td, J=9, 2Hz), 7.23 (1H, td, J=9, 2Hz), 7·46 (1H, dd, J=9, 2Hz), 7·83 (1H, d, J=9Hz), 7,92 (1H, d, J=2Hz), 8.01 (1H, dd, J二9, 2Hz)。 mp : 111 - 113〇C 〇 <實施例6-8; 1-(2-氯代苄基)-6-乙氧羰基-2-正戊基 苯並咪唑(54)> [化合物(54)的物性] ^-NMR (CDCla, δ) : 0.87 (3H5 t, J-7.5Hz), 1.22-L47 (7H5 m)3 1.74^1.93 (2H, m), 2·80 (2H, t, J=7.5Hz), 4·37 (2H, q, J=7.5Hz), 5·47 (2H, s), 6 39 (1H, dd, J二9, 2Hz), 7.08 (1H, td, J二9, 2Hz), 7.19-7.33 (1H5 m), 7.48 (1H, dd, J=9, 2IL), 7.79 (1H, d, J二9Hz), 7,94 (1H, d3 J二2Hz), 8.00 (iH d d, J二9, 2Hz)〇 <實施例7;5-羧基-1 -(2-氯代苄基)-2-正丙基笨並味 唑(55)> 本紙張尺度速用中國國家標準(CNS ) A4規格(210X297公釐) 5你272 A7 ________________B7 五、發明説明(77) 將乙醇(20ml)與1〇。/。氫氧化鈉水溶液(1〇4g)加入 1 -(2-氣代苄基)-5-乙氧羰基j正丙基苯並咪唑(2.8g) (讀先閱讀背面之注意事項再填寫本頁) 中’加熱迴流4小時。反應液經冷卻後,使用丨〇%鹽酸 以將PH調整成6。將結晶收集起來,經水洗、減壓乾燥 以得出無色固體的5-羧基-1气2_氯代苄基)-2-正丙基苯並 咪唑(55)(2.46g)。 [化合物(55)的物性] 4-NMR (DMS0-d6,(5) : 0·93 (3H,t,J:7.5Hz),1·75 (2H,m),2·79 (2H, t, J=7.5Hz), 5.61 (2H, s), 6·49 (1H, d, J:7.5Hz), 7·21 (1H, t, J:7.5Hz), 7.33 (1H, t, J=7.5Hz), 7.46 (1H, d, J=7.5Hz), 7.56 (1H, d, J=7.5Hz), 7.8 〇 (1H, d, J=7.5Hz)3 8.20 (1H, s)〇 <實施例8> 使用相同於實施例7之方法以合成出以下的化合 物。 <貫施例8-1;6-羧基-1-(3-甲基苄基)正丙基苯並 咪唑(56)> [化合物(56)的物性] 無色固体。 w-醒⑽ so-d6, cnu ⑽,t,J=7.5Hz),L78 (2H,m),2·23 (3h,s)Mass (FAB): 308 (M + 1) 〇IR (Nujol): 2210 cm 10 < Example 6-7; 1- (2-chlorobenzyl) -2-cyclobutyl-6-ethoxycarbonyl Benzimidazole (53) > [Physical properties of compound (53)] ^ -NMR (CDCh, δ): 1.38 (3Η, t3 J = 7.5Hz), 1.90-2.21 (2H5 m) 5 2.Z1-2.24 ( 2H3 m) 5 2.46-2.70 (2H3 m) 3 3.52-3,73 (1H, m), 4.37 (2H3 q3 J = 7.5Hz) 3 5 • 39 (2H, s), 6.34 (1H, dd3 J = 9 , 2Hz), 7.06 (1H, td, J = 9, 2Hz), 7.23 (1H, td, J = 9, 2Hz), 7.46 (1H, dd, J = 9, 2Hz), 7.83 (1H, d, J = 9Hz), 7,92 (1H, d, J = 2Hz), 8.01 (1H, dd, J = 9, 2Hz). mp: 111-113 ° C < Examples 6-8; 1- (2-chlorobenzyl) -6-ethoxycarbonyl-2-n-pentylbenzimidazole (54) > [Compound (54 Physical properties) ^ -NMR (CDCla, δ): 0.87 (3H5 t, J-7.5Hz), 1.22-L47 (7H5 m) 3 1.74 ^ 1.93 (2H, m), 2.80 (2H, t, J = 7.5Hz), 4.37 (2H, q, J = 7.5Hz), 5.47 (2H, s), 6 39 (1H, dd, J2, 9, 2Hz), 7.08 (1H, td, J2 9, 2Hz), 7.19-7.33 (1H5 m), 7.48 (1H, dd, J = 9, 2IL), 7.79 (1H, d, J = 9Hz), 7,94 (1H, d3 J = 2Hz), 8.00 (iH dd, J 9.2, 2 Hz) < Example 7; 5-carboxy-1-(2-chlorobenzyl) -2-n-propylbenzimidazole (55) > The paper scale speed Use Chinese National Standard (CNS) A4 specification (210X297 mm) 5 you 272 A7 ________________B7 V. Description of the invention (77) Combine ethanol (20ml) with 10%. /. Aqueous sodium hydroxide solution (104 g) is added with 1- (2-gaso-benzyl) -5-ethoxycarbonyl j n-propylbenzimidazole (2.8 g) (read the precautions on the back before filling this page) Middle 'reflux for 4 hours. After the reaction solution was cooled, 0% hydrochloric acid was used to adjust the pH to 6. The crystals were collected, washed with water and dried under reduced pressure to give 5-carboxy-1 gas 2-chlorobenzyl) -2-n-propylbenzimidazole (55) (2.46 g) as a colorless solid. [Physical properties of compound (55)] 4-NMR (DMS0-d6, (5): 0.93 (3H, t, J: 7.5Hz), 1.75 (2H, m), 2.79 (2H, t , J = 7.5Hz), 5.61 (2H, s), 6.49 (1H, d, J: 7.5Hz), 7.21 (1H, t, J: 7.5Hz), 7.33 (1H, t, J = 7.5Hz), 7.46 (1H, d, J = 7.5Hz), 7.56 (1H, d, J = 7.5Hz), 7.8 〇 (1H, d, J = 7.5Hz) 3 8.20 (1H, s) 〇 < Example 8> The following compound was synthesized using the same method as in Example 7. < Example 8-1; 6-carboxy-1- (3-methylbenzyl) -n-propylbenzimidazole (56 ) > [Physical properties of compound (56)] A colorless solid. w-⑽⑽ so-d6, cnu⑽, t, J = 7.5Hz), L78 (2H, m), 2.23 (3h, s)

,3·86 (2H,q,J=7.5Hz),5.53 (2H,s),6·80 (1H,d,J:7.5Hz),6·91 (1H,S ),7·〇7 (1H,d,J:7,5Hz),7.21 (1H3 t,J=7.5Hz),7』5 (1H,d,j:7.5Hz),7 •79 (1H, d, J:7.5Hz), 8.04 (1H, s)〇 ’ <實施例8-2;2·正丁基羧基氯代苄基)苯並 咪唑(57)> 本紙張尺度適ffl中國國家標隼(CNS ) A4規格(210X297公釐) 548272 A7 __________ _B7 五、發明説明(78 ) [化合物(57)的物性] INMR (DMS0-d6,6) : 0.84 (3H,t,J:7.5Hz),1.34 (2H,id),[π ⑽,m) ,2·80 (2H, t, J:7.5Hz), 5.89 (2H, s), 6·03 (1H, d5 J:7.5Hz), 7.13 (1Η, t,J:7.5Hz),7·27 (2H,t5 7·48 (1H,d,J:7.5Hz),7·63 (1H,d, J-7.5Hz)3 7.87 (1H3 d3 J-7.5Hz)〇 <實施例8-3;6-魏基-2-環丙基-1-(2-氟代节基)苯並 咪唑C58)> [化合物(58)的物性] 4-醜(DMS〇-d6,d) : 1.04-1.19 (4H,m),2·37 (1H,m),5·79 (2H, s),7. 〇MlH,t,J:7.5Hz),7·15 (1H,t,Jt7.5Hz),7·27 (1H,t,J:l〇.5Hz),7.37 (1H, m), 7·60 (1H, d, J=7.5Hz), 7·82 (1H, d, J:7.5Hz), 8·11 (1H, s)。 即:224 - 229°C〇 <實施例8-4;2-正丁基-6-羧基-1-(2-氟代苄基)苯並 咪唑(59)> [化合物(59)的物性] -舰(DMS0-d6, ά) : 〇·87 (3H,t,J:7.5Hz),1.26-1.48 (2H,m),1.60-1. 80 (2H,m),2·90 (2H,t3 J:7.5Hz),5·63 (2H,s)3 6·89 (1H,td,J:9, 2Hz) ,7.13 (1H, td, J二9, 2Hz), 7.20-7·44 (2H, m), 7·64 (1H, d, J二9Hz), 7.80 (1H, dd, J:9, 2Hz), 8·08 (1H, d, J:2Hz)。 mp : 216-219°C〇 <實施例9; 1-(2-氣代苄基)-6-氣代羰基-2-環丙基苯 並咪唑鹽酸鹽(60)之合成> 將6-羧基-1-(2-氯代苄基)-6-氯羰基-2-環丙基苯並 咪吐(390g)加入含有N,N-二曱基曱醯胺(1滴)之二氯曱烷 本紙張尺度適/fll7關家標準(CNS ) A4規格(21GX 297^釐) (請先閱讀背面之注意事項再填寫本頁) 訂 -ΦΙ. 548272 A7 B7 五、發明説明(79) - (誚先閱讀背面之注意事項再填寫本頁) 〇㈣中以調製出懸濁液。在室溫下,經數分以將氣化乙 一醯(〇.2〇8ml)滴入懸濁液中。在室溫下攪拌2小時後, 進行混合物之減壓濃縮。將異㈣加人殘留物中並進行 ^末化以得出白色粉末之!♦氯代节基X氯代幾基士 環丙基苯並咪唑鹽酸鹽(6〇)(45〇mg)。由於其不安定^特 性故不須經精製而直接作為下個步驟之原料物質。 〆 < 實施例10;1-(2_氯代苄基>6_(4_二甲基胺基苯甲 基氨基甲醯基)-2-正丙基苯並咪唑(61)之合成> 將6-幾基-1-(2-氯代苄基)_2_正丙基笨並咪唑 (40〇mg)溶解於加入有j滴n,n_二曱基甲醯胺之二氯甲 烷(3ml)中。在5C下將氯化乙二醯(28mg)加入前述溶液 中。在室溫下將所得之溶液攪拌丨小時後,進行減壓濃 縮。將殘留物溶解於二氯曱烧(3mi)中,在室溫下加入由 一曱基胺基苯醯胺鹽酸鹽(27 lmg)與加入有三乙胺 (lml)之二氯曱烷(i〇mi)所構成之混合液中。所得之反應 混合物在室溫下攪拌丨小時,經水洗乾燥後進行減壓濃 縮。使用薄層色譜以將殘渣展開、精製,而得出丨_(2_ 氯代苄基)-6-(4-二曱基胺基苯甲基氨基曱醯基)_2-正丙 基笨並咪唑(61)(215mg)。 [化合物(61)的物性] 無色結晶。 (CDCl3,ά) : (3H,t,J:7Hz),1·88 (2H,sextet,J:7Hz),2. (2H, t, J:7Hz), 2·95 (6H, s), 4.50 (2H, d, J:5Hz), 5·45 (2H, s), 6.32 1H3 d, J:5Hz), 6·36 UH, d, J:7Hz), 6·72 (2H, d, J:歷z)3 7·〇7 (1H, dt 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 __________________B7_ 五、發明説明(8〇 ) ' 问,8Hz),7.20-7.25 (3H,m),7·46 (1H,dd,J二 1,8Hz) 3 7.58 (1H,dd,J:i ,8Hz), 7·76 (1H, d, J:8Hz), 7.82 (1H, d, J:lHz)。 即:155 - 156°C〇 <實施例1 l;l-(2-氯代苄基)-6-嗎琳氨基甲醯基_2-正丙基苯並味峻(62)的合成> 使用6-魏基-1-(2-氯代节基)-2-正丙基苯並味ϋ坐 (200mg)與4-胺基嗎淋(I24mg)並藉由相同於實施例 之方法以得出1-(2-氣代苄基)-6-嗎淋氨基曱酿基-2-正丙 基苯並哺唾(62)(205mg)。 [化合物(62)的物性] 無色結晶。 lH-NMR (CDCh, δ) : 1.03 (3H5 t5 J=8Hz)3 1.88 (2H, sextet, J=8Hz)5 2.62 (4H, bs), 2·72 (2H, t, J:8Hz), 3·85 (4H, bs), 5.42 (2H, s), 6·42 (1H, d d, J:l, 8Hz), 7·〇8 (1H, dt, J:l, 8Hz), 7.20-7.28 (3H, m), 7·47 (1H, dd, J-l, 8Hz), 7.78 (1H3 dd, J=l3 8Hz)〇 即:195 - 197°C〇 <實施例12; 1-(2-氯代苄基)-2-正丙基-6-硫代嗎啉 氨基甲醯基-苯並咪唑(63)的合成> 使用6 -叛基-1-(2-氣代节基)-2-正丙基笨並味。坐 (200mg)與硫代嗎啉(l25mg)並藉由相同於實施例10之 方法以得出1-(2-氯代苄基)-2-正丙基-6·硫代嗎啉氨基曱 醯基-笨並咪唑(63)(160mg)。 [化合物(63)的物性] - --;--μ—— 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁j 、11 548272 A7 --*----------------------B7____ 五、發明説明(81 ) 一 — 無色結晶。 (請先閱讀背面之注意事項再填寫本頁) H-麵(CDCh,(5) : 1·〇3 (3H,t,J:8Hz),1·88 (2H,sextet,J:8Hz),2.78 (2H, t, J:8Hz), 2·96 (4H, bt, J:5Hz), 3·88 (4H, bt, J:5Hz), 5·46 (2H, s ),6·34 (1H,dd,J=l,8Hz),7.08 (1H,dt,J二 1,8Hz),7·26 (2H,dt,J二1, 8Hz), 7·47 UH, dd, J:l5 8Hz), 7·58 (1H, bd, J=8Hz), 7.76 (1H, s), 7.78 (1H5 d, J二8Hz)〇 mp : 160- 162°C〇 〈貫施例13;2-正丁基-1-(2-氣代苄基)-6-[(2-吡啶甲 基)氨基甲醯基]苯並咪唾(64)之合成> 使用6_羧基-2-正丁基-1-(2-氯代苄基)苯並咪唑 (200mg)與2-胺基甲基。比啶(126mg)並藉由相同於實施例 10之方法以得出2-正丁基-1-(2-氯代苄基)-6-[(2-吡啶甲 基)氣基曱酿基]苯並口米嗤(64)(2 3 Omg)。 [化合物(64)的物性] 無色結晶。 4-疆(CDC13,(S) : 〇·92 (3H,t,J:8Hz),1.42 (2H,sextet,J:8Hz),1.82 (2H, quintet, J:8Hz), 2·82 (2H, t, J:8Hz), 4·76 (1H, d, J:5Hz), 5.46 (2 H, s), 6.38 (1H, dd, J:l, 8Hz), 7.08 (1H3 dt, J=l, 8Hz), 7.18-7.26 (2H, m), 7.32 (1H, d, J:8Hz), 7·46 (1H, dd, J:l, 8Hz), 7·62 (1H, dt, J:l, 8Hz ),7.72 (1H,dt,J二1,8Hz),7·82 (1H,d,J二8Hz)3 7.88 (1H,d,J二1Hz),8. 56 (1H, dd, J:l, 8Hz)。 mp : 175- 176°C〇 <實施例14;2-正丁基-5-氨基甲醯基-1-(2-氯代苄基) 苯並咪唑(65)之合成> 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 _________________ __B7 五、發明説明(82 ) '~~ 使用2-正丁基氯代苄基)_5_氨基曱醯基苯並咪 唑(lOOmg)並藉由相同於實施例1〇之方法以得出孓正丁 基-5-氨基曱醯基_1-(2_氯代苄基)苯並咪唑(65)(i7〇mg)。 [化合物(65)的物性] 無色結晶。 ^-NMR (DMS0-d6, d) : 0.84 (3H5 t3 J^8Hz)5 1.35 (2H, sextet, J=8Hz), 1. 68 (2H3 quints J二8Hz),2·78 (2H, t,J:8Hz),5·58 (2H,s),6·50 (1h3 dd ,J:l3 8Hz), 7·25 (1H, dt3 J=l3 8Hz), 7.28 (1H, bs), 7.35 (1H, dt, J:l, 8Hz)5 7.42 (1H, d3 J^lOHz), 7.56 (1H3 dd5 J,l3 8Hz), 7.74 (1H, dd5 J=l5 10Hz), 7.96 (1H3 bs), 8.20 (1H, d, J:lHz)。 mp : 195—198°C。 <實施例15; 1 _(2-氯代苄基)_2_環丙基_6-嗎啉羰基 苯並咪唑(66)之合成> 將嗎啉(298mg、30%曱醇溶液)加入二氣曱烷(1〇ml) 中以調製成溶液。在室溫下將氯代苄基)_6_氣代羰 基-2_環丙基笨並咪唑鹽酸鹽(14〇mg)加入前述溶液中。 將削述反應混合物在室溫下攪拌1小時後,進行水洗、 經沪部中^it^-^h 3消费合竹私印東 (誚先閱讀背面之注意事項再填寫本頁) 乾爍及減壓濃縮。使用醚以再結晶殘渣,而得出i -(2__ 氣代苄基)-2-環丙基-6-嗎琳羰基笨並咪唑(66)(2〇mg)。 [化合物(66)的物性] 無色結晶。 旧-腿(CDCh,ά) ·· 1.04-1.12 (2H3 m),1.25-1.32 (2H,m)3 1·82-1·96 (1H ,m),3·68 (8H,bs),5.56 UH,s),6.55 (1H,dd,J=l,8Hz),7.13 (1H3 dt ,J=l,8Hz),7·22-7·29 (2H,m),7·3〇(1η,d,J=1Hz),7·46 (m,dd,J=1, 本紙張尺度適州中國國家標準(CNS ) A4規格(21〇'x 297公楚) 548272 A7 B7 五、發明説明(83) 8Hz), 7.77 (1H, d3 J-8Hz)N mp : 193 — 1950C〇 <實施例16;l-(2-氯代苄基)-2-環丙基-6-[(2-吡啶甲 基)氨基甲醯基]苯並1^米唾(67)之合成> 使用1 -(2-氯代苄基)-6-氯代羰基-2-環丙基苯並咪 唑鹽酸鹽(150mg)、2-胺基甲基吡啶(85mg)並藉由相同於 實施例15之方法以得出1-(2-氣代苄基)-2-環丙基-6-[(2-。比啶甲基)氨基甲醯基]苯並咪唑(67)(95mg)。 [化合物(67)的物性] 無色結晶。 IMR (CDC13, 6) : 1.02-1.13 (2H,m),1.24-1.32 (2H,瓜),1·82_1·95 (1H ,m),4.76 (2H3 d3 J二5Hz),5.59 (2Η,s),7·11 (1H,dt3 扣1,8Ηζ),7·20_7 • 26 (2Η3 m)3 7.34 ( 1Η3 d,J二8Ηζ)3 7·46 (1Η,dd3 J:l5 8Ηζ),7·60 (1Η,t, J二5Ηζ), 7·66 (1Η, dd, J=l, 8Ηζ), 7.73 (1Η, s), 7.88 (1Η, s)。 mp : 134— 1350C〇 <實施例17> 依據相同於實施例15之方法以得出以下之化合物。 <實施例17-1; 1-(2-氣代苄基)_2_環丙基_6-(2•吡啶 氨基甲醯基)苯並咪唑(68)> [化合物(68)的物性] !H-眶(CDC13, 6) : 1.16 (2H,m),1·32 (2H,π〇, ^ (1H,『),5·61 (2H, s),6.57 (1H,d,J二7.5 及 1·5Ηζ),7.15 (1H,dt,J=7.5 及 1·5Ηζ),7. 22-7·31 (2H,πι),7.48 (1H,dd,J=7.5 及 1·5ηζ),γ.77 (iH,山 J:9Hz),8 .05 (2H, m)〇 mp : 206 —209°C。 ____&JZ-_ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁), 3.86 (2H, q, J = 7.5Hz), 5.53 (2H, s), 6.80 (1H, d, J: 7.5Hz), 6.91 (1H, S), 7.07 ( 1H, d, J: 7, 5Hz), 7.21 (1H3 t, J = 7.5Hz), 7′5 (1H, d, j: 7.5Hz), 7 • 79 (1H, d, J: 7.5Hz), 8.04 (1H, s) 0 '< Example 8-2; 2 · n-butylcarboxychlorobenzyl) benzimidazole (57) > This paper is suitable for the national standard (CNS) A4 specification of F1 ( 210X297 mm) 548272 A7 __________ _B7 V. Description of the invention (78) [Physical properties of compound (57)] INMR (DMS0-d6, 6): 0.84 (3H, t, J: 7.5Hz), 1.34 (2H, id) , [Π ⑽, m), 2.80 (2H, t, J: 7.5Hz), 5.89 (2H, s), 6.03 (1H, d5 J: 7.5Hz), 7.13 (1Η, t, J: 7.5Hz), 7.27 (2H, t5 7.48 (1H, d, J: 7.5Hz), 7.63 (1H, d, J-7.5Hz) 3 7.87 (1H3 d3 J-7.5Hz). Example 8-3; 6-Weiyl-2-cyclopropyl-1- (2-fluorobenzyl) benzimidazole C58) > [physical properties of compound (58)] 4-ugly (DMS〇- d6, d): 1.04-1.19 (4H, m), 2.37 (1H, m), 5.79 (2H, s), 7.0MlH, t, J: 7.5Hz), 7.15 (1H , T, Jt 7.5 Hz), 7.27 (1H, t, J: 10.5 Hz) 7.37 (1H, m), 7 · 60 (1H, d, J = 7.5Hz), 7 · 82 (1H, d, J: 7.5Hz), 8 · 11 (1H, s). That is: 224-229 ° C < Example 8-4; 2-n-butyl-6-carboxy-1- (2-fluorobenzyl) benzimidazole (59) > [Compound (59) Physical properties]-Ship (DMS0-d6, ά): 〇 87 (3H, t, J: 7.5Hz), 1.26-1.48 (2H, m), 1.60-1. 80 (2H, m), 2.90 ( 2H, t3 J: 7.5Hz), 5.63 (2H, s) 3 6.89 (1H, td, J: 9, 2Hz), 7.13 (1H, td, J2 9, 2Hz), 7.20-7 · 44 (2H, m), 7.64 (1H, d, J = 9Hz), 7.80 (1H, dd, J: 9, 2Hz), 8.08 (1H, d, J: 2Hz). mp: 216-219 ° C. < Example 9; Synthesis of 1- (2-gaso benzyl) -6-gasocarbonyl-2-cyclopropylbenzimidazole hydrochloride (60) > 6-Carboxy-1- (2-chlorobenzyl) -6-chlorocarbonyl-2-cyclopropylbenzimidone (390 g) was added with the second one containing N, N-difluorenimidine (1 drop) Chloroprene This paper is suitable for standard / fll7 standard (CNS) A4 (21GX 297 ^ cent) (Please read the precautions on the back before filling this page) Order-ΦΙ. 548272 A7 B7 V. Description of the invention (79) -(诮 Please read the precautions on the back before filling this page) 〇㈣ to prepare the suspension. At room temperature, vaporized ethyl acetate (0.208 ml) was dropped into the suspension over several minutes. After stirring at room temperature for 2 hours, the mixture was concentrated under reduced pressure. Diisocyanate is added to the residue and ^ finished to obtain a white powder! ♦ Chlorobenzyl X chlorochixyl cyclopropylbenzimidazole hydrochloride (60) (45 mg). Due to its unstable nature, it does not need to be refined and can be directly used as the raw material for the next step. 〆 < Example 10; Synthesis of 1- (2-chlorobenzyl) > 6_ (4-dimethylaminobenzylaminomethylamidino) -2-n-propylbenzimidazole (61) >; 6-Chloro-1- (2-chlorobenzyl) _2-n-propylbenzimidazole (40 mg) was dissolved in methylene chloride added with j drops of n, n_dimethylformamide (3 ml). Ethylene dichloride (28 mg) was added to the aforementioned solution at 5 C. The resulting solution was stirred at room temperature for 1 hour and then concentrated under reduced pressure. The residue was dissolved in dichloromethane ( 3mi), was added at room temperature to a mixed solution consisting of monomethylaminobenzidine hydrochloride (27 lmg) and dichloromethane (iomi) added with triethylamine (1ml). The obtained reaction mixture was stirred at room temperature for 丨 hours, washed with water and dried, and then concentrated under reduced pressure. The residue was developed and purified using thin-layer chromatography to obtain 丨 _ (2_chlorobenzyl) -6- (4- Difluorenylaminobenzylaminofluorenyl) _2-n-propylbenzimidazole (61) (215mg). [Physical properties of compound (61)] Colorless crystal. (CDCl3, ά): (3H, t, J: 7Hz), 1.88 (2H, sextet, J: 7Hz), 2. (2H, t, J: 7Hz), 2.95 (6H, s), 4.50 (2H, d, J: 5Hz), 5.45 (2H, s), 6.32 1H3 d, J: 5Hz), 6.36 UH, d, J: 7Hz), 6.72 (2H, d, J: calendar z) 3 7 · 07 (1H, dt This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 __________________B7_ V. Description of the invention (8〇) 'Q , 8Hz), 7.20-7.25 (3H, m), 7.46 (1H, dd, J 2 1,8Hz) 3 7.58 (1H, dd, J: i, 8Hz), 7.76 (1H, d, J : 8Hz), 7.82 (1H, d, J: lHz). That is: 155-156 ° C. ≪ Example 1 l; (l- (2-chlorobenzyl) -6-morpholinaminomethylfluorenyl-2-n-propylbenzobenzoic acid (62) synthesis >; Using 6-Weiyi-1- (2-chlorobenzyl) -2-n-propylbenzo miso (200mg) and 4-aminomorphine (I24mg) and by the same method as in the examples In order to obtain 1- (2- oxobenzyl) -6-morphine aminopyrene-2-n-propylbenzoxaline (62) (205 mg). [Physical properties of compound (62)] Colorless crystals. lH-NMR (CDCh, δ): 1.03 (3H5 t5 J = 8Hz) 3 1.88 (2H, sextet, J = 8Hz) 5 2.62 (4H, bs), 2.72 (2H, t, J: 8Hz), 3 85 (4H, bs), 5.42 (2H, s), 6.42 (1H, dd, J: 1, 8Hz), 7.08 (1H, dt, J: 1, 8Hz), 7.20-7.28 ( 3H, m), 7.47 (1H, dd, Jl, 8Hz), 7.78 (1H3 dd, J = 113 8Hz). That is: 195-197 ° C. ≪ Example 12; 1- (2-chloro Synthesis of benzyl) -2-n-propyl-6-thiomorpholinecarbamoyl-benzimidazole (63) > Use of 6-retyl-1- (2-oxobenzyl) -2- N-propyl is stupid. Sit (200 mg) with thiomorpholine (125 mg) and use the same method as in Example 10 to give 1- (2-chlorobenzyl) -2-n-propyl-6 · thiomorpholine aminofluorene Fluorenyl-benzimidazole (63) (160 mg). [Physical properties of compound (63)]--; --μ—— This paper is suitable for China National Standard (CNS) A4 size (210X 297 mm) (please read the precautions on the back before filling in this page) 11 548272 A7-* ---------------------- B7____ 5. Description of the invention (81) A-colorless crystal. (Please read the precautions on the back first Fill in this page) H-plane (CDCh, (5): 1.03 (3H, t, J: 8Hz), 1.88 (2H, sextet, J: 8Hz), 2.78 (2H, t, J: 8Hz ), 2.96 (4H, bt, J: 5Hz), 3.88 (4H, bt, J: 5Hz), 5.46 (2H, s), 6.34 (1H, dd, J = 1, 8Hz ), 7.08 (1H, dt, J-2 1, 8Hz), 7.26 (2H, dt, J-2 1, 8Hz), 7.47 UH, dd, J: 15-8Hz), 7.58 (1H, bd , J = 8Hz), 7.76 (1H, s), 7.78 (1H5 d, J 2 8Hz), mp: 160-162 ° C, 〈Example 13; 2-n-butyl-1- (2-gas generation) Synthesis of benzyl) -6-[(2-pyridylmethyl) carbamoyl] benzilide (64) > using 6-carboxy-2-n-butyl-1- (2-chlorobenzyl ) Benzimidazole (200 mg) and 2-aminomethyl. Bipyridine (126 mg) and by the same method as in Example 10 to obtain 2- Butyl-1- (2-chlorobenzyl) -6-[(2-pyridylmethyl) aminomethyl] benzocarbamidine (64) (2 3 Omg). [Compound (64) 's Physical properties] Colorless crystal. 4- Xinjiang (CDC13, (S): 0.92 (3H, t, J: 8Hz), 1.42 (2H, sextet, J: 8Hz), 1.82 (2H, quintet, J: 8Hz), 2.82 (2H, t, J: 8Hz), 4.76 (1H, d, J: 5Hz), 5.46 (2 H, s), 6.38 (1H, dd, J: 1, 8Hz), 7.08 (1H3 dt, J = 1, 8Hz), 7.18-7.26 (2H, m), 7.32 (1H, d, J: 8Hz), 7.46 (1H, dd, J: l, 8Hz), 7.62 (1H, dt, J: 1, 8Hz), 7.72 (1H, dt, J2, 1,8Hz), 7.82 (1H, d, J2, 8Hz) 3 7.88 (1H, d, J2, 1Hz), 8.56 ( 1H, dd, J: l, 8Hz). mp: 175-176 ° C. < Example 14; Synthesis of 2-n-butyl-5-aminomethylamidin-1- (2-chlorobenzyl) benzimidazole (65) > Paper size Shizhou Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 _________________ __B7 V. Description of the invention (82) '~~ Use 2-n-butylchlorobenzyl) _5_aminofluorenylbenzimidazole (100 mg) and by the same method as in Example 10 to give fluorene n-butyl-5-aminofluorenyl-1- (2-chlorobenzyl) benzimidazole (65) (i70 mg) . [Physical properties of compound (65)] Colorless crystals. ^ -NMR (DMS0-d6, d): 0.84 (3H5 t3 J ^ 8Hz) 5 1.35 (2H, sextet, J = 8Hz), 1. 68 (2H3 quints J 2 8Hz), 2.78 (2H, t, J: 8Hz), 5.58 (2H, s), 6.50 (1h3 dd, J: 13 8Hz), 7.25 (1H, dt3 J = 13 8Hz), 7.28 (1H, bs), 7.35 (1H , Dt, J: l, 8Hz) 5 7.42 (1H, d3 J ^ lOHz), 7.56 (1H3 dd5 J, l3 8Hz), 7.74 (1H, dd5 J = l5 10Hz), 7.96 (1H3 bs), 8.20 (1H , D, J: lHz). mp: 195-198 ° C. < Example 15; Synthesis of 1_ (2-chlorobenzyl) _2_cyclopropyl_6-morpholinecarbonylbenzimidazole (66) > Morpholine (298mg, 30% methanol solution) was added Dioxane (10 ml) was prepared as a solution. Chlorobenzyl) -6-fluorocarbonyl-2-cyclopropylbenzimidazole hydrochloride (14 mg) was added to the aforementioned solution at room temperature. After stirring the descriptive reaction mixture at room temperature for 1 hour, it was washed with water and passed through the Shanghai Department ^ it ^-^ h Concentrated under reduced pressure. Ether was used to recrystallize the residue to give i- (2-fluorobenzyl) -2-cyclopropyl-6-morpholinylbenzimidazole (66) (20 mg). [Physical properties of compound (66)] Colorless crystals. Old-leg (CDCh, ά) · 1.04-1.12 (2H3 m), 1.25-1.32 (2H, m) 3 1.82-1 · 96 (1H, m), 3.68 (8H, bs), 5.56 UH, s), 6.55 (1H, dd, J = 1, 8Hz), 7.13 (1H3 dt, J = 1, 8Hz), 7.22-7 · 29 (2H, m), 7.30 (1η, d, J = 1Hz), 7.46 (m, dd, J = 1, the paper size is in accordance with China National Standard (CNS) A4 specification (21〇'x 297)) 548272 A7 B7 V. Description of the invention (83 ) 8Hz), 7.77 (1H, d3 J-8Hz) N mp: 193-1950C0 < Example 16; l- (2-chlorobenzyl) -2-cyclopropyl-6-[(2-pyridine Synthesis of methyl) carbamoyl] benzo1 ^ sal (67) > using 1- (2-chlorobenzyl) -6-chlorocarbonyl-2-cyclopropylbenzimidazole hydrochloride (150 mg), 2-aminomethylpyridine (85 mg) and the same method as in Example 15 was used to obtain 1- (2-fluorobenzyl) -2-cyclopropyl-6-[(2- Acetidylmethyl) carbamoyl] benzimidazole (67) (95 mg). [Physical properties of compound (67)] Colorless crystals. IMR (CDC13, 6): 1.02-1.13 (2H, m), 1.24-1.32 (2H, melon), 1.82_1.95 (1H, m), 4.76 (2H3 d3 J 2 5Hz), 5.59 (2Η, s ), 7 · 11 (1H, dt3 with 1,8Ηζ), 7 · 20_7 • 26 (2Η3 m) 3 7.34 (1Η3 d, J 2 8Ηζ) 3 7 · 46 (1Η, dd3 J: 15 5ΗΗ), 7 · 60 (1Η, t, J = 5Ηζ), 7.66 (1Η, dd, J = 1, 8Ηζ), 7.73 (1Η, s), 7.88 (1Η, s). mp: 134-1350C. < Example 17 > Following the same method as in Example 15, the following compounds were obtained. < Example 17-1; 1- (2-Azobenzyl) _2_cyclopropyl_6- (2 • pyridylaminomethylamidino) benzimidazole (68) > [Physical properties of compound (68) ]! H-orbit (CDC13, 6): 1.16 (2H, m), 1.32 (2H, π〇, ^ (1H, "), 5.61 (2H, s), 6.57 (1H, d, J 2 7.5 and 1.5Ηζ), 7.15 (1H, dt, J = 7.5 and 1.55Ηζ), 7.22-7 · 31 (2H, π), 7.48 (1H, dd, J = 7.5 and 1.55 ζ) , Γ.77 (iH, Mountain J: 9Hz), 8.05 (2H, m), mp: 206 —209 ° C. ____ & JZ-_ This paper standard applies to China National Standard (CNS) A4 specification (210X297 (Mm) (Read the notes on the back before filling in this page)

、1T A7 B7 甲基)氨基甲酿基]苯並味唾(71 )> 548272 &、發明説明(84) <貝^例17_2;6-(2-緩基+地略烧幾基)-1-(2-氯代 卞基)-2-正丙基苯並咪唑(69)> [化合物(69)的物性], 1T A7 B7 methyl) carbamyl] benzoflavor (71) > 548272 &, Description of the invention (84) < 贝 ^ 例 17_2; 6- (2-branched + ground slightly burned several bases ) -1- (2-chlorofluorenyl) -2-n-propylbenzimidazole (69) > [physical properties of compound (69)]

'H'-NMR (DMS0-d6, (5 ) · 0 Q9 (QU f T ).〇·92 (3H,t,j:7.5Hz),j (抓 2 丨“),2.77 (2H,t,J:7.5Hz),3 % r9w (2H,m),4.4〇 (1H,ID),5.52 (2H, s) •53 (1H,d,J:7.5Hz)5 7·2卜7·71 (6H,幻。 ’ 邺:96〇C0 :實施例叫吵氯代节基)_2·環丁基«Α。比咬 甲基)氣基甲酿基]苯並咪唾(7〇 [化合物(70)的物性] 1臟咖3,<n:1|2.21(2H,E),2.25_2 37 (2H,E)24 > 3.64 (1H, m), 4.76 (2H, d, J=5Hz), 5.39 (2H, s), 6.33 ΠΗ , ! 5Hz)’ 7.05 (1H,t,J=7.5Hz),7.16-7.26 (2H,m),7 33 (1H ,,J-7. 屬⑽,d,J:7.5Hz),7.69_7.76 (3H,n),7 7 ·3 ⑽,山村_5Hz),7'H'-NMR (DMS0-d6, (5) · 0 Q9 (QU f T). 92 · (3H, t, j: 7.5Hz), j (catch 2 丨 "), 2.77 (2H, t, J: 7.5Hz), 3% r9w (2H, m), 4.40 (1H, ID), 5.52 (2H, s) • 53 (1H, d, J: 7.5Hz) 5 7 · 2 · 7 · 71 ( 6H, phantom. 邺: 96 ° C0: Examples are called chloro chlorobenzyl) _2 · cyclobutyl «A. Specific methyl) carbamoylmethyl] benzimidal (70 [Compound (70 )] 1 dirty coffee 3, < n: 1 | 2.21 (2H, E), 2.25_2 37 (2H, E) 24 > 3.64 (1H, m), 4.76 (2H, d, J = 5Hz) , 5.39 (2H, s), 6.33 ΠΗ,! 5Hz) '7.05 (1H, t, J = 7.5Hz), 7.16-7.26 (2H, m), 7 33 (1H ,, J-7. ⑽, d , J: 7.5Hz), 7.69_7.76 (3H, n), 7 7 · 3 ⑽, mountain village _5Hz), 7

> s), 8.55 (1H, d, J=5Hz)〇 , , J—7‘5Hz), 7.86 (1H flip : 183 — 1850C〇> s), 8.55 (1H, d, J = 5Hz), J-7'5Hz, 7.86 (1H flip: 183-1850C)

LV^-UPCLV ^ -UPC

[化合物(71)的物性] !H-醒(CDCh,d) : 1.03 (3H,t,J:7.5Hz),1 90 (2H 、9 ◦ 叫 UH,吐 2.80 (2H,t j 二7·5Ηζ), 4·80 (2H, d, J:5Hz), 5·44 (2H, s), 6 40 (1Η η 。 ’ ’ νιπ5 α, J=^.5Hz)3 7.09 (1Η, t, J=7.5Hz), 7·2卜7.27 (3Η, m), 7·34 (1Η d 卜7 ςυ \ 5 U, j~7-5Hz), 7.47 (1Η5 d J二7·5Ηζ)3 7.64-7.72 (2Η, m), 7.83 (1Η, dd, J:7.5 及 2Hz) 8 30 ,J:2Hz),8.56 (1H,d3 J:5Hz)。 ’ ·(况 d mp : 115—116°C〇 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (讀先閲讀背面之注意事項再镇寫本頁)[Physical properties of compound (71)] H-wake (CDCh, d): 1.03 (3H, t, J: 7.5Hz), 1 90 (2H, 9 ◦ UH, vomit 2.80 (2H, tj 2 7. 5Ηζ ), 4.80 (2H, d, J: 5Hz), 5.44 (2H, s), 6 40 (1Η η. '' Νιπ5 α, J = ^. 5Hz) 3 7.09 (1Η, t, J = 7.5Hz), 7 · 2, 7.27 (3Η, m), 7 · 34 (1Η d, 7 υυ \ 5 U, j ~ 7-5Hz), 7.47 (1Η5 d J, 2 · 7 · 5Ηζ) 3 7.64-7.72 ( 2Η, m), 7.83 (1Η, dd, J: 7.5 and 2Hz) 8 30, J: 2Hz), 8.56 (1H, d3 J: 5Hz). ’· (Condition d mp: 115—116 ° C 〇 This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) (Read the precautions on the back before writing this page)

548272 A7 五、發明説明(85 ) <貝她例17-5;1-(2-氯代苄基)_6_[N-甲基-N-(2·吡啶 甲基)氣基甲醯基]-2-正丙基苯並味唾(72)> [化合物(72)的物性] (謂先閱讀背面之注意事項再填寫本頁) H NKR (DMS0-d6, δ) : l.〇3 (3Η, t3 J=7.5Hz), 1.87 (2H, m), 2.79 (2H, t, J-7.5Hz), 3.05 (3H} brs), 4.60 (1H, brs), 4.87 (1H, brs), 5.40 (2H, d, J〜未知),6.38 (1H3 d,J二未知),7·05 (1H,brs)3 7·2〇 (3H,id), 7.35-7.49 ( 3H, m)3 7.60-7.81 (2H3 m), 8.54 (1H3 brs)〇 : 990C〇 <實施例17-6;l-(2-氯代苄基;胡椒基氨基甲醯基 -2-正丙基苯並咪唾(73)> [化合物(73)的物性]548272 A7 V. Description of the invention (85) < Beta Example 17-5; 1- (2-chlorobenzyl) _6_ [N-methyl-N- (2.pyridylmethyl) aminomethylmethyl] -2-N-propylbenzo sial (72) > [Physical properties of compound (72)] (It is necessary to read the precautions on the back before filling in this page) H NKR (DMS0-d6, δ): 1.03 (3Η, t3 J = 7.5Hz), 1.87 (2H, m), 2.79 (2H, t, J-7.5Hz), 3.05 (3H) brs), 4.60 (1H, brs), 4.87 (1H, brs), 5.40 (2H, d, J ~ Unknown), 6.38 (1H3 d, J is unknown), 7.05 (1H, brs) 3 7.2.2 (3H, id), 7.35-7.49 (3H, m) 3 7.60 -7.81 (2H3 m), 8.54 (1H3 brs) 0: 990C < Example 17-6; l- (2-chlorobenzyl; piperonylcarbamoyl-2-n-propylbenzimidazole) (73) > [physical properties of compound (73)]

tNMR (CDC13,6) : 1·〇1 (3H3 t,J:7.5Hz),1·88 (2H,m),2·78 (2H,t,J 々•5Hz),4.54 (2H,d,J=5Hz),5·45 (2H,s)5 5·95 (2H3 s),6.36 (1H,d,JtNMR (CDC13,6): 1.01 (3H3 t, J: 7.5Hz), 1.88 (2H, m), 2.78 (2H, t, J 々 • 5Hz), 4.54 (2H, d, J = 5Hz), 5.45 (2H, s) 5 5.95 (2H3 s), 6.36 (1H, d, J

:7·5Ηζ),6·44 (1H,t,J:5Hz),6.75-6.85 (3H, in),7·08 (1H,t,J二7·5Ηζ), 7.23 (1H, t, J:7.5Hz), 7.45 (1H, d, J=7.5Hz), 7.67 (1H, dd, , 2H z), 7.78 (1H, d, J=7.5Hz), 7.83 (1H, s)。 mp : 13l-134°C〇 &lt;實施例17-7;l-(2-氯代苄基)_6_苯基氨基曱醯基_2_ 正丙基苯並味唾(74)&gt; [化合物(74)的物性] 'H-NMR (CDCh, (5) ; L03 (3H5 t, J=7.5Hz), 1.90 (2H, m), 2.81 (2H, t5 J =7.5Hz), 5.47 (2H, s), 6.40 (1H, d5 J-7.5Hz), 7.06-7.18 (2H, m), 7.26 (1 H, t, J:7.5Hz), 7·35 (2H3 t, J二7·5Ηζ), 7.48 (1H, d, J二7.5Hz), 7.64 (2H, d, J-7.5Hz), 7.72 (1H, dd, J:7.5 及 2Hz), 7·85-7.95 (3H, m)。 mp : 168〇C〇 本紙張尺度如 548272 A7 B7 五、發明説明(86) &lt;貫施例17_8;1-(2_氯代节基)-2-正丙基- 6-[(4-σι^σ定 甲基)氨基曱醯基]苯並咪唑(75)&gt; (請先閲讀背面之注意事項再填寫本頁) [化合物(75)的物性] Ή-NMR (DMS0-d6, δ) : 0.93 (3Η, t, J=7.5Hz)5 1.76 (2H, m), 2.78 (2H, t, J二7.5Hz),4.49 (2H,d,J=5Hz),6.42 (1H,d5 J=7.5Hz), 7·22 (1H,t。J二7. 5Hz), 7.27 (2H, d, J二7·5Ηζ), 7·34 (1H, t, J二7·5Ηζ), 7·57 (1H, d, J=7.5Hz ),7·69 (1H, d, J二7、5Hz), 7.80 (1H, d, J二7.5Hz), 7.97 (1H, s), 8.48 (2H, d, J=7.5Hz), 9.03 (1H, t, J二5Hz)。 mp : 170- 173°C〇 &lt;貫施例l7_9;l-(2_氯代节基)·2-正丙基-6-[(3-。比。定 甲基)氨基甲醯基]苯並咪唑(76)&gt; [化合物(76)的物性] 4-臓(DMS0-d6,ά) : 0·95 (3H,t,J=7.5Hz),1.76 (2H,m),2.80 (2H,t5 J=7.5Hz),4.50(2H,d,J:5Hz),5.60(2H,s),6.42(lH,d,J=7.5Hz),7.2 3 (1H, t, J二7.5Hz), 7.30-7.58 (2H, in), 7.57 (1H, d, J二7.5Hz), 7.67-7.74 (2H3 m)5 7.75 (1H, d5 J=7.5Hz), 7.97 (1H, s), 8.46 (1H, d, J=5Hz), 8.56 (1H, s), 9.0 (1H, t, J=5Hz)。 mp : 193 — 195°C〇 &lt;實施例l7-l〇;l-(2·氯代苄基)-6-[N-曱基-N-(2-吡 啶)氨基曱醯基]-2-正丙基苯並咪唑(77)&gt; [化合物(77)的物性] ^-NMR (DMS0-d6, δ) : 0.90 (3Η, t, J=7.5Hz), 1.70 (2H, m), 2.73 (2H? t, J=7.5Hz), 3.40 (3H, s), 5.42 (2H, s), 6.23 (1H, d, J=7.5Hz), 6.91 (1H, d, J=7.5Hz)3 6.98 (1H, m), 7.15-7.25 (3H3 m)5 7.36 (1H, t, J=7.5Hz), 7.4 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(87) —7.57 (3H,瓜),8·23'(ιη3 m)( nip : 143 — 146oC0 &lt; (請先閱讀背面之注意事項再填寫本頁) 貝施例Π_1 1;1_(2·氯代苄基)_ό_(均哌啶基羰基)_ 2-正丙基苯並咪唑(78)&gt; [化合物(78)的物性] 'H-NMR (CDCla, (5) · 1 〇〇 , t J-75Hz) w/, ),M6丄94 (刚,m),2.80 ⑽ UH,^ ,W,3 64 (2H,t,㈣ _,5 A (肌认 6.似 , z 5 7·°7 (1H, t, J-7.5Hz), 7.19-7.29 (3H, m), 7 45 (1H d &gt; 7.76 (1H, d, J=7.5Hz)〇 UH)d mp : 136- 137°C〇 &lt;實施例Π-12; W3_甲基苄基)_2_正丙基_6_[(2_吡 啶甲基)氨基甲醯基]苯並咪唑(79)&gt; [化合物(79)的物性] iHiMR (CDCh,幻·· 1·〇2 (3H,t5 J=7.5Hz),1.88 (2H3 m),2·26 (3H5 s), 2·81 (2H,t,J:7.5Hz),4·76 (2H,d,J:5Hz),5·36 (2H,s),6·78—6·84 (2h3 m),7·07 (1H,d,J:7.5Hz),7.13-7.22 (2H,id),7.33 (1H,d,J:7.5Hz),7· 57-7·72 (2H,m),7.78 (1H,d,J:7.5Hz),7.94 (1H,s),8,55 (1H,d5 J二5Hz )〇 mp : 129- 1310C〇 部 中 次 未?: 消 fc 合 竹 卬 t 〈實施例17_13;2-正丁基氟代苄基)_6-[N-甲基 -N(2-。比啶曱基)氨基甲醯基]苯並咪唑(8〇)&gt; [化合物(80)的物性] 1腿(CDCh,d) : 〇·92 (3H,t,J:7.5Ηζ),1·45 (2H,瓜),1·83 (2H,m), 2·86 (2H,t3 J=7.5Hz),3·06 (3H,brs),4.61 (1H,brs),4·86 (1H,brs), 5.37 (2H, brd)3 6.62 (1H, brd)3 6.97 (1H, brs), 7.07-7.85 (8H, m)3 8.57 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 M浐部中戎打季而:只_T消贽合竹打印 A7 B7 五、發明説明(88) (1H, d, J:5Hz)。 mp : 97— 100°C〇 〈實施例17]4;1-(2-氯代苄基)_2_乙基冬[(2-吡啤 曱基)氨基甲醯基]苯並咪唑(81)&gt; [化合物(8 1)的物性] ^-NMR (CDCh, δ) : 1.43 (3H5 t5 J=7.5Hz), Z.84 (2H5 q5 J-7.5Hz), 4.76 (2H,d,J:5Hz),5·45 (2H,s),6·37 (1H,d,J:7.5Hz),7.07 (1H,t,J:7.5H z),7.19-7.28 (2H,ffl),7·33 (1H,d5 J:7.5Hz),7·45 (1H,dd,J=7.5 及莎 2 Hz), 7.62-7·75 (3H, m), 7·82 (1H, d, J:7.5Hz), 7.89 (1H3 d, J:2Hz), 8·55 (1H, d, J二5Hz)。 mp : 167—168〇C〇 &lt;實施例ΙΉ;2·正丁基氯代苄基)_7_[(2_吡 啶甲基)氨基甲醯基]苯並咪唑(82)&gt; [化合物(82)的物性] NMR (CDCh3 (5) : 〇·93 (3H,t,J=7.5Hz),1·42 (2H,m),1.83 (2H,m) 2.81 (2H,t,J=7.5Hz),4·44 (2H,d,J二5Hz),5·70 (2H,s),6·13 (m’’ ddl J=7.5 及 2Hz),6.85-6.97 (3H,m),7.12-7.28 (4H,m),7.34 (1H,d,J二7 5Hz), 7.62 (1H, dt, J:7.5 及 2Hz), 7.88 (1H, d, J=7.5Hz), 8.40 (ih, (j J=5Hz)〇 ^ mp : U2—1140C〇 ^ &lt;實施例17·16;2-環丙基-1-(2-氟代苄基)-M胡椒基 氨基甲酿基)笨並味。坐(83 )&gt; [化合物(8 3)的物性] 'H-NMR (DMSO-dfi 5.71 (2Η, 3), 5598 Π),2 27 UH,Π),4·38 (2Η&gt; &quot; J=5H^ ·98 (2Η, S), 6.73-6.91 (4Η, m), 7.14 (lHj t, j=7.5Hz)) 7 (誚先閱讀背面之注意事項再填寫本頁): 7 · 5Ηζ), 6.44 (1H, t, J: 5Hz), 6.75-6.85 (3H, in), 7.08 (1H, t, J = 7.5 · 5Ηζ), 7.23 (1H, t, J : 7.5Hz), 7.45 (1H, d, J = 7.5Hz), 7.67 (1H, dd,, 2H z), 7.78 (1H, d, J = 7.5Hz), 7.83 (1H, s). mp: 13l-134 ° C. &lt; Example 17-7; l- (2-chlorobenzyl) -6-phenylaminofluorenyl_2-n-propyl benzoyl salivary (74) &gt; [Compound (Physical properties of (74)] 'H-NMR (CDCh, (5); L03 (3H5 t, J = 7.5Hz), 1.90 (2H, m), 2.81 (2H, t5 J = 7.5Hz), 5.47 (2H, s), 6.40 (1H, d5 J-7.5Hz), 7.06-7.18 (2H, m), 7.26 (1 H, t, J: 7.5Hz), 7.35 (2H3 t, J 2 7.5 · ζ), 7.48 (1H, d, J 7.5Hz), 7.64 (2H, d, J-7.5Hz), 7.72 (1H, dd, J: 7.5 and 2Hz), 7.85-7.95 (3H, m). Mp: 168〇C〇 The paper size is 548272 A7 B7 V. Description of the invention (86) &lt; Guan Example 17_8; 1- (2-Chlorobenzyl) -2-n-propyl-6-[(4-σι ^ σ-Determined methyl) aminofluorenyl] benzimidazole (75) &gt; (Please read the precautions on the back before filling in this page) [Physical properties of compound (75)] Ή-NMR (DMS0-d6, δ): 0.93 (3Η, t, J = 7.5Hz) 5 1.76 (2H, m), 2.78 (2H, t, J = 7.5Hz), 4.49 (2H, d, J = 5Hz), 6.42 (1H, d5 J = 7.5 Hz), 7.22 (1H, t. J 2: 7. 5Hz), 7.27 (2H, d, J: 7.5Ηζ), 7.34 (1H, t, J: 7.5Ηζ), 7.57 ( 1H, d, J = 7.5Hz), 7 · 6 9 (1H, d, J2 7, 5Hz), 7.80 (1H, d, J2 7.5Hz), 7.97 (1H, s), 8.48 (2H, d, J = 7.5Hz), 9.03 (1H, t, J 2 5Hz). Mp: 170-173 ° C. &Lt; Example 17-7; l- (2-chlorobenzyl) · 2-n-propyl-6-[(3-. Ratio. Fixed methyl) Carbamidyl] benzimidazole (76) &gt; [physical properties of compound (76)] 4-pyrene (DMS0-d6, ά): 0.95 (3H, t, J = 7.5Hz), 1.76 (2H, m), 2.80 (2H, t5 J = 7.5Hz), 4.50 (2H, d, J: 5Hz), 5.60 (2H, s), 6.42 (lH, d, J = 7.5Hz), 7.2 3 (1H, t , J2 7.5Hz), 7.30-7.58 (2H, in), 7.57 (1H, d, J2 7.5Hz), 7.67-7.74 (2H3 m) 5 7.75 (1H, d5 J = 7.5Hz), 7.97 (1H , s), 8.46 (1H, d, J = 5Hz), 8.56 (1H, s), 9.0 (1H, t, J = 5Hz). mp: 193-195 ° C. &lt; Examples 17-lO; l- (2.chlorobenzyl) -6- [N-fluorenyl-N- (2-pyridine) aminofluorenyl] -2 -N-propylbenzimidazole (77) &gt; [physical properties of compound (77)] ^ -NMR (DMS0-d6, δ): 0.90 (3Η, t, J = 7.5Hz), 1.70 (2H, m), 2.73 (2H? T, J = 7.5Hz), 3.40 (3H, s), 5.42 (2H, s), 6.23 (1H, d, J = 7.5Hz), 6.91 (1H, d, J = 7.5Hz) 3 6.98 (1H, m), 7.15-7.25 (3H3 m) 5 7.36 (1H, t, J = 7.5Hz), 7.4 This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 5 、 Explanation of the invention (87) —7.57 (3H, melon), 8.23 '(ι3m) (nip: 143 — 146oC0 &lt; (Please read the precautions on the back before filling out this page) 贝 施 例 Π_1 1; 1_ (2 · Chlorobenzyl) _ό_ (piperidinylcarbonyl) _ 2-n-propylbenzimidazole (78) &gt; [Physical properties of compound (78)] 'H-NMR (CDCla, (5) · 1 〇〇, t J-75Hz) w /,), M6 丄 94 (rigid, m), 2.80 ⑽ UH, ^, W, 3 64 (2H, t, ㈣ _, 5 A (muscle recognition 6.like, z 5 7 ° 7 (1H, t, J-7.5Hz), 7.19-7.29 (3H, m), 7 45 (1H d &gt; 7.76 (1H, d, J = 7.5Hz)) UH) d mp: 136 -137 ° C〇 &lt; Example Π-12; W3_methylbenzyl) _2-n-propyl-6 _ [(2-pyridylmethyl) aminomethylamidino] benzimidazole (79) &gt; [Physical properties of compound (79) ] iHiMR (CDCh, Magic · 1.02 (3H, t5 J = 7.5Hz), 1.88 (2H3 m), 2.26 (3H5 s), 2.81 (2H, t, J: 7.5Hz), 4.76 (2H, d, J: 5Hz), 5.36 (2H, s), 6.78-6.84 (2h3 m), 7.07 (1H, d, J: 7.5Hz), 7.13- 7.22 (2H, id), 7.33 (1H, d, J: 7.5Hz), 7.57-7.72 (2H, m), 7.78 (1H, d, J: 7.5Hz), 7.94 (1H, s) , 8,55 (1H, d5 J 2 5Hz) 〇mp: 129-1310C 〇 The middle part ?: Digestion fc Hexylidine t <Example 17_13; 2-n-butylfluorobenzyl) _6- [N -Methyl-N (2-. Pyridinyl) carbamoyl] benzimidazole (80) &gt; [physical properties of compound (80)] 1 leg (CDCh, d): 0.92 (3H, t, J: 7.5Ηζ), 1 · 45 (2H, melon), 1.83 (2H, m), 2.86 (2H, t3 J = 7.5Hz), 3.06 (3H, brs), 4.61 (1H, brs), 4.86 ( 1H, brs), 5.37 (2H, brd) 3 6.62 (1H, brd) 3 6.97 (1H, brs), 7.07-7.85 (8H, m) 3 8.57 This paper is compliant with China National Standard (CNS) A4 specifications ( (210X 297mm) 548272 M 浐 Department Zhong Rong playing season and: only _T eliminates the need to print A7 B7 V. Description of the invention (88) (1H, d, J: 5Hz). mp: 97-100 ° C. <Example 17] 4; 1- (2-chlorobenzyl) _2-ethyl winter [(2-pyridyl) carbamoyl] benzimidazole (81) &gt; [Physical properties of compound (8 1)] ^ -NMR (CDCh, δ): 1.43 (3H5 t5 J = 7.5Hz), Z.84 (2H5 q5 J-7.5Hz), 4.76 (2H, d, J: 5Hz), 5.45 (2H, s), 6.37 (1H, d, J: 7.5Hz), 7.07 (1H, t, J: 7.5H z), 7.19-7.28 (2H, ffl), 7. · 33 (1H, d5 J: 7.5Hz), 7.45 (1H, dd, J = 7.5 and Sha 2 Hz), 7.62-7 · 75 (3H, m), 7.82 (1H, d, J: 7.5 Hz), 7.89 (1H3 d, J: 2Hz), 8.55 (1H, d, J = 5Hz). mp: 167-168 ° C &lt; Example 1Ή; 2. n-butylchlorobenzyl) -7 _ [(2-pyridylmethyl) carbamoyl] benzimidazole (82) &gt; [Compound (82 ) Properties] NMR (CDCh3 (5): 0.93 (3H, t, J = 7.5Hz), 1.42 (2H, m), 1.83 (2H, m) 2.81 (2H, t, J = 7.5Hz ), 4.44 (2H, d, J 2 5Hz), 5.70 (2H, s), 6.13 (m '' ddl J = 7.5 and 2Hz), 6.85-6.97 (3H, m), 7.12- 7.28 (4H, m), 7.34 (1H, d, J 2 7 5Hz), 7.62 (1H, dt, J: 7.5 and 2Hz), 7.88 (1H, d, J = 7.5Hz), 8.40 (ih, (j J = 5Hz) ^ mp: U2-1140C ^ &lt; Example 17 · 16; 2-cyclopropyl-1- (2-fluorobenzyl) -M piperonylcarbamyl) is unpleasant. (83) &gt; [Physical properties of compound (8 3)] 'H-NMR (DMSO-dfi 5.71 (2Η, 3), 5598 Π), 2 27 UH, Π), 4.38 (2Η &gt; &quot; J = 5H ^ · 98 (2Η, S), 6.73-6.91 (4Η, m), 7.14 (lHj t, j = 7.5Hz)) 7 (诮 Please read the precautions on the back before filling this page)

、1T ^_wl. 548272 A7 _____—_____B7 __ 五、發明説明(8 9 ) 27 (1H, t, J二7·5Ηζ), 7·36 (1H, m), 7.55 (1H, d, J:7.5Hz), 7.73 (1H, dd, J=7,5 及 2Hz), 8·04 (1H, s)3 8·87 (1H, t, J二5Hz)。 mP : 170-173°C〇 &lt;實施例17-17;2-[[l-(2-氯代苄基)-2-乙基苯並咪唑 -6-基]戴基胺基甲基]比。定_1_氧化物(84)&gt; [化合物(84)的物性] ^-NMR (CDCla, 6) : 1.42 (3Η, t3 J-7.5Hz)3 2.82 (2H, q5 J=7.5Hz), 4.81 (2H,d,J:7.5Hz),5.43 (2H3 s),6·31 (1H,d,J:7.5Hz),7.06 UH,t,J二7· 5Hz)3 7.20-7.31 (3H,in),7·44 (1H,d,J二7·5Ηζ),7·52 (1H,dd,J:7,5 及 2Hz)3 7·65 (1H, dd, J=7.5 及 2Hz)3 7.77-7.83 (2H, m), 7·96 (1H, t, J二 7·5Ηζ), 8·23 (lH, dd, J=7.5 及 2Hz)。 mp : 204—207°C。 &lt;實施例Π-18;2-正丁基-1·(2_氟代苄基)_6_(2-吡啶 甲基氨基甲醯基)苯並咪唑(85)&gt; [化合物(85)的物性] 1 麵(CDCL,6) : 〇·92 (3H,t,J:7.5Hz),1.38-1.49 (2H,m)5 1.77-1.88 (2H, in), 2.86 (2H, t, J=7.5Hz), 4.78 (2H, d, J=5Hz), 5.46 (2H, s), 6.67 (1H, t, J=9Hz), 7.00 (1H, t, J=9Hz), 7.13 (1H, t, J=9Hz), 7.19-7.31 (2H ,m),7·33 (1H, d, J=9Hz),7.60 (1H,br 最大値),7.65-7.74 (2H, m), 7.79 (1H,d,J=9Hz),7·97 (1H,d,J二2Hz), 8.58 PH, d,J二5Hz)c mp : 154— 155°C〇 &lt;實施例18;6-第3 丁氧羰基胺基-1-(2-氣代苄基)-2-正丙基苯並咪唑(86)的合成&gt; 本纸張尺度通/fl中國國家標準(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁) 、11 548272 Α7 _______________B7 五、發明説明(9〇) ' (翱先閱讀背面之注意事項再填寫本頁) 將6-緩基-1-(2-氣代卞基)-2-正丙基苯並咪唾(2〇〇爪幻 懸濁於第3 丁醇(5ml)中,並在室溫下加入二苯基磷酸醯 胺(〇· 19ml)及二異丙基乙胺(0·2 i mi)。將反應混合物迴流4 小時後,使用醋酸乙酯及水以使其分層,對於有機層進 行水洗、乾燥及減壓濃縮。使用醋酸乙酯/己烷(丨·· : 3)並藉由柱色譜以展開並精製殘渣,接著使用醋酸乙醋/ 己烷以進行再結晶而得出6_第3 丁氧羰基胺基-1-(2•氣代 苄基)-2_正丙基苯並咪唾(86)(16511^;)。 [化合物(86)的物性] 無色結晶。 1隱(CDC13,d) : 0·98 (3H,t,J:8Hz)3 1.50 (9H,s),1·86 (2H, sextet ,J=8Hz), 2·72 (2H3 t, J:8Hz), 5.38 (2H, s), 6·40 (1H, dd, J:l3 8Hz), 6· 95 (1H, dd, J=l, 10Hz), 7·08 (1H, dt, J二1, 8Hz), 7·24 (1H, dt, J:l, 8Hz) ,7·28 (1H, d, J=lHz), 7·45 (1H, dd, J=l3 8Hz), 7.66 (1H, d, J:10Hz)。 mp : 166 —168°C〇 &lt;實施例19; 1-(2-氯代苄基)-6-氰基-2-正丙基苯並 味σ坐(87)的合成&gt; 在OC下將四氣化鈦之1莫耳濃度的二氣曱烧溶液 (0.14ml)與三乙胺(0.36ml)加入6-氨基曱醯基-1-(2-氣代 苄基)-2-正丙基苯並咪唑(200mg)之四氫吹喃溶液(4ml) 中,在20°C下攪拌2小時。使用醋酸乙酯及水以將反應 混合物分層,並對有機層進行水洗、乾燥及減壓濃縮。 使用醋酸乙酯/己烷(1 : 10〜1 : 3)並藉由柱色譜以展開並 精製殘渣,接著使用醋酸乙酯/己烷以進行再結晶而得 _— ___aj______ 本紙張尺度中國國家標準(CNS ) Α4規格(210X 297公釐) 548272 A7 B7 五、發明説明(91) 出1-(2_氯代苄基)-6_氰基i正丙基苯並咪唑 (87) (140mg) 〇 [化合物(87)的物性] (誚先閱讀背面之注意事項再填寫本頁) 無色結晶。 lH-NMR (CDCls, (5) : 1 05 t 1 nn , • (3H, t, J一8Hz), 1·9〇 (2H, sextet, J=8Hz), 2·85 (2H,t,J二8Hz),5·45 (2H s) 6 4? ΠΗ w τ 1 。、 s;3 b.4Z (lH, dd, J=l5 8Hz)5 7.15 (1H, dt, J- U 8Hz),7·28 (1H,dt,J二i 8Hz) 7 AR (\ η r i,刪),,·48 (1H,s),7·50 (1H,d,J:10Hz), 7. 54 (1H, dd, J-l5 8Hz), 7.85 (1H3 d, J-10Hz)〇 mp : 124-126°C〇 &lt;實施例20; 1-(2-氣代苄基)_6_甲胺基_2_正丙基苯 並咪唑(88)的合成&gt; 將1-(2-氯代苄基)-2-正丙基苯並咪唑(15〇mg)與三 乙胺(61 mg)溶解於二氣甲烷(3ml)中,在室溫下加入曱磺 醯氯化物(70mg)並攪拌1小時後,使用稀鹽酸洗淨,並 進行水洗、乾燥及減壓蒸餾。使用醚過濾殘渣固體,以 得出1-(2-氯代苄基)-6_甲胺基士正丙基笨並咪唑 (88) (124mg)。 [化合物(88)的物性] W-證(CDCl3-CD3〇D,ά) : 0.94 (3H,t,J二7·5Ηζ),1.76 (2H,m),2.71 (2H ,t,J二7·5Ηζ),2.81 (3H, s),5·36 (2H,s),6.40 (1H,d,J:7.5Hz),6,98-7 •22 (4H, m), 7,40 (1H, d, J:7.5Hz), 7.5Q (1H3 d, J:7.5Hz)。 mp : 191 — 1930C〇 &lt;實施例21 ;6-乙醯胺-l-(2-氯代苄基)-2-正丙基笨 並咪唑(89)之合成&gt; 95 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 一— __________________ B7 五、發明説明(92) (讀先閱讀背面之注意事項再填寫本頁) 在室溫下將醋酸酐(62mg)加入6-胺基-1-(2-氯代苄 基)-2-正丙基苯並咪哇(15〇mg)與三乙胺(61mg)之二氯甲 燒(3ml)溶液中,攪拌1小時後,進行水洗、乾燥及減壓 洛鶴。使用_以結晶化殘渣而得出6_乙醯胺氣代 苄基)_2_正丙基苯並咪唑(89)(143mg)。 [化合物(8 9)的物性] Η 麵(CDCh,: i·00 (3H,t,J:7.5Hz),1·86 (2H,m),2·17 (3H,s), 2.73 (2H,t,J-7·5Ηζ),5·39 (2H,s),6·43 (1H,d,J二7·5Ηζ),6·98-7·11 (2 H, m), 7.22 (1H, t, J:7.5Hz), 7·45 (1H, d3 J:7.5Hz), 7.59 (1H, brs)3 7·6 8 (1H, d, J:7.5Hz), 7.84 (1H, d, J:1.5Hz)。 mp : 180— 182〇C0 &lt;貝鈀例22;6-胺基-1-(2-氯代苄基)_2_正丙基苯並 咪唑(90)之合成&gt; 將6-第3 丁氧羰基胺基(孓氯代苄基)_2_正丙基 苯並咪唾(7〇0mg)溶解於二氯甲烧〇〇ml)與三氣醋酸㈣) 之混合溶媒中,在室溫下授拌5小時。將少量的二氯甲 烧加=反應液中,經碳酸鈉水溶液洗淨後,進行乾燥、 減壓蒸館。使用正己燒與_之混合溶媒以進行殘渣之再 結晶化,而得出6-胺基]_(2_氯代节基)^正丙基= 唑(90)(455mg)。 [化合物(90)的物性] !H-m (CDCla, d) · 1 πι ημ + r .丨.G1 ⑽,t,J:7.5Hz),h86 (2Η、 1T ^ _wl. 548272 A7 _____—_____ B7 __ V. Description of the invention (8 9) 27 (1H, t, J 2 7.5Ηζ), 7.36 (1H, m), 7.55 (1H, d, J: 7.5 Hz), 7.73 (1H, dd, J = 7, 5 and 2Hz), 8 · 04 (1H, s) 3 8 · 87 (1H, t, J = 5Hz). mP: 170-173 ° C. &lt; Examples 17-17; 2-[[l- (2-chlorobenzyl) -2-ethylbenzimidazole-6-yl] daiylaminomethyl] ratio. Determination of 1_oxide (84) &gt; [physical properties of compound (84)] ^ -NMR (CDCla, 6): 1.42 (3Η, t3 J-7.5Hz) 3 2.82 (2H, q5 J = 7.5Hz), 4.81 (2H, d, J: 7.5Hz), 5.43 (2H3 s), 6.31 (1H, d, J: 7.5Hz), 7.06 UH, t, J-27.5Hz) 3 7.20-7.31 (3H, in), 7.44 (1H, d, J 2 7.5Ηζ), 7.52 (1H, dd, J: 7, 5 and 2Hz) 3 7 · 65 (1H, dd, J = 7.5 and 2Hz) 3 7.77-7.83 (2H, m), 7.96 (1H, t, J = 7.5Ηζ), 8.23 (lH, dd, J = 7.5 and 2Hz). mp: 204-207 ° C. &lt; Example Π-18; 2-n-butyl-1 · (2-fluorobenzyl) -6_ (2-pyridylmethylaminomethyl) benzimidazole (85) &gt; [Compound (85) Physical properties] 1 surface (CDCL, 6): 0.92 (3H, t, J: 7.5Hz), 1.38-1.49 (2H, m) 5 1.77-1.88 (2H, in), 2.86 (2H, t, J = 7.5Hz), 4.78 (2H, d, J = 5Hz), 5.46 (2H, s), 6.67 (1H, t, J = 9Hz), 7.00 (1H, t, J = 9Hz), 7.13 (1H, t, J = 9Hz), 7.19-7.31 (2H, m), 7.33 (1H, d, J = 9Hz), 7.60 (1H, br maximum 値), 7.65-7.74 (2H, m), 7.79 (1H, d , J = 9Hz), 7.97 (1H, d, J = 2Hz), 8.58 PH, d, J = 5Hz) c mp: 154-155 ° C. &Lt; Example 18; 6th butoxycarbonyl group 3 Synthesis of Amino-1- (2-Azobenzyl) -2-n-propylbenzimidazole (86) &gt; This paper is standard / fl China National Standard (CNS) A4 specification (210X 297 mm) (Read the precautions on the back before you fill out this page), 11 548272 Α7 _______________B7 V. Description of the invention (9〇) '(翱 Read the precautions on the back before filling out this page) 6-pont-1- (2 -Air substituted fluorenyl) -2-n-propylbenzimidal (200 claws suspended in 3 butanol (5 ml) and Diphenylphosphonium phosphate (0.19 ml) and diisopropylethylamine (0.2 μm) were added below. After the reaction mixture was refluxed for 4 hours, ethyl acetate and water were used to separate the layers. The layer was washed with water, dried, and concentrated under reduced pressure. Ethyl acetate / hexane (丨 ·: 3) was used to develop and refine the residue by column chromatography, followed by recrystallization using ethyl acetate / hexane. 6_ 3rd Butoxycarbonylamino-1- (2 • Azobenzyl) -2-n-propylbenzimidal (86) (16511 ^;). [Physical Properties of Compound (86)] Colorless crystal. 1 hidden (CDC13, d): 0 · 98 (3H, t, J: 8Hz) 3 1.50 (9H, s), 1.86 (2H, sextet, J = 8Hz), 2.72 (2H3 t, J: 8Hz), 5.38 (2H, s), 6.40 (1H, dd, J: 13 8Hz), 6.95 (1H, dd, J = 1, 10Hz), 7.08 (1H, dt, J2 1 , 8Hz), 7.24 (1H, dt, J: l, 8Hz), 7.28 (1H, d, J = lHz), 7.45 (1H, dd, J = 13 8Hz), 7.66 (1H, d, J: 10 Hz). mp: 166-168 ° C. &lt; Example 19; Synthesis of 1- (2-chlorobenzyl) -6-cyano-2-n-propylbenzo sigma (87) &gt; under OC Add 1 mole of dioxan solution (0.14ml) and triethylamine (0.36ml) of titanium tetragas to 6-aminofluorenyl-1- (2-fluorobenzyl) -2-n In a tetrahydropyran solution (4 ml) of propyl benzimidazole (200 mg), stir at 20 ° C for 2 hours. The reaction mixture was separated using ethyl acetate and water, and the organic layer was washed with water, dried, and concentrated under reduced pressure. Ethyl acetate / hexane (1: 10 ~ 1: 3) was used to develop and refine the residue by column chromatography, and then ethyl acetate / hexane was used for recrystallization to obtain ___________ This paper is a Chinese national standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 V. Description of the invention (91) 1- (2-chlorobenzyl) -6-cyano-n-propylbenzimidazole (87) (140mg) 〇 [Physical properties of compound (87)] (诮 Please read the precautions on the back before filling in this page) Colorless crystal. lH-NMR (CDCls, (5): 1 05 t 1 nn, • (3H, t, J-8Hz), 1.90 (2H, sextet, J = 8Hz), 2.85 (2H, t, J 8Hz), 5.45 (2H s) 6 4? ΠΗ w τ 1., S; 3 b.4Z (lH, dd, J = 15 8Hz) 5 7.15 (1H, dt, J- U 8Hz), 7 · 28 (1H, dt, J 2i 8Hz) 7 AR (\ η ri, deleted), · 48 (1H, s), 7.50 (1H, d, J: 10Hz), 7. 54 (1H, dd, J-l5 8Hz), 7.85 (1H3 d, J-10Hz), mp: 124-126 ° C, &lt; Example 20; 1- (2-Gas benzyl) _6_methylamino group_2_ Synthesis of n-propylbenzimidazole (88) &gt; Dissolving 1- (2-chlorobenzyl) -2-n-propylbenzimidazole (150 mg) and triethylamine (61 mg) in two gases In methane (3 ml), sulfonium sulfonium chloride (70 mg) was added at room temperature and stirred for 1 hour, then washed with dilute hydrochloric acid, washed with water, dried and distilled under reduced pressure. The residue solid was filtered using ether to obtain 1- (2-chlorobenzyl) -6-methylaminos-n-propylbenzimidazole (88) (124 mg). [Physical Properties of Compound (88)] W-Certificate (CDCl3-CD3〇D , ά) : 0.94 (3H, t, J 2 7.5Ηζ), 1.76 (2H, m), 2.71 (2H, t, J 2 7 · 5Ηζ), 2.81 (3H, s), 5.36 (2H s), 6.40 (1H, d, J: 7.5Hz), 6,98-7 • 22 (4H, m), 7,40 (1H, d, J: 7.5Hz), 7.5Q (1H3 d, J: 7.5Hz). Mp: 191-1930C0 &lt; Example 21; Synthesis of 6-acetamidinyl-1- (2-chlorobenzyl) -2-n-propylbenzimidazole (89) &gt; 95 copies Paper size China State Standard (CNS) A4 (210X297 mm) 548272 A7 I — __________________ B7 V. Description of the invention (92) (Read the precautions on the back before filling this page) At room temperature, mix acetic anhydride (62mg) A solution of 6-amino-1- (2-chlorobenzyl) -2-n-propylbenzimidazole (150mg) and triethylamine (61mg) in dichloromethane (3ml) was added. After stirring for 1 hour, it was washed with water, dried, and decompressed Luohe. 6_Ethylamine benzyl) was obtained by crystallization of the residue) _2-n-propylbenzimidazole (89) (143mg) . [Physical properties of compound (8 9)] Η face (CDCh ,: i · 00 (3H, t, J: 7.5Hz), 1.86 (2H, m), 2.17 (3H, s), 2.73 (2H , T, J-7 · 5Ηζ), 5.39 (2H, s), 6.43 (1H, d, J 2 7.5Ηζ), 6.98-7 · 11 (2 H, m), 7.22 ( 1H, t, J: 7.5Hz), 7.45 (1H, d3 J: 7.5Hz), 7.59 (1H, brs) 3 7 · 6 8 (1H, d, J: 7.5Hz), 7.84 (1H, d , J: 1.5Hz). Mp: 180-182 ° C0 &lt; Example of palladium palladium 22; Synthesis of 6-amino-1- (2-chlorobenzyl) _2-n-propylbenzimidazole (90) &gt;; Dissolve 6- 3rd butoxycarbonylamino (fluorenyl chlorobenzyl) _2-n-propylbenzimidal (700 mg) in dichloromethane (00 ml) and trigas hydrazone acetate) In the vehicle, the mixture was stirred at room temperature for 5 hours. A small amount of methylene chloride was added to the reaction solution, washed with an aqueous sodium carbonate solution, and then dried and evaporated under reduced pressure. A mixed solvent of n-hexane and _ was used to recrystallize the residue to obtain 6-amino] _ (2-chlorobenzyl) ^ n-propyl = azole (90) (455 mg). [Physical properties of compound (90)]! H-m (CDCla, d) · 1 π ημ + r. 丨. G1 ⑽, t, J: 7.5Hz), h86 (2Η

=7.5HZ), 5.30 (2H, S), 6 41 (IH h . , , J (2H' J •4i (吼 d,J二 1·5Ηζ),6.48 (1H,d 卜7 π、 r 66 (1H,dd,J:7.5 及丨 5Hz) 7 Mu ,^7·5Ηζ),6· ΗΖ),7.1〇(ίΗ,υ-7._,7.25(1Η,υ:75 本纸張尺㈣ 548272 五、 A7 B7 發明説明(93) Ηζ)3 7·46 (1H,d,j:7.5Hz),7·57 (11],d,j=7 5Hz)。 mp : 121-122°C〇 &lt;貝施例23;1-(2-氯代苄基)-2-正丙基-6-脲基苯並 咪唑(91)之合成&gt; 使用相同於實施例21之方法以製造出1-(2_氯代苄 基)-2-正丙基-6-脲基苯並咪唑(91)。 [化合物(91)的物性] ^NMR (DMS0-d63 ,):〇.93 (3H3 t3 J.7.5Hz)3 L7Z (ZH, .), 2.73 (2H, t5 J-7.5Hz)3 5.43 (2H3 s)3 5.73 (2H5 s), 6.42 (1H3 dd5 J-7.5 R l.5Hz)3 ?,〇5 (1H,dd,J:7,5 及 h5Hz)3 7·22 (1H,狀,问·5 及 15Hz),7·33 ( 1H, dt, J—7.5 及 1,5Hz), 7·45 (1H, d, J:7.5Hz), 7.50 (1H, s), 7.57 (1H ,dd, J:7.5 及 1·5Ηζ), 8.50 (1H3 s)。 mp : 198°C〇 &lt;製造例12;3-乙醯胺_4_硝基安息香酸乙酯的製造&gt; 在冰浴下將乙醯(9ml)加入3-胺基-4-硝基安息香酸 乙酯(18.4g)與N,N-二曱基苯胺(2〇〇ml)的混合物中,在室 溫下攪拌2小時,接著在5〇它下攪拌2小時。將反應液 倒入經冷卻之1N鹽酸中,並使用醋酸乙酯以進行2次 之萃取。對於有機層進行1N鹽酸、水洗淨、乾燥及溶 媒之餾除。藉由矽膠柱色譜法(溶離液··醋酸乙酯/己烷 = 1/10〜1/4)以精製殘渣,而得出3_乙醯胺硝基安息香 酸乙酯(19.6g)。 [化合物的物性] ^-NMRiCDCh, 6) : L42(3H, t5 J=7.1Hz), 2.3Z(3H, s), 4.43(2H, q, J-7.1 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐 (讀先閲讀背面之注意事項再填寫本頁) 訂 548272 A7 B7 五、發明説明(94) Ηζ), 7·82(1Η, dd, J二1.8 及 8.7Hz), 8.25(1H, d, J=8.7Hz), 9.35(1H, d, J 二 1.8Hz)3 10.19(1H,s)。 (誚先閱讀背面之注意事項再填寫本頁) &lt;製造例13;4-梢基-3-苯基乙酿胺安息香酸乙酯的 製造&gt; 依據製造例12之方法,使用3-胺基-4-硝基安息香 酸乙酯(2.02g)與氣化苯基乙醯(187g)以得出4-硝基-3-苯基乙酿胺安息香酸乙g旨(3.3Og)。 [化合物的物性] iH-NMIUCDCh,6) : 1·41(3Η,t,J:7.2Hz),3·85(肌 s),4·42(2Η,q,J二7·2 Ηζ)3 7·34-7·49(5Η3 m)3 7·79(1Η3 m)3 8.19(1Η, d, J:8.7Hz), 9·39(1Η, d,扣 1·6Ηζ^ 1G.15(1H,s)。 &lt;製造例l4;3-[N-(2_氯代苄基)乙醯胺]-4-硝基安息 香酸乙酯的製造&gt; 在冰浴下將60%氫化鈉(0.406g)加入3 -乙醯胺基-4-硝基安息香酸乙酯(1.706g)之N,N-二曱基曱醯胺(12ml) 溶液中,在室溫下攪拌40分。加入2-氯代苄基溴(1.806g) 之N,N-二甲基甲醯胺(l〇ml)溶液,在室溫下攪拌3小時。 將反應混合物倒入經冷卻之1N鹽酸中,並使用醋酸乙酯 以進行2次之萃取。對於有機層進行in鹽酸、水洗淨、 乾燥及溶媒之餾除。藉由矽膠柱色譜法(溶離液:醋酸乙 酯/己烷= 1/10〜1/4)以精製殘渣,而得出油狀的3-[N-(2-氯 代苄基)乙醯胺]-4-硝基安息香酸乙酯(2.08g)。 [化合物的物性] lH-NMR(CDCl3, δ) : 1.38(3H, t, J=7.1Hz), 1.92(3H5 s), 4.Z8-4.45(2H, m)5 4.72(1H, d, J=14.5Hz), 5.34(1H, d, J二14·5Ηζ), 7·16_7·44(4Η3 m), 7·69(1Η _____ω___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(95) ,d,J:1.7Hz),7.94(1H,d,J:8.他),8·13(1Η,dd,J=1.7 及 8·4Ηζ)〇 (請先閱讀背面之注意事項再填寫本頁) &lt;製造例15;4-硝基-3-[N-[2-(三氟甲基)苄基]乙醯胺 基]安息香酸乙酯的製造&gt; 依據製造例14之方法,使用3-乙醯胺-4-硝基安息 香酸乙酯(1.49g)與2-(三氟甲基)节基溴(1.69g)以得出4-硝基-3-[N-[2-(三氟甲基)苄基]乙醯胺基]安息香酸乙酯 (1.82g)。 [化合物的物性] lH-NMR(CDCl3, δ) : 1.37(3H, t3 J=7.1Hz)5 1.96(3H, s)3 4.29-4.42(2H, m), 4·78(1Η, d, J=15.4Hz), 5·40(1Η, d, J=15.4Hz), 7·38(1Η, t, J=7.6Hz), 7.5 1-7.58(2H, m), 7·61(1Η, d, J二1·7Ηζ), 7·67(1Η, d, J二7.8Hz), 7,92(1H, d3 J =8·4Ηζ), 8·13(1Η, dd, J=1.7 及 8·4Ηζ)。 mp : 153·5-158.0oC〇 &lt;製造例16;4_硝基-3-[N-[4-(三氟甲基)苄基]乙醯胺 基]安息香酸乙酯的製造&gt; 依據製造例14之方法,使用3-乙醯胺-4-硝基安息 香酸乙酯(l.5〇g)與4-(三氟甲基)苄基溴(1.71g)以得出4-硝基-3-[N-[4-(三氟曱基)苄基]乙醯胺基]安息香酸乙酯 (1.52g)。 [化合物的物性] ^-NMRiCDCh, δ) : 1.36(3H3 t, J=7.1Hz), 1.91(3H, s), 4.32-4.43(2H, m), 4·42(1Η, d, J二14·6Ηζ), 5.33(1H, d, J=14.6Hz), 7.30(2H, d, J=8.1Hz), 7.5 4(2H5 d, J-8.1Hz)3 7.6K1H, d, J=1.8Hz), 7.96(1H3 d5 J-8.4Hz), 8.1Z(1H, dd, J二1.8 及 8.4Hz)。 __________qq_____________ . 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(96) &lt;製造例17;3·[Ν-(2-氰基苄基)乙醯胺基]-4-硝基安 息香酸2_氰基节基酯的製造&gt; (讀先閲讀背面之注意事項再填寫本頁) 在室溫下’將3-乙醯胺基—4-硝基安息香酸(1.50g) 之N,N-二曱基曱醯胺(l〇mi)溶液滴入6〇0/。氫化鈉(〇 8〇2g) 與N,N-二曱基甲醯胺(i〇mi)之漿液中,並攪拌3〇分。接 著滴入2-氰基苄基溴(3.93g)之Ν,Ν·二甲基甲醯胺(10ml) 溶液,並攪拌30分。將反應液注入醋酸乙酯中,過濾 出所析出之結晶。使用醋酸乙酯洗淨所得出之結晶,然 後將其溶解於三氣甲烷中。將除去固體成分之濾液濃縮 而得出黃色結晶之3-[N-(2-氰基苄基)乙醯胺基]-4-硝基 安息香酸2_氰基苄基酯1.96g。 [化合物的物性] -- lH-NMR(CDCl3, δ) : 1.92(3H3 s), 4.92(1H, d3 J=4.8Hz)3 5,24(2H, d3 J=4.9 Hz), 5.44(2H, dd, J二7·9 及 2·9Ηζ), 7·36(1Η, t, J:7.5Hz), 7·47(1Η, d, J 二7·7Ηζ), 7.52(1H, t, J=7.7Hz), 7.56-7·62(2Η, m), 7·63-7·71(2Η, m), 7·76( 1H, d, J二7·8Ηζ), 7·80(1Η, d, J=1.7Hz), 7·99(1Η, d, J二8.4Hz), 8.25(1H, dd ,11二8.4 及 1·8Ηζ)。 經系部中央榡準趵只工消t合作私印製 &lt;製造例18;4-胺基-3-(N-異丙基丁醯胺基)安息香 酸乙酯之製造&gt; 在室溫下將3-丁醯胺-4-硝基安息香酸乙酯(2.00g) 之N,N_二甲基甲醯胺(10ml)溶液滴入60%氫化鈉(〇.428g) 與N,N-二甲基甲醯胺(10ml)之漿液中,攪拌30分。接著 滴入異丙基碘(1.46g)之N,N-二甲基甲醯胺(10ml)溶液, 在100°C下攪拌5天。將反應液注入稀鹽酸(80g)與醋酸乙 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 經浐部中央标率而货工消費合作私印衆 A7 B7 五、發明説明(97) ^ 酯(8〇g)之混合液中以進行分層,對於所得之有機層進〜 水洗(50g)、減壓濃縮。藉由矽膠柱色譜法(溶離液· 丁 烷/醋酸乙醋=4Π)精製殘渣,而得出4_胺基_3_(n_異丙1 丁醯胺基)安息香酸乙酯之粗精製物(〇26〇g)。接著,$ 室溫下,將乙醇(3ml)與醋酸(2ml)加入4_胺基_3_(n•異丙 基丁醯胺基)安息香酸乙酯(〇26〇§)中,再加入還原鐵 (〇.519g),令其加熱迴流4小時。使用過濾助劑以除去固 形物,並濃縮濾液。將殘渣加入醋酸乙酯(3〇ml)與稀鹽 酸(30ml)中以使其分層,對於有機層進行水洗(3〇mi)、減 壓濃縮。藉由分離用薄層矽膠色譜法(展開溶媒:己烷/ 醋酸乙酯=1/1)之精製以得出‘胺基_3_(冰異丙基丁醯胺 基)安息香酸乙酯(0.06g)。 [化合物的物性] iH-NMMCDCh,ά) : 〇·82(3Η,t,J:7.4Hz),1·01(3Η,d,㈣·9Ηζ),1·24(3Η, d, J:6.6Hz), 1·38(3Η, t, J:7.0Hz), 1·54-1·62(2Η, m), 1·87_2·04(2Η, m), 4·34(2Η,q,J=7.0Hz),4·45(2Η,s),4.88-4·96(1Η,ιη),6·78(1Η,d,&lt;Ι:8·4Ηζ ),7·64(1Η5 d, J:1.9Hz), 7·87(1Η3 dd, J=8.4 及 1·9Ηζ)。 &lt;裝ie例19;3-硝基-4_苯基乙醯胺基安息香酸乙醋 的製造&gt; 依據製造例12之方法,使用4-胺基-3-硝基安息香 酸乙酯(4.04g)及苯基乙醯基氣(3 74g)以得出硝基-4-苯基乙酿胺基安息香酸乙酯(6 〇〇g)。 &lt;製造例20;N-苯磺醯基_3_胺基_4_硝基苯並醯胺之 製造&gt; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公羞) (請先閱讀背面之注意事項再填寫本頁} 訂- -%». 548272 A7 B7 五、發明説明(98) 將N,N 基一咪唑(28.9g)加入3 -乙醯胺基-4-硝基 安息香酸(20.0g)之N,N-二甲基甲醯胺(3〇〇ml)溶液中,在 (讀先閱讀背面之注意事項再填寫本頁) 室溫下攪拌1小時。再加入苯磺醯胺(28〇〇g)與二氮二環 十一烯(27.16g),在lOOt下攪拌4天。經餾除溶媒後, 將二氯曱烧及10%鼠氧化鈉水溶液加入殘渣中,並進行 激烈地攪拌。將所得之水層加入10%鹽酸以進行中和, 再加入三氯甲烷並進行激烈地攪拌。過濾所析出之結 晶,經乾燥而得出N-苯磺醯基-3-胺基-4-硝基苯並醯胺 (I4.4g) 〇 [化合物的物性] INMIUDMSO-d6,ά ) : 6·93(1Η,dd,J:1.8 及 9·0Ηζ),7·43(1Η,d,J:1.8H z)5 7.52(2H, br s), 7.65(2H, t, J=7.5Hz), 7.74(1H, t, J=7.5Hz), 7.98-7.8 2(3H, m)5 12.74(1H, s)〇 &lt;製造例21;N-苯磺醯基-3-(聯苯甲胺基)_各硝基 苯並醯胺鉀鹽之製造&gt; 將20%碳酸氫卸水溶液(56_5g)與4-溴甲基聯苯 (11.5g)加入N-苯續醯基-3-胺基-4-硝基苯並醯胺(i〇.〇g) 之甲醇溶液(150ml)中,在70°C下攪拌3小時。過濾冷卻 後所析出之結晶,經乾燥而得出N-苯磺醯基-3-(聯苯-4-甲胺基)-4-石肖基苯並酸胺卸鹽(4.27g)。 [化合物的物性] W-NMR(DMS0-d6, ά) : 4·65(2Η, d, J:5.8Hz), 7·19(1Η3 d, J=8.9Hz), 7.33-7 •42(4H, m), 7·57-7·71(4Η, m)3 7·75-7·81(2Η, m), 8·02(1Η, d, J二8·9Ηζ), 8· 61(1H, br t)〇 IR(Nujol) : 1598cm1〇 -__—- _1(1?______ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 _____________________B7 五、發明説明(99) &lt;製造例22;N-苯磺醯基-4-胺基-3-(聯苯-4-甲胺基) 笨並醯胺鉀鹽之製造&gt; (誚先閱讀背面之注意事項再填寫本頁) 將5%鈀/碳(〇.64g)加入N-笨磺醯基_3_(聯苯-4-甲胺 基)-4-硝基苯並醯胺鉀鹽(4.27g)、2〇%碳酸氫鉀水溶液 (l〇.7g)、及曱醇(200ml)之混合物中,在氫環境氣體、35 C下攪拌14小時。加入丙酮與水之混合溶液(丙酮/水 = 5/2、400ml)以溶解所析出之結晶,並過濾出固體。將 瀘液濃縮並過濾所析出之濾液,經乾燥而得出N-苯磺醯 基-4-胺基-3-(聯笨-4-甲胺基)苯並醯胺鉀鹽(3· 15g)。 [化合物的物性] ^-NMRCDMSO-dG, δ) : 4.31(2H, d, J=5.7Hz), 4.85(2H, s), 4.91(1H3 br t5 J二5·7Ηζ)3 6.45(1H, d, J=7.9Hz),7.07(lH,s),7.13(lH,d,J:7.9Hz),7.29-7.36(4H, m), 7.43-7.47(4H, m), 7.60(ZH, d, J=8.1Hz), 7.65(2H, d, J=7.6Hz ),7.73-7·76(2Η, m)。 IR(Nujol) : 1574cm l〇 &lt;製造例23;&gt;^-(2_吡啶甲基乙醯胺基-3-硝基苯 並醯胺之製造&gt; 在冰浴下將氯化乙二醯(1.25g)滴入4-乙醯胺基-3-硝 基安息香酸(l.OOg)與N,N-二曱基甲醯胺(〇.20g)之二氣甲 烧(15ml)溶液中。接著在室溫下攪拌1小時。將反應液濃 縮’並加入二異丙醚,以使其結晶化。將此結晶加入2-胺基曱基。比啶(〇.483g)與三乙胺(〇.35g)之二氣曱烷(15ml) 溶液中。在室溫下攪拌1小時後,對於有機層進行水洗 (100mlX2次)及碳酸氫鈉水溶液(iQ〇ml)之洗淨。濃縮有 本紙張尺錢關家辟(CNS ) A4規格(210X29'^ ) 548272 A7 B7 五、發明説明(10¾ 機層而得出N-(2-。比唆甲基)-4-乙醢胺基-3-石肖基苯並醯 胺(0.99g)。 [化合物的物性] 'H-NMR(CDCl3, δ) : 2.33(3H, s), 4.76(2H, d5 J=4.8Hz), 7.25(1H, dd, J=5. 〇 及 7·2Ηζ), 7·34(1Η, d, J=7.9Hz), 7.71(1H, dt” J=1.8 及 7.8Hz), 7.8 4(1H, s)5 8·14(1Η5 dd, J=2.1 及 8.8Hz), 8·58(1Η, d, J二4·9Ηζ), 8.77(1H, d, J=2.1Hz), 8·90(1Η, d, J=8.0Hz), 10·47(1Η, s)。 &lt;製造例24;N-(2-吡啶曱基)-4-乙醯胺基-3-胺基苯 並醯胺之製造&gt; 將5%把/碳(2.53g)加入Ν-(2-α比咬曱基)-4-乙醯胺基 -3-硝基苯並醯胺(lO.Og)之甲醇(150ml)溶液中,在氫環境 氣體、60°C下攪拌15小時。過濾出固體,藉由矽膠柱 色譜法(溶離液:醋酸乙酯/甲醇=7/3)以精製經濃縮濾液 所得出之殘渣,而得出N-(2-吡啶曱基)-4-乙醯胺基_3_ 胺基苯並醯胺(8.02g)。 [化合物的物性] lH~NMR(DMS0-d6, δ) : 2.06(3H, s), 4.52(2H, d, J=5.9Hz), 5.09(2H, s), 7. 10(1H, dd, J=1.9 及 8·2Ηζ), 7.22-7·30(3Η, m), 7·38(1Η, d, J二8.2Hz), 7. 75(1H,dt,J二 1·7 及 7·6Ηζ),8.50(1H,d,J=4.6Hz),8.84UH,t,J=5.8Hz) ,9.19(1H, s)〇 〈製造例25;N-(2-吡啶甲基)-4-乙醯胺基-3-(4-苄氧 苄基胺基)苯並醯胺之製造&gt; 將4_苄氧苄基氯(1.31g)與碳酸氫鈉(i.i8g)加入N-(2-吡啶曱基)-4-乙醯胺基_3_胺基苯並醯胺(〇.80g)之N,N-二 :----uu__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁) -訂 Ψ A7 548272 B7 五、發明説明(l〇j (讀先閱讀背面之注意事項再填寫本頁) 曱基曱醯胺(10ml)溶液中,在90°C下攪拌2小時。將三 氯甲烷與水加入反應液中,使用三氯甲烷進行萃取。對 於有機層進行水洗、濃縮,並藉由矽膠柱色譜之精製而 得出N-(2-吡啶曱基)-4_乙醯胺基_3_(4_苄氧苄基胺基)笨 並醯胺(0.434g)。 [化合物的物性] lH-NMR(DMS0-d6, δ) : 2.07(3H, s), 4.30(2H, d, J=5.6Hz), 4.51(2H, d, J=5 •9Hz), 5·07(2Η, s), 5·68(1Η, t, J二5·6Ηζ), 6.97(2H, d, J=8.6Hz), 7.14(2H, m),7.25(2H,dd,J二3·4 及 7·4Ηζ),7.32UH,t,7.5Hz),7·38(2Η,t3 J二7 •1Hz), 7·44(2Η, d, J二7·2Ηζ), 7·72(1Η, dt, J二1·8 及 7·7Ηζ), 8·49(1Η, dd ,J=1.9 及 5.3Hz), 8·89(1Η, t, J=5.9Hz), 9·28(1Η3 s)。 &lt;製造例26;N-(2-吡啶甲基)-4-乙醯胺基-3-(3,4-甲 二氧基苄基胺基)苯並醯胺之製造&gt; 經浐部中央榀^-Λθ 5消費合竹ii印父 將3,4_甲二氧基苄基氯(〇.962g)與碳酸氫鈉(〇.71〇g) 加入N-(2-吡啶甲基)_4_乙醯胺基-3_(4_苄氧苄基胺基)苯 並醯胺(0.80g)之N,N-二甲基甲醯胺(10ml)溶液中,在8〇 C下攪拌4小時。將三氯曱烧及水加入反應液中,使用 三氣甲烷進行萃取。對於有機層進行水洗、濃縮,並藉 由矽膠柱色譜(溶離液:醋酸乙酯/曱醇=9/1)之精製而得 出N-(2-吡啶曱基)-4-乙醯胺基-3-(3,4_甲二氧基节基胺 基)笨並醯胺(0.49g)。 [化合物的物性] INMIUDMSO-de,d) : 2·08(3Η,s),4·29(2Η,s),4.52UH,d,J:5.9Hz),5. 27(1H,s),5·97(2Η,s),6·84-6·88(2Η,m)5 6·96(1Η,s),7.10(1H, d,J二 1.3 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 548272 A7 __ ____B7__ 五、發明説明(i〇i Ηζ), 7·13(1Η, dd, J=1.6 及 8.2Hz), 7.25-7·32(3Η, m), 7·76(1Η, dt, J二1. 2 及 7.6Hz), 8·51(1Η, d, J二4·8Ηζ), 8·90(1Η, J二5·8Ηζ), 9·28(1Η, s)。 &lt;製造例 27;Ν-(2-吡啶甲基)-4-乙醯胺基-3-[4· (1,2,3-噻二唑-4-基)苄基胺基]苯並醯胺之製造&gt; 將4-(4-溴代甲基苯基)-1,2,3-噻二唑(1.08g)與碳酸 氫鈉(0.710g)加入Ν-(2-α比啶甲基)-4-乙醯胺基_3_胺基苯 並醯胺(0.800g)之甲醇溶液(10ml)中,在70°C下攪拌1小 時。濃縮反應液,並藉由矽膠柱色譜法(溶離液:醋酸乙 酉旨/曱醇=9/1)之精製以得出N-(2-吡啶曱基)-4-乙醯胺基-3-[4-(1,2,3-噻二唑-4-基)苄基胺基]苯並醯胺(〇.830g)。 [化合物的物性] ^-NKRiCDCh, δ) : 2.1Κ3Η, s), 4.43-5.56(2H, m) 3 5.92( 1H, t, J=5.9Hz)5 7.5U1H,d,J二 1·4Ηζ),7·15(1Η,dd5 J二 1·6 及 8·1Ηζ),7·22(2Η,dd,J二 1· 9 及 8·1Ηζ),7·33(1Η,d,J二8·1Ηζ),7.57UH,d,J=8.1Hz),7·69(1Η,dt, J二 1·8 及 7·7Ηζ),8.09(2H,d,J二8·2Ηζ),8·47(1Η,dd,J二1.9 及 5·2Ηζ)3 8·89(1Η3 t, J二5.9Ηζ), 9·34(1Η, s), 9·58(1Η, s)。 &lt;製造例28;Ν-苯磺醯基-4-乙醯胺基-3-硝基笨並醯 胺之製造&gt; 經浐部中戎«.卑ΛΜ:τ*;/ί贽合竹淞印來 (誚先閱讀背面之注意事項再填寫本頁) 將Ν,Ν’-魏基二味唾(14.45g)加入4-乙醯胺基-3-硝 基安息香酸(lO.OOg)之N,N,-二甲基甲醯胺(300ml)溶液 中’在室溫下搜拌1小時。接著,加入苯績醯基酿胺(14.〇3g) 及二氮二環十一烯(13.58g),在10(rc下攪拌72小時。加 入三氯甲烷及水以形成分層後,將有機層濃縮而得出殘 渣,藉由矽膠柱色譜法(溶離液:醋酸乙酯/甲醇=4/丄) ________106 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 一~ 548272 A7 '— ----------------B7 ______ 五、發明説明(1〇3 之精製’以得出N-苯磺醯基-心乙醯胺基_3_硝基苯並醯 胺(12.67g)。 (諳先閱讀背面之注意事項再填寫本頁) [化合物的物性] W-NMmDMSO-d6,(5) ·· 2.08(3H,s),7.39-7·47(3Η,m),7·65(1Η,d,J:8.5Hz ),7.84(2H5 dd, J:1.4 及 7.7Hz), 8·11(1Η, dd, J=1.9 及 8·4Ηζ), 8.38( iH,d,JL),ι〇·34(1Η,s)。 &lt;製造例29;N-笨磺醯基-4-乙醯胺基-3-胺基苯並醯 胺之製造&gt; 將N-苯磺醯基乙醯胺基-3_硝基苯並醯胺 (12.67g)溶解於甲醇(200ml)與水30(ml)中,並加入碳酸 氫鉀(7.59g)。在氫環境氣體、4〇ι下使用5%鈀/碳(2.53g) 之觸媒以將其氫化24小時。過濾出固體,濃縮濾液而 得出殘渣’藉由矽膠柱色譜法(溶離液:醋酸乙酯/甲醇 =4/1)之精製,以得出N-笨磺醯基-4-乙醯胺基-3-胺基苯 並醯胺(6.72g)。 [化合物的物性] W-NMMDMSO-d6,(5) : 2·06(3Η,s)3 7·07(1Η,dd,J二 1.8 及 8·3Ηζ)3 7.17( 1H, d3 J=1.8Hz)3 7.44(1H5 d, J=8.3Hz), 7.61(2H3 t), 7.68(1H, t)3 7.96(2H ,d, J=7.5Hz), 9·19(1Η, s)。 IR(Nujol) : 1682cm 丨。 &lt;製造例30;N-笨磺醯基_4_乙醯胺基_3_(2_硝基苄基 胺基)苯並醯胺之製造&gt; 依據製造例32之方法,使用N-苯磺醯基-4-乙醯胺 基-3-胺基笨並醯胺(〇.6〇幻與2_硝基苄基溴(〇 52g)以得出 -----— 1 〇7 _____ 本紙張尺度適用中國國家標準(CNS ) A4規格(2K)'x297公釐) 548272 A7 ___________B7 五、發明説明(l〇4 N-笨磺醯基-4-乙醯胺基-3-(2-硝基苄基胺基)苯並醯胺 (〇.79g) 〇 [化合物的物性] (請先閱讀背面之注意事項再填寫本頁) A-NMlUDMSO-de,ά) : 2·08(3Η,s),4.72(2H,d,J=5.0Hz),5·92(1Η,s),6. 86(1H,s),7.13(1H,d,J:8.1Hz),7·31(1Η,d5 J:8.0Hz),7.49-7,58(3H,mh 7.60(2H3 d3 J=7.6Hz)3 7.66(1H3 t5 J=7.4Hz)3 7.86(2H3 d, J=7.7Hz), 8.11( 1H, d, J=8.3Hz), 9·37(1Η, s)。 &lt;製造例31;N-苯磺醯基-4-乙醯胺基-3-苄基胺基苯 並醯胺之製造&gt; 依據製造例32的方法,使用N-苯磺醯基·4_乙醯胺 基-3-胺基苯並醯胺與苄基溴(〇.47g)以得出Ν-笨確醯基-4_乙醯胺基-3-苄基胺基笨並醯胺(〇.3 8g)。 [化合物的物性] INMR (DMSO-d6,d) : 2·07 (3H,s),4.35(2H,d,J=5.5Hz),5·73(1Η,s) ,7·〇6(1Η, s), 7·14(1Η, d, J二8·3Ηζ), 7·21-7·28(2Η, m), 7·32(2Η, t, J二7·3 Hz), 7·37(2Η, d, J二7·6Ηζ), 7·53(2Η, t, J=7.4Hz), 7·59(1Η, t, J:7.〇Hz), 7 •88(2H, d, J:7.7Hz), 9·29(1Η, s), 12·34(1Η, s)。 &lt;製造例32;N-苯磺醯基-4-乙醯胺基-3-(2,4-二氟代 苄基胺基)苯並醯胺之製造&gt; 在60°C下,將N-苯磺醯基-4-乙醯胺基-3-胺基苯並 酿胺(0.60g)、2,4_二氟代苄基溴(0.656g)、與碳酸氫鉀 (0.423g)之甲醇(7ml)溶液攪拌1小時。將反應液濃縮, 藉由矽膠柱色譜法(溶離液:醋酸乙酯/曱醇=9/1)之精製 以传出N-苯績醢基-4-乙驢胺基-3-(2,4-二氟代节基胺基)苯 ------ - 108___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 ________________________B7_ 五、發明説明(1〇5) 並醯胺(0.370g)。 [化合物的物性] (讀先閱讀背面之注意事項再填寫本頁} lH-NMR(DMS0-d63 δ) : 2.05(3H, s), 4.34(2H, d, J=5.5Hz), 5.60(1H, s), 7. 〇2(lH, t3 J-8.0Hz), 7.06(1H, s), 7.16-7.27(3H, m), 7.38-7.51(411, m), 7.8 2(ZH, d, J-7.2Hz), 9,27(1H, s)3 1Z.35(1H, s)〇 &lt;製造例33;N-苯磺醯基-4-乙醯胺基-3-(4-硝基苄基 胺基)苯並醯胺之製造&gt; 依據製造例32之方法,使用N-苯磺醯基-4_乙醯胺 基-3-胺基苯並醯胺(0.50g)與4-硝基苄基溴(0.436g)以得 出N-苯磺醯基-4-乙醯胺基-3-(4-硝基苄基胺基)苯並醯 胺(〇.52g)。 [化合物的物性] ^-NMRiDMSO-dG, δ) : 2.09(3H, s), 4.54(2H, d, J=5.0Hz), 6.10(1H, s), 6. 89(1H,d,J=1.8Hz), 7·14(1Η,dd,J=1.8 及 8.2Hz),7.39UH,d…)=8·2Ηζ) ,7·58-7.65(4Η, m), 7·68(1Η, t, J=7.6Hz), 7·92(2Η, dd, J=1.4 及 7.4Hz) 3 8.20(2H, d, J二8.7Hz), 9.36(1H, s), 12.28(1H, s)。 〈製造例34;N-苯磺醯基-4-乙醯胺基-3-[4-(l,2,3-噻 二唑-4-基)苄基醯胺]苯並醯胺之製造&gt; 依據製造例32之方法,使用N-苯磺醯基-4-乙醯胺 基-3-胺基苯並醯胺(0.50g)、4-(4-溴代甲基苯基)-l,2,3-噻二唑(0·45g)以得出N-苯磺醯基-4-乙醯胺基-3-[4-(l,2,3-噻二唑-4-基)苄基醯胺]苯並醯胺(0·38g)。 [化合物的物性] iH-NMR(DMS(Hi6,(5) : 2.HK3H,s),4.46(2H,d,J:5.3Hz)· 5·96(1Η,s),7. ______IM_____ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 ___________________ B7 五、發明説明(1〇6 ) ~~ 03(1H, s), 7.14(1H, dd, J=1.7 及 8·2Ηζ), 7·40(1Η, d, J二8·0Ηζ), 7.52-7. 61(411, in), 7.65(1H, t, J-7.1Hz), 7.93(2H, d5 J-7.6Hz), 8.10(2H, d, J=8.2 Hz),9.35(1H,s),9·58(1Η,s),12.31UH,s)〇 (誚先閱讀背面之注意事項再填寫本頁) &lt;製造例35;3-胺基-2-硝基安息香酸乙g旨之製造&gt; 在加熱迴流下攪拌3-乙醯胺基-2-硝基安息香酸 (20.2g)、97%硫酸(ll.4g)及乙醇(3〇〇ml)的混合物23小 時。經餾除乙醇100ml並冷卻至室溫後,將反應液倒入 含有碳酸氫鈉(19.5g)之冰水(200ml)中。將析出之結晶過 濾出,並進行水洗。接著,將結晶分散在醋酸乙酯與己 烷1 ·· 2之混合液(3〇ml)中,過濾出結晶,並進行使用己 烧之洗淨及乾燥。藉此以得出3-胺基-2-石肖基安息香酸乙 酯(18.0g)。 [化合物的物性] 'H-NMRiCDCh, δ) : 1.39(3H, t, J-7.1Hz), 4.37(2H, q, J=7.1Hz), 6.41(2H? br s),6.83(1H,d,J二8.7Hz),8.00UH, dd,J=1.8 及 8·7Ηζ),8.85(1H,d ,J二1.8Hz)。 &lt;製造例3 6;3-乙酿胺基-2-石肖基安息香酸乙g旨之製 造&gt; 在冰浴下,將乙It基氯(13ml)滴入3-胺基-2_石肖基安 息香酸乙酯(2.98g)與N,N-二甲基苯胺(2〇ml)之溶液中, 在室溫下攪拌48小時。使用10%鹽酸以使得反應液形成 酸性,以醋酸乙酯萃取2次,並水洗有機層3次。將己 烷加入經減壓餾除溶媒所得之殘渣中以使其結晶化。藉 由過濾、己烷之洗淨、乾燥以得出3-乙醯胺基硝基安 本紙張尺度適/ΪΓ巾國ΐ家襟準(CNS ) A4規格(21QX2=瘦) 548272 A7 B7 五、發明説明(10)7 息香酸乙醋(3.30g)。 [化合物的物性]、 (¾先閱讀背面之注意事項再填寫本頁) W-NMIUCDCI3,(5) : 1·42(3Η,t),2·33(3Η,s),U2(2H,q),8·27(1Η3 dd3 J二 1.9 及 8.9Hz),8·89(1Η,d,J:1.9Hz),8·91(1Η,d,J=8.9Hz),ι〇·54(1Η, br s)〇 &lt;製造例37;4-乙醯胺基_3_胺基安息香酸乙酯之製 造&gt; 在氫環境氣體下,將3-乙醯胺基-2-硝基安息香酸 乙酯(149.4g)、5%鈀/碳(14.9§)、及乙醇(1500ml)的混合 物攪拌15小時。過濾出固體,將濃縮濾液所得出之殘 潰溶解於少量的乙醇中,並添加二異丙醚。藉由過濾、 乾燥所析出之結晶以得出‘乙醯胺基-3_胺基安息香酸 乙酯(114.4g)。 [化合物的物性] fNMRiDMSO-dG,(5) : 1·27(3Η5 t),2.G5(3H3 s),4.23(2H,q),5·19(2Η,s) ,7.13UH,d,J=8.2Hz),7,35(1Η,s)5 7·47(1Η,d,J=8.2Hz),9·19(ίΗ,s) &lt;實施例24; 1-(2-氯代苄基)-6-乙氧羰基_2_甲基笨 並咪唑(92)之合成&gt; 將乙.醇(2〇ml)、醋酸及還原鐵(3.〇7g)加入3-[N-(2-氣代苄基)乙醯胺基]-4-硝基安息香酸乙酯(2.〇7g) 中’並迴流4小時。過濾出固體,並使用乙醇洗淨。經 /辰%濾液後’將碳酸氫納水溶液加入殘潰中,使用醋酸 乙醋進行萃取。經乾燥後,減壓蒸餾以除去溶媒,並藉 由石夕膠色睹法(溶離液:己烧/醋酸乙g旨:=100/0〜70/30)之精 ------nj___ 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公楚) 548272 A7 B7_ 五、發明説明(1〇8) 製以得出1-(2-氣代苄基)-6_乙氧羰基_2_曱基笨並咪唑 (92) (1.46g)。 (許先閱讀背面之注意事項再填寫本頁) [化合物(92)的物性] 1H-NMR(CDCl3, δ) : 1.39(3H t 卜7 ih?、9 0 w,J-7·1Ηζ),2.57(3H,s),4·37(2Η,q, J二7.1= 7.5HZ), 5.30 (2H, S), 6 41 (IH h.,, J (2H 'J • 4i (Roll d, J 2 1.5 μΗζ), 6.48 (1H, d 7 π, r 66 ( 1H, dd, J: 7.5 and 5Hz) 7 Mu, ^ 7 · 5Ηζ), 6. · Z), 7.1〇 (ίΗ, υ-7._, 7.25 (1Η, υ: 75 paper size 548272) A7 B7 Description of the invention (93) Ηζ) 3 7 · 46 (1H, d, j: 7.5Hz), 7.57 (11), d, j = 7 5Hz). Mp: 121-122 ° C. &Lt; Example 23; Synthesis of 1- (2-chlorobenzyl) -2-n-propyl-6-ureidobenzimidazole (91) &gt; The same method as in Example 21 was used to produce 1- ( 2-chlorobenzyl) -2-n-propyl-6-ureidobenzimidazole (91). [Physical properties of compound (91)] NMR (DMS0-d63,): 0.93 (3H3 t3 J. 7.5Hz) 3 L7Z (ZH,.), 2.73 (2H, t5 J-7.5Hz) 3 5.43 (2H3 s) 3 5.73 (2H5 s), 6.42 (1H3 dd5 J-7.5 R 1.5.5Hz) 3?, 〇 5 (1H, dd, J: 7, 5 and h5Hz) 3 7 · 22 (1H, shape, Q · 5 and 15Hz), 7.33 (1H, dt, J—7.5 and 1,5Hz), 7.45 (1H, d, J: 7.5Hz), 7.50 (1H, s), 7.57 (1H, dd, J: 7.5 and 1.5Ηζ), 8.50 (1H3 s). Mp: 198 ° C &lt; Production Example 12 ; 3-Acetylamine_4_nitrobenzoic acid Production of esters> Acetamidine (9 ml) was added to a mixture of ethyl 3-amino-4-nitrobenzoate (18.4 g) and N, N-dimethylaniline (200 ml) in an ice bath. The mixture was stirred at room temperature for 2 hours, and then at 50 ° C for 2 hours. The reaction solution was poured into cooled 1N hydrochloric acid, and ethyl acetate was used for extraction twice. The organic layer was subjected to 1N hydrochloric acid. , Washing with water, drying and distilling off the solvent. The residue was purified by silica gel column chromatography (eluent ·· ethyl acetate / hexane = 1/10 ~ 1/4) to obtain 3_acetamidine Ethyl nitrobenzoate (19.6g). [Physical properties of compound] ^ -NMRiCDCh, 6): L42 (3H, t5 J = 7.1Hz), 2.3Z (3H, s), 4.43 (2H, q, J- 7.1 This paper size applies the Chinese National Standard (CNS) A4 specification (210x297 mm (read the precautions on the back before filling this page). Order 548272 A7 B7 V. Description of the invention (94) Ηζ), 7.82 (1Η, dd, J = 1.8 and 8.7Hz), 8.25 (1H, d, J = 8.7Hz), 9.35 (1H, d, J = 1.8Hz) 3 10.19 (1H, s). (诮 Please read the precautions on the reverse side before filling in this page) &lt; Production Example 13; Production of 4-Tyrol-3-phenylethylamine benzoate ethyl ester &gt; Use 3-amine according to the method of Production Example 12 Ethyl-4-nitrobenzoate (2.02g) and vaporized phenylacetamidine (187g) to give 4-nitro-3-phenylethylamine benzoate ethyl acetate (3.30g). [Physical properties of compound] iH-NMIUCDCh, 6): 1.41 (3Η, t, J: 7.2Hz), 3.85 (muscle s), 4.42 (2Η, q, J 2 7 · 2 Ηζ) 3 7 · 34-7 · 49 (5Η3 m) 3 7.79 (1Η3 m) 3 8.19 (1Η, d, J: 8.7Hz), 9 · 39 (1Η, d, deduction of 1.6Ηζ ^ 1G.15 (1H &Lt; Production Example 14; Production of 3- [N- (2-chlorobenzyl) acetamidamine] -4-nitrobenzoate ethyl ester &gt; 60% sodium hydride ( (0.406 g) was added to a solution of ethyl 3-ethylamido-4-nitrobenzoate (1.706 g) in N, N-diamidinofluorenamine (12 ml), and stirred at room temperature for 40 minutes. Added 2 -A solution of chlorobenzyl bromide (1.806 g) in N, N-dimethylformamidine (10 ml) and stirred at room temperature for 3 hours. Pour the reaction mixture into cooled 1N hydrochloric acid and use Ethyl acetate was extracted twice. The organic layer was washed with hydrochloric acid, washed with water, dried, and distilled off the solvent. By silica gel column chromatography (eluent: ethyl acetate / hexane = 1/10 ~ 1 / 4) The residue was purified to obtain ethyl 3- [N- (2-chlorobenzyl) acetamidin] -4-nitrobenzoate (2.08 g). [Physical properties of the compound] 1H -NMR (CDCl3, δ): 1.38 (3H, t, J = 7.1Hz), 1.92 (3H5 s), 4.Z8-4.45 (2H, m) 5 4.72 (1H, d, J = 14.5Hz), 5.34 (1H, d, J 2 14.5Ηζ), 7 · 16_7 · 44 (4Η3 m), 7 · 69 (1Η _____ ω ___ This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (95), d, J: 1.7Hz) 7.94 (1H, d, J: 8. he), 8.13 (1Η, dd, J = 1.7 and 8.4Ηζ) 〇 (Please read the precautions on the back before filling this page) &lt; Manufacturing example 15; 4 Production of -nitro-3- [N- [2- (trifluoromethyl) benzyl] acetamido] ethyl benzoate &gt; According to the method of Production Example 14, 3-acetamidine-4- Ethyl nitrobenzoate (1.49g) and 2- (trifluoromethyl) benzyl bromide (1.69g) to give 4-nitro-3- [N- [2- (trifluoromethyl) benzyl ] Acetylamino] Ethyl Benzoate (1.82g). [Physical Properties of Compound] lH-NMR (CDCl3, δ): 1.37 (3H, t3 J = 7.1Hz) 5 1.96 (3H, s) 3 4.29-4.42 (2H, m), 4.78 (1Η, d, J = 15.4Hz), 5.40 (1Η, d, J = 15.4Hz), 7.38 (1Η, t, J = 7.6Hz), 7.5 1 -7.58 (2H, m), 7.61 (1Η, d, J 2 1.7Ηζ), 7.67 (1Η, d, J 2 7.8Hz), 7,92 (1H, d3 J = 8 · 4Ηζ), 8 · 13 (1Η, dd, J = 1.7 and 8 · 4Ηζ). mp: 153.5-158.0 ° C. &lt; Production Example 16; Production of 4-nitro-3- [N- [4- (trifluoromethyl) benzyl] acetamido] ethyl benzoate &gt; According to the method of Production Example 14, ethyl 3-acetamidin-4-nitrobenzoate (1.5 g) and 4- (trifluoromethyl) benzyl bromide (1.71 g) were used to obtain 4- Nitro-3- [N- [4- (trifluorofluorenyl) benzyl] acetamido] ethyl benzoate (1.52 g). [Physical properties of compound] ^ -NMRiCDCh, δ): 1.36 (3H3 t, J = 7.1Hz), 1.91 (3H, s), 4.32-4.43 (2H, m), 4.42 (1Η, d, J 2:14 · 6Ηζ), 5.33 (1H, d, J = 14.6Hz), 7.30 (2H, d, J = 8.1Hz), 7.5 4 (2H5 d, J-8.1Hz) 3 7.6K1H, d, J = 1.8Hz) , 7.96 (1H3 d5 J-8.4Hz), 8.1Z (1H, dd, J2 1.8 and 8.4Hz). __________qq_____________. This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 V. Description of the invention (96) &lt; Manufacturing example 17; 3. [Ν- (2-cyanobenzyl) ethyl醯 Amino group] Manufacture of 4-nitrobenzoic acid 2-cyanobenzyl ester &gt; (Read the precautions on the back before filling in this page) At room temperature, ' A solution of nitrobenzoic acid (1.50 g) in N, N-diamidinofluorenamine (10 mi) was dropped into 600 /. A slurry of sodium hydride (0.82 g) and N, N-dimethylformamide (iomi) was stirred for 30 minutes. Then, a solution of 2-cyanobenzyl bromide (3.93 g) in N, N-dimethylformamide (10 ml) was added dropwise, followed by stirring for 30 minutes. The reaction solution was poured into ethyl acetate, and the precipitated crystals were filtered out. The obtained crystals were washed with ethyl acetate, and then dissolved in three gas methane. The solid-removed filtrate was concentrated to obtain 1.96 g of 3- [N- (2-cyanobenzyl) acetamidinyl] -4-nitrobenzoic acid 2-cyanobenzyl ester as yellow crystals. [Physical properties of compound]-lH-NMR (CDCl3, δ): 1.92 (3H3 s), 4.92 (1H, d3 J = 4.8Hz) 3 5,24 (2H, d3 J = 4.9 Hz), 5.44 (2H, dd, J 2 7.9 and 2.9Ηζ), 7 · 36 (1Η, t, J: 7.5Hz), 7.47 (1Η, d, J 2 7 · 7Ηζ), 7.52 (1H, t, J = 7.7Hz), 7.56-7 · 62 (2Η, m), 7.63-7 · 71 (2Η, m), 7.76 (1H, d, J 2 7.8Ηζ), 7.80 (1Η, d , J = 1.7Hz), 7.99 (1Η, d, J = 8.4Hz), 8.25 (1H, dd, 11 = 8.4, and 1.8Ηζ). Cooperative private printing of the Ministry of Economic Affairs and Industry & Co., Ltd. & private printing &lt; Manufacturing Example 18; Production of 4-Amino-3- (N-Isopropylbutylamino) Ethyl Benzoate &gt; At Room Temperature Next, a solution of ethyl 3-butanamine-4-nitrobenzoate (2.00 g) in N, N-dimethylformamide (10 ml) was dropped into 60% sodium hydride (0.428 g) and N, N. -In a slurry of dimethylformamide (10 ml), stir for 30 minutes. Next, a solution of isopropyl iodide (1.46 g) in N, N-dimethylformamide (10 ml) was added dropwise, and the mixture was stirred at 100 ° C for 5 days. The reaction solution is injected with dilute hydrochloric acid (80g) and ethyl acetate. The paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) 548272. The goods and workers are co-operated with private label A7 B7 according to the central standard of the Ministry. (97) ^ ester (80 g) was mixed to separate the layers, and the obtained organic layer was washed with water (50 g) and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent · butane / ethyl acetate = 4Π) to obtain a crude product of 4_amino group_3_ (n_isopropyl 1 butanylamino) benzoate ethyl ester. (〇26〇g). Next, at room temperature, ethanol (3 ml) and acetic acid (2 ml) were added to 4-amino_3_ (n • isopropylbutylamidino) ethyl benzoate (〇26〇§), and then reduced. Iron (0.519 g), which was heated to reflux for 4 hours. A filtration aid was used to remove solids, and the filtrate was concentrated. The residue was added to ethyl acetate (30 ml) and dilute hydrochloric acid (30 ml) to separate the layers, and the organic layer was washed with water (30 mi) and concentrated under reduced pressure. Purification by thin-layer silica gel chromatography for separation (developing solvent: hexane / ethyl acetate = 1/1) to obtain 'amino_3_ (iceisopropylbutyrylamido) ethyl benzoate (0.06 g). [Physical properties of the compound] iH-NMMCDCh, ά): 〇 82 (3Η, t, J: 7.4 Hz), 1.01 (3Η, d, ㈣ 9Ηζ), 1.24 (3Η, d, J: 6.6 Hz), 1.38 (3Η, t, J: 7.0Hz), 1.54-1 · 62 (2Η, m), 1.87_2 · 04 (2Η, m), 4.34 (2Η, q, J = 7.0 Hz), 4.45 (2Η, s), 4.88-4.96 (1Η, ιη), 6.78 (1Η, d, &lt; 1: 1: 8 · 4Ηζ), 7.64 (1Η5 d, J : 1.9 Hz), 7.87 (1Η3 dd, J = 8.4 and 1.9Ηζ). &lt; Example 19; Production of 3-nitro-4_phenylacetamidinyl benzoate ethyl acetate &gt; According to the method of Production Example 12, ethyl 4-amino-3-nitrobenzoate ( 4.04 g) and phenylacetamidine (3 74 g) to give ethyl nitro-4-phenylethylaminobenzoate (600 g). &lt; Manufacturing Example 20; Manufacturing of N-benzenesulfonamido_3_amino_4_nitrobenzopyrene &gt; This paper size applies Chinese National Standard (CNS) A4 (210X297), (please first Read the notes on the back and fill out this page} Order--% ». 548272 A7 B7 V. Description of the invention (98) Add N, N-imidazole (28.9g) to 3 -acetamido-4-nitrobenzoin Acid (20.0g) in a solution of N, N-dimethylformamide (300ml), stir at room temperature for 1 hour (read the precautions on the back before reading this page). Add benzenesulfon Amidine (2800 g) and diazabicycloundecene (27.16 g) were stirred at 100 t for 4 days. After distilling off the solvent, dichloromethane and 10% aqueous sodium oxide solution were added to the residue. The mixture was stirred vigorously. The obtained aqueous layer was added with 10% hydrochloric acid for neutralization, and then chloroform was added and stirred vigorously. The precipitated crystals were filtered and dried to obtain N-benzenesulfonyl-3. -Amino-4-nitrobenzopyramine (I4.4g) 〇 [Physical properties of compound] INMIUDMSO-d6,): 6.93 (1Η, dd, J: 1.8 and 9.0Ηζ), 7.43 (1Η, d, J: 1.8H z) 5 7.52 (2H, br s), 7. 65 (2H, t, J = 7.5Hz), 7.74 (1H, t, J = 7.5Hz), 7.98-7.8 2 (3H, m) 5 12.74 (1H, s) 〇 &lt; Manufacture example 21; N-benzene Sulfonyl-3- (benzylamino) _Production of each nitrobenzylamine potassium salt &gt; Add 20% hydrogen carbonate solution (56_5g) and 4-bromomethylbiphenyl (11.5g) In a methanol solution (150 ml) of N-benzofluorenyl-3-amino-4-nitrobenzofluorenamine (iog) was stirred at 70 ° C for 3 hours. The crystals precipitated after filtration and cooling were dried to obtain N-benzenesulfonyl-3- (biphenyl-4-methylamino) -4-stoneshozylbenzoate salt (4.27 g). [Physical properties of compounds] W-NMR (DMS0-d6, ά): 4.65 (2Η, d, J: 5.8Hz), 7.19 (1Η3 d, J = 8.9Hz), 7.33-7 • 42 (4H , M), 7.57-7.71 (4Η, m) 3 7.75-7 · 81 (2Η, m), 8.02 (1Η, d, J 2 8.9Ηζ), 8.61 (1H , br t) 〇IR (Nujol): 1598cm1〇 -__—- _1 (1? ______ This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 _____________________ B7 V. Description of invention (99) &lt; Production Example 22; Production of N-benzenesulfonamido-4-amino-3- (biphenyl-4-methylamino) benzamidine potassium salt &gt; (诮 Please read the precautions on the back before filling this page ) 5% palladium / carbon (0.64 g) was added to N-benzylsulfonyl-3- (biphenyl-4-methylamino) -4-nitrobenzofluorenamine potassium salt (4.27 g), 20% In a mixture of potassium bicarbonate aqueous solution (10.7 g) and methanol (200 ml), stir under a hydrogen ambient gas at 35 C for 14 hours. Add a mixed solution of acetone and water (acetone / water = 5/2, 400 ml) ) To dissolve the precipitated crystals and filter out the solids. The mash is concentrated and the precipitated filtrate is filtered and dried to give N-benzenesulfonyl-4-amino-3- (biben-4-methyl) Amine) Potassium salt of benzopyrene (3.15g). [Physical properties of compound] ^ -NMRCDMSO-dG, δ): 4.31 (2H, d, J = 5.7Hz), 4.85 (2H, s), 4.91 ( 1H3 br t5 J2 5.7Ηζ) 3 6.45 (1H, d, J = 7.9Hz), 7.07 (lH, s), 7.13 (lH, d, J: 7.9Hz), 7.29-7.36 (4H, m), 7.43-7.47 (4H, m), 7.60 (ZH, d, J = 8.1Hz), 7.65 (2H, d, J = 7.6Hz), 7.73-7 · 76 (2Η, m). IR (Nujol): 1574cm l &lt; Production Example 23 &gt; ^-(Production of 2-pyridylmethylacetamido-3-nitrobenzopyramine) &gt; Ethyl chloride in an ice bath Rhenium (1.25g) was added dropwise to a solution of 4-ethanesulfonylamino-3-nitrobenzoic acid (1,000g) and N, N-dimethylformamidine (0.20g) in dipyridine (15ml). Then, the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated, and diisopropyl ether was added to crystallize. This crystal was added with 2-aminofluorenyl group. Bipyridine (0.483 g) and triethyl A solution of amine (0.35 g) in dioxane (15 ml). After stirring at room temperature for 1 hour, the organic layer was washed with water (100 ml x 2 times) and washed with an aqueous sodium hydrogen carbonate solution (iQ 0 ml). Concentrated There is a paper ruler Guan Jiapi (CNS) A4 specification (210X29 '^) 548272 A7 B7 V. Description of the invention (10¾ machine layer and N- (2-. Than methyl) -4-acetamido -3-Shithosylbenzofluorenamine (0.99g). [Physical properties of the compound] 'H-NMR (CDCl3, δ): 2.33 (3H, s), 4.76 (2H, d5 J = 4.8Hz), 7.25 (1H, dd, J = 5. 〇 and 7.2Ηζ), 7.34 (1Η, d, J = 7.9Hz), 7.71 (1H, dt ”J = 1.8 and 7.8Hz), 7.8 4 (1H, s) 5 8 · 14 (1Η5 dd, J = 2.1 and 8.8Hz), 8.58 (1Η, d, J = 4 · 9Ηζ), 8.77 (1H, d, J = 2.1Hz), 8.90 (1Η, d, J = 8.0Hz), 10 · 47 (1Η, s). &Lt; Production Example 24; Production of N- (2-pyridinyl) -4-acetamido-3-aminobenzobenzoamide &gt; Add 5% carbon / carbon (2.53g) to a solution of N- (2-α specific amidino) -4-acetamido-3-nitrobenzopyramine (10.Og) in methanol (150ml). , Stir for 15 hours at 60 ° C in a hydrogen ambient gas. Filter out the solid and purify the residue from the concentrated filtrate by silica gel column chromatography (eluent: ethyl acetate / methanol = 7/3) to obtain N- (2-Pyridinyl) -4-acetamido-3_aminobenzobenzopyrene (8.02g) was obtained. [Physical properties of the compound] lH ~ NMR (DMS0-d6, δ): 2.06 (3H, s), 4.52 (2H, d, J = 5.9Hz), 5.09 (2H, s), 7. 10 (1H, dd, J = 1.9 and 8 · 2Ηζ), 7.22-7 · 30 (3Η, m), 7.38 (1Η, d, J = 8.2Hz), 7.75 (1H, dt, JJ1.7 and 7.6Ηζ), 8.50 (1H, d, J = 4.6Hz), 8.84UH, t, J = 5.8Hz), 9.19 (1H, s). 〈Production Example 25; N- (2-pyridylmethyl) -4-acetamido-3- (4-benzyloxybenzylamino) benzopyrene Manufacture &gt; Add 4-benzyloxybenzyl chloride (1.31g) and sodium bicarbonate (i.i8g) to N- (2-pyridinyl) -4-acetamido-3_aminobenzofluorene Amine (〇.80g) of N, N-II: ---- uu__ This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (read the precautions on the back before filling this page)-Order Ψ A7 548272 B7 V. Description of the invention (10j (Read the precautions on the back before filling this page) In a solution of fluorenylamine (10ml), stir at 90 ° C for 2 hours. Trichloromethane and water were added to the reaction solution, and extraction was performed using chloroform. The organic layer was washed with water, concentrated, and purified by silica gel column chromatography to obtain N- (2-pyridinyl) -4_acetamido_3_ (4_benzyloxybenzylamino) benzene. Amine (0.434 g). [Physical properties of compounds] lH-NMR (DMS0-d6, δ): 2.07 (3H, s), 4.30 (2H, d, J = 5.6Hz), 4.51 (2H, d, J = 5 • 9Hz), 5 · 07 (2Η, s), 5.68 (1Η, t, J 2 5.6Ηζ), 6.97 (2H, d, J = 8.6Hz), 7.14 (2H, m), 7.25 (2H, dd, J 2 3 · 4 and 7. · 4Ηζ), 7.32UH, t, 7.5Hz), 7.38 (2Η, t3 J 2 7 • 1Hz), 7.44 (2Η, d, J 2 7 · 2Ηζ), 7.72 ( 1Η, dt, J 2 1.8 and 7 · 7Ηζ), 8 · 49 (1Η, dd, J = 1.9 and 5.3Hz), 8.89 (1Η, t, J = 5.9Hz), 9 · 28 (1Η3 s). &lt; Production Example 26; Production of N- (2-pyridylmethyl) -4-acetamidinyl-3- (3,4-methoxydioxybenzylamino) benzopyramine &gt; Central 榀 ^ -Λθ 5 Consumption Hezhu II Yinfu added 3,4-dimethoxybenzyl chloride (.962g) and sodium bicarbonate (0.71〇g) to N- (2-pyridylmethyl) _4_Ethylamido-3_ (4-benzyloxybenzylamino) benzopyramine (0.80g) in a solution of N, N-dimethylformamide (10ml), stirred at 80 ° C for 4 hour. Trichloroarsine and water were added to the reaction solution, and extraction was performed using trigas methane. The organic layer was washed with water, concentrated, and purified by silica gel column chromatography (eluent: ethyl acetate / methanol = 9/1) to obtain N- (2-pyridinyl) -4-acetamido -3- (3,4-methoxydioxybenzylamino) benzylamine (0.49 g). [Physical properties of the compound] INMIUDMSO-de, d): 2.08 (3Η, s), 4.29 (2Η, s), 4.52UH, d, J: 5.9Hz), 5.27 (1H, s), 5.97 (2Η, s), 6.84-6 · 88 (2Η, m) 5 6.96 (1Η, s), 7.10 (1H, d, J2 1.3) This paper standard applies to the Chinese National Standard (CNS) A4 specifications (21 OX 297 mm) 548272 A7 __ ____B7__ 5. Description of the invention (ioi Ηζ), 7 · 13 (1 (, dd, J = 1.6 and 8.2Hz), 7.25-7 · 32 (3Η, m) , 7.76 (1Η, dt, J2 1.2 and 7.6Hz), 8.51 (1Η, d, J2 4.8Ηζ), 8.90 (1Η, J2 5.8Ηζ), 9.28 (1Η, s). &Lt; Production Example 27; N- (2-pyridylmethyl) -4-acetamido-3- [4 · (1,2,3-thiadiazol-4-yl) benzyl Propylamino] Manufacture of benzopyramine &gt; 4- (4-Bromomethylphenyl) -1,2,3-thiadiazole (1.08 g) and sodium bicarbonate (0.710 g) were added to N- (2-α-pyridinylmethyl) -4-acetamido-3_aminobenzylidene (0.800 g) in a methanol solution (10 ml), and stirred at 70 ° C. for 1 hour. The reaction solution was concentrated, And purified by silica gel column chromatography (eluent: ethyl acetate / acetol = 9/1) to obtain N- (2-pyridinyl) -4-acetamido- 3- [4- (1,2,3-thiadiazol-4-yl) benzylamino] benzofluorenamine (0.830 g). [Physical properties of the compound] ^ -NKRiCDCh, δ): 2.1K3Κ, s), 4.43-5.56 (2H, m) 3 5.92 (1H, t, J = 5.9Hz) 5 7.5U1H, d, J 2 1. 4Ηζ), 7 · 15 (1Η, dd5 J 2 1.6 and 8 · 1Ηζ), 7.22 (2Η, dd, J 2 1.9 and 8.1Ηζ), 7.33 (1Η, d, J 2 8.1Ηζ), 7.57UH, d, J = 8.1Hz), 7 69 (1Η, dt, J 2 1.8 and 7 · 7Ηζ), 8.09 (2H, d, J 2 8.2Ηζ), 8.47 (1Η, dd, J 2 1.9 and 5. 2Ηζ) 3 8 · 89 (1Η3t, J = 5.9Ηζ), 9.34 (1Η, s), 9.58 (1Η, s). &lt; Manufacturing Example 28; Production of N-benzenesulfonyl-4-ethylamido-3-nitrobenzimidamine &gt; Zhong Rong of the Ministry of Economic Affairs «. 卑 ΛΜ: τ *; / ί 贽 合 竹淞 印 来 (诮 Please read the notes on the back before filling in this page) Add Ν, Ν'-Weiji Diwei saliva (14.45g) to 4-acetamido-3-nitrobenzoic acid (l.OOg) In a solution of N, N, -dimethylformamide (300 ml), search and stir at room temperature for 1 hour. Next, benzamidine (14.03 g) and diazabicycloundecene (13.58 g) were added and stirred at 10 (rc for 72 hours. Trichloromethane and water were added to form a layer, and then The organic layer was concentrated to obtain a residue, which was subjected to silica gel column chromatography (eluent: ethyl acetate / methanol = 4 / 丄) ________106 This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1 ~ 548272 A7 '----------------- B7 ______ V. Description of the invention (refined by 103) to obtain N-benzenesulfonyl-ethenylamino group_3_ nitrate Benzofluorenamine (12.67g). (谙 Please read the precautions on the back before filling in this page) [Physical Properties of Compounds] W-NMmDMSO-d6, (5) ·· 2.08 (3H, s), 7.39-7 · 47 (3Η, m), 7.65 (1Η, d, J: 8.5Hz), 7.84 (2H5 dd, J: 1.4 and 7.7Hz), 8.11 (1Η, dd, J = 1.9 and 8.4 · ζ) , 8.38 (iH, d, JL), ι · 34 (1 Η, s). &Lt; Production Example 29; Production of N-benzylsulfonyl-4-ethylfluorenamino-3-aminobenzofluorenamine &gt; Dissolve N-benzenesulfonylacetamidinyl 3-nitrobenzofluorenamine (12.67g) in methanol (200ml) and water 30 (ml), and add potassium bicarbonate ( 7.59g). The catalyst was hydrogenated under a hydrogen ambient gas at 40% for 5 hours using a 5% palladium / carbon (2.53g) catalyst. The solid was filtered off and the filtrate was concentrated to give a residue 'by silica gel column chromatography. (Eluent: ethyl acetate / methanol = 4/1) was purified to obtain N-benzylsulfonyl-4-ethylamido-3-aminobenzobenzoamide (6.72g). [Compound of Physical properties] W-NMMDMSO-d6, (5): 2 · 06 (3Η, s) 3 7 · 07 (1Η, dd, J 2 1.8 and 8 · 3Ηζ) 3 7.17 (1H, d3 J = 1.8Hz) 3 7.44 (1H5 d, J = 8.3Hz), 7.61 (2H3 t), 7.68 (1H, t) 3 7.96 (2H, d, J = 7.5Hz), 9.19 (1Η, s) IR (Nujol): 1682cm丨. Manufacture Example 30; Production of N-benzylsulfonyl_4_acetamido_3_ (2-nitrobenzylamino) benzopyramine &gt; According to the method of Production Example 32, N was used -Benzenesulfonyl-4-ethylamido-3-aminobenzylideneamine (0.6 mg and 2-nitrobenzyl bromide (0522 g) to give ------ 1. 7 _____ This paper size applies Chinese National Standard (CNS) A4 size (2K) 'x297 mm) 548272 A7 ___________ B7 V. Description of the invention (104 N-benzylsulfonyl-4-acetamido-3- ( 2-nitrobenzylamino) benzofluorene (〇.79g) 〇 [Physical properties of the compound] (Please read the precautions on the back before filling this page) A-NMlUDMSO-de , ά): 2.08 (3Η, s), 4.72 (2H, d, J = 5.0Hz), 5.92 (1Η, s), 6.86 (1H, s), 7.13 (1H, d, J: 8.1Hz), 7.31 (1Η, d5 J: 8.0Hz), 7.49-7 , 58 (3H, mh 7.60 (2H3 d3 J = 7.6Hz) 3 7.66 (1H3 t5 J = 7.4Hz) 3 7.86 (2H3 d, J = 7.7Hz), 8.11 (1H, d, J = 8.3Hz), 9 · 37 (1Η, s). &lt; Production Example 31; Production of N-benzenesulfonyl-4-ethylamido-3-benzylaminobenzylamine &gt; According to the method of Production Example 32, N-benzenesulfonyl · 4 was used _Ethylamino-3-aminobenzobenzylamine and benzyl bromide (0.47 g) to give N-benzyl-4-benzylamino-3-benzylaminobenzylamine (0.38g). [Physical properties of compound] INMR (DMSO-d6, d): 2.07 (3H, s), 4.35 (2H, d, J = 5.5Hz), 5.73 (1Η, s), 7.06 (1Η , S), 7 · 14 (1Η, d, J 2 8.3Ηζ), 7 · 21-7 · 28 (2Η, m), 7 · 32 (2Η, t, J 2 7.3 Hz), 7 · 37 (2Η, d, J 2 7.6Ηζ), 7.53 (2Η, t, J = 7.4Hz), 7.59 (1Η, t, J: 7.0 Hz), 7 • 88 (2H, d , J: 7.7 Hz), 9 · 29 (1Η, s), 12 · 34 (1Η, s). &lt; Production Example 32; Production of N-benzenesulfonamido-4-ethylamidoamino-3- (2,4-difluorobenzylamino) benzopyramine &gt; At 60 ° C, N-benzenesulfonyl-4-ethylamido-3-aminobenzamine (0.60g), 2,4-difluorobenzyl bromide (0.656g), and potassium bicarbonate (0.423g) The methanol (7 ml) solution was stirred for 1 hour. The reaction solution was concentrated, and purified by silica gel column chromatography (eluent: ethyl acetate / methanol = 9/1) to give N-phenylphenethyl-4-ethylammonyl-3- (2, 4-Difluorobenzylamino) benzene -------108___ This paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 ________________________ B7_ V. Description of the invention (105) Amine (0.370 g). [Physical properties of compounds] (Read the precautions on the back before filling in this page} lH-NMR (DMS0-d63 δ): 2.05 (3H, s), 4.34 (2H, d, J = 5.5Hz), 5.60 (1H , s), 7. 〇2 (lH, t3 J-8.0Hz), 7.06 (1H, s), 7.16-7.27 (3H, m), 7.38-7.51 (411, m), 7.8 2 (ZH, d, J-7.2Hz), 9,27 (1H, s) 3 1Z.35 (1H, s) 0 &lt; Production Example 33; N-benzenesulfonyl-4-ethylamido-3- (4-nitrate) Benzylamino) Benzofluorenamine Production> According to the method of Production Example 32, N-benzenesulfonamido-4_acetamido-3-aminobenzophenamine (0.50 g) and 4 were used. -Nitrobenzyl bromide (0.436 g) to give N-benzenesulfonyl-4-ethylamido-3- (4-nitrobenzylamino) benzofluorenamine (0.52 g). [ Physical properties of compound] ^ -NMRiDMSO-dG, δ): 2.09 (3H, s), 4.54 (2H, d, J = 5.0Hz), 6.10 (1H, s), 6. 89 (1H, d, J = 1.8 Hz), 7 · 14 (1Η, dd, J = 1.8 and 8.2Hz), 7.39UH, d ...) = 8 · 2Ηζ), 7.58-7.65 (4Η, m), 7.68 (1Η, t, J = 7.6Hz), 7.92 (2Η, dd, J = 1.4 and 7.4Hz) 3 8.20 (2H, d, J = 8.7Hz), 9.36 (1H, s), 12.28 (1H, s). <Manufacturing Example 34; Production of N-benzenesulfonamido-4-ethylamidoamino-3- [4- (l, 2,3-thiadiazol-4-yl) benzylamido]] benzopyrene &gt; According to the method of Production Example 32, N-benzenesulfonyl-4-ethylaminoamino-3-aminobenzofluorenamine (0.50 g), 4- (4-bromomethylphenyl)- 1,2,3-thiadiazole (0.45 g) to give N-benzenesulfonyl-4-ethylamidino-3- [4- (l, 2,3-thiadiazol-4-yl ) Benzylfluorenamine] Benzofluorenamine (0.38 g). [Physical properties of compounds] iH-NMR (DMS (Hi6, (5): 2.HK3H, s), 4.46 (2H, d, J: 5.3Hz) · 5.96 (1Η, s), 7. ______IM_____ Paper Zhang scale is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 ___________________ B7 V. Description of the invention (1 06) ~~ 03 (1H, s), 7.14 (1H, dd, J = 1.7 and 8 · 2Ηζ), 7.40 (1Η, d, J = 8 · 0Ηζ), 7.52-7. 61 (411, in), 7.65 (1H, t, J-7.1Hz), 7.93 (2H, d5 J-7.6Hz ), 8.10 (2H, d, J = 8.2 Hz), 9.35 (1H, s), 9.58 (1Η, s), 12.31UH, s) 〇 (诮 Please read the notes on the back before filling this page) & lt Production Example 35; Production of 3-amino-2-nitrobenzoic acid ethyl g &gt; Stir 3-acetamido-2-nitrobenzoic acid (20.2 g), 97% sulfuric acid ( 11.4 g) and a mixture of ethanol (300 ml) for 23 hours. After distilling 100 ml of ethanol and cooling to room temperature, the reaction solution was poured into ice water (200 ml) containing sodium bicarbonate (19.5 g). The precipitated crystals were filtered off and washed with water. Next, the crystals were dispersed in a mixed solution (30 ml) of ethyl acetate and hexane 1.2, and the crystals were filtered, washed with hexane, and dried. Thereby, 3-amino-2-stone-shokylic benzoate (18.0 g) was obtained. [Physical properties of compound] 'H-NMRiCDCh, δ): 1.39 (3H, t, J-7.1Hz), 4.37 (2H, q, J = 7.1Hz), 6.41 (2H? Br s), 6.83 (1H, d , J = 8.7Hz), 8.00UH, dd, J = 1.8 and 8.7Ηζ), 8.85 (1H, d, J = 1.8Hz). &lt; Manufacturing Example 3 6; Production of 3-ethylethylamino-2-stone-shoky benzoic acid ethyl ester &gt; Under an ice bath, ethyl It-chloride (13 ml) was dripped into 3-amino-2_stone-shoky benzoin In a solution of ethyl acetate (2.98 g) and N, N-dimethylaniline (20 ml), the mixture was stirred at room temperature for 48 hours. 10% hydrochloric acid was used to make the reaction solution acidic, extraction was performed twice with ethyl acetate, and the organic layer was washed three times with water. Hexane was added to the residue obtained by distilling off the solvent under reduced pressure to crystallize it. By filtration, washing with hexane, and drying to obtain 3-acetamidonitro nitroamphenicol paper, the size of the paper is suitable for China National Standard (CNS) A4 (21QX2 = thin) 548272 A7 B7 V. Invention Explanation (10) 7 Ethyl benzoate (3.30g). [Physical properties of compounds], (¾Read the precautions on the back before filling this page) W-NMIUCDCI3, (5): 1.42 (3Η, t), 2.33 (3Η, s), U2 (2H, q ), 8.27 (1Η3 dd3 J 2 1.9 and 8.9Hz), 8.89 (1Η, d, J: 1.9Hz), 8.91 (1Η, d, J = 8.9Hz), ι54 · 1 (1Η , Br s) 〇 &lt; Production Example 37; Production of 4-Ethylamido-3_aminobenzoic acid ethyl ester &gt; 3-Ethylamino-2-nitrobenzoic acid was produced under a hydrogen atmosphere. A mixture of ethyl acetate (149.4 g), 5% palladium / carbon (14.9§), and ethanol (1500 ml) was stirred for 15 hours. The solid was filtered off, the residue obtained by concentrating the filtrate was dissolved in a small amount of ethanol, and diisopropyl ether was added. The precipitated crystals were filtered and dried to obtain 'ethyl ethylamino-3 -aminobenzoate (114.4 g). [Physical properties of compound] fNMRiDMSO-dG, (5): 1.27 (3Η5 t), 2.G5 (3H3 s), 4.23 (2H, q), 5.19 (2Η, s), 7.13UH, d, J = 8.2Hz), 7,35 (1Η, s) 5 7 · 47 (1Η, d, J = 8.2Hz), 9.19 (ίΗ, s) &lt; Example 24; 1- (2-chloro Synthesis of benzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (92) &gt; Ethanol (20 ml), acetic acid and reduced iron (3.07 g) were added to 3- [N- (2-Azobenzyl) acetamido] -4-nitrobenzoate (2.07 g) and refluxed for 4 hours. The solid was filtered off and washed with ethanol. After the filtrate was evaporated, the sodium bicarbonate aqueous solution was added to the residue and extracted with ethyl acetate. After drying, distilled under reduced pressure to remove the solvent, and the essence of Shi Xijiao color method (dissolving solution: hexane / ethyl acetate g purpose: = 100/0 ~ 70/30) ------ nj___ The size of this paper is / 1] Chinese National Standard (CNS) A4 specification (210X297 Gongchu) 548272 A7 B7_ V. Description of the invention (108) to obtain 1- (2-Azobenzyl) -6_B Oxocarbonyl_2-fluorenylbenzimidazole (92) (1.46g). (Xu first read the precautions on the back before filling in this page) [Physical properties of compound (92)] 1H-NMR (CDCl3, δ): 1.39 (3H t 7 ih ?, 9 0 w, J-7 · 1Ηζ), 2.57 (3H, s), 4.37 (2Η, q, J27.1

Hz), 5.46(2H3 s)3 6.4K1H, d, J,7.8Hz)3 7.10(1H5 t, J=7.8Hz), 7.25(111, t)5 7.47(1H5 d3 J,8.0Hz)3 7.75(1H3 d5 J=8.4Hz)3 7.94(1H, s)3 8.00(1H3 d d, J二1·5 及 8·4Ηζ)。 &lt;實施例25;6-乙氧羰基-1-曱基-2-正丙基苯並咪唑 (93) 之合成&gt; 依據製造例14之方法,使用3_丁醯胺基-4-安息香 酸乙酯(l.OOg)與甲基碘(0 843g)以得出3-(Ν-曱基丁醯胺 基)-4-硝基安息香酸乙酯之粗精製物(1〇〇g)。接著使用 實施例24之方法以得出6_乙氧羰基-;1-甲基正丙基苯 並咪唑(93)(0.56g)。 [化合物(93)的物性] H-NMR(CDCl3, δ) : 1.08(3H, t, J=7.4Hz), 1.43(3H, t, J=7.〇Hz), 1.89-L9 7(2H,m),2·89(2Η,t,J:7.7Hz),3·79(3Η,s),4.38-4.44(2H,E),7_71UH, d, J:8.4Hz), 7.96(1H, dd5 J:8.4 及 1·5Ηζ, ), 8·05(1Η, d, J:1.4Hz)。 &lt;實施例26;1-正丁基-6-乙氧羰基_2_正丙基苯並咪 唑(94)之合成&gt; 在至溫下,將3-丁醯胺基-4-硝基安息香酸乙酯(186g) 之N,N-二曱基甲醯胺(1〇mi)溶液滴入6〇%氫氧化納 (0.428g)與N,N-二曱基甲醯胺(1〇ml)所構成之漿液中在 室溫下攪拌3〇分。接著滴入正丁基碘(i.97g)之n,N-二甲 ____ 本紙張尺度適/7^5^準(CNS) A4規格(210x2m羞) ------ 548272 ^沪'^|中决^^-而’,只二消贽合竹^印製 113 A7 B7 五、發明説明(1()9 ) ~~ 基甲酿胺(10ml),在50它下加熱13小時。將反應液注入 稀鹽酸(70g)與醋酸乙酯(7〇g)之混合液中以進行萃取。水 洗(2次)、乾燥、減壓濃縮所得之有機層以得出3_(N_正 丁基丁 胺基)-4_硝基安息香酸乙酯之粗精製物 (2.59g)。接著,使用實施例24的方法以得出1·正丁基_ 6_乙氧羰基-2-正丙基苯並咪唑(94)(〇.81g)。 [化合物(94)的物性]Hz), 5.46 (2H3 s) 3 6.4K1H, d, J, 7.8Hz) 3 7.10 (1H5 t, J = 7.8Hz), 7.25 (111, t) 5 7.47 (1H5 d3 J, 8.0Hz) 3 7.75 ( 1H3 d5 J = 8.4Hz) 3 7.94 (1H, s) 3 8.00 (1H3 dd, J 2 1.5 and 8 · 4Ηζ). &lt; Example 25; Synthesis of 6-ethoxycarbonyl-1-fluorenyl-2-n-propylbenzimidazole (93) &gt; According to the method of Production Example 14, 3-butanylamino-4-benzoin was used Ethyl acetate (1000 g) and methyl iodide (0 843 g) to give 3- (N-fluorenbutylamido) -4-nitrobenzoate as a crude product (100 g) . The method of Example 24 was then used to obtain 6-ethoxycarbonyl-; 1-methyl-n-propylbenzimidazole (93) (0.56 g). [Physical properties of compound (93)] H-NMR (CDCl3, δ): 1.08 (3H, t, J = 7.4Hz), 1.43 (3H, t, J = 7.0 Hz), 1.89-L9 7 (2H, m), 2.89 (2Η, t, J: 7.7Hz), 3.79 (3Η, s), 4.38-4.44 (2H, E), 7_71UH, d, J: 8.4Hz), 7.96 (1H, dd5 J: 8.4 and 1.5 Η ζ,), 8.05 (1 Η, d, J: 1.4 Hz). &lt; Example 26; Synthesis of 1-n-butyl-6-ethoxycarbonyl-2-n-propylbenzimidazole (94) &gt; At room temperature, 3-butylamido-4-nitro A solution of ethyl benzoate (186 g) in N, N-dimethylformamide (10 mi) was dropped into 60% sodium hydroxide (0.428 g) and N, N-dimethylformamide (1 g). The slurry consisting of ml) was stirred at room temperature for 30 minutes. Then drip n, N-dimethyl iodide of n-butyl iodine (i.97g) ____ This paper is suitable for 7/5 ^ standard (CNS) A4 size (210x2m shame) ------ 548272 ^ 沪 ' ^ | Zhong Jue ^^-and ', only diazepam ^ ^ printed 113 A7 B7 V. Description of the invention (1 () 9) ~ ~ Methylamine (10ml), heated at 50 for 13 hours. The reaction solution was poured into a mixed solution of dilute hydrochloric acid (70 g) and ethyl acetate (70 g) for extraction. The organic layer obtained was washed with water (twice), dried, and concentrated under reduced pressure to obtain a crude product of ethyl 3- (N-n-butylbutylamino) -4-nitrobenzoate (2.59 g). Next, the method of Example 24 was used to obtain 1.n-butyl-6-ethoxycarbonyl-2-n-propylbenzimidazole (94) (0.81 g). [Physical Properties of Compound (94)]

(CDCl33 δ) : 〇.98(3H5 t3 J=7.4Hz)5 1.08(3H, t3 J-7.4Hz); 1.43(3H &gt; t, J=7.1Hz), 1.75-1.83(2H, m), 1.91-1.98(2H5 m)5 2.88(2H) t, J=7.6Hz), 4.15(2Η, t, J=7.5Hz), 4.42(2H, q5 J,7.2Hz), 7.73(lHj d, J,8.4Hz)5 7.96( 1H, dd, J=8.5 R i.5Hz)j 8&lt;06(1Hj dj J=L4Hz)〇 &lt;實施例27; 1 -(3-氯代苄基)_6_乙氧羰基_2_正丙基 苯並咪唑(95)之合成&gt; 依據製造例14之方法,使用3_ 丁醯胺基冬確基安 息香酸乙醋(1.86g)與3_氯代¥基漠(1.64g)以得出3-[n_3_ 氯代苄基)丁醯胺基]-4-硝基安息香酸乙酿之粗精製物。 不用進行再精製而依照實施例24之方法即可得出卜(3_ 氣代苄基)-6-乙氧羰基·2_正丙基苯並咪唑(95)(〇 57§)。 [化合物(9^)的物性] 'H-NMR(CDCl3, c5) : 1.02(3H, t, J,7.4Hz), 1.39(3H, t, J=7.lHz), 1.85-1.9 2(2H,m),2·80(2Η,t,J二7.5Hz),4.38(2H,q,J:7.mz),5·37(2Η,s),6.86( 1H5 d3 J^4Hz)3 7.04(1H, s), 7.21-7.29(2H, m)3 7.77( 1H, d, J=8.4Hz)3 7. 96(1H, d, J=1.2Hz), 7·99(1Η, dd, J:8.5 及 1.5HZ)。 &lt;實施例28;q基·6·乙氧幾基正丙基苯並咪峻 Μ氏張尺度適/fl中國國家標準(CNS ) A4規格(210X297公釐) (翱先閱讀背面之注意事項再填寫本頁)(CDCl33 δ): 0.98 (3H5 t3 J = 7.4Hz) 5 1.08 (3H, t3 J-7.4Hz); 1.43 (3H &gt; t, J = 7.1Hz), 1.75-1.83 (2H, m), 1.91-1.98 (2H5 m) 5 2.88 (2H) t, J = 7.6Hz), 4.15 (2Η, t, J = 7.5Hz), 4.42 (2H, q5 J, 7.2Hz), 7.73 (lHj d, J, 8.4Hz) 5 7.96 (1H, dd, J = 8.5 R i.5Hz) j 8 &lt; 06 (1Hj dj J = L4Hz) 〇 &lt; Example 27; 1-(3-chlorobenzyl) _6_ethoxy Synthesis of carbonyl_2-n-propylbenzimidazole (95) &gt; According to the method of Production Example 14, 3-butyramidinyldongkuyl benzoic acid ethyl acetate (1.86g) and 3-chlorochlorobenzyl ( 1.64g) to obtain a crude product of 3- [n_3_chlorobenzyl) butyramidinyl] -4-nitrobenzoate. Without re-refining, the method of Example 24 can be used to obtain (3_ oxobenzyl) -6-ethoxycarbonyl · 2-n-propylbenzimidazole (95) (〇 57§). [Physical properties of compound (9 ^)] 'H-NMR (CDCl3, c5): 1.02 (3H, t, J, 7.4Hz), 1.39 (3H, t, J = 7.1 Hz), 1.85-1.9 2 (2H M), 2.80 (2Η, t, J 7.5Hz), 4.38 (2H, q, J: 7.mz), 5.37 (2Η, s), 6.86 (1H5 d3 J ^ 4Hz) 3 7.04 (1H, s), 7.21-7.29 (2H, m) 3 7.77 (1H, d, J = 8.4Hz) 3 7.96 (1H, d, J = 1.2Hz), 7.99 (1Η, dd, J : 8.5 and 1.5HZ). &lt; Example 28; q-based · 6 · ethoxypropyl-n-propylbenzimidazole M-scale scale / fl China National Standard (CNS) A4 specification (210X297 mm) (Read the precautions on the back first (Fill in this page again)

548272 經浐部中决i?^r^m.T消贽合作扣印來 A7 B7 五、發明説明(110) (96)之合成&gt; 依據製造例14之方法,使用3-丁醯胺基—4-硝基安 息香酸乙酯(l.86g)與苄基溴(1.36g)以得出3-[N-节基丁 醯胺基]-4-硝基安息香酸乙酯。不用進行再精製而依照 實施例24之方法即可得出丨_苄基-6_乙氧羰基正丙基 苯並咪吐(96)(0.97g)。 [化合物(96)的物性] JH-NMR(CDCl35 5) : 1.0K3H, t3 J,7.4Hz)3 1.39(3H5 t3 L83,L9 K2H5 m)5 2.8K2H, t5 J=7.5Hz)3 4.37(2H5 q5 5.40(2H, s) 5 7.03( 1H,d,J=6.4Hz),7·28-7.33(3Η,ffl),7·76(1Η,d,j:8•他),7·98⑽,^ 8.4 及 1·2Ηζ)3 8·00(1Η, s)。 ,’- &lt;實施例29; 1 -(4-氯代苄基)_6_乙氧羰基_2_正丙基 苯並咪唑(97)之合成&gt; 依據製造例14之方法,使用3_丁醯胺基-4_硝基安 息香酸乙酯(1.86g)與4-氯代苄基溴(1.64g)以得出3_[ν· (4-氣代苄基)丁醯胺基]_4_硝基安息香酸乙酯。不用進行 再精製而依據實施例24之方法即可得出丨_(4_氯代苄 基)-6-乙氧幾基-2-正丙基苯並味σ坐(97)(1 ·〇6β)。 [化合物(97)的物性] INMMCDCh,6) : 1·02(3Η,t,J:7.4Hz),1.39(3H,t,J=7.1Hz),1·83-1 9 2(2H, m), 2·80(2Η, t, J:7.8Hz), 4·38(2Η, q, J二7.5Hz), 5·36(2Η, s), 6.96( 2H, d, J:8.2Hz), 7.29(2H, d, J:8.3Hz), 7·76(1Η, d, J:8.4Hz), 7.96(1H, d J=1.2Hz), 7·99(1Η, dd, J二8.3 及 1.2Hz)。 &lt;實施例30;6-乙氧羰基-2-甲基三氟代曱基) ---------#! (諳先閱讀背面之注意事項再填寫本頁j 、一'll Φ— 548272 A7 B7 五、發明説明(111) 苄基]苯並咪唑(98)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 依據實施例24之方法,使用4-硝基-3-[N-[2-(三氟 代甲基)苄基]乙醯胺基]安息香酸乙酯(1.82g)以得出6-乙氧羰基-2-甲基-1-[2-(三氟代甲基)苄基]苯並咪唑 (98) (1.32g)。 [化合物(98)的物性] iH-NMR(CDCh,6) : 1·38(3Η,t,J二7·1Ηζ),2·53(3Η,s),4_37(2H,q,J二7.1 Hz), 5.58(2H, s), 6·47(1Η, d, J=7.7Hz), 7·36(1Η3 t, J=7.5Hz), 7.41(1H, t, J二7·5Ηζ), 7.75-7.97(2H, m), 7·94(1Η, d, J二1·0Ηζ), 8.02(1H, dd, J二1.6 及 8.6Hz)。 &lt;實施例31;6-乙氧羰基-2·曱基-l-[4-(三氟代甲基) 苄基]苯並咪唑(99)之合成&gt; 依據實施例24之方法,使用4-硝基-3-[N-[4-(三敗 代甲基)苄基]乙醯胺基]安息香酸乙酯(1.52g)以得出6-乙氧戴基-2-甲基-1-[4-(三氟代甲基)节基]苯並η米σ坐 (99) (1.22g)。 [化合物(99)的物性] ^-NMRiCDCh, δ) : L39(3H, t, J-7.1Hz), 2.58(3H, s), 4.38(2H, q, J=7.1 Hz), 5.44(ZH^ s), 7.15(ZH, d, J=8.2Hz), 7.59(2H, d, J=8.ZHz), 7.75(1H, d ,J=8.3Hz), 7·97(1Η, s), 8.00(1H, dd, J二1·5 及 8.5Hz)。 &lt;實施例32;l-(3,4-二氣代苄基)-6-乙氧羰基-2-甲基 苯並咪唑(100)之合成&gt; 依據製造例14之方法,使用3-乙醯胺基-4-硝基安 息香酸乙酯(1.50g)與3,4-二氯代苄基(1.74g)以得出3-[N- 115 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(112) (3,4-二氣代节基)乙醯胺基]-4-硝基安息香酸乙g旨。不用 再精製而依據實施例24的方法以得出ι_(3,4-二氯代节 基)-6-乙氧幾基-2 -甲基苯並味唾(100)^0.76g)。 [化合物(100)的物性] ’H-NKR(CDCh,ά) : 1·40(3Η,t3 J二7·1Ηζ),2·58(3Η,s),4·39(2Η,q, J=7.2 心),5·33(2Η,s),6.84(1Η,dd,J二8.4 及 2·3Hz)5 7· 16(2H,d, J二2·0Hz), 7.39(1H, d, J=8.3Hz), 7.74(1H, d, J=8.4Hz), 7.96(1H, d, J=1.2Hz), 8.00(1 H, dd, J=8.4 及 1.5Hz)。 〈實施例33; 1 -(聯笨-4-甲基)-6-乙氧幾基-2-甲基苯 並咪唑(101)之合成&gt; 依據製造例14之方法,使用3-乙衋胺基-4-硝基安 息香酸乙酯(1.51g)及4-氯代甲基聯苯(l.46g)以得出3-[N-(聯苯-4-曱基)乙醯胺基]-4-石肖基安息香酸乙g旨之粗精 製物(1.44g)。接著依據實施例24之方法以得出1-(聯笨 -4-甲基)-6-乙氧魏基-2 -曱基苯並口米吐(101)(1.13 g)。 [化合物(101)的物性] ^-NMRiCDCh, δ) : 1.39(3Η5 t3 J=7,1Hz)3 2.62(3H, s)3 4.38(2H, q3 J=7.1 Hz) 5 5.42(2H, s), 7.1K2H, d, J=8.2Hz)5 7.34( 1H, m), 7.42(2H, m), 7.54(4 經Μ部中决ii^f-^m 5消贽合竹淞卬少 H,m),7·74(1Η, d,J二8.4Hz), 7.99UH, dd,J二 1·5 及 8·4Ηζ),8·06(1Η,d, J=1.5Hz)〇 &lt;實施例34;6-乙氧羰基-2-甲基-1-(2-甲基基)笨並 咪唑(102)之合成&gt; 依據製造例14之方法,使用3-乙醯胺基-4-硝基安 息香酸乙酯(1.5〇g)及2-甲基苄基溴(1.65g)以得出3-[N-(2- 本紙張尺度追州中國國家標率(CNS ) A4規格(210X 297公釐) 548272 A7 __________________________ B7 五、發明説明(113) ' 一 甲基节基)乙醯胺基]-4-硝基安息香酸乙酿。不用進行精 製而依據實施例24之方法即可得出6_乙氧羰基_2-甲‘ -1-(2_甲基基)苯並咪唾(l〇2)(〇81g)。 (誚先閱讀背面之注意事項再填寫本頁) [化合物(102)的物性] lH-NKR(CDCl35 6 ) : 1.38(3H, t, J=7,2Hz)3 2.43(3H, s)3 2.54(3H3 s)3 4 36 (2H, q, J:7.2Hz), 5.33(2H, s), 6·35(1Η, d, J:7.7Hz)5 7·03(1Η, j:8,2Hz ),7.18-7.25(2H, m), 7.75(1H, d, J=8.5Hz), 7.91(1H, d, J=1.2Hz), 7.98(ih ,dd, 及 1.5Hz)。 &lt;貫施例35;6-乙氧羰基(孓曱氧苄基)_2_甲基笨 並咪唑(103)之合成&gt; 依據製造例14之方法,使用3_乙醯胺基硝基安 息香酸乙S旨(1.16g)與2-曱氧节基氯(1.44g)以得出3:[n_ (2-甲氧苄基)乙醯胺基]-4_硝基安息香酸乙酯之粗精製 物。接著依據實施例24的方法以得出6•乙氧羰基 曱氧节基)_2_甲基苯並咪唾(103)(1.18g)。 [化合物(103)的物性]548272 A7 B7 was eliminated by cooperation of the Ministry of Justice i? ^ R ^ mT. 5. Synthesis of the description of the invention (110) (96) &gt; According to the method of Manufacturing Example 14, 3-butanylamino-4 was used. -Ethyl nitrobenzoate (1.86 g) and benzyl bromide (1.36 g) to give 3- [N-benzylbutyramido] -4-nitrobenzoate ethyl. Without further refining, the method of Example 24 was used to obtain Benzyl-6-ethoxycarbonyl-n-propylbenzimidone (96) (0.97 g). [Physical properties of compound (96)] JH-NMR (CDCl35 5): 1.0K3H, t3 J, 7.4Hz) 3 1.39 (3H5 t3 L83, L9 K2H5 m) 5 2.8K2H, t5 J = 7.5Hz) 3 4.37 (2H5 q5 5.40 (2H, s) 5 7.03 (1H, d, J = 6.4Hz), 7.28-7.33 (3Η, ffl), 7.76 (1Η, d, j: 8 • he), 7.98⑽, ^ 8.4 and 1 · 2Ηζ) 3 8 · 00 (1Η, s). '-&Lt; Example 29; Synthesis of 1- (4-chlorobenzyl) _6_ethoxycarbonyl_2_n-propylbenzimidazole (97) &gt; According to the method of Production Example 14, 3_ Butylamino-4_nitrobenzoate ethyl ester (1.86g) and 4-chlorobenzyl bromide (1.64g) to give 3_ [ν · (4-Azobenzyl) butylamidoamine] _4 _ Ethyl nitrobenzoate. Without further refining, according to the method of Example 24, __ (4-chlorobenzyl) -6-ethoxyquinyl-2-n-propylbenzo sigma (97) (1 · 〇 6β). [Physical properties of compound (97)] INMMCDCh, 6): 1.02 (3Η, t, J: 7.4Hz), 1.39 (3H, t, J = 7.1Hz), 1.83-1 9 2 (2H, m ), 2.80 (2Η, t, J: 7.8Hz), 4.38 (2Η, q, J = 7.5Hz), 5.36 (2Η, s), 6.96 (2H, d, J: 8.2Hz) , 7.29 (2H, d, J: 8.3Hz), 7.76 (1H, d, J: 8.4Hz), 7.96 (1H, d J = 1.2Hz), 7.99 (1H, d, J: 8.3Hz) 1.2Hz). &lt; Example 30; 6-ethoxycarbonyl-2-methyltrifluorofluorenyl) --------- #! (谙 Please read the notes on the back before filling in this page j, a'll Φ— 548272 A7 B7 V. Description of the invention (111) Synthesis of benzyl] benzimidazole (98) &gt; (Read the precautions on the back before filling this page) According to the method of Example 24, use 4-nitro -3- [N- [2- (trifluoromethyl) benzyl] acetamido] ethyl benzoate (1.82g) to give 6-ethoxycarbonyl-2-methyl-1- [2 -(Trifluoromethyl) benzyl] benzimidazole (98) (1.32 g). [Physical properties of compound (98)] iH-NMR (CDCh, 6): 1.38 (3Η, t, J 2 7 · 1Ηζ), 2.53 (3Η, s), 4_37 (2H, q, J 7.1 Hz), 5.58 (2H, s), 6.47 (1Η, d, J = 7.7Hz), 7.36 ( 1Η3 t, J = 7.5Hz), 7.41 (1H, t, J 2 7.5Ηζ), 7.75-7.97 (2H, m), 7.94 (1Η, d, J 2 1.0Ηζ), 8.02 (1H, (dd, J. 1.6 and 8.6 Hz). &lt; Example 31; Synthesis of 6-ethoxycarbonyl-2 · fluorenyl-l- [4- (trifluoromethyl) benzyl] benzimidazole (99) &gt; According to the method of Example 24, 4-nitro-3- [N- [4- (tridecylmethyl) benzyl] acetamido] an Ethyl benzoate (1.52g) to give 6-ethoxydiyl-2-methyl-1- [4- (trifluoromethyl) benzyl] benzo η σ σ (99) (1.22g [Physical properties of compound (99)] ^ -NMRiCDCh, δ): L39 (3H, t, J-7.1Hz), 2.58 (3H, s), 4.38 (2H, q, J = 7.1 Hz), 5.44 ( ZH ^ s), 7.15 (ZH, d, J = 8.2Hz), 7.59 (2H, d, J = 8.ZHz), 7.75 (1H, d, J = 8.3Hz), 7.97 (1Η, s) , 8.00 (1H, dd, J 2 1.5 and 8.5Hz). &lt; Example 32; Synthesis of l- (3,4-digaso-benzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (100) &gt; According to the method of Production Example 14, 3- Acetylamino-4-nitrobenzoic acid ethyl ester (1.50g) and 3,4-dichlorobenzyl (1.74g) to obtain 3- [N- 115 This paper is applicable to Chinese National Standards (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (112) (3,4-di-gasoyl) acetamido] -4-nitrobenzoic acid ethyl g. Without further purification, the method of Example 24 was used to obtain i_ (3,4-dichlorobenzyl) -6-ethoxyepi-2-methylbenzobenzoal (100) (0.76 g). [Physical properties of compound (100)] 'H-NKR (CDCh, ά): 1.40 (3Η, t3 J 2 7.1Ηζ), 2.58 (3Η, s), 4.39 (2Η, q, J = 7.2 heart), 5.33 (2Η, s), 6.84 (1Η, dd, J 2 8.4, and 2.3 Hz) 5 7 · 16 (2H, d, J 2 2.0 Hz), 7.39 (1H, d, J = 8.3Hz), 7.74 (1H, d, J = 8.4Hz), 7.96 (1H, d, J = 1.2Hz), 8.00 (1 H, dd, J = 8.4 and 1.5Hz). <Example 33; Synthesis of 1- (bibenz-4-methyl) -6-ethoxyquinyl-2-methylbenzimidazole (101)> According to the method of Production Example 14, 3-acetamidine was used Ethyl-4-nitrobenzoate (1.51g) and 4-chloromethylbiphenyl (1.46g) to give 3- [N- (biphenyl-4-fluorenyl) acetamido ] -4-Shishiki Benzoic acid ethyl g crude refined product (1.44g). Then, the method of Example 24 was used to obtain 1- (biben-4-methyl) -6-ethoxyweilyl-2 -fluorenylbenzometer (101) (1.13 g). [Physical properties of compound (101)] ^ -NMRiCDCh, δ): 1.39 (3Η5 t3 J = 7,1Hz) 3 2.62 (3H, s) 3 4.38 (2H, q3 J = 7.1 Hz) 5 5.42 (2H, s) , 7.1K2H, d, J = 8.2Hz) 5 7.34 (1H, m), 7.42 (2H, m), 7.54 (4 In the Ministry of Commerce, ii ^ f- ^ m 5 eliminates the need for H, m), 7.74 (1Η, d, J = 8.4Hz), 7.99UH, dd, J 二 1.5, and 8.4Ηζ), 8.06 (1Η, d, J = 1.5Hz). &lt; Implementation Example 34; Synthesis of 6-ethoxycarbonyl-2-methyl-1- (2-methyl) benzimidazole (102) &gt; According to the method of Production Example 14, 3-acetamido-4- Ethyl nitrobenzoate (1.50g) and 2-methylbenzyl bromide (1.65g) to obtain 3- [N- (2- This paper scale follows the China National Standards (CNS) A4 specification (210X 297 mm) 548272 A7 __________________________ B7 V. Description of the invention (113) 'monomethylbenzyl) acetamido] -4-nitrobenzoic acid ethyl alcohol. According to the method of Example 24 without purification, 6-ethoxycarbonyl-2-methyl'-1- (2-methylyl) benzimidal (102) (0 81 g) was obtained. (诮 Please read the precautions on the back before filling this page) [Physical properties of compound (102)] lH-NKR (CDCl35 6): 1.38 (3H, t, J = 7,2Hz) 3 2.43 (3H, s) 3 2.54 (3H3 s) 3 4 36 (2H, q, J: 7.2Hz), 5.33 (2H, s), 6.35 (1Η, d, J: 7.7Hz) 5 7 · 03 (1Η, j: 8,2Hz ), 7.18-7.25 (2H, m), 7.75 (1H, d, J = 8.5Hz), 7.91 (1H, d, J = 1.2Hz), 7.98 (ih, dd, and 1.5Hz). &lt; Example 35; Synthesis of 6-ethoxycarbonyl (fluorenylbenzyl) -2-methylbenzimidazole (103) &gt; According to the method of Production Example 14, 3-acetamidonitrobenzoin was used Ethyl acetate (1.16g) and 2-fluorenylbenzyl chloride (1.44g) to give 3: [n_ (2-methoxybenzyl) acetamido] -4_nitrobenzoate Coarse refined product. Then, according to the method of Example 24, 6 • ethoxycarbonyl, fluorenyloxy) -2-methylbenzimidal (103) (1.18 g) was obtained. [Physical Properties of Compound (103)]

HiMEXCDCh,6) · 1.39(3H,t,J:7.2Hz),2·60(3Η,s),3·90(3Η,s) 4 37 (2Η, q, J=?.2Hz), 5·36(2Η, s), 6·61(1Η, d, J:7.4Hz), 6·82(1Η, t, J=7 5Hz )3 6.92(1H, d3 J-8-3Hz), 7.27(1H, m), 7.71(1H, d, J=8.4Hz), 7.96(1H dd J二 1.5 及 8·4Ηζ),8·03(1Η,d,J:1.3Hz)。 &lt;實施例36;6-乙氧幾基- i-(4_甲氧苄基)_2_甲基苯 並咪唑(104)之合成&gt; 依據製造例14之方法,使用3_乙醯胺基_4_硝基安 息香酸乙酯(1.60g)與4-甲氧苄基氣(1.49g)以得出3_[n_(4_ __ _ . …. 117 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) ----*---— 548272 A7 _______ B7 五、發明説明(114) 甲氧苄基)乙醯胺基]-4-硝基安息香酸乙酯之粗精製物。 (^先閲讀背面之注意事項再填寫本頁) 接著依據實施例24的方法以得出6-乙氧羰基-1-(4-甲氧 午基)-2-曱基苯並口米。坐(104)(1.27g)。 [化合物(104)的物性] W-NMiUCDChJ) : 1.40(3H,t,J二7·1Ηζ),2·59(3Η,s),3·77(3Η,s),4.38( 2Η,q,J=7.1Hz)3 5·31(2Η3 s),6·84(2Η,m)5 7·0〇(2Η,ιη)3 7·71(1Η,d,J:8. 4Hz), 7·97(1Η, dd, J二1·4 及 8·4Ηζ), 8·03(1Η, d, J二1.3Hz)。 &lt;實施例37;1-[2-(苯磺醯甲基)苄基]-6-乙氧羰基-2-曱基苯並咪唑(105)之合成&gt; 依據製造例I4之方法,使用3-乙醯胺基-4-硝基安 息香酸乙酯(l.OOg)與2-(苯磺醯甲基)节基溴(l.93g)以得 出3-[N-[2-(苯績醯甲基)苄基]乙驢胺基]_4_硝基安息香 酸乙酯。不用進行再精製而依據實施例24之方法即可 得出1&lt;2-(苯磺醯曱基)苄基]-6_乙氧羰基_2_甲基苯並咪 唑(105)(0.89g)。 [化合物(105)的物性] ^-NMRiCDCh, δ) : 1.37(3H, t, J-7.1Hz), 2.57(3H, s)5 4.36(2H3 q3 J-7.1HiMEXCDCh, 6) · 1.39 (3H, t, J: 7.2Hz), 2.60 (3Η, s), 3.90 (3Η, s) 4 37 (2Η, q, J = ?. 2Hz), 5 · 36 (2Η, s), 6.61 (1Η, d, J: 7.4Hz), 6.82 (1Η, t, J = 7 5Hz) 3 6.92 (1H, d3 J-8-3Hz), 7.27 (1H , m), 7.71 (1H, d, J = 8.4Hz), 7.96 (1H dd J2 1.5 and 8.4Ηζ), 8.03 (1Η, d, J: 1.3Hz). &lt; Example 36; Synthesis of 6-ethoxyquinyl-i- (4-methoxybenzyl) -2-methylbenzimidazole (104) &gt; According to the method of Production Example 14, 3-acetamidine was used _4_Nitrobenzoate (1.60g) and 4-methoxybenzyl gas (1.49g) to obtain 3_ [n_ (4_ __ _... 117. This paper is in accordance with the Chinese National Standard of CNS (CNS ) A4 specification (210X297 mm) ---- * ---- 548272 A7 _______ B7 V. Description of the invention (114) Methoxybenzyl) acetamido] -4-nitrobenzoic acid ethyl ester Thing. (^ Please read the notes on the back before filling this page) Then follow the method of Example 24 to get 6-ethoxycarbonyl-1- (4-methoxypentyl) -2-fluorenylbenzyl. Sit (104) (1.27g). [Physical properties of compound (104)] W-NMiUCDChJ): 1.40 (3H, t, J 27.1Ηζ), 2.59 (3Η, s), 3.77 (3Η, s), 4.38 (2Η, q, J = 7.1Hz) 3 5 · 31 (2Η3 s), 6.84 (2Η, m) 5 7 · 0〇 (2Η, ιη) 3 7 · 71 (1Η, d, J: 8.4 Hz), 7 · 97 (1Η, dd, J = 1.4 and 8.4Ηζ), 8.03 (1Η, d, J = 1.3Hz). &lt; Example 37; Synthesis of 1- [2- (benzenesulfonylmethyl) benzyl] -6-ethoxycarbonyl-2-fluorenylbenzimidazole (105) &gt; According to the method of Production Example I4, 3-Ethylamido-4-nitrobenzoic acid ethyl ester (1,000 g) and 2- (benzenesulfonylmethyl) benzyl bromide (1.93 g) to give 3- [N- [2- ( Phenylmethyl) benzyl] ethylammonium] -4-nitrobenzoate. According to the method of Example 24 without further refining, 1 &lt; 2- (benzenesulfonyl) benzyl] -6-ethoxycarbonyl-2-methylbenzimidazole (105) (0.89 g) . [Physical properties of compound (105)] ^ -NMRiCDCh, δ): 1.37 (3H, t, J-7.1Hz), 2.57 (3H, s) 5 4.36 (2H3 q3 J-7.1

Hz), 4·50(2Η, s), 5.60(2H, s), 6·38(1Η, d, J:6.7Hz), 6·88(1Η, dd, J二1.5 及 7.3Hz), 7·10-7·18(2Η, m)5 7·57(2Η, t, J=7.6Hz), 7·69-7·78(2Η3 m), 7 •79(1H, dd, J=0.8 及 8·1Ηζ), 7·92(1Η, d3 J:1.2Hz), 7·99(1Η, dd5 J:1.5 及 8.4Hz)。 &lt;實施例38;l-(2-氰基苄基)-6-(2_氰基苄氧基羰基)_ 2-甲基苯並咪唑(106)之合成&gt; 依據實施例24之方法,使用3-[N-(2-氰基苄基)乙醯 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(115) 胺基]-4-硝基安息香酸2-氧基苄基酯(3.33g)以得出1-(2- 氰基苄基)_6_(2_氰基苄氧基羰基)-2-甲基苯並咪唑 (106)(1.75g)。 (翱先閱讀背面之注意事項再填寫本頁) [化合物(106)的物性]Hz), 4.50 (2Η, s), 5.60 (2H, s), 6.38 (1Η, d, J: 6.7Hz), 6.88 (1Η, dd, J = 1.5 and 7.3Hz), 7 · 10-7 · 18 (2Η, m) 5 7 · 57 (2Η, t, J = 7.6Hz), 7.69-7 · 78 (2Η3 m), 7 • 79 (1H, dd, J = 0.8 and 8 · 1Ηζ), 7.92 (1Η, d3 J: 1.2Hz), 7.99 (1Η, dd5 J: 1.5 and 8.4Hz). &lt; Example 38; Synthesis of l- (2-cyanobenzyl) -6- (2-cyanobenzyloxycarbonyl) -2-methylbenzimidazole (106) &gt; A method according to Example 24 Using 3- [N- (2-cyanobenzyl) acetamidine This paper is sized to the Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the Invention (115) Amine] 2-oxybenzyl nitrobenzoate (3.33g) to give 1- (2-cyanobenzyl) -6_ (2_cyanobenzyloxycarbonyl) -2-methylbenzimidazole (106) (1.75g). (翱 Please read the precautions on the back before filling this page) [Physical properties of compound (106)]

H-腿(CDCh,d) : 2·60(3Η,s),5_55(2H,s),5.6QUH,s),6.68(1H,d,J =7.3Hz), 7.41-7.48(3H3 m)5 7.61(2H, m), 7.72(1H5 d3 J=7.6Hz), 7.76(1H, d ,J=7.6Hz)3 7·77(1Η, d3 J:8.6Hz)3 8·02(1Η, s)3 8.05(1H, dd, J:8.4 及 1. 5Hz)〇 &lt;實施例39;1-(聯苯-2_甲基)-6_乙氧羰基-2-甲基苯 並咪唑(107)之合成&gt; 依據製造例14之方法,使用3-乙醯胺基_4_硝基安 息香酸乙酯(l.OOg)與2-溴代甲基聯苯(1.47g)以得出3-[N_(聯苯-2-曱基)乙醯胺基]_4_硝基安息香酸乙酯。不用 進行再精製而依據實施例24之方法即可得出1 -(聯苯—2-甲基)-6-乙氧羰基-2-甲基苯並咪。坐(107)(1.3 lg)。 [化合物(107)的物性] 'H-NMRiCDCh, ά) : 1.41(3Η5 t, J-7.3Hz), 2.39(3H, s), 4.38(2H, q, J-7.3H-leg (CDCh, d): 2.60 (3Η, s), 5_55 (2H, s), 5.6QUH, s), 6.68 (1H, d, J = 7.3Hz), 7.41-7.48 (3H3 m) 5 7.61 (2H, m), 7.72 (1H5 d3 J = 7.6Hz), 7.76 (1H, d, J = 7.6Hz) 3 7.77 (1Η, d3 J: 8.6Hz) 3 8 · 02 (1Η, s ) 3 8.05 (1H, dd, J: 8.4 and 1.5 Hz) &lt; Example 39; 1- (biphenyl-2-methyl) -6-ethoxycarbonyl-2-methylbenzimidazole (107 ) Synthesis> According to the method of Production Example 14, ethyl 3-acetamido-4-nitrobenzoate (1,000 g) and 2-bromomethylbiphenyl (1.47 g) were used to obtain 3 -[N_ (biphenyl-2-fluorenyl) ethenylamino] _4-nitrobenzoate. Without further refining, 1- (biphenyl-2-methyl) -6-ethoxycarbonyl-2-methylbenzimidone was obtained according to the method of Example 24. Sit (107) (1.3 lg). [Physical properties of compound (107)] 'H-NMRiCDCh, ά): 1.41 (3Η5 t, J-7.3Hz), 2.39 (3H, s), 4.38 (2H, q, J-7.3

Hz),5·27(2Η,s),6·68(1Η,d,J二7·9Ηζ)5 7·21(1Η,dt,J二9·0 及 2.1Hz), 7·32-7·39(4Η, m), 7·43(1Η, dd5 J=7.3 及 1·9Ηζ), 7·46-7·51(2Η, m)3 7·68 (1Η, d, J二8·他),7·87(1Η, d3 J=1.3Hzh 7·95(1Η, dd, J=8.4 及 1·5Η &lt;實施例40;1-苄基-6-乙氧羰基-2-甲基苯並咪唑 (108)之合成&gt; 依據製造例14之方法,使用3-乙醯胺基-4-硝基安息 香酸乙醋(1.00g)與苄基溴(1 〇2g)以得出3_(N_苄基乙醯胺 本紙張尺度適/1]竹觸家標準((:奶)44規格(21()\;297公釐) 548272 A7 __ B7 五、發明説明(116) ' ' ~ &quot; 基M-石肖基安息香酸乙醋。不用進行再精製而依據實施 例24之方法即可得丨卜节基冬乙氧幾基_2•甲基苯並味 唑(108)(0.71g)。 (讀先閱讀背面之注意事項再填寫本頁) [化合物(108)的物性] 猶(CDCh,(5) : 1·39(3Η,t,J:7.1Hz),2·58(3Η,s),4·38(2Η,q,J二7.1 ,5·38(2Η, s)3 7·05(2Η, dd, J二8·3 及 ΐ·8Ηζ), 7.28-7.33(3H, m), 7.72 ,d,J=8.4Hz),7·98(1Η,dd,J:8.4 及 Hz), 8.02(1H,d,J:1.2Hz) &lt;實施例41;l-(4-第3 丁基苄基)_6_乙氧羰基_2_曱基 苯並味唾(109)之合成&gt; 依據製造例14之方法,使用3_乙醯胺基硝基安 息香酸乙酯(l.OOg)與4-第3 丁基苄基溴〇35g)以得出 3-[N-(4-第3 丁基苄基)乙醯胺基卜4_硝基安息香酸乙 酉曰不用進行再精製而依據實施例24之方法即可得出 1-(4-第3 丁基苄基)-6-乙氧羰基_2_甲基笨並咪唑(1〇9)之 粗精製物(1.60g)。 &lt;實施例42;6-乙氧羰基_2_甲基-1-(2_萘甲基)苯並 咪唑(110)之合成&gt; 依據製造例14之方法,使用3_乙醯胺基-4_硝基安 息香酸乙酯(l.OOg)與2-萘基甲基溴(h32g)以得出3-[N-(2萘甲基)乙醯胺基]-4-確基安息香酸乙酯。不用進行再 精製而依據實施例24之方法即可得出6_乙氧羰基-2一甲 基-1-(2_萘甲基)苯並咪唑〇28g)。 &lt;實施例43;1-(聯苯-4-甲基)_6_乙氧羰基_2·乙基苯 本紙張尺度通^7^^準(CNS ) A4規格(210/29^¾^ --- 548272 A7 --〜一 B7 五、發明説明(117) 並咪唑(111)之合成&gt; (讀先閱讀背面之注意事項再瑣寫本頁) 依據製造例14之方法,使用4-硝基-3-丙醯胺基安 息香酸乙酯(2.00g)與4-氯代曱基聯苯(2.28g)以得出3-[N-(聯苯_4_甲基)丙醯胺基]-4-石肖基安息香酸乙酯。不用 進行再精製而依據實施例24之方法即可得出1_(聯苯_4-甲基)-6-乙氧羰基-2-乙基苯並咪唑(111)(2.07g)。 [化合物(111)的物性] lH-NMR(CDCl33 δ) : 1.39(3Η5 t, J-7.2Hz), 1.45(3H, t, J-7.5Hz), 2.90(2H5 ^ J=7.5Hz), 4·38(2Η, q, J=7.2Hz), 5.43(2H3 s), 7·10(2Η, d, J:8,3Hz), 7 .33-7·36(1Η3 m),7·43(2Η,t,J:7.4Hz)3 7.5卜7·56(4Η,m),7,79(1H,d,J二8 •5Hz), 7·80(1Η, dd, J=1.5 及 8.4Hz)5 8·05(1Η3 d5 J=1.3Hz)。 &lt;實施例44; 1-(2-氯代苄基)-5-乙氧羰基-2-甲基苯 並咪唑(112)之合成&gt; 依據製造例14之方法,使用4-乙醯胺基-3-頌基安 息香酸乙酯(3.15g)與2-氣代苄基溴(3.85g)以得出4-[N_ (2 -氣代卞基)乙酿胺基]-3 -硝基安息香酸乙酯。不用進行 再精製而依據實施例24之方法即可得出142-氯代节 基)-5-乙氧羰基-2-甲基苯並咪唑(112)(2.54g)。 [化合物(Π2)的物性] 'H-NKRiCDCh, d) ; 1.4K3H, t, J=7.1Hz), 2.59(3Η, s)5 4.40(2H, q5 !Hz), 5.27 (2Η, s), 6.68 (1Η, d, J 2 7.9Ηζ) 5 7 · 21 (1Η, dt, J 2 9.0 and 2.1 Hz), 7.32-7 · 39 (4Η, m), 7.43 (1Η, dd5 J = 7.3 and 1.9Ηζ), 7.46-7 · 51 (2Η, m) 3 7 · 68 (1Η, d, J 2: 8 · he ), 7.87 (1Η, d3 J = 1.3Hzh 7.95 (1Η, dd, J = 8.4 and 1.5Η) &lt; Example 40; 1-Benzyl-6-ethoxycarbonyl-2-methylbenzene Synthesis of Benzimidazole (108) &gt; According to the method of Production Example 14, 3-acetamido-4-nitrobenzoic acid ethyl acetate (1.00 g) and benzyl bromide (102 g) were used to obtain 3_ ( N_benzylacetamide The size of this paper is suitable / 1] Bamboo touch standard ((: milk) 44 size (21 () \; 297 mm) 548272 A7 __ B7 V. Description of the invention (116) '' ~ & quot Based on M-stone benzoic acid ethyl vinegar. According to the method of Example 24 without further refining can be obtained 丨 Buddenyl ethoxy-2-yl-2-methylbenzimidazole (108) (0.71g); (Read the precautions on the back before you fill in this page) [Physical properties of compound (108)] (CDCh, (5): 1.39 (3Η, t, J: 7.1Hz), 2.58 (3Η, s ), 4 · 38 (2Η, q, J 2 7.1, 5.38 (2Η, s) 3 7 · 05 (2Η, dd, J. 2 · 3 and ΐ · 8Ηζ), 7.28-7.33 (3H, m), 7.72, d, J = 8.4Hz), 7.98 (1Η, dd, J: 8.4 and Hz), 8.02 (1H, d , J: 1.2 Hz) &lt; Example 41; Synthesis of 1- (4-third butylbenzyl) _6_ethoxycarbonyl_2_fluorenylbenzo salivary (109) &gt; Method: 3-ethylammonium aminonitrobenzoate (1,000 g) and 4-third butylbenzyl bromide (35 g) were used to obtain 3- [N- (4-third butylbenzyl ) Acetaminophen 4- 4-nitrobenzoic acid acetamidine can be obtained according to the method of Example 24 without further refining, and 1- (4-third butylbenzyl) -6-ethoxycarbonyl_2_ Crude refined product of methylbenzimidazole (109) (1.60 g). &Lt; Example 42; 6-ethoxycarbonyl-2-methyl-1- (2-naphthylmethyl) benzimidazole (110 ) Synthesis> According to the method of Production Example 14, 3-ethylacetamido-4-nitrobenzoate (1,000 g) and 2-naphthylmethyl bromide (h32g) were used to obtain 3- [ N- (2naphthylmethyl) acetamidinyl] -4-acrylic acid ethyl ester. Without further purification, 6-ethoxycarbonyl-2-methyl-1- (2-naphthylmethyl) benzimidazole (28 g) was obtained according to the method of Example 24. &lt; Example 43; 1- (biphenyl-4-methyl) _6_ethoxycarbonyl_2 · ethylbenzene paper standard ^ 7 ^^ standard (CNS) A4 specification (210/29 ^ ¾ ^- -548272 A7-~ One B7 V. Description of the invention (117) Synthesis of benzimidazole (111) &gt; (Read the precautions on the back and then write this page) According to the method of manufacturing example 14, use 4-nitrate Ethyl-3-propanamidinyl benzoate (2.00g) and 4-chlorofluorenylbiphenyl (2.28g) to give 3- [N- (biphenyl_4-methyl) propanamido ] -4-Ethyl benzoate benzoate. Without further refining, 1_ (biphenyl_4-methyl) -6-ethoxycarbonyl-2-ethylbenzimidazole ( 111) (2.07g). [Physical properties of compound (111)] 1H-NMR (CDCl33 δ): 1.39 (3Η5 t, J-7.2Hz), 1.45 (3H, t, J-7.5Hz), 2.90 (2H5 ^ J = 7.5Hz), 4.38 (2Η, q, J = 7.2Hz), 5.43 (2H3 s), 7.10 (2Η, d, J: 8,3Hz), 7.33-7 · 36 (1Η3 m), 7.43 (2Η, t, J: 7.4Hz) 3 7.5 Bu 7.56 (4Η, m), 7,79 (1H, d, J 2 8 • 5Hz), 7.80 (1Η, dd , J = 1.5 and 8.4 Hz) 5 8 · 05 (1Η3 d5 J = 1.3 Hz). &Lt; Example 44; 1- (2-chlorobenzyl) -5-ethoxycarbonyl-2 -Synthesis of methyl benzimidazole (112) &gt; According to the method of Production Example 14, ethyl 4-acetamido-3-sonylbenzoate (3.15 g) and 2-air benzyl bromide (3.85) were used. g) to obtain 4- [N_ (2--Arylidene) ethynylamino] -3 -nitrobenzoate. 142-chlorine can be obtained according to the method of Example 24 without further refining. Benzyl) -5-ethoxycarbonyl-2-methylbenzimidazole (112) (2.54 g). [Physical properties of compound (Π2)] 'H-NKRiCDCh, d); 1.4K3H, t, J = 7.1Hz), 2.59 (3Η, s) 5 4.40 (2H, q5!

Hz),5.43UH,s),6·43(1Η,d,J=7.8Hz),7.KK1H,t,」:7·5Ηζ),7.19UH,d ,J=8.5Hz),7·25(1Η,m)3 7·46(1Η,d,J:8.1Hz),7.95UH,dd,J:1.4 及 .4Hz), 8.47(1H3 s)〇 〈實施例45;l-(2,6-二氯代苄基乙氧羰基_2•甲 本紙張尺度適财關家標準(CNS ) A4規格(21G X2$i釐) — '&quot; 548272 A7 ______________ _ B7 五、發明説明(118) 基苯並咪唑(113)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 依據製造例14之方法,使用3-乙醯胺基-4-確基安 息香酸乙酯(1.50g)與2,6-二苯並咪唑溴(2.14g)以得出3_ [N-(2,6-一氯代卞基)乙醯胺基]_4_石肖基安息香酸乙g旨。不 用進行再精製而依據實施例24之方法即可得出ι_(2,6-一氣代卞基)-6-乙氧幾基-2 -曱基苯並味σ坐(113)(0.91g)。 [化合物(113)的物性] H-NMR(CDC13,d) : 1·38(3Η,t,J=7.1Hz),2·64(3Η,s),4.34(2H,q3 J:7. iHz), 5·61(2Η, s), 7.30(1H, dd, J:7.6 及 8·5Ηζ), 7.40(2H, d, J:8.0Hz), 7.66(1H, d, J=8.4Hz), 7·87(1Η, d, J=1.1Hz)3 7.91(1H, dd, J二8·4 及 1.5Hz), 5.43UH, s), 6.43 (1Η, d, J = 7.8Hz), 7.KK1H, t, ": 7.5Ηζ), 7.19UH, d, J = 8.5Hz), 7.25 (1Η, m) 3 7 · 46 (1Η, d, J: 8.1Hz), 7.95UH, dd, J: 1.4 and .4Hz), 8.47 (1H3 s). <Example 45; 1- (2,6 -Dichlorobenzylethoxycarbonyl_2 • A paper size standard (CNS) A4 specification (21G X2 $ i%) — '&quot; 548272 A7 ______________ _ B7 V. Description of the invention (118) Synthesis of benzimidazole (113) &gt; (Read the precautions on the reverse side before filling in this page) According to the method of Production Example 14, use 3-ethylamido-4-chlorobenzoate ethyl ester (1.50g) And 2,6-dibenzimidazole bromide (2.14g) to give 3_ [N- (2,6-monochlorofluorenyl) acetamidinyl] _4_ shishothyl benzoate ethyl ester. No further purification required According to the method of Example 24, ι_ (2,6-monogasofluorenyl) -6-ethoxyquinyl-2 -fluorenylbenzo sigma (113) (0.91g) can be obtained. [Compound ( 113) Physical properties] H-NMR (CDC13, d): 1.38 (3Η, t, J = 7.1Hz), 2.64 (3Η, s), 4.34 (2H, q3 J: 7.iHz), 5 61 (2Η, s), 7.30 (1H, dd, J: 7.6 and 8.5Ηζ), 7. 40 (2H, d, J: 8.0Hz), 7.66 (1H, d, J = 8.4Hz), 7.87 (1Η, d, J = 1.1Hz) 3 7.91 (1H, dd, J 2: 8 · 4 and 1.5

Hz)〇 &lt;實施例46;6-乙氧羰基-2-正丙基-1-異丙基苯並咪 唑(114)之合成&gt; 將4-胺基-3-(N-異丙基丁醯胺基)安息香酸乙酯 (0.06g)加入醋酸(2ml)中,在90°C下攪拌14小時。對於 反應液進行減壓濃縮以得出6_乙氧羰基-2-正丙基-1-異 丙基苯並咪唑(114)(0.05g)。 [化合物(114)的物性]Hz) &lt; Example 46; Synthesis of 6-ethoxycarbonyl-2-n-propyl-1-isopropylbenzimidazole (114) &gt; 4-amino-3- (N-isopropyl Ethyl butylammonium benzoate (0.06 g) was added to acetic acid (2 ml) and stirred at 90 ° C. for 14 hours. The reaction solution was concentrated under reduced pressure to obtain 6-ethoxycarbonyl-2-n-propyl-1-isopropylbenzimidazole (114) (0.05 g). [Physical Properties of Compound (114)]

il-NMRiCDCh, δ) : 1.07(3Η, t5 J=7.4Hz), 1.43(3H, t, J-7.0Hz), 1.69(6H, d, J=6.9Hz)3 1.85-1.92(2H3 m), 2.91(2H, t, J=7.7Hz), 4.41(2H, q, J=7.3H z), 4.67-4.76(lH, m), 7.72(1H, d, J=8.3Hz), 7.9^(1H, dd, J=8.7 ^ 1.5H z), 8.25(1H, d, J=1.2Hz)〇 &lt;實施例47;2-苄基-6-乙氧羰基-1-甲基苯並咪唑 (115)之合成&gt; ______122_____ 本紙張尺度適ffl中國國家標準(CNS〉A4規格(210X297公釐) 548272 A7 五、發明説明(丨19) 在冰浴下將60%氫氧化納(〇· 166g)加入4-硝基_3-苯 基乙醯基胺基安息香酸乙酯(〇.924g)之N,N-二甲基甲酿 胺(10ml)溶液中,在室溫下攪拌丨小時。接著加入甲基 峨(0.50ml),在室溫下再攪拌1小時。將反應液倒入冷 卻之1N鹽酸中,經醋酸乙酯萃取2次。對於有機層進 行1N鹽酸洗淨、水洗淨、乾燥、餾除溶媒以得出殘渣。 藉由矽膠柱色譜法(溶離液:醋酸乙酯/己烷 之精製以得出2-苄基-6-乙氧羰基-1-甲基苯並咪唑 (115)(0.090g)。 [化合物(115)的物性]il-NMRiCDCh, δ): 1.07 (3Η, t5 J = 7.4Hz), 1.43 (3H, t, J-7.0Hz), 1.69 (6H, d, J = 6.9Hz) 3 1.85-1.92 (2H3 m), 2.91 (2H, t, J = 7.7Hz), 4.41 (2H, q, J = 7.3H z), 4.67-4.76 (lH, m), 7.72 (1H, d, J = 8.3Hz), 7.9 ^ (1H , dd, J = 8.7 ^ 1.5Hz), 8.25 (1H, d, J = 1.2Hz) &lt; Example 47; 2-benzyl-6-ethoxycarbonyl-1-methylbenzimidazole (115 Synthesis of) ______122_____ This paper is suitable for Chinese national standard (CNS> A4 size (210X297mm)) 548272 A7 V. Description of the invention (丨 19) Add 60% sodium hydroxide (〇. 166g) in an ice bath In a solution of 4-nitro_3-phenylethylamidoaminobenzoic acid ethyl ester (.924 g) in N, N-dimethylformamide (10 ml), stir at room temperature for one hour. Then add Methyl ethyl ether (0.50ml), stirred for an additional hour at room temperature. The reaction solution was poured into cooled 1N hydrochloric acid and extracted twice with ethyl acetate. The organic layer was washed with 1N hydrochloric acid, washed with water, and dried. 2. Distillate the solvent to obtain the residue. Purify by silica gel column chromatography (eluent: ethyl acetate / hexane to obtain 2-benzyl-6-ethoxycarbonyl-1-methylbenzimidazole (115 ) (0. 090g). [Physical properties of compound (115)]

HNMR(CDC13, ό) : 1·41(3Η,t,J:7.1Hz),3·63(3Η,s),4,32(2H5 s),4 40 (2Η3 q3 α=7·1Ηζ)3 7·21-7·26(3Η3 m)3 7·27-7·32(2Η,m)3 ?.72(iH,d,J14H z),7·98(1Η,dd,J:1.5 及 8·他),8·03(1ϋ3 d,J:1.3Hz)。 &lt;實施例48; l-(2,4-二氯代苄基)_6_乙氧羰基_2_甲基 笨並咪唾(116)之合成&gt; 在室溫下’將3-乙醯胺基_4_硝基安息香酸乙酯 (1.50g)之n,N-二曱基曱醯胺(8ml)溶液滴入由6〇%氫氧化 鈉\0.357g)與N,N-二甲基曱醯胺(8ml)所構成之漿液中, 進仃3〇分之攪拌。接著滴入2,4-二氯代苄基氯(1.74g)之 N,N-—甲基甲醯胺(8ml)溶液並攪拌3〇分。將反應液注入 稀现馱50g與醋酸乙酯(6〇幻之混合液中,使用水(5叫)洗 #所得之有機層2次。對於有機層進行減壓濃縮以得出 [^2’4 一氣代苄基)乙醯胺基]-4-硝基安息香酸乙酯之 +精衣物3.5g。不用進行再精製而直接將其溶解於乙醇 A4規格(210x297公釐) (誚先閱讀背面之注意事項再填荇本頁) 本紙張尺料 548272 A7 B7 五、發明説明(丨2〇) (23ml)、醋酸(12ml)中,接著加入還原鐵(3.32g),並加熱 迴流6小時。使用過濾助劑以除去固體,並對濾液進行 減壓濃縮。將醋酸乙酯(60ml)與稀鹽酸(5〇ml)加入所得之 殘渣中以形成分層。對於有機層進行使用飽和碳酸氫鈉 水溶液(50g)之洗淨、2次水(50g)之洗淨、及減壓濃縮以 得出殘渣。藉由矽膠柱色譜法(溶離液··己烷/醋酸乙酯 =4/1〜1/1)精製所得之殘渣而製造出卜(2,4_二氯代苄基&gt; 乙氧幾基-2-曱基苯並口米。坐(116)(〇. 9 4g)。 [化合物(116)的物性] W-NMIUCDCh,6) : 1·40(3Η,t,J二7·1Ηζ),2·56(3Η,s),4.38(2H,q,J二7.1 Ηζ), 5·41(2Η, s), 6·34(1Η, d, J=8.4Hz)3 7·09(1Η, dd, J二8.4 及 2·0Ηζ), 7·49(1Η, d, J二2·0Ηζ), 7·75(1Η, d, J二8·4Ηζ), 7·92(1Η, s): 8.00(1Η, dd5 8·5 及 1·4Ηζ)〇 &lt;實施例49;6-羧基-1-(4-氯代苄基)-2-正丙基苯並 咪唑(117)之合成&gt; 將10%氫氧化鈉水溶液(3.57g)、乙醇(5mi)與水 (3.57g)加入i-(4-氣代苄基)_6_乙氧羰基正丙基苯並咪 唑(1.06g)中,加熱迴流i小時,使用1〇%鹽酸以使得反 應液形成.pH6。將乙醇加入經減壓濃縮所得之殘逢中, 並濾除無機鹽。對於濾液進行減壓濃縮以得出〇.8〇g之 殘渣。藉由矽膠柱色譜法(溶離液:醋酸乙酯/甲醇=4/1) 之精製殘渣以得出6-羧基-1-(4-氣代苄基)_2_正丙基苯並 咪唑(117)(〇.63g)。 [化合物(117)的物性] 本紙張尺度適標準(CNS) A4· (21GX2=董) &quot;~~—--- 548272 Α7 Β7 五、發明説明(121) (許先閲讀背面之注意事項再填寫本頁) ^'NMRiDMSO-dG, δ) : 0.96(3H, t, J=7.3Hz), 1.76-1.88(211, m), 3.10-3.23( 2H,rn),5·83(2Η,s),7·27(2Η,d,J:8.4Hz),7·44(2Η,d, J:8.4Hz),7.89(1 H,d,J:=8.4Hz),7·89(1Η,d,J二8·5Ηζ),8.28(1H,s)。 &lt;實施例50;6-魏基-1-甲基-2-正丙基笨並味σ坐(ns) 之合成&gt; 依據實施例49之方法,使用6-乙氧羰基甲基_2-正丙基苯並咪唑(0.5 6g)以得出6-羧基-1-曱基_2_正丙基 笨並味唾(118)(0.46g)。 [化合物(118)的物性] ^-NMRiDMSO-dG, 6) : 1.00(3H, t3 J=7,3Hz), 1.79-1.93(2H3 m)3 3.06(3H, t ,J=7.4Hz), 3·92(3Η, s)5 7·76(1Η, d, J=8.4Hz), 7.97(1H, d, J=8.4Hz), 8·3 1(1H5 s)〇 &lt;實施例51;6-羧基-2-正丙基-1-異丙基苯並咪唑 (119) 之合成&gt; 争· 依據實施例49的方法,使用6-乙氧羰基-2-正丙基 -1-異丙基苯並咪唑(0.045g)以得出6-羧基-2-正丙基-1-異丙基苯並咪唑(119)(0.〇45g)。 [化合物(119)的物性] ^-NMRiCDaOD, .5) : 0.98(3H5 t, J=7.4Hz), 1.61(6H, d5 J-6.9Hz), L74-1.8 2(2H3 m), 2.89(2H, t3 J=7.5Hz), 3.21-3.24(2H5 m), 4.78-4.83(1H, m), 7.51 (1H, d, J二8.3Hz), 7.84(1H, dd, J=8.4 及 1·5Ηζ), 8·26(1Η, s)。 &lt;貝例52,1 -正丁基-6-魏基-2-正丙基笨並味σ坐 (120) 之合成&gt; 依據貫施例49之方法,使用1 _正丁基_6-乙氧幾基 --—----L15_ 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) ~ -- 548272 Α7 Β7 五、發明説明(122) -2-正丙基苯並咪唑(0.81g)以得出丨_正丁基_6_羧基_2_正 丙基笨並咪唑(120)(0.60g)。 (誚先閱讀背面之注意事項再填寫本頁) [化合物(120)的物性] .41(2H, m)5 1.70-1.77(2H3 m)7 1.85-1.93(2H5 m)5 3.07(2H, t, J=7.6Hz), 4. 42(2H, t, J:7.4Hz), 7·78(1Η, d, J:8.5Hz), 7.99(1H, dd, J:8.5 及 1.0Hz) ,8.35(1H, s)5 13.13(1H5 s)〇 &lt;實施例53;6-羧基-1-(2-氣代苄基)-2-曱基苯並咪 唑(121)之合成&gt; 將乙醇(80ml)與10%氫氧化鈉水溶液(37g)加入^ (2-氣代卞基)-6-乙氧k基-2-曱基苯並味σ坐(10.〇g)中並進 行4小時之加熱迴流。在冷卻反應液後,使用丨〇%鹽酸 以调整成pH6。藉由水洗、減壓乾燥所收集的沉澱物以 得出6-羧基-1-(2-氯代苄基)_2_甲基苯並咪唑(12ι)。 &lt;實施例54;6-羧基-l-(2,6-二氯代苄基)-2-曱基苯並 咪唑(122)之合成&gt; 依據實施例53之方法,使用l-(2,6-二氯代苄基)-6-乙氧羰基-2-甲基苯並咪唑(〇.9〇g)以得出6-羧基-1-(2,6_二氯代苄基)_2·甲基苯並咪唑(m)(0.72g)。 [化合物(122)的物性] 'H-NKRiDMSO-dG, δ) : 2.60(3H, s), 〇.71(2H3 s), 7.46(1Η, t, J=7.9Hz)? 7. 57(3H, t, J二8·2Ηζ), 7·73(2Η, m), 12.57(1H, s)。 &lt;實施例55;6·羧基-2-甲基-l-[2-(三氟曱基)苄基]苯 並咪唑(123)之合成&gt; 一 ____—_-_— \ Ύί\ 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) 548272 A7 _____________________ B7 五、發明説明(123) ^ ^ ~~' (邡先閱讀背面之注意事項再填寫本頁} 依據實施例53之方法,使用6_乙氧羰基_2•甲基_ 1-[2-(二氟甲基)苄基]笨並咪唑(117g)以得出6_羧基_之· 曱基-1-[2-(三氟曱基)节基]苯並咪唑(123)(0 98g)。 [化合物(123)的物性] iNMIUDMSO-de,(5) : 2·49(3Η,s),5.7Q(2H,s),6·46-6·51(1Η,πι),7,5】(2 H,卟 7·65(1Ηί d,扣8•他),7·81(1η,虮 J=14 及 8·4Ηζ), H, m), 7·91(1Η3 s)〇 &lt;實施例56;6_羧基-2-甲基-l-[4-(三氟甲基)苄基]苯 並咪唑(124)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基-2-甲基_ 1-[4-(三氟甲基)苄基]苯並咪唑22g)以得出6_羧基_2_ 曱基-1-[4_(三氟曱基)节基]苯並咪唑(124)(i.〇7g)。 [化合物(124)的物性] ^-NMRiDMSO-dG, d) : 2.85(3H3 s), 5.92(2H, s)3 7.50(2H, d, J,8.1Hz), 7. 74(2H, d, J-8.1Hz)5 7.88(1H, d, J=8.5Hz), 8.07(1H, d? J=8.5Hz), 8.31(1H, s), 13·3(1Η, br s)。 ’ &lt;實施例57;6-羧基-l-(3,4-二氯代苄基)-2-甲基苯並 咪唑(125)之合成&gt; 依據實施例53之方法,使用1-(3,4-二氣代节基)-6-乙氧羰基-2-甲基苯並咪唑(〇.76g)以得出6-羧基-1-(3,4-^一氣代卞基)-2-曱基苯並口米嗤(125)(0.55g)。 [化合物(125)的物性] NMR(DMS0-d6,6) : 2·56(3Η,s),5.61(2H,s), 6.98(1H,dd,J二8.4 及 1.9Hz),7·46(1Η,d,J=1.9Hz),7·59(1Η, d,J二8·3Ηζ),7.63(111, d,J二8·4Ηζ) ,7·81(1Η, dd, J二8·4 及 1.4Hz), 8,07(1H, s), 12·76(1Η, s)。 本紙張尺度適/1]中國國家標準(CNS ) Α4規格(210X2^1釐) ' ' 548272 A7 B7 五、發明説明24) &lt;貫施例58;1-苄基_6_羧基·2_正丙基苯並咪唑(126) 之合成&gt; 將10%氫氧化鈉水溶液61g)、乙醇(5ml)、水(3ml) 加入1-苄基-6_乙氧羰基正丙基苯並咪唑(〇 97g)中,進 行1小時之加熱迴流,使用10%鹽酸以將反應液調整成 PH6。將乙醇加入經減壓濃縮所得之殘渣,並過濾出無 機鹽,以得出1-苄基_6_羧基冬正丙基苯並咪唑 (126)(0.85g) 〇 [化合物(126)的物性] ffmiUDMSO-d6,d) : 0·94(3Η,t,J:7.4Hz),1·73-1.81(2Η,m)3 2.85(2H,1 ,J-7,3Hz), 5·59(2Η, s), 7.07(2H, dd, J:l.l 及 8.3Hz), 7.27(1H, t, J : 7·3Ηζ), 7·33(2Η, t, J:7.4Hz), 7.65(1H, d, J=8.4Hz), 7·79(1Η, dd, J:1.5 及 8.他),8·04(1Η,s)。 &lt;貫施例59;6-羧基-1-(3-氣代苄基)正丙基苯並 咪唑(127)的合成&gt; 依據貫施例58的方法,使用丨_(3_氯代苄基)乙 氧羰基-2-正丙基苯並咪唑(0.57g)以得出6_羧基_1_(3_氣 代苄基)-2-正丙基苯並咪唑(127)(〇.35@)。 [化合物(〖27)的物性] fNMMDMSO-de,d) : 0.94(3H,t,J=7.3Hz),1·70-1·79(2Η,m),2·83(2Η, t, J=7.4Hz), 5.59(2H5 s), 6.94(1H, s), 7.15(1H? s), 7.34(211, d, J=4.4Hz) ,7.59(lH,d,J=8.4Hz),7.81(lH,d,J=8.1Hz),8.02(lH,s)。 &lt;實施例60;6-羧基-2-甲基-1-(2-硝基苄基)苯並咪 唑(128)之合成〉 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (掮先閱讀背面之注意事項再填寫本頁)HNMR (CDC13, ό): 1.41 (3Η, t, J: 7.1Hz), 3.63 (3Η, s), 4,32 (2H5 s), 4 40 (2Η3 q3 α = 7 · 1Ηζ) 3 7 · 21-7 · 26 (3Η3 m) 3 7 · 27-7 · 32 (2Η, m) 3? .72 (iH, d, J14H z), 7.98 (1Η, dd, J: 1.5 and 8 · He), 8.03 (1ϋ3 d, J: 1.3 Hz). &lt; Example 48; Synthesis of l- (2,4-dichlorobenzyl) _6_ethoxycarbonyl_2_methylbenzimidazoline (116) &gt; Amino_4-nitrobenzoate ethyl ester (1.50g) solution of n, N-diamidinofluorenamine (8ml) was dripped with 60% sodium hydroxide (0.357g) and N, N-dimethyl In a slurry consisting of methylamine (8 ml), stir 30 minutes. Then, a solution of 2,4-dichlorobenzyl chloride (1.74 g) in N, N-methylformamide (8 ml) was added dropwise and stirred for 30 minutes. The reaction solution was poured into a mixed solution of 50 g of dilute sodium hydroxide and ethyl acetate (60%), and the obtained organic layer was washed twice with water (5 called). The organic layer was concentrated under reduced pressure to obtain [^ 2 ' 4 One-generation benzyl) acetamido] -4-nitrobenzoate + 3.5g of fine clothing. Dissolve it in ethanol A4 (210x297 mm) without further refining (诮 Read the precautions on the back before filling this page) This paper ruler 548272 A7 B7 V. Description of the invention (丨 2〇) (23ml ), Acetic acid (12 ml), followed by adding reduced iron (3.32 g), and heating to reflux for 6 hours. A filtering aid was used to remove solids, and the filtrate was concentrated under reduced pressure. Ethyl acetate (60 ml) and dilute hydrochloric acid (50 ml) were added to the obtained residue to form a layer. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution (50 g), washed twice with water (50 g), and concentrated under reduced pressure to obtain a residue. The residue was purified by silica gel column chromatography (eluent ·· hexane / ethyl acetate = 4/1 ~ 1/1) to produce (2,4_dichlorobenzyl) ethoxylated -2-Azobenzobenzoate. Sitting (116) (0.94 g). [Physical properties of compound (116)] W-NMIUCDCh, 6): 1.40 (3Η, t, J 2 7.1Ηζ) , 2.56 (3Η, s), 4.38 (2H, q, J 2 7.1 Ηζ), 5.41 (2Η, s), 6.34 (1Η, d, J = 8.4Hz) 3 7 · 09 (1Η , Dd, J2 8.4 and 2.00Ηζ), 7.49 (1Η, d, J2 2.00Ηζ), 7.75 (1Η, d, J2 8.4Ηζ), 7.92 (1Η, s) : 8.00 (1Η, dd5 8.5 and 1.4Ηζ) &lt; Example 49; Synthesis of 6-carboxy-1- (4-chlorobenzyl) -2-n-propylbenzimidazole (117) &gt; 10% sodium hydroxide aqueous solution (3.57g), ethanol (5mi) and water (3.57g) were added to i- (4-gasbenzyl) _6_ethoxycarbonyl-n-propylbenzimidazole (1.06g) , Heated to reflux for 1 hour, 10% hydrochloric acid was used to make the reaction solution form pH 6. Ethanol was added to the residue obtained by concentration under reduced pressure, and the inorganic salt was filtered off. The filtrate was concentrated under reduced pressure to obtain 0.80 g of a residue. The residue was purified by silica gel column chromatography (eluent: ethyl acetate / methanol = 4/1) to obtain 6-carboxy-1- (4-gaso benzyl) _2_n-propylbenzimidazole (117 ) (0.63 g). [Physical properties of compound (117)] Standards for this paper (CNS) A4 · (21GX2 = Dong) &quot; ~~ ----- 548272 Α7 Β7 V. Description of the invention (121) (Fill in this page) ^ 'NMRiDMSO-dG, δ): 0.96 (3H, t, J = 7.3Hz), 1.76-1.88 (211, m), 3.10-3.23 (2H, rn), 5.83 (2Η, s ), 7.27 (2Η, d, J: 8.4Hz), 7.44 (2Η, d, J: 8.4Hz), 7.89 (1 H, d, J: = 8.4Hz), 7.89 (1Η, d, J 2: 8 · 5Ηζ), 8.28 (1H, s). &lt; Example 50; Synthesis of 6-Weiyl-1-methyl-2-n-propylbenzyl sigma (ns) &gt; According to the method of Example 49, 6-ethoxycarbonylmethyl_2 was used -N-propylbenzimidazole (0.5 6 g) to give 6-carboxy-1-fluorenyl-2-n-propylbenzyl salicylate (118) (0.46 g). [Physical properties of compound (118)] ^ -NMRiDMSO-dG, 6): 1.00 (3H, t3 J = 7,3Hz), 1.79-1.93 (2H3 m) 3 3.06 (3H, t, J = 7.4Hz), 3 · 92 (3Η, s) 5 7 · 76 (1Η, d, J = 8.4Hz), 7.97 (1H, d, J = 8.4Hz), 8.3.1 (1H5 s). 〈Example 51; 6 -Synthesis of -carboxy-2-n-propyl-1-isopropylbenzimidazole (119) &gt; According to the method of Example 49, 6-ethoxycarbonyl-2-n-propyl-1-isopropyl was used Benzimidazole (0.045 g) to give 6-carboxy-2-n-propyl-1-isopropylbenzimidazole (119) (0.045 g). [Physical properties of compound (119)] ^ -NMRiCDaOD, .5): 0.98 (3H5 t, J = 7.4Hz), 1.61 (6H, d5 J-6.9Hz), L74-1.8 2 (2H3 m), 2.89 (2H , t3 J = 7.5Hz), 3.21-3.24 (2H5 m), 4.78-4.83 (1H, m), 7.51 (1H, d, J two 8.3Hz), 7.84 (1H, dd, J = 8.4 and 1.5 · ζ ), 8.26 (1Η, s). &lt; Synthesis of Example 52,1-n-butyl-6-Weiyl-2-n-propylbenzyl sigma (120) &gt; According to the method of Example 49, 1_n-butyl_6 was used -Ethoxyoxyl ---------- L15_ This paper size is in accordance with China State Standard (CNS) A4 (210X297 mm) ~-548272 Α7 Β7 5. Description of the invention (122) -2- n-propyl Benzimidazole (0.81 g) to give n-butyl-6-carboxy_2-n-propylbenzimidazole (120) (0.60 g). (诮 Please read the precautions on the back before filling this page) [Physical properties of compound (120)] .41 (2H, m) 5 1.70-1.77 (2H3 m) 7 1.85-1.93 (2H5 m) 5 3.07 (2H, t , J = 7.6Hz), 4. 42 (2H, t, J: 7.4Hz), 7.78 (1Η, d, J: 8.5Hz), 7.99 (1H, dd, J: 8.5 and 1.0Hz), 8.35 (1H, s) 5 13.13 (1H5 s) 0 &lt; Example 53; Synthesis of 6-carboxy-1- (2-fluorobenzyl) -2-fluorenylbenzimidazole (121) &gt; Ethanol ( (80ml) and 10% aqueous sodium hydroxide solution (37g) were added to (2-oxofluorenyl) -6-ethoxykyl-2-fluorenylbenzo sigma (10.〇g) for 4 hours It is heated under reflux. After the reaction solution was cooled, it was adjusted to pH 6 with 10% hydrochloric acid. The collected precipitate was washed with water and dried under reduced pressure to obtain 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzimidazole (12m). &lt; Example 54; Synthesis of 6-carboxy-l- (2,6-dichlorobenzyl) -2-fluorenylbenzimidazole (122) &gt; According to the method of Example 53, l- (2 , 6-dichlorobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (0.90 g) to give 6-carboxy-1- (2,6-dichlorobenzyl) _2.methylbenzimidazole (m) (0.72g). [Physical properties of compound (122)] 'H-NKRiDMSO-dG, δ): 2.60 (3H, s), 0.71 (2H3 s), 7.46 (1Η, t, J = 7.9Hz)? 7. 57 (3H , T, J 2 8 · 2Ηζ), 7.73 (2Η, m), 12.57 (1H, s). &lt; Example 55; Synthesis of 6 · carboxy-2-methyl-l- [2- (trifluorofluorenyl) benzyl] benzimidazole (123) &gt;-____—_-_— \ Ύί \ The size of this paper is China State Standard (CNS) A4 (210X297 mm) 548272 A7 _____________________ B7 V. Description of the invention (123) ^ ^ ~~ '(邡 Please read the notes on the back before filling this page} According to the example 53 method, using 6_ethoxycarbonyl_2 • methyl_1- [2- (difluoromethyl) benzyl] benzimidazole (117g) to obtain 6_carboxyl-fluorenyl-1- [2- (trifluorofluorenyl) benzyl] benzimidazole (123) (0 98 g). [Physical properties of compound (123)] iNMIUDMSO-de, (5): 2.49 (3Η, s), 5.7Q (2H, s), 6.46-6.51 (1Η, π), 7,5] (2H, porphyrin 7.65 (1Ηί d, buckle 8 • him), 7.81 (1η, 虮 J = 14 and 8 · 4Ηζ), H, m), 7.91 (1Η3 s). &Lt; Example 56; 6-carboxy-2-methyl-l- [4- (trifluoromethyl) benzyl] benzene Synthesis of Benzimidazole (124) &gt; According to the method of Example 53, 6-ethoxycarbonyl-2-methyl_1- [4- (trifluoromethyl) benzyl] benzimidazole (22 g) was used to obtain 6_carboxy_2_ fluorenyl-1- [4_ (trifluorofluorenyl) benzyl ] Benzimidazole (124) (1.07 g). [Physical properties of compound (124)] ^ -NMRiDMSO-dG, d): 2.85 (3H3 s), 5.92 (2H, s) 3 7.50 (2H, d, J, 8.1Hz), 7. 74 (2H, d, J-8.1Hz) 5 7.88 (1H, d, J = 8.5Hz), 8.07 (1H, d? J = 8.5Hz), 8.31 (1H, s), 13.3 (1Η, br s). '&lt; Example 57; Synthesis of 6-carboxy-l- (3,4-dichlorobenzyl) -2-methylbenzimidazole (125) &gt; According to the method of Example 53, 1- ( 3,4-Dioxobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (0.76 g) to give 6-carboxy-1- (3,4- ^ mono-gas-fluorenyl)- 2-Amidinobenzopyrene (125) (0.55g). [Physical Properties of Compound (125)] NMR (DMS0-d6,6): 2.56 (3Η, s), 5.61 (2H, s), 6.98 (1H, dd, J = 8.4 and 1.9Hz), 7.46 (1Η, d, J = 1.9Hz), 7.59 (1Η, d, J 2 8.3Ηζ), 7.63 (111, d, J 2 8.4Ηζ), 7.81 (1Η, dd, J 2 8 · 4 and 1.4 Hz), 8,07 (1H, s), 12 · 76 (1Η, s). The size of this paper is / 1] Chinese National Standard (CNS) A4 specification (210X2 ^ 1 centimeter) '' 548272 A7 B7 V. Description of the invention 24) &lt; 实施 例 58; 1-Benzyl_6_carboxyl · 2_ Synthesis of n-propylbenzimidazole (126) &gt; 10% sodium hydroxide aqueous solution 61g), ethanol (5ml), water (3ml) were added to 1-benzyl-6-ethoxycarbonyl-n-propylbenzimidazole ( 〇97g), heating and refluxing was performed for 1 hour, and the reaction solution was adjusted to pH 6 using 10% hydrochloric acid. Ethanol was added to the residue obtained by concentration under reduced pressure, and the inorganic salt was filtered to obtain 1-benzyl-6-carboxyl-n-propylbenzimidazole (126) (0.85 g). [Physical properties of compound (126) ] ffmiUDMSO-d6, d): 0.94 (3Η, t, J: 7.4Hz), 1.73-1.81 (2Η, m) 3 2.85 (2H, 1, J-7, 3Hz), 5.59 ( 2Η, s), 7.07 (2H, dd, J: ll and 8.3Hz), 7.27 (1H, t, J: 7. · 3Ηζ), 7.33 (2Η, t, J: 7.4Hz), 7.65 (1H, d, J = 8.4Hz), 7.79 (1Η, dd, J: 1.5 and 8. he), 8.04 (1Η, s). &lt; Example 59; Synthesis of 6-carboxy-1- (3-fluorobenzyl) -n-propylbenzimidazole (127) &gt; According to the method of Example 58, using __ (3_chloro Benzyl) ethoxycarbonyl-2-n-propylbenzimidazole (0.57g) to give 6-carboxyl_1- (3-gasobenzyl) -2-n-propylbenzimidazole (127) (0. 35 @). [Physical properties of compound (〖27)] fNMMDMSO-de, d): 0.94 (3H, t, J = 7.3Hz), 1.70-1 · 79 (2Η, m), 2.83 (2Η, t, J = 7.4Hz), 5.59 (2H5 s), 6.94 (1H, s), 7.15 (1H? S), 7.34 (211, d, J = 4.4Hz), 7.59 (lH, d, J = 8.4Hz), 7.81 (lH, d, J = 8.1 Hz), 8.02 (lH, s). &lt; Example 60; Synthesis of 6-carboxy-2-methyl-1- (2-nitrobenzyl) benzimidazole (128)> This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) ) (掮 Please read the notes on the back before filling this page)

、1T 548272 A7 B7 五、發明説明(125) 依據實施例58之方法,使用乙氧羰基_2_甲基一 1_(2_硝基苄基)苯並咪唑(〇.61g)以得出6·羧基_2-甲基 Ο硝基苄基)苯並咪唑(128)(0.35g)。 [化合物(128)的物性] ^-NMRiDMSO-dG, δ) : 2.5Κ3Η, s), 5.96(2H, s), 6.33(1H, d, J=7.0Hz)7 7. 55-7·62(2Η, m), 7.66(1H, d3 J=8.3Hz), 7.81(1H, d, J二8.4Hz) 8 06(1H s) 8·24(1Η3 d, J二7·0Ηζ), 12·66(1Η, s)。 &lt;貫施例61 ;6-羧基-1-(2-氯代苄基)_2_曱基苯並咪 唑(121)之合成&gt; 將乙醇(15ml)及5%氫氧化鈉水溶液(1〇.6g)加入卜 (2-氯代苄基)-6-乙氧羰基-2-曱基苯並咪唑(1456g)中,令 其迴流1小時。反應液經冷卻後,使用1〇%鹽酸調整成 pH6。收集沉殿物,經由水洗、減壓乾燥以得出6_羧基 氯代苄基)_2_甲基苯並咪唑(121)(0.645g)。 &lt;實施例62;6-羧基-1-(2,4-二氯代苄基)_2_甲基苯並 咪唑(129)之合成&gt; 將10%氫氧化鈉水溶液(3.10g)及乙醇(10ml)加入 1-(2,4-二氣代苄基乙氧羰基-2-曱基苯並咪唑(〇.94g) 妓浐部中决打^-^h 5消费合竹卬欠 (讀先閱讀背面之注意事項再填寫本頁) 中,令其加熱迴流1小時。使用10%鹽酸將反應液調整 成PH6。藉由過濾乾燥所析出之結晶以得出羧基4- (2,4_一氣代苄基)-2_甲基苯並咪唾(129)(0.68g)。 [化合物(129)的物性] mMiUDMSQ-dG, d) ·· 2.52(3H,s),5·61(2Η,s),6,54(1H,d,J:8.4Hz),7. 33(1H, dd, J=8.4 及 2·1Hz), 7.64(1H, d, J:8·4Hz), 7·74(1H, d, J:2·1Hz) ,7.81UH,dd,J=8.4 及 1·5Ηζ),7·98(1Η,s),12.72UH,s)。1T 548272 A7 B7 V. Description of the invention (125) According to the method of Example 58, ethoxycarbonyl-2-methyl-1_ (2-nitrobenzyl) benzimidazole (0.61g) was used to obtain 6 Carboxy_2-methylonitrobenzyl) benzimidazole (128) (0.35 g). [Physical properties of compound (128)] ^ -NMRiDMSO-dG, δ): 2.5K3Η, s), 5.96 (2H, s), 6.33 (1H, d, J = 7.0Hz) 7 7. 55-7 · 62 ( 2Η, m), 7.66 (1H, d3 J = 8.3Hz), 7.81 (1H, d, J = 8.4Hz) 8 06 (1H s) 8 · 24 (1Η3 d, J = 7 · 0Ηζ), 12 · 66 (1Η, s). &lt; Example 61; Synthesis of 6-carboxy-1- (2-chlorobenzyl) _2-fluorenylbenzimidazole (121) &gt; Ethanol (15 ml) and a 5% aqueous sodium hydroxide solution (1. .6 g) was added to (2-chlorobenzyl) -6-ethoxycarbonyl-2-fluorenylbenzimidazole (1456 g), and it was refluxed for 1 hour. After the reaction solution was cooled, it was adjusted to pH 6 using 10% hydrochloric acid. The sink was collected, washed with water, and dried under reduced pressure to give 6-carboxychlorobenzyl) -2-methylbenzimidazole (121) (0.645 g). &lt; Example 62; Synthesis of 6-carboxy-1- (2,4-dichlorobenzyl) -2-methylbenzimidazole (129) &gt; A 10% aqueous solution of sodium hydroxide (3.10 g) and ethanol (10ml) Add 1- (2,4-dioxobenzylethoxycarbonyl-2-fluorenylbenzimidazole (0.94g) in the prostitutes department. First read the precautions on the reverse side and fill in this page), and let it heat to reflux for 1 hour. Adjust the reaction solution to pH 6 with 10% hydrochloric acid. The crystals precipitated are dried by filtration to obtain the carboxyl 4- (2,4_ Monobenzyl) -2-methylbenzimidal (129) (0.68g). [Physical properties of compound (129)] mMiUDMSQ-dG, d) ·· 2.52 (3H, s), · 61 (2Η , S), 6,54 (1H, d, J: 8.4Hz), 7.33 (1H, dd, J = 8.4 and 2.1Hz), 7.64 (1H, d, J: 8.4Hz), 7. · 74 (1H, d, J: 2.1 Hz), 7.81UH, dd, J = 8.4 and 1.51ζ), 7.98 (1Η, s), 12.72UH, s).

--------— τ 2Q 本紙張尺度速/1]中國國家標準(CNS ) A4規格(210X2^7公釐) - 548272 A7 B7 五、發明説明(126) &lt;實施例63; 1-(聯笨-4-甲基&gt;6-羧基-2-甲基苯並咪 唑(130)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 依據貫施例53之方法,使用(聯苯甲基乙 氧羰基-2-甲基苯並咪唑(i.i〇g)以得出(聯苯_4_曱基)_ 6-緩基-2-甲基苯並1[1米唾(13〇)(〇.838)。 [化合物(130)的物性] iH-NMIUDMSQ-ciG,d) : 2,53(3H3 s)3 5.61(2H3 s)5 7.18(2H,d,J:8.2Hz),7 34(1H3 m)3 7·43(2Η,m)3 7·62(5Η3 m)3 7,79(1H,dd,J=1.6 及 8·5Ηζ),8·〇 9(1H,d,J=1.0Hz)3 12·72(1Η3 br s)。 &lt;實施例64;1-(4-第3 丁基苄基)-6-羧基-2-甲基苯並 咪唑(131)之合成&gt; 依據實施例53之方法,使用1_(4_第3 丁基节基)_ 6-乙氧羰基-2-曱基苯並咪唑(l.34g)以得出i-(4-第3 丁基 苄基)-6-羧基-2-甲基笨並咪唑(i31)(〇e55g)。 [化合物(131)的物性] H-NMR(DMSQ-d6,ά) : H(9H,s),2·57(3Η,s), 5·52(2Η,s),7.Q3(2H,d, J-8.2Hz), 7·35(1Η, d, J:8.3Hz), 7·60(1Η, d, J:8.4Hz), 7·78(1Η, dd, J=8 4 及 1·5Ηζ), 8·06(1Η, s), 12·71(1Η, s)。 &lt;實施例65 ;6-羧基-2-甲基-1-(2-曱基苄基)苯並咪 唑(132)之合成&gt; 依據實施例53之方法,使用6-乙氧幾基-2-曱基_ 1-(2-甲基苄基)苯並咪唑(〇.81g)以得出6_羧基曱基 Ο甲基苄基)苯並咪唑(132)(0.49g)。 [化合物(132)的物性] 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 ____ B7 五、發明説明(127) (諳先閱讀背面之注意事項再填寫本頁) inm^DMSO-d6, 6) ·· 2·41(3Η,s),2·48(3Η,S),5·55(2Η,s),614(1H,d, J:7.6Hz),7·02(1Η,t,J:7.4Hz),7.miH,t,J:7.3Hz) 5 7 26(此 d,j:7 4 Hz),7·65(1H,d,J-8.4Hz),7.81(1H,dd,J1^·4 及 1 4Hz) 7 97( 1H d J =l.lHz), 12.71(1H, s)。 &lt;實施例66;6-羧基-1-(2-甲基苄基)-2-甲基苯並咪 唑(133)之合成&gt; 依據實施例53之方法,使用乙氧羰基_丨_(2_甲基 苄基)-2-甲基苯並咪唑(l.63g)以合成出6-魏基甲基 卞基)-2-甲基苯並蜂唾(I33)(1.00g)。 [化合物(133)的物性] 臟(DMSO-d6,0) U5(3H,s),3·81(3Η,s)3 5·42(2Η,s),6·77(1Η,m) ,6·85(1Η,in),7.G5UH,m),7·28(1Η,m),7,58(1Η,ιη),7·76(1Η,ιη),7.99( 1H, s), 12·65(1Η, br s)〇 &lt;實施例67;6-羧基-1-(4-曱基苄基)_2-甲基苯並咪 唑(134)之合成〉 依據實施例53之方法,使用6-乙氧魏基-1-(4-甲基 苄基)-2_甲基苯並咪唑(l.27g)以得出6_羧基曱基节 基)-2-曱基苯並咪唑(134)(0.99g)。 [化合物(L34)的物性] W-NM^DMSQ-de,ά) : 2.86(3H,s),3·71(3Η,s),5·69(2Η,s),6·92(2Η,d3 J二8·4Ηζ), 7·27(?Η, d, J=8.4Hz), 7·84(1Η, d, J=8.5Hz)3 8.〇4(1Η, d, J二8·5 Hz), 8·33(1Η, s), 13·25(1Η, br t)。 &lt;實施例68;6-羧基-2-甲基-l-[2-(苯磺醯基甲基)节 基]苯並咪唑(135)之合成&gt; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) \Ί 五、發明説明(128) 依據實施例53之方法,使用6-乙氧羰基_2_甲基_ 1-[2-(苯磺醯基甲基)苄基]苯並咪唑(〇 89g)以得出卜羧 (誦先閱讀背面之注意事項再填寫本頁} 基-2-甲基-1-[2-(苯磺醯基甲基)苄基]苯並咪唑 (135)(0.74g)。 [化合物(135)的物性] H-NMR(DMS0-d6, δ) : 2.44(3H, s)5 4.99(2H, s), 5.71(2H3 s), 6 08(1H d--------— τ 2Q Speed of this paper / 1] Chinese National Standard (CNS) A4 specification (210X2 ^ 7 mm)-548272 A7 B7 V. Description of the invention (126) &lt; Example 63; 1- (Synthesis of 4-benzyl-4-methyl &gt; 6-carboxy-2-methylbenzimidazole (130) &gt; (Read the precautions on the back before filling in this page) The method according to Example 53 , Using (biphenylmethylethoxycarbonyl-2-methylbenzimidazole (ii0g) to obtain (biphenyl_4_fluorenyl) _6-branzyl-2-methylbenzo1 [1 Misa (13〇) (〇.838). [Physical properties of compound (130)] iH-NMIUDMSQ-ciG, d): 2,53 (3H3 s) 3 5.61 (2H3 s) 5 7.18 (2H, d, J : 8.2Hz), 7 34 (1H3 m) 3 7 · 43 (2Η, m) 3 7 · 62 (5Η3 m) 3 7,79 (1H, dd, J = 1.6 and 8.5Ηζ), 8.09 (1H, d, J = 1.0 Hz) 3 12 · 72 (1Η3 br s). &Lt; Example 64; 1- (4- 3rd butylbenzyl) -6-carboxy-2-methylbenzimidazole Synthesis of (131) &gt; According to the method of Example 53, 1- (4- 3rd butyl benzyl) -6-ethoxycarbonyl-2-fluorenylbenzimidazole (1.34 g) was used to obtain i- (4-third butylbenzyl) -6-carboxy-2-methylbenzimidazole (i31) (〇e55g). [Physical properties of compound (131)] HN MR (DMSQ-d6, ά): H (9H, s), 2.57 (3Η, s), 5.52 (2Η, s), 7.Q3 (2H, d, J-8.2Hz), 7. · 35 (1Η, d, J: 8.3Hz), 7.60 (1Η, d, J: 8.4Hz), 7.78 (1Η, dd, J = 8 4 and 1.5Ηζ), 8.06 (1Η, s), 12.71 (1Η, s). &lt; Example 65; Synthesis of 6-carboxy-2-methyl-1- (2-fluorenylbenzyl) benzimidazole (132) &gt; According to the examples Method 53 using 6-ethoxyquinyl-2-fluorenyl-1- (2-methylbenzyl) benzimidazole (0.81g) to give 6-carboxyfluorenylmethylmethylbenzyl) benzene Benzimidazole (132) (0.49 g). [Physical properties of compound (132)] This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 ____ B7 V. Description of the invention (127) (谙 Please read the precautions on the back before filling in this page) inm ^ DMSO-d6, 6) 2.41 (3 ·, s), 2.48 (3Η, S), 5.55 (2Η, s), 614 (1H, d, J: 7.6Hz), 7 · 02 (1Η, t, J: 7.4Hz), 7.miH, t, J: 7.3Hz) 5 7 26 (this d, j: 7 4 Hz), 7.65 (1H, d, J-8.4Hz ), 7.81 (1H, dd, J1 ^ · 4 and 14Hz) 7 97 (1H d J = 1.1 Hz), 12.71 (1H, s). &lt; Example 66; Synthesis of 6-carboxy-1- (2-methylbenzyl) -2-methylbenzimidazole (133) &gt; According to the method of Example 53, ethoxycarbonyl group was used. 2-methylbenzyl) -2-methylbenzimidazole (1.63 g) to synthesize 6-weilylmethylfluorenyl) -2-methylbenzyl saliva (I33) (1.00 g). [Physical properties of compound (133)] Dirty (DMSO-d6,0) U5 (3H, s), 3.81 (3Η, s) 3 5 · 42 (2Η, s), 6.77 (1Η, m), 6.85 (1Η, in), 7.G5UH, m), 7.28 (1Η, m), 7,58 (1Η, ιη), 7.76 (1Η, ιη), 7.99 (1H, s), 12 · 65 (1Η, br s) 〇 Example 67; Synthesis of 6-carboxy-1- (4-fluorenylbenzyl) _2-methylbenzimidazole (134)> According to the method of Example 53, 6-ethoxyweilyl-1- (4-methylbenzyl) -2-methylbenzimidazole (1.27 g) was used to give 6-carboxyfluorenylbenzyl) -2-fluorenylbenzimidazole (134) (0.99 g). [Physical properties of compound (L34)] W-NM ^ DMSQ-de, ά): 2.86 (3H, s), 3.71 (3Η, s), 5.69 (2Η, s), 6.92 (2Η, d3 J 2: 8 · 4Ηζ), 7.27 (? Η, d, J = 8.4Hz), 7.84 (1Η, d, J = 8.5Hz) 3 8.〇4 (1Η, d, J = 8 · 5 Hz), 8 · 33 (1Η, s), 13 · 25 (1Η, br t). &lt; Example 68; Synthesis of 6-carboxy-2-methyl-l- [2- (benzenesulfonylmethyl) benzyl] benzimidazole (135) &gt; The paper size applies the Chinese National Standard (CNS ) A4 specification (210X297 mm) \ Ί 5. Description of the invention (128) According to the method of Example 53, 6-ethoxycarbonyl_2_methyl_ 1- [2- (benzenesulfonylmethyl) benzyl [Yl] benzimidazole (〇89g) to get the carboxyl (read the notes on the back before filling out this page} group-2-methyl-1- [2- (benzenesulfonylmethyl) benzyl] Benzimidazole (135) (0.74g). [Physical properties of compound (135)] H-NMR (DMS0-d6, δ): 2.44 (3H, s) 5 4.99 (2H, s), 5.71 (2H3 s), 6 08 (1H d

J-6.5Hz),7·12-7·20(3Η,m),7·64-7·70(3Η,m),7,77-7·83(2Η,in),7 89(2H ,s)3 7.90(1H, s), 12.71(1H3 s)。 &lt;實施例69;6-羧基-:u(2_氰基苄基)_2-甲基苯並咪 唑(136)之合成&gt; 依據實施例53之方法,使用i_(2_氰基苄基)_6_(2_ 氰基苄氧羰基)-2-甲基苯並咪唑(2.〇4g)以得出6-幾基_1β (2_氰基苄基)_2_甲基苯並咪唑(136)(1.14g)。 [化合物(136)的物性] ^-NMRiDMSO-dB, δ) : 2.54(3H, s), 5.80(2H, s)5 6.78( 1H, d, J==7.8Hz), 7 51(1H,t,J二7.4Hz),7·61(1Η,dt,J:7.8 及 1.2Hz),7.64(m,d,J:8.4Hz) Ψ ,7·80(1Η,dd,J=8.4 及 1.5Hz),7.94(1H,d,J:6.7Hz),8.00UH, d,J:l. 1Hz), 1Z.70(1H, s)〇 &lt;實施例70 ;6-叛基-1-(聯笨-2-曱基)-2-曱基苯並啼 唑(137)之合成&gt; 依據貫施例53之方法,使用ι_(聯苯甲基匕 氧羰基-2-甲基苯並咪唑(l.31g)以得出6-羧基_丨_(聯苯-2_ 曱基)-2-甲基苯並咪唑(137)(1.07g)。 [化合物(137)的物性] ___U2_ 本紙張尺度適川中國國家標準(CNS ) A4規格(210X297公釐) ' 548272 A7 B7 五、發明说明(129) 1 匪(DMS0-d6,(5) ·· 2·32(3Η,s),5.45(2H,s),6.61(1H,d,J:7.7Hz),7. 26(1H,dt,J=7.7 及 i.4Hz),7.31UH,dd,J:7.5 及 1.3Hz),7.36(1H,d (麴先閱讀背面之注意事項再填寫本頁 t,J:7.5 及 0.7Hz),7.40-7.46(lH,m),7.46-7.52(4H, id),7.57(1H,d,J二 8·4Ηζ),7.76(1H,dd,J-7.9 及!.5Hz),7,86( 1H, d,1.2Hz),12.72(1H, s )〇 &lt;實施例71 ;1-苄基-6-羧基-2-曱基苯並咪唑(138)之 合成&gt; 依據實施例53之方法,使用ι_苄基-6_乙氧幾基 甲基苯並咪唑(0.71g)以得出卜苄基_6_羧基_2_甲基苯並 咪唑(138)(0.59g)。 [化合物(138)的物性]J-6.5Hz), 7.12-7 · 20 (3Η, m), 7.64-7 · 70 (3Η, m), 7,77-7 · 83 (2Η, in), 7 89 (2H, s) 3 7.90 (1H, s), 12.71 (1H3 s). &lt; Example 69; Synthesis of 6-carboxy-: u (2-cyanobenzyl) _2-methylbenzimidazole (136) &gt; According to the method of Example 53, i_ (2-cyanobenzyl ) _6_ (2_cyanobenzyloxycarbonyl) -2-methylbenzimidazole (2.04g) to give 6-quinyl_1β (2_cyanobenzyl) _2_methylbenzimidazole (136 ) (1.14g). [Physical properties of compound (136)] ^ -NMRiDMSO-dB, δ): 2.54 (3H, s), 5.80 (2H, s) 5 6.78 (1H, d, J == 7.8Hz), 7 51 (1H, t , J = 7.4Hz), 7.61 (1Η, dt, J: 7.8 and 1.2Hz), 7.64 (m, d, J: 8.4Hz) ,, 7.80 (1Η, dd, J = 8.4 and 1.5Hz ), 7.94 (1H, d, J: 6.7Hz), 8.00UH, d, J: 1.1Hz), 1Z.70 (1H, s) 〇 Example 70 Synthesis of benz-2-fluorenyl) -2-fluorenylbenzoxazole (137) &gt; According to the method of Example 53, ι_ (biphenylmethyloxycarbonyl-2-methylbenzimidazole ( l.31g) to obtain 6-carboxyl_ 丨 _ (biphenyl-2_fluorenyl) -2-methylbenzimidazole (137) (1.07g). [Physical properties of compound (137)] ___U2_ This paper is suitable for this paper Sichuan China National Standard (CNS) A4 specification (210X297 mm) '548272 A7 B7 V. Description of the invention (129) 1 Bandit (DMS0-d6, (5) · 2.32 (3Η, s), 5.45 (2H, s), 6.61 (1H, d, J: 7.7Hz), 7.26 (1H, dt, J = 7.7 and i.4Hz), 7.31UH, dd, J: 7.5 and 1.3Hz), 7.36 (1H, d (麴 Please read the notes on the back before filling in this page t, J: 7.5 and 0.7 Hz), 7.40-7.46 (lH, m), 7.46-7.52 (4H, id), 7.57 (1H, d, J) 8 · 4Ηζ), 7.76 (1H, dd, J-7.9 and!. 5Hz), 7,86 (1H, d, 1.2Hz), 12.72 (1H, s). &Lt; Example 71; 1-benzyl- Synthesis of 6-carboxy-2-fluorenylbenzimidazole (138) &gt; According to the method of Example 53, ι_benzyl-6_ethoxyepimethylbenzimidazole (0.71g) was used to obtain the benzyl group _6_carboxy_2_methylbenzimidazole (138) (0.59g). [Physical properties of compound (138)]

、1T W-NMR(DMSQ-d6, ά) : 2·56(3Η, s)5 5·57(2Η, s), 7.11(1H, d, J=8.GHz), 7· 27(1Η3 t, J:7.2Hz), 7·32-7·35(2Η, m), 7·61(1Η, d, J:8.3Hz), 7·79(1Η, dd, J=8.4 及 1·3Ηζ),8·06(1Η,s),12.75UH,s)。 &lt;貫施例72;6-羧基-2-甲基_l-(2-萘基甲基)苯並咪 唑(139)之合成&gt; 依據實施例53之方法,使用6_乙氧羰基甲基· 1-(2-萘基甲基)苯並咪唑(1.28§)以得出卜羧基_2_甲基-^ (2_萘基曱,基)苯並咪唑(139)(0.80g)。 [化合物(139)的物性] ^腿(DMSO-j6, d) : 2.61(3H,s),5·74(2Η,s),7·29(1Η,d,J:8.6Hz),7. 46 7·52(2Η, m), 7.59(1H, s), 7·63(1Η, d, J:8.3Hz), 7.78-7·92(4Η, m), 8.0 9(!H, s), 12,68(1H, s)。 &lt;貫施例73;l-(聯苯-4-甲基)-6-綾基乙基苯並咪唑 —--------L3-3_____ 本紙張尺度適川中國國家標準(CNS ) A4規格(210X 297公釐' 548272 A7 _______ B7 五、發明説明(131) [化合物(142)的物性] (讀先閱讀背面之注意事項再填寫本頁) W-NMRiDMSO-de,ά) : 2·49(3Η,s)5 5.9K2H,s)3 6·36(1Η,吡 J=7 2 及 1.8Hz), 7·52(1Η, d, J:8.5Hz), 7.55-7·62(2Η, m), 7.77(1h,机 J=85 及} • 5HZ),8.節H,d,机3„z),8.2額,dd,㈣ 4 及 i 6Hz) i2 69(n )〇 &lt;實施例76;2-苄基-5-羧基氣代苄基)苯並咪 唑(143)之合成&gt; 14. 依據實施例53之方法,使用2_节基氣代节 基)-5-乙氧羰基苯並咪唑(〇.635g)以得出2_苄基羧基· 1-(2-氯代节基)苯並味峻(143)(0.488g)。 [化合物(143)的物性] ^.(DMSO-de,(5) : 4.27(^ s),5.57(2H,S),6·27(1Η,d,J=7 1Hz),7 〇6(lH, t), 7.1〇-7.29(6H5 m), 7.39(1H, d, J=8.6Hz), 7.47(1H, d, J,7.9Hz), 7.贱 dd,J=1.4 及 8刪,8·21(1Η,d,J=12Hz), i2 職 &amp; s)。 &lt;貫施例77;2_苄基-6-羧基- l-(2_氯代苄基)苯並咪 唑(144)之合成&gt; 依據實施例53之方法,使用2_苄基-1β(2_氣代节 基)-6-乙氧羰基苯並咪唑(l.〇〇g)以得出2_苄基叛基_ 1-0氯代芣基)笨並咪唑(144)(0.780g)。 [化合物(144)的物性] ^-NMRiDMSO-dG, d) : 4.29(2H, s), 5.63(2H, s)5 6.28( 1H, d, J=7.8Hz), 7 07(1H,t,J:7.6Hz)5 7·15(1Η,in),7·19-7·29(5Η,ffl),7·49(1η,d,j:7 4Hz) 7·70(1Η,d,J二8.4Hz),7.81UH,d,J=8.4Hz),7·91(1Η,s),12·73(1Η,br )〇 , 本紙張尺度通州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(132) &lt;實施例78;2-节基_5_叛基二氣代节基)苯並 咪唑(145)之合成&gt; 依據實施例53之方法,使用孓苄基4兴2,‘二氣代 苄基)-5-乙氧羰基苯並咪唑(0.5〇g)以得出孓苄基羧基 -1-(2,4-二氯代苄基)苯並咪唑(145)(〇4〇幻。 [化合物(14 5)的物性] H~NMR(DMS0-d65 δ) ; 4.28(2H s) 5 55(?η \ ^ 〇〇7?9iRH , v 〖,S), 5_55(2H, s), 6·19(1Η, d, J:8.他),7. ⑽-7.22(6H,m),7.4ί(1Η,d,J:8 4Hz) 7 ^ T。 4叫,7.62(1H,d,扣2.2Hz),7.79(1H,dd, 1.5 及 8·6Ηζ),8·22(1Η3 s),12.72UH,br s)。 &lt;貫施例79;2-苄基羧基-le(2,‘二氣代苄基)苯並 咪唑(146)之合成&gt; 依據實施例53之方法,使用孓苄基_1-(2,‘二氣代 苄基)-6-乙氧羰基苯並咪唑(〇.48g)以得出1苄基羧基 -1 -(2,4-,一 鼠代卞基)求並味 η坐(146)(0.35g)。 [化合物(146)的物性] lH-NMR(DMS0-d6? ά) : 4.30(2H? s), 5.61(2H7 s), 6.19(111, d? J=8.4Hz), 7. 09 7.22(6H, m), 7·64(1Η, d, J=2,lHz), 7.71(1H, d, J:8.4Hz), 7.82(1H, dd, J二1,5 及 8·他),7·94(1Η,d,J:1.2Hz),12·78(1Η,br s)(: &lt;實施例80;l-(聯苯-4-曱基)-6-羧基-2-三氟甲基苯 並咪唑(147)之合成&gt; 依據實施例53之方法,使用1-(聯笨-4-甲基)-6-乙 氧羰基-2-三氟曱基苯並咪嗤(〇.690g)以得出1-(聯苯-4-曱基)-6-羧基-2-三氟甲基笨並咪唑(i47)(0.483g)。 [化合物(147)的物性] 本紙張尺度遍州屮國國家標準(CNS ) Μ規格(210 X 297公釐) 經妒部中Λ打卑而’,;1.τ消贽合竹杉印54 548272 A7 B7 五、發明説明(133 ) 1 腿(DMSQ-d6,ά) ·· 5·87(2Η,s),7·18(2Η,d,J:8.2Hz),7·35(1Η, t,J二7 •4Hz)3 7.44(2H3 t3 J-7.5Hz)3 7.60-7.67(4H, m)3 7.98(2H, d5 J=0.7Hz), 8.3 2(1H3 s)3 13.15(1H, s)〇 &lt;貫施例81;l-(聯苯-4-甲基)-5-羧基-2-三氟甲基苯 並咪唑(148)之合成&gt; 依據實施例53之方法,使用1-(聯苯-4-甲基)-5-乙 氧羰基-2-三氟甲基苯並咪唑(〇.38g)以得出1_(聯苯甲 基)-5-羧基-2-三氟甲基苯並咪唑(148)(0.270g)。 [化合物(148)的物性] lH-臟⑽S0-d6,0) : 5.80UH,s),7.19UH,d,J:6.3Hz),7·35(1Η3 t,J:7 • 2Hz),7·43(2Η,t,J:7.3Hz)3 7·82(1Η,d,J=8.7Hz),8.Q4UH,d,J:8.7Hz), 8.45(1H3 s)〇 &lt;實施例82;5-乙氧羰基-2_甲基笨並咪唑(149)之合 成&gt; 將還原鐵(6.64g)、乙醇(48ml)及醋酸(24ml)加入3· 乙酿胺基-4-硝基安息香酸乙酯(3.〇〇g)中,加熱迴流I〕 小時。使用過濾助劑以除去固形物,對濾液進行減壓濃 縮。將乙醇(100ml)及35%鹽酸(5.2g)加入殘渣中,加熱 迴流5小時。使用碳酸氫鈉(6 3g)中和反應液,減壓濃 縮經過濾所得之濾液。將醋酸乙酯(7〇ml)與水(70ml)加入 所得之殘渣中以進行分層。使用水洗淨有機層3次,並 使用醋酸乙酷對水層進行3次之萃取。對於所得出之有 機層進行減壓濃縮即可得出5_乙氧羰基-2_甲基笨並咪 唑(149)的粉末(l.53g)。 (讀先閱讀背面之注意事項再填寫本頁}, 1T W-NMR (DMSQ-d6, ά): 2.556 (3Η, s) 5 5.57 (2Η, s), 7.11 (1H, d, J = 8.GHz), 7.27 (1Η3 t , J: 7.2 Hz), 7.32-7.35 (2Η, m), 7.61 (1Η, d, J: 8.3Hz), 7.79 (1Η, dd, J = 8.4, and 1.3Ηζ) , 8.06 (1Η, s), 12.75UH, s). &lt; Example 72; Synthesis of 6-carboxy-2-methyl-1- (2-naphthylmethyl) benzimidazole (139) &gt; According to the method of Example 53, 6-ethoxycarbonylmethyl was used 1- (2-naphthylmethyl) benzimidazole (1.28§) to give carboxy-2-methyl-^ (2-naphthylfluorenyl, benzyl) benzimidazole (139) (0.80g) . [Physical properties of compound (139)] ^ leg (DMSO-j6, d): 2.61 (3H, s), 5.74 (2Η, s), 7.29 (1Η, d, J: 8.6Hz), 7. 46 7.52 (2Η, m), 7.59 (1H, s), 7.63 (1Η, d, J: 8.3Hz), 7.78-7 · 92 (4Η, m), 8.0 9 (! H, s) , 12,68 (1H, s). &lt; Example 73; l- (biphenyl-4-methyl) -6-fluorenylethylbenzimidazole —-------- L3-3 _____ This paper is compliant with Sichuan National Standards (CNS) A4 specifications (210X 297 mm '548272 A7 _______ B7 V. Description of the invention (131) [Physical properties of compound (142)] (Read the precautions on the back before filling in this page) W-NMRiDMSO-de, ά): 2 · 49 (3Η, s) 5 5.9K2H, s) 3 6 · 36 (1Η, pyridine J = 7 2 and 1.8Hz), 7.52 (1Η, d, J: 8.5Hz), 7.55-7 · 62 ( 2Η, m), 7.77 (1h, machine J = 85 and} • 5HZ), 8. H, d, machine 3 „z), 8.2, dd, ㈣ 4 and i 6Hz) i2 69 (n) 〇 & lt Example 76; Synthesis of 2-benzyl-5-carboxy-substituted benzyl) benzimidazole (143) &gt; 14. According to the method of Example 53, a 2-benzyl-substituted benzyl group) -5- Ethoxycarbonyl benzimidazole (0.635 g) to give 2-benzylcarboxyl 1- (2-chlorobenzyl) benzobenzyl (143) (0.488 g). [Physical Properties of Compound (143)] ^. (DMSO-de, (5): 4.27 (^ s), 5.57 (2H, S), 6.27 (1Η, d, J = 7 1Hz), 7〇6 (lH, t), 7.1〇- 7.29 (6H5 m), 7.39 (1H, d, J = 8.6Hz), 7.47 (1H, d, J, 7.9Hz), 7. Low dd, J = 1.4 and 8 , 8.21 (1Η, d, J = 12Hz), i2 &amp; s). &Lt; Example 77; 2-benzyl-6-carboxyl- (2-chlorobenzyl) benzimidazole (144) Synthesis> According to the method of Example 53, 2-benzyl-1β (2-oxobenzyl) -6-ethoxycarbonylbenzimidazole (1.00 g) was used to obtain 2_ Benzylsulfonyl_ 1-0 chlorofluorenyl) benzimidazole (144) (0.780g). [Physical properties of compound (144)] ^ -NMRiDMSO-dG, d): 4.29 (2H, s), 5.63 ( 2H, s) 5 6.28 (1H, d, J = 7.8Hz), 7 07 (1H, t, J: 7.6Hz) 5 7 · 15 (1Η, in), 7.19-7 · 29 (5Η, ffl ), 7.49 (1η, d, j: 7 4Hz), 7.70 (1Η, d, J = 8.4Hz), 7.81UH, d, J = 8.4Hz), 7.91 (1Η, s), 12 · 73 (1Η, br) 〇, this paper size Tongzhou Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 V. Description of the invention (132) &lt; Example 78; 2-section base_5_ Synthesis of benzimidobenzyl) benzimidazole (145) &gt; According to the method of Example 53, fluorenylbenzyl-4,2, 'dioxobenzyl) -5-ethoxycarbonylbenzimidazole ( 0.50 g) to give fluorenylbenzylcarboxy-1- (2,4-dichlorobenzyl) benzimidazole (145)[Physical properties of compound (14 5)] H ~ NMR (DMS0-d65 δ); 4.28 (2H s) 5 55 (? Η \ ^ 〇〇〇? 7iRH, v 〖, S), 5_55 (2H, s), 6.19 (1Η, d, J: 8. he), 7. ⑽-7.22 (6H, m), 7.4ί (1Η, d, J: 8 4Hz) 7 ^ T. 4 calls, 7.62 (1H, d, 2.2Hz), 7.79 (1H, dd, 1.5, and 8.6 · ζ), 8.22 (1Η3 s), 12.72UH, br s). &lt; Example 79; Synthesis of 2-benzylcarboxy-le (2, 'digaso-benzyl) benzimidazole (146) &gt; According to the method of Example 53, fluorenylbenzyl-1- (2 , 'Digasobenzyl) -6-ethoxycarbonylbenzimidazole (0.48g) to give 1benzylcarboxyl-1-(2,4-, monomurinofluorenyl) 146) (0.35 g). [Physical properties of compound (146)] lH-NMR (DMS0-d6? Ά): 4.30 (2H? S), 5.61 (2H7 s), 6.19 (111, d? J = 8.4Hz), 7. 09 7.22 (6H , M), 7.64 (1Η, d, J = 2, lHz), 7.71 (1H, d, J: 8.4Hz), 7.82 (1H, dd, J2, 1, 5 and 8. he), 7 · 94 (1Η, d, J: 1.2 Hz), 12.78 (1Η, br s) (&lt; Example 80; l- (biphenyl-4-fluorenyl) -6-carboxy-2-trifluoromethyl Of Benzobenzimidazole (147) &gt; According to the method of Example 53, 1- (bibenzyl-4-methyl) -6-ethoxycarbonyl-2-trifluorofluorenylbenzimidazine (〇. 690g) to obtain 1- (biphenyl-4-fluorenyl) -6-carboxy-2-trifluoromethylbenzimidazole (i47) (0.483g). [Physical properties of compound (147)] State National Standard (CNS) M specifications (210 X 297 mm) Λ beat bei 'in the jealous department ,; 1.τ eliminate the combination of bamboo and fir seal 54 548272 A7 B7 5. Description of the invention (133) 1 leg (DMSQ-d6, ά) 5.87 (2Η, s), 7.18 (2Η, d, J: 8.2Hz), 7.35 (1Η, t, J 2 7 • 4Hz) 3 7.44 (2H3 t3 J-7.5Hz) 3 7.60-7.67 (4H, m) 3 7.98 (2H, d5 J = 0.7Hz), 8.3 2 (1H3 s) 3 13.15 (1H, s) 〇 &lt; Example 81; l- (Biphenyl-4-methyl) -5-carboxy Synthesis of 2-trifluoromethylbenzimidazole (148) &gt; According to the method of Example 53, 1- (biphenyl-4-methyl) -5-ethoxycarbonyl-2-trifluoromethylbenzene was used Benzimidazole (0.38 g) to give 1_ (biphenylmethyl) -5-carboxy-2-trifluoromethylbenzimidazole (148) (0.270 g). [Physical properties of compound (148)] lH-dirty ⑽S0-d6,0): 5.80UH, s), 7.19UH, d, J: 6.3Hz), 7.35 (1Η3 t, J: 7 • 2Hz), 7.43 (2Η, t, J: 7.3Hz ) 3 7 · 82 (1Η, d, J = 8.7Hz), 8.Q4UH, d, J: 8.7Hz), 8.45 (1H3 s) 〇 Example 82; 5-ethoxycarbonyl-2-methyl Synthesis of Benzimidazole (149) &gt; Added reduced ethyl iron (6.64g), ethanol (48ml) and acetic acid (24ml) to ethyl ethyl 3-nitro-4-nitrobenzoate Medium, heated to reflux for 1 hour. A filtering aid was used to remove solids, and the filtrate was concentrated under reduced pressure. Ethanol (100 ml) and 35% hydrochloric acid (5.2 g) were added to the residue, and the mixture was heated under reflux for 5 hours. The reaction solution was neutralized with sodium bicarbonate (63 g), and the filtrate obtained by filtration was concentrated under reduced pressure. Ethyl acetate (70 ml) and water (70 ml) were added to the obtained residue to separate the layers. The organic layer was washed three times with water, and the aqueous layer was extracted three times with ethyl acetate. The obtained organic layer was concentrated under reduced pressure to obtain a 5-ethoxycarbonyl-2-methylbenzimidazole (149) powder (1.53 g). (Read the notes on the back before filling in this page}

|548272 A7 __一 B7 五、發明説明 134 [化合物(149)的物性]| 548272 A7 __ 一 B7 V. Description of the invention 134 [Physical properties of compound (149)]

Η-眶(CDCh,d) ·· 1.41(3H,t,J:6.9Hz),2·67(3Η,s),4·40(2Η,q,J二7·1 Ηζ), 7·55(1Η3 d, J二8·4Ηζ), 7·96(1Η, dd, J:8.4 及 1.5Ηζ), 8·27(1Η, d, J =1.4Hz)。 &lt;貫施例83;2-苄基-5-乙氧羰基苯並咪唑(丨50)之合 成&gt; 加熱迴流3-硝酸-4-苯基乙醯胺基安息香酸乙酯 (3.60g)之乙醇(47ml)、醋酸(23ml)及還原鐵(6.4g)之混合 物4小時。過濾出固體並濃縮濾液。將乙醇(5〇1111)與35〇/〇 鹽酸(5g)加入殘渣中,在加熱迴流下攪拌4〇小時。使用 碳酸氫納進行中和,使用三氯曱烷進行萃取。減壓濃縮 有機層,藉由矽膠柱層析法之精製而得出2-苄基-5-乙氧 羰基苯並咪唑(150)(2.30g)。 [化合物(150)的物性] ^-NMRiCDCh, δ) : 1.39(3H5 t, J=7.1Hz), 4.26(ZH3 s), 4.37(ZH, q3 J=7.1Η-orbital (CDCh, d) · 1.41 (3H, t, J: 6.9Hz), 2.67 (3Η, s), 4.40 (2Η, q, J 2 7.1 Ηζ), 7.55 (1Η3 d, J 2 8.4Ηζ), 7.96 (1Η, dd, J: 8.4 and 1.5Ηζ), 8.27 (1Η, d, J = 1.4Hz). &lt; Example 83; Synthesis of 2-benzyl-5-ethoxycarbonylbenzimidazole (50) &gt; Ethyl 3-nitro-4-phenylacetamidoaminobenzoate (3.60g) under reflux A mixture of ethanol (47 ml), acetic acid (23 ml) and reduced iron (6.4 g) was used for 4 hours. The solid was filtered off and the filtrate was concentrated. Ethanol (501111) and 35/0 hydrochloric acid (5 g) were added to the residue, and stirred under heating and refluxing for 40 hours. Neutralize with sodium bicarbonate and extract with trichloromethane. The organic layer was concentrated under reduced pressure and purified by silica gel column chromatography to give 2-benzyl-5-ethoxycarbonylbenzimidazole (150) (2.30 g). [Physical properties of compound (150)] ^ -NMRiCDCh, δ): 1.39 (3H5 t, J = 7.1Hz), 4.26 (ZH3 s), 4.37 (ZH, q3 J = 7.1

Hz), 7.22-7·36(5Η, m), 7·50(1Η, d, J=8.6Hz), 7·94(1Η, dd, J=1.5 及 8.6Hz), 7.22-7 · 36 (5Η, m), 7.50 (1Η, d, J = 8.6Hz), 7.94 (1Η, dd, J = 1.5 and 8.6

Hz), 8.23(1Η3 d3 J=1.3Hz)〇 &lt;實施例84、85;6-乙氧羰基-2-甲基-1-(2-硝基苄基) ^y、-^1中次^纠^1,;^^消於合竹^印^ (諳先閱讀背面之注意事項再填寫本頁) 苯並咪唑(151)及5-乙氧羰基-2-甲基-1-(2-硝基苄基)笨 並咪唑(152)之合成&gt; 將N,N-二甲基甲醯胺(1加1)、2_硝基苄基溴(1.59g) 及碳酸氫鈉(1.23g)加入5-乙氧羰基-2-甲基苯並咪唑 (l.OOg)中,在60°C下加熱1小時。將醋酸乙酯70ml及水 (70ml)加入反應液中以進行分層後,使用水洗淨有機層3 本纸張尺度適用中國國家標準(CNS ) A4規格(21^297^1 ) ~ —- 548272 A7 ------------------- B7 五、發明説明(135) --- 人亚使用醋酸乙g旨萃取水層3次。減壓濃縮所得之有 機層’以知出6-乙氧幾基七甲基-叩“肖基节基)苯並咪 錢^乙氧幾基-2-甲基小(2_硝基节基)苯並味唾之混合 物藉由中壓矽膠柱色譜法(溶離液:己烷/醋酸乙酯 1/4〜0/100)之精製而得丨卜乙氧幾基_2_甲基小(2-确基 苄基)苯並咪唑(151)(〇.6Mg)及5-乙氧羰基-2-曱基-K2-硝基苄基)苯並咪唑(152)(0.259g)。 [化合物(15 1)的物性] H_(CDCh,6) · 1·38(3Η,t,J:7.2Hz),2·56(3Η,s),4.37(2H,q,J二7·1 Hz),5.84(2H,s),6·41(1Η,d,J:6.8Hz),7.44-7.53(2H,m),7.78(1H,d,J: 8.6Hz),7.88(1H,s),8·02(1Η,dd,J:8.3 及 1·5Ηζ),8.30UH,dd,J=7.9 及 1,5Hz)q [化合物(152)的物性] tfiMIUCDCla,ά) : 1·42(3Η,t,J:7.0Hz),2·56(3Η,s),4.40(2H, q,J:7.0 Hz),5·80(2Η,s),6.43(1H,dd,J:7.6 及 Hz), 7·14ΠΗ,j:8.3Hz)i 7·45-7·53(2Η, m), 7.95(1H, dd, J:8.4 及 1.5Hz), 8.27(1H, dd, J:8.0 及 1.7Hz), 8.48(1H3 d, J-1.2Hz)〇 &lt;實施例86、87;2·苄基-l-(2_氯代苄基)_6_乙氧羰基 苯並咪唑(l53)及2-苄基-1_(2_氣代苄基乙氧羰基笨 並咪唑(154)之合成&gt; 依據實施例84、85之方法,使用2_苄基-5-乙 氧羰基苯並咪唑(2.37g)與2-氯代苄基溴(3.94g)以得 出2-卞基-1-(2-氯代节基)-6-乙氧幾基苯並味嗤 (153)(1.06g)及2-卞基-1 -(2-氣代节基)-5 -乙氧幾基苯並u米σ坐 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁) 訂 Φ. 548272 A7 B7 五、發明说明(136^ (154) (0.640g)。 [化合物(153)的物性]Hz), 8.23 (1.33 d3 J = 1.3 Hz) &lt; Examples 84, 85; 6-ethoxycarbonyl-2-methyl-1- (2-nitrobenzyl) ^ y,-^ 1 ^^^ 1,; ^^ 消 于 合 竹 ^ 印 ^ (谙 Please read the precautions on the back before filling this page) Benzimidazole (151) and 5-ethoxycarbonyl-2-methyl-1- (2 -Nitrobenzyl) Benzimidazole (152) Synthesis> N, N-dimethylformamide (1 plus 1), 2-nitrobenzyl bromide (1.59g) and sodium bicarbonate (1.23 g) Add 5-ethoxycarbonyl-2-methylbenzimidazole (1000 g) and heat at 60 ° C for 1 hour. After adding 70 ml of ethyl acetate and water (70 ml) to the reaction solution for layer separation, the organic layer was washed with water. 3 The paper size is in accordance with China National Standard (CNS) A4 (21 ^ 297 ^ 1) ~ --- 548272 A7 ------------------- B7 V. Description of the invention (135) --- Human Asia uses ethyl acetate for 3 times to extract the water layer. The organic layer obtained by concentration under reduced pressure was used to obtain 6-ethoxyquinyl heptamethyl-fluorenyl "shawyl" benzimidin ^ ethoxy-2-yl small (2-nitrobenzyl) ) The mixture of benzoic saliva was purified by medium pressure silica gel column chromatography (eluent: hexane / ethyl acetate 1/4 ~ 0/100) to obtain buethoxyquinyl-2-methyl small ( 2-Azylbenzyl) benzimidazole (151) (0.6Mg) and 5-ethoxycarbonyl-2-fluorenyl-K2-nitrobenzyl) benzimidazole (152) (0.259g). [Compound (15 1) Physical properties] H_ (CDCh, 6) · 1.38 (3Η, t, J: 7.2Hz), 2.56 (3Η, s), 4.37 (2H, q, J = 7.1 Hz) , 5.84 (2H, s), 6.41 (1Η, d, J: 6.8Hz), 7.44-7.53 (2H, m), 7.78 (1H, d, J: 8.6Hz), 7.88 (1H, s), 8 · 02 (1Η, dd, J: 8.3 and 1.5Ηζ), 8.30UH, dd, J = 7.9 and 1,5Hz) q [physical properties of compound (152)] tfiMIUCDCla , ά): 1.42 (3Η, t, J: 7.0 Hz), 2.56 (3Η, s), 4.40 (2H, q, J: 7.0 Hz), 5.80 (2Η, s), 6.43 (1H, dd, J: 7.6 and Hz) , 7.14ΠΗ, j: 8.3Hz) i 7.45-7.53 (2Η, m), 7.95 (1H, dd, J: 8.4 and 1.5Hz), 8.27 (1H, dd, J: 8.0 and 1.7Hz ), 8.48 (1H3 d, J-1.2 Hz) &lt; Examples 86, 87; 2 · Benzyl-l- (2-chlorobenzyl) -6-ethoxycarbonylbenzimidazole (l53) and 2-benzyl-1_ (2_ Synthesis of gasified benzylethoxycarbonylbenzimidazole (154) &gt; According to the method of Examples 84 and 85, 2-benzyl-5-ethoxycarbonylbenzimidazole (2.37g) and 2-chlorobenzyl were used Bromide (3.94g) to give 2-fluorenyl-1- (2-chlorobenzyl) -6-ethoxyepibenzobis (153) (1.06g) and 2-fluorenyl-1- (2-Azoyl) 5-Ethoxybenzoyl benzophenone sigma paper size of this paper applies Chinese National Standard (CNS) A4 specification (210X 297 mm) (Read the precautions on the back before filling in this 548272 A7 B7 V. Description of the invention (136 ^ (154) (0.640g). [Physical properties of compound (153)]

Hz), 5.36(2H, s), 6·23(1Η, d, J:7.8Hz), 6·97(1Η, t, J:7.6Hz), 7.1卜7 45( 7H,m)5 7,85(1H,d3 J:8.5Hz),7.91(1H,s),8.02UH,dd,J:i.2 &amp; δ 6Hz )〇 [化合物(154)的物性]Hz), 5.36 (2H, s), 6.23 (1Η, d, J: 7.8Hz), 6.97 (1Η, t, J: 7.6Hz), 7.1b 7 45 (7H, m) 5 7, 85 (1H, d3 J: 8.5Hz), 7.91 (1H, s), 8.02UH, dd, J: i.2 & δ 6Hz) [Physical properties of compound (154)]

^-NMRiCDCla, δ) : 1.41(3Η3 t3 J-7.1Hz)3 4.25(2H3 s), 4.41(2H, q3 j^A Hz), 5·33(2Η3 s), 6·22(1Η3 d5 J二6.9Hz), 6.97(1H, t, J二7·6Ηζ)3 7.12~7.28 (7H5 m)3 7·40(1Η? d5 J=8.0IIz)t 7.95(1H, dd5 J^i.6 R 8.6Hs); 8.60(lH d,J二 1·他)。 &lt;實施例88、89;2_苄基-l-(2,4-二氯代苄基)_6_乙氧 羰基苯並咪唑(I55)及2_苄基-l-(2,4-二氯代苄基)_5_乙氧 羰基苯並咪唑(156)之合成&gt; 依據實施例84、85之方法,使用2_苄基-5-乙氧幾 基苯並咪唑(2.37g)與2,4-二氣代苄基溴(4.45g)以得出2_ 苄基-1-(2,4-二氯代苄基)_6·乙氧羰基苯並咪唾 經y部中次i?.^-^h 3消资合竹私印來 (讀先閱讀背面之注意事項再填寫本頁j (155) (0.49g)及2_苄基小(2,4-二氣代苄基)_%乙氧魏基笨 並咪唑(156)(0.52g)。 [化合物(155)的物性] ^-NMRiCDCh, d) : L39(3H3 t), 4.24(2H, s), 4.37(2H, q)5 5.32(2HS s), 6·08(1Η,d,J=8.3Hz),6·90(1Η,d,J=8.4ilz),7.12-7·24(5Η, m),7.41(ih s ),7·84(1Η, i J:8.4Hz), 7·88(1Η, s), 8.G3(1H, d, J:8.4Hz)。 [化合物(156)的物性] 本紙張尺度適W國國家標準(CNS ) A4規格(210x29m ) ---— ------ 548272 A7 __ B7 五、發明説明(137) lH-NMR(CDCl3, δ) : 1.42(3H, t5 J-7.1Hz)5 4.25(2H, s), 4.4i(2H, q j Hz), 5·28(2Η, s), 6·07(1Η, d, J=8.4Hz), 6·90(1Η, dd, J二1·9 及 8 4Hz) 7·08-7·28(6Η, m), 7·40(1Η, d, J二2·1Ηζ), 7·96(1Η, dd, J二1·3 及 8 3Ηζ) 8·56(1Η, d, J=0.9Hz)。 &lt;實施例90;5-乙氧羰基-2-三氟甲基苯並咪唑(157) 之合成〉 將5%把/石反(0.50g)加入3 -胺基-4-硝基-安息香酸乙 酯(4.00g)之曱醇(100ml)溶液中,在氫環境氣體下、5(rc 攪拌16小時。過濾出固體,藉由濃縮濾液以得出3,4_ 二胺基安息香酸乙酯。將三氟醋酸(20ml)加入其中並在 6〇°C攪拌2小時。濃縮反應液,藉由過濾、乾燥經加入 三氣甲烧所析出之結晶而得出5-乙氧羰基-2-三氟i甲基 苯並咪唑(l57)(4.46g)。 [化合物(157)的物性] 1NMR(DMS0-d6,(5) : 1·36(3Η,t3 J:7.0Hz),4·36(2Η,q3 J:7.0Hz),7 82(1 H3 d, J:8.5Hz), 7·99(1Η, dd, J=1.5 及 8·7Ηζ), 8·33(1Η, s)。 好浐旬中^;i?準^hJr.消费合竹打卬f (誚先閱讀背面之注意事項再填寫本頁) &lt;實施例91、92; 1-(聯苯-4-曱基)-6-乙氧羰基-2_三 氟甲基苯並咪唑(158)及1-(聯苯-4-曱基)-5-乙氧幾基_2_ 三氟甲基多並咪唑(I59)之合成〉 依據實施例84、85之方法,使用5-乙氧羰基三 氟甲基笨並咪唾(2.00g)及4-溴曱基聯苯(1〇 〇gg)以得出 1-(聯苯-4-甲基)-6-乙氧羰基-2-三氟甲基苯並咪唑 (158)(0.69g)及1-(聯笨-4-甲基)-5-乙氧羰基-2-三氟曱基 苯並咪唑(159)(0.38g)。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297U^ ) ----- 548272 kl B7 麪浐部中戎榀卑而,,^^消贽合竹^印掣 五、發明説明(13θ [化合物(158)的物性] 醒(CDCh,0) : 1.39(3H,t),4·38(2Η,q),5.64(2H,s),7.18(2H,d3 J 二8·2Ηζ), 7.34(1H, t, J:7.4Hz), 7·42(2Η, t, J=7.4Hz), 7·52-7·57(4Η, m), 7 • 95(1H,d,J=8.8Hz),8·09(2Η,dd,J二 1.4 及 8·8Ηζ),8· 14( 1H,d,J=MHz )〇 [化合物(159)的物性]^ -NMRiCDCla, δ): 1.41 (3Η3 t3 J-7.1Hz) 3 4.25 (2H3 s), 4.41 (2H, q3 j ^ A Hz), 5.33 (2Η3 s), 6.22 (1Η3 d5 J 6.9Hz), 6.97 (1H, t, J = 7 · 6Ηζ) 3 7.12 ~ 7.28 (7H5 m) 3 7.40 (1Η? D5 J = 8.0IIz) t 7.95 (1H, dd5 J ^ i.6 R 8.6 Hs); 8.60 (lH d, J 2: 1 · he). &lt; Examples 88 and 89; 2-benzyl-l- (2,4-dichlorobenzyl) -6-ethoxycarbonylbenzimidazole (I55) and 2-benzyl-l- (2,4- Synthesis of dichlorobenzyl) _5_ethoxycarbonylbenzimidazole (156) &gt; According to the method of Examples 84 and 85, 2-benzyl-5-ethoxyquinylbenzimidazole (2.37g) and 2,4-Dioxobenzyl bromide (4.45g) to give 2_benzyl-1- (2,4-dichlorobenzyl) _6 · ethoxycarbonylbenzimidyl salivate in the middle part of y? . ^-^ h 3 Consumers' private seal (Read the precautions on the back before filling in this page j (155) (0.49g) and 2_benzyl small (2,4-dioxobenzyl)) _% Ethoxybenzylbenzimidazole (156) (0.52g). [Physical properties of compound (155)] ^ -NMRiCDCh, d): L39 (3H3 t), 4.24 (2H, s), 4.37 (2H, q ) 5 5.32 (2HS s), 6.08 (1Η, d, J = 8.3Hz), 6.90 (1Η, d, J = 8.4ilz), 7.12-7 · 24 (5Η, m), 7.41 (ih s), 7.84 (1Η, i J: 8.4Hz), 7.88 (1Η, s), 8.G3 (1H, d, J: 8.4Hz). [Physical properties of compound (156)] This paper is suitable for the national standard (CNS) A4 size (210x29m) ----- ------ 548272 A7 __ B7 V. Description of the invention (137) lH-NMR (CDCl3 , δ): 1.42 (3H, t5 J-7.1Hz) 5 4.25 (2H, s), 4.4i (2H, qj Hz), 5.28 (2Η, s), 6.07 (1Η, d, J = 8.4Hz), 6.90 (1Η, dd, J2 1.9 and 8 4Hz) 7.08-7 · 28 (6Η, m), 7 · 40 (1Η, d, J2 2.12ζ), 7 96 (1Η, dd, J 2 1.3 and 8 3Ηζ) 8.56 (1Η, d, J = 0.9Hz). &lt; Example 90; Synthesis of 5-ethoxycarbonyl-2-trifluoromethyl benzimidazole (157)> 5% / stone (0.50 g) was added to 3-amino-4-nitro-benzoin In a solution of ethyl acetate (4.00 g) in methanol (100 ml), under hydrogen atmosphere, stir at 5 (rc for 16 hours. The solid was filtered, and the filtrate was concentrated to obtain 3,4-diaminobenzoic acid ethyl ester. Trifluoroacetic acid (20 ml) was added thereto and stirred at 60 ° C. for 2 hours. The reaction solution was concentrated, and the crystals precipitated by adding trifluoromethane were filtered and dried to obtain 5-ethoxycarbonyl-2- Trifluoroimethylbenzimidazole (l57) (4.46g). [Physical properties of compound (157)] 1NMR (DMS0-d6, (5): 1.36 (3Η, t3 J: 7.0Hz), 4.36 (2Η, q3 J: 7.0Hz), 7 82 (1 H3 d, J: 8.5Hz), 7.99 (1Η, dd, J = 1.5 and 8.7Ηζ), 8.33 (1Η, s). OK浐 中 中 ^; i? Quasi ^ hJr. Consumption and Bamboo 卬 f (诮 Please read the precautions on the back before filling in this page) &lt; Examples 91, 92; 1- (biphenyl-4-fluorenyl)- Of 6-ethoxycarbonyl-2_trifluoromethylbenzimidazole (158) and 1- (biphenyl-4-amidino) -5-ethoxychiyl_2_trifluoromethyl polyimidazole (I59) Synthesis> Basis In the method of Examples 84 and 85, 5-ethoxycarbonyltrifluoromethylbenzimidazole (2.00 g) and 4-bromofluorenylbiphenyl (100gg) were used to obtain 1- (biphenyl-4 -Methyl) -6-ethoxycarbonyl-2-trifluoromethylbenzimidazole (158) (0.69g) and 1- (biben-4-methyl) -5-ethoxycarbonyl-2-trifluoro Pyridyl benzimidazole (159) (0.38g). This paper size is applicable to the Chinese National Standard (CNS) A4 (210X297U ^) ----- 548272 kl B7 The middle part of the noodles is humble, ^^ 消竹 合 竹 ^ 印 掣 5. Description of the invention (13θ [physical properties of compound (158)] Xing (CDCh, 0): 1.39 (3H, t), 4.38 (2Η, q), 5.64 (2H, s), 7.18 (2H, d3 J 2: 8.2Ηζ), 7.34 (1H, t, J: 7.4Hz), 7.42 (2Η, t, J = 7.4Hz), 7.52-7 · 57 (4Η, m) , 7 • 95 (1H, d, J = 8.8Hz), 8.09 (2Η, dd, J = 1.4 and 8.8Ηζ), 8.14 (1H, d, J = MHz) 〇 [Compound (159) Physical properties]

4-醒(CDC13,6) : 1·40(3Η,t),4·40(2Η3 q),5·59(2Η,s),7.16(2H,d,J =8.1Hz)3 7.34(2H3 t3 J=6.2Hz)3 7.41(2H3 t3 J-7.5Hz)3 7.53(4H3 m)3 8.08(1 H, dd, J=1.3 及 9.1Hz), 8·65(1Η, s)。 &lt;製造例38; 1-(2-氯代苄基)-6-羥基甲基_2_甲基苯 並咪唑之製造&gt; 在20〜25°C下慢慢地將1-(2-氯代苄基)_6_乙氧羰基 -2-甲基苯並咪唑(2.66g)之四氫呋喃(2〇ml)溶液加入氫化 鉀銘(1.54g)之四氫σ夫喃(2 0ml)溶液中。接著,在室溫下 授拌1小時。加入四氫吹喃3 0ml以稀釋反應液。加入 飽和硫酸鈉水溶液以分解、固化氫化鉀銘,藉此以分離 出四氫決喃層。蒸餾除去溶媒,藉由矽膠柱色譜(溶離 液:三氯曱烷/甲醇=9/1)之精製以得出i_(2-氯代苄基)_ 6-¾基甲基-2 -曱基笨並蛛σ坐(145 g)。 [化合物的物性] ^-NMRiCDCla, δ) : 2.53(3Η3 s), 4.77(2H3 s)5 5.39(2H, s)3 6.40(1H, d3 J=7.7Hz), 7·08(1Η, t, J二7·7Ηζ), 7·20-7·28(3Η, m)3 7·45(1Η, d, J二7·9Ηζ), 7.70(1H, d, JH=8.2Hz)。 &lt;製造例39,1 -(聯本甲基)_6-經甲基_2-甲基苯並味 本紙張尺度適用中國國家標率(CNS ) A4規格(2H)x 297公鐘) (請先閱讀背面之注意事項再填寫本頁) 、\ί 口 .91. Μ^.、·δ1中^i?^-^h,T^)费合竹*1印t 548272 A7 B7 五、發明説明(139) 。坐之製造&gt; 依據製造例38之方法,使用1兴聯苯-4_甲基乙 氧羰基-2-甲基苯並咪唑(5.3〇g)與氫化鉀鋁(2.17g)以得 出1-(聯苯-4-甲基)-6-羥甲基-2-甲基苯並咪唾(3.72g)。 [化合物的物性]4-wake (CDC13, 6): 1.40 (3Η, t), 4.40 (2Η3 q), 5.59 (2Η, s), 7.16 (2H, d, J = 8.1Hz) 3 7.34 (2H3 t3 J = 6.2Hz) 3 7.41 (2H3 t3 J-7.5Hz) 3 7.53 (4H3 m) 3 8.08 (1 H, dd, J = 1.3 and 9.1Hz), 8.65 (1Η, s). &lt; Production Example 38; Production of 1- (2-chlorobenzyl) -6-hydroxymethyl-2-methylbenzimidazole &gt; The 1- (2- Chlorobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (2.66g) in tetrahydrofuran (20ml) was added to a solution of potassium hydride (1.54g) in tetrahydroσfuran (20ml). . Then, it was stirred at room temperature for 1 hour. 30 ml of tetrahydropyran was added to dilute the reaction solution. A saturated aqueous sodium sulfate solution was added to decompose and solidify the potassium hydride, thereby separating the tetrahydrocaran layer. The solvent was distilled off and purified by silica gel column chromatography (eluent: trichloromethane / methanol = 9/1) to obtain i_ (2-chlorobenzyl) _ 6-¾ylmethyl-2 -fluorenyl Stupid spider σ sitting (145 g). [Physical properties of compound] ^ -NMRiCDCla, δ): 2.53 (3Η3 s), 4.77 (2H3 s) 5 5.39 (2H, s) 3 6.40 (1H, d3 J = 7.7Hz), 7.08 (1Η, t, J 2 7 · 7Ηζ), 7.20-7 · 28 (3Η, m) 3 7 · 45 (1Η, d, J 2 7.9 · ζ), 7.70 (1H, d, JH = 8.2 Hz). &lt; Manufacturing Example 39,1-(bibenzylmethyl) _6-Methylbenzyl-2-methylbenzol This paper is sized for China National Standards (CNS) A4 (2H) x 297 meters) (Please Read the precautions on the back before filling in this page), \ ί 口. 91. Μ ^., Δ1 in ^ i? ^-^ H, T ^) Feizhu * 1print t 548272 A7 B7 V. Description of the invention (139). Production of the seat> According to the method of Production Example 38, using 1-xylbiphenyl-4-methylethoxycarbonyl-2-methylbenzimidazole (5.30 g) and potassium aluminum hydride (2.17 g) to obtain 1 -(Biphenyl-4-methyl) -6-hydroxymethyl-2-methylbenzimidal (3.72 g). [Physical properties of compound]

H-NMR(CDC1:3,5) · 2·59(3Η,s),4·78(2Η,s),5·37(2Η,s)3 7.11(2H,d,J -8·3Ηζ)3 7.24(1Η, d, J~8.3Hz), 7.30~7.37(2Η, in), 7·42(2Η, t), 7 51~7 56( 4Η, m), 7.70(1Η, d, J=8.2Hz)。 &lt;製造例40;l-(2-氯代苄基)-6-氣甲基-2-甲基苯並 咪唑鹽酸鹽之製造&gt; 將將氣化亞硫醯(5ml)加入1-(2-氣代节基)-6-經甲 基-2-甲基苯並咪唑(3.56g)中,在室溫、2(TC、80°C下分 別攪拌20分。經減壓蒸餾以除去過剩的氯化亞硫醯後, 將殘渣溶解於三氯甲烧(1 〇ml)中,加入己烧以使其結晶 化。過慮出結晶’藉由己烧之洗淨、乾燥以得出1_(2一 氯代苄基)-6-氯曱基-2-曱基苯並咪唑鹽酸鹽4.〇7g。 [化合物的物性] lH-NMR(CDCl35 δ) : 3.0Κ3Η, s)3 4.68(2H, s), 5.61(2H, s)5 6.71(1H3 d5 J 二7·5Ηζ), 7·24-7·29(1Η, m)3 7·38(1Η, t, J:7.7Hz), 7.44(1H, s), 7.52(2H, d ,J=8.2Hz), 7.92(1H, d, J二8·4Ηζ)。 〈製造例41;l-(聯苯-4-曱基)-6-氯曱基-2-曱基苯並 咪唑之製造&gt; 在室溫下將氯化亞硫醯(2ml)加入1-(聯笨-4-甲基)_ 6-¾曱基-2-甲基苯並咪唑(3.62g)之三氯甲烷溶液(3〇mi) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁)H-NMR (CDC1: 3,5) · 2.59 (3Η, s), 4.78 (2Η, s), 5.37 (2Η, s) 3 7.11 (2H, d, J -8 · 3 ζ) 3 7.24 (1Η, d, J ~ 8.3Hz), 7.30 ~ 7.37 (2Η, in), 7.42 (2Η, t), 7 51 ~ 7 56 (4Η, m), 7.70 (1Η, d, J = 8.2Hz). &lt; Production Example 40; Production of l- (2-chlorobenzyl) -6-gasmethyl-2-methylbenzimidazole hydrochloride &gt; Gasified thionyl chloride (5ml) was added to 1- (2-Azobenzyl) -6-methyl-2-methylbenzimidazole (3.56g), stirred at room temperature, 2 (TC, 80 ° C) for 20 minutes. Distilled under reduced pressure to After removing the excess thionyl chloride, the residue was dissolved in trichloromethane (10 ml), and hexane was added to crystallize it. The crystals were filtered out, washed and dried to obtain 1_ (2-chlorobenzyl) -6-chlorofluorenyl-2-fluorenylbenzimidazole hydrochloride 4.07 g. [Physical properties of the compound] lH-NMR (CDCl35 δ): 3.0K3Η, s) 3 4.68 (2H, s), 5.61 (2H, s) 5 6.71 (1H3 d5 J 2 7.5Ηζ), 7.24-7 · 29 (1Η, m) 3 7 · 38 (1Η, t, J: 7.7Hz) , 7.44 (1H, s), 7.52 (2H, d, J = 8.2Hz), 7.92 (1H, d, J = 8 · 4Ηζ). <Manufacturing Example 41; Production of 1- (biphenyl-4-fluorenyl) -6-chlorofluorenyl-2-fluorenylbenzimidazole &gt; Add thionyl chloride (2ml) at room temperature to 1- (Biben-4-methyl) _ 6-¾fluorenyl-2-methylbenzimidazole (3.62g) in trichloromethane solution (30mi) The paper size is applicable to China National Standard (CNS) A4 specifications ( 210X 297 mm) (Read the precautions on the back before filling this page)

548272 A7 B7548272 A7 B7

五、發明説明(14〇) --S 中,在60 C下攪拌1小時。加入碳酸氫鈉水溶液,停止 反應,並乾燥、水洗三氯曱烷層。經減壓蒸餾以除去溶 媒後,加入醋酸乙酯以使其結晶化。過濾出結晶,藉由 醋酸乙醋之洗淨、乾燥以得出(聯苯-4_甲基)_6_氯甲基 -2-曱基苯並咪唑2.04g。 [化合物的物性] lH-NMR(CDCl33 δ) : 2.67(3H, s)3 4.71(2H5 s), 5.40(2H3 s), 7.12(2H, d, J 二8.2Hz), 7·31_7·38(3Η, m), 7·43(2Η, t), 7·52-7·58(4Η, m), 7.75(1H, d, &gt; 8·2Ηζ)〇 &lt;製造例42; 1-(2-氯代苄基)-6-甲醯基-2-曱基苯旅 咪唑之製造&gt; 將二氧化錳(3.46g)加入1-(2-氯代苄基)-6-羥甲基-2-曱基苯並咪唑(3.46g)之曱苯(l〇〇ml)溶液中,一面藉由 分子篩4A脫水同時進行3.5小時之加熱迴流。過濾出固 體,使用三氯甲烷洗淨。濃縮濾液而得出1-(2-氯代苹 基)-6-曱醯基-2-曱基苯並咪唑3.35g。 [化合物的物性] 'H-NMRiCDCh, 6) : 2.61(3H, s)5 5.48(2H, s), 6.42(1H, d, J=7.8Hz), 7*U (1H, t, J=7.6Hz), 7·27(1Η, t), 7.48(1H, d, J二8·0Ηζ), 7·76(1Η, s), 7*81(1 H,dd,&lt;Μ·4 及 8·3Ηζ),7·86(1Η,d,J二8·3Ηζ),10·02(1Η,s)。 IR(KBr) : 1676(^0 mp : 124.1 — 125.2°C。 &lt;製造例43; 1-(2-氣代苄基)-2-曱基苯並咪唑-6-乙 腈之製造&gt; 本紙張尺度適用中i國家標準(CNS ) A4規格(210/ 2971^ ) (讀先閱讀背面之注意事項爲填寫本畜〇V. Description of the invention (14〇) -S, stir at 60 C for 1 hour. An aqueous sodium hydrogen carbonate solution was added to stop the reaction, and the trichloromethane layer was dried and washed with water. After removing the solvent by distillation under reduced pressure, ethyl acetate was added to crystallize. The crystals were filtered, washed with ethyl acetate, and dried to obtain 2.04 g of (biphenyl-4-methyl) -6-chloromethyl-2-fluorenylbenzimidazole. [Physical properties of the compound] lH-NMR (CDCl33 δ): 2.67 (3H, s) 3 4.71 (2H5 s), 5.40 (2H3 s), 7.12 (2H, d, J 8.2Hz), 7 · 31_7 · 38 ( 3Η, m), 7.43 (2Η, t), 7.52-7 · 58 (4Η, m), 7.75 (1H, d, &gt; 8 · 2Ηζ) 〇 &lt; Manufacture example 42; 1- (2 -Chlorobenzyl) -6-methylamino-2-fluorenylbenzimidazole &gt; Manganese dioxide (3.46g) was added to 1- (2-chlorobenzyl) -6-hydroxymethyl- A solution of 2-fluorenylbenzimidazole (3.46 g) in toluene (100 ml) was dehydrated with molecular sieve 4A while heating and refluxing for 3.5 hours. The solid was filtered and washed with chloroform. The filtrate was concentrated to give 3.35 g of 1- (2-chloroimidyl) -6-fluorenyl-2-fluorenylbenzimidazole. [Physical properties of compound] 'H-NMRiCDCh, 6): 2.61 (3H, s) 5 5.48 (2H, s), 6.42 (1H, d, J = 7.8Hz), 7 * U (1H, t, J = 7.6 Hz), 7 · 27 (1Η, t), 7.48 (1H, d, J = 8 · 0Ηζ), 7.76 (1Η, s), 7 * 81 (1 H, dd, &lt; M · 4 and 8 · 3Ηζ), 7.86 (1Η, d, J 2 8.3Ηζ), 10 · 02 (1Η, s). IR (KBr): 1676 (^ 0 mp: 124.1-125.2 ° C. &Lt; Production Example 43; Production of 1- (2-Gasoxybenzyl) -2-fluorenylbenzimidazole-6-acetonitrile &gt; The paper size applies the Chinese National Standard (CNS) A4 specification (210/29711). (The first note on the back is to fill in this animal.)

1T Φ1. 548272 A7 __________________B7 五、發明説明(141) ^ — 將氰化鉀(0.450g)及18-冠醚-6(0.450g)加入1-(2-氯代 苄基)-6-氯甲基士甲基笨並咪唑〇 ·2〇幻之二甲基亞砜 (10ml)溶液中,在室溫下攪拌18小時。加入三氯甲烷、 水及少量之氨水,並進行萃取。濃縮有機層以得出殘渣, 藉由矽膠柱色譜(溶離液:三氣甲烧/甲醇=2〇/1)之精製以 得出1_(2_氣代苄基)-2-甲基苯並咪唑_6_乙腈(〇 5〇〇g)。 [化合物的物性] ^-NMRiCDCh, δ) : 2.52(3H3 s), 3.80(2H5 s), 5.37(2H3 s), 6.40(1H, d, J =7.6Hz),7.09(lH,t),7.10-7.19(2H,m),7.23(lH,t),7,44(lH,d,J=7.9Hz )3 7.70(1H3 d3 J-8.2Hz)〇 &lt;製造例44;6-羧基-1-(2-氯代苄基)苯並咪唑之製造&gt; 將98%之蟻酸(〇.5ml)加入依據美國專利第5294631 號所揭示之方法所合成之4-胺基_3-(2-氣代苄基)胺基安 息香酸(0.490g)中’迴流1小時。收集反應液中析出之固 體。藉由水洗、乾燥以得出6-羧基-1-(2-氯代苄基)苯並 口米唾 0.468g。 [化合物的物性] W-NMiUDMSO-dG,6) : 5·69(2Η,s),7.02(1H,dd,J:1.5 及 7.7Hz),7.30( 1H,t,J二7.5Hz),7·36(1Η5 dt,J=1.7 及 7.5Hzh 7·53(1Η, dd,J=1.3 及 7.9Hz), 7·75(1Η, d5 J二8·4Ηζ), 7·83(1Η, dd, J=1.5 及 8·4Ηζ), 8.09(1H, s), 8.54(1H, s), 12.8(1H, br s)〇 &lt;實施例93;l-(2-氯代苄基)-6-乙氧羰基-2-甲基苯 並咪唑(92)之合成&gt; 將2-氣代苄基溴(l〇〇g)加入4-乙醯胺基-3-胺基安息 -------14S___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 、11 548272 A7 -------------------- B7 五、發明説明(142)' ' &quot;&quot; ~·—一 ' 香酸乙酯(86.0g)與碳酸鈣(37 3g)之乙醇(75〇mi)溶液 中,在60°C下授拌14小時。過滤出固體,對遽液進行 減壓而濃縮至500ml。加入35%鹽酸(38 7g),在6〇它下 攪拌2小時。過濾出固體,經碳酸氫鈉中和後,減壓蒸 餾以除去乙醇。加入醋酸乙酯及水,進行萃取(3次)。經 水洗、乾燥有機層後,蒸餾除去溶媒直到有機層為3〇〇mi 止。過濾出析出之結晶,藉由乙醇之再結晶以得出丨_(2_ 氯代苄基)-6-乙氧羰基_2_甲基苯並咪唑54 3g。又,收集 所有的濾液,藉由乙醇之再結晶經濃縮所得出之結晶以 得出1-(2-氣代苄基)_6_乙氧羰基士甲基苯並咪唑 (92)18.lg 〇 [化合物(92)的物性] ^ ,57(3, s)5 ,37(2H3 q3 ,,, '5 5,46(2H3 S), 6-41(1H5 di J=?-8HZ^ 7-l〇(lH3 t3 J,7.8Hz)3 7.25(1H3 .7.47(1H, d5 J,8.0Hz)3 7.75(1H5 d, J,8.4Hz)5 7.94(1H3 s), 8.00(1H3 d d, J二1.5 及 8·4Ηζ)。 mp : 126.0 —127·0Τ。 &lt;貝鈀例94;6-羧基-1-(2-氯代苄基)-2_甲基苯並咪 唑(121)之合成&gt; 將10/。氫氧化鈉水溶液(24〇g)與乙醇(2〇〇ml)加入 1-(2-氯代苄基)-6-乙氧羰基-2-甲基苯並咪唑(6〇 〇g)中, 加熱迴流2小時。冷卻後,使用1〇%鹽酸將反應液調整 成pH6過澹、乾燥所析出之結晶而得出6-竣基-1-(2-氯代苄基)·2-甲基苯並咪唑021)(54.7g)。 本紙張尺度制巾國國家標準(CNS ) A4規格(21Gxl^^ (讀先閱讀背面之注意事項再填寫本頁) 1 丁 奉 548272 A7 B7 五、發明説明(143) [化合物(121)的物性] 旧-臟_0_(16,6) : 2·51(3Η,s),5·62(2Η,s),6·54(1Η,d,J:7.7Hz)3 7· (請先閱讀背面之注意事項再填寫本頁 23(1H3 t, J:7.5Hz), 7·33(1Η,t3 J:7.7Hz),7·55(1Η,d,J:8.z),7·63(1Η, d5 J=8.4Hz)3 7.79(1H, d5 J=8.4Hz), 7.95(1H, s)〇 inp : 300.8 —303.0oC〇 &lt;實施例95;l-(2-氯代苄基)-2-甲基苯並咪唑-6_醋 酸(160)之合成&gt; 將10°/。鹽酸加入1-(2-氯代苄基)-2-甲基苯並咪唑_ 6-乙腈(0.500g)中,加熱迴流15小時,使用飽和碳酸氫 鈉水溶液進行中和,使用三氯甲烷進行萃取。濃縮有機 層’藉由矽膠柱色譜(溶離液:三氯甲烷/甲醇=9/1〜4/1) 、11 之精製以得出1-(2-氯代苄基)-2-甲基苯並咪唑-6-醋酸 (160)(0.170g)。 [化合物(160)的物性] ^-NMRCCDCh, 6) : 2.42(3H, s), 3.56(2H, s)3 5.15(2H3 s) 3 6.33( 1H5 d)3 6·96(1Η, t), 7·〇3(1Η, s), 7·13(2Η, m), 7·35(1Η, d, J:7.9Hz), 7·62(1Η, d) ,8·90(1Η, br s)0 &lt;實施例96; 1-(2-氯代苄基)-2-甲基苯並咪唑-6-丙 稀酸曱酯(161)之合成&gt; 將三苯基磷醢^醋食曱酯(4.49g)加入1-(2_氯代苄基)一 6-曱醯-2-曱基苯並咪唑(2.73幻之二噁烷(5〇ml)溶液 中’在加熱迴流下攪拌6小時。冷卻反應液後,餾除溶 媒’藉由矽膠柱色譜(溶離液:三氣甲烷/甲醇=9/1)之精 製殘渣而得出H2-氣代苄基)_2_甲基苯並咪唑_6_丙烯酸 本紙張尺料财關€榡準(CNS ) Α4規;(ΓΠΓ0Χ297Ά ) 548272 A7 B7 五、發明説明(144) ^— 甲酯(161)之粗精製物743g。將此粗精製物直接用於以 下之反應。 (請先閱讀背面之注意事項再填寫本頁) &lt;貫施例97;1-(2-氯代苄基)-2-甲基苯並咪唑丙 烯酸(162)之合成&gt; 將上述之1-(2-氯代卞基)_2_甲基苯並味唾丙烯 酸甲酯(161)之粗精製物3·29§溶解於乙醇(2〇mi)中,加 入5%氫鈉水溶液(10.lg),迴流2小時。使用鹽酸水溶液 中和反應液,將經減壓濃縮溶媒所得之殘渣藉由矽膠柱 色譜(溶離液··三氯甲烷/甲醇=9/1〜6/1)之精製以得出^ 〇氯代苄基)_2_甲基苯並咪唑_6_丙烯酸(162)i 1〇g。 [化合物(162)的物性] 4-賺⑽S0-d6, ά) : 2·56(3Η,s),5·65(2Η,s)3 6·54(1Η,d,#15·9Ηζ),6 • 62(1H,d,J:7』Hz),7·25(1Η,t),7·35(1Η,t),7·56(1Η,d,J:8.1Hz),7 6 〇-7.7G(3H, m), 7·99(1Η, s), 12.35(1H, br s)。 &lt;貫施例98;6-苯績酿基氨基甲酿基氣代苄 基)-2-曱基苯並味唾(163)之合成&gt; 將N,N -魏基二味唾⑷七冰入卜鲮基小(2_氣代节 基)-2-甲基苯並咪唑(45.0g)之N,N-二甲基甲醯胺(95〇ml) 溶液中,在室溫下授拌1小時。接著,加入笨石夤醢胺(471g) 及二氮二環十一烯(35.0g),在100°C下攪拌7〇小時。冷 卻反應液,在減壓下蒸餾除去溶媒。將水(3〇〇ml)及曱醇 (200ml)加入殘渣中,接著加入35%鹽酸(6〇7g)以將溶液 調整成ρΗ5·5。過濾出所析出的結晶,以曱醇與水(1/1) 之混合液(200ml)洗淨,經乾燥以得出6•笨磺醯基氨基曱 本紙張尺度適用中國國家標準(CNS ) A4規格(210x^97^1 )— 548272 A7 B7 五、發明説明(14女 (誚先閱讀背面之注意事項再填寫本頁) 醯基+(2-氯代节基)丄甲基苯並咪峻38々。又,將水加 入濾液中,過濾出所析出的結晶,經水洗、乾燥以得出 13.3g。將上述2結晶加在一起,加入丙酮⑺〇〇如)及水 (900ml),加熱以使其溶解。在加熱下餾除溶媒2〇〇mi, 將其冷卻。過濾出所析出的結晶,藉由乾燥以得出6_笨 磺醯基乱基甲醯基+(2_氯代苄基)_2_甲基笨並咪唑 (163) 33.8g。 [化合物(163)的物性] -腿«0-d6, : 2.53(3H,s),5.46(2H,s),6.34(1H,d,时),7 ,J-8.6Hz)5 7.90(1H3 m) 7,60(1H5 7.69(lH3d ».〇9(2H5 m)3 8.11(1H3 s), 11.84(1H5 br s)〇 IR(KBr) : 1684, 1448CDT1。1T Φ1. 548272 A7 __________________B7 V. Description of the invention (141) ^ — Add potassium cyanide (0.450g) and 18-crown ether-6 (0.450g) to 1- (2-chlorobenzyl) -6-chloroform The solution was stirred in room temperature for 18 hours in a solution of ketosmethylbenzimidazole 0.20 dimethylsulfoxide (10 ml). Add chloroform, water, and a small amount of ammonia, and extract. The organic layer was concentrated to obtain a residue, and the residue was purified by silica gel column chromatography (eluent: trifluoromethane / methanol = 20/1) to give 1_ (2_gaso benzyl) -2-methylbenzo. Imidazole-6-acetonitrile (500 g). [Physical properties of compound] ^ -NMRiCDCh, δ): 2.52 (3H3 s), 3.80 (2H5 s), 5.37 (2H3 s), 6.40 (1H, d, J = 7.6Hz), 7.09 (lH, t), 7.10 -7.19 (2H, m), 7.23 (lH, t), 7,44 (lH, d, J = 7.9Hz) 3 7.70 (1H3 d3 J-8.2Hz) 〇 &lt; Production Example 44; 6-carboxyl-1 -Production of (2-chlorobenzyl) benzimidazole &gt; 98% of formic acid (0.5ml) was added to 4-amino_3- (2- Benzyl) aminobenzoic acid (0.490 g) was refluxed for 1 hour. The solid precipitated in the reaction solution was collected. After washing with water and drying to obtain 0.468 g of 6-carboxy-1- (2-chlorobenzyl) benzoacetone. [Physical properties of compound] W-NMiUDMSO-dG, 6): 5.69 (2Η, s), 7.02 (1H, dd, J: 1.5 and 7.7Hz), 7.30 (1H, t, J = 7.5Hz), 7 · 36 (1Η5 dt, J = 1.7 and 7.5Hzh 7.53 (1Η, dd, J = 1.3 and 7.9Hz), 7.75 (1Η, d5 J = 8 · 4Ηζ), 7.83 (1Η, dd, J = 1.5 and 8.4Ηζ), 8.09 (1H, s), 8.54 (1H, s), 12.8 (1H, br s) 〇 &lt; Example 93; l- (2-chlorobenzyl) -6- Synthesis of ethoxycarbonyl-2-methylbenzimidazole (92) &gt; 2-Gas benzyl bromide (100 g) was added to 4-acetamido-3-amino-benzoate ----- --14S ___ This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page), 11 548272 A7 ------------- ------- B7 V. Description of the invention (142) '' &quot; &quot; ~ · — 一 'Ethyl benzoate (86.0g) and calcium carbonate (37 3g) in ethanol (75〇mi) solution Stir at 60 ° C for 14 hours. Filter the solids, reduce the mash to 500ml under reduced pressure. Add 35% hydrochloric acid (38 7g), and stir at 60 ° C for 2 hours. Filter the solids and pass through carbonic acid. After neutralization with sodium hydrogen, ethanol was distilled off under reduced pressure. Ethyl acetate and water were added for extraction (three times). After washing with water and drying the organic layer, the solvent was distilled off until the organic layer was 300 mi. The precipitated crystals were filtered and recrystallized from ethanol to obtain丨 _ (2_ chlorobenzyl) -6-ethoxycarbonyl_2_methylbenzimidazole 54 3g. Also, all the filtrate was collected, and the crystals obtained by recrystallization from ethanol were concentrated to obtain 1- (2-Gas-benzyl) -6-ethoxycarbonylmethylbenzimidazole (92) 18.lg [Physical properties of compound (92)], 57 (3, s) 5, 37 (2H3 q3 ,, , '5 5,46 (2H3 S), 6-41 (1H5 di J =?-8HZ ^ 7-l0 (lH3 t3 J, 7.8Hz) 3 7.25 (1H3 .7.47 (1H, d5 J, 8.0Hz) 3 7.75 (1H5 d, J, 8.4Hz) 5 7.94 (1H3 s), 8.00 (1H3 dd, J2 1.5 and 8. 4Ηζ). Mp: 126.0 —127 · 0 Τ. &Lt; Peipalladium Example 94; 6-carboxyl Synthesis of -1- (2-chlorobenzyl) -2-methylbenzimidazole (121) &gt; 10 /. An aqueous solution of sodium hydroxide (240 g) and ethanol (200 ml) were added to 1- (2-chlorobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (600 g), Heat to reflux for 2 hours. After cooling, the reaction solution was adjusted to pH 6 with 10% hydrochloric acid, and the precipitated crystals were dried to obtain 6-endyl-1- (2-chlorobenzyl) · 2-methylbenzimidazole 021). (54.7g). National paper standard (CNS) A4 size (21Gxl ^^ (Read the precautions on the back before filling this page) 1 Ding Feng 548272 A7 B7 V. Description of the invention (143) [Physical properties of compound (121) ] Old-dirty_0_ (16,6): 2.51 (3Η, s), 5.62 (2Η, s), 6.54 (1d, d, J: 7.7Hz) 3 7 · (Please read first Note on the back page: 23 (1H3 t, J: 7.5Hz), 7.33 (1Η, t3 J: 7.7Hz), 7.55 (1Η, d, J: 8.z), 7.63 (1Η, d5 J = 8.4Hz) 3 7.79 (1H, d5 J = 8.4Hz), 7.95 (1H, s) 〇inp: 300.8-303.0oC 〈Example 95; l- (2-chlorobenzyl ) Synthesis of 2-methylbenzimidazole-6-acetic acid (160) &gt; Add 10 ° /. Hydrochloric acid to 1- (2-chlorobenzyl) -2-methylbenzimidazole_6-acetonitrile ( 0.500g), heated to reflux for 15 hours, neutralized with a saturated sodium bicarbonate aqueous solution, and extracted with chloroform. The organic layer was concentrated by silica gel column chromatography (eluent: chloroform / methanol = 9/1 ~ 4/1) and 11 were refined to obtain 1- (2-chlorobenzyl) -2-methylbenzimidazole-6-acetic acid (160) (0.170 g). [Physical properties of compound (160)] ^ -NMRCCDCh, 6): 2.42 ( 3H, s), 3.56 (2H, s) 3 5.15 (2H3 s) 3 6.33 (1H5 d) 3 6.96 (1Η, t), 7.03 (1Η, s), 7.13 (2Η, m ), 7.35 (1Η, d, J: 7.9Hz), 7.62 (1Η, d), 8.90 (1Η, br s) 0 &lt; Example 96; 1- (2-chlorobenzyl ) Synthesis of 2-methylbenzimidazole-6-acrylic acid ethyl ester (161) &gt; Triphenylphosphonium acetoacetate (4.49 g) was added to 1- (2-chlorobenzyl) A 6-fluoren-2-fluorenylbenzimidazole (2.73 p-dioxane (50 ml) solution was 'stirred under heating and refluxing for 6 hours. After cooling the reaction solution, the solvent was distilled off' by silica gel column chromatography (Dissolved liquid: three gas methane / methanol = 9/1) refined residue to get H2-gaso benzyl) _2_methylbenzimidazole_6_Acrylic paper scales (CNS) Α4 gauge; (ΓΠΓ0 × 297)) 548272 A7 B7 V. Description of the invention (144) ^ — crude refined product of methyl ester (161) 743g. This crude refined product is directly used in the following reaction. (Please read the precautions on the back before reading) (Fill in this page) &lt; Example 97; Synthesis of 1- (2-chlorobenzyl) -2-methylbenzimidazole acrylic acid (162) &gt; Add 1- (2-chlorofluorenyl) _2_methyl The crude refined product of methyl benzoyl sialic acid (161) 3.29§ was dissolved in ethanol (20 mi), and a 5% aqueous sodium hydrogen solution (10.lg) was added and refluxed for 2 hours. The reaction solution was neutralized with an aqueous hydrochloric acid solution, and the residue obtained by concentrating the solvent under reduced pressure was purified by silica gel column chromatography (eluent ·· trichloromethane / methanol = 9/1 ~ 6/1) to obtain ^ 〇 chloro Benzyl) 2-methylbenzimidazole-6-acrylic acid (162) i 10 g. [Physical properties of compound (162)] 4- earning S0-d6, ά): 2.56 (3 (, s), 5.65 (2Η, s) 3 6.54 (1Η, d, # 15 · 9Ηζ), 6 • 62 (1H, d, J: 7'Hz), 7.25 (1Η, t), 7.35 (1Η, t), 7.56 (1Η, d, J: 8.1Hz), 7 6 -7.7G (3H, m), 7.99 (1Η, s), 12.35 (1H, br s). &lt; Example 98; Synthesis of 6-benzylaminocarbamoyl-based benzyl) -2-fluorenylbenzyl salivary (163) &gt; Iced into a solution of dioxanyl (2-oxobenzyl) -2-methylbenzimidazole (45.0g) in N, N-dimethylformamide (95ml), and stirred at room temperature 1 hour. Next, sparbenamine (471 g) and diazabicycloundecene (35.0 g) were added and stirred at 100 ° C. for 70 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Water (300 ml) and methanol (200 ml) were added to the residue, followed by 35% hydrochloric acid (607 g) to adjust the solution to pH 5.5. The precipitated crystals were filtered out, washed with a mixture of methanol and water (1/1) (200ml), and dried to obtain 6 • benzylsulfonylamino. This paper is sized to the Chinese National Standard (CNS) A4. (210x ^ 97 ^ 1) — 548272 A7 B7 V. Description of the invention (14 women (诮 first read the notes on the back and then fill out this page) 醯 + + (2-chlorobenzyl) 丄 methyl benzimidazole 38 々. In addition, water was added to the filtrate, and the precipitated crystals were filtered, washed with water, and dried to obtain 13.3 g. The above 2 crystals were added together, and acetone (⑺00) and water (900 ml) were added, and heated to make Its dissolved. The solvent 200 mi was distilled off under heating, and it was cooled. The precipitated crystals were filtered off, and dried to obtain 33.8 g of 6-benzylsulfanylmethanylmethyl (+ 2-chlorobenzyl) -2-methylbenzimidazole (163). [Physical Properties of Compound (163)]-Legs «0-d6,: 2.53 (3H, s), 5.46 (2H, s), 6.34 (1H, d, hours), 7, J-8.6Hz) 5 7.90 (1H3 m) 7,60 (1H5 7.69 (lH3d ».09 (2H5 m) 3 8.11 (1H3 s), 11.84 (1H5 br s)) IR (KBr): 1684, 1448CDT1.

Mass(FAB) : m/e 440(M+l)o 即:273.5-274.30C〇 〈實施例99;6_笨磺醯基氨基曱醯基_l-(聯苯-4-曱 基)-2-乙基苯並咪ϋ坐(164)之合成&gt; 4. 依據實施例98之方法,使用1-(聯苯-4-曱基)_2_乙 基-6-羧基苯並咪唑(0·600§)、Ν,Ν,羰基二咪唑(〇 546g)、 苯磺醯胺(0.529g)、二氮二環十一烯(〇512幻以得出6•苯 磺醯基氨基甲醯基-1-(聯苯I曱基)_2-乙基苯並咪唑 (164) (0、473g)。 [化合物(164)的物性] lH~NMR(DMS0-d63 δ) : 1.29(3H, t, J=7.4Hz)3 2.88(2H, q3 J-7.4Hz), 5.59(2 H, s)3 7.16(2H3 d5 J=8.2Hz), 7.33-7.37(1H, m), 7.44(2H, t, J=7.5Hz), 7.5Mass (FAB): m / e 440 (M + 1). That is: 273.5-274.30C. <Example 99; 6-benzylsulfonylaminofluorenyl-1- (biphenyl-4-fluorenyl)- Synthesis of 2-ethylbenzimidazole (164) &gt; 4. According to the method of Example 98, 1- (biphenyl-4-fluorenyl) _2_ethyl-6-carboxybenzimidazole (0 600§), Ν, Ν, carbonyldiimidazole (0546g), benzylsulfonamide (0.529g), diazabicycloundecene (〇512) to give 6 • benzenesulfonylcarbamidine -1- (Biphenyl Ifluorenyl) _2-ethylbenzimidazole (164) (0,473g). [Physical properties of compound (164)] lH ~ NMR (DMS0-d63 δ): 1.29 (3H, t, J = 7.4Hz) 3 2.88 (2H, q3 J-7.4Hz), 5.59 (2 H, s) 3 7.16 (2H3 d5 J = 8.2Hz), 7.33-7.37 (1H, m), 7.44 (2H, t, J = 7.5Hz), 7.5

9-7.71(8H, m), 7·74(1Η, dd, J:8.4 及 1.4Hz), 7.98-8·02(2Η, m), 8.21(1H 5 s), 12.43(1H5 s)〇 IR(KBr) : 1684cm-1〇 mp : 149,5-157.0°C〇 本紙張尺度適—家縣(CNS—) A^T( 210X29^^7 548272 A7 B7 五、發明説明(146) &lt;實施例100;5-苯磺醯基氨基曱醯基-;ι_(2-氯代苄 基)-2-甲基苯並咪唑(165)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用5-羧基-1-(2-氯代苄 基)-2-曱基苯並咪唑(0.450g)、Ν,Ν’-羰基二咪唑 (0.485g)、苯績 S&amp; 胺(0.470g)、二氮二環十一稀(〇.456g) 以得出5-苯磺醯基氨基曱醯基-1-(2-氯代苄基)-2-曱基苯 並咪唑(165)(0.480g)。 [化合物(165)的物性] W-NMIUDMS◦-d6,d) : 2·53(3Η,s)3 5.61(2H3 s),6·57(1Η,d,J二7·4Ηζ),7· 22(1H, t)3 7·33(1Η, t), 7·50(1Η, d, J=8.6Hz), 7·54(1Η, dd, J二7.9 及 0. 9Ηζ), 7·63(2Η, t), 7.71(2H, m), 8·00(2Η, d, J=7.3Hz), 8·21(1Η, d, J=1.4H z)5 12.50(1H, br s)〇 IR(KBr) : 1685cm' mp : 137.0 — 138.5oC〇 &lt;實施例101 ;5-(4-氣苯磺醯基氨基曱醯基)-1-(2-氯 代苄基)_2·甲基苯並咪唑(166)之合成&gt; 依據實施例98之方法,使用5-羧基-1-(2-氯代苄 基)-2-甲基苯並咪唑(0.450g)、N,N’-羰基二咪唑 (0.485g)&gt;4-氯苯磺醯胺(0.573g)、二氮二環十一烯(〇.456g) 以得出5-(4-氣苯磺醯基氨基甲醯基)-1-(2-氣代苄基)-2-曱基苯並咪唑(166)(0.520g)。 [化合物(166)的物性] lH-NMR(DMS0-d6,6) : 2.49(3H,s),5.58(2H,s),6.51UH,d,J:7.6Hz),7. t), 7·32(1Η, t), 7·45(1Η, d, J=8.6Hz), 7·53(1Η, d, J=7.8Hz), 7.69 本紙張尺度適用中國國家標準(CNS ) A4規格(21(^ 297^1 ) 548272 A7 ____ B7 五、發明説明(147) (3H,d,J=8.6Hz),7·99(2Η,d,J:8.6Hz),8·18(1Η,s),12.58UH,br s)。 iR(KBr) : 1619cm-丨。 (讀先閲讀背面之注意事項再填寫本頁) 即:261.5 —263.0oCo &lt;實施例l〇2;l-(2-氯代苄基)-2-甲基_5_(2-萘磺醯基 氨基曱醯基)笨並咪唑(167)之合成&gt; 依據實施例98之方法,使用5-羧基-1-(2-氯代苄 基)-2-甲基苯並咪唑(〇.450g)、N,N,-羰基二口米唑 (〇.485g)、2-萘苯磺醯胺(0.620g)、二氮二環十一烯(〇_456g) 以得出1-(2_氣代苄基)-2_甲基-5_(2_萘磺醯基氨基甲醯 基)笨並咪唑(167)(0.352g)。 [化合物(167)的物性] lH-NMR(DMS0-d6, δ) : 2.48(3H, s)3 5.56(2H, s), 6.49(1H3 d, J-7.7Hz), 7. 20(1H, t5 J=7,6Hz), 7.3K1H, t3 J=7.7Hz)3 7.44(1H, d, J=8.6Hz), 7.52(1H,9-7.71 (8H, m), 7.74 (1Η, dd, J: 8.4 and 1.4Hz), 7.98-8 · 02 (2Η, m), 8.21 (1H 5 s), 12.43 (1H5 s) .IR (KBr): 1684cm-1〇mp: 149,5-157.0 ° C. The paper size is suitable-Jiaxian County (CNS-) A ^ T (210X29 ^^ 7 548272 A7 B7 V. Description of the invention (146) &lt; Implementation Example 100; Synthesis of 5-benzenesulfonylaminoaminofluorenyl-; ι_ (2-chlorobenzyl) -2-methylbenzimidazole (165) &gt; (Read the precautions on the back before filling in this Page) According to the method of Example 98, 5-carboxy-1- (2-chlorobenzyl) -2-fluorenylbenzimidazole (0.450 g), N, N'-carbonyldiimidazole (0.485 g), Phenyl S &amp; amine (0.470g), diazabicycloundecene (0.4456g) to give 5-benzenesulfonylaminofluorenyl-1- (2-chlorobenzyl) -2-fluorene Benzimidazole (165) (0.480 g). [Physical properties of compound (165)] W-NMIUDMS◦-d6, d): 2.53 (3Η, s) 3 5.61 (2H3 s), 6.57 (1Η) , D, J 2 7 · 4Ηζ), 7.22 (1H, t) 3 7 · 33 (1Η, t), 7.50 (1 (, d, J = 8.6Hz), 7.54 (1 (, dd, JII 7.9 and 0.9Ηζ), 7.63 (2Η, t), 7.71 (2H, m), 8.00 (2Η, d, J = 7.3Hz) 8.21 (1Η, d, J = 1.4H z) 5 12.50 (1H, br s) 〇IR (KBr): 1685cm 'mp: 137.0-138.5oC &lt; Example 101; 5- (4-Gasbenzene) Synthesis of sulfonylaminofluorenyl) -1- (2-chlorobenzyl) _2.methylbenzimidazole (166) &gt; According to the method of Example 98, 5-carboxy-1- (2- Chlorobenzyl) -2-methylbenzimidazole (0.450 g), N, N'-carbonyldiimidazole (0.485 g) &gt; 4-chlorobenzenesulfonamide (0.573 g), diazepine Ene (〇.456g) to give 5- (4-Gabenzenesulfenylcarbamoylmethyl) -1- (2-gasobenzyl) -2-fluorenylbenzimidazole (166) (0.520g) . [Physical properties of compound (166)] 1H-NMR (DMS0-d6,6): 2.49 (3H, s), 5.58 (2H, s), 6.51UH, d, J: 7.6Hz), 7.t), 7 · 32 (1Η, t), 7.45 (1Η, d, J = 8.6Hz), 7.53 (1Η, d, J = 7.8Hz), 7.69 This paper size applies the Chinese National Standard (CNS) A4 specification ( 21 (^ 297 ^ 1) 548272 A7 ____ B7 V. Description of the invention (147) (3H, d, J = 8.6Hz), 7.99 (2Η, d, J: 8.6Hz), 8.18 (1Η, s ), 12.58UH, br s). iR (KBr): 1619cm- 丨. (Read the precautions on the back before filling in this page) That is: 261.5-263.0oCo &lt; Example 102; l- (2-chlorobenzyl) -2-methyl-5_ (2-naphthalenesulfonium Synthesis of Benzylaminofluorenyl) Benzimidazole (167) &gt; According to the method of Example 98, 5-carboxy-1- (2-chlorobenzyl) -2-methylbenzimidazole (0.450 g) was used ), N, N, -carbonyl diamnidazole (.485g), 2-naphthylbenzenesulfonamide (0.620g), diazabicycloundecene (0_456g) to give 1- (2_ Gaso-benzyl) -2-methyl-5_ (2-naphthylsulfonylcarbamoyl) benzimidazole (167) (0.352 g). [Physical properties of compound (167)] 1H-NMR (DMS0-d6, δ): 2.48 (3H, s) 3 5.56 (2H, s), 6.49 (1H3 d, J-7.7Hz), 7. 20 (1H, t5 J = 7,6Hz), 7.3K1H, t3 J = 7.7Hz) 3 7.44 (1H, d, J = 8.6Hz), 7.52 (1H,

d, J二8.0Hz), 7.66-7.75(3H, m)5 7.97(1H, d, J=8.8Hz), 8·04(1Η, d, J二8.0H z)5 8.14(1H, d, J-8.8Hz), 8.19(1H, s)5 8.23(1H, d, J-8.0Hz), 8.68(1H, s) ,1Z.55(1H, br s)〇 IR(KBr) : 1685cm—1。 mp : 236.5—238.0oC〇 &lt;實施例103; 1-(2-氯代苄基)-6-曱磺醯基氨基甲醯 基-2-曱基苯並咪唑(168)之合成&gt; 依據實施例98之方法,使用6-羧基-1-(2-氯代节 基)-2-甲基苯並味唾(0.500g)、N,N,-獄基二口米唆 (0.539g)、甲磺醯胺(0.316g)、二氮二環十一烯(〇 5〇6g) 以得出1-(2-氯代苄基)-6-甲磺醯基氨基曱醯基_2_曱基苯並 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(148) 咪唑(168)(0.564g)。 [化合物(168)的物性] (請先閱讀背面之注意事項再填寫本頁) !Η-眶(DMS〇-d6,d) : 2·49(3Η,s),3·35(3Η,s),5·60(2Η,s),6.43UH,d, J二7·8Ηζ), 7·23(1Η, t), 7·34(1Η, t, J=7.7Hz), 7.57(1Η, d, J=8.0Hz), 7.68 (1H, d, J二8.5Hz), 7·81(1Η, dd, J=1.7 及 8.5Hz), 8.13(1H, d, J=i.5Hz), 11.94(1H3 br s)〇 IR(KBr) : 1670cm—、 mp : 302·0 —303.0oC〇 &lt;實施例l〇4;6-(l-丁磺醯基氨基甲醯基氣代 苄基)-2-甲基苯並咪唑(169)之合成&gt; 依據實施例98之方法,使用6-羧基氯代节 基)-2·曱基苯並咪唑(0.500g)、N,N’-羰基二口米唾 (0.539g)、1-丁 磺醯胺(0.456g)、二氮二環十一烯5〇6g) 以得出6-(1-丁石黃醯基氨基曱醯基)-1-(2-氣代节基)_2_甲 基苯並咪唑(169)(0.595g)。 [化合物(169)的物性] lH-NMR(DMS0-d63 δ) : 0.84(3H, t, J=7.4Hz), 1.38(2H, m), L65(2H, m), 2. 49(3H, s), 3·49(2Η, m), 5·60(2Η3 s), 6.44(1H, d, J=7.6Hz), 7·23(1Η, t, J 二7.6Hz), 7·35(1Η, t), 7·56(1Η, d, J:8.0Hz), 7·68(1Η, d, J:8.4Hz), 7.80(1 H, dd, J:1.6 及 8·4Ηζ), 8·11(1Η, d, J:1.4Hz), 11·86(1Η, br s)。 IR(KBr) : 1684cm'l〇 mp : 214.0—217.0oC〇 &lt;實施例105;1-(2-氣代苄基)_2_甲基_6_〇_辛磺醯基 氨基甲醯基)苯並咪唑(170)之合成&gt; 依據實施例98之方法,使用6_羧基_1-(2_氯代苄 本紙張尺度適用中國國家標準(CNS ) A4規格(210x 297公釐) 548272 A7 ___ B7 五、發明説明(149) (讀先閱讀背面之注意事項再填寫本頁) 基)-2-曱基苯並咪唑(0.4〇Og)、N,N’-羰基二咪唑 (0.431g)、1-辛磺醯胺(0.406g)、二氮二環十一烯(〇.404g) 以得出1-(2-氯代苄基)-2-甲基-6-(1-辛磺醯基氨基甲醯 基)苯並咪唑(170)(0.309g)。 [化合物(170)的物性] 醒(DMSQ-d63 (5) : 〇·82(3Η,t,J:7.3Hz),1·13-1·28(8Η,m),1.32-1.41( 2Η3 m), 1.62-1.7Κ2Η, m)3 2.50(3H, s), 3.50(2H5 t3 J-8.5Hz), 5.61(2H, s) ,6·45(1Η, d3 J二7·7Ηζ), 7·24(1Η, t, J二7·5Ηζ), 7·35(1Η, t, J=7.5Hz), 7,58 (1H, d, J=8.0Hz), 7·69(1Η, d, J=8.4Hz), 7·81(1Η, d3 J:8.5Hz), 8·12(1Η, s )3 11.86(1H ,s)〇 IfUKBr) : 1674CHT1。 nip : 180.0 — 183.0°C。 〈貫施例l〇6;l-(2-氯代卞基)-2·甲基- 6-(2 -丙石黃酿基 氨基甲醯基)苯並咪唑(171)之合成&gt; 依據實施例98之方法,使用6-羧基-1-(2-氣代苄 基)-2-曱基苯並咪唑(0.400g)、N,N、羰基二咪唑 (0.431g)、2-丙磺醯胺(0.328g)、二氮二環十一烯(〇.404g) 以得出1 -(2-氣代卞基)-2-曱基-6-(2-丙石黃酿基氨基甲酿 基)苯並咪唑(171)(0.417g)。 [化合物(171)的物性] lH-NMR(DMS0-d6, δ) : 1.30(6H, d, J=6.9Hz), 2.50(3H, s), 3.81-3.87(1H, m ),5.62(2H3 s), 6·46(1Η5 d, J二7·7Ηζ), 7.25(1H3 t, J二7·5Ηζ), 7·35(1Η, t, J=7.5Hz), 7·62(1Η, d, J=7.9Hz), 7·69(1Η, d, J二8·5Ηζ), 7·81(1Η, d, J二8·6Η z), 8·12(1Η, s), 11·83(1Η, s)。 —--IS3__ _ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 五、發明説明(丨5q) IR(KBr) : 1670^^0 mp : 215·0-217.5°C〇 &lt;實施例107; 1-(聯苯-4-甲基)-6-(1-丁磺醯基氨基曱 醯基)-2-甲基苯並咪唑(172)之合成&gt; 依據實施例98之方法,使用1-(聯苯-4-甲基)_6_羧 基-2-甲基苯並咪唑(0.300g)、N,N’_羰基二咪唑(〇.323g)、 1- 丁磺醯胺(〇.273g)、二氮二環十一烯(0.303g)以得出卜 (聯苯-4-甲基)-6-(1-丁石黃酿基氣基甲龜基)_2_曱基苯並味 口坐(172)(0.349g) 〇 [化合物(172)的物性] lH-臟(DMS(H16,d) : G.85(3H,t,#7·4Ηζ),1·36_1·43(2Η,m),1·63-1·72( 2H,m),2.57(3H,s),3.52(2H,t,J:7.7Hz)35.60(2H3s)37.21(2H3d,J:8· 2Ηζ), 7·35(1Η, t, J=7.3Hz), 7·44(2Η, t, J:7.5Hz), 7·60-7·68(5Η, m), 7·81 (1Η, dd, J=1.6 及 8·4Ηζ), 8.26(1Η, d, J=1.4Hz), 11·97(1Η, s)。 IR(KBr) : 1676cm-1。 mp : 219.5 —222.5°C〇 &lt;實施例108;6-(1-丁磺醯基氨基甲醯基)-l_(2,4-二 氯代苄基)-2-曱基苯並咪唑(173)之合成&gt; 經浐部中央«:率^$ τ,消贽合竹私印¾ (讀先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用6-羧基-1-(2,4-二氯代 节基)_2-曱基苯並口米嗤(〇.4〇Og)、Ν,Ν、幾基二味σ坐 (0_431g)、1-丁磺醯胺(〇.364g)、二氮二環十一烯(〇.4〇4g) 以得出6-(1-丁磺醯基氨基甲醯基)-l-(2,4-二氯代节基)· 2- 甲基笨並咪唑(173)(0.459g)。 [化合物(173)的物性] W-NMR(DMS0-d6, ά) : 0·85(3Η3 t, J=7.3Hz), 1·36-1·42(2Η, m), 1.63-1,70( 本紙張尺度適用中國國家標準(CNS ) A4規格(210 χ 297公4 ) 548272 A7 B7 五、發明説明(15} (讀先閱讀背面之注意事項再填寫本頁) 2H, m), 2·50(3Η, s), 3·51(2Η, t, J:7.7Hz), 5·59(2Η, s)3 6·45(1Η5 d, J二8· 他),7.33(1H, dd3 J:2.1 及 8·4Ηζ)3 7·69(1Η3 d5 J:8.4Hz)3 7·76(1Η, d, J=2.0Hz),7·81(1Η,dd,J:L7 及 8·5Ηζ),8·11(1Η,d,J:1.3Hz)3 11·90(1Η 3 s)〇 IR(KBr) : 1670cm-丨。 H2.0 —223.0oCo &lt;實施例109; 1-(聯苯-4-甲基)-6-(1-丁磺醯基氨基甲 醯基)-2-乙基苯並咪唑(174)之合成&gt; 依據實施例98之方法,使用1-(聯苯-4-甲基)-6-羧 基-2-乙基苯並味哇(0.300g)、N,N’-幾基二ϋ米唾(〇.340g)、 丁磺醯胺(0.300g)、二氮二環十一烯(0.320g)以得出1 -(聯 苯-4-甲基)-6-(1-丁績酸基氨基甲酿基)-2-乙基苯並咪〇坐 (174)(0.300g)。 [化合物(174)的物性] 4-NMR(DMS0-d6, 6) : 〇.85(3H, t3 J二7·3Ηζ), 1·30(3Η, t, J二7.5Hz), 1.35-1 •44(2H, m), 1·64_1·72(2Η, m), 2.9G(2H, q, J=7.4Hz), 3·52(2Η, t, J=7.7Hz) ,5.61(2H, s), 7·19(2Η, d, J二8·3Ηζ), 7,35(1H, t, J二7·3Ηζ), 7·44(2Η, t, J 二7·5Ηζ), 7·61-7·67(4Η, m), 7·71(1Η, d, J=8.5Hz), 7·82(1Η, dd, J=1.6 及 8·5Ηζ),8·27&lt;1Η, d,J二 1·3Ηζ),12·01(1Η,s)。IR(Nujol) : 1687,1682cni 1 mp : 171.8- 173.0oC〇 &lt;實施例ll〇;6-苯磺醯基氨基甲醯基-1-(聯苯_4_曱 基)-2-三氟甲基苯並咪唑(175)之合成&gt; 依據實施例98之方法,使用1-(聯苯-4-甲基)-6-羧 基-2-三氟曱基笨並咪唑(0.483g)、N,N’-羰基二咪唑 ^-------tss---- 本紙張尺度遙州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(15j (〇.396g)、苯磺醯胺(0.383g)、二氮二環十一稀(〇.371g) (諳先閱讀背面之注意事項再填寫本頁) 以得出6-苯石黃醯基氨基曱酿基-1-(聯笨曱基)三氣 甲基苯並咪唑(175)(0.508g)。 [化合物(175)的物性] lH-NMR(DMS0-d6, δ) : 5.81(2H3 s)3 7.15(2H, d3 J=8.3Hz), 7.35(1H, t, J-7 .5Hz), 7.44(2H, t, J=7.5Hz), 7.60-7.66(6H, m), 7.70(1H, t, J=7.4Hz), 7.9 1(1H, dd, J=8.7 及 1.4Hz), 7.96-8.01(3H, m), 8·42(1Η, s), 12·65(1Η, s)( IR(KBr) : nip : 164.5 —167.(TC〇 &lt;實施例111 ;5 -苯石黃醯基氨基甲醯基_i_(聯苯_心曱 基)-2-三氟曱基苯並咪唑(176)之合成&gt; 依據實施例98之方法,使用1_(聯苯甲基)-5-魏 基-2-三It曱基苯並味峻(0.270g)、N,N’·幾基二口米唾 (0.221g)、苯磺醯胺(0.214g)、二氮二環十一烯(〇.2〇7g) 以得出5 -苯石黃酿基氨基甲酿基-1-(聯苯-4-甲基)-2-三氟 曱基苯並咪唑(176)(0.286g)。 [化合物(176)的物性] INMlUDMSiH^,6) : 5·79(2Η,s)5 7·15(2Η,d,J:8.1Hz),7·35(1Η,t,J二7 •5Hz), 7·43(2Η, t3 J=7.5Hz), 7·59-7·67(6Η, m), 7·72(1Η, t, J:7.6Hz), 7.8 3(1H, d, J=8.8Hz), 7·94(1Η, d, J=8.9Hz), 8·02(2Η, d, J:7.4Hz), 8.49(1H, s), 12.69(1H3 s)。 IR(KBr) : 1699cm—、 mp : 248.5 — 251.0oC〇 &lt;實施例112;6-苯磺醯基氨基曱醯基-2-環丙基-1-(2_氟代苄基)苯並咪唑(177)之合成&gt; -------- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 好浐部中呔枚^-^h τ,消贽合竹ii印f A7 B7 五、發明説明(15j 依據實施例98之方法,使用6-羧基-2-環丙基-1-(2-氟代苄基)苯並咪唑(〇.93〇g)、N,N,-幾基二味唑 (〇.972g)、苯磺醯胺((K942g)、二氮二環十一烯(〇.906g) 以得出6-苯磺醯基氨基甲醯基-2-環丙基-1-(2-氟代节基) 苯並咪唑(177)(0.730g)。 [化合物(17 7)的物性] lH-NMR (DMS0-d63 δ) : 1.04 (4H3 m)3 2.15 (1H, m), 5.70 (2H5 s), 6.85 (1 H,t3 J:7.5Hz),7·12 (1H,t,J=7.5Hz〉,7·22-7·38 (2H,扭),7·54-7·70 (5H, m), 7·99 (2H, d, J=7.5Hz), 8·11 (1H, s)。 白色粉末。 &lt;實施例113;N-苯磺醯基-3-[1·(2-氯代苄基)_2_甲基 苯並咪唑-6-基]丙烯醯胺(178)之合成&gt; 依據實施例198之方法,使用1-(2-氣代节基)_2-甲 基苯並咪唑-6-丙烯酸(l.i〇g)、N,N,幾基二咪唑(1〇9g)、 苯磺醯胺(1.06g)、二氮二環十一烯(1.02§)以得出N-苯磺 醯基-3_[ 1-(2-氯代苄基)-2-甲基苯並咪唑-6-基]丙烯醯胺 (178)(1.05g) 〇 [化合物(178)的物性] -賺(DMSO-d6, cS) : 2.47(3H,s)3 5,55(2H,s),6.46-6.S5UH,m),7·22(1 H, t, J=7.6Hz), 7·32(1Η3 t, J:7.7HZ), 7·40(1Η, d, J:8.4Hz), 7·52-7·66(6Η ,m), 7·69(1Η, t), 7·93(2Η, d, J=7.9Hz), 12·17(1Η, br s)。 IR(KBr) ·· 1687cm—!。d, J = 8.0Hz), 7.66-7.75 (3H, m) 5 7.97 (1H, d, J = 8.8Hz), 8.04 (1Η, d, J = 8.0H z) 5 8.14 (1H, d, J-8.8Hz), 8.19 (1H, s) 5 8.23 (1H, d, J-8.0Hz), 8.68 (1H, s), 1Z.55 (1H, br s), IR (KBr): 1685cm-1 . mp: 236.5-238.0 ° C &lt; Example 103; Synthesis of 1- (2-chlorobenzyl) -6-fluorenylsulfonylaminomethylfluorenyl-2-fluorenylbenzimidazole (168) &gt; basis The method of Example 98 was performed using 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzoxyl saliva (0.500 g), N, N,-prison-based rice noodles (0.539 g) Methanesulfonylamine (0.316g), diazabicycloundecene (0506g) to give 1- (2-chlorobenzyl) -6-methanesulfonylaminofluorenyl_2_ The paper size of fluorenylbenzo is applicable to Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (148) Imidazole (168) (0.564g). [Physical properties of compound (168)] (Please read the precautions on the back before filling in this page)! Η-orbital (DMS〇-d6, d): 2.49 (3Η, s), 3.35 (3Η, s ), 5.60 (2Η, s), 6.43UH, d, J 2 7.8Ηζ), 7.23 (1Η, t), 7.34 (1Η, t, J = 7.7Hz), 7.57 (1Η, d, J = 8.0Hz), 7.68 (1H, d, J = 8.5Hz), 7.81 (1Η, dd, J = 1.7 and 8.5Hz), 8.13 (1H, d, J = i.5Hz), 11.94 (1H3 br s) 〇IR (KBr): 1670cm—, mp: 302 · 30—303.0 ° C— &lt; Example 104; 6- (l-butanesulfonylcarbamoylamino benzyl)- Synthesis of 2-methylbenzimidazole (169) &gt; According to the method of Example 98, using 6-carboxychlorobenzyl) -2 · fluorenylbenzimidazole (0.500g), N, N'-carbonyldi Oral saliva (0.539g), 1-butanesulfonamide (0.456g), diazabicycloundecene 506g) to give 6- (1-butanthanthenylaminofluorenyl) -1- ( 2-Azobenzyl) -2-methylbenzimidazole (169) (0.595g). [Physical properties of compound (169)] 1H-NMR (DMS0-d63 δ): 0.84 (3H, t, J = 7.4Hz), 1.38 (2H, m), L65 (2H, m), 2. 49 (3H, s), 3.49 (2Η, m), 5.60 (2Η3 s), 6.44 (1H, d, J = 7.6Hz), 7.23 (1Η, t, J = 7.6Hz), 7.35 ( 1Η, t), 7.56 (1Η, d, J: 8.0Hz), 7.68 (1Η, d, J: 8.4Hz), 7.80 (1H, dd, J: 1.6 and 8.4Ηζ), 8 · 11 (1Η, d, J: 1.4Hz), 11 · 86 (1Η, br s). IR (KBr): 1684cm'l0mp: 214.0-217.0 ° C (&lt; Example 105; 1- (2-Atomylbenzyl) -2-methyl-6-octylsulfonylcarbamoylmethyl) Synthesis of benzimidazole (170) &gt; According to the method of Example 98, 6_carboxyl 1- (2_chlorobenzyl) was used. The paper size applies the Chinese National Standard (CNS) A4 (210x 297 mm) 548272 A7 ___ B7 V. Description of the invention (149) (Read the precautions on the back before filling in this page) Base) -2-Azobenzimidazole (0.4〇g), N, N'-carbonyldiimidazole (0.431g) , 1-octanesulfonamide (0.406g), diazabicycloundecene (0.404g) to give 1- (2-chlorobenzyl) -2-methyl-6- (1-octanesulfonate Amidinocarbamoyl) benzimidazole (170) (0.309 g). [Physical properties of compound (170)] (DMSQ-d63 (5): 0.82 (3Η, t, J: 7.3Hz), 1.13-1.28 (8Η, m), 1.32-1.41 (2Η3 m ), 1.62-1.7Κ2Η, m) 3 2.50 (3H, s), 3.50 (2H5 t3 J-8.5Hz), 5.61 (2H, s), 6.45 (1Η, d3 J 2 7 · 7Ηζ), 7 · 24 (1Η, t, J, 27.5Ηζ), 7.35 (1Η, t, J = 7.5Hz), 7,58 (1H, d, J = 8.0Hz), 7.69 (1Η, d, J = 8.4Hz), 7.81 (1Η, d3 J: 8.5Hz), 8.12 (1Η, s) 3 11.86 (1H, s). IfUKBr): 1674CHT1. nip: 180.0 — 183.0 ° C. <Example 106; Synthesis of l- (2-chlorofluorenyl) -2 · methyl-6- (2-propanthazinylaminocarbamyl) benzimidazole (171) &gt; Basis The method of Example 98 uses 6-carboxy-1- (2-fluorobenzyl) -2-fluorenylbenzimidazole (0.400 g), N, N, carbonyldiimidazole (0.431 g), and 2-propanesulfonic acid. Fluorenamine (0.328g), diazabicycloundecene (0.404g) to give 1- (2-gasofluorenyl) -2-fluorenyl-6- (2-propanthazolylcarbamate) Alkyl) benzimidazole (171) (0.417 g). [Physical properties of compound (171)] 1H-NMR (DMS0-d6, δ): 1.30 (6H, d, J = 6.9Hz), 2.50 (3H, s), 3.81-3.87 (1H, m), 5.62 (2H3 s), 6.46 (1Η5 d, J 2 7.7Ηζ), 7.25 (1H3 t, J 2 7.5Ηζ), 7.35 (1Η, t, J = 7.5Hz), 7.62 (1Η, d , J = 7.9Hz), 7.69 (1Η, d, J 2 8.5Ηζ), 7.81 (1Η, d, J 2 8.6Η z), 8 · 12 (1Η, s), 11 · 83 (1Η, s). —-- IS3__ _ This paper is a Chinese standard (CNS) A4 size (210X297 mm) 548272 A7. 5. Description of the invention (5q) IR (KBr): 1670 ^^ 0 mp: 215 · 0-217.5 ° Co. Example 107 Synthesis of 1- (biphenyl-4-methyl) -6- (1-butanesulfonylaminofluorenyl) -2-methylbenzimidazole (172) &gt; Basis The method of Example 98 uses 1- (biphenyl-4-methyl) -6-carboxy-2-methylbenzimidazole (0.300 g), N, N'-carbonyldiimidazole (0.323 g), 1- Butylsulfonamide (0.273 g) and diazabicycloundecene (0.303 g) to obtain di (biphenyl-4-methyl) -6- (1-butane yellow base, aeroylmethytyl ) _2_Aminobenzobenzoate (172) (0.349g) 〇 [Physical properties of compound (172)] lH-dirty (DMS (H16, d): G.85 (3H, t, # 7 · 4Ηζ) , 1.36_1 · 43 (2Η, m), 1.63-1 · 72 (2H, m), 2.57 (3H, s), 3.52 (2H, t, J: 7.7Hz) 35.60 (2H3s) 37.21 (2H3d , J: 8. 2Ηζ), 7.35 (1Η, t, J = 7.3Hz), 7.44 (2Η, t, J: 7.5Hz), 7.60-7 · 68 (5Η, m), 7 · 81 (1Η, dd, J = 1.6 and 8.4Ηζ), 8.26 (1Η, d, J = 1.4Hz), 11.97 (1Η, s). IR (KBr): 1676cm-1. Mp : 219.5-222.5 ° C &lt; Example 108; 6- (1-Butanesulfonylcarbamoyl) -l- (2,4-dichlorobenzyl) -2-fluorenylbenzimidazole (173 ) Synthesis &gt; The central part of the warp section «: rate ^ $ τ, eliminate the private seal of the bamboo ¾ (read the precautions on the back before filling this page) According to the method of Example 98, use 6-carboxy-1- (2,4-dichlorobenzyl) _2-fluorenylbenzofluorene (0.40 g), Ν, Ν, quinone disigma (0-431 g), 1-butanesulfonamide ( .364g), diazabicycloundecene (0.404g) to give 6- (1-butanesulfonylcarbamoamido) -l- (2,4-dichlorobenzyl) · 2-methylbenzimidazole (173) (0.459g). [Physical properties of compound (173)] W-NMR (DMS0-d6, ά): 0.85 (3Η3 t, J = 7.3Hz), 1.36 -1 · 42 (2Η, m), 1.63-1, 70 (This paper size applies to Chinese National Standard (CNS) A4 specifications (210 x 297 male 4) 548272 A7 B7 V. Description of the invention (15) Please fill in this page again for the matters needing attention) 2H, m), 2.50 (3Η, s), 3.51 (2Η, t, J: 7.7Hz), 5.59 (2Η, s) 3 6.45 (1Η5 d, J 2: 8 · he), 7.33 (1H, dd3 J: 2.1 and 8. 4Ηζ) 3 7 · 6 9 (1Η3 d5 J: 8.4Hz) 3 7.76 (1Η, d, J = 2.0Hz), 7.81 (1Η, dd, J: L7 and 8.5Ηζ), 8.11 (1Η, d, J : 1.3 Hz) 3 11 · 90 (1Η 3 s). IR (KBr): 1670 cm-. H2.0-223.0oCo &lt; Example 109; 1- (Biphenyl-4-methyl) -6- (1-butanesulfonylaminomethylamidino) -2-ethylbenzimidazole (174) Synthesis &gt; According to the method of Example 98, 1- (biphenyl-4-methyl) -6-carboxy-2-ethylbenzowow (0.300 g), N, N'-jikylobiazepine was used Saliva (.340g), sulfasalazine (0.300g), diazabicycloundecene (0.320g) to give 1- (biphenyl-4-methyl) -6- (1-butyric acid (Carbamoyl) -2-ethylbenzimidazole (174) (0.300 g). [Physical properties of compound (174)] 4-NMR (DMS0-d6, 6): 0.85 (3H, t3 J-2 7.3Ηζ), 1.30 (3Η, t, J-2 7.5Hz), 1.35-1 • 44 (2H, m), 1.64_1 · 72 (2Η, m), 2.9G (2H, q, J = 7.4Hz), 3.52 (2Η, t, J = 7.7Hz), 5.61 (2H, s), 7 · 19 (2Η, d, J 2 8.3Ηζ), 7,35 (1H, t, J 2 7.3Ηζ), 7.44 (2Η, t, J 2 7.5Ηζ), 7 · 61-7 · 67 (4Η, m), 7.71 (1Η, d, J = 8.5Hz), 7.82 (1Η, dd, J = 1.6 and 8. · 5Ηζ), 8.27 &lt; 1Η, d, J 2: 1.3Ηζ), 12.01 (1 (, s). IR (Nujol): 1687, 1682cni 1 mp: 171.8-173.0oC 0 &lt; Example 11; 6-benzenesulfonylcarbamoyl-1- (biphenyl-4-fluorenyl) -2-trifluoro Synthesis of methylbenzimidazole (175) &gt; According to the method of Example 98, 1- (biphenyl-4-methyl) -6-carboxy-2-trifluorofluorenylbenzimidazole (0.483 g), N, N'-carbonyldiimidazole ^ --------- tss ---- The paper size is Yaozhou Chinese National Standard (CNS) A4 (210X 297 mm) 548272 A7 B7 V. Description of the invention (15j ( 〇.396g), sulfasalazine (0.383g), diazabicyclo eleven dilute (〇.371g) (谙 Please read the precautions on the back before filling this page) to get 6-benzoxanthinamine amino -1- (bibenzylidene) trifluoromethylbenzimidazole (175) (0.508g). [Physical properties of compound (175)] lH-NMR (DMS0-d6, δ): 5.81 (2H3 s) 3 7.15 (2H, d3 J = 8.3Hz), 7.35 (1H, t, J-7 .5Hz), 7.44 (2H, t, J = 7.5Hz), 7.60-7.66 (6H, m), 7.70 (1H, t , J = 7.4Hz), 7.9 1 (1H, dd, J = 8.7 and 1.4Hz), 7.96-8.01 (3H, m), 8.42 (1Η, s), 12 · 65 (1Η, s) (IR (KBr): nip: 164.5 to 167. (TC0 &lt; Example 111; 5-benzothiazinoyl Synthesis of methylmethylfluorenyl_i_ (biphenyl_cardiacyl) -2-trifluorofluorenylbenzimidazole (176) &gt; According to the method of Example 98, 1_ (biphenylmethyl) -5-Wei Syl-2-trisitinobenzobenzoic acid (0.270g), N, N '· kisyl bisalamine (0.221g), benzylsulfonamide (0.214g), diazabicycloundecene 0.207 g) to give 5-benzoxanthenylcarbamoyl-1- (biphenyl-4-methyl) -2-trifluorofluorenylbenzimidazole (176) (0.286 g). [Physical properties of compound (176)] INMlUDMSiH ^, 6): 5.79 (2Η, s) 5 7 · 15 (2Η, d, J: 8.1Hz), 7.35 (1Η, t, J = 7 · 5Hz ), 7.43 (2Η, t3 J = 7.5Hz), 7.59-7 · 67 (6Η, m), 7.72 (1Η, t, J: 7.6Hz), 7.8 3 (1H, d, J = 8.8Hz), 7.94 (1Η, d, J = 8.9Hz), 8.02 (2Η, d, J: 7.4Hz), 8.49 (1H, s), 12.69 (1H3 s). IR (KBr): 1699cm-, mp: 248.5-251.0oC &lt; Example 112; 6-benzenesulfonylaminoaminofluorenyl-2-cyclopropyl-1- (2-fluorobenzyl) benzo Synthesis of imidazole (177) &gt; -------- This paper size applies Chinese National Standard (CNS) A4 (210X 297 mm) 548272 呔 呔 呔, ^ ^ Bamboo II f A7 B7 V. Description of the invention (15j According to the method of Example 98, 6-carboxy-2-cyclopropyl-1- (2-fluorobenzyl) benzimidazole (0.993 g) was used , N, N, -Ichizodiazole (〇.972g), sulfenamide ((K942g), diazabicycloundecene (.906g) to give 6-benzenesulfonylcarbamidine Phenyl-2-cyclopropyl-1- (2-fluorobenzyl) benzimidazole (177) (0.730 g). [Physical properties of compound (17 7)] 1H-NMR (DMS0-d63 δ): 1.04 ( 4H3 m) 3 2.15 (1H, m), 5.70 (2H5 s), 6.85 (1 H, t3 J: 7.5Hz), 7 · 12 (1H, t, J = 7.5Hz>, 7.22-7 · 38 (2H, twist), 7.54-7.70 (5H, m), 7.99 (2H, d, J = 7.5Hz), 8.11 (1H, s). White powder. &Lt; Example 113 ; N-benzenesulfonyl-3- [1 · (2-chlorobenzyl) _2_methylbenzimidazole-6-yl] acrylamide 178) Synthesis> According to the method of Example 198, 1- (2-Gastilbyl) _2-methylbenzimidazole-6-acrylic acid (liOg), N, N, and bis-diimidazole ( (109g), benzylsulfonamide (1.06g), diazabicycloundecene (1.02§) to give N-benzenesulfonyl-3_ [1- (2-chlorobenzyl) -2- Methylbenzimidazole-6-yl] propenamide (178) (1.05g) 〇 [Physical properties of compound (178)]-Earn (DMSO-d6, cS): 2.47 (3H, s) 3 5,55 ( 2H, s), 6.46-6.S5UH, m), 7.22 (1 H, t, J = 7.6Hz), 7.32 (1Η3 t, J: 7.7HZ), 7.40 (1Η, d, J: 8.4 Hz), 7.52-7.66 (6Η, m), 7.69 (1Η, t), 7.93 (2Η, d, J = 7.9Hz), 12 · 17 (1Η, br s ) IR (KBr) · 1687cm— !.

Mass(FAB) : m/e 466(M+l)〇 jap : 243.1 — 244.3°C〇 本紙張尺度中國國家標準(CNS ) A4規格(21〇χ29^^ —-- (讀先閱讀背面之注意事項再填寫本頁} 、1Τ ^ 548272 A7 B7 五、發明説明(15j &lt;實施例114;N-苯磺醯基_2_[1-(2-氯代苄基)_2-甲基 笨並哺嗤-6-基]乙醯胺(179)之合成&gt; 依據實施例98之方法,使用ι_(2-氯代苄基&gt;2-甲 基笨並咪唑-6-醋酸(0.170§)、队:^,-羰基二咪唑(0.1758)、 苯磺醯胺(〇.170g)、二氮二環十一烯(〇.i64g)以得出N-苯石黃酸基-2-[1-(2-氯代苄基)-2-曱基苯並咪吐-6-基]乙驢 胺(179)(0.09g)。 [化合物(179)的物性] ^-NMRiDMSO-dG, δ) : 2.44(3H, s)3 3.57(2H, s), 5.46(2H, s), 6.41(1H3 d, J=7.7Hz), 6·96(1Η, d, J:7.0Hz), 7·16(1Η, s)3 7.20(1H, t), 7·32(1Η3 t)3 7·47(1Η,d3 J=8Iz),7·52-7·59(3Η,m),7·67(1Η,t,J:7.5Hz)3 7·84(2Η,d 3 J-7.4Hz)5 12.28(1H, br s)〇 IR(KBr) 1719cm-l〇 mp : 236.2-237.8°C〇 &lt;實施例1 l5;l-(2,4-二氯代苄基)—2_曱基吡啶 甲基)氨基曱醯基]苯並咪唾(180)之合成&gt; 經沪部中央榀準而只τ,消贽合作*印?水 (請先閱讀背面之注意事項再填寫本頁) 將二氣曱烷(150ml)與數滴Ν,Ν-二甲基曱醯胺加入 6-竣基-1-(2,4-二氣代卡基)-2-曱基苯並味η坐(9.00 g)中,冰 冷之。滴入氣化乙二醯(6.48g) ’攪拌數分。接著在室溫 下攪拌1 · 5小時後,減壓濃縮至約3分之1的容積。收集 析出物,在冰冷下分數次加入2-胺基曱基吡啶(2.69g)與 三乙胺(7.34g)之二氯甲院(200ml)溶液中。攪拌15小時 後,用水洗淨反應液3次,接著以飽和碳酸氩鈉水溶液洗 淨。對有機層進行減壓濃縮,使用醋酸乙酯以使其結晶化。 奉紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 Μ Β7 五、發明説明(15j 過渡出結晶’乾餘以付出1-(2,4 -二氯代节基)-2-曱基-6_ [(2-0比σ疋曱基)氣基甲基]苯並味σ坐(i80)4.35g。 (讀先閱讀背面之注意事項再填寫本頁) [化合物(180)的物性] H NMR(CDCl35 δ) : 2.56(3H3 s), 4.76(2H3 d3 J=4.8Hz)3 5.40(2H3 s), 6.33 (1H’ d, J:8,4Hz), 7·07(1Η3 dd, J:8.4 及 2·0Ηζ), 7·22(1Η, dd, J=7.4 及 4.9Hz),7.33(1H,d,J:7,9Hz),7·48(1Η,d3 J:2.1Hz)3 7·62_7·79(4Η,ιη), 7·86(1Η, d, J=l.lHz)8.57, (1H, d, J:4.9Hz)。 IR(KBr) : 1645cm l〇 即:204.5 —206,5oC〇 &lt;實施例116;1-甲基·2-正丙基_6_[(2-吡啶甲基)氨基 甲醯基]苯並咪唑(181)之合成&gt; 依據實施例115之方法,使用6_羧基_丨_曱基正 丙基苯並咪唑(〇.402g)、氯化乙二醯(〇.468g)、2-胺基甲 基吡啶(0.199g)、三乙胺(〇.559g)以得出1_曱基-2-正丙基 -6-[(2-。比啶甲基)氨基曱醯基]苯並咪唑(181)(〇.213§)。 [化合物(181)的物性] lH-NMR(CDCl3, δ) : 1.08(3H3 t3 J=7.4Hz) 1.92(2H, m) 2.88(2H, m) 3.76 (3H, s) 4·80(2Η, d, J=4.8Hz), 7·22(1Η, dd, J=2.5 及 7·5Ηζ), 7.35(1H, d,J=7.8Hz),J.67-7.77(4H,m),7·80(1Η,s),8·58(1Η,dd,&lt;Μ·9 及 0.9 Hz)〇 IR(KBr) : 1647cm_1〇 mp : 140.5 —141-50C〇 〈實施例117; 1-(2-氯代苄基)-2-曱基-6-[(2-吡啶甲 基)氨基甲醯基]苯並咪唑(182)之合成&gt; 本紙張尺度適州中國國家標率(CNS ) Α4規格(21〇χ297公釐) 548272 經浐部中决«.绛而只T,消費合竹私印絮 A7 B7 五、發明説明(15g 依據實施例115之方法,使用6-羧基-1-(2-氣代节 基:)-2-甲基苯並咪唑(0.300g)、氯化乙二醯(0.253g)、2、 胺基甲基吡啶(0.108g)、三乙胺(0.302g)以得出1-(2-氯代 苄基)-2-甲基-6-[(2-α比啶甲基)氨基甲醯基]苯並咪。坐 (182)(0.164g)。 [化合物(182)的物性] lH-NMR(CDCl33 δ) : 2.56(3H3 s)5 4.76(2H3 d3 J=4.8Hz), 5.45(2H3 s)3 6.4〇 (1H, d, J=7.8Hz), 7·08(1Η, t, J二7·6Ηζ), 7·20-7·27(2Η, m), 7·33(1Η, d, j二 ?·8Ηζ), 7·45(1Η, dd, J=0.9 及 8·1Ηζ), 7.64(1H3 s)3 7,65-7·69(1Η, m), 7 • 72(1H,dd,J二 1·5 及 8·4Ηζ),7·77(1Η,d,J=8.4Hz),7·88(1Η,d,Jq,2Hz )3 8.56(1H5 d, J-4.7Hz)〇 IR(KBr) : 1646cffl_1。 mp : 156.5-157.50C〇 &lt;實施例ll8;2-正丙基-1-異丙基_6_[(2-吡啶甲基)氨 基甲醯基]苯並味σ坐(183)之合成&gt; 依據實施例115之方法,使用6-羧基-2-正丙基 異丙基苯並味唾(0.095g)、氯化乙二酿(〇·ΐ〇〇g)、2-胺基甲 基吡啶(0.039g)、三乙胺(0.097g)以得出2-正丙基-1-異丙 基-6-[(2-,比咬曱基)氨基曱醯基]苯並咪唑(183)(〇.〇20§)。 [化合物(183)的物性] W-NMR(CDC13, (5) : 1·08(3Η, t, J二7·4Ηζ), 1.69(6H, d, J=7.1Hz), 1.87-1.9 3(2H, m), 2·90(2Η, t, J=7.8Hz), 4.69-4.75(1H, m), 4·80(2Η, d, J:4.9Hz), 7·23(1Η, dd, J=7.3 及 2.1Hz), 7.37(1H, d3 J=7.7Hz), 7·62-7·77(4Η, m), 8·21(1Η, s), 8·58(1Η, d, J二4·5Ηζ)。 _____ι^ο_______ 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) '--- (讀先閲讀背面之注意事項再镇寫本頁j -、可 548272 A7 B7 五、發明説明(15) IR(KBr) : Ιθβίοιη ^ nip : 155.0 —156.9°C〇 &lt;實施例119;1-正丁基-2-正丙基_6-[(2-吡啶曱基)氨 基曱醯基]苯並咪唑(184)之合成&gt; 依據實施例115之方法,使用1-正丁基-6-羧基-2-正 丙基苯並咪唑(0.500g)、氣化乙二醯(〇.487g)、2-胺基甲基 吡啶(0.208g)、三乙胺(0.582)以得出1-正丁基-2-正丙基_ 6-[(2-喊唆曱基)氨基曱驢基]笨並咪σ坐(184)(0.283 g)。 [化合物(184)的物性] W-NMR(CDC133 (5) : 0·97(3Η3 t5 J:7.3Hz),1·〇8(3Η,t,J:7·他),1,37-1.4 6(2H,m),1·76-1,83(2Η,m),1·92-2·00(2Η,m)3 2·86(2Η3 t,J:7.8Hz)5 4·15 (2H, t, J:7.6Hz), 4·81(2Η, d5 J二4·8Ηζ), 7·23(1Η, dd, J:7.3 及 2.4Hz), 7·36(1Η, d, J=7.8Hz), 7.63-7·76(4Η, m), 8·02(1Η3 s), 8·58(1Η, d, J:4.7Hz )〇 IR(KBr) : 1631cm1。 mp : 105.8—107.2。〇。 〈實施例120; 1-(3-氣代苄基)-2-正丙基-6-[(2-吡啶 甲基)氨基甲醯基]苯並味唾(185)之合成&gt; 依據實施例115之方法,使用6-羧基-1-(3-氣代苄 基)-2-正丙基苯並咪唑(〇.580g)、氯化乙二醯(0.407g)、2-胺基甲基吡啶(〇·173g)、三乙胺(0.486)以得出1-(3-氯代 节基)-2-正丙基-6-[(2-°比唆甲基)氨基甲醯基]苯並味ϋ圭 (185)(0.311g)。 [化合物(185)的物性] ---— _161 —__ 本紙張尺度適/fl中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁} -丁 、-5口 Ψ 548272 Α7 Β7 五、發明説明(15会 (讀先閱讀背面之注意事項再填寫本頁) 'H-NMRCCDCb, 6) : 1.03(3H, t3 J=7.4Hz)3 1.85-1.93(2H, m), 2.80(2H, t3 &gt;7·5Ηζ),4·77(2Η,d3 J=4.8Hz),5·36(2Η,s),6.86(1H,d,J=7·他),7.02( 1H,s),7·20_7·28(3Η,m),7·33(1Η,d,J:7.8Hz),7.63-7.73(3H,m),7.79(1 H, d, J:8.4Hz), 7·91&lt;1Η, d3 J二1·3Ηζ), 8·57(1Η, d, J=4.7Hz)。 IR(KBr) : 1643cm-1。 mp : 157.7—158.80C〇 〈貫施例121; 1 -卞基-2-正丙基-6-[(2-0比σ定甲基)氨基 甲醯基]苯並咪唑(186)之合成&gt; 依據實施例Π5之方法,使用1-节基-6-羧基-2-正 丙基苯並咪唑(0.850g)、氯化乙二醯(〇.949g)、2-胺基甲 基吡啶(0.404g)、三乙胺(1.132g)以得出1-苄基-2-正丙基 -6-[(2·吡啶甲基)氨基曱醯基]苯並咪唑(186)(0,35 Og)。 [化合物(186)的物性] W-NMiUCDCh,ά) : 1·01(3Η,t,J=7.4Hz),1,83]·似2H,m),2·82(2Η,t, J二7·6Ηζ), 4·77(2Η, d, J=4.8Hz), 5.4G(2H, s)3 7.G3(2H, d, J=6.5Hz), 7·21( 1H, dd, J:7.1 及 2·1Ηζ), 7·18-7·34(4Η, m), 7·60(1Η3 s), 7·65-7·72(2Η, m),7·78(1Η,d,J:8.4Hz),7·94(1Η,d,J=1.2Hz),8·56(1Η,Μ=4·2Ηζ)。 IR(KBr) : 1642cffi-l〇 mp : 121.9 — 123.10C〇 〈實施例l22;l-(4_氣代节基)_2_丙基_6-[(2-。比咬曱 基)氨基甲醯基]苯並咪唑(187)之合成&gt; 依據實施例115之方法,使用6-羧基-1J4-氯代苄 基)-2-丙基苯並咪唑(0.547g)、氯化乙二醯(〇 384g)、2-胺基曱基吡啶(〇.163g)、三乙胺(0.458g)以得出ι_(扣氣代 _____ _L£2___ 本紙張尺Ζϊϋ國國家標準(CNS ) A4規格(210X297公楚)' ' ' ^沪部中^ir-^-^h 3消贽合竹和印象 548272 A7 ________ ____ B7_____ 五、發明説明(15$ 苄基)-2-丙基-6-[(2-吡啶甲基)氨基甲醯基]苯並咪唑 (187)(0.089g)。 [化合物(187)的物性] tNMIUCDCh,(5) ·· 1·02(3Η,t,J:7.4Hz),1·84_1.92(2Η,m),2.77-2.83(2H ,m), 4·76(2Η, d, J=4.8Hz), 5·36(2Η, s), 6.96(2H, d, J二8·3Ηζ), 7.22(1H, dd,J=6.4 及 0·4Ηζ),7·27(2Η3 dd,J:8.3 及 1·3Ηζ),7·33(1Η,d,J二7·8 Ηζ)5 7.62-7.73(3Η3 ιπ)5 7.78(1Η3 d3 J-8.4Hz), 7.91(1Η3 d3 J=0.9Hz)5 8. 56( 1Η, dd, J=4.9 及 0·8Ηζ)。 IR(KBr) : 1643cm-1〇 mp : 158.8 —161.0oC〇 &lt;實施例123;2-苄基-1-甲基-6-[(2-吡啶甲基)氨基甲 醯基]苯並咪唑(188)之合成&gt; 依據實施例115之方法,使用2-苄基-6-羧基-1-甲 基苯並咪唑(0.310g)、氯化乙二醯(〇.295g)、2-胺基甲基 吡啶(0.108g)、三乙胺(0.303g)以得出2-苄基-1-曱基_6-[(2-吡啶曱基)氨基曱醯基]笨並咪唑(188)(0.17 lg)。 [化合物(188)的物性] lH-NMR(CDCl3) δ) : 3.66(3H, s), 4.35(2H, s), 4380(2H3 d, J=4.8Hz), 7.21 -7·37(7Η,πι),·7·66(1Η,br t),7·67-7·73(2Η,m),7.78(1H, d,J二8·4Ηζ),7· 98(1H, s), 8·58(1Η, d3 J二4.9Hz) IR(KBr) : 1632cm1〇 mp : 168.5 — 169.50C〇 〈實施例124;l-(2,6-二氯代苄基)-2-甲基-6-[(2-吡啶 曱基)氨基甲醯基]苯並咪唑(189)之合成&gt; 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 548272 A7 __ B7 五、發明説明(16g 依據實施例115之方法,使用6-羧基-ΐ-(2,6·二氣 代苄基)-2-曱基苯並咪唑(〇.600g)、氯化乙二醯 (〇.472§)、2-胺基曱基吡啶(〇.201§)、三乙胺(〇.188§)以得 出1-(2,6· 一氣代卞基)-2-甲基- 6-[(2-σ比咬曱基)氨基甲酿 基]笨並咪唑(189)(0.040g)。 [化合物(189)的物性] ^-NMRCCDCh, δ) : 2.62(3H, s)3 4.76(2H3 d3 J-4.7Hz), 5.62(2H, s)3 7.23 (1H, dd, J=7.1 及 2·2Ηζ), 7·28(1Η, d, J=7.8Hz), 7·32(1Η, d, J:7.9Hz), 7-39(2H, d3 J=8.1Hz), 7.54(1H3 s)3 7.66-7.71(3H5 m)3 7.78(1H5 s)5 8.60(1 d, J=4.6Hz)。 IR(KBr) : 1635cm-l〇 mp : 225.7-226.9°C〇 &lt;實施例125;2-曱基-6-[(2-吡啶甲基)氨基甲醯基]_ 1-[2_(三氟甲基)苄基]苯並味唾(190)之合成&gt; 依據實施例115之方法,使用6-羧基-2-甲基-1-[2-(三氟曱基苄基]苯並咪唑(〇970g)、氯化乙二醯 (〇.736g)、2-胺基甲基吡啶(〇.261g)、三乙胺(0.726g)以得 出2-甲基-6_[(2“比啶甲基)氨基甲醯基]-卜[2-(三氟曱基) 苄基]苯並咪唑(190)(0.713g)。 [化合物(190)的物性] ^-NMRiCDCla, δ) : 2,54(3H, s), 4.76(2H3 d3 J^4.8Hz), 5.59(2H, s), 6,45 (1H, d, J=7.9Hz), 7.22(1H, t, J-5.8Hz), 7.34(2H, t, J=8.8Hz)5 7.40(1H, t ,J二7·5Ηζ), 7·62(1Η, br s), 7·68(1Η, dt, J:1.7 及 7·7Ηζ), 7·72-7·82(3Η ,m), 7.87(1H, s), 8.56(1H, d3 J=4.9Hz)〇 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 、1Τ 548272 Α7 Β7 五、發明説明(l6j IR(KBr) : 1648cm-1。 mp : 172 —174°C。 (讀先閱讀背面之注意事項再填寫本頁) &lt;實施例126;2-甲基-6-[(2-吡啶曱基)氨基甲醯基]_ 1-[4-(三氟曱基)节基]苯並味唾(191)之合成&gt; 依據實施例115之方法,使用6-羧基-2-甲基_1-[4-(三氟甲基苄基]苯並咪唑(〇.97〇g)、氯化乙二醯 (〇.736§)、2-胺基曱基吨啶(〇.261§)、三乙胺(〇.7268)以得 出2-甲基-6-[(2-α比啶甲基)氨基甲醯基]“-μ·(三氟甲基) 苄基]苯並咪唑(191)(0.194g)。 [化合物(191)的物性] ^-NMRiCDCh, δ) : 2.59(3H3 s)3 4·77(2Η, d, J-4.7Hz)3 5.45(2H, s)3 7,15 (2H, d, J=8.2Hz), 7·23(1Η3 m)3 7·33(1Η, d3 J=7.9Hz), 7·58(2Η, d, J:8.2Hz ^ )5 7.63(1H, br s), 7.67-7.74(2H3 m), 7.77(1H, d5 J=8.3Hz), 7.93(1H, s), 8·57(1Η, d, J=4.9Hz)〇 IR(KBr) : 1637cm'l〇 nip : 188.5 — 190.0oC〇 〈實施例l27; l-(3,4-二氣代苄基)_2_甲基-6-[(2-吡啶 曱基)氨基甲醯基]苯並咪唑(192)之合成&gt; 依據實施例115之方法,使用6-羧基-l-(3,4-二氣 代苄基)-2-甲基苯並咪唑(〇.500g)、氯化乙二醯 (0.393g)、2-胺基甲基呲啶(〇」67g)、三乙胺(0.469g)以得 出1-(3,4-二氣代苄基)-2-曱基-6-[(2-吡啶甲基)氨基曱醯 基]苯並咪唑(192)(0.264g)。 [化合物(192)的物性] -----L4S- 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(16i W-NMlUCDCh,6) : 2·58(3Η,s),4.77(2H,d,J:4.8Hz),5.33(2H,s)3 6.85 (111,(1(1,#8.3及2.2此),7.14(1[1,(1,付.1叫,7.22(111,(1(15扣7.3及 5·6Ηζ), 7·33(1Η, d, J:7.8Hz), 7·38(1Η, d, J:8.3Hz), 7.65-7·77(4Η, m), 7.92(1H, d, J二1·2Ηζ), 8.57(1H, d, J二4·8Ηζ)。 IR(KBr) : 1638cm-l〇 mp ·· 219.0 — 220.7°C。 &lt;實施例l28;2-曱基-l-(2-曱基苄基)_6_[(2_2啶甲基) 氨基甲醯基]苯並咪唑(193)之合成&gt; 依據實施例115之方法,使用6-竣基-2-甲基-1-(2-曱基苄基)苯並味σ坐(0.453g)、氯化乙二醯(〇 41 lg)、2-胺 基曱基吡啶(0.175g)、三乙胺(0.490g)以得出2-曱基-1-(2-曱基节基)-6-[(2-2咬甲基)氨基甲酿基]苯並味峻 (193)(0.100g) 〇 [化合物(193)的物性] H-_(CDCh,cn : 2.42(3H,S),2·54(3Η,S),4·75(2Η,d,J:4.9Hz),5.32 (2H,s),6·33(1Η,d,J-7·8Ηζ),7·01(1Η,t,J:7.8Hz),7,17-7·24(3Η,m),7 .33(1H, d5 J.7.8HZ), 7.60(1H, s)3 7.63-7.73(2H5 7.76(1H, d5 J-8.4Hz) ,7.84(1H3 d, J:1.4Hz), 8·56(1Η, d, J=4.9Hz)。 經浐部中次«.-^-^1、只τ-消费合竹淞印來 (請先閱讀背面之注意事項再填寫本頁) IR(KBr) : 1635cm~1〇 即:154.0- 157.0°C〇 &lt;實施例129;1-(2-甲氧苄基)-2-甲基-6-[(2-处唆甲 基)氨基曱醯基]苯並咪唑(194)之合成&gt; 依據實施例115之方法,使用6-羧基-1 _(2_甲氧节 基)·2-曱基苯並咪唾(0.997g)、氯化乙二醯(〇.858g)、2- --- 16^___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(16》 胺基曱基吡啶(〇.309g)、三乙胺(i.〇2g)以得出]μ(2-甲氧 苄基)-2-甲基-6-[(2-。比啶甲基)氨基甲醯基]苯並咪唑 (194) (0.918g)。 [化合物(194)的物性] 4-醜(CDCh,d) : 2·60(3Η,s),3·89(3Η,s),4·77(2Η,d,㈣·8Hz),5 36 UH,s),6·60(1Η,d,j:7.4Hz),6.79(1Η,扎 J=〇 8 及 7•刪,6·9ι(ιη, d, J-7.4HZ), 7.20-7.28(2Η3 m), 7.34(1Η3 d, J=7.9Hz), 7.56(1H, br t), 7.6 6-7.75(3H, m)5 7.95(1H, m), 8.57(1H, d, J-4.9Hz)〇 IR(KBr) : 1652cm-^ mp : 136—138.5°C。 〈實施例130;1_(4-曱氧苄基)_2_曱基_6_[(2_吡啶甲 基)氨基曱醯基]苯並咪唑(195)之合成&gt; 依據實施例115之方法,使用6_羧基甲氧苄 基)-2-甲基本並味吐(0.985g)、氣化乙二酿(〇 85 gg)、2_ 胺基曱基吡啶(0.309g)、三乙胺(i.02g)以得出1-(4_曱氧 苄基)-2-曱基-6-[(2-此啶曱基)氨基曱醯基]苯並咪唑 (195) (0.697g)。 [化合物(195)的物性] lH-NMR(CDCl35^) : 2.59(3Η, s)3 3.76(3H3 s)5 4.78(2H, d, J=4.8Hz), 5.32 (2H, s)3 6.83(2H3 m)5 7.00(2H5 m)3 7.22(1H, dd3 J,5.l * 6.8Hz)5 7.34( 1H3 d, J-7.8Hz), 7.60(1H, br t), 7.67-7.76(3H, m)3 7.97(1H, d3 J=1.2Hz)5 8·57(1Η, d, J=4.9Hz)。 IR(KBr) : 1652cm-l〇 mp : 191.5-192.20。。 _____t (si 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁) 訂 ^ewi. 548272 A7 B7 五、發明説明(16》 &lt;實施例131;1-[2-(苯磺醯甲基)苄基]-2-甲基-6_[(2· 叶匕咬甲基)氨基甲醯基]苯並咪唾(196)之合成&gt; 依據實施例115之方法,使用1-[2-(苯磺醯甲基) 节基]-6-羧基-2-甲基苯並味哇(〇.74g)、氯化乙二酿 (0.45g)、2-胺基曱基吡啶(〇.19g)、三乙胺(〇.53g)以得出 1 - [ 2 -(本石頁ii&amp;甲基)卞基]· 2 -甲基-6 - [ ( 2 - σ定甲基)氨基甲 醯基]笨並咪唑(196)(0.64g)。 [化合物(196)的物性] a-NM^CDCh,(5) : 2·57(3Η,s),4·50(2Η,s),4.74(2H,d,J二4.9Hz),5.59 (2H, s), 6·63(1Η, d, J二7·7Ηζ), 6·87(1Η, d, J=7,4 及 1·5Ηζ), 7·〇9-7·ΐ9( 3Η, m), 7·31(1Η, d, J=7.8Hz), 7·53_7·61(3Η, m)5 7·64(1Η3 dt, J:7.6 及 1·6Ηζ), 7·68-7·79(5Η, m), 7·84(1Η, s), 8·52(1Η, d, J=4.8Hz)。、 IR(neat) 1646CHT1。 液体。 〈實施例l32;l-(2-氰基苄基)-2_甲基_6_[(2_吡啶甲 基)氨基甲酸基]苯並味唾(197)之合成&gt; 依據實施例115之方法,使用6-羧基-1-(2-氰基苄 基)-2-甲基苯並咪唑(1.14g)、氯化乙二醯(〇.998g)、2-胺 基曱基咻啶(〇.425g)、三乙胺(l.i9g)以得出i-(2-氰基节 基)-2-曱基-6-[(2-咐啶曱基)氨基曱醯基]苯並咪唑 (197)(1.03g) 〇 [化合物(197)的物性] 旧-腿(CDCh,6) : 2·58(3Η,s),4.76UH,d,J=4.8Hz),5·59(2Η,s),6.64 (1Η,d,J=7.他),7·21(1Η,dt,J:5.6 及 1·8Ηζ),7·33(1Η,d,J:7.9Hz), __ 16« _ 本纸張尺度適中國國家標率(CNS) A4規格(210X 297公釐) '~ (讀先閱讀背面之注意事項再镇寫本頁) 、=口 争 548272 A7 B7 五、發明説明(16身 7·39~7·47(2Η, m), 7·65-7.79(5Η, m), 7·89(1Η, s), 8·56(1Η, dd, J二4.9 及 〇.9Hz)〇 IR(KBr) : 2223,1642cnT1。 即:150.5-151.4。。。 &lt;實施例133;1-(聯苯-2-甲基)_2·甲基_6-[(2_吡啶曱 基)氨基甲醯基]苯並咪唑(198)之合成&gt; 依據實施例115之方法,使用丨_(聯苯_2_甲基)_6_ 羧基-2-甲基苯並咪唑(1.07g)、氯化乙二醯(〇 796g)、孓 胺基甲基吡啶(0.339g)、三乙胺((K950g)以得出丨_(聯苯_ 2-甲基)-2-甲基-6_[(2_吡啶甲基)氨基甲醯基]苯並咪唑 (198)(0.672g) 〇 [化合物(198)的物性] lH-NMR(CDCl3, δ) : 2.380H, s), 4.78(2H3 d3 J-4.8Hz)5 5.27(2H3 s)3 6.64 (1H,d,J:8.0Hz),7·17-7·24(2Η,m),7·29-7·43(6Η,in),7·48(2Η5 t3 J:5.5H z),7.49UH,s),7·57_7·73(3Η,m),7·80(1Η,d,8·58(1Η,d,J二4 .9Hz)。 IR(KBr) : 1630, 1619cm—1。 mp : 179.8 —180.8oC〇 經浐部中央ii.-^-^h 3消费合竹W印來 (讀先閱讀背面之注意事項再填寫本頁) 施例134;1-苄基-2-甲基-6-[(2-吡啶甲基)氨基甲 醯基]苯並咪唑(199)之合成&gt; 依據實施例115之方法,使用丨_苄基_6-羧基甲 基苯並咪唑(0.59g)、氯化乙二醯(0.56g)、2_胺基甲基。比 啶(0.24g)、三乙胺(0.67g)以得出1·苄基·2_甲基-6_[(2_吡 啶甲基)氨基甲醯基]笨並咪唑(199)(0.66g)。 —__ ____L6J2___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(16g [化合物(199)的物性] lH-NMR(CDCl33 δ) : 2·58(3Η5 s), 4.76(ZH5 d, J^4.9Hz)3 5.36(2H3 s)3 7.02 一7·〇6(2Η,瓜),7·21(1Η, dd, J=6.9 及 5·0Ηζ), 7.27-7.35(4H, m), 7.65-7.7 5(4H3 m)3 7·96(1Η, d3 扣0·8Ηζ)3 8·56(1Η, d3 J二4·8Ηζ)。 IR(KBr) ; 1640cm'1〇 即:124.0 —124.9〇C〇 &lt;實施例135;l-(4-第3 丁基苄基)-2-甲基-6-[(2-吡啶 甲基)氨基曱醯基]苯並味°坐(2 00)之合成&gt; 依據實施例115之方法,使用1-(4-第3 丁基苄 基)-6-叛基-2-甲基苯並味嗤(〇.544g)、氣化乙二醯 (〇.428g)、2-胺基甲基吡啶(0.183g)、三乙胺(0.511g)以得 出1-(4-弟3 丁基卞基)-2-曱基- 6- [(2 - 0比咬甲基)氣基甲酿 基]笨並咪唑(200)(0.477g)。 [化合物(200)的物性] lH-NMR(CDCl33 δ) : 1.27(9H3 s)3 2.60(3H3 s)3 4.77(2H, d? J=4.9Hz)? 5.34 (2H, s), 6·98(2Η, d, J=8.3Hz), 7·21(1Η, dd, J二7·3 及 5·1Ηζ), 7·29-7·35 經浐部中央榀準M T,消贽合竹私印^ (讀先閱讀背面之注意事項再填寫本頁) (3Η, m), 7.62(1Η, br s)3 7,65-7·75(3Η5 m)3 7·96(1Η, d, J二1.1Hz), 8·57(1Η ,d, J 二4·7Ηζ)〇 IR(KBr) : 1646cm·1〇 mp ·· 140.4—142.8°C。 &lt;實施例136;2-甲基-1-(2 -茶基甲基)-6-[(2-σΛσ定甲 基)氨基甲醯基]苯並咪唑(201)之合成&gt; 依據實施例Π5之方法,使用6-羧基-2-曱基-1-(2-萘基曱基)苯並咪唑(〇.8〇g)、氣化乙二醯(〇.64g)、胺基 _____U10-- 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(1 甲基σ比唆(0.27g)、三乙胺(0.77g)以得出2_甲基小(2_萘基 甲基)_6-[(2- °比咬甲基)氨基甲酿基]苯並味唾 (讀先閲讀背面之注意事項再填寫本頁) (201) (〇.47g)。 [化合物(201)的物性] lH~NMR(CDCl35 δ) : 2.60(3H, s)5 4.75(2H3 d3 J=4.9Hz), 5.52(2H3 s)5 7.17 -7』3(2H,m),7.31(lH,d,J:7.8Hz),7.38(lH,s),7.43-7.48(2H,in),7.60-7·82(7Η, m), 8·00(1Η, d, J=l.〇Hz), 8·53(1Η3 d, J :4.7Hz)。 IR(KBr) : 1640cm-l〇 耶:143.0—144.5°C。 &lt;實施例137;1-(聯苯-4-甲基)_2-乙基-6-[(2-。比咬曱 基)氨基甲醯基]苯並咪唑(202)之合成&gt; 依據實施例115之方法,使用1_(聯苯甲基)-6-羧基-2·乙基苯並咪唑(0.500g)、氯化乙二醯(0 356g)、2_ 胺基甲基σ比唆(0.15 lg)、三乙胺(〇.424g)以得出1_(聯苯_ 4-曱基)-2-乙基-6-[(2-叶b咬甲基)氨基甲醯基]苯並咪唾 (202) (0」04g) ° [化合物(202)的物性] ^-NMRiCDCh, δ) : L45(3H3 t3 J-7,7Hz), 2·90(2Η3 q, J-7.4Hz), 4.77(2H5 d, J=4.7Hz), 5.43(2H, s), 7.10(2H, d, J=8.2Hz), 7.20(1H3 dt, J二4.9 及 7·7Ηζ), 7·33(2Η, t, J=7.4Hz), 7·42(2Η, t, J=7.5Hz), 7·49-7·55(4Η3 m), 7 •61(1H, br t), 7·67(1Η, dt, J=7.8 及 1·8Ηζ), 7·72(1Η, d, J二8·4Ηζ), 7·8 1(1Η, d, J:8.4Hz), 7·99(1Η, s), 8.56(1Η3 d, J:4.9Hz)。 IR(KBr) : 1640cm1。 mp : 123·0 —124.0oC〇 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 〜〜_______________ B7______ 五、發明説明(16》 〈實施例I38; 1-(2-氣代苄基)_6_[2_(吡啶甲基)氨基 甲醯基]苯並咪唑(203)之合成&gt; (請先閱讀背面之注意事項再填寫本頁) 依據貫施例115之方法,使用魏基4-(2-氯代苄 基)苯並咪唑(0.461g)、氯化乙二醯(〇.728g)、2-胺基甲基 吡啶(O.lMg)、三乙胺(〇.468g)以得出丨-仏氣代苄基)-6· [2十比啶甲基)氨基甲醯基]苯並咪唑(2〇3)(〇 u〇g)。 [化合物(203)的物性]Mass (FAB): m / e 466 (M + l) 〇 jap: 243.1 — 244.3 ° C 〇 This paper standard Chinese National Standard (CNS) A4 specification (21〇χ29 ^^ --- (Read the note on the back first Please fill out this page again for the matter}, 1T ^ 548272 A7 B7 V. Description of the invention (15j &lt; Example 114; N-benzenesulfonyl-2-_2- [1- (2-chlorobenzyl) _2-methylbenzyl) Synthesis of fluoren-6-yl] acetamide (179) &gt; According to the method of Example 98, ι_ (2-chlorobenzyl) &gt; 2-methylbenzimidazole-6-acetic acid (0.170§), Team: ^,-carbonyldiimidazole (0.1758), benzylsulfonamide (0.170 g), diazabicycloundecene (0.164 g) to obtain N-benzoxanthanyl-2- [1- (2-chlorobenzyl) -2-fluorenylbenzimidone-6-yl] ethynylamine (179) (0.09 g). [Physical properties of compound (179)] ^ -NMRiDMSO-dG, δ): 2.44 (3H, s) 3 3.57 (2H, s), 5.46 (2H, s), 6.41 (1H3 d, J = 7.7Hz), 6.96 (1Η, d, J: 7.0Hz), 7.16 ( 1Η, s) 3 7.20 (1H, t), 7.32 (1Η3 t) 3 7 · 47 (1Η, d3 J = 8Iz), 7.52-7 · 59 (3Η, m), 7.67 (1Η , T, J: 7.5 Hz) 3 7.84 (2 Η, d 3 J-7.4 Hz) 5 12.28 (1H, br s) IR (KBr) 1719 cm-10 mp: 236.2-237.8 ° C. &lt; Example 1 15; l- (2,4-dichlorobenzyl) -2-methylpyridylmethyl) aminofluorenyl] benzimidal (180) &gt; Only τ, eliminate cooperation * print? Water (please read the precautions on the back before filling this page) Add dioxane (150ml) and a few drops of Ν, Ν-dimethylphosphonium amine to 6-end Base-1- (2,4-digasocarbyl) -2-fluorenylbenzo (η) (9.00 g), ice-cold. Drop into the gasified ethylenedifluorene (6.48 g) and stir for a few minutes. After stirring at room temperature for 1.5 hours, it was concentrated under reduced pressure to a volume of about one-third. The precipitate was collected and 2-aminopyridine (2.69 g) and triethylamine ( 7.34g) in a solution of dichloromethane (200ml). After stirring for 15 hours, the reaction solution was washed three times with water, and then washed with a saturated sodium bicarbonate aqueous solution. The organic layer was concentrated under reduced pressure, and ethyl acetate was used to To make it crystallize. Feng paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 Μ B7 V. Description of the invention (15j transition out of crystalline 'dry surplus to pay 1- (2,4 -dichloro section) Base) -2-fluorenyl-6_ [(2-0 Specific σ 疋 曱 group) Gasomethyl] benzo sigma (i80) 4.35g. (Read the precautions on the back before you fill in this page) [Physical properties of compound (180)] H NMR (CDCl35 δ): 2.56 (3H3 s), 4.76 (2H3 d3 J = 4.8Hz) 3 5.40 (2H3 s), 6.33 (1H 'd, J: 8, 4Hz), 7.07 (1Η3 dd, J: 8.4 and 2.00Ηζ), 7.22 (1Η, dd, J = 7.4 and 4.9Hz), 7.33 (1H, d , J: 7, 9Hz), 7.48 (1Η, d3 J: 2.1Hz) 3 7.62_7 · 79 (4Η, ιη), 7.86 (1Η, d, J = l.lHz) 8.57, (1H , D, J: 4.9 Hz). IR (KBr): 1645cm l0: 204.5-206,5oC &lt; Example 116; 1-methyl · 2-n-propyl-6-[(2-pyridylmethyl) carbamoyl] benzimidazole Synthesis of (181) &gt; According to the method of Example 115, 6-carboxyl-fluorenyl-n-propylbenzimidazole (0.402 g), ethylene dichloride (0.468 g), and 2-amino group were used. Methylpyridine (0.199g), triethylamine (0.559g) to give 1-fluorenyl-2-n-propyl-6-[(2-.pyridinylmethyl) aminofluorenyl] benzimidazole (181) (0.213 §). [Physical properties of compound (181)] 1H-NMR (CDCl3, δ): 1.08 (3H3 t3 J = 7.4Hz) 1.92 (2H, m) 2.88 (2H, m) 3.76 (3H, s) 4.80 (2Η, d, J = 4.8Hz), 7 · 22 (1Η, dd, J = 2.5 and 7. · 5Ηζ), 7.35 (1H, d, J = 7.8Hz), J.67-7.77 (4H, m), 7 · 80 (1Η, s), 8.58 (1Η, dd, &lt; M · 9 and 0.9 Hz) IR (KBr): 1647cm_1mp: 140.5 -141-50C. <Example 117; 1- (2- Synthesis of chlorobenzyl) -2-fluorenyl-6-[(2-pyridylmethyl) aminomethylfluorenyl] benzimidazole (182) &gt; This paper is compliant with China National Standard (CNS) Α4 specification (21 × 297 mm) 548272 After the final decision «. 绛 and only T, consumption Hezhu private printing A7 B7 V. Description of the invention (15g according to the method of Example 115, using 6-carboxy-1- (2 -Azobenzyl:)-2-methylbenzimidazole (0.300g), ethylenedifluoride chloride (0.253g), 2, aminomethylpyridine (0.108g), triethylamine (0.302g) to This gives 1- (2-chlorobenzyl) -2-methyl-6-[(2-α-pyridinylmethyl) carbamoyl] benzimid. (182) (0.164 g). [Compound (Physical properties of (182)] lH-NMR (CDCl33 δ): 2.56 (3H3 s) 5 4.76 (2H3 d3 J = 4.8Hz), 5.45 (2H3 s) 3 6.4 (1H, d, J = 7.8Hz), 7.08 (1Η, t, J 2 7.6Ηζ), 7.20-7 · 27 (2Η, m), 7.33 ( 1Η, d, j = 8Ηζ), 7.45 (1Η, dd, J = 0.9 and 8.1Ηζ), 7.64 (1H3 s) 3 7,65-7 · 69 (1Η, m), 7 • 72 (1H, dd, J 2 1.5 and 8. 4Ηζ), 7.77 (1Η, d, J = 8.4Hz), 7.88 (1Η, d, Jq, 2Hz) 3 8.56 (1H5 d, J- 4.7Hz) IR (KBr): 1646cffl_1. Mp: 156.5-157.50C0 &lt; Example 1118; 2-n-propyl-1-isopropyl-6-[(2-pyridylmethyl) carbamoyl] Synthesis of Benzo sigma (183) &gt; According to the method of Example 115, 6-carboxy-2-n-propylisopropylbenzo saliva (0.095 g) and ethylene chloride (〇 · ΐ) were used 〇g), 2-aminomethylpyridine (0.039g), triethylamine (0.097g) to give 2-n-propyl-1-isopropyl-6-[(2-, ) Aminofluorenyl] benzimidazole (183) (0.020 §). [Physical properties of compound (183)] W-NMR (CDC13, (5): 1.08 (3Η, t, J 二 7.4Ηζ), 1.69 (6H, d, J = 7.1Hz), 1.87-1.9 3 ( 2H, m), 2.90 (2Η, t, J = 7.8Hz), 4.69-4.75 (1H, m), 4.80 (2Η, d, J: 4.9Hz), 7.23 (1Η, dd, J = 7.3 and 2.1Hz), 7.37 (1H, d3 J = 7.7Hz), 7.62-7 · 77 (4Η, m), 8.21 (1Η, s), 8.58 (1Η, d, J II 4 · 5Ηζ). _____ ι ^ ο _______ The paper size is appropriate / 1] Chinese National Standard (CNS) A4 specification (210X297 mm) '--- (Read the precautions on the back before writing this page j-, may 548272 A7 B7 V. Description of the invention (15) IR (KBr): Ιθβίοιη ^ nip: 155.0-156.9 ° C &lt; Example 119; 1-n-butyl-2-n-propyl-6-[(2-pyridine Synthesis of fluorenyl) aminofluorenyl] benzimidazole (184) &gt; According to the method of Example 115, 1-n-butyl-6-carboxy-2-n-propylbenzimidazole (0.500 g), Ethylenediamine (0.487 g), 2-aminomethylpyridine (0.208 g), and triethylamine (0.582) to give 1-n-butyl-2-n-propyl-6-[(2- Fluorenyl) Amino acyl donkey] Stupid and Mimic σ sitting (184) (0.283 g) [Physical properties of compound (184)] W-NMR (CDC133 (5): 0.97 (3Η3 t5 J: 7.3Hz), 1.08 (3Η, t, J: 7 · other), 1,37- 1.4 6 (2H, m), 1.76-1,83 (2Η, m), 1.92-2 · 00 (2Η, m) 3 2.86 (2Η3 t, J: 7.8Hz) 5 4 · 15 (2H, t, J: 7.6Hz), 4.81 (2Η, d5 J, 2 · 8Ηζ), 7.23 (1Η, dd, J: 7.3 and 2.4Hz), 7.36 (1Η, d, J = 7.8Hz), 7.63-7 · 76 (4Η, m), 8.02 (1Η3 s), 8.58 (1Η, d, J: 4.7Hz) IR (KBr): 1631cm1. Mp: 105.8-107.2 〈〈 Example 120; Synthesis of 1- (3-Azobenzyl) -2-n-propyl-6-[(2-pyridylmethyl) aminomethylamidino} benzoyl salivary (185)〉 According to the method of Example 115, using 6-carboxy-1- (3-fluorobenzyl) -2-n-propylbenzimidazole (0.580 g), ethylene dichloride (0.407 g), 2- Aminomethylpyridine (.173g), triethylamine (0.486) to give 1- (3-chlorobenzyl) -2-n-propyl-6-[(2- ° to fluorenylmethyl) amino Methylfluorenyl] benzobispyrene (185) (0.311 g). [Physical properties of compound (185)] ---— _161 —__ This paper is suitable for size / fl Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page}-Ding, -5 口 Ψ 548272 Α7 Β7 V. Description of the invention (15 sessions (read the precautions on the back before filling this page) 'H-NMRCCDCb, 6): 1.03 (3H, t3 J = 7.4Hz) 3 1.85-1.93 ( 2H, m), 2.80 (2H, t3 &gt; 7. · 5Ηζ), 4.77 (2Η, d3 J = 4.8Hz), 5.36 (2Η, s), 6.86 (1H, d, J = 7 · he ), 7.02 (1H, s), 7.20_7 · 28 (3Η, m), 7.33 (1Η, d, J: 7.8Hz), 7.63-7.73 (3H, m), 7.79 (1 H, d, J: 8.4 Hz), 7.91 &lt; 1Η, d3 J 2 1.3Ηζ), 8.57 (1Η, d, J = 4.7Hz). IR (KBr): 1643cm-1. mp: 157.7-158.80C. <Consistent Example 121; Synthesis of 1-fluorenyl-2-n-propyl-6-[(2-0 ratio σ-determined methyl) aminomethylfluorenyl] benzimidazole (186) &gt; According to the method of Example Π5, 1-benzyl-6-carboxy-2-n-propylbenzimidazole (0.850 g), ethylene dichloride (0.949 g), and 2-aminomethylpyridine were used. (0.404g), triethylamine (1.132g) to give 1-benzyl-2-n-propyl-6-[(2.pyridylmethyl) aminofluorenyl] benzimidazole (186) (0, 35 Og). [Physical properties of compound (186)] W-NMiUCDCh , ά): 1.01 (3Η, t, J = 7.4Hz), 1,83] · 2H, m), 2.82 (2Η, t, J2) 7 · 6Ηζ), 4.77 (2Η, d, J = 4.8Hz), 5.4G (2H, s) 3 7.G3 (2H, d, J = 6.5Hz), 7.21 (1H, dd, J : 7.1 and 2.1Ηζ), 7.18-7 · 34 (4Η, m), 7.60 (1Η3 s), 7.65-7 · 72 (2Η, m), 7.78 (1Η, d, J: 8.4 Hz), 7.94 (1Η, d, J = 1.2Hz), 8.56 (1Η, M = 4 · 2Ηζ). IR (KBr): 1642cffi-l0mp: 121.9-123.10C. <Example 122; l- (4-Azobenzyl) _2_propyl_6-[(2-. Specific fluorenyl) carbamate Fluorenyl] Synthesis of benzimidazole (187) &gt; According to the method of Example 115, 6-carboxy-1J4-chlorobenzyl) -2-propylbenzimidazole (0.547 g) and ethylenedifluorene chloride were used. (〇384g), 2-aminopyridylpyridine (〇.163g), triethylamine (0.458g) to get ι_ (deduction of gas generation _____ _L £ 2 ___) This paper rule Z national standard (CNS) A4 specifications (210X297 Gongchu) '' '^ Hubuzhong ^ ir-^-^ h 3 Eliminate the combination of bamboo and impression 548272 A7 ________ ____ B7_____ V. Description of the invention (15 $ benzyl) -2-propyl-6- [ (2-Pyridylmethyl) carbamoyl] benzimidazole (187) (0.089 g). [Physical properties of compound (187)] tNMIUCDCh, (5) ··· 02 (3Η, t, J: 7.4 Hz ), 1.84_1.92 (2Η, m), 2.77-2.83 (2H, m), 4.76 (2Η, d, J = 4.8Hz), 5.36 (2Η, s), 6.96 (2H, d , J 2: 8 · 3Ηζ), 7.22 (1H, dd, J = 6.4 and 0.4Ηζ), 7.27 (2 (3 dd, J: 8.3 and 1.31ζ), 7.33 (1Η, d, J 2: 7 8 Ηζ) 5 7.62-7.73 (3Η3 ιπ) 5 7.78 (1Η3 d3 J-8. 4Hz), 7.91 (1Η3 d3 J = 0.9Hz) 5 8.56 (1Η, dd, J = 4.9 and 0 · 8Ηζ). IR (KBr): 1643cm-1〇mp: 158.8-161.0oC. &Lt; Examples 123; Synthesis of 2-benzyl-1-methyl-6-[(2-pyridylmethyl) carbamoyl] benzimidazole (188) &gt; According to the method of Example 115, 2-benzyl- 6-carboxy-1-methylbenzimidazole (0.310g), ethylenedichloride (0.295g), 2-aminomethylpyridine (0.108g), triethylamine (0.303g) to give 2 -Benzyl-1-fluorenyl-6-[(2-pyridinyl) aminofluorenyl] benzimidazole (188) (0.17 lg). [Physical properties of compound (188)] 1H-NMR (CDCl3) δ ): 3.66 (3H, s), 4.35 (2H, s), 4380 (2H3 d, J = 4.8Hz), 7.21 -7 · 37 (7Η, π), · 7 · 66 (1Η, br t), 7 · 67-7 · 73 (2Η, m), 7.78 (1H, d, J = 8 · 4Ηζ), 7.98 (1H, s), 8.58 (1Η, d3 J = 4.9Hz) IR (KBr) : 1632 cm10 mp: 168.5-169.50C. <Example 124; l- (2,6-dichlorobenzyl) -2-methyl-6-[(2-pyridinyl) carbamoyl] benzene Synthesis of Benzimidazole (189) &gt; This paper is suitable for Chinese National Standard (CNS) A4 size (210X 297 mm) (Please read the back first Note: Please fill in this page again) 548272 A7 __ B7 V. Description of the invention (16g according to the method of Example 115, using 6-carboxy-fluorene- (2,6 · digaso-benzyl) -2-fluorenylbenzimidazole (〇.600g), ethylene dichloride (0.472 §), 2-aminomethylpyridine (0.201 §), triethylamine (0.188 §) to give 1- (2,6 · Mono-amorphous fluorenyl) -2-methyl-6-[(2-σ than fluorenyl) carbamyl] benzimidazole (189) (0.040 g). [Physical properties of compound (189)] ^ -NMRCCDCh, δ): 2.62 (3H, s) 3 4.76 (2H3 d3 J-4.7Hz), 5.62 (2H, s) 3 7.23 (1H, dd, J = 7.1 and 2 · 2Ηζ), 7.28 (1Η, d, J = 7.8Hz), 7.32 (1Η, d, J: 7.9Hz), 7-39 (2H, d3 J = 8.1Hz), 7.54 (1H3 s) 3 7.66-7.71 (3H5 m) 3 7.78 (1H5 s) 5 8.60 (1 d, J = 4.6Hz). IR (KBr): 1635cm-lmp: 225.7-226.9 ° C &lt; Example 125; 2-fluorenyl-6-[(2-pyridylmethyl) carbamoyl] -1- [2_ (tri Synthesis of fluoromethyl) benzyl] benzozal (190) &gt; According to the method of Example 115, 6-carboxy-2-methyl-1- [2- (trifluorofluorenylbenzyl] benzo) was used. Imidazole (0970g), ethylenedichloride (0.736g), 2-aminomethylpyridine (0.261g), triethylamine (0.726g) to give 2-methyl-6 _ [(2 " Pididylmethyl) carbamoyl]-[[2- (trifluorofluorenyl) benzyl] benzimidazole (190) (0.713g). [Physical Properties of Compound (190)] ^ -NMRiCDCla, δ): 2,54 (3H, s), 4.76 (2H3 d3 J ^ 4.8Hz), 5.59 (2H, s), 6,45 (1H, d, J = 7.9Hz), 7.22 (1H, t, J-5.8Hz ), 7.34 (2H, t, J = 8.8Hz) 5 7.40 (1H, t, J = 7.55Ηζ), 7.62 (1Η, br s), 7.68 (1Η, dt, J: 1.7 and 7 · 7Ηζ), 7.72-7 · 82 (3Η, m), 7.87 (1H, s), 8.56 (1H, d3 J = 4.9Hz). The paper size is in accordance with China National Standard (CNS) A4 specifications (210X297). (Mm) (Please read the precautions on the back before filling this page), 1T 548272 Α7 Β7 V. Description of the invention (16j IR (KBr): 1648cm-1. Mp: 172 —174 ° C (Read the precautions on the back before filling this page) &Example; Example 126; 2-Methyl-6-[(2-pyridinyl) carbamoyl] -1- [4- (trifluorofluorene Group) benzyl] Synthesis of benzoyl salivary (191) &gt; According to the method of Example 115, 6-carboxy-2-methyl_1- [4- (trifluoromethylbenzyl] benzimidazole ( 0.997 g), ethylene dichloride (0.736 §), 2-aminofluorenyl toxidine (0.261 §), triethylamine (0.7268) to give 2-methyl- 6-[(2-αbipyridylmethyl) carbamoyl] "-μ · (trifluoromethyl) benzyl] benzimidazole (191) (0.194g). [Physical Properties of Compound (191)] ^ -NMRiCDCh, δ): 2.59 (3H3 s) 3 4.77 (2Η, d, J-4.7Hz) 3 5.45 (2H, s) 3 7,15 (2H, d, J = 8.2Hz), 7.23 (1Η3 m) 3 7 · 33 (1Η, d3 J = 7.9Hz), 7.58 (2Η, d, J: 8.2Hz ^) 5 7.63 (1H, br s), 7.67-7.74 (2H3 m), 7.77 (1H, d5 J = 8.3Hz), 7.93 (1H, s), 8.57 (1Η, d, J = 4.9Hz) IR (KBr): 1637cm'l0nip: 188.5-190.0oC. <Examples l27; l- (3,4-dioxobenzyl) -2-methyl-6-[(2-pyridinyl) carbamoyl] benzimidazole (192) Synthesis &gt; According to Example 115 Method to make 6-carboxy-l- (3,4-dioxobenzyl) -2-methylbenzimidazole (0.500 g), ethylenedichloride (0.393 g), 2-aminomethylpyridine (〇 ”67g), triethylamine (0.469g) to give 1- (3,4-digaso-benzyl) -2-fluorenyl-6-[(2-pyridylmethyl) aminofluorenyl] Benzimidazole (192) (0.264 g). [Physical properties of compound (192)] ----- L4S- This paper is suitable for Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (16i W-NMlUCDCh, 6): 2 58 (3Η, s), 4.77 (2H, d, J: 4.8Hz), 5.33 (2H, s) 3 6.85 (111, (1 (1, # 8.3 and 2.2 this), 7.14 (1 [1, ( 1, pay .1 call, 7.22 (111, (1 (15 deduction 7.3 and 5. 6Ηζ), 7.33 (1Η, d, J: 7.8Hz), 7.38 (1Η, d, J: 8.3Hz) , 7.65-7 · 77 (4Η, m), 7.92 (1H, d, J 二 1.2 · ΗΗζ), 8.57 (1H, d, J 二 4 · 8Ηζ). IR (KBr): 1638cm-lmp ··· 219.0-220.7 ° C. &Lt; Example l28; Synthesis of 2-fluorenyl-l- (2-fluorenylbenzyl) _6 _ [(2_2 pyridylmethyl) carbamoyl] benzimidazole (193) &gt; According to the method of Example 115, using 6-endyl-2-methyl-1- (2-fluorenylbenzyl) benzozine (0.453 g), ethylene dichloride (〇41 lg), 2 -Aminopyridine (0.175g), triethylamine (0.490g) to give 2-fluorenyl-1- (2-fluorenylbenzyl) -6-[(2-2methylmethyl) carbamate Fermentation group] Benzo flavor (193) (0.100 g) 〇 [Physical properties of compound (193)] H -_ (CDCh, cn: 2.42 (3H, S) 2.54 (3Η, S), 4.75 (2Η, d, J: 4.9Hz), 5.32 (2H, s), 6.33 (1Η, d, J-7 · 8Ηζ), 7.01 (1Η , T, J: 7.8Hz), 7,17-7 · 24 (3Η, m), 7.33 (1H, d5 J.7.8HZ), 7.60 (1H, s) 3 7.63-7.73 (2H5 7.76 (1H , d5 J-8.4Hz), 7.84 (1H3 d, J: 1.4Hz), 8.56 (1Η, d, J = 4.9Hz). The middle part of the warp «.- ^-^ 1, only τ-consumption Sealed with bamboo (please read the precautions on the back before filling this page) IR (KBr): 1635cm ~ 10 namely: 154.0-157.0 ° C. &Lt; Example 129; 1- (2-methoxybenzyl) ) Synthesis of 2-methyl-6-[(2-methylamino) aminofluorenyl] benzimidazole (194) &gt; According to the method of Example 115, 6-carboxy-1 _ (2_ Methoxybenzyl) · 2-fluorenyl benzimidal (0.997g), ethylene dichloride (〇.858g), 2- --- 16 ^ ___ This paper size applies to China National Standard (CNS) A4 (210X 297mm) 548272 A7 B7 V. Description of the invention (16) Aminopyridine (0.309g), triethylamine (1.02g) to obtain] μ (2-methoxybenzyl)- 2-methyl-6-[(2-. Pididylmethyl) carbamoyl] benzimidazole (194) (0.918g). [Physical properties of compound (194)] 4-ug (CDCh, d): 2.60 (3Η, s), 3.89 (3Η, s), 4.77 (2Η, d, ㈣8Hz), 5 36 UH, s), 6.60 (1Η, d, j: 7.4Hz), 6.79 (1Η, J = 08 and 7 • deleted, 6.9ι (ι, d, J-7.4HZ), 7.20-7.28 (2Η3 m), 7.34 (1Η3 d, J = 7.9Hz), 7.56 (1H, br t), 7.6 6-7.75 (3H, m) 5 7.95 (1H, m), 8.57 (1H, d, J-4.9 Hz) 〇IR (KBr): 1652cm- ^ mp: 136-138.5 ° C. <Example 130; 1- (4-fluorenyloxybenzyl) _2_fluorenyl_6 _ [(2-pyridylmethyl) aminofluorene Synthesis of benzimidazole (195) &gt; According to the method of Example 115, 6-carboxymethoxybenzyl) -2-methylbenzomime (0.985g), gasified ethylene distillate (〇85 gg ), 2-aminopyridinylpyridine (0.309g), triethylamine (i.02g) to give 1- (4_fluorenylbenzyl) -2-fluorenyl-6-[(2-this pyrimidinyl ) Aminofluorenyl] benzimidazole (195) (0.697 g). [Physical properties of compound (195)] 1H-NMR (CDCl35 ^): 2.59 (3Η, s) 3 3.76 (3H3 s) 5 4.78 (2H, d, J = 4.8Hz), 5.32 (2H, s) 3 6.83 ( 2H3 m) 5 7.00 (2H5 m) 3 7.22 (1H, dd3 J, 5.l * 6.8Hz) 5 7.34 (1H3 d, J-7.8Hz), 7.60 (1H, br t), 7.67-7.76 (3H, m) 3 7.97 (1H, d3 J = 1.2Hz) 5 8 · 57 (1Η, d, J = 4.9Hz). IR (KBr): 1652cm-lOmp: 191.5-192.20. . _____t (si The size of this paper is / 1] Chinese National Standard (CNS) A4 specification (210X 297 mm) (Read the precautions on the back before filling this page) Order ^ ewi. 548272 A7 B7 V. Description of the invention (16 "&Lt; Example 131; 1- [2- (benzenesulfonylmethyl) benzyl] -2-methyl-6 _ [(2 · leaf bite methyl) carbamoyl] benzimidal (196 ) Synthesis> According to the method of Example 115, 1- [2- (benzenesulfonylmethyl) benzyl] -6-carboxy-2-methylbenzowow (0.74 g), ethyl chloride Distillate (0.45g), 2-aminopyridylpyridine (0.19g), and triethylamine (0.53g) to give 1-[2-(this stone page ii & methyl) fluorenyl] · 2 -Methyl-6-[(2-σ fixed methyl) carbamoyl] benzimidazole (196) (0.64g). [Physical properties of compound (196)] a-NM ^ CDCh, (5): 2 · 57 (3Η, s), 4.50 (2Η, s), 4.74 (2H, d, J = 4.9Hz), 5.59 (2H, s), 6.63 (1Η, d, J = 7 · 7Ηζ) , 6.87 (1Η, d, J = 7, 4 and 1.5Ηζ), 7.09-9-7ΐ9 (3Η, m), 7.31 (1Η, d, J = 7.8Hz), 7 · 53_7 · 61 (3Η, m) 5 7 · 64 (1Η3 dt, J: 7.6 and 1.6Ηζ), 7.68-7 · 79 (5Η, m) 7.84 (1Η, s), 8.52 (1Η, d, J = 4.8Hz), IR (neat) 1646CHT1. Liquid. <Example l32; l- (2-cyanobenzyl) -2_ Synthesis of methyl-6-[(2-pyridylmethyl) carbamic acid group] benzo saliva (197)> According to the method of Example 115, 6-carboxy-1- (2-cyanobenzyl)- 2-methylbenzimidazole (1.14g), ethylenedifluoride chloride (.998g), 2-aminopyridinium pyridine (0.425g), triethylamine (1.19g) to obtain i- (2-cyanobenzyl) -2-fluorenyl-6-[(2-methylpyridinyl) aminofluorenyl] benzimidazole (197) (1.03g) 〇 [Physical properties of compound (197)] Used -Leg (CDCh, 6): 2.58 (3Η, s), 4.76UH, d, J = 4.8Hz), 5.59 (2Η, s), 6.64 (1Η, d, J = 7. He), 7 · 21 (1Η, dt, J: 5.6 and 1.8Ηζ), 7 · 33 (1Η, d, J: 7.9Hz), __ 16 «_ This paper is in accordance with China National Standards (CNS) A4 specifications ( 210X 297 mm) '~ (Read the precautions on the back before writing this page), == 548,272 A7 B7 V. Description of the invention (16 · 39 ~ 7 · 47 (2Η, m), 7 · 65-7.79 (5Η, m), 7.89 (1Η, s), 8.56 (1Η, dd, J 4.9 and 0.9Hz) IR (KBr): 2223, 1642cnT1. That is: 150.5-151.4. . . &lt; Example 133; Synthesis of 1- (biphenyl-2-methyl) _2 · methyl-6-[(2-pyridinyl) carbamoyl] benzimidazole (198) &gt; According to Examples Method 115, using 丨 _ (biphenyl_2_methyl) _6_ carboxy-2-methylbenzimidazole (1.07g), ethylene dichloride (〇796g), and amidomethylpyridine (0.339g ), Triethylamine ((K950g) to give 丨 _ (biphenyl_ 2-methyl) -2-methyl-6 _ [(2_pyridylmethyl) aminomethylamidino] benzimidazole (198) ( 0.672g) 〇 [Physical properties of compound (198)] lH-NMR (CDCl3, δ): 2.380H, s), 4.78 (2H3 d3 J-4.8Hz) 5 5.27 (2H3 s) 3 6.64 (1H, d, J : 8.0Hz), 7.17-7 · 24 (2Η, m), 7.29-7 · 43 (6Η, in), 7.48 (2Η5 t3 J: 5.5H z), 7.49UH, s), 7.57_7 · 73 (3Η, m), 7.80 (1Η, d, 8.58 (1Η, d, J = 4.9 Hz). IR (KBr): 1630, 1619cm-1. Mp: 179.8-180.8 oC〇 Via the central part of the crotch ii .- ^-^ h 3 Consumption of Hezhu Bamboo (read the precautions on the back before filling this page) Example 134; 1-benzyl-2-methyl-6- [ Synthesis of (2-pyridylmethyl) carbamoyl] benzimidazole (199) &gt; According to the method of Example 115, 丨 _benzyl_6-carboxyl was used Methyl benzimidazole (0.59 g), ethylene dichloride (0.56 g), 2-aminomethyl. Pyridine (0.24 g), triethylamine (0.67 g) to give 1 · benzyl · 2 _Methyl-6 _ [(2_pyridylmethyl) carbamoyl] benzimidazole (199) (0.66g). —__ ____L6J2___ This paper size applies to China National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (16g [physical properties of compound (199)] lH-NMR (CDCl33 δ): 2.58 (3Η5 s), 4.76 (ZH5 d, J ^ 4.9Hz) 3 5.36 (2H3 s) 3 7.02 -7.06 (2Η, melons), 7.21 (1Η, dd, J = 6.9, and 5.0Ηζ), 7.27-7.35 (4H, m), 7.65-7.7 5 (4H3 m) 3 7.96 ( 1Η, d3 is 0 · 8Ηζ) 3 8 · 56 (1Η, d3 J 2 · 4Η8Ηζ). IR (KBr); 1640cm'1〇 That is: 124.0-124.90C0 &lt; Example 135; 1- (4 -Synthesis of 3rd butylbenzyl) -2-methyl-6-[(2-pyridylmethyl) aminofluorenyl] benzo (° 00) &gt; According to the method of Example 115, use 1- (4- 3rd butylbenzyl) -6-benzyl-2-methylbenzo miso (0.544 g), vaporized ethylene difluorene (0.428 g), 2-aminomethylpyridine (0.183g), triethylamine (0.511g) to get 1- (4-brother 3 Butylfluorenyl) -2-fluorenyl-6-[(2-0 specific methyl) aminomethyl] benzimidazole (200) (0.477g). [Physical properties of compound (200)] 1H-NMR (CDCl33 δ): 1.27 (9H3 s) 3 2.60 (3H3 s) 3 4.77 (2H, d? J = 4.9Hz)? 5.34 (2H, s), 6.98 (2Η, d, J = 8.3Hz), 7 · 21 (1Η, dd, J 2 7.3 and 5 · 1Ηζ), 7 · 29-7 · 35 via the central part of the quasi-MT, eliminate Seal ^ (Read the precautions on the back before filling in this page) (3Η, m), 7.62 (1Η, br s) 3 7,65-7 · 75 (3Η5 m) 3 7 · 96 (1Η, d, J 1.1Hz), 8.57 (1Η, d, J 二 4 · 7Ηζ) 〇IR (KBr): 1646cm · 10mp ·· 140.4-142.8 ° C. &lt; Example 136; Synthesis of 2-methyl-1- (2-theylmethyl) -6-[(2-σΛσdefinitemethyl) aminomethylamidino] benzimidazole (201) &gt; The method of Example II5 uses 6-carboxy-2-fluorenyl-1- (2-naphthylfluorenyl) benzimidazole (0.80 g), vaporized ethylene difluorene (0.64 g), and amine group. ____ U10-- This paper is in accordance with China ’s National Standard (CNS) A4 size (210X297 mm) 548272 A7 B7 V. Description of the invention (1 Methyl σ ratio 唆 (0.27g), triethylamine (0.77g) to get 2_methyl small (2_naphthylmethyl) _6-[(2- ° specific bite methyl) carbamyl] benzo-flavored saliva (read the precautions on the back before filling in this page) (201) (〇.47g). [Physical properties of compound (201)] lH ~ NMR (CDCl35 δ): 2.60 (3H, s) 5 4.75 (2H3 d3 J = 4.9Hz), 5.52 (2H3 s) 5 7.17 -7′3 (2H, m), 7.31 (lH, d, J: 7.8 Hz), 7.38 (lH, s), 7.43-7.48 (2H, in), 7.60-7 · 82 (7Η, m), 8.00 (1Η , D, J = 1.0 Hz), 8.53 (1.33 d, J: 4.7 Hz). IR (KBr): 1640 cm- 10 Ye: 143.0-144.5 ° C. &Lt; Example 137; 1- ( Biphenyl-4-methyl) _2-ethyl-6-[(2-. Specific fluorenyl) carbamyl] benzimidyl Synthesis of azole (202) &gt; According to the method of Example 115, 1- (biphenylmethyl) -6-carboxy-2 · ethylbenzimidazole (0.500 g), ethylene dichloride (0 356 g), 2-Aminomethyl σ is better than fluorene (0.15 lg) and triethylamine (0.424g) to give 1_ (biphenyl_ 4-fluorenyl) -2-ethyl-6-[(2-leaf b bite nail Group) carbamoyl] benzimidal (202) (0 ″ 04g) ° [physical properties of compound (202)] ^ -NMRiCDCh, δ): L45 (3H3 t3 J-7,7Hz), 2.90 ( 2Η3 q, J-7.4Hz), 4.77 (2H5 d, J = 4.7Hz), 5.43 (2H, s), 7.10 (2H, d, J = 8.2Hz), 7.20 (1H3 dt, J2 4.9 and 7. · 7Ηζ), 7.33 (2Η, t, J = 7.4Hz), 7.42 (2Η, t, J = 7.5Hz), 7.49-7 · 55 (4Η3 m), 7 • 61 (1H, br t), 7.67 (1Η, dt, J = 7.8 and 1.8 · ζ), 7.72 (1Η, d, J = 8 · 4Ηζ), 7.8.1 (1Η, d, J: 8.4Hz), 7.99 (1Η, s), 8.56 (1Η3 d, J: 4.9Hz). IR (KBr): 1640cm1. mp: 123 · 0 —124.0oC. This paper size is suitable for China National Standard (CNS) A4 size (210X297 mm) 548272 A7 ~~ _______________ B7______ 5. Description of the invention (16) <Example I38; 1- (2- Synthesis of Benzyl) _6_ [2_ (pyridylmethyl) carbamoyl] benzimidazole (203) &gt; (Please read the precautions on the back before filling this page) According to the method of Example 115, use Weyl 4- (2-chlorobenzyl) benzimidazole (0.461 g), ethylene dichloride (0.728 g), 2-aminomethylpyridine (0.1 Mg), triethylamine (0.1 468 g) to give 丨 -fluorenylbenzyl) -6 · [2 decapyridylmethyl) carbamoyl] benzimidazole (203) (〇u〇g). [Physical Properties of Compound (203)]

士賺⑽…,6) : 4·78(2Η,d3 J:4』Hz),5·51(2Η,s),6·92(1Η, d,J:6.5 Ηζ),7.17-7·31(3Η,m),7.34(1Η,d,J=7.8Hz),7·45(1Η,dd,J:l.i 及 8·0 Ηζ),7·69(1Η,dt,J=1.8 及 7.7Ηζ),7·67-7·73(1Η,br s),7.76(1Η,dd,J -1·5 及 8·4Ηζ),7·87(1Η,d,J=8.4Hz),8·05(2Η,s),8·57(1Η,d,J :4.9H z)〇 IR(KBr) : 1646cm1〇 mp : 144.0 —145.0°C。 &lt;貫施例139;2_甲基-1 -(2-石肖基节基)_6_[(2_σ比咬曱 基)氨基曱醯基]苯並咪唑(204)之合成&gt; 經 部 中 决 而 j 消 合 竹 印 |____ 172_ 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) 依據實施例115之方法,使用6_緩基j-甲基-1-(2-硝基苄基)苯並咪哇(〇.367g)、氯化乙二醯(〇·29%)、2-胺 基甲基,啶(0.217g)、三乙胺(0.360g)以得出2-甲基-1-(2-硝基苄基)-6-[(2-。比啶甲基)氨基甲醯基]苯並味唑 (204)(0.241g) 〇 [化合物(204)的物性]Shijiu ..., 6): 4.78 (2Η, d3 J: 4'Hz), 5.51 (2Η, s), 6.92 (1Η, d, J: 6.5 Ηζ), 7.17-7 · 31 (3Η, m), 7.34 (1Η, d, J = 7.8Hz), 7.45 (1Η, dd, J: li and 8.0 Ηζ), 7.69 (1Η, dt, J = 1.8, and 7.7Ηζ ), 7.67-7 · 73 (1Η, br s), 7.76 (1Η, dd, J -1 · 5 and 8.4Ηζ), 7.87 (1Η, d, J = 8.4Hz), 8.05 (2Η, s), 8.57 (1Η, d, J: 4.9Hz) 〇IR (KBr): 1646 cm10 mp: 144.0-145.0 ° C. &lt; Executive Example 139; Synthesis of 2-methyl-1-(2-stone-sweetyl benzyl) _6 _ [(2_σ than fluorenyl) aminofluorenyl] benzimidazole (204) &gt; j Bamboo Seal | ____ 172_ The paper size is / 1] Chinese National Standard (CNS) A4 size (210X297 mm) According to the method of Example 115, 6_Retarder j-methyl-1- (2- Nitrobenzyl) benzimidazole (0.367 g), ethylene dichloride (0.29%), 2-aminomethyl, pyridine (0.217 g), triethylamine (0.360 g) to obtain 2-methyl-1- (2-nitrobenzyl) -6-[(2-.pyridinylmethyl) carbamoyl] benzazole (204) (0.241 g) 〇 [Compound (204) Physical properties]

^-NMRiCDCh, δ) : 2.56(3H, s), 4.75(2H, d3 J=4.8Hz), 5.83(2H, s)5 6.41 (1H, d, J二7.8 及 1·2Ηζ), 7·22(1Η, dt, J二5·0 及 1·7ΗΖ), 7·32(1Η, d, J 548272 A7 B7 五、發明説明(16)9 (讀先閱讀背面之注意事項再填寫本頁) 二7·9Ηζ), 7·43-7·52(2Η, m), 7·64(1Η, s), 7·68(1Η, dt, J二7.6 及 1.7Hz),7 •75(1H, dd, J二8·4 及 1·5Ηζ), 7,80(1H, d, J二8,4Hz), 7·82(1Η, d, J=1.3Hz ),8·28(1Η, dd, J二8.0 及 1·7Ηζ), 8·56(1Η, d3 J=4.9Hz)。 IR(KBr) : 1645CHT1。 nip : 194.8 —196.7°C。 &lt;實施例14〇;2_甲基-1-(2-石肖基节基)-5-[(2-^1比0定甲 基)氨基甲醯基]苯並咪唑(205)之合成&gt; 依據實施例115之方法,使用5·羧基-2-甲基-1-(2-硝基苄基)苯並咪唑(0.096g)、氣化乙二醯(〇.〇78g)、2-胺 基甲基吡啶(0.048g)、三乙胺(0.093g)以得出2_甲基-1-(2-硝基苄基)-5-[(2-此啶甲基)氨基甲醯基]苯並咪唑 (205)(0.079g)。 [化合物(205)的物性] iH-NMlUCDCh,(5) : 2·57(3Η,s),4·80(2Η,d,J:4.7Hz),5·80(2Η,s),6·43 (1Η, d, J:7.4 及 0·8Ηζ), 7·17(1Η, d, J=8.4Hz), 7·22(1Η, dt, J:5.5 及 1·8Ηζ), 7·35(1Η, d, J:7.8Hz), 7·44_7·52(2Η, m), 7·67(1Η, s), 7·69(1Η, d t,J:7.8 及 1·9Ηζ),7·82(1Η,dd,J:8.4 及 1·5Ηζ),8·27(1Η,dd,J二8.0 及 1·6Ηζ), 8·28(1Η,d,J^UHz),8·56(1Η,d, J:4.9Hz)。 IR(KBr) : 1645CHT1。 mp :〜96T(分解奁伴予)。 &lt;實施例141;1-(2_氯代苄基)_2_甲基-6_(2-萘磺醯基 氨基甲酿基)苯並17米嗤鈉鹽(206)之合成&gt; 將N,N’-幾基二。米唾(〇.541g)加入6-魏基-1-(2-氯代节 基)-2-甲基苯並咪唑(0.500g)之N,N-二曱基曱醯胺(20ml) ________ 173_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 _____________ B7 五、發明説明(17]t) 溶液中,在室溫下攪拌1小時。接著,加入2-萘磺醯胺 (0.689g)及二氮二環十一烯(〇 5〇6幻之N,N_二甲基甲醯 胺(5ml)溶液,在100t:下攪拌48小時。冷卻反應液,在 減壓下餾去溶媒。將水及三氯甲烷加入殘渣中,添加丨〇% 鹽酸至水層形成酸性為止。使用三氯甲烷進行萃取 次)’將飽和碳酸氫鈉水溶液加入所得之有機層中,攪拌 之。過濾出所析出的結晶,將其溶解於少量的曱醇中, 加入醋酸乙酯使其結晶化。過濾出結晶,經乾燥得出 1-(2-氣代苄基)_2_甲基_6_(2_萘磺醯基氨基甲醯基)苯並 咪唑鈉鹽(206)0.508g。 [化合物(206)的物性] 6) : 2·46(3Η,s)3 5·51(2Η,s),6·38(1Η,d,J=7.9Hz),7· 17(1H,t,J=7.5Hz),7·30(1Η,t)3 7·45(1Η,d,J=8.5Hz),7·51-7·57(3Η,in), 7·77-7·93(5Η,m),7.99(1H,ιη),8·35(1Η3 s)。 IR(KBr) : 1594cm1。^ -NMRiCDCh, δ): 2.56 (3H, s), 4.75 (2H, d3 J = 4.8Hz), 5.83 (2H, s) 5 6.41 (1H, d, J = 7.8 and 1.2 · ζ), 7.22 (1Η, dt, J 2 5.0 and 1. 7ΗZ), 7 · 32 (1Η, d, J 548272 A7 B7 V. Description of the invention (16) 9 (Read the precautions on the back before filling this page) 2 7 · 9Ηζ), 7.43-7 · 52 (2Η, m), 7.64 (1Η, s), 7.68 (1Η, dt, J = 7.6 and 1.7Hz), 7 • 75 (1H, dd , J 2 8 · 4 and 1.5 5Ηζ), 7,80 (1H, d, J 2 8,4 Hz), 7.82 (1Η, d, J = 1.3Hz), 8.28 (1Η, dd, J 8.0 and 1. 7Ηζ), 8.56 (1Η, d3 J = 4.9Hz). IR (KBr): 1645CHT1. nip: 194.8 —196.7 ° C. &lt; Example 14〇; Synthesis of 2-methyl-1- (2-stone-sweetylbenzyl) -5-[(2- ^ 1 to 0-determined methyl) aminomethylamino] benzimidazole (205) According to the method of Example 115, 5. · carboxy-2-methyl-1- (2-nitrobenzyl) benzimidazole (0.096 g), vaporized ethylene difluorene (0.078 g), 2- Aminomethylpyridine (0.048g), triethylamine (0.093g) to give 2-methyl-1- (2-nitrobenzyl) -5-[(2-this pyridylmethyl) carbamidine Group] benzimidazole (205) (0.079 g). [Physical properties of compound (205)] iH-NMlUCDCh, (5): 2.57 (3Η, s), 4.80 (2Η, d, J: 4.7Hz), 5.80 (2Η, s), 6. · 43 (1Η, d, J: 7.4 and 0 · 8Ηζ), 7 · 17 (1Η, d, J = 8.4Hz), 7.22 (1Η, dt, J: 5.5 and 1.81ζ), 7.35 ( 1Η, d, J: 7.8Hz), 7.44_7.52 (2Η, m), 7.67 (1Η, s), 7.69 (1Η, dt, J: 7.8 and 1.9Ηζ), 7.82 (1Η, dd, J: 8.4 and 1.5Ηζ), 8.27 (1Η, dd, J2 8.0 and 1.6Ηζ), 8.28 (1Η, d, J ^ UHz), 8.56 (1Η, d, J: 4.9 Hz). IR (KBr): 1645CHT1. mp: ~ 96T (decomposed by 奁). &lt; Example 141; Synthesis of 1- (2-chlorobenzyl) _2_methyl-6_ (2-naphthalenesulfonylcarbamoyl) benzo 17 m pyrene sodium salt (206) &gt; N , N'-Jijiji. Misal (0.541g) was added with 6-Weiji-1- (2-chlorobenzyl) -2-methylbenzimidazole (0.500g) of N, N-dimethylamidamine (20ml) ________ 173_ This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 _____________ B7 V. Description of the invention (17) t) Stir for 1 hour at room temperature in the solution. Next, 2-naphthalenesulfonamide (0.689g) and a solution of diazabicycloundecene (0550 N, N-dimethylformamide (5ml) were added, and stirred at 100t for 48 hours. .Cool the reaction solution and distill off the solvent under reduced pressure. Add water and chloroform to the residue and add 丨 0% hydrochloric acid until the water layer becomes acidic. Extraction with chloroform is performed.) 'Saturated aqueous sodium bicarbonate solution Add the obtained organic layer and stir it. The precipitated crystals were filtered out, dissolved in a small amount of methanol, and ethyl acetate was added to crystallize. The crystals were filtered off and dried to give 0.508 g of 1- (2-gaso-benzyl) -2-methyl-6- (2-naphthalenesulfonamidocarbamoyl) benzimidazole sodium salt (206). [Physical properties of compound (206)] 6): 2.46 (3Η, s) 3 5.51 (2Η, s), 6.38 (1Η, d, J = 7.9Hz), 7.17 (1H, t , J = 7.5Hz), 7 · 30 (1Η, t) 3 7 · 45 (1Η, d, J = 8.5Hz), 7.51-7 · 57 (3Η, in), 7.77-7 · 93 (5Η, m), 7.99 (1H, ιη), 8.35 (1Η3 s). IR (KBr): 1594cm1.

Mass(FAB) : m/e 512(M+1)。 mp : 352.0-354.50C〇 經浐部中次榀挲而找3消贽合作私印賞 (誚先閱讀背面之注意事項再填寫本頁) &lt;實施例l42;l-(2-氣代苄基)_2_甲基-6_(1-萘磺醯基 氨基甲醪基)苯並咪唑鈉鹽(207)之合成&gt; 依據實施例141之方法,使用6-羧基-1-(2-氣代节 基)-2-曱基苯並口米。坐(0.600g)、N,N’-幾基二。米ϋ坐 (0.647g)、1-萘磺醯胺(〇.829g)、二氮二環十一稀(〇 6〇8g) 以得出1-(2-氯代苄基)-2-甲基-6-(1-萘磺醯基氨基甲醯 基)苯並咪唑鈉鹽(207)(0.390g)。 ______174____ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 ___ B7 五、發明説明(17\ [化合物(207)的物性] (誚先閱讀背面之注意事項再填寫本頁) lH~NMR(DMS0-d63 δ) : 2.46(3H3 s)3 5.49(2H, s)5 6.39( 1H3 d3 J=7.8Hz), 7. 16(1H3 t, J二7·5Ηζ), 7·31(1Η, t, J二7·3Ηζ)5 7.36(1H, t), 7·40-7.45(2Η, m), 7·50(1Η3 J二7·7Ηζ),7·54(1Η,d3 J二8·0Ηζ),7·75-7·81(2Η,in),7·87(1Η, d,J二7·9Ηζ),7·93(1Η,d,J二8·2Ηζ),8.09UH,d,J二7·3Ηζ),8.86(1H,d,J=8 .5Hz)〇 IR(KBr) : 1633cm1。Mass (FAB): m / e 512 (M + 1). mp: 352.0-354.50C. The third part of the ministry's cooperation and private printing rewards (read the precautions on the back before filling this page) &lt; Example l42; l- (2-Azobenzyl) (Synthesis) _2_methyl-6_ (1-naphthalenesulfonylcarbamoyl) benzimidazole sodium salt (207) &gt; According to the method of Example 141, 6-carboxy-1- (2-gas Substituted base) -2-fluorenylbenzomethyl. Sit (0.600g), N, N'-Chichi. Mesalazine (0.647g), 1-naphthalenesulfonamide (0.829g), and diazabicycloundecene (0.608g) to give 1- (2-chlorobenzyl) -2-methyl 6- (1-naphthalenesulfonylcarbamoyl) benzimidazole sodium salt (207) (0.390 g). ______174____ The paper size is in accordance with China State Standard (CNS) A4 (210X297 mm) 548272 A7 ___ B7 V. Description of the invention (17 \ [physical properties of compound (207)] (诮 Please read the precautions on the back before filling this page ) lH ~ NMR (DMS0-d63 δ): 2.46 (3H3 s) 3 5.49 (2H, s) 5 6.39 (1H3 d3 J = 7.8Hz), 7. 16 (1H3 t, J 2 7 · 5Ηζ), 7 · 31 (1Η, t, J 2 7.3Ηζ) 5 7.36 (1H, t), 7.40-7.45 (2Η, m), 7.50 (1Η3 J 2 7.7 · ζ), 7.54 (1Η, d3 J 2 8.0Ηζ), 7.75-7 · 81 (2Η, in), 7.87 (1Η, d, J 2 7.9Ηζ), 7.93 (1Η, d, J 2 8.2Ηζ), 8.09 UH, d, J 2 7. 3Ηζ), 8.86 (1H, d, J = 8.5 Hz). IR (KBr): 1633 cm1.

Mass(FAB) : m/e 512(M+1)。 mp :〜265°C(分解奁伴3)。 &lt;實施例143;6-(4-氣苯磺醯基氨基曱醯基)-1-(2-氣 代苄基)-2_甲基苯並咪唑鈉鹽(208)之合成&gt; 依據實施例114之方法,使用6-羧基-1-(2-氯代苄 基)-2-曱基苯並咪唑(0.400g)、N,N’-羰基二咪唑 (0.4328)、4-氣苯績酿胺(〇.51〇8)、二氮二環十一稀(〇.404@) 以得出6-(4-氯笨磺醯基氨基甲醯基)-1-(2-氯代苄基)-2-甲基苯並咪唑鈉鹽(208)(0.270g)。 [化合物(208)的物性] ^-NMRiDMSO-de, δ) : 2.46(3H3 s)3 5.52(2H, s) 3 6.38( 1H5 d3 J=7.4Hz)3 7. 19(1H, t, J=7.6Hz), 7·31(1Η, t, J=7.6Hz), 7·39(2Η, d, J=8.5Hz), 7·45(1Η, d, J=8.9Hz), 7·54(1Η, d, J=8.0Hz), 7·76-7·82(4Η, m)。 IR(KBr) : 1592cm—、Mass (FAB): m / e 512 (M + 1). mp: ~ 265 ° C (decomposition 奁 Companion 3). &lt; Example 143; Synthesis of 6- (4-fluorobenzenesulfonylaminofluorenyl) -1- (2-fluorobenzyl) -2-methylbenzimidazole sodium salt (208) &gt; The method of Example 114 uses 6-carboxy-1- (2-chlorobenzyl) -2-fluorenylbenzimidazole (0.400 g), N, N'-carbonyldiimidazole (0.4328), and 4-benzene Benzamine (0.5108) and diazabicycloundecene (0.404 @) to give 6- (4-chlorobenzylsulfonylaminocarbamyl) -1- (2-chloro Benzyl) -2-methylbenzimidazole sodium salt (208) (0.270 g). [Physical properties of compound (208)] ^ -NMRiDMSO-de, δ): 2.46 (3H3 s) 3 5.52 (2H, s) 3 6.38 (1H5 d3 J = 7.4Hz) 3 7. 19 (1H, t, J = 7.6Hz), 7.31 (1Η, t, J = 7.6Hz), 7.39 (2Η, d, J = 8.5Hz), 7.45 (1Η, d, J = 8.9Hz), 7.54 ( 1Η, d, J = 8.0Hz), 7.76-7 · 82 (4Η, m). IR (KBr): 1592cm-- 、

Mass(FAB) : m/e 496(M+l)〇 mp : 360 — 362°C (分解)。 &lt;實施例144;6-(3-氣苯磺醯基氨基甲醯基)-1-(2-氯代 本紙張尺度適用中國國家標率(CNS ) A4規格(210X 297公釐) 548272 A7 五、發明説明(17j 苄基)_2-甲基苯並咪唑(2〇9)之合成&gt; 依據實施例丨4丨之方法,使用6_鲮基_K2氯代苄 基)-2-曱基苯並咪唑(0.450g)、ν,Ν,_羰基二味嗤 (〇.486g)、3-氯苯磺醯胺(0.573g)、二氮二環十一烯(〇 456g) 以得出6-(3-氣苯磺醯基氨基甲醯基卜^^-氯代节基)_2_ 曱基苯並咪唑鈉鹽。將其溶解於甲醇與水之混合溶液 中,使用10%鹽酸調整成PH5〜6。過濾出所析出的結晶, 經乾燥得出6-(3-氣苯磺醯基氨基甲醯基)_1-(2_氣代节 基)-2-甲基苯並咪唑(209)(0.420g)。 [化合物(209)的物性] 'H-NMEaMSO-d6,(5) : 2·51(3Η,s)3 5.63(2H,s),6·48(1Η,d,J二7.7Hz),7· 22(1H, t, J:7.6Hz), 7·34(1Η, t, J=7.7Hz), 7.56(1H, t, J=8.0Hz), 7·64(1Η3 t5 ^8·0Ηζ), 7,68(1H, d, J=8.5Hz)3 7,78(2H, t, J=8.6Hz), 7.91(1H, d, J= 7.6Hz), 7·95(1Η, d, J=1.6Hz), 8.10(1H, s)。 IR(KBr) : 16870111^0 Mass(FAB) ·· m/e 474(M+1)。 mp ·· 254.5 —257.5°C(分解左伴3)。 &lt;實施例145;5_苯續酿基氨基甲酿基节基-i_(2_ 氣代苄基)苯並咪唑(210)之合成&gt; 依據實施例144之方法,使用2-节基-5-羧基-1-(2-氯代苄基)苯並咪唑(〇.466g)、N,N、羰基二咪唾 (0.401g)、苯續醯胺(〇.389g)、二氮二環十一稀(〇3 77g) 以得出5_苯磺醯基氨基甲醯基苄基-l-(2·氯代节基)苯 並咪唑(210)(0.447g)。 ____—-176 —__________ 本紙張尺度適W中國國家標準(CNS ) A4規格(210X297公釐) (誚先閱讀背面之注意事項再填寫本頁)Mass (FAB): m / e 496 (M + l) 〇 mp: 360—362 ° C (decomposed). &lt; Example 144; 6- (3-Gasbenzenesulfonylcarbamoyl) -1- (2-chloro) This paper is sized for China National Standard (CNS) A4 (210X 297 mm) 548272 A7 V. Description of the invention Synthesis of (17j benzyl) _2-methylbenzimidazole (209) &gt; According to the method of Example 丨 4 丨, 6_fluorenyl_K2 chlorobenzyl) -2- 曱 is used Benzimidazole (0.450 g), ν, N, -carbonyldiisocyanate (0.486 g), 3-chlorobenzenesulfonamide (0.573 g), diazabicycloundecene (〇456 g) to obtain 6- (3-Gassulfenylcarbamoylcarbamyl ^^-chlorobenzyl) _2_fluorenylbenzimidazole sodium salt. This was dissolved in a mixed solution of methanol and water, and adjusted to pH 5 to 6 using 10% hydrochloric acid. The precipitated crystals were filtered out, and dried to give 6- (3-airbenzenesulfonylaminocarbamyl) _1- (2_oxobenzyl) -2-methylbenzimidazole (209) (0.420g) . [Physical properties of compound (209)] 'H-NMEaMSO-d6, (5): 2.51 (3Η, s) 3 5.63 (2H, s), 6.48 (1Η, d, J = 7.7Hz), 7 22 (1H, t, J: 7.6Hz), 7.34 (1Η, t, J = 7.7Hz), 7.56 (1H, t, J = 8.0Hz), 7.64 (1Η3 t5 ^ 8 · 0Ηζ) , 7,68 (1H, d, J = 8.5Hz) 3 7,78 (2H, t, J = 8.6Hz), 7.91 (1H, d, J = 7.6Hz), 7.95 (1Η, d, J = 1.6Hz), 8.10 (1H, s). IR (KBr): 16870111 ^ 0 Mass (FAB) ·· m / e 474 (M + 1). mp · 254.5-257.5 ° C (decompose left companion 3). &lt; Example 145; Synthesis of 5-benzylaminocarbamoyl benzyl-i_ (2_ oxobenzyl) benzimidazole (210) &gt; According to the method of example 144, 2-benzyl- 5-carboxy-1- (2-chlorobenzyl) benzimidazole (0.466 g), N, N, carbonyl diimidosulfan (0.401 g), benzodiazepine (0.389 g), diazabicyclo Eleven dilute (0 77g) to give 5-benzenesulfonylcarbamoylbenzyl-l- (2.chlorobenzyl) benzimidazole (210) (0.447g). ____—- 176 —__________ This paper is suitable for Chinese National Standard (CNS) A4 (210X297 mm) (诮 Please read the notes on the back before filling in this page)

、1T 548272 A7 B7 五、發明説明(17i [化合物(210)的物性] lH-NMR(DMS0-d6, δ) : 4.28(2H3 s)3 5.57(2H? s) 5 6.23( 1H, d, J=7.6Hz), 7. 〇4(lH, t, J=7.6Hz), 7·10-7·26(6Η, m), 7·40(1Η, d, J二8·6Ηζ), 7.46(1H, d, J=8.0Hz), 7·61-7·73(4Η, m), 8·00(2Η, d, J:7.6Hz), 8·23(1Η, s), 12.43(1H, br s)0 IR(KBr) : 1685cm_1〇 mp : 152.0 — 155.0°C。 &lt;實施例146;6-苯磺醯基氨基曱醯基-2-苄基-1-(2-氣代苄基)苯並咪唑(211)之合成&gt; 依據實施例I44之方法,使用2_苄基-6-羧基-1-(2-氯代苄基)苯並咪唑(〇.76〇g)、N,N,-羰基二咪唑 (0.654g)、苯磺醯胺(0.634g)、二氮二環--烯(〇.614g) 以得出6_苯磺醯基氨基甲醯基苄基-l-(2_氣代节基)苯 並咪唑(21 1)(0.803g)。 [化合物(211)的物性] W-NMIUDMSiHlG,c5) : 4.41(2H,s),5·71(2Η,s),6.32(1H,d,J:7,7Hz),7. 06(1H, t, J=7.7Hz), 7·14-7·30(6Η, m), 7·50(1Η, d,㈣.GHz), 7·62(2Η, t), 7·70(1Η, t), 7·81(1Η, d, J二8.6Hz), 7.87(1H, d, J二8.5Hz), 7.97(2H, d, J二 8·2Ηζ), 8·16(1Η, s), 12·60(1Η, br s)。 IR(KBr) : 1704cm-l〇 mp : 143.0 —144.5°C。 &lt;實施例147; 1 -(2,4-二氣代苄基)_2_甲基-6_[(2·吡啶 曱基)氨基甲醯基]苯並咪唑(180)之合成&gt; 將1滴N,N-二甲基甲酿胺加入叛基小(2,4_二氣代 __—____Λ22___ 本紙張尺度遙用中國國家標準(CNS ) Λ4規格(210X297^3 ---- (請先閱讀背面之注意事項再填寫本頁) -一口 άψ. 經浐部中呔«.-绛而^-消費合作^印^ 548272 Α7 Β7 五、發明説明(17j 〜 节基)-2-甲基苯並咪嗤(〇.627g)中,冰冷之。滴入氯化乙 一醯(0.493g)並攪拌數分。接著在室溫下攪拌丨小時後, 進行減壓濃縮,以除去氣化乙二醯,將殘渣溶解於三氯 甲燒(10ml)中。在冰冷下將此溶液滴入孓胺基甲基。比。定 (〇.1678)與二乙胺(〇.4698)之二氣甲烧(51111)溶液中。授拌 1小時後,以水洗淨反應液3次,接著使用飽和碳酸氫 鈉水溶液洗淨。減壓濃縮有機層,使用薄層矽膠色譜法 (展開 &gt;谷媒·丙_/二乙醚= 1/1)精製之。接著溶解於醋酸 乙酯(5ml)中,加入己烷(2ml)以使其結晶化。過溏出結 晶,經乾燥得出1 -(2,4-二氯代苄基)_2_曱基_6_[(2_吡啶曱 基)氨基曱醯基]苯並咪唑(180)0.359g。 [化合物(180)的物性] 4-NMR(CDC13, (S) : 2·56(3Η, s), 4.76(2H, d3 5.4G(2H, s), 6·33 (1H, d, J=8,4Hz), 7·07(1Η, dd, J=8.4 及 2·0Ηζ), 7·22(1Η, dd, J:7.4 及 4·9Ηζ), 7.33(1H, d, J=7.9Hz), 7·48(1Η, d, J=2.1Hz), 7·62_7·79(4Η, m), 7·86(1Η, d, J=l.lHz), 8.57, (1H, d, J:4.9Hz)。 IR(KBr) : 1645cm&quot;1〇 mp : 204.1 —206.3°C。 &lt;實施例148; 1-(聯苯-4-曱基)-2-曱基-6-[(2-a比。定甲 基)氨基甲醯基]苯並咪唑(212)之合成&gt; 在冰冷下將氣化乙二醯(0.655g)加入1·(聯苯甲 基)-6-敌基-2-甲基苯並。米ϋ坐(〇.866g)與N,N-二甲基甲醯胺 (1滴)之二氣曱烷(13ml)溶液中,在室溫下攪拌15小時。 過渡出所析出的結晶,以二氣甲烷洗淨,進行減壓乾燥。 二·— ------- 1 7 Λ 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇X2^H ) ' ' ^ (謂先閱讀背面之注意事項再填寫本頁) 訂 Φ. 548272 Μ ________________Β7 五、發明説明(17$ (誚先閱讀背面之注意事項再填寫本頁) 在冰冷下將此結晶加入2-胺基曱基。比咬(0.235g)與三乙 胺(0.635g)之二氣甲烷(i5mi)溶液中,攪拌i小時。將水 加入反應液中以停止反應,經水洗(2次)、飽和碳酸氫鈉 水溶液洗淨後,乾燥有機層,對溶媒進行減壓濃縮。以 醋酸乙酯與乙醇之混合溶媒進行殘渣之再結晶,而得出 1 -(聯苯-4-甲基甲基-6-[(2-σ比啶甲基)氨基甲醯基]苯 並咪唑(212)0.774g。 [化合物(212)的物性] H-NMR(CDCh3 δ) : 2.62(3H3 s)3 4.77(2H3 d5 J=4.8Hz), 5.42(2H, s), 7.12 (2H5 d3 J^8.5Hz), 7.21(1H3 m)3 7.34(2H5 m)5 7.42(2H3 m)3 7.51-7.55(4H, m ),7·62(1Η, br t), 7·67(1Η3 dt, J=1.7 及 7·7Ηζ), 7·71(1Η, dd, J:1.6 及 8.4Hz)5 7.76(1H3 d3 J=8.4Hz)3 8.00(1H3 d3 J=1.2Hz), 8.56(1H5 d3 J-4.8 Hz)〇 IR(KBr) : 1642CET1。 mp : 205.0—206.5°C。 &lt;實施例149;6-苯磺醯基氨基曱醯基-1-(2-氯代苄 基)-2-甲基苯並咪。坐(163)之合成&gt; 將Ν,Ν’-羰基二咪唑(〇.973g)加入6_羧基―丨兴2—氯代苄 基)-2_甲基苯並咪唑(〇,9〇2g)之N,N-二曱基甲醯胺(20ml) 溶液中,在室溫下攪拌1小時。接著,加入苯磺醯胺(〇.943g) 及二氮二環十一烯(〇.9i3g)之N,N-二曱基曱醯胺(5ml)溶 液,在100°C下攪拌70小時。冷卻反應液,在減壓下餾 去溶媒。將水及三氯甲烷加入殘渣中,添加10%鹽酸至水 層形成酸性為止。使用三氯甲烷進行萃取(2次),以飽 本紙張尺度適^中國國家標準(〔呢)八4規格(210&gt;&lt;297公釐) 548272 A7 B7 五、發明説明(17g 和碳酸氫鈉水溶液洗淨所得之有機層,在減壓下餾去溶 媒。將殘渣溶解於少量的三氯曱烷中,加入醋酸乙酯使 其結晶化。過濾出結晶,經乾燥得出6-苯磺醯基氨基甲 酿基氯代苄基)_2·甲基苯並咪唑(163)0.667g。 &lt;實施例150;6-苯磺醯基氨基甲醯基_丨_(聯苯-4_甲 基)-2-甲基苯並咪唑鈉鹽(213)之合成&gt; 依據實施例141之方法,使用6-羧基_;μ(聯笨甲 基)-2-曱基苯並咪唑(〇j37g)、苯磺醯胺(〇.516g)、二氮 二環十一烯(0.500g)以得出6-苯磺醯基氨基甲醯基-1-(聯苯曱基)-2_曱基苯並咪唑鈉鹽(213)(0.365g)。 [化合物(213)的物性] W-NMBXDMSO-d6,6) : 2·52(3Η,s),5·52(2Η,s),7·13(2Η,d,J:8.1Hz),7· 3卜7·37(4Η,m),7·39-7·45(3Η,m),7·58-7·63(4Η,in),7·78-7·82(3Η,m),7· 97(1H, s)。 IR(Nujc)l) : 1591CET1。 瓜P : 289.0 — 290.0°C(分解奁伴弋)。 &lt;實施例151;6-苯磺醯基氨基曱醯基-1-(2-氯代苄 基)-2-甲基苯並咪唑(163)之合成&gt; 將N,N’-幾基二咪峻(5.41g)加入6-叛基-1-(2-氣代节 基)-2-曱基苯並咪唑(5 〇2g)之n,N-二甲基甲醯胺(110ml) 溶液中,在室溫下攪拌1小時。接著,加入笨磺醯胺(5.24g) 及二氮二環十一烯(5.〇8g)之N,N_二曱基曱醯胺(20ml)溶 液’在100°C下攪拌70小時。冷卻反應液,在減壓下餾 去溶媒。將水及三氣曱烷加入殘渣中,一面混合同時添 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------^------1T------ (誚先閱讀背面之注意事項再填寫本頁) 548272 A7 B7 五、發明説明(17) 加·鹽酸至水層形成酸性為止。使用三氣甲烧進行萃 取(2次),以飽和碳酸氫鈉水溶液洗淨所得之有機層,在 減壓下鶴去溶媒的-部分。過濾所析出之結晶,經乾燥 知出6-苯磺醯基氨基甲醯基“—(、氣代苄基甲基苯並 口米。坐(163)4.96g。 、 产 &lt; 實施例152;H2-氣代节基)-2_甲基_6_三氟甲磺醯 基氣基甲酿基苯並味唾鹽酸鹽(214)之合成&gt; 將N,N’-羰基二咪唑(0.647g)加入卜羧基_i_(2_氯代 苄基)-2-甲基苯並咪唑(〇.6〇〇g)之n,n_二甲基甲醯胺 (20ml)/§^液中’在室溫下攪拌1小時。接著,加入三氟 曱磺醯胺(0.596g)及二氮二環十一烯(〇 6〇9幻之N,N_: 曱基甲醯胺(5ml)溶液,在10(rC下攪拌72小時。冷卻反 應液,在減壓下餾去溶媒。將水及三氯甲烷加入殘渣 中,一面混合同時添加1〇〇/。鹽酸至水層形成酸性為止。 以乙醇(25ml)與甲醇(25ml)之混合溶媒洗淨析出之結 晶。藉由乾燥結晶以得出1-(2-氯代苄基)-2-甲基-6-三氟 曱磺醯基氨基曱醯基苯並咪唑鹽酸鹽(214)0.420g。 [化合物(214)的物性] W-NMR(DMSQ-d6,6) : 2.84(3H,s),5·82(2Η,s),7.G8(1H,d,J=7.5Hz),7. 30(1H5 t)3 7.40(1H3 t, J=7.7Hz), 7.58(1H, d, J=8.0Hz), 7.79(1H, d, J^8,6 Hz), 8.07-8.13(2H5 m)〇 IR(KBr) : 1634cm1。1T 548272 A7 B7 V. Description of the invention (17i [Physical properties of compound (210)] lH-NMR (DMS0-d6, δ): 4.28 (2H3 s) 3 5.57 (2H? S) 5 6.23 (1H, d, J = 7.6Hz), 7.〇4 (lH, t, J = 7.6Hz), 7.10-7 · 26 (6Η, m), 7.40 (1Η, d, J = 8 · 6Ηζ), 7.46 ( 1H, d, J = 8.0Hz), 7.61-7 · 73 (4Η, m), 8.00 (2Η, d, J: 7.6Hz), 8.23 (1Η, s), 12.43 (1H, br s) 0 IR (KBr): 1685cm-10mp: 152.0-155.0 ° C. &lt; Example 146; 6-benzenesulfonylaminofluorenyl-2-benzyl-1- (2-fluorobenzyl) ) Synthesis of benzimidazole (211) &gt; According to the method of Example I44, 2-benzyl-6-carboxy-1- (2-chlorobenzyl) benzimidazole (0.776 g), N , N, -carbonyldiimidazole (0.654g), benzylsulfonamide (0.634g), diazabicyclo-ene (0.614g) to give 6-benzenesulfonylcarbamoylbenzyl-l -(2-Azobenzyl) benzimidazole (21 1) (0.803g). [Physical properties of compound (211)] W-NMIUDMSiHlG, c5): 4.41 (2H, s), 5.71 (2Η, s ), 6.32 (1H, d, J: 7,7Hz), 7.06 (1H, t, J = 7.7Hz), 7.14-7 · 30 (6Η, m), 7.50 (1Η, d, ㈣.GHz), 7 62 (2Η, t), 7.70 (1Η, t), 7.81 (1Η, d, J = 8.6Hz), 7.87 (1H, d, J = 8.5Hz), 7.97 (2H, d, J = 8 · 2Ηζ), 8 · 16 (1Η, s), 12 · 60 (1Η, br s). IR (KBr): 1704cm-10 mp: 143.0-144.5 ° C. &lt; Example 147; Synthesis of 1- (2,4-digaso-benzyl) _2_methyl-6 _ [(2 · pyridinyl) aminomethylfluorenyl] benzimidazole (180) &gt; Drop of N, N-dimethylmethanamine was added to the base group (2,4_ 二 气 代 _______ Λ22 ___ This paper is used in China National Standard (CNS) Λ4 specification (210X297 ^ 3 ---- (Please (Please read the notes on the back before filling this page)-口 ψ. .. 浐.. ^-^-Consumer cooperation ^ ^ 548272 Α7 Β7 5. Description of the invention (17j ~ section base) -2-methyl In benzimidazine (0.627 g), ice-cooled. Ethylene chloride (0.493 g) was added dropwise and stirred for several minutes. After stirring at room temperature for 丨 hours, it was concentrated under reduced pressure to remove gasified ethylene dichloride. Alas, the residue was dissolved in trichloromethane (10ml). This solution was dripped into amidinomethyl under ice-cooling. Pyridine (0.1678) and diethylamine (0.4698) (51111) solution. After being stirred for 1 hour, the reaction solution was washed 3 times with water, and then washed with a saturated sodium bicarbonate aqueous solution. The organic layer was concentrated under reduced pressure, and thin-layer silica gel chromatography (expansion> cereal media) C-diethyl ether = 1/1) refined Then dissolve in ethyl acetate (5ml), add hexane (2ml) to crystallize it. The crystals are decanted and dried to give 1- (2,4-dichlorobenzyl) _2_yl. _6 _ [(2-Pyridinyl) aminoamino] benzimidazole (180) 0.359 g. [Physical properties of compound (180)] 4-NMR (CDC13, (S): 2.56 (3Η, s) , 4.76 (2H, d3 5.4G (2H, s), 6.33 (1H, d, J = 8,4Hz), 7.07 (1Η, dd, J = 8.4 and 2.00 · ζ), 7.22 ( 1Η, dd, J: 7.4 and 4.9Ηζ), 7.33 (1H, d, J = 7.9Hz), 7.48 (1Η, d, J = 2.1Hz), 7.62_7 · 79 (4Η, m), 7.86 (1Η, d, J = 1.lHz), 8.57, (1H, d, J: 4.9Hz). IR (KBr): 1645cm &quot; 10mp: 204.1-206.3 ° C. &Lt; Example 148 Synthesis of 1- (biphenyl-4-fluorenyl) -2-fluorenyl-6-[(2-a ratio. Fixed methyl) aminomethylfluorenyl] benzimidazole (212) &gt; Gasified ethylenedifluoride (0.655g) was added with 1 · (biphenylmethyl) -6-enyl-2-methylbenzo. Mizidine (0.866g) and N, N-dimethylformamide (1 drop) of a solution of dioxane (13 ml) and stirred at room temperature for 15 hours. The precipitated crystals transitioned out, washed with digas methane, and dried under reduced pressure. Two. — ------- 1 7 Λ This paper size applies to the Chinese National Standard (CNS) Α4 specification (21〇X2 ^ H) '' ^ (It is necessary to read the precautions on the back before filling this page) Order Φ 548272 Μ ________________B7 V. Description of the invention (17 $ (诮 Please read the notes on the back before filling this page) Add this crystal to 2-aminofluorenyl group under ice cold. Specific bite (0.235g) and triethylamine (0.635 g) Digas methane (i5mi) solution, stirring for i hours. Water was added to the reaction solution to stop the reaction. After washing with water (twice) and saturated sodium bicarbonate aqueous solution, the organic layer was dried and the solvent was reduced. The solution was concentrated under pressure. The residue was recrystallized from a mixed solvent of ethyl acetate and ethanol to obtain 1- (biphenyl-4-methylmethyl-6-[(2-σ than pyridylmethyl) carbamoyl). ] 0.774 g of benzimidazole (212). [Physical properties of compound (212)] H-NMR (CDCh3 δ): 2.62 (3H3 s) 3 4.77 (2H3 d5 J = 4.8Hz), 5.42 (2H, s), 7.12 (2H5 d3 J ^ 8.5Hz), 7.21 (1H3 m) 3 7.34 (2H5 m) 5 7.42 (2H3 m) 3 7.51-7.55 (4H, m), 7.62 (1Η, br t), 7.67 ( 1Η3 dt, J = 1.7 and 7 · 7Ηζ), 7 · 71 (1Η, dd, J: 1.6 and 8.4Hz) 5 7.76 (1H3 d3 J = 8.4Hz) 3 8.00 (1H3 d3 J = 1.2Hz), 8.56 (1H5 d3 J-4.8 Hz) IR (KBr): 1642CET1. Mp: 205.0-206.5 ° C. &Lt; Examples 149; 6-benzenesulfonamidoaminofluorenyl-1- (2-chlorobenzyl) -2-methylbenzimid. Synthesis of (163) &gt; N, N'-carbonyldiimidazole ( 0.973 g) was added to a solution of 6-carboxyl-hexyl 2-chlorobenzyl) -2-methylbenzimidazole (0.90 g) in N, N-dimethylformamide (20 ml), Stir at room temperature for 1 hour. Next, add a solution of benzenesulfonamide (.943g) and diazabicycloundecene (0.99g) in N, N-difluorenylamine (5ml). Stir at 100 ° C for 70 hours. Cool the reaction solution and distill off the solvent under reduced pressure. Add water and chloroform to the residue and add 10% hydrochloric acid until the water layer becomes acidic. Extraction with chloroform (2 times ), The size of the paper is suitable for the Chinese National Standard ([?) 8 4 specifications (210 &gt; &lt; 297 mm) 548272 A7 B7 5. Description of the invention (17g and the organic layer obtained by washing with sodium bicarbonate aqueous solution, in The solvent was distilled off under reduced pressure. The residue was dissolved in a small amount of trichloromethane, and ethyl acetate was added to crystallize it. The crystals were filtered off and dried to give 0.667 g of 6-benzenesulfonylcarbamoylchlorobenzyl) _2 · methylbenzimidazole (163). &lt; Example 150; Synthesis of 6-benzenesulfonylaminocarbamyl group 丨 丨 (biphenyl-4-methyl) -2-methylbenzimidazole sodium salt (213) &gt; According to Example 141 Method, using 6-carboxyl; μ (bibenzylmethyl) -2-fluorenylbenzimidazole (〇j37g), benzylsulfonamide (0.516g), diazabicycloundecene (0.500g) to This gives 6-benzenesulfonylcarbamoyl-1- (biphenylfluorenyl) -2-fluorenylbenzimidazole sodium salt (213) (0.365 g). [Physical properties of compound (213)] W-NMBXDMSO-d6,6): 2.52 (3Η, s), 5.52 (2Η, s), 7.13 (2Η, d, J: 8.1Hz), 7 · 3 Bu 7.37 (4Η, m), 7.39-7 · 45 (3Η, m), 7.58-7 · 63 (4Η, in), 7.78-7 · 82 (3Η, m) , 7.97 (1H, s). IR (Nujc) l): 1591CET1. Melon P: 289.0 — 290.0 ° C (decomposed 奁 with 弋). &lt; Example 151; Synthesis of 6-benzenesulfonamidoaminofluorenyl-1- (2-chlorobenzyl) -2-methylbenzimidazole (163) &gt; Dimethyl Jun (5.41g) was added with 6-alkyl-1- (2-Azobenzyl) -2-fluorenylbenzimidazole (502g) of n, N-dimethylformamide (110ml) The solution was stirred at room temperature for 1 hour. Next, a solution of bensulfenamide (5.24 g) and diazabicycloundecene (5.08 g) in N, N-diamidinofluorenamine (20 ml) was added and stirred at 100 ° C for 70 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Add water and trifluoromethane to the residue and add it while mixing. The paper size applies the Chinese National Standard (CNS) A4 (210X297 mm) --------- ^ ------ 1T- ----- (诮 Please read the precautions on the back before filling this page) 548272 A7 B7 V. Description of the invention (17) Add hydrochloric acid until the water layer becomes acidic. Extraction was carried out using tri-gas methylbenzene (twice), and the obtained organic layer was washed with a saturated sodium bicarbonate aqueous solution, and the-part of the solvent was removed under reduced pressure. The precipitated crystals were filtered, and the 6-benzenesulfonylcarbamoamidinyl group "-(, oxobenzylmethylbenzyl) was found to be dried. (163) 4.96g., &Lt; Example 152; H2-Azobenzyl) Synthesis of 2_methyl_6_trifluoromethanesulfonylaminomethylbenzylbenzoyl sialic hydrochloride (214) &gt; N, N'-carbonyldiimidazole ( 0.647g) added n-n-dimethylformamidine (20ml) / § ^ solution of p-carboxyl-i_ (2-chlorobenzyl) -2-methylbenzimidazole (0.600 g) The mixture was stirred at room temperature for 1 hour. Next, trifluorosulfonamide (0.596 g) and diazabicycloundecene (0.609 N, N_: fluorenylformamidine (5 ml) were added. The solution was stirred at 10 ° C for 72 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Water and chloroform were added to the residue, and 100 /% hydrochloric acid was added while mixing until the aqueous layer became acidic. The precipitated crystals were washed with a mixed solvent of ethanol (25 ml) and methanol (25 ml). The crystals were dried to obtain 1- (2-chlorobenzyl) -2-methyl-6-trifluorofluorenylsulfonyl. 0.420 g of aminoamidobenzimidazole hydrochloride (214) [Physical properties of compound (214)] WN MR (DMSQ-d6,6): 2.84 (3H, s), 5.82 (2Η, s), 7.G8 (1H, d, J = 7.5Hz), 7.30 (1H5 t) 3 7.40 (1H3 t, J = 7.7Hz), 7.58 (1H, d, J = 8.0Hz), 7.79 (1H, d, J ^ 8,6 Hz), 8.07-8.13 (2H5 m), IR (KBr): 1634cm1.

Mass(CI) : m/e 432_-HCl)〇 mp : 332 — 335°C(分解奁伴3)。 本紙張尺度適中國國家標準(CNS ) Α4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁)Mass (CI): m / e 432_-HCl). Mp: 332-335 ° C (decomposition of accompany 3). The size of this paper is in accordance with Chinese National Standard (CNS) Α4 specification (210X297 mm)

、1T 548272 A7 ___〜 五、發明説明(17$ &lt;實施例153、154;6-苯磺醯基氨基甲醯基-1-(2,4-一氣代节基)-2-甲基苯並咪唾鹽酸鹽(215)及6-笨確醯基 氣基甲&amp;&amp;基-1-(2,4 - 一氣代卞基)-2-甲基苯並口米嗤(216)之 合成&gt; 依據貫施例152之方法,使用6-叛基-1-(2,4-二氯 代节基)-2-甲基苯並咪唾(〇.460g)、N,N,-幾基二咪嗤 (〇.445g)、苯磺醯胺(0.431g)、二氮二環十一烯(〇 4l8g) 以得出6-苯磺醯基氨基甲醯基_i_(2,4-二氯代苄基)-2-甲 基笨並咪唑鹽酸鹽(215)0.540§。 [化合物(215)的物性]. lH-NMR(DMS0-d63 δ) : 2.71(3H3 s)3 5.74(2H, s)5 6.83(1H, d, J^8.4Hz), 7. 33(1H,dt J二2·0 及 8.4Hz),7.63(21 t),7.71(1H3 t),7.78(1H,d,J二2· 0Hz),7·86(1Η,d,J-8.7Hz),7·95(1Η,dd,J=1.4 及 8·7Ηζ),7·99(2Η,in), 8·29(1Η, s)〇 IR(KBr) : 1686cm—1。 mp : 236.0 — 238.0°C。 將其溶解於碳酸氫鈉水溶液與甲醇之混合溶媒中,使用 10%鹽酸調整成PH5〜6。收集所析出之結晶,經水洗、 甲醇洗淨後,藉由乾燥而得出6_笨磺醯基氨基甲醯基_ 1-(2,4_一氣代卡基)_2_甲基苯並咪。坐(216)。 f化合物(216)的物性] 1誰_80-(16,(5) : 2·48(3Η,s),5.58(2H, s),6.42UH,d,J:8.4Hz),7. 31(1H, dd, J:2.2 及 8·4Ηζ), 7·60-7·75(6Η, m), 7·99(2Η, d, J二7·4Ηζ), 8· 〇6(1Η, s), 12·40(1Η, s)。 本紙張尺度適ϋ關家標準(CNS ) Α4規格(2歐29^ )---- (讀先閱讀背面之注意事項再填寫本頁)1T 548272 A7 ___ ~ V. Description of the invention (17 $ &lt; Examples 153, 154; 6-benzenesulfonylaminocarbamoyl-1- (2,4-monoatomyl) -2-methylbenzene Benzosial hydrochloride (215) and 6-benzylpyridylaminomethyl &amp; &amp; yl-1- (2,4 -monogasoyl) -2-methylbenzomethylpyridine (216) Synthesis &gt; According to the method of Example 152, 6-alkyl-1- (2,4-dichlorobenzyl) -2-methylbenzimidal (0.460 g), N, N, -Chlorodistilbene (0.445 g), benzylsulfonamide (0.431 g), and diazabicycloundecene (0418 g) to give 6-benzenesulfonylcarbamoyl-i- (2, 4-Dichlorobenzyl) -2-methylbenzimidazole hydrochloride (215) 0.540§. [Physical properties of compound (215)]. LH-NMR (DMS0-d63 δ): 2.71 (3H3 s) 3 5.74 (2H, s) 5 6.83 (1H, d, J ^ 8.4Hz), 7.33 (1H, dt J 2 2.0 and 8.4Hz), 7.63 (21 t), 7.71 (1H3 t), 7.78 ( 1H, d, J = 2.0 Hz), 7.86 (1Η, d, J-8.7Hz), 7.95 (1Η, dd, J = 1.4 and 8.7Ηζ), 7.99 (2Η, in) , 8 · 29 (1Η, s) 〇IR (KBr): 1686cm-1. Mp: 236.0-238.0 ° C. It was dissolved in a mixed solution of sodium bicarbonate aqueous solution and methanol. 10% hydrochloric acid was used to adjust the pH to 5 ~ 6. The precipitated crystals were collected, washed with water, washed with methanol, and dried to obtain 6-benzylsulfonylcarbamoamidinyl_ 1- (2,4_ 1-kilocarboxyl) _2-methylbenzimid. Sitting (216). Physical properties of compound (216)] 1 who _80- (16, (5): 2.48 (3Η, s), 5.58 (2H , s), 6.42UH, d, J: 8.4Hz), 7.31 (1H, dd, J: 2.2 and 8.4Ηζ), 7.60-7 · 75 (6Η, m), 7.99 (2Η , D, J 2 7 · 4Ηζ), 8 · 〇6 (1Η, s), 12 · 40 (1Η, s). The size of this paper conforms to the Family Standard (CNS) A4 specification (2Euro 29 ^)- -(Read the notes on the back before filling in this page)

、1T 548272 A7 五、發明説明(i7) IR(KBr) : 1540cm~l〇 mp ·· 238·2· -239.9〇C〇 (讀先閱讀背面之注意事項再填寫本頁) &lt;實施例155;l-(2-氣代苄基)_6_(4-甲氧苯磺醯基氨 基甲醯基)-2-甲基苯並咪唑(217)之合成&gt; 將N,N’-幾基二咪唑(〇.431g)加入6-羧基小(2-氯代 午基)-2-甲基苯並口米σ坐(〇 4〇〇g)之n,N-二曱基甲醯胺 (15ml)溶液中,在室溫下攪拌1小時。接著,加入各曱 氧基苯磺醯胺(〇.498g)及二氮二環十一烯(〇.4〇5g)之 N,N-二甲基曱醯胺(5mi)溶液,在1〇〇t下攪拌67小時。 冷卻反應液,在減壓下餾去溶媒。將水及三氣甲烷加入 殘盧中,一面混合同時添加1 〇%鹽酸至水層形成酸性為 止。使用三氣甲烷進行萃取(2次),以飽和碳酸氫鈉水溶 液洗淨所得之有機層,在減壓下餾去溶媒。藉由矽膠柱 色譜法(溶離液··三氯曱烷/甲醇=1〇〇/2〜1〇〇/1〇)精製,經 濃縮後,使用醋酸乙酯及二乙醚之混合液進行結晶化。 過濾出結晶,經乾燥而得出丨气孓氯代苄基)-6_(4_甲氧苯 磺醯基氨基甲醯基)-2-曱基笨並咪唑(217)0.45〇g。 [化合物(217)的物性] 4-賺_30-(16,d) ·· 2.46(3H,s),3·83(3Η,s),5·58(2Η,s)3 7.12(2H3 d J二9·0Ηζ), 7·21(1Η, t, J=7.3Hz), 7·33(1Η, t), 7·56(1Η, d, J=7.GHz), 7.63 (1H,d,J=8.5Hz),7·71(1Η,dd,J=1.6 及 8·5Ηζ),7·91(2Η, d,战·), 8·05(1Η,d,&gt;1·3Ηζ)。 IR(KBr) ·· 1683cm1。1T 548272 A7 V. Description of the Invention (i7) IR (KBr): 1540cm ~ 10mp ·· 238 · 2 · -239.9〇C〇 (Read the precautions on the back before filling this page) &lt; Example 155 ; Synthesis of l- (2-Azobenzyl) _6_ (4-methoxybenzenesulfonylaminocarbamyl) -2-methylbenzimidazole (217) &gt; N, N'-Chloroyl Imidazole (0.431 g) was added with 6-carboxyl (2-chloroammonyl) -2-methylbenzomethylbenzoate (0.400 g) of n, N-dimethylformamide (15 ml) ) The solution was stirred at room temperature for 1 hour. Next, a solution of each oxybenzamide (0.0498 g) and diazabicycloundecene (0.405 g) in N, N-dimethylamidamine (5mi) was added at 1.0. Stir for 67 hours. The reaction liquid was cooled, and the solvent was distilled off under reduced pressure. Add water and three gas methane to the residual water. While mixing, add 10% hydrochloric acid until the water layer becomes acidic. Extraction was performed using trigas methane (twice), and the obtained organic layer was washed with a saturated sodium bicarbonate aqueous solution, and the solvent was distilled off under reduced pressure. Purified by silica gel column chromatography (eluent ·· trichloromethane / methanol = 1 00/2 ~ 100/1/10). After concentration, the mixture was crystallized using a mixed solution of ethyl acetate and diethyl ether. . The crystals were filtered and dried to give 0.450 g of tris (chloromethoxybenzyl) -6- (4-methoxybenzenesulfonylaminomethylamidino) -2-fluorenylbenzimidazole (217). [Physical properties of compound (217)] 4-earning_30- (16, d) ·· 2.46 (3H, s), 3.83 (3Η, s), 5.58 (2Η, s) 3 7.12 (2H3 d J 2 9 · 0Ηζ), 7.21 (1Η, t, J = 7.3Hz), 7.33 (1Η, t), 7.56 (1Η, d, J = 7.GHz), 7.63 (1H, d , J = 8.5Hz), 7.71 (1Η, dd, J = 1.6 and 8. · 5Ηζ), 7.91 (2Η, d, war ·), 8.05 (1Η, d, &gt; 1. · 3Ηζ) . IR (KBr) · 1683cm1.

Mass(FAB) : m/e 470(M+l)o mp : 271.0-274.0°C〇 本紙張尺度適州中國國家標準(CNS ) ( -----_ 548272 A7 B7 五、發明説明(180 &lt;實施例156;1-(2_氣代苄基)-2_曱基_6_(α -甲笨石黃 醯基氨基曱醯基)苯並咪唑(218)之合成&gt; 依據實施例155之方法,使用6-羧基氣代节 基)-2-甲基笨並咪唑(〇.450g)、Ν,Ν,-羰基二味唾 (〇.485g)、α -甲苯石黃醯胺(〇.512g)、二氮二環十一稀 (0.456g)以得出1-(2-氯代节基)-2-曱基-6-( α -甲笨石夤酉篮 基氨基曱醯基)苯並咪唑(218)0.350g。 [化合物(218)的物性] iH-NMIUDMSO-dG,(5) : 2·48(3Η,s),4·36(2Η,s),5·53(2Η3 s)3 6·40(1Η3 d, J-6·8Ηζ), 7·15-7·28(6Η, m), 7·32(1Η, t), 7·49(1Η, d, J:8.3Hz)3 7·55(1Η ,d), 7·83-7·87(2Η, m)0 IR(KBr) ·· 1593CHT1。Mass (FAB): m / e 470 (M + l) o mp: 271.0-274.0 ° C 〇The paper size is suitable for China National Standards (CNS) (-----_ 548272 A7 B7 V. Description of the invention (180 &lt; Example 156; Synthesis of 1- (2_fluorobenzyl) -2_fluorenyl_6_ (α-methylbenzite fluorenylaminofluorenyl) benzimidazole (218) &gt; According to Example 155 Methods: 6-Carboxycarbatobenzyl) -2-methylbenzimidazole (0.450 g), Ν, Ν, -carbonyl disalanilide (.485 g), α-toluene scutamine (0.05. (512g), diazabicycloundecene (0.456g) to give 1- (2-chlorobenzyl) -2-fluorenyl-6- (α-methylbenzylfluorenylaminofluorenyl) benzo 0.350 g of imidazole (218). [Physical properties of compound (218)] iH-NMIUDMSO-dG, (5): 2.48 (3Η, s), 4.36 (2Η, s), 5.53 (2 3 s) 3 6 · 40 (1Η3 d, J-6 · 8Ηζ), 7 · 15-7 · 28 (6Η, m), 7.32 (1Η, t), 7.49 (1Η, d, J: 8.3Hz) 3 7 · 55 (1Η, d), 7.83-7 · 87 (2Η, m) 0 IR (KBr) ·· 1593CHT1.

Mass(FAB) : m/e 454(M+l)〇 mp : 193— 196°C(泡状)。 &lt;實施例157;1-(2-氯代苄基)-6-(2,5-二甲基苯磺醯 基氣基甲酿基)-2 -甲基苯並味唾(219)之合成&gt; 依據實施例155之方法,使用6-羧基-1-(2-氯代苄 基)-2-甲基苯並咪唑(0.500g)、n,N,-羰基二咪唑 ®浐部中λ«·導而找3消费合作扣卬繁 (諳先閱讀背面之注意事項再填寫本頁) (〇.539g)·、2,5-二甲苯磺醯胺(〇.616g)、二氮二環十一烯 (〇.506g)以得出1-(2-氯代苄基)-6-(2,5-二甲基苯磺醯基 氨基甲醯基)-2-甲基苯並咪唑(219)0.490g。 [化合物(219)的物性] ^-NMRiDMSO-dG, δ) : 2.35(3H, s), 2.48(3H, s), 2.5K3H, s)3 5.58(2H, s) ,6.45UH,d,J=7.5Hz),7·20-7·27(2Η,m),7·31-7·39(2Η,m),7·56(1Η,d, J=8,0Hz), 7.64(1H, d, J=8.5Hz), 7.75(1H, d, J=8.5Hz), 7.82(1H, s), 8.06( ---—____ISA___ 本紙張尺度適川中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 &gt; —-----—--------------—__ B 7 五、發明説明(18 j 一 iH, s), 12·45(1Η, br s)。 IR(KBr) : 1690cm' (讀先閱讀背面之注意事項再填寫本頁)Mass (FAB): m / e 454 (M + 1). Mp: 193-196 ° C (bubble). &lt; Example 157; of 1- (2-chlorobenzyl) -6- (2,5-dimethylbenzenesulfonylmethylaminomethyl) -2-methylbenzopyrene (219) Synthesis> According to the method of Example 155, using 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzimidazole (0.500 g), n, N, -carbonyldiimidazole® λ «· Guide to find 3 consumer cooperation (please read the precautions on the back before filling in this page) (〇.539g), 2,5-xylene sulfonamide (〇.616g), Cycloundecene (0.506 g) to give 1- (2-chlorobenzyl) -6- (2,5-dimethylbenzenesulfonylaminocarbamyl) -2-methylbenzimidazole (219) 0.490 g. [Physical properties of compound (219)] ^ -NMRiDMSO-dG, δ): 2.35 (3H, s), 2.48 (3H, s), 2.5K3H, s) 3 5.58 (2H, s), 6.45UH, d, J = 7.5Hz), 7.20-7 · 27 (2Η, m), 7.31-7 · 39 (2Η, m), 7.56 (1Η, d, J = 8,0Hz), 7.64 (1H, d, J = 8.5Hz), 7.75 (1H, d, J = 8.5Hz), 7.82 (1H, s), 8.06 (---—____ ISA___ This paper is suitable for Sichuan National Standard (CNS) A4 specifications (210X297) (%) 548272 A7 &gt; —-----—--------------__ B 7 V. Description of the invention (18 j-iH, s), 12 · 45 (1Η, br s). IR (KBr): 1690cm '(Read the precautions on the back before filling this page)

Mass(FAB) : m/e 468(M+1)。 mp : 266.5-267.5°C〇 &lt;只轭例158;l-(2-氯代苄基)_2-甲基_6_(4_硝基苯磺 醯基氨基曱醯基)苯並咪唑(22〇)之合成&gt; 將N,N、羰基二咪唑(〇.432g)加入卜羧基-丨-^-氣代 苄基)-2-甲基苯並咪唑(〇4〇〇幻之N,N_二甲基甲醯胺 (15ml)溶液中,在室溫下攪拌丨小時。接著,加入乒硝 基笨%醯胺(0.538g)及二氮二環十一浠(〇 4〇5g)之N,N-二甲基甲醯胺(5ml)溶液,在10(rc下攪拌84小時。冷卻 反應液,在減壓下餾去溶媒。將三氯甲烷及鹽酸加入殘 渣中,經攪拌以析出結晶。過濾出結晶,藉由乾燥以得 出1-(2-氯代苄基)-2-甲基-6-(4-硝基苯磺醯基氨基甲醯 基)苯並咪唑(220)0.300g。 [化合物(220)的物性] -NMR(DMS0-d6, 6) : 2·56(3Η,s),5·65(2Η,s),6·54(1Η,d,J:7.6Hz),7· 23(1H, t, J=7.6Hz), 7·34(1Η, t, J:7.6Hz), 7·56(1Η, t, J:8.0Hz), 7·68(1Η, d,J=8.5Hz)3 7·83(1Η,d,J:8.3Hz),8·07(1Η,s)3 8.16(2M,J=8.7Hz),8.3 7(2H, d, J二8·7Ηζ)〇 IR(KBr) : 1621CHT1。Mass (FAB): m / e 468 (M + 1). mp: 266.5-267.5 ° C. &lt; Conjugate Example 158; l- (2-chlorobenzyl) _2-methyl-6_ (4-nitrobenzenesulfonylaminofluorenyl) benzimidazole (22 〇) Synthesis &gt; N, N, carbonyldiimidazole (0.432g) was added to the carboxyl- 丨-^-oxobenzyl) -2-methylbenzimidazole (040,00N, N In a solution of dimethylformamide (15ml), and stirred at room temperature for 1 hour. Then, add nitrobenzidine (0.538g) and diazabicycloundecium (0405g) N, N-dimethylformamide (5 ml) solution, stirred at 10 (rc for 84 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Trichloromethane and hydrochloric acid were added to the residue and stirred to precipitate Crystals. The crystals were filtered and dried to give 1- (2-chlorobenzyl) -2-methyl-6- (4-nitrobenzenesulfonylaminocarbamyl) benzimidazole (220) 0.300 g. [Physical properties of compound (220)] -NMR (DMS0-d6, 6): 2.56 (3Η, s), 5.65 (2Η, s), 6.54 (1Η, d, J: 7.6 Hz), 7.23 (1H, t, J = 7.6Hz), 7.34 (1Η, t, J: 7.6Hz), 7.56 (1Η, t, J: 8.0Hz), 7.68 (1Η , D, J = 8.5Hz) 3 7 · 83 (1Η, d, J: 8.3Hz) 8 · 07 (1Η, s) 3 8.16 (2M, J = 8.7Hz), 8.3 7 (2H, d, J two 8 · 7Ηζ) square IR (KBr): 1621CHT1.

Mass(FAB) : m/e 485(M+1)。 瓜p ·· 330 —332°C。 &lt;實施例l59;l-(2_氣代苄基)_2_甲基-6-[‘(三氟曱基) ___^-—__ 本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐) 548272 經浐部中央^準^Β,τ消費合作私印t A7 __________________ B7_ 五、發明説明(183 ~ 苯磺醯基氨基甲醯基]笨並咪唑(221)之合成&gt; 依據實施例158之方法,使用6-羧基-1-(2-氯代节 基)-2-甲基笨並咪唑(〇.45〇g)、N,N,-羰基二咪嗅 (0.486g)、4_(三氟甲基)笨石黃醯胺(〇 676g)、二氮二環十 一烯(0.457g)以得出1-(2-氣代苄基)-2-曱基-6-[4-(三氟甲 基)苯磺醯基氨基甲醯基]苯並咪唑(221)0.39(^。 [化合物(221)的物性] Η-醜(DMS0-d6,6) : 2·52(3Η,s),5·62(2Η,s),6·47(1Η,d,扣7·2ΗΖ) 22(1Η, t, J:7.5Hz), 7.34(1Η, t), 7.56(1Η, d, H=8.GHz), 7·66(1Η, d, 8 5 ),7·78(1Η,d),7·97(2Η3 d,J=8.3Hz),8.06(1H,s),8.15(2H,d,J:8.3如) o IR(KBr) : 1620(^-1。Mass (FAB): m / e 485 (M + 1). Melon · · 330 —332 ° C. &lt; Example l59; l- (2_fluorobenzyl) _2_methyl-6-['(trifluorofluorenyl) ___ ^ -—__ This paper is in accordance with China National Standard (CNS) A4 specification (210X297 (Mm) 548272 The central part of the Ministry of Economic Affairs ^ quasi ^ B, τ Consumer cooperation private printing t A7 __________________ B7_ V. Description of the invention (183 ~ benzenesulfonylcarbamoyl) synthesis of benzimidazole (221) &gt; The method of Example 158 uses 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzimidazole (0.450 g), N, N, -carbonyldiimidazole (0.486 g), 4- (trifluoromethyl) benzite baicaleamine (0676 g), diazabicycloundecene (0.457 g) to give 1- (2-fluorobenzyl) -2-fluorenyl-6- [ 4- (trifluoromethyl) benzenesulfonylaminocarbamyl] benzimidazole (221) 0.39 (^. [Physical properties of compound (221)] Η-ugly (DMS0-d6, 6): 2.52 ( 3Η, s), 5.62 (2Η, s), 6.47 (1Η, d, 7.27Z) 22 (1Η, t, J: 7.5Hz), 7.34 (1Η, t), 7.56 (1Η, d, H = 8.GHz), 7.66 (1Η, d, 8 5), 7.78 (1Η, d), 7.97 (2Η3 d, J = 8.3Hz), 8.06 (1H, s), 8.15 (2H, d, J: 8.3 as) o IR (KBr): 1620 (^ -1.

Mass(FAB) : m/e 508(M+1)〇 nip : 288.0-292.0°C〇 ' &lt;實施例160;6-(2-氣苯磺醯基氨基曱醯基)-卜(2-氣 代苄基)_2_甲基苯並咪唑銨鹽(222)之合成&gt; 將N,N -^厌基^一味σ坐(0.485g)加入6-魏基-1-(2-氣代 苄基)-2-甲基苯並咪唑(〇.45〇g)之N,N-二甲基甲醯賤 (15ml)溶.液中,在室溫下攪拌1小時。接著,加入三氟甲 磺醯胺(0.575g)及二氮二環十一烯(〇.457g)之N,N-二甲基 曱醯胺(5ml)溶液,在l〇〇°c下攪拌72小時。冷卻反應液, 在減壓下餾去溶媒。將水及醋酸乙酯加入殘渣中,一务 混合同時加入10%鹽酸至水層形成酸性為止。過濾出所 析出的結晶。將結晶溶解於乙醇中,並加入氨水調整成 I紙張尺度適用巾關家標準(CNS ) A4規格(210X29^^Mass (FAB): m / e 508 (M + 1) Onip: 288.0-292.0 ° C 0 '&lt; Example 160; 6- (2-Gasylsulfonylaminoamidino) -Bu (2- Synthesis of Benzyl) -2-Methylbenzimidazolium Ammonium Salt (222) &gt; Add N, N-^ Anidol ^ Blind Sigma (0.485g) to 6-Weiyi-1- (2-Gas A solution of benzyl) -2-methylbenzimidazole (0.450 g) in N, N-dimethylformamidine (15 ml) was stirred at room temperature for 1 hour. Next, a solution of trifluoromethanesulfonamide (0.575 g) and diazabicycloundecene (0.457 g) in N, N-dimethylamidamine (5 ml) was added, and the mixture was stirred at 100 ° C. 72 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Water and ethyl acetate were added to the residue, and 10% hydrochloric acid was added while mixing until the water layer became acidic. The precipitated crystals were filtered off. Dissolve the crystals in ethanol and add ammonia to adjust to I paper size. Applicable to household standards (CNS) A4 specifications (210X29 ^^

(讀先閱讀背面之注意事項再填寫本頁J(Read the notes on the back before filling in this page J

548272 A7 B7 五、發明説明(18$ PH7,接著加人二異丙醚,過濾出析出的結晶,經乾燥 知出6-(2-氯苯磺醯基氨基曱醯基&gt;1_(2_氯代苄基卜孓甲 基笨並咪唑銨鹽(222)0.360g。 [化合物(222)的物性] 'H-麵(DMS0-d6, : 2.47(3H,s),5.51(2H,s),6 43(ih,&amp; j=7 5Hz) 7 12(4H, br s), 7.19(1H, t, J=7.6Hz), 7.28-7.38(4«, m), 7.46(1H5 d, J=8.3H Z), 7.53(1H, d, J:7.9Hz), 7.78-7.82(2H, m), 7·97(1Η m) IR(KBr) : 1590cm—1。 '548272 A7 B7 V. Description of the invention (18 $ PH7, then adding diisopropyl ether, filtering out the precipitated crystals, and drying, it is known that 6- (2-chlorobenzenesulfonylaminofluorenyl) &gt; 1_ (2_ 0.360 g of chlorobenzylbuthylmethylbenzimidazole ammonium salt (222). [Physical properties of compound (222)] 'H-plane (DMS0-d6,: 2.47 (3H, s), 5.51 (2H, s) , 6 43 (ih, &amp; j = 7 5Hz) 7 12 (4H, br s), 7.19 (1H, t, J = 7.6Hz), 7.28-7.38 (4 «, m), 7.46 (1H5 d, J = 8.3HZ), 7.53 (1H, d, J: 7.9Hz), 7.78-7.82 (2H, m), 7.97 (1Η m) IR (KBr): 1590cm-1. '

Mass(FAB) : πι/e 474(M+1-NH3)。 mp : 264.0 —267.0cC。 &lt;實施例ΐόΐ;6-氨基甲醯基-丨_(2,‘二氣代苄基)_2_ 曱基苯並咪唑(223)之合成&gt; 在冰冷下將氯化乙二醯(0.437g)加入6_羧基_H2,4-二氣代节基)-2-甲基苯並喷唾(〇.49〇g)與n,N-二甲基甲 MM部中央榀率^m.T消费合竹ii印 (讀先閱讀背面之注意事項再填寫本頁) 醢胺(1滴)之氣化乙二(gml)溶液中,在室溫下授拌I〕 小時。將水與乳化乙二醯加入反應液中以進行萃取。將 有機層濃縮後收集所析出之結晶,經乾燥得出6-氨基甲 醯基-1-(2,4-二氯代节基)-2-甲基苯並咪唾(223)0.240g。 [化合物(223)的物性] 4-腿(DMSO-d6,(5) : 2·48(3Η3 s),5·54(2Η,3),6·41(1Η,d,J二8.4Hz),7· 21 -8·02(3Η,m),7·31(1Η,dd,私2 及 8·4Ηζ), 7.60(1H,d,J:8.4Hz), 7· 75(1H, m), 7.93(1H, s)。 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) 548272 經潢部中决«.-枣而找-Τ消費合作牡印^ A7 B7 五、發明説明(18j IR(KBr) : 1666cm-1〇 mp ·· 112.0 —114.0oC〇 &lt;實施例162;6-苯磺醯基氨基甲醯基_2_节基_;μ (2,4-一氣代卞基)苯並味唾(224)之合成&gt; 將N,N’-羰基二咪唑(0.248g)加入2_苄基&lt;·羧基·卜 (2-氣代苄基)苯並咪唑(0·315§)之N,N-二曱基曱醯胺(5ml) /谷液中’在室溫下攪拌1小時。接著,力口入苯磺醯胺(〇.24〇g) 及二氮二環十一烯(0.233g)之N,N-二甲基曱醯胺(4ml)溶 液,在100 C下攪拌62小時。冷卻反應液,在減壓下餾 去溶媒。將水及三氯曱烷加入殘渣中,一面混合同時加入 10°/。鹽酸至水層形成酸性為止。使用三氣曱烷進行萃取(2 次),以飽和碳酸氫鈉水溶液洗淨所得之有機層,在減壓 下餾去溶媒的一部分。將甲醇(4mi)與2〇%碳酸氫鉀水溶 液(4ml)加入殘渣中,以10%鹽酸調整成pH5〜6。過濾、乾 燥所析出之結晶以得出6-苯磺醯基氨基甲醯基_2_苄基―卜 (2,4-一氣代卞基)苯並咪。坐(224)0.31(^。 [化合物(224)的物性] |H-瞧⑽s0-d6, w : 4.32(1H,s),5.61(2H,s),6.16(1H,d,㈣他),7 09(1H,dd,J:8,4 及 UHz),7.18_7·1〇(5Η,π),7·82 7 58(6h,‘ 7 97(2 H,d,J=7.6Hz),8·10(1Η,s),12·43(1Η,br s)。 IR(KBr) : 1703^^0 mp : 236.0 —238.0°C。 &lt;實施例163;5-苯磺醯基氨基甲醯基苄基-卜 (2,4-一^氣代卞基)本並ϋ米唾(225)之合成&gt; (誚先閱讀背面之注意事項再填寫本頁) 、1Τ 争· 548272 經沪部中次^枣^只工消贽合作^印« A7 B7 五、發明説明(18$ 依據實施例152之方法,使用2-苄基-5-羧基-1·(2,4-二氯代节基)苯並味嗤(〇.385g)、Ν,Ν、緩基二咪唾 (〇.304g)、苯磺醯胺(0.294g)、二氮二環十一烯(〇 285g) 以得出5_苯磺醯基氨基甲醯基苄基_1-(2,4_二氯代节 基)苯並咪唑(225)0.270g。 [化合物(225)的物性] tNMROiMSO-d6, d) : 4·28(2Η,s),5·52(2Η,s)5 6.14UH,d,J=8·他),7· 2卜7·06(6Η, m), 7·42(1Η, d, J=8.6Hz), 7·76-7·57(5Η, m)3 8.05-7·95(2Η, m) ,8·24(1Η, s), 12·43(1Η, br s)。 IR(KBr) : 1691cm'!〇 即:107.0-ll〇.〇〇co &lt;實施例164;6-苯磺醯基氨基甲醯基(聯苯_4-甲 基)-2-羥基苯並咪唑(226)之合成&gt; 將四曱氧基曱烷(0.220g)加入N-苯磺醯基-4-胺基-3-(聯苯-4-曱基胺基)苯並醯胺(〇.4〇〇g)之醋酸溶液(5ml) 中’在80°C下攪拌2小時。濃縮反應液,加入20%碳酸 氫鈣水溶液以形成鹼性後,使用10%鹽酸調整成pH5〜6。 收集所析出之結晶,加入甲醇(l〇ml)、10%鹽酸(0.50g)、 35%鹽酸(〇.35g),60°C下攪拌15小時。加入20%碳酸氫 鈣水溶液以成為鹼性後,使用10%鹽酸調整成pH5〜6。 過濾、乾燥所析出之結晶而得出6_苯磺醯基氨基甲醯基 -1-(聯苯-4-甲基)-2-羥基苯並咪唑(226)0.219g。 [化合物(226)的物性] ^-NMRiDMSO-dG, δ) : 5.07(2H, s), 7.08(1H3 d3 J=8.2Hz), 7,33-7.39(3H, ni ----------—______I flQ_ _____ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) n 訂 ' (讀先閱讀背面之注意事項再填寫本頁) 548272 A7 B7 五、發明説明(18g 7.44(2H, t5 J=7.5Hz)3 7.60-7.65(7H, m)3 7.66-7.72(2H5 m)3 7.96-7.80(2 H, 11·46(1Η3 s), 12.34(11 s)。Mass (FAB): π / e 474 (M + 1-NH3). mp: 264.0 —267.0cC. &lt; Example ΐόΐ; 6-aminomethylfluorenyl- 丨 _ (2, 'di-gas benzyl) _2_ fluorenyl benzimidazole (223) Synthesis &gt; Ethyl hydrazone chloride (0.437 g ) Add 6-carboxy_H2,4-di-aminobenzyl) -2-methylbenzoxazone (0.49 g) and n, N-dimethylmethyl MM central central rate ^ mT consumption combined Bamboo II (read the precautions on the reverse side and then fill out this page) In a solution of ammonium amine (1 drop) in gasified ethylene dichloride (gml), stir at room temperature for I] hours. Water and emulsified ethylenediamine were added to the reaction solution for extraction. The organic layer was concentrated, and the precipitated crystals were collected and dried to give 0.240 g of 6-carbamoyl-1- (2,4-dichlorobenzyl) -2-methylbenzimidazole (223). [Physical properties of compound (223)] 4-leg (DMSO-d6, (5): 2.48 (3Η3 s), 5.54 (2Η, 3), 6.41 (1Η, d, J = 8.4Hz) , 7.21 -8 · 02 (3Η, m), 7.31 (1Η, dd, private 2 and 8.4Ηζ), 7.60 (1H, d, J: 8.4Hz), 7.75 (1H, m) , 7.93 (1H, s). This paper size is applicable to Chinese National Standard (CNS) A4 (210x297 mm) 548272 Ministry of Economic Affairs decided «.- Jujube and find -T consumption cooperation seal ^ A7 B7 V. Description of the invention (18j IR (KBr): 1666cm-10 mp · 112.0-114.0 ° C &lt; Example 162; 6-benzenesulfonylcarbamoamido-2-decyl_; μ (2,4-monogas Synthesis of fluorenyl) benzoyl salivary (224) &gt; N, N'-carbonyldiimidazole (0.248g) was added to 2-benzyl &lt; · carboxyl · (2-oxobenzyl) benzimidazole ( 0.315§) in N, N-diamidinofluorenamine (5ml) / cereal solution was stirred at room temperature for 1 hour. Then, benzylsulfonamide (0.224g) and A solution of azabicycloundecene (0.233 g) in N, N-dimethylamidamine (4 ml) was stirred at 100 C for 62 hours. The reaction solution was cooled, and the solvent was distilled off under reduced pressure. Water and three Add chloromethane to the residue and mix while At the same time, 10 ° /. Hydrochloric acid was added until the water layer became acidic. Extraction was performed using trisfane (2 times), and the resulting organic layer was washed with a saturated sodium bicarbonate aqueous solution, and a part of the solvent was distilled off under reduced pressure. Methanol (4mi) and 20% potassium hydrogencarbonate aqueous solution (4ml) were added to the residue, and the pH was adjusted to 5 to 6 with 10% hydrochloric acid. The precipitated crystals were filtered and dried to obtain 6-benzenesulfonylcarbamoamido. 2_benzyl-Bu (2,4-monofluorofluorenyl) benzimid. Sitting (224) 0.31 (^. [Physical properties of compound (224)] | H-Luo⑽s0-d6, w: 4.32 (1H, s), 5.61 (2H, s), 6.16 (1H, d, Sunda), 7 09 (1H, dd, J: 8, 4 and UHz), 7.18_7 · 1〇 (5Η, π), 7.82 7 58 (6h, '7 97 (2 H, d, J = 7.6Hz), 8.10 (1Η, s), 12.43 (143, br s). IR (KBr): 1703 ^^ 0 mp: 236.0-238.0 ° C. &Lt; Example 163; Synthesis of 5-benzenesulfonylaminocarbamoylbenzyl-Bu (2,4-a ^ amino substituted fluorenyl) Benzosalamine (225) &gt; (Please read the notes on the back before filling this page), 1T contention, 548272 by the Ministry of Shanghai ^ Jujube ^ only workers eliminate cooperation ^ printed «A7 B7 V. Description of the invention (18 $ according to The method of Example 152 was carried out using 2-benzyl-5-carboxy-1 · (2,4-dichlorobenzyl) benzobis (嗤 .385g), Ν, Ν, glutaimide (. .304g), benzylsulfonamide (0.294g), and diazabicycloundecene (〇285g) to give 5-benzenesulfonylcarbamoylmethylbenzyl_1- (2,4-dichloro Benzyl) 0.270 g of benzimidazole (225). [Physical properties of compound (225)] tNMROiMSO-d6, d): 4.28 (2Η, s), 5.52 (2Η, s) 5 6.14UH, d, J = 8 · he), 7.2 and 7 · 06 (6Η, m), 7.42 (1Η, d, J = 8.6Hz), 7.76-7 · 57 (5Η, m) 3 8.05-7 · 95 (2Η, m), 8.24 ( 1Η, s), 12 · 43 (1Η, br s). IR (KBr): 1691 cm ′! 〇 That is: 107.0-110.co &lt; Example 164; 6-benzenesulfonylcarbamoyl (biphenyl-4-methyl) -2-hydroxybenzo Synthesis of imidazole (226) &gt; Tetramethoxyoxane (0.220g) was added to N-benzenesulfonyl-4-amino-3- (biphenyl-4-fluorenylamino) benzoxamine ( In 400 g) of an acetic acid solution (5 ml), it was stirred at 80 ° C for 2 hours. The reaction solution was concentrated, and a 20% aqueous solution of calcium bicarbonate was added to make it alkaline, and then adjusted to pH 5 to 6 using 10% hydrochloric acid. The precipitated crystals were collected, and methanol (10 ml), 10% hydrochloric acid (0.50 g), and 35% hydrochloric acid (0.35 g) were added thereto, followed by stirring at 60 ° C for 15 hours. After adding a 20% aqueous solution of calcium bicarbonate to make it alkaline, the pH was adjusted to 5 to 6 using 10% hydrochloric acid. The precipitated crystals were filtered and dried to obtain 0.219 g of 6-benzenesulfonylcarbamoyl-1- (biphenyl-4-methyl) -2-hydroxybenzimidazole (226). [Physical properties of compound (226)] ^ -NMRiDMSO-dG, δ): 5.07 (2H, s), 7.08 (1H3 d3 J = 8.2Hz), 7,33-7.39 (3H, ni ------- ---—______ I flQ_ _____ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) n Order '(Read the precautions on the back before filling this page) 548272 A7 B7 V. Description of the invention (18g 7.44 (2H, t5 J = 7.5Hz) 3 7.60-7.65 (7H, m) 3 7.66-7.72 (2H5 m) 3 7.96-7.80 (2 H, 11.46 (1Η3 s), 12.34 (11 s).

IiUKBr) : i7〇4,1686cm—、 (誚先閱讀背面之注意事項再填寫本頁)IiUKBr): i7〇4, 1686cm—, (诮 Read the precautions on the back before filling in this page)

Mass(FD) : m/e 483(M)〇 即:268· 7 — 273· 9°C。 &lt;實施例165;6-苯磺醯基氨基甲醯基(聯苯甲 基)-2-巯基苯並咪唑(227)之合成&gt; 將二硫化碳(2ml)加入N-笨磺醯基氨基甲醯基-4_胺 基-3-(聯苯-4-曱基胺基)苯並醯胺(〇.8〇〇g)之甲醇(1〇ml) 溶液中,在50°C下攪拌70小時。加入三氯甲烷及水, 過;慮、乾燥所析出之結晶而得出6-苯確醯基氨基甲醯基 -1-(聯苯-4-甲基)-2-疏基苯並咪唾(227)0.719g。 [化合物(227)的物性] iH-NM^DMSO-d6,6) : 5·55(2Η,s),7·28(1Η,d,J二8·4Ηζ),7·35(1Η,t,J二6 •3Hz), 7.39-7.47(4Η, m), 7·61-7·65(6Η, m), 7·69(1Η, t, J:7.4Hz), 7.78(1Η ,dd,J=8.4 及 1·4Ηζ),7·87(1Η,s),7·81-7·98(2Η,m),12.5K1H,s),13 ·29(1Η, s)〇 IR(KBr) : 1701cm 〗。 mp : 320.0 — 321.0°C。 &lt;實施例166;6-苯磺醯基氨基甲醯基-1-(聯苯-4-甲 基)-2-甲氧基笨並咪唑(228)之合成&gt; 將四甲氧基甲烷(0.250g)加入N-苯磺醯基-4-胺基-3_(聯苯_4_甲基胺基)苯並醯胺(〇.400g)之醋酸(3ml)溶液 中,在80°C下攪拌2小時。將甲醇加入反應液中,收集 --------------Lift----—. 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(18) 所析出的結晶。使用丙酮(lml)與甲醇(8ml)之混合溶媒以 洗淨結晶,經過濾、乾燥以得出6-苯磺醯基氨基甲醯基 -1-(聯笨-4-甲基)-2-曱氧基苯並咪唑(228)0.280g。 [化合物(228)的物性] lH-NMR(DMS0~d6, δ) : 4.17(3H3 s), 5.33(2H, s), 7.30(2H, d, J=8.2Hz)5 7. 35(1H5 t5 J=7.4Hz), 7.44(2H5 t, J-7.5Hz)5 7.50(1H, d, J=8.4Hz), 7.60-7.6 5(6H3 m)3 7·68-7·72(2Η, m), 7·98-8·01(2Η, m)3 8·05(1Η3 d, J:1.5Hz), 8·18 UH,s)3 12·50(1Η,s)〇 IR(KBr) : 1690cm~!〇 即:136.0 —138.5°C。 &lt;實施例167;6-苯磺醯基氨基甲醯基-i-(聯苯-4-甲 基)_2_羧基苯並咪唑(229)之合成&gt; 將三乙胺(0.080g)與氯化甲基乙二醯(o.HSg)加入 N-苯磺醯基-4-胺基-3-(聯苯-4-曱基胺基)苯並醯胺 (0.400g)之N,N-二曱基甲醯胺(3ml)溶液中,在室溫下授 拌2小時。濃縮反應液,藉由矽膠柱色譜(溶離液:醋酸 乙酯/甲崞=9/1)之精製以得出6-苯磺醯基氨基甲醯基 (聯苯-4-甲基)-2-羧基苯並咪唑之粗精製物。將其溶解於 醋酸(lml)與甲醇(5ml)中,在6〇°C下攪拌ls小時。以氫 氧化鉀水溶液中和,藉由過濾、乾燥所析出的結晶而得 出6-苯磺醯基氨基曱醯基-i-(聯苯_4_甲基)-2-羧基笨並 咪唑(229)0.245g。 [化合物(229)的物性] ^-NMRiDMSO-de, δ) : 5.44(2H3 s), 7.23(1H, d, J=8.4Hz)3 7.36(1H, t3 J-7 .6Hz), 7.4K2H, d3 J=8.1Hz), 7.45(2H, t, J=7.5Hz), 7.58(2H3 t, J=7.8Hz) (讀先閱讀背面之注意事項再填寫本頁) 訂Mass (FD): m / e 483 (M). That is: 268 · 7—273 · 9 ° C. &lt; Example 165; Synthesis of 6-benzenesulfonylcarbamoyl (biphenylmethyl) -2-mercaptobenzimidazole (227) &gt; Carbon disulfide (2ml) was added to N-benzylsulfonylcarbamyl In a solution of fluorenyl-4-amino-3- (biphenyl-4-fluorenylamino) benzofluorenamine (0.800 g) in methanol (10 ml), stir at 50 ° C for 70 minutes. hour. Add chloroform and water, and dry the precipitated crystals to obtain 6-benzylaminocarbamyl-1- (biphenyl-4-methyl) -2-sulfobenzimidazole. (227) 0.719 g. [Physical properties of compound (227)] iH-NM ^ DMSO-d6,6): 5.55 (2Η, s), 7.28 (1Η, d, J 2 8.4Ηζ), 7.35 (1Η, t , J 2 6 • 3 Hz), 7.39-7.47 (4Η, m), 7.61-7 · 65 (6Η, m), 7.69 (1Η, t, J: 7.4Hz), 7.78 (1Η, dd, J = 8.4 and 1.4 ζ), 7.87 (1 Η, s), 7.81-7 · 98 (2 Η, m), 12.5K1H, s), 13.29 (1 Η, s), IR (KBr) : 1701cm 〖. mp: 320.0 — 321.0 ° C. &lt; Example 166; Synthesis of 6-benzenesulfonylaminocarbamoyl-1- (biphenyl-4-methyl) -2-methoxybenzimidazole (228) &gt; Tetramethoxymethane (0.250 g) was added to a solution of N-benzenesulfonyl-4-amino-3 ((biphenyl-4-methylamino) benzopyramine (0.400 g) in acetic acid (3 ml) at 80 ° C Stir for 2 hours. Add methanol to the reaction solution and collect -------------- Lift ------. This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 5 Description of the invention (18) Crystals precipitated. A mixed solvent of acetone (1 ml) and methanol (8 ml) was used to wash and crystallize, and filtered and dried to obtain 6-benzenesulfonylcarbamoyl-1- (biben-4-methyl) -2- Benzoxybenzimidazole (228) 0.280 g. [Physical properties of compound (228)] lH-NMR (DMS0 ~ d6, δ): 4.17 (3H3 s), 5.33 (2H, s), 7.30 (2H, d, J = 8.2Hz) 5 7. 35 (1H5 t5 J = 7.4Hz), 7.44 (2H5 t, J-7.5Hz) 5 7.50 (1H, d, J = 8.4Hz), 7.60-7.6 5 (6H3 m) 3 7 · 68-7 · 72 (2Η, m) , 7 · 98-8 · 01 (2Η, m) 3 8 · 05 (1Η3 d, J: 1.5Hz), 8.18 UH, s) 3 12 · 50 (1Η, s), IR (KBr): 1690cm ~! 〇 That is: 136.0-138.5 ° C. &lt; Example 167; Synthesis of 6-benzenesulfonylaminocarbamoyl-i- (biphenyl-4-methyl) _2-carboxybenzimidazole (229) &gt; Triethylamine (0.080g) and Methylethanedichloride (o.HSg) added N, N-benzenesulfonyl-4-amino-3- (biphenyl-4-fluorenylamino) benzofluorenamine (0.400g) -In a solution of dimethylformamide (3 ml), stir for 2 hours at room temperature. The reaction solution was concentrated and purified by silica gel column chromatography (eluent: ethyl acetate / formamidine = 9/1) to give 6-benzenesulfonylcarbamoyl (biphenyl-4-methyl) -2 -Crude refined product of carboxybenzimidazole. This was dissolved in acetic acid (1 ml) and methanol (5 ml), and stirred at 60 ° C for 1 hour. It was neutralized with an aqueous potassium hydroxide solution, and the precipitated crystals were filtered and dried to obtain 6-benzenesulfonylaminofluorenyl-i- (biphenyl_4-methyl) -2-carboxybenzimidazole ( 229) 0.245 g. [Physical properties of compound (229)] ^ -NMRiDMSO-de, δ): 5.44 (2H3 s), 7.23 (1H, d, J = 8.4Hz) 3 7.36 (1H, t3 J-7 .6Hz), 7.4K2H, d3 J = 8.1Hz), 7.45 (2H, t, J = 7.5Hz), 7.58 (2H3 t, J = 7.8Hz) (Read the precautions on the back before filling this page) Order

548272 A7 B7 五、發明説明(188) 7·6〇-7·71(7Η, m)3 7·94(2Η, d, J:8.3Hz), 12·38(1Η, s)3 12.52(1H, s)。 IR(KBr) : 1670cm-1。 mp : 247·5—250.0oC〇 &lt;實施例168;6-苯磺醯基氨基甲醯基(聯苯_4_甲 基)-2-甲基胺基笨並味σ坐(230)之合成&gt; 在室溫下攪拌Ν-苯磺醯基氨基曱醯基_4_胺基_3_ (¼本-4-曱基胺基)笨並酸胺(〇 3〇〇g)、甲基異硫氰酸鹽 (0.200g)、曱醇(5ml)及丙酮(5ml)之混合物12小時。接著 加入97%硫酸(lml),在室溫下攪拌43小時。加入2〇% 碳酸氫鉀水溶液至反應液中以形成鹼性後,將其濃縮, 加入醋酸乙酯與水以萃取出殘渣。濃縮有機層,將其溶 解於三氯甲烷中,加入己烷以析出結晶,經過濾、乾燥 以得出6_苯石黃醯基氨基曱酿基_ι_(聯苯甲基)_2_甲基 胺基苯並咪唑(230)0.140g。 [化合物(230)的物性] H NMR(DMS0-d6, δ) : 2.98(3H, d, J=4.4Hz)3 5.34(2H, s)3 7.22(2H, d5 J=8 經淤部中λ«.^-Λ員5消費合竹私印繁 (誚先閱讀背面之注意事項再填寫本頁)548272 A7 B7 V. Description of the invention (188) 7.60-7.71 (7Η, m) 3 7.94 (2Η, d, J: 8.3Hz), 12 · 38 (1Η, s) 3 12.52 (1H , S). IR (KBr): 1670cm-1. mp: 247 · 5-250.0 ° C. &lt; Example 168; 6-benzenesulfonylaminocarbamoyl (biphenyl-4-methyl) -2-methylamino group benzoyl sigma (230) Synthesis &gt; Stir N-benzenesulfonylaminofluorenyl-4-amino_3_ (¼ben-4-methylamino) benzanoic acid amine (0.300g), methyl at room temperature A mixture of isothiocyanate (0.200 g), methanol (5 ml) and acetone (5 ml) for 12 hours. Then, 97% sulfuric acid (1 ml) was added, and the mixture was stirred at room temperature for 43 hours. After adding a 20% potassium hydrogen carbonate aqueous solution to the reaction solution to make it alkaline, it was concentrated, and ethyl acetate and water were added to extract the residue. Concentrate the organic layer, dissolve it in chloroform, add hexane to precipitate crystals, filter and dry to obtain 6_benzoxanthanylaminopyreno_ι_ (biphenylmethyl) _2_methylamine 0.140 g of benzimidazole (230). [Physical properties of compound (230)] H NMR (DMS0-d6, δ): 2.98 (3H, d, J = 4.4Hz) 3 5.34 (2H, s) 3 7.22 (2H, d5 J = 8 «. ^-Λmember 5 Consumption Hezhu Private Printing Fan (诮 Please read the precautions on the back before filling this page)

•2Hz), 7·26(1Η, d, J=8.4Hz), 7·34(1Η3 t, J=7.3Hz), 7·44(2Η, t, J:7.5Hz), 7·57(2Η, t, 4=7·6Ηζ)3 7·59-7·68(6Η, m), 7·76(1Η, s), 7·95(2Η, d, J:7.4H z), 12·28(1Η, s)〇 IR(KBr) : 1672cm—1。• 2 Hz), 7.26 (1Η, d, J = 8.4Hz), 7.34 (1Η3 t, J = 7.3Hz), 7.44 (2Η, t, J: 7.5Hz), 7.57 (2Η , T, 4 = 7 · 6Ηζ) 3 7 · 59-7 · 68 (6Η, m), 7.76 (1Η, s), 7.95 (2Η, d, J: 7.4H z), 12 · 28 (1Η, s) .IR (KBr): 1672cm-1.

Mass(FAB) : m/e 497(M+l)〇 mp : 225.0—228.0°C。 &lt;實施例169;2-胺基-6-笨磺醯基氨基曱醯基-i_(聯苯 . ___L22____ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 —__ B7 五、發明説明(18j ~— -4-甲基)苯並咪唑(231)之合成&gt; (請先閱讀背面之注意事項再填寫本頁) 將甲醇(10ml)、丙酮(l〇ml)、氰基溴(〇.395g)加入N-苯磺醯基氨基甲醯基-4-胺基-3-(聯苯-4-甲基胺基)苯並 醯胺(1.500g)中,在室溫下攪拌10〇小時,接著在5(rc 下攪拌3 0小時。加入三氯甲烷與水以進行萃取。對於 有機層進行水洗(6次)、濃縮,藉由矽膠柱色譜(溶離液: 醋酸乙酯/甲醇=9/1)之精製殘渣以得出2_胺基-6_苯石黃醯 基氣基甲醯基-1-(聯苯-4-甲基)苯並味σ坐(231)0.i35g。 [化合物(231)的物性]Mass (FAB): m / e 497 (M + 1). Mp: 225.0-228.0 ° C. &lt; Example 169; 2-Amino-6-benzylsulfonylaminofluorenyl-i_ (biphenyl. _L22____) This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 —__ B7 V. Description of the invention Synthesis of (18j ~ -4-methyl) benzimidazole (231) &gt; (Please read the notes on the back before filling this page) Methanol (10ml), acetone (10ml), Cyanobromide (.395g) was added to N-benzenesulfonylcarbamoyl-4-amino-3- (biphenyl-4-methylamino) benzofluorenamine (1.500g), and Stir at room temperature for 10 hours, then at 5 ° C for 30 hours. Add chloroform and water for extraction. The organic layer was washed with water (6 times), concentrated, and subjected to silica gel column chromatography (eluent: acetic acid). Ethyl acetate / methanol = 9/1) refined residue to give 2_amino-6_benzoxanthan fluorenylaminomethylmethyl-1- (biphenyl-4-methyl) benzo sigma (231) 0.i35g [Physical properties of compound (231)]

(5) ·· 5.32(2H,s),6·77(2Η3 s),7·05(1Η,d,#8·8Ηζ)5 7. 21(2H, d, J=8.3Hz), 7·31-7·38(4Η, m), 7·43(2Η, t, J:7.5Hz), 7.58-7.65(6H ,m), 7·79-7·82(2Η, m)。 IR(KBr) : 1684cm~l〇 Mass(FAB) : m/e 483(M+l)〇 mp : 352.5 —355,0°C〇 &lt;實施例170;6-苯磺醯基氨基曱醯基_丨_(聯苯甲 基)-2-正丙基苯並咪唑鉀鹽(232)之合成&gt; 將三乙胺(0.060g)與丁醯氣(〇.〇84g)加入N•苯磺醯基 -4-胺基-3-(聯苯-4-甲基胺基)苯並醯胺)(〇 3〇〇g)之N,N&lt; 曱基甲醯胺)(2ml)溶液中,在室溫下攪拌15小時。直接 使用矽膠柱色譜以精製反應液,而得出队苯磺醯基_3_(聯 苯_4_曱基胺基)-4-丁醯胺苯並醯胺(0e25〇g)。加入甲醇(5ml) 與35%鹽酸(0.50g),在60它下攪拌3小時。加入2〇%碳 酸氫鉀以停止反應,加入醋酸乙酯及水以進行萃取。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) v548272 A7 五、發明説明(193 ' 濃縮有機層,將生成物溶解於少量的三氯甲烷中,加入 乙醚以使其結θθ化。藉由過濾、乾燥結晶以得出6-苯磺 (詞先閱讀背面之注意事項再填寫本頁) 醯基氨基曱醯基-1-(聯笨甲基)_2_正丙基笨並咪唑鉀 鹽(232)(0.157g)。 [化合物(232)的物性] 1 臟(DMS0-d6,(5) : G.95(3H,t,扣7.他),1·77(2Η,q3 村·5Ηζ),2.82( 2H,t,J=7.5Hzh 5·55(2Η,s),7·11(2Η3 d3 J:8.2Hz),7·32-7.38(4H,m),7· 43(2H, t, J:7.5Hz)3 7·47(1Η, d, J=8.4Hz), 7·58-7·64(4Η, m), 7·79-7·83(3Η ,7·96(1Η, s)〇 IR(Nujol) ·· 1592CHT1。(5) ·· 5.32 (2H, s), 6.77 (2Η3 s), 7.05 (1Η, d, # 8 · 8Ηζ) 5 7. 21 (2H, d, J = 8.3Hz), 7 · 31-7 · 38 (4Η, m), 7.43 (2Η, t, J: 7.5Hz), 7.58-7.65 (6H, m), 7.79-7 · 82 (2Η, m). IR (KBr): 1684cm ~ 10 Mass (FAB): m / e 483 (M + 1) 0mp: 352.5-355, 0 ° C 0 &lt; Example 170; 6-benzenesulfonylaminofluorenyl _ 丨 _ (Synthesis of 2-benzyl) -2-n-propylbenzimidazole potassium salt (232) &gt; Triethylamine (0.060g) and butane gas (0.084g) were added to N • benzenesulfonate In a solution of fluorenyl-4-amino-3- (biphenyl-4-methylamino) benzofluorenamine) (0,300 g) in N, N &lt; fluorenylformamidine) (2ml), Stir at room temperature for 15 hours. The reaction solution was directly purified using a silica gel column chromatography to obtain threonylsulfonium_3_ (biphenyl_4-fluorenylamino) -4-butanamide benzopyreneamine (0e25 g). Methanol (5 ml) and 35% hydrochloric acid (0.50 g) were added and stirred at 60 for 3 hours. 20% potassium hydrogen carbonate was added to stop the reaction, and ethyl acetate and water were added for extraction. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) v548272 A7 V. Description of the invention (193 'Concentrated organic layer, dissolve the product in a small amount of chloroform, add ether to make it θθ. . Filter and dry the crystals to get 6-benzenesulfonate (read the precautions on the back of the word before filling out this page) fluorenylaminofluorenyl-1- (bibenzylmethyl) _2_n-propylbenzimidazole Potassium salt (232) (0.157g). [Physical properties of compound (232)] Dirty (DMS0-d6, (5): G.95 (3H, t, deduction of 7. other), 1.77 (2Η, q3 Mura · 5Ηζ), 2.82 (2H, t, J = 7.5Hzh 5.55 (2Η, s), 7.11 (2Η3 d3 J: 8.2Hz), 7.32-7.38 (4H, m), 7.43 (2H, t, J: 7.5Hz) 3 7 · 47 (1Η, d, J = 8.4Hz), 7.58-7 · 64 (4Η, m), 7 · 79-7 · 83 (3Η, 7 · 96 (1Η, s). IR (Nujol) · 1592CHT1.

Mass(FAB) ·· m/e 548(M+1)。 mp : 279.0-282.0°C。 &lt;實施例171;6_苯磺醯基氨基甲醯基_丨_(聯苯_4_甲 基)-2-正庚基笨並咪唑(233)之合成&gt; 依據實施例170之方法,使用义苯磺醯基_4-胺基 -3-(聯苯-4-曱基胺基)苯並醯胺(〇.4〇〇g)、三乙胺 (0.080g)'辛醯氣(〇.17〇g)以得出6-苯磺醯基氨基甲醯基 -1-(聯苯-4-甲基)-2-正庚基苯並咪唑(233)0.232吕。 經浐部中夾i?.·^-^找τ,消贽合竹扣印家 [化合物〔233)的物性] lH-NMR(DMS0-d63 δ) : 0.79(3H, t, J=7.3Hz), L12-1.24(6H, m), 1.24-1.31( 2H, m), 1.66-1.73(2H, m)3 2-84(2H5 t3 J-7.6Hz)3 5.58(2H5 s)5 7.14(2H, d, J=8.1Hz), 7.34(2H, t, J二7.6Hz), 7·43(2Η, t, J二7·4Ηζ), 7·52-7·66(7Η, m), 7·75(1Η, d, J二8·8Ηζ), 7·95(2Η, d, J二7·6Ηζ), 8·15(1Η, s), 12·45(1Η, s)。 IR(KBr) : 1688cm-1〇 ^ mp ·· 112.0- 117.5°C〇 _ ——_ 1 Qd____ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(19ί &lt;實施例172;6-苯磺醯基氨基曱醯基-1-(聯苯-4-甲 基)-2-氣甲基苯並咪唑(234)之合成&gt; (請先閱讀背面之注意事項再填寫本頁) 依據實施例170之方法,使用N-苯磺醯基-4-胺基 -3-(聯苯-4-甲基胺基)苯並醯胺(0.300g)、三乙胺 (0.060g)、氣代乙醯氯(〇.102g)以得出6-苯磺醯基氨基甲 醯基-1-(聯苯-4-曱基)-2-氯曱基苯並咪唑(234)0.193g。 [化合物(234)的物性] ^-NMRiDMSO-dG, δ) : 5.10(2H3 s)3 5.71(2H3 s), 7·23(2Η, d3 J=8.3Hz)5 7. 35(1H, t, J=7.3Hz), 7.44(2H, t, J:7.5Hz), 7.60-7.66(6H, m), 7·69(1Η, t, J二7·5Ηζ),7·75-7.81(2Η,in)5 7.98-8·01(2Η3 m),8,16(1H,s),12.52UH,s) 〇 IR(KBr) ·· 1700cm—、 mp : 220.5-223.5oC〇 &lt;實施例173;6-苯磺醯基氨基甲醯基-1-(聯苯-4-曱 基)-2 -乙氧基甲基苯並味哇(235)之合成&gt; 依據實施例170之方法,使用N-苯磺醯基-4-胺基-3-(聯苯-4-曱基胺基)苯並醯胺(〇.400g)、三乙胺(0.115g)、 甲基乙醯氯(0.131g)以得出6-苯磺醯基氨基甲醯基-1-(聯 苯-4-曱基)-2-乙氧基甲基苯並咪唑(235)0.183g。 [化合物(235)的物性] lH-NMR(DMS0-d6, ό') : 3.31(3H5 s)5 4.72(2H3 s), 5.63(2H, s), 7.23(2H, d3 J二8.3Hz), 7·35(1Η, t, J:7.4Hz), 7·44(2Η, t5 J:7.5Hz), 7.60-7.65(6H, m), 7.70(1H3 t, J-7.5Hz), 7.72-7.79(2H, m), 7.98-8.0K2H, ffl), 8.18(1H5 s), 12.50(1H, s)〇 ______IQ岑 —____ 本紙張尺度適Λ中國國家標準(CNS ) A4規格(21〇X297公釐) 548272 A7 B7 ir 五、發明説明( IR(KBr) : ΙβθΟοιη ^ mp : 195.0-198.0°C〇 &lt;貫施例174;6-苯磺醯基氨基甲醯基_丨_(聯苯_4-甲 基)-2-異丙基苯並咪唑鉀鹽(236)之合成&gt; 依據實施例m之方法,使用N_笨石黃醯基冰胺基 _3-(聯苯-4-甲基胺基)苯並醯胺(〇 4〇〇幻、三乙胺 (〇._g)、異丁醯氯((U i2g)作為原料以進行反應—。將粗 精製物溶解於曱醇與20%碳酸氫鉀水溶液之混合溶媒 中’使用10%鹽酸調整至pH7。所析出之結晶即苯 磺醯基氨基甲醯基-1-(聯苯-4-甲基)_2-異丙基苯並咪唑 鉀鹽(236)0.167g。 [化合物(236)的物性] 1醜〇)_-d6, w : L26(6H,d,㈣·8Ηζ),3·25_3·鐵ih,虼 5·58(2η,s ),7·09(2Η, d, J=8.3Hz), 7·32-7·37(4Η3 m), 7.43(2H3 t3 J=7.5Hz), 7·48(1Η ,d, J:8.4Hz), 7·58-7·64(4Η, m)5 7·79-7·83(3Η, m)3 7·95(1Η, s)。 IR(Nujol) : 1592cmΛ Mass(FAB) : m/e 548(M+1)。 即:310.1 — 312.7〇C〇 &lt;貫施例175;6-苯磺醯基氨基曱醯基_丨_(聯苯_4_曱 基)-2-曱硫基苯並咪唑(237)之合成&gt; 將20%氫氧化鉀水溶液(〇 323g)、水(2ml)加入卜苯 續醯基氨基甲醯基-1-(聯苯甲基酼基苯並咪唑 (0.310g)之甲醇(5ml)溶液中,接著加入曱基溴(0123g), 在室溫下攪拌2小時。以1〇%鹽酸調整成ph5〜6,過濾、 本紙張尺度適财關家標準(CNS ) A4規格(2lGx29m ) (請先閱讀背面之注意事項再填寫本頁) &quot;口 1«.Mass (FAB) · m / e 548 (M + 1). mp: 279.0-282.0 ° C. &lt; Example 171; Synthesis of 6-benzenesulfonylaminocarbamyl group 丨 丨 (biphenyl_4-methyl) -2-n-heptylbenzimidazole (233) &gt; Method according to Example 170 Benzenesulfonyl-4-amino-3- (biphenyl-4-fluorenylamino) benzofluorenamine (0.400 g) and triethylamine (0.080 g) were used. (0. 17 g) to give 6-benzenesulfonylcarbamoyl-1- (biphenyl-4-methyl) -2-n-heptylbenzimidazole (233) 0.232 lum. I?. · ^-^ In the crotch part to find τ, eliminate the compound of the bamboo buckle [physical properties of compound [233]] lH-NMR (DMS0-d63 δ): 0.79 (3H, t, J = 7.3Hz ), L12-1.24 (6H, m), 1.24-1.31 (2H, m), 1.66-1.73 (2H, m) 3 2-84 (2H5 t3 J-7.6Hz) 3 5.58 (2H5 s) 5 7.14 (2H , d, J = 8.1Hz), 7.34 (2H, t, J = 7.6Hz), 7.43 (2Η, t, J = 7 · 4Ηζ), 7.52-7 · 66 (7Η, m), 7 75 (1Η, d, J 2 8.8Ηζ), 7.95 (2Η, d, J 2 7.6Ηζ), 8.15 (1Η, s), 12 · 45 (1Η, s). IR (KBr): 1688cm-1〇 ^ mp ·· 112.0- 117.5 ° C〇 —— _ 1 Qd____ This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention ( 19ί &lt; Example 172; Synthesis of 6-benzenesulfonylaminoaminofluorenyl-1- (biphenyl-4-methyl) -2-aminomethylbenzimidazole (234) &gt; (Please read the back first (Notes on this page, please fill in this page) According to the method of Example 170, N-benzenesulfonyl-4-amino-3- (biphenyl-4-methylamino) benzofluorenamine (0.300 g), Triethylamine (0.060g) and acetylacetonyl chloride (0.102g) to give 6-benzenesulfonylaminocarbamoyl-1- (biphenyl-4-fluorenyl) -2-chlorofluorenylbenzene 0.193 g of benzimidazole (234). [Physical properties of compound (234)] ^ -NMRiDMSO-dG, δ): 5.10 (2H3 s) 3 5.71 (2H3 s), 7.23 (2Η, d3 J = 8.3Hz) 5 7. 35 (1H, t, J = 7.3Hz), 7.44 (2H, t, J: 7.5Hz), 7.60-7.66 (6H, m), 7.69 (1Η, t, J 2 7.5Ηζ), 7.75-7.81 (2Η, in) 5 7.98-8 · 01 (2Η3 m), 8,16 (1H, s), 12.52UH, s) 〇IR (KBr) ·· 1700cm—, mp: 220.5-223.5 oC &lt; Example 173; 6-benzenesulfonylcarbamoamidin-1- ( Synthesis of Phenyl-4-fluorenyl) -2-ethoxymethylbenzobenzo (235) &gt; According to the method of Example 170, N-benzenesulfonyl-4-amino-3- (diphenyl Phenyl-4-fluorenylamino) benzofluorenamine (0.400 g), triethylamine (0.115 g), methyl ethyl fluorenyl chloride (0.131 g) to give 6-benzenesulfonylaminocarbamyl- 0.183 g of 1- (biphenyl-4-fluorenyl) -2-ethoxymethylbenzimidazole (235). [Physical properties of compound (235)] lH-NMR (DMS0-d6, ό '): 3.31 (3H5 s) 5 4.72 (2H3 s), 5.63 (2H, s), 7.23 (2H, d3 J = 8.3Hz), 7.35 (1Η, t, J: 7.4Hz), 7.44 (2Η, t5 J: 7.5Hz), 7.60-7.65 (6H, m), 7.70 (1H3 t, J-7.5Hz), 7.72-7.79 (2H, m), 7.98-8.0K2H, ffl), 8.18 (1H5 s), 12.50 (1H, s) 〇 ______ IQ 岑 —____ This paper is suitable for China National Standard (CNS) A4 specification (21〇X297) 5%) 548272 A7 B7 ir V. Description of the invention (IR (KBr): ΙβθΟοιη ^ mp: 195.0-198.0 ° C 〇 &lt; Example 174; 6-benzenesulfonylaminocarbamoyl group_ 丨 _ (biphenyl_ Synthesis of 4-methyl) -2-isopropylbenzimidazole potassium salt (236) &gt; According to the method of Example m, N_benzite lutetyl cetylamido_3- (biphenyl-4-methyl Amine) Benzofluorenamine (04000), triethylamine (0. _g), isobutylammonium chloride ((U i2g) as raw materials for the reaction-dissolve the crude product in methanol and 20% In a mixed solvent of aqueous potassium hydrogen carbonate solution, the pH was adjusted to 7 with 10% hydrochloric acid. The crystals precipitated were benzenesulfonylcarbamoyl-1- (biphenyl-4-methyl) _2-isopropylbenzimidazole. Potassium salt (236) 0.167 g. [Physical properties of compound (236)] U-d6, w: L26 (6H, d, ㈣ · 8Ηζ), 3.25_3 · iron ih, 虼 5.58 (2η, s ), 7.09 (2Η, d, J = 8.3Hz), 7.32-7 · 37 (4Η3 m), 7.43 (2H3 t3 J = 7.5Hz), 7.48 (1Η, d, J: 8.4Hz ), 7.58-7 · 64 (4Η, m) 5 7 · 79-7 · 83 (3Η, m) 3 7.95 (1Η, s) IR (Nujol): 1592cmΛ Mass (FAB): m / e 548 (M + 1). That is: 310.1-312.7 ° C &lt; Example 175; 6-benzenesulfonylaminoaminofluorenyl_ 丨 _ (biphenyl_4_fluorenyl) -2-fluorenylsulfide Of Benzylbenzimidazole (237) &gt; 20% potassium hydroxide aqueous solution (0323g) and water (2ml) were added to benzodiamidinocarbamoyl-1- (biphenylmethylfluorenylbenzimidazole) (0.310 g) of a methanol (5 ml) solution, followed by addition of fluorenyl bromide (0123 g), and stirred at room temperature for 2 hours. It is adjusted to ph5 ~ 6 with 10% hydrochloric acid, filtered, and the paper size is suitable for family care standards (CNS) A4 (2lGx29m) (Please read the precautions on the back before filling this page) &quot; 口 1 «.

I 548272 A7 B7 Ψ 'A 部 中 it 導 消 f: 合 竹 印 五、發明説明(19$ - 乾燥所析出之結晶而得出6_苯磺醯基氨基曱醯基_丨_(聯 本甲基)-2-甲硫基笨並咪唾(237)0.28lg。 [化合物(237)的物性] 'h-__6, w : 2.75(3H,s),5._,s),7·25(2Η,d,战施),7. 35(1H, t, J-7.4Hz), 7.44(2H, t, J=7.5Hz), 7.60-7.66(7H, m), 7.68-7.75(2H ,m), 7.82-7.99(2H, E), 8.19(1H, d, J=i6Hz), i243(ih, s)。 IR(KBr) ·· 1685cm—1。 fflP : 218.8-22(K40C。 &lt;實施例176;6-苯磺醯基氨基甲醯基_;μ(聯苯甲 基)-2-乙硫基苯並咪唑(238)之合成&gt; 依據實施例175之方法,使用6-苯磺醯基氨基甲醯 基-1-(聯苯-4-甲基)-2-疏基苯並咪唾(〇.240g)與乙基溴 (0.117g)以得出6-苯磺醯基氨基甲醯基(聯笨曱 基)-2-乙硫基苯並咪唑(238)0.225g。 [化合物(238)的物性] H-NMR(DMS0-d6, 6) : 1·39(3Η, t, J:7.3Hz), 3·37(2Η, q, J:7.3Hz), 5·47(ί H, s)3 7·24(2Η, d, J=8.1Hz)3 7·35(1Η, t, J:7.1Hz), 7·44(2Η, t, J:7.6Hz)3 7·57-7.68(8Η, m), 7.75(1H3 d, J:8.4Hz), 7·98(2Η3 d3 J:7.5Hz), 8·15(1Η, s), 12e43(lH,_s)。 IR(KBr) : 1686cm—、 mp : 125.5-12S.50C〇 &lt;實施例177;6-笨磺醯基氨基曱醯基4-(聯苯曱 基)-2-正丙硫基苯並咪唑(239)之合成&gt; 依據實施例175之方法,使用6-笨磺醯基氨基曱醯 (舜先閱讀背面之注意事項再填寫本頁) 訂 I Q7 本紙張尺度遙州中國國家標準(CNS ) A4規格(210X 297公釐) 輕术部中-Ai?卑^BJT消贽合竹W印^ 548272 A7 B7I 548272 A7 B7 Ψ 'it in the A part f: He Zhu Yin 5. Description of the invention (19 $-6_benzenesulfonylaminoamino group obtained by drying the precipitated crystal_ 丨 _ (Lianbenjia Group) -2-methylthiobenzimidazole (237) 0.28 lg. [Physical properties of compound (237)] 'h -__ 6, w: 2.75 (3H, s), 5 ._, s), 7.25 (2Η, d, warfare), 7.35 (1H, t, J-7.4Hz), 7.44 (2H, t, J = 7.5Hz), 7.60-7.66 (7H, m), 7.68-7.75 (2H, m), 7.82-7.99 (2H, E), 8.19 (1H, d, J = i6Hz), i243 (ih, s). IR (KBr) · 1685cm-1. fflP: 218.8-22 (K40C. &lt; Example 176; 6-benzenesulfonylaminocarbamyl group ;; μ (biphenylmethyl) -2-ethylthiobenzimidazole (238) synthesis &gt; basis The method of Example 175 was performed using 6-benzenesulfonylcarbamoyl-1- (biphenyl-4-methyl) -2-sulfobenzimidazole (0.240 g) and ethyl bromide (0.117 g ) To obtain 0.225 g of 6-benzenesulfonylcarbamoyl (bibenzylidene) -2-ethylthiobenzimidazole (238). [Physical properties of compound (238)] H-NMR (DMS0-d6 , 6): 1.39 (3Η, t, J: 7.3Hz), 3.37 (2Η, q, J: 7.3Hz), 5.47 (ίH, s) 3 7 · 24 (2Η, d, J = 8.1Hz) 3 7 · 35 (1Η, t, J: 7.1Hz), 7.44 (2Η, t, J: 7.6Hz) 3 7 · 57-7.68 (8 (, m), 7.75 (1H3 d, J: 8.4Hz), 7.98 (2Η3 d3 J: 7.5Hz), 8.15 (1Η, s), 12e43 (lH, _s). IR (KBr): 1686cm—, mp: 125.5-12S.50C. &lt; Example 177; Synthesis of 6-benzylsulfonylaminofluorenyl 4- (biphenylfluorenyl) -2-n-propylthiobenzimidazole (239) &gt; According to the method of example 175, 6 was used -Bensulfonylaminoamino (Shun first read the notes on the back before filling out this page) Order I Q7 State Chinese National Standard (CNS) A4 specification (210X 297 mm) in the Ministry of Light Technology-Ai? Bei ^ BJT eliminates the combination of bamboo and W ^ 548272 A7 B7

五、發明説明(194 S 基-1-(聯苯-4-曱基)-2-疏基笨並咪唑(〇.220g)與正兩基漠 (0.117g)以得出6-苯石黃醯基氨基甲醯基_1_(聯笨_4•甲 基)-2-正丙硫基笨並味唾(239)0.156g。 [化合物(239)的物性] H-NMR(DMS0-d6,6) : 〇.97(3H,t3 J:7.4Hz),1.76(2H, q5 J:7.2Hz),3 29 3 .36(2H3 ni)3 5.48(2H, s)5 7.24(2H, d3 J-8.3Hz), 7.35(1H3 t3 J^7,3Hz) ? 4(2H,t,&gt;7·4Ηζ),7·58-7·71(8Η,m)3 7,74(1H3 dd3 J=8.5 及 1?Hz) 9(2H, d, J-7.7HZ), 8.17(1H, s), 12.43(1H3 s)〇 . z ’ 7·9 IR(KBr) : 1690cm-1〇 mp : 106.0—111.5°C。 &lt;實施例178;6-苯磺醯基氨基甲醯基(聯笨甲 基)-2-正己硫基苯並咪唾(240)之合成&gt; 依據貫施例175之方法,使用6-苯石黃醯基氨基甲酿 基-1-(聯苯-4-甲基)-2-魏基苯並u米唾(〇.250g)與正己基填 (0.166g)以得出6-苯磺醯基氨基曱醯基-1兴聯笨甲 基)-2-正己硫基苯並味唾(240)0.212@。 [化合物(240)的物性] IMlUDMSiHlG,(5) : 0·82(3Η3 t,J=7.9Hz),1.19-1.33(吼 m)5 1.33-1 44( 2H,ιη),1·68_1·75(2Η,m),3.3G-3.43(2H,ιη),5·48(2Η,s),7·23(2Η,d3 J=8 • 2Hz),7·35(1Η,t,J:7.1Hz),7.44UH,t,J:7.6Hz),7.60-7·75(9Η,m)3 8 〇 0(2H, d, J=7.7hz), 8.19(1H, s), 12.44(1H3 s)〇 IR(KBr) : 1688CDT1。 mp : 139.5 —141.0°C(分解)。 &lt;實施例179;6-苯磺醯基氨基甲醯基-1-(聯笨甲基) (誚先閱讀背面之注意事項再填寫本頁) 、11 本纸張尺度適用I7國國家標準(CNS ) A4規格(210X297公羡) ' 一 548272 A7 B7 五、發明説明( 苯並味吐(241)之合成&gt; (誚先閲讀背面之注意事項再填寫本頁) 在90°C下攪拌N-苯磺醯基-4-胺基-3-(聯笨-4-曱基 胺基)苯並醯胺(0.400g)與蟻酸(2ml)之混合物3小時。濃 縮反應液,加入曱醇以析出結晶,藉由過濾、乾燥以得 出6-苯磺醯基氨基甲醯基- i-(聯苯_4_甲基)笨並咪唑 (241)0.243g 〇 [化合物(241)的物性] 4-腿(DMSO-d6,(5) : 5·60(2Η,s),7·35(1Η,t3 J=7.2Hz),7·39(2Η,d,J:8 •2Hz), 7·44(2Η, t, J:7.6Hz)3 7·61-7·77(9Η, m), 8·00(2Η, d, J=7.7HZ), 8·2 6(1H, s), 8·66(1Η, s), 12.5(1H3 s)。 IR(KBr) : 1683cm'!〇 mp : 141.5 — 143.60C〇 〈實施例l8〇;l-(4-苄氧基苄基)_2_曱基-6-[(2-吡啶 甲基)氨基甲醯基]苯並味嗤(2 42)之合成&gt; 將醋酸(4ml)與乙醇(8ml)加入Ν-(2-α比咬甲基)-4-乙 醯胺基_3-(4-节氧基节基胺基)苯並醯胺(〇.434g)中,在90 °C攪拌7小時。減壓濃縮以得出殘渣,將醋酸乙酯及乙 醚加入其中使其結晶化。藉由過濾、乾燥結晶以得出 1_(4_苄氧基苄基)_2_甲基-6_[(2_吡啶甲基)氨基甲醯基] 苯並咪唑(242)0.375g。 [化合物(242)的物性] *H-NMR(CDCl3, c5) : 2.59(3H, s), 4.78(2H, dj J=4.8Hz)) 5.〇1(2H3 s), 5.31 (2H,s),6.89(2H,d,㈣.服),6.99(2H,d,㈣·),7 2i(ih,此,付.iV. Description of the invention (194 S-I-1- (biphenyl-4-fluorenyl) -2-sulfenylbenzimidazole (0.220 g) and n-phenyl molybdenum (0.117 g) to obtain 6-benzite stilbene 0.156 g of carbamate_1_ (biben_4 • methyl) -2-n-propylthiobenzyl (239). [Physical properties of compound (239)] H-NMR (DMS0-d6, 6) : 〇.97 (3H, t3 J: 7.4Hz), 1.76 (2H, q5 J: 7.2Hz), 3 29 3 .36 (2H3 ni) 3 5.48 (2H, s) 5 7.24 (2H, d3 J-8.3 Hz), 7.35 (1H3 t3 J ^ 7,3Hz)? 4 (2H, t, &gt; 7 · 4Ηζ), 7.58-7 · 71 (8Η, m) 3 7,74 (1H3 dd3 J = 8.5 and 1? Hz) 9 (2H, d, J-7.7HZ), 8.17 (1H, s), 12.43 (1H3 s) .z '7.9 IR (KBr): 1690cm-1〇mp: 106.0-111.5 ° C. &lt; Example 178; Synthesis of 6-benzenesulfonylaminocarbamyl (bibenzylmethyl) -2-n-hexylthiobenzimidal (240) &gt; According to the method of Example 175, use 6-Benzyl luteol carbamoyl-1- (biphenyl-4-methyl) -2-weilyl benzosulfazone (0.25g) and n-hexyl (0.166g) were filled to give 6-benzene Sulfonylaminofluorenyl-1 Xinglianbenzylmethyl) -2-n-hexylthiobenzophenone (240) 0.212 @. [Physical properties of compound (240)] IMlUDMSiHlG, (5): 0 · 82 (3Η3 t, J = 7.9Hz), 1.19-1.33 (however m) 5 1.33-1 44 (2H, ιη), 1.68_1 · 75 (2Η, m), 3.3G-3.43 (2H, ιη), 5.48 (2Η, s), 7.23 (2Η, d3 J = 8 • 2Hz), 7.35 (1Η, t, J: 7.1 Hz), 7.44UH, t, J: 7.6Hz), 7.60-7 · 75 (9Η, m) 3 8 0 (2H, d, J = 7.7hz), 8.19 (1H, s), 12.44 (1H3 s ) IR (KBr): 1688CDT1. mp: 139.5 —141.0 ° C (decomposed). &lt; Example 179; 6-benzenesulfonylaminocarbamyl-1- (bibenzylmethyl) (诮 Please read the precautions on the back before filling out this page), 11 This paper size applies the national standard of I7 country ( CNS) A4 specification (210X297 public envy) '' 548272 A7 B7 V. Description of the invention (Synthesis of benzo-spit (241) &gt; (诮 Please read the precautions on the back before filling this page) Stir N at 90 ° C -Benzenesulfonyl-4-amino-3- (biben-4-ylamino) benzofluorenamine (0.400 g) and formic acid (2 ml) for 3 hours. The reaction solution was concentrated, and methanol was added to Crystals were precipitated, and filtered and dried to obtain 6-benzenesulfonylcarbamoyl-i- (biphenyl-4-methyl) benzimidazole (241) 0.243 g. [Physical properties of compound (241)] 4-leg (DMSO-d6, (5): 5.60 (2Η, s), 7.35 (1Η, t3 J = 7.2Hz), 7.39 (2Η, d, J: 8 • 2Hz), 7 · 44 (2Η, t, J: 7.6Hz) 3 7 · 61-7 · 77 (9Η, m), 8 · 00 (2Η, d, J = 7.7HZ), 8 · 2 6 (1H, s), 8.66 (1Η, s), 12.5 (1H3 s). IR (KBr): 1683cm '! 〇mp: 141.5-143.60C. <Example 18o; l- (4-benzyloxybenzyl) _2_ Fluorenyl-6-[(2-pyridylmethyl) carbamate Synthesis of Benzo] benzo miso (2 42) &gt; Add acetic acid (4 ml) and ethanol (8 ml) to N- (2-α specific methyl) -4-acetamidoamino_3- (4-section In oxybenzylamino) benzopyramine (0.434 g), it was stirred at 90 ° C for 7 hours. It was concentrated under reduced pressure to obtain a residue, and ethyl acetate and diethyl ether were added thereto to crystallize it. By filtration 1. Dry the crystals to give 1_ (4-benzyloxybenzyl) _2_methyl-6 _ [(2-pyridylmethyl) aminomethylamidino] 0.375 g of benzimidazole (242). [Compound (242) Physical properties] * H-NMR (CDCl3, c5): 2.59 (3H, s), 4.78 (2H, dj J = 4.8Hz)) 5.〇1 (2H3 s), 5.31 (2H, s), 6.89 (2H, d, ㈣. service), 6.99 (2H, d, ㈣ ·), 7 2i (ih, this, pay.i

及 7.4Hz), 7.29-7.42(6H, m), 7.62(1H, br t), 7.65-7.75(3H, m), 7.98(1HAnd 7.4Hz), 7.29-7.42 (6H, m), 7.62 (1H, br t), 7.65-7.75 (3H, m), 7.98 (1H

____1 QO 一本紙適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 _____________________ B7_ 五、發明説明(19g~ ~ ,s), 8·57(1Η, d, J :4·1Ηζ)。 IR(KBr) : 1640cm-1。 mp : 169.0—170.0oC〇 (讀先閱讀背面之注意事項再填寫本頁) &lt;實施例181;2_曱基-:^3,4·甲二氧基苄基)_6-[(2_吡 咬甲基)氨基曱醯基]苯並咪唑(243)之合成&gt; 將醋酸(2ml)與曱醇(5ml)加入N-(2-呲咬甲基)_4_乙 fe &amp;c基-3-(3,4-曱二氧基苄基胺基)笨並醯胺(〇49〇g) 中’在70 C攪拌8小時。減壓濃縮以得出殘渣,藉由石夕 膠柱色譜(溶離液:醋酸乙酯/甲醇=9/1)之精製,並藉由 醋酸乙酯以使其結晶化。藉由過濾、乾燥結晶以得出2_ 甲基-l-(3,4-甲二氧基苄基)_6_[(2_吡啶甲基)氨基甲醯基] 苯並咪唑(243)0.270§。 [化合物(243)的物性] H_NMR(CDCl3, &lt;5) : 2·59(3Η, s), 4·78(2Η, d, J:4.8Hz), 5·28(2Η, s), 5.93 (2H, s), 6·51(1Η, d, J=1.6Hz), 6·55(1Η, dd, J=1.4 及 7.9Hz), 6.72(2H, d, J二8·0Ηζ), 7·22(1Η, dd, J二6·7 及 5·0Ηζ), 7·34(1Η, d, J:7.7Hz), 7.62( 1H,br t),7.67_7·75(3Η,m),7·96(1Η,d,J:l.lHz),8.58UH,d,J二4·9Ηζ) ο IR(KBr) : 163了cnT1。 mp : 190·5 — 192·0ο0〇 &lt;實施例182;2-甲基-6-[(2-吡啶甲基)氨基甲醯基]_ 1-[4_(1,2,3_雀二唾-4-基)卞基]苯並嗦唾(244)之合成&gt; 依據實施例180之方法,使用N-[(2-吡啶甲基)-4-乙醯胺基-3-[4-(l,2,3-噻二唑-4-基)苄基胺基]笨並咪唑 ____im___ 本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 ____________________B7 ___一 五、發明説明(19) (0.50g)以得出2-甲基-6-[(2-吡啶曱基)氨基甲醯基]-l-[4-(I,2,3·噻二唑_4·基)苄基]苯並咪唑(244)〇 33g。 (讀先閱讀背面之注意事項存填寫本頁 [化合物(244)的物性] H NMR(CDCh3 δ) : 2.58(3H, s), 4.58(2H, d, J-5.9Hz), 5.62(2H, s)3 7.24 (1H,dd,J:7.3 及 5·0Ηζ),7.28-7.33(3H,ni),7·64(1Η,d,J:8.4Hz),7.73 (1H3 dt3 J:7.7 及 1·6Ηζ),7·81(1Η,吡扣8 4 及 h3Hz),81〇(1H,山 J-8.2Hz)3 8.13(1H, s)3 8.49(1H3 d3 J=4.2Hz)3 9.04(1H5 t, J=5.9Hz), 9.58( 1H, s)〇 IR(KBr) : 1642cm_1。 即:216,0—217.0oC〇 &lt;實施例183;6-苯磺醯基氨基曱醯基_i_(2,4-二氟苄 基)-2-甲基苯並咪唑(245)之合成&gt; 將N-本石頁基_4_乙酿胺基_3_(2,4_二氟节基胺基) 苯並醯胺(0.370g)溶解於1〇%鹽酸(3.3g)、甲醇(6ml)、水 (4ml)之混合溶媒中,接著加入35%鹽酸(0.5g)在60°C下 攪拌3小時。加入20%碳酸氫鉀水溶液而使反應液成為 鹼性後,使用10%鹽酸調整成PH5〜6。藉由過濾、乾燥 所析出的結晶以得出6-苯磺醯基氨基曱醯基-l-(2,4-二 氟苄基)-J2-曱基苯並味唾(245)0.1 82g。 [化合物(245)的物性] ^-NMIwDMSO-de, δ) : 2.53(3H3 s) 3 5.56(2H, s)3 6.95-7.0K1H, m)3 7.04(1 H,dt, J=8.7 及 1·4Ηζ),7.32(1H,dt,J=1(K7 及 2.1Hz),7·59-7·66(3Η3 m), 7·68-7·74(2Η, m)3 8·00(2Η, d, J:8.1Hz)3 8.13(1H, s), 12.43(1H, s)。 IR(KBr) : 1686cm—1。 mp : 234.5 — 235.5eC(分解奁伴*5)。 -------—-xw----- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 五、發明説明(19g &lt;貝鉍例184;6-苯磺醯基氨基甲醯基(聯苯_4_甲 基)-2-苯基苯並咪唑(246)之合成〉 將三乙胺(0.115g)與苯醯氯(0.200g)加入N-苯磺醯 基4-胺基-3-(聯笨-4-甲基胺基)苯並驢胺(〇.5〇〇g)之N,N_ -甲基曱酸胺(5ml)溶液中,在室溫下攪拌15小時後,加 入石反酸氫鉀水溶液以停止反應。在減壓下餾去溶媒,將 殘渣溶於水與甲醇之混合液中,以1〇%鹽酸調整成 pH5〜6。收集所析出之結晶,藉由乾燥以得出N_苯磺醯 基-4-苯醯胺基(聯苯甲基胺基)苯並醯胺之粗精製物 (〇.393g)。藉由實施例183之方法,以得出&amp;苯磺醯基氨 基甲基-1-(聯苯-4-甲基)-2-苯基苯並咪。坐(246)0.270g。 [化合物(246)的物性] 1 賺⑽S〇-d6, : 5.7Q(2H,s),7 〇7⑽,d,㈣·2Hz),7 32—7 37⑽,m )5 7.43(2H) t, J=5.7HZ), 7.53-7.58(2H, m), 7.58-7.65(^, ffl), 7.68-7.72(1 H’ m), 7.77(2H, dd, J=7.5 及 1.5Hz), 7·81-7,83(2Η, m), 7.98-8.02(2H, ^ ),8·22(1Η, s), 12,47(1H, s)。 IR(KBr) : 1690cm'!〇 mp : 138·5-139.5°C〇 &lt;實施例185;6-苯磺醯基氨基甲醯基_孓甲基el_(2_ 硝基苄基)苯並咪唑(247)之合成&gt; 依據實施例183之方法,使用冰苯磺醯基乙 醯胺基-3-(2-硝基苄基胺基)苯並醯胺(〇.79g)以得出6_ 苯磺醯基氨基甲醯基-2-曱基-1-(2-硝基苄基)苯並啼 口坐 U12. (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7___ 五、發明説明(id (247)0.237g。 [化合物(247)的物性] (請先閱讀背面之注意事項再填寫本頁) H-NMR(DMS0-d6, δ) : 2.48(3H, s)3 5.01(2H, s), 5.93(2H, s), 6.28-6.30(1 m), 7.55-7.62(4H, m), 7.64~7.74(3H, m), 7.97(2H, d, J=8.0i^), 8.10(1H ,s), 8.22-8·28(1Η, m)5 12.39(1H, s)。 IR(KBr) : 1686cm_,〇 mp : 269·5 —272-5(分解$:伴〇)。 &lt;實施例186;6-苯磺醯基氨基曱醯基-2-甲基-1-苄 基苯並咪唑(248)之合成&gt; 依據實施例183之方法,使用N-苯磺醯基-4-乙醯 胺基-3-卞基胺基笨並酿胺(〇.38g)以得出6-苯績酿基氣 基甲醯基-2·曱基-1-节基苯並味唾(248)0.222g。 [化合物(248)的物性] 'H-NMRiDMSO-dG, δ) : 2.54(3H5 s) 5 5.55(2H3 s)3 7.12(2H, d3 J=7.9Hz)5 7. 28(1H, t, J=7.3Hz), 7·34(2Η, t, J:7,0Hz), 7·61-7·66(3Η, m), 7·69-7.76(2Η ,m),8·00(2Η,d,J:7.9Hz),8·18(1Η,s),12.43UH,s)。 IR(KBr) : 1695cm ]〇 nip : 260.0-262.0°C(分解奁伴〇)。 &lt;實·施例187、188;6-笨磺醯基氨基曱醯基-2-甲基-1-(4-硝基卞基)苯並味°坐(249)及6 -苯績酿基氨基甲酿基 -2-曱基-1-(4-硝基卡基)苯並味唾卸鹽(250)之合成&gt; 依據實施例183之方法,使用N-苯磺醯基-4-乙 酿胺基- 3- (4-硝基卡基胺基)苯並酿胺(〇.5〇5g)以得出 6-苯磺醯基氨基曱醯基-2-甲基-1-(4-硝基苄基)苯並咪唑 ____24U___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(2〇d (249) 0.255g之結晶。又,藉由濃縮濾液以得出6_苯磺醯 基氨基甲醯基-2-甲基-1-(4-硝基苄基)笨並咪唑鉀鹽 (250) 0.136g 之結晶。 [化合物(249)的物性] ^-NMRiDMSO-dG, d) : 2.50(3H5 s)5 5.70(2H, s), 7.30(2H5 d, J,8.7Hz), 7 52(2H,t,J:7.6Hz),7·57(2Η3 d3 J二8·3Ηζ),7·76(1Η,吡 Jr:8 4 及工.他) ,7·92(2Η, d, J:7,3Hz), 8·05(1Η, s), 8·20(2Η, d, J:8.7Hz), 12·43(1Η, s) o IR(KBr) : 1686cm'l〇 mp : 164.5-167.0oC。 [化合物(250)的物性] lH-NMR(DMS0-d63 δ) : 2.51(3Η3 s)3 5,68(2Η3 s), 7.28(2Η, d3 J -8.5Hz), 7 •32-7.41(3H, m), 7·46(1Η, d, J=8.4Hz), 7·78-7·86(3Η, m), 7·91(1Η, s), 8· 20(2H, d, J=8,5Hz)。 IR(KBr) : 15940111-^ mp : 326.0 —328.0°C(分解奁伴《5)。 &lt;實施例189;6-笨磺醯基氨基曱醯基-丨兴仁苄氧基 苄基)_2_曱基苯並咪唑(251)之合成&gt; 好浐部中决榀^-^Μ.τ消贽合竹ii印來 (謂先閱讀背面之注意事項再填寫本頁) 在9〇°C下攪拌N-笨磺醯基-3-胺基-4-乙醯胺基苯並 醯胺鉀鹽(0.5〇Og)、4_苄氧苄基溴(〇.470g)、20%碳酸氫鉀 水溶液(0.925g)及N,N-二甲基甲醯胺(3ml)之混合物1小 時。濃縮反應液,藉由矽膠柱色譜(溶離液:醋酸乙酯/ 甲醇-9/1)之精製以得出N-笨石黃酿基-4-乙酿胺基-3-(4-卞 氧基苄基胺基)笨並醯胺之粗精製物。依據實施例183之 -----— _2Π4___________— 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 B7 五、發明説明(20j) 方法,經由環化而得出6_苯磺醯基氨基甲醯基_1_(4_苄 氧基苄基)_2_甲基苯並咪唑(251)〇.16(^。 [化合物(251)的物性] (讀先閱讀背面之注意事項再填寫本頁) fNMlUDMSQ-de,: 2·54(3Η,s),5.Q5(2H,s),5·44(軋 sh 7 q9(2h,d, J二8·7Ηζ),7·32(2Η,d,J:7.QHz)3 7·29-7·44(5Η,in),7·58-7·67(3Η,ffl),7·6 8-7·75(2Η, m), 7·79-8·02(2Η, m), 8.18(1H, s), 12·46(1Η, s)。 IR(KBr) : 1685cm—1。 ° - mp : 111.0-114.0oC。 &lt;實施例190;2-甲基-5-[(2-吡啶曱基)氨基甲醯基] 苯並咪唑(252)之合成&gt; 將5%鈀/碳(0.10g)加入N-(2-吡啶曱基)-4-乙醯胺基 -3-梢基苯並醯胺之粗精製物(1 ·〇〇§)與醋酸(8mi)及甲醇 (12ml)之混合物中,在水環境氣體、8(TC下攪拌7小時。 過濾出固體,藉由乾燥以得出2-甲基-5·[(2—比唆甲基) 氨基甲醯基]苯並咪唑(252)0.57g。 [化合物(252)的物性] 1 眶(CDC13,&lt;5) : 2·52(3Η,s),4.59(2H,d,J:5.9Hz),7.26UH,dd,J二7. 1 及 5.1Hz),7_33UH,d,J=7.8Hz),7·50(1Η,d,J=8.4Hz),7.72-7·78(2Η, m) 5 8.08( 1H, s), 8.5K1H, d, J=4.8Hz), 9.04(1H, t5 J=5.8Hz), 12.44(1H, s) 〇 IR(KBr) : 1641cm '〇 mp : 212.0 —215.0°C。 &lt;實施例191、192;1-苯磺醯基-2-甲基-6-[(2-吡啶甲 ________9 0S_ 本紙張尺度適用中國國家標準(CNS) A4規格(21〇x 297公釐) 548272 Α7 五、發明説明(2〇i 基)氨基曱醯基]苯並咪唑(253)及^苯磺醯基_2_甲基_5_ [(2-吡啶曱基)氨基甲醯基]苯並咪唑(254)之合成&gt; (讀先閲讀背面之注意事項再填寫本頁} 將二氣曱烷(10ml)與三乙胺(0760g)加入^甲基_5一 [(2-吡啶甲基)氨基甲醯基]苯並咪唑(1〇〇§)中,接著滴入 苯磺醯氯(0.994g)。攪拌3小時後,以水洗淨反應液(3 次)’接著以碳酸氫鈉水溶液洗淨。減壓濃縮有機層,藉 由矽膠柱色譜(溶離液:醋酸乙酯/曱醇=9/1)之精製以得 出1-苯磺醯基-2-甲基-6_[(2_吐啶甲基)氨基甲醯基]苯並 咪唑與1-苯磺醯基-2-甲基-5-[(2-外t啶曱基)氨基甲醯基] 苯並咪唑之混合物1.38〇g。接著藉由中壓矽膠柱色譜(溶 離液··醋酸乙酯/曱醇=^00/3)之精製此混合物以得出油 狀的1-笨磺醯基-2-甲基-6-[(2-α比啶甲基)氨基甲醯基]苯 並咪唑(253)0.55〇g、油狀的1-苯磺醯基-2-甲基-6-[(2-吡 α疋甲基)氨基曱酿基]苯並味峻(25 4)0.540g。將油狀物溶 在二氯甲烷(1.5ml)中,加入二乙醚以使其結晶化。 [化合物(253)的物性] lH-fmR(CDCh,6) ·· 2,84(3H,s),4.81UH,d,J:4.8Hz),7.24UH,dd,J:5. 1 及 7·3Ηζ),7·37(1Η,d,J:7.7Hz),7.53(2H,dd,J=7.9 及 7.5Hz),7.6 3-7.74(2H,m)”7.85(lH,dd,J=8.4&amp;1.2Hz),7.97(2H,dd,J:9.6^ 1 • 1Hz)5 8.58-8.6K2H, m)〇 IR(KBr) : 16360111^ nip : 163.4-164.30C〇 [化合物(254)的物性] ______206 本紙張尺度適用中國國家標準(CNS )以規格(2H)x297公釐) 548272 Δ7 A7 B7____1 QO A paper conforms to the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 _____________________ B7_ 5. Description of the invention (19g ~~, s), 8.57 (1Η, d, J: 4 · 1Ηζ). IR (KBr): 1640cm-1. mp: 169.0-170.0oC (read the precautions on the back before filling this page) &lt; Example 181; 2-Methenyl-: ^ 3,4 · methoxydioxybenzyl) _6-[(2_ Synthesis of pyridylmethyl) aminofluorenyl] benzimidazole (243) &gt; Add acetic acid (2ml) and methyl alcohol (5ml) to N- (2-pyridylmethyl) _4_ethylfe &amp; c group In 3- (3,4-fluorenedioxybenzylamino) benzamine (0,490 g), it was stirred at 70 C for 8 hours. The residue was concentrated under reduced pressure to obtain a residue. The residue was purified by column chromatography (eluent: ethyl acetate / methanol = 9/1) and crystallized by ethyl acetate. The crystals were filtered and dried to give 2-methyl-l- (3,4-methyldioxybenzyl) -6-[(2-pyridylmethyl) aminomethylamidino] benzimidazole (243) 0.270§. [Physical properties of compound (243)] H-NMR (CDCl3, &lt; 5): 2.59 (3Η, s), 4.78 (2Η, d, J: 4.8Hz), 5.28 (2Η, s), 5.93 (2H, s), 6.51 (1Η, d, J = 1.6Hz), 6.55 (1Η, dd, J = 1.4 and 7.9Hz), 6.72 (2H, d, J = 8 · 0Ηζ), 7 · 22 (1Η, dd, J = 6.7 and 5.0Ηζ), 7.34 (1Η, d, J: 7.7Hz), 7.62 (1H, br t), 7.67_7 · 75 (3Η, m), 7.96 (1Η, d, J: l.lHz), 8.58UH, d, J = 4.9Ηζ) IR (KBr): 163 and cnT1. mp: 190 · 5-192 · 0ο0〇 &lt; Example 182; 2-methyl-6-[(2-pyridylmethyl) aminomethyl}-1- [4_ (1,2,3_Janji Synthesis of sial-4-yl) fluorenyl] benzofluorene (244) &gt; According to the method of Example 180, N-[(2-pyridylmethyl) -4-acetamido-3- [4 -(l, 2,3-thiadiazol-4-yl) benzylamino] benzimidazole ____im___ This paper is suitable for Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 ____________________ B7 ___One five 2. Description of the invention (19) (0.50 g) to obtain 2-methyl-6-[(2-pyridinyl) carbamoyl] -1- [4- (I, 2,3 · thiadiazole_ 4-yl) benzyl] benzimidazole (244) 033 g. (Read the precautions on the back and fill in this page. [Physical properties of compound (244)] H NMR (CDCh3 δ): 2.58 (3H, s), 4.58 (2H, d, J-5.9Hz), 5.62 (2H, s) 3 7.24 (1H, dd, J: 7.3 and 5.0 Ηζ), 7.28-7.33 (3H, ni), 7.64 (1 Η, d, J: 8.4 Hz), 7.73 (1H3 dt3 J: 7.7 and 1 · 6Ηζ), 7.81 (1Η, pyridine 8 4 and h3Hz), 81〇 (1H, J-8.2Hz) 3 8.13 (1H, s) 3 8.49 (1H3 d3 J = 4.2Hz) 3 9.04 (1H5 t, J = 5.9Hz), 9.58 (1H, s). IR (KBr): 1642cm_1. That is: 216,0-217.0oC. &lt; Example 183; 6-benzenesulfonylaminoamidino_i_ ( Synthesis of 2,4-difluorobenzyl) -2-methylbenzimidazole (245) &gt; The N-benzylbenzyl_4_ethynamine_3_ (2,4_difluorobenzylamine) Benzylpyridine (0.370g) was dissolved in a mixed solvent of 10% hydrochloric acid (3.3g), methanol (6ml), and water (4ml), and then 35% hydrochloric acid (0.5g) was added and stirred at 60 ° C. 3 hours. After adding 20% potassium bicarbonate aqueous solution to make the reaction solution alkaline, the pH was adjusted to 5 to 6 using 10% hydrochloric acid. The precipitated crystals were filtered and dried to obtain 6-benzenesulfonylaminofluorene. -L- (2,4-difluorobenzyl) -J2-fluorenylbenzo 245) 0.1 82 g. [Physical properties of compound (245)] ^ -NMIwDMSO-de, δ): 2.53 (3H3 s) 3 5.56 (2H, s) 3 6.95-7.0K1H, m) 3 7.04 (1 H, dt, J = 8.7 and 1. · 4Ηζ), 7.32 (1H, dt, J = 1 (K7 and 2.1Hz), 7.59-7 · 66 (3Η3 m), 7.68-7 · 74 (2Η, m) 3 8 · 00 (2Η, d, J: 8.1Hz) 3 8.13 (1H, s), 12.43 (1H, s). IR (KBr): 1686cm-1. Mp: 234.5-235.5eC (decomposition of 奁 companion * 5) ---------- xw ----- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 V. Description of the invention (19g &lt; Bei Bi case 184; 6- Synthesis of benzenesulfonylaminocarbamyl (biphenyl_4-methyl) -2-phenylbenzimidazole (246)> Triethylamine (0.115g) and phenylphosphonium chloride (0.200g) are added to N- Benzenesulfonyl 4-amino-3- (biben-4-methylamino) benzodonamine (0.500 g) in a solution of N, N_-methylphosphonium amine (5 ml), After stirring at room temperature for 15 hours, an aqueous potassium hydrogen acid salt was added to stop the reaction. The solvent was distilled off under reduced pressure, and the residue was dissolved in a mixed solution of water and methanol, and adjusted to pH 5 to 6 with 10% hydrochloric acid. The precipitated crystals were collected and dried to obtain a crude product (0.393 g) of N-benzenesulfonamido-4-phenylamidoamino (biphenylmethylamino) benzamidoamine. By the method of Example 183, &amp; benzenesulfonylaminomethyl-1- (biphenyl-4-methyl) -2-phenylbenzimide was obtained. Sit (246) 0.270g. [Physical properties of compound (246)] 1 ⑽ S〇-d6,: 5.7Q (2H, s), 〇07⑽, d, ㈣ · 2Hz), 7 32-7 37⑽, m) 5 7.43 (2H) t, J = 5.7HZ), 7.53-7.58 (2H, m), 7.58-7.65 (^, ffl), 7.68-7.72 (1 H 'm), 7.77 (2H, dd, J = 7.5 and 1.5Hz), 7 · 81-7, 83 (2Η, m), 7.98-8.02 (2H, ^), 8.22 (1Η, s), 12,47 (1H, s). IR (KBr): 1690cm '! 〇mp: 138.5-139.5 ° C &lt; Example 185; 6-benzenesulfonylcarbamoylmethylsulfonium-methylmethyl el_ (2-nitrobenzyl) benzimidazole (247) Synthesis> According to the method of Example 183, benzenesulfenylacetamidinyl-3- (2-nitrobenzylamino) benzofluorenamine (0.79 g) was used to obtain 6- Phenylsulfonylaminocarbamyl-2-fluorenyl-1- (2-nitrobenzyl) benzophenone U12. (Read the precautions on the back before filling this page) This paper is applicable to China Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7___ 5. Description of the invention (id (247) 0.237g. [Physical properties of compound (247)] (Please read the precautions on the back before filling this page) H-NMR (DMS0-d6, δ): 2.48 (3H, s) 3 5.01 (2H, s), 5.93 (2H, s), 6.28-6.30 (1 m), 7.55-7.62 (4H, m), 7.64 ~ 7.74 ( 3H, m), 7.97 (2H, d, J = 8.0i ^), 8.10 (1H, s), 8.22-8 · 28 (1Η, m) 5 12.39 (1H, s). IR (KBr): 1686cm_, 〇mp: 269-5, 272-5 (decomposition $: companion). &Lt; Example 186; 6-benzenesulfonylaminoamidino-2-methyl-1-benzylbenzimidazole (248) Synthesis &gt; Method according to Example 183 N-benzenesulfonyl-4-ethylamido-3-fluorenylaminobenzylamine (0.38g) was used to obtain 6-benzylaminomethylamino-2, fluorenyl- 0.222 g of 1-benzyl benzo saliva (248). [Physical properties of compound (248)] 'H-NMRiDMSO-dG, δ): 2.54 (3H5 s) 5 5.55 (2H3 s) 3 7.12 (2H, d3 J = 7.9Hz) 5 7. 28 (1H, t, J = 7.3Hz), 7.34 (2Η, t, J: 7,0Hz), 7.61-7 · 66 (3Η, m), 7.69 -7.76 (2Η, m), 8.00 (2Η, d, J: 7.9Hz), 8.18 (1Η, s), 12.43UH, s). IR (KBr): 1695cm] nip: 260.0-262.0 ° C (decomposition of accompany 〇). &lt; Examples 187, 188; 6-benzylsulfonylaminofluorenyl-2-methyl-1- (4-nitrofluorenyl) benzo (°) (249) and 6-benzene Of carbamoyl-2-methyl-1- (4-nitrocarbyl) benzoxalate salt (250) &gt; According to the method of Example 183, N-benzenesulfonyl-4 -Ethylamine- 3- (4-nitrocarboxamino) benzophenamine (0.505g) to give 6-benzenesulfonylaminofluorenyl-2-methyl-1- (4-Nitrobenzyl) benzimidazole ____24U___ This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 548272 A7 B7 V. Description of the invention (20d (249) 0.255g crystal. Furthermore, 0.136 g of 6-benzenesulfonylcarbamoyl-2-methyl-1- (4-nitrobenzyl) benzimidazole potassium salt (250) was obtained by concentrating the filtrate. [Compound (Physical properties of (249)] ^ -NMRiDMSO-dG, d): 2.50 (3H5 s) 5 5.70 (2H, s), 7.30 (2H5 d, J, 8.7Hz), 7 52 (2H, t, J: 7.6Hz ), 7.57 (2Η3 d3 J 2 8.3Ηζ), 7.76 (1Η, pyr Jr: 8 4 and Gong. He), 7.92 (2Η, d, J: 7, 3Hz), 8.05 (1Η, s), 8 · 20 (2Η, d, J: 8.7Hz), 12 · 43 (1Η, s) o IR (KBr): 1686cm'10mp: 164.5-167.0oC. [Physical properties of compound (250)] 1H-NMR (DMS0-d63 δ): 2.51 (3Η3 s) 3 5,68 (2Η3 s), 7.28 (2Η, d3 J -8.5Hz), 7 • 32-7.41 (3H , M), 7.46 (1Η, d, J = 8.4Hz), 7.78-7 · 86 (3Η, m), 7.91 (1Η, s), 8.20 (2H, d, J = 8,5Hz). IR (KBr): 15940111- ^ mp: 326.0 -328.0 ° C (decomposed with "5"). &lt; Example 189; Synthesis of 6-benzylsulfenylaminofluorenyl group-Xingren benzyloxybenzyl) _2-fluorenylbenzimidazole (251) &gt; In the Ministry of Chemistry ^-^ Μ .τ 消 贽 合 竹 ii imprinted (that is, read the precautions on the back before filling this page) Stir N-benzylsulfonyl-3-amino-4-acetamidobenzopyrene at 90 ° C Amine potassium salt (0.50 g), 4-benzyloxybenzyl bromide (0.470 g), 20% aqueous potassium hydrogen carbonate solution (0.925 g) and N, N-dimethylformamide (3 ml) for 1 hour . The reaction solution was concentrated and purified by silica gel column chromatography (eluent: ethyl acetate / methanol-9 / 1) to obtain N-benzite yellow ethyl-4-ethyl ethylamine-3- (4-fluorene oxygen Crude benzylamino) benzylamine. According to Example 183 -----— _2Π4 ___________— The paper size is in accordance with the Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 V. Description of the invention (20j) The method is obtained through cyclization 6_benzenesulfonylaminocarbamyl_1_ (4-benzyloxybenzyl) _2_methylbenzimidazole (251) 0.16 (^. [Physical properties of compound (251)] (read first on the back) Please fill in this page again) fNMlUDMSQ-de ,: 2.54 (3 2, s), 5.Q5 (2H, s), 5.44 (roll sh 7 q9 (2h, d, J 2 8.7Ηζ) , 7.32 (2Η, d, J: 7.QHz) 3 7 · 29-7 · 44 (5Η, in), 7.58-7 · 67 (3Η, ffl), 7.6 8-7 · 75 (2Η, m), 7.79-8 · 02 (2Η, m), 8.18 (1H, s), 12.46 (1Η, s). IR (KBr): 1685cm-1. °-mp: 111.0- 114.0oC. &Lt; Example 190; Synthesis of 2-methyl-5-[(2-pyridinyl) carbamoyl] benzimidazole (252) &gt; 5% palladium / carbon (0.10 g) was added In a mixture of N- (2-pyridylfluorenyl) -4-acetamidinyl-3-pentylbenzofluorenyl crude product (1.0.§) and acetic acid (8mi) and methanol (12ml), Stir under water ambient gas, 8 ° C for 7 hours. Filter out the solid By drying, 0.57 g of 2-methyl-5 [[2-pyridylmethyl] carbamoyl] benzimidazole (252) was obtained. [Physical properties of compound (252)] 1 orbital (CDC13, &lt; 5): 2.52 (3Η, s), 4.59 (2H, d, J: 5.9Hz), 7.26UH, dd, J2 7.1 and 5.1Hz), 7_33UH, d, J = 7.8Hz), 7 · 50 (1Η, d, J = 8.4Hz), 7.72-7 · 78 (2Η, m) 5 8.08 (1H, s), 8.5K1H, d, J = 4.8Hz), 9.04 (1H, t5 J = 5.8Hz), 12.44 (1H, s) 〇IR (KBr): 1641cm ′ mp: 212.0-215.0 ° C. &lt; Examples 191, 192; 1-benzenesulfonyl-2-methyl-6-[(2-pyridinemethyl ________ 9 0S_ This paper size applies to the Chinese National Standard (CNS) A4 specification (21 × 297 mm) ) 548272 A7 V. Description of the invention (20i group) aminofluorenyl] benzimidazole (253) and ^ benzenesulfonyl-2-methyl-5 _ [(2-pyridinyl) carbamoyl] Synthesis of benzimidazole (254) &gt; (Read the precautions on the reverse side before filling out this page} Add dioxane (10ml) and triethylamine (0760g) to ^ methyl_5-a [(2-pyridine Methyl) carbamoyl] benzimidazole (100 §), and then benzylsulfenyl chloride (0.994 g) was added dropwise. After stirring for 3 hours, the reaction solution was washed with water (3 times), and then with carbonic acid. Wash with aqueous sodium hydrogen solution. The organic layer was concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate / methanol = 9/1) to obtain 1-benzenesulfonyl-2-methyl-6_ [(2-Turadinylmethyl) carbamoyl] benzimidazole and 1-benzenesulfonyl-2-methyl-5-[(2-epiridinyl) carbamoyl] benzimidazole The mixture was 1.38 g. Then, it was subjected to medium pressure silica gel column chromatography (eluent ·· ethyl acetate / methanol = ^ 00/3). This mixture was refined to give 1-benzylsulfonyl-2-methyl-6-[(2-α-pyridinylmethyl) carbamoyl] benzimidazole (253) as an oil, 0.55 g, as an oil. 0.540 g of 1-benzenesulfonyl-2-methyl-6-[(2-pyridine α-methyl) aminopyrene] (25 4). The oil was dissolved in dichloromethane (1.5 ml), diethyl ether was added to crystallize it. [Physical properties of compound (253)] lH-fmR (CDCh, 6) ··· 2,84 (3H, s), 4.81UH, d, J: 4.8 Hz), 7.24UH, dd, J: 5.1 and 7. 3Ηζ), 7.37 (1Η, d, J: 7.7Hz), 7.53 (2H, dd, J = 7.9 and 7.5Hz), 7.6 3- 7.74 (2H, m) "7.85 (lH, dd, J = 8.4 &amp; 1.2Hz), 7.97 (2H, dd, J: 9.6 ^ 1 • 1Hz) 5 8.58-8.6K2H, m) IR (KBr): 16360111 ^ nip: 163.4-164.30C〇 [Physical properties of compound (254)] ______206 This paper size applies Chinese National Standard (CNS) to specifications (2H) x 297 mm) 548272 Δ7 A7 B7

五、發明説明(2〇S ^-NMRiCDCh, d):2-83(3H, s)3 4.78(2H3 d, J=4.7Hz), 7.23(1H3 dd, J=4.9 及 8·6Ηζ), 7·34(1Η, d, J=7.9Hz), 7·53(2Η3 dd, J二7·5 及 8·4Ηζ), 7.64-7·75(3Η, m), 7·91-7.96(3Η, m),8.10(lH, d, J二9·1Ηζ), 8·14(1Η5 d3 J二1·3Ηζ) ,8·56(1Η, dd, J=4.9 及 1.0Hz)。 IR(KBr) : 1657cm~l〇 :88.3 — 91 ·30C〇 〈貫施例l93、194;2_甲基- l- (4_石肖基节基)-6_[(2_11比咬 曱基)氨基甲醯基]苯並咪唑(255)及2-曱基-1_(4-硝基节 基)-5-[(2-α比啶甲基)氨基曱醯基]苯並咪唑(256)之合成&gt; 將Ν,Ν-二甲基甲醯胺(l〇ml)、4·硝基苄基溴(3.24g) 及碳酸氫鈉(2.52g)加入2-甲基-5-[(2-β比咬甲基)氨基甲 醯基]苯並咪唑(3.56g)中,在80°C下加熱2小時。將水 及三氯甲烷加入反應液中,以使其分層。減壓濃縮有機 層’藉由石夕膠柱色譜(溶離液··醋酸乙/甲醇=4/1)之精 製以得出2-甲基-1-(4·硝基苄基)-6-[(2-吡啶甲基)氨基甲 酿基]苯並咪唑與2-甲基-^(4-硝基苄基)-5·[(2_吡啶甲基) 氨基甲醯基]苯並咪唑之混合物。接著藉由中壓矽膠柱色 5晋(溶離液:醋酸乙酯/甲醇=85/15)以進行位置異構物之 分離’然後分別藉由使用三氯曱烷與二乙醚混合溶媒之 再結晶而得出2-甲基-1-(4-硝基苄基)-6-[(2-吡啶甲基)氨 基甲基]苯並咪唑及2-甲基-1-(4-硝基节 基&gt;5-[(2-&quot;比啶曱基)氨基甲醯基]笨並咪唑(256)1.19g。 [化合物(255)的物性] H-NMR(CDC13, 6) : 2.59(3H, s), 4.77(2H, d, J-4.8Hz), 5.48(2H, s)3 7,09 本紙張尺度㈣1&quot;(2ΐ〇χΐ9^¥Τ (請先閱讀背面之注意事項再楨寫本頁) 訂 548272 A7 B7 五、發明説明(20j (2H3 d,J=8.7Hz),7·22(1Η,dd,J=7.2 及 4·9Ηζ)3 7.33(1H,d,J:7』Hz), 7·66-7·70(2Η, m), 7·73(1Η, dd, J:8.4 及 1·5Ηζ), 7·78(1Η, d, J:8.4Hz), 7.9K1H, d, J=1.2Hz), 8.15-8.19(2H, m)3 8.56( 1H3 d3 J=4.6Hz)〇 IR(KBr) : 1652cm—、 nip : 116.1 —119.l0C〇 [化合物(256)的物性] W-NMlUCDCh,6) : 2·59(3Η,s),4·79(2Η,d,J二4·8Ηζ),5.46(2H,s)3 7·17 -7.24(4H, m)3 7·35(1Η, d, J二7·8Ηζ)3 7·69(2Η3 dt, J二7·6 及 1·7Ηζ), 7·83 (1Η, d, J二8·4Ηζ), 8·19(2Η, d, J二8·6Ηζ), 8·26(1Η, d, J=1.3Hz), 8·57(1Η, d ,J=4.8Hz)〇 IR(KBr) : 1634CET1。 mp : 203,7-206.3°C〇 經浐部中戎打卑AM T,消贽合竹:印1·'! (翱先閲讀背面之注意事項再填寫本頁) &lt;實施例195、196;2-甲基-1-(2-苯乙基)-6-[(2-吡啶 曱基)氨基曱醯基]苯並咪唑(257)及2-曱基-1-(2-苯乙 基)-5-[(2-α比啶甲基)氨基甲醯基]苯並咪唑(258)之合成〉 依據實施例193、194之方法,使用2-甲基-5-[(2-地啶甲基)氨基曱醯基]苯並咪唑(2.〇〇g)與苯乙基碘 (15.0g)以得出2-甲基-1-(2-苯乙基)-6-[(2-α比啶曱基)氨基 曱醯基]苯並咪唑(257)(0.30g)及2-曱基-1-(2-苯乙基)-5-[(2-吡啶曱基)氨基甲醯基]苯並咪唑(25 8)(0.23g)。 [化合物(257)的物性] ^-NMRiCDCla, δ) : 2.17(3Η5 s), 3.10(2H, t, J=6.8Hz)3 4.35(ZH, t, J=6.8 Hz), 4-82(2H, d, J=4.8Hz), 6.92-6.97(2H, m)3 7,21-7.28(4H, m), 7.38(1H, d, J-7-SHz), 7.78(1H, br t), 7.68-7.73(3H, m), 7.98(1H, d, J-0.9Hz), 8.6 ---—_ ?n« _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A7 548272 ________________ B7 五、發明説明(2〇i 0(1H,dd,J二1·〇 及 4·9Κ·ζ)。 IR(neat) : 1633cm_10 液体。 (許先閱讀背面之注意事項再填寫本頁) [化合物(258)的物性] ^-NHRCCDCla, δ) : 2.19(3H, s), 3.08(2H, t, J=6.8Hz), 4.35(2H, t3 J=6.8 Hz), 4.8K2H, d3 J=4.8Hz), 6.91-6.96(2H, m), 7.19-7.26(4H, m), 7.31(1H, d,J:8.4Hz),7.36(1H,d,J:7.8Hz),7·64-7·73(2Η,m),7.85(1H,&lt;ld,J=1.7 及 8·4Ηζ), 8·19(1Η, d, J二1·3Ηζ), 8·58(1Η, d, J:4.0Hz)。 IR(neat) : 1643cm—1。 液体。 &lt;實施例197、198;1-(2,4-二氟代苄基)_2-曱基-6-[(2- 此啶甲基)氨基甲醯基]苯並咪唑(259)及i_(2,4_二氟代苄 基)-2-甲基-5-[(2-处啶曱基)氨基曱醯基]苯並咪唑(26〇) 之合成&gt; 依據實施例193、194之方法,使用2-甲基-5-[(2-外匕咬甲基)氨基甲酸基]苯並味。坐(1 〇〇g)與2,4-二氣代节 基溴(l.OOg)以得出1-(2,4_二氟代苄基)_2_曱基-6-[(2-吡 啶曱基)氨基曱醯基]苯並咪唑(259)0.25g及1-(2,4-二氟 代苄基):2-曱基-5·[(2-呲啶甲基)氨基甲醯基]苯並咪唑 (260)0.25g ° [化合物(259)的物性] H-NMR(CDC13, d) : 2·62(3Η, s), 4,78(2H, d, J:4.7Hz), 5.38(2H, s), 6·73 〜6·79(2Η, m), 6·88(1Η, t, J:l〇.〇Hz), 7.24(1H, dd, J:7.3 及 5·1Ηζ), 7.3 5(1H, d, J=7.8Hz), 7·67-7·76(4Η, m), 7·97(1Η, s), 8·58(1Η, d, J=4.4Hz)。 ___ 209___ 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) 548272 經浐部中头i?.準而只-Τ消贽合竹妇印¾ A7 ______ B7 五、發明説明(2以 ^^ IR(KBr) : 1642cm-丨。 即:98· 0 — 104· 0°C。 [化合物(260)的物性] ^-NMRCCDCh, δ) : 2.62(3H3 s)5 4.79(2H, d3 J-4.7Hz)5 5.35(2H5 s), 6.72 -6·81(2Η, m), 6·89(1Η3 t, J=9.8Hz), 7·22(1Η, t, J=6.2Hz), 7·28(1Η, d3 8.4Hz), 7.34(1H, d, J=7.8Hz), 7.63-7.71(2H, m), 7.83(1H3 d, J=8.4Hz), 7. 97(1H5 s), 8.57(1H, d, J=4.7Hz)〇 IR(KBr〇 : 1647cm1。 mp : 143.5 —144.0°C。 · 〈實施例199、2〇o; 1 -(4-胺基苄基)_2_甲基_6_[(2_吡咬 甲基)氨基甲醯基]苯並咪唑(261)及1-(4-胺基苄基)_2-曱 基-5-[(2-。比啶甲基)氨基甲醯基]苯並咪唑(262)之合成&gt; 將曱醇(30ml)與5%鈀/碳(0.20g)加入2-甲基_1-(4- 硝基苄基)-6-[(2-吡啶甲基)氨基甲醯基]苯並咪唑與2_甲 基-1-(4-硝基苄基)-5-[(2-α比啶曱基)氨基甲醯基]苯並咪 唾之混合物(2.32g)中,在室溫、氫環境氣體下攪拌至原 料消失為止。過濾出固體,經濃縮濾液而得出殘渣,藉 由中壓矽膠柱色譜(溶離液:醋酸乙酯/甲醇=85/丨5)之精 製以分離成1-(4-胺基节基)-2-甲基-6-[(2-α比唆甲基)氨基 甲醯基]苯並咪唑及1-(4-胺基苄基)-2-甲基-5-[(2-吡啶曱 基)氨基甲醯基]苯並咪唾。使用三氯甲烧與二乙鱗之混 合溶媒以使其結晶化。藉由過濾、乾燥結晶而得出^(4-胺基苄基)-2-甲基-6-[(2-吡啶甲基)氨基甲醯基]苯並咪 嗤(26l)0.354g及1_(4_胺基苄基)_2·曱基吡啶甲基)氨 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 548272 A7 B7 五、發明説明(20) 基曱醯基]苯並咪唑(262)0.33(^。 [化合物(261)的物性] 'H-NMRiCDCL·, δ) : 3.00(3R, s)3 4.98(2H3 s)3 5.88(2H, s), 7.55(2H3 d, J 二8·6Ηζ)3 7.69(2H,d,J:8.6Hz),7.90(1H,d3 J=8.6Hz),7·96(1Η,dt,J二7·1 及 〇.6Hz), 8·12(1Η3 J:8.0Hz)3 8,18(1H, dd3 J:8.5 及 1·他),8,55(1H, dt, J二8·0 及 l_7Hz)3 8.62(1H, d, J二1.1Hz), 8·77(1Η, dd, J二5.9 及 1. 1Ηζ)0 IR(KBr) : 1643cm-1。 mp : 180.0 —181.0°C。 · [化合物(262)的物性] lH-NMR(CDCl33 δ) : 3.00(3H, s)3 5.01(2H3 s)3 5.83(2H, s), 7.47(2H, d, J =8·5Ηζ)3 7.78(2H,d3 J二8·5Ηζ),7.78(1H,d,J二8·9Ηζ),7.97(1H,dt,J二7.2 及 〇·7Ηζ),8·13(1Η5 J=8.1Hz), 8·15(1Η,d,J=8.9Hz),8.51UH,s),8·55( 1H,dt3 J=7.9 及 1·6Ηζ),8.77( 1H,d3 J=5.8Hz)。 IR(KBr) : 1639,1612(^0 mp : 168.0—171.0QC。 &lt;實施例201;l-[4-(苯磺醯基胺基)苄基]_2-曱基-6-[(2-吡啶甲基)氨基甲醯基]苯並咪唑(263)之合成&gt; 將三乙胺(0.185g)及苯磺醯氣(〇.21〇g)加入;胺 基苄基)-2-曱基-6-[(2-吡啶曱基)氨基曱醯基]苯並咪唑 (0.340g)之三氯甲烷(l〇ml)溶液中,在室溫下授拌8小 時。加入水以停止反應,使用三氯曱烷進行萃取。水洗 有機層(3次),經乾燥、濃縮後,藉由矽膠柱色譜(溶離 液·醋酸乙S旨/甲酵=1〇〇/〇〜4/1)之精製殘渣以得出ι_[4_(苯 2\ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (讀先閱讀背面之注意事項再填寫本頁)V. Description of the invention (20S ^ -NMRiCDCh, d): 2-83 (3H, s) 3 4.78 (2H3 d, J = 4.7Hz), 7.23 (1H3 dd, J = 4.9 and 8.6Ηζ), 7 · 34 (1Η, d, J = 7.9Hz), 7.53 (2Η3 dd, J = 7.5 and 8.4Ηζ), 7.64-7 · 75 (3Η, m), 7.91-7.96 (3Η, m), 8.10 (lH, d, J = 9 · 1Ηζ), 8.14 (1Η5 d3 J = 1 · 3Ηζ), 8.56 (1Η, dd, J = 4.9 and 1.0 Hz). IR (KBr): 1657cm ~ 10: 88.3 — 91 · 30C〇 <Conductive Examples 193, 194; 2-Methyl-l- (4-Shotosylbenzyl) -6 _ [(2_11 ratio fluorenyl) carbamate Synthesis of fluorenyl] benzimidazole (255) and 2-fluorenyl-1_ (4-nitrobenzyl) -5-[(2-αpyridinylmethyl) aminofluorenyl] benzimidazole (256) &gt; Add N, N-dimethylformamide (10 ml), 4 · nitrobenzyl bromide (3.24 g) and sodium bicarbonate (2.52 g) to 2-methyl-5-[(2- Beta ratio: methyl) carbamoyl] benzimidazole (3.56 g), heated at 80 ° C. for 2 hours. Water and chloroform were added to the reaction solution to separate the layers. The organic layer was concentrated under reduced pressure, and purified by column chromatography on silica gel (eluent ·· ethyl acetate / methanol = 4/1) to obtain 2-methyl-1- (4 · nitrobenzyl) -6- [(2-Pyridylmethyl) carbamyl] benzimidazole and 2-methyl-^ (4-nitrobenzyl) -5 · [(2-pyridylmethyl) carbamoyl] benzimidazole Of a mixture. Then use medium pressure silica gel column color 5 Jin (eluent: ethyl acetate / methanol = 85/15) to separate the positional isomers, and then recrystallize by using a mixture of trichloromethane and diethyl ether. And 2-methyl-1- (4-nitrobenzyl) -6-[(2-pyridylmethyl) aminomethyl] benzimidazole and 2-methyl-1- (4-nitro Group> 5-[(2- &quot; pyridinyl) carbamoyl] benzimidazole (256) 1.19 g. [Physical properties of compound (255)] H-NMR (CDC13, 6): 2.59 (3H , s), 4.77 (2H, d, J-4.8Hz), 5.48 (2H, s) 3 7,09 This paper size ㈣1 &quot; (2ΐ〇χΐ9 ^ ¥ Τ (Please read the notes on the back before copying Page) Order 548272 A7 B7 V. Description of the invention (20j (2H3 d, J = 8.7Hz), 7.22 (1Η, dd, J = 7.2 and 4 · 9Ηζ) 3 7.33 (1H, d, J: 7 』Hz ), 7.66-7 · 70 (2Η, m), 7.73 (1Η, dd, J: 8.4 and 1.5Ηζ), 7.78 (1Η, d, J: 8.4Hz), 7.9K1H, d , J = 1.2Hz), 8.15-8.19 (2H, m) 3 8.56 (1H3 d3 J = 4.6Hz) 〇IR (KBr): 1652cm—, nip: 116.1 —119.100C〇 [Physical properties of compound (256)] W-NMlUCDCh, 6): 2.59 (3Η, s), 4.79 (2Η, d, J 2 4.8Ηζ ), 5.46 (2H, s) 3 7 · 17 -7.24 (4H, m) 3 7 · 35 (1Η, d, J 2 7 · 8Ηζ) 3 7 · 69 (2Η3 dt, J 2 7 · 6 and 1 · 7Ηζ), 7.83 (1Η, d, J 2 8.4Ηζ), 8.19 (2Η, d, J 2 8.6Ηζ), 8.26 (1Η, d, J = 1.3Hz), 8.57 (1Η, d, J = 4.8Hz) 〇IR (KBr): 1634CET1. Mp: 203,7-206.3 ° C 〇Beijing Zhong Rong Dabei AM T, eliminate the combination of bamboo: Yin 1 '! (翱Read the precautions on the back before filling this page) &lt; Examples 195, 196; 2-methyl-1- (2-phenethyl) -6-[(2-pyridinyl) aminofluorenyl] benzene Synthesis of benzimidazole (257) and 2-fluorenyl-1- (2-phenethyl) -5-[(2-α than pyridylmethyl) aminomethylfluorenyl] benzimidazole (258)> According to the Examples The method of 193 and 194, using 2-methyl-5-[(2-dipyridylmethyl) aminofluorenyl] benzimidazole (2.0 g) and phenethyl iodide (15.0 g) to obtain 2-methyl-1- (2-phenethyl) -6-[(2-αbipyridinyl) aminofluorenyl] benzimidazole (257) (0.30g) and 2-fluorenyl-1- (2-Phenethyl) -5-[(2-pyridinyl) carbamoyl] benzimidazole (25 8) (0.23 g). [Physical properties of compound (257)] ^ -NMRiCDCla, δ): 2.17 (3Η5 s), 3.10 (2H, t, J = 6.8Hz) 3 4.35 (ZH, t, J = 6.8 Hz), 4-82 (2H , d, J = 4.8Hz), 6.92-6.97 (2H, m) 3 7,21-7.28 (4H, m), 7.38 (1H, d, J-7-SHz), 7.78 (1H, br t), 7.68-7.73 (3H, m), 7.98 (1H, d, J-0.9Hz), 8.6 -----_? N «_ This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) A7 548272 ________________ B7 V. Description of the invention (20i 0 (1H, dd, J 2 1.0 and 4. 9K · ζ). IR (neat): 1633cm_10 Liquid. (Permit reading the precautions on the back before filling in this page) [Physical properties of compound (258)] ^ -NHRCCDCla, δ): 2.19 (3H, s), 3.08 (2H, t, J = 6.8Hz), 4.35 (2H, t3 J = 6.8 Hz), 4.8K2H, d3 J = 4.8Hz), 6.91-6.96 (2H, m), 7.19-7.26 (4H, m), 7.31 (1H, d, J: 8.4Hz), 7.36 (1H, d, J: 7.8Hz), 7.64 -7 · 73 (2Η, m), 7.85 (1H, &lt; ld, J = 1.7 and 8.4Ηζ), 8.19 (1Η, d, J 2 1.3Ηζ), 8.58 (1Η, d, J: 4.0Hz). IR (neat): 1643cm-1. liquid. &lt; Examples 197, 198; 1- (2,4-difluorobenzyl) _2-fluorenyl-6-[(2- this pyridylmethyl) carbamoyl] benzimidazole (259) and i_ Synthesis of (2,4-difluorobenzyl) -2-methyl-5-[(2-pyridinofluorenyl) aminofluorenyl] benzimidazole (26) &gt; According to Examples 193, 194 As a method, 2-methyl-5-[(2-exomethyl) carbamate] benzo is used. Sit (100g) with 2,4-dioxobenzyl bromide (1000g) to give 1- (2,4-difluorobenzyl) _2_fluorenyl-6-[(2- Pyridinyl) aminoamino] benzimidazole (259) 0.25g and 1- (2,4-difluorobenzyl): 2-fluorenyl-5 · [(2-pyridinylmethyl) carbamoyl Fluorenyl] benzimidazole (260) 0.25 g ° [physical properties of compound (259)] H-NMR (CDC13, d): 2.62 (3Η, s), 4,78 (2H, d, J: 4.7Hz ), 5.38 (2H, s), 6.73 to 6.79 (2Η, m), 6.88 (1Η, t, J: 10 Hz), 7.24 (1H, dd, J: 7.3 and 5 · 1Ηζ), 7.3 5 (1H, d, J = 7.8Hz), 7.67-7 · 76 (4Η, m), 7.97 (1Η, s), 8.58 (1Η, d, J = 4.4 Hz). ___ 209___ This paper size is applicable to China National Standards (CNS) A4 specification (210X297 mm) 548272 In the head of the Ministry of Economic Affairs i ?. quasi-only-T eliminates the seal of the woman ¾ A7 ______ B7 V. Description of the invention (2 ^^ IR (KBr): 1642cm- 丨. That is: 98 · 0 — 104 · 0 ° C. [Physical properties of compound (260)] ^ -NMRCCDCh, δ): 2.62 (3H3 s) 5 4.79 (2H, d3 J-4.7Hz) 5 5.35 (2H5 s), 6.72-6 · 81 (2Η, m), 6.89 (1Η3 t, J = 9.8Hz), 7 · 22 (1Η, t, J = 6.2Hz), 7 · 28 (1Η, d3 8.4Hz), 7.34 (1H, d, J = 7.8Hz), 7.63-7.71 (2H, m), 7.83 (1H3 d, J = 8.4Hz), 7. 97 (1H5 s) , 8.57 (1H, d, J = 4.7Hz) .IR (KBr0: 1647cm1. Mp: 143.5-144.0 ° C. · <Examples 199, 20o; 1-(4-aminobenzyl) _2_ Methyl-6-[(2-pyridylmethyl) carbamoyl] benzimidazole (261) and 1- (4-aminobenzyl) _2-fluorenyl-5-[(2-.pyridine (Synthesis) Carbamidyl] Synthesis of Benzimidazole (262) &gt; Methanol (30ml) and 5% palladium / carbon (0.20g) were added to 2-methyl_1- (4-nitrobenzyl)- 6-[(2-Pyridylmethyl) carbamoyl] benzimidazole and 2-methyl-1- (4-nitrobenzyl) -5-[(2-α ratio Pyridinyl) carbamoyl] benzimidal mixture (2.32g), stirred at room temperature under hydrogen atmosphere until the raw materials disappeared. The solid was filtered, and the filtrate was concentrated to obtain a residue. Purification by silica gel column chromatography (eluent: ethyl acetate / methanol = 85 / 丨 5) to separate into 1- (4-aminobenzyl) -2-methyl-6-[(2-α Methyl) carbamoyl] benzimidazole and 1- (4-aminobenzyl) -2-methyl-5-[(2-pyridinyl) carbamoyl] benzimidazole. Trichloro A mixed solvent of methylbenzene and diethyl scale is used to crystallize. ^ (4-aminobenzyl) -2-methyl-6-[(2-pyridylmethyl) amino is obtained by filtering and drying the crystals. Formamyl] 0.354 g of benzimidazole (26l) and 1_ (4_aminobenzyl) _2 · fluorenylpyridylmethyl) ammonia paper standard Shizhou Chinese National Standard (CNS) A4 size (210X297 mm) (Please read the precautions on the back before filling out this page) Order 548272 A7 B7 V. Description of the invention (20) Base fluorenyl] benzimidazole (262) 0.33 (^. [Physical properties of compound (261)] 'H-NMRiCDCL ·, δ): 3.00 (3R, s) 3 4.98 (2H3 s) 3 5.88 (2H, s), 7.55 (2H3 d, J 2 8.6Ηζ) 3 7.69 (2H, d, J: 8.6Hz), 7.90 (1H, d3 J = 8.6Hz), 7.96 (1Η, dt, J 2 7.1 and 0.6Hz), 8 · 12 (1Η3 J: 8.0Hz ) 3 8,18 (1H, dd3 J: 8.5 and 1. he), 8,55 (1H, dt, J 2 8.0 and l_7 Hz) 3 8.62 (1H, d, J 2 1.1 Hz), 8.77 (1Η, dd, J 二 5.9 and 1.1Ηζ) 0 IR (KBr): 1643cm-1. mp: 180.0 —181.0 ° C. · [Physical properties of compound (262)] lH-NMR (CDCl33 δ): 3.00 (3H, s) 3 5.01 (2H3 s) 3 5.83 (2H, s), 7.47 (2H, d, J = 8 · 5Ηζ) 3 7.78 (2H, d3 J2 8.5Ηζ), 7.78 (1H, d, J2 8.98ζ), 7.97 (1H, dt, J2 7.2 and 0.77Ηζ), 8.13 (1Η5 J = 8.1Hz) , 8.15 (1Η, d, J = 8.9Hz), 8.51UH, s), 8.55 (1H, dt3 J = 7.9 and 1.6Ηζ), 8.77 (1H, d3 J = 5.8Hz). IR (KBr): 1639, 1612 (^ 0 mp: 168.0-171.0QC. &Lt; Example 201; l- [4- (benzenesulfonylamino) benzyl] _2-fluorenyl-6-[(2 -Synthesis of pyridylmethyl) carbamoyl] benzimidazole (263) &gt; Triethylamine (0.185g) and benzenesulfonium (0.221g) were added; aminobenzyl) -2- In a solution of fluorenyl-6-[(2-pyridylfluorenyl) aminofluorenyl] benzimidazole (0.340 g) in chloroform (10 ml), it was stirred at room temperature for 8 hours. Water was added to stop the reaction, and extraction was performed using trichloromethane. The organic layer was washed with water (three times), dried and concentrated, and then the residue was purified by silica gel column chromatography (eluent · ethyl acetate / formase = 1〇〇 / 〇〜4 / 1) to obtain ι_ [4_ (Benzene 2 \ This paper size applies to Chinese National Standard (CNS) A4 specifications (210X 297 mm) (Read the precautions on the back before filling in this page)

訂 548272 經浐部中Air準h消費合作ii印 A7 B7 五、發明説明(20表 磺醯基胺基)苄基]-2-甲基«(2-吡啶甲基)氨基甲醯基] 笨並咪唑(263)0.300g。 [化合物(263)的物性] H'NHR(CDCl33 δ) : 2.53(3H3 s)5 4.78(2H3 d3 J-4.8Hz), 5.28(2H, s)3 6.90 (2H,t3 J=8.6Hz),6.99(2H,d3 J:8.5Hz)3 7·11(1Η,s),7.23UH,dd,J:5.5 及 7.2Hz),7·34(1Η,d,J:7.7Hz)3 7,40(2H,J=81Hz) 3 7 5〇(m,t,J=7 •5Hz)3 7.66-7.74(6H, m), 7.92(1H, s)5 8.56(1H3 d3 J=4.8Hz)〇 IR(KBr) : 1642cm-l〇 即:204.4 —206.5oC〇 &lt;實施例202;6-笨磺醯基胺基甲基_]μ(2_氣代苄基)_ 2-甲基苯並咪唑(264)之合成&gt; 在室溫下將60%氫氧化鈉(0.127g)加入苯磺酸醯胺 (0.667g)之N,N-一曱基甲酸胺(5ml)溶液中,攪拌1小 時。接著加入1-(2-氯代苄基)_6_氯甲基甲基苯並咪唑 鹽酸鹽(0.648g),在室溫下攪拌18小時。將水加入反應 液中以停止反應,在減壓下餾去溶媒。將醋酸乙酯及水 加入殘渣中以進行萃取。濃縮有機層,藉由矽膠柱色譜 (&gt;谷離液:醴酸乙酯)之精製以得出6_苯磺醯基胺基甲基 -1-(2-氣代苄基)_2_甲基笨並咪唑(264)0 240g。 [化合物(264)的物性] lH-NMR(DMS0-d6, d ) : 2.42(3H5 s)3 4.02(2H3 m)3 4.02(2H, m)3 5.44(2H, s) ,6·36(1Η, d, J:7.7Hz), 7·03(1Η, d, J:8.4Hz)5 7.18(1H, s), 7·21(1Η, t), 7.33(1H, t), 7.59-7.43(5H, m), 7.73(2H3 d3 J,7.5Hz), 8.08(1H, s)〇 IR(KBr) : 1522cm-1。 mp : 164.5-167.0oC〇 217 不...氏张尺及中國國家標準(CNS ) A4規格(210X 297公羞) (請先閱讀背面之注意事項再填寫本頁) 、\ν'ί&gt; Γ 548272 kl B7 五、發明説明(20合 〈貝施例203; 1-(聯笨-4-甲基)-2-甲基-6-[(2-咕啶甲 基)胺基甲基]笨並咪唑(265)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 將2-胺基曱基吡啶(〇 372g)加入卜(聯苯_4•曱基)_2_ 甲基-6-氯甲基-2-甲基苯並咪唑(0.597g)與碳酸鉀(〇 35〇g) 之N,N-二甲基甲醯胺(3ml)溶液中,在6〇。〇下攪拌2小 時。加入水與醋酸乙酯以進行萃取,水洗有機層(2次)。 減壓除去溶媒以得殘渣,藉由矽膠柱色譜(溶離液:三氯 曱烷/甲醇=9/1)之精製以得出丨·(聯苯-4_曱基)_2_曱基-心 [(2-吡啶甲基)胺基甲基]苯並咪唑(265)〇 3〇〇g。 [化合物(265)的物性] [H-NMR(CDC13, c5) : 2.57(3H, s)3 3.91(2H, s), 3·93(2Η, s), 5·35(2Η, s), 7·08-7·14(3Η, m), 7·23(2Η, d3 J:7.3Hz), 7.30-7,35(2H, m), 7·41(2Η, t)3 7 ·50-7·55(4Η, m), 7·57(1Η, dt, J=1.8 及 7·6Ηζ)3 7·68(1Η, d, J:8,1Hz)5 8 .53(1Η, d3 J=4.9Hz)〇 IR(KBr) : 1618cm1〇 即:104.5 —106.0oC〇 〈實施例204;N-苯磺醯基-3-[1·(2-氣代苄基)-2-甲基 苯並咪唑-6-基]丙醯胺(266)之合成&gt; 將鈀/碳(〇.5〇〇g)加入N_苯磺醯基小(2_氣代苄 基)-2-甲基苯並咪唑-6-丙烯醯胺(〇.607g)之乙醇(15〇mi) 溶液中,在氫環境氣體、室溫下攪拌43小時。過濾出 固體,濃縮濾液並將其溶解於20%碳酸氫鉀水溶液與甲 醇之混合溶液中,以1〇〇/0鹽酸調整成pH5〜6。過濾出所 析出的結曰曰,精由乾餘以得出N·苯石黃酿基-3-[ 1 -(2·氯代节 —-—_ 213 _ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) &quot; - 548272 A7 ___________________B7__ 五、發明説明(2 1¾ 基)-2-甲基苯並味峻-6-基]丙酸胺(2 66)0.25 Og。 [化合物(266)的物性] 4-臟_50-(16,6) : 2·45(3Η,s),2.52(2H,t),2·78(2Η,t),5·37(2Η,s) ,6·88(1Η, d, J:8.4Hz), 7·08(2Η, d, J:7.4Hz), 7·22-7·34(3Η,瓜),7·36(1Η, t, J=8.1Hz), 7·55(2Η, t), 7.67(1Η, t), 7·84(2Η3 d, J二7·6Ηζ), 12·04(1Η, br s)〇 IR(KBr) : 1715cmi〇 Mass(FAB) : m/e 468(M+1)。 mp : 229.8 —233.0°C。 〈貫施例205;6 -苯石夤酿基氨基甲酿基-2-甲基- l- [4-(I,2,3-噻二唑_4_基)苄基]笨並咪唑(267)之合成&gt; 依據貫施例18 3之方法,使用N -苯績聽基-4 -乙酸 胺基-3-[4-(l,2,3-噻二唑-4-基)苄基胺基]苯並醯胺 (0.382g)以得出6-苯石黃酿基氨基曱酿基-2-甲基-l-[4-(1,2,3-噻二唑-4-基)苄基]笨並咪唑(267)〇.279g。 [化合物(267)的物性] lH-NMR(DMS0-d6, δ) : 2.56(3H, s), 5.62(2H, s), 7.28(2H, d, J=8.2Hz), 7. 58-7·63(3Η, m)3 7·67(1Η, t, J二7·3Ηζ), 7·74(1Η, dd, J=8.5 及 1·2Ηζ), 7· 經浐部中夾榀卑而M.T消贽告竹凇印象 (讀先閱讀背面之注意事項再填寫本頁) 99(2H3 dd, J二S.4 及 1.2Hz), 8·10(2Η, d, J二8·2Ηζ), 8·19(1Η, s)3 9·58(1Η ,s), 12·47(1Η5 s)〇 IR(KBr) : 1617, 1556cm 、 mp : 258.5 —260.0°C(分解奁伴〇)。 &lt;實施例206; 1-(2-氯代苄基)_2-甲基-6-(8-喳啉磺醯 基氨基甲醯基)苯並咪唑鈉鹽(268)之合成&gt; -------204----- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(21 j (#先閱讀背面之注意事項再填寫本頁) 依據實施例141之方法’使用6-叛基-1_(2-氯代节 基)-2-甲基苯並咪唑(0.450g)、N,N’-羰基二啼唑 (0.485§)、8-咬淋續1蓝胺(0.625§)、二氮二環十一烯(0.457g) 以得出1-(2 -氯代节基)-2-甲基- 6-(8 -嗜淋石黃酸基氨基甲 醯基)苯並咪唑鈉鹽(268)0.400g。 [化合物(268)的物性] ^-NMRCDMSO-dG, δ) : 2.4Z(3H3 s), 5.48(2H, s)3 6.32(1Η, d5 J=7.7Hz)5 7. 17(1H, t, J=7.5Hz), 7.30(1H, t3 J二7.7Hz), 7·42(1Η, d, J=8.4Hz), 7·48(1Η, dd, J=4.2 及 8·2Ηζ)3 7.53(1H, d3 J二8·0Ηζ), 7·64(1Η3 t, J二7·7Ηζ), 7.79 (1H, d, J=8.5Hz), 7·88(1Η, s), 8·04(1Η, d, J:8.1Hz), 8·33-8·37(2Η, m), 8 •85(1H, dd)。 IR(KBr) : 1594cm1。 .·Order 548272 Air quasi-h consumer cooperation in the Ministry of Economic Affairs II India A7 B7 V. Description of the invention (Table 20 sulfoamidoamino) benzyl] -2-methyl «(2-pyridylmethyl) carbamoyl] Benzimidazole (263) 0.300 g. [Physical properties of compound (263)] H'NHR (CDCl33 δ): 2.53 (3H3 s) 5 4.78 (2H3 d3 J-4.8Hz), 5.28 (2H, s) 3 6.90 (2H, t3 J = 8.6Hz), 6.99 (2H, d3 J: 8.5Hz) 3 7 · 11 (1Η, s), 7.23UH, dd, J: 5.5 and 7.2Hz), 7.34 (1Η, d, J: 7.7Hz) 3 7,40 (2H, J = 81Hz) 3 7 5〇 (m, t, J = 7 • 5Hz) 3 7.66-7.74 (6H, m), 7.92 (1H, s) 5 8.56 (1H3 d3 J = 4.8Hz) (KBr): 1642cm-10, that is, 204.4-206.5oC &lt; Example 202; 6-benzylsulfonamidoaminomethyl _] μ (2-Gas benzyl) 2-methylbenzimidazole (264) Synthesis> At room temperature, 60% sodium hydroxide (0.127 g) was added to a solution of ammonium besylate (0.667 g) in N, N-monoammonium formate (5 ml) and stirred for 1 hour . Next, 1- (2-chlorobenzyl) -6-chloromethylmethylbenzimidazole hydrochloride (0.648 g) was added, and the mixture was stirred at room temperature for 18 hours. Water was added to the reaction solution to stop the reaction, and the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to the residue for extraction. The organic layer was concentrated and purified by silica gel column chromatography (&gt; Valley Liquid: Ethyl Acetate) to give 6_benzenesulfonylaminomethyl-1- (2-gaso benzyl) _2_form Base benzimidazole (264) 0 240 g. [Physical properties of compound (264)] 1H-NMR (DMS0-d6, d): 2.42 (3H5 s) 3 4.02 (2H3 m) 3 4.02 (2H, m) 3 5.44 (2H, s), 6.36 (1Η , D, J: 7.7Hz), 7.03 (1Η, d, J: 8.4Hz) 5 7.18 (1H, s), 7.21 (1Η, t), 7.33 (1H, t), 7.59-7.43 ( 5H, m), 7.73 (2H3 d3 J, 7.5Hz), 8.08 (1H, s), IR (KBr): 1522cm-1. mp: 164.5-167.0oC〇217 No ... ruler and Chinese National Standard (CNS) A4 specification (210X 297 male shame) (Please read the precautions on the back before filling this page), \ ν'ί &gt; Γ 548272 kl B7 V. Description of the invention (20 in combination <Beijing Example 203; 1- (biben-4-methyl) -2-methyl-6-[(2-glutidinylmethyl) aminomethyl] benzyl Synthesis of Benzimidazole (265) &gt; (Read the precautions on the back before filling this page) Add 2-Aminopyridylpyridine (〇372g) to (Biphenyl_4 • fluorenyl) _2_methyl-6 -A solution of chloromethyl-2-methylbenzimidazole (0.597 g) and potassium carbonate (0350 g) in N, N-dimethylformamide (3 ml) and stirred at 60.0 2 Hours. Water and ethyl acetate were added for extraction, and the organic layer was washed with water (twice). The solvent was removed under reduced pressure to obtain a residue, which was purified by silica gel column chromatography (eluent: trichloromethane / methanol = 9/1). In order to obtain 丨 · (biphenyl-4_fluorenyl) _2_fluorenyl-cardio [(2-pyridylmethyl) aminomethyl] benzimidazole (265) 0300 g. [Compound (265) Physical properties] [H-NMR (CDC13, c5): 2.57 (3H, s) 3 3.91 (2H, s), 3.93 (2Η, s), 5.35 (2Η, s), 7.08-7 · 14 (3Η, m), 7.23 (2Η, d3 J: 7.3Hz), 7.30-7, 35 (2H, m), 7.41 (2Η, t) 3 7 · 50-7 · 55 (4Η, m), 7.57 (1Η, dt, J = 1.8 and 7.6Ηζ) 3 7 · 68 (1Η, d, J: 8,1Hz) 5 8 .53 (1Η, d3 J = 4.9Hz) IR (KBr): 1618cm1〇 That is: 104.5-106.0oC. <Example 204; N-benzenesulfonyl-3- [1 ((2-fluorobenzyl) -2-methyl) Of benzimidazol-6-yl] propanamide (266) &gt; Add palladium / carbon (0.500 g) to N-benzenesulfonyl small (2-gaso-benzyl) -2- In a solution of methyl benzimidazole-6-propenylamine (0.607 g) in ethanol (150 mi), stir at room temperature for 43 hours under hydrogen atmosphere. The solid was filtered off, and the filtrate was concentrated and dissolved in 20 In a mixed solution of a potassium potassium carbonate aqueous solution and methanol, the pH was adjusted to 5 to 6 with 100/0 hydrochloric acid. The precipitated precipitate was filtered off, and the residue was dried to obtain N · benzenestone yellow brewing group-3- [1-(2 · Chlorination Festival —-—_ 213 _ This paper size is suitable for China National Standard (CNS) A4 specification (210X297 mm) &quot;-548272 A7 ___________________B7__ V. Description of the invention (2 1¾ basis) -2 -Methylbenzo -6-yl] amine propionate (2 66) 0.25 Og. [Physical properties of compound (266)] 4-dirty_50- (16,6): 2.45 (3Η, s), 2.52 (2H, t), 2.78 (2Η, t), 5.37 (2Η , S), 6.88 (1Η, d, J: 8.4Hz), 7.08 (2Η, d, J: 7.4Hz), 7.22-7 · 34 (3Η, melon), 7.36 (1Η , T, J = 8.1Hz), 7.55 (2Η, t), 7.67 (1Η, t), 7.84 (2Η3 d, J = 7 · 6Ηζ), 12 · 04 (1Η, br s) .IR (KBr): 1715 cm. Mass (FAB): m / e 468 (M + 1). mp: 229.8 —233.0 ° C. <Example 205; 6-Benzylpyridinylcarbamyl-2-methyl-l- [4- (I, 2,3-thiadiazol-4-yl) benzyl] benzimidazole ( Synthesis of 267) &gt; According to the method of Example 18 3, N-benzyl-4-acetamido-3- [4- (l, 2,3-thiadiazol-4-yl) benzyl was used Aminoamino] benzofluorenamine (0.382g) to give 6-benzite yellow aminoaminopyrenyl-2-methyl-l- [4- (1,2,3-thiadiazole-4- (Benzyl) benzyl] benzimidazole (267) 0.279 g. [Physical properties of compound (267)] 1H-NMR (DMS0-d6, δ): 2.56 (3H, s), 5.62 (2H, s), 7.28 (2H, d, J = 8.2Hz), 7. 58-7 · 63 (3Η, m) 3 7 · 67 (1Η, t, J 2 · 7Η3Ηζ), 7.74 (1Η, dd, J = 8.5 and 1.2Ηζ), 7 · The meridian is interposed MT dismisses the impression of bamboo shoots (read the precautions on the back before filling this page) 99 (2H3 dd, J2 S.4 and 1.2Hz), 8 · 10 (2Η, d, J2 8 · 2Ηζ), 8.19 (1Η, s) 3 9 · 58 (1Η, s), 12.47 (1Η5 s), IR (KBr): 1617, 1556cm, mp: 258.5-260.0 ° C (decomposition of 奁 companion 0). &lt; Example 206; Synthesis of 1- (2-chlorobenzyl) _2-methyl-6- (8-fluorolinesulfonylaminocarbamyl) benzimidazole sodium salt (268) &gt;- ----- 204 ----- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (21 j (#Read the precautions on the back before filling this page) ) According to the method of Example 141, 'Using 6-benzyl-1_ (2-chlorobenzyl) -2-methylbenzimidazole (0.450 g), N, N'-carbonyldiazole (0.485§), 8-biting leaching 1 blueamine (0.625§), diazabicycloundecene (0.457g) to give 1- (2-chlorobenzyl) -2-methyl-6- (8-leaching 0.400 g of luteinylcarbamoyl) benzimidazole sodium salt (268). [Physical properties of compound (268)] ^ -NMRCDMSO-dG, δ): 2.4Z (3H3 s), 5.48 (2H, s) 3 6.32 (1Η, d5 J = 7.7Hz) 5 7. 17 (1H, t, J = 7.5Hz), 7.30 (1H, t3 J = 7.7Hz), 7.42 (1Η, d, J = 8.4Hz) , 7.48 (1Η, dd, J = 4.2 and 8.2Ηζ) 3 7.53 (1H, d3 J 2: 8.0Ηζ), 7.64 (1Η3 t, J 2: 7.7Ηζ), 7.79 (1H, d, J = 8.5Hz), 7.88 (1Η, s), 8.04 (1Η, d, J: 8.1Hz), 8.33-8 · 37 (2Η, m), 8 • 85 (1H, dd). IR (KBr): 1594cm1. . ·

Mass(FAB) : m/e 513(M+1)。 mp : 348 — 352°C(分解奁伴3)。 &lt;實施例207;6-(4-第3 丁基苯磺醯基氨基曱醯基)_ 1-(2-氣代苄基)-2-甲基苯並咪唾鈉鹽(269)之合成&gt; 依據實施例141之方法,使用6-羧基-1-(2-氯代苄 基)-2-曱基苯並口米。坐(〇.450g)、N,N’-魏基二味唾 (0.486g)、2-第3 丁基磺醯胺(0.640g)、二氮二環十一烯 (0.657g)以得出6-(4-第3 丁基苯磺醯基氨基甲醯基)-1-〇氯代苄基)-2-甲基苯並咪唑鈉鹽(269)0.280g。 [化合物(269)的物性] lH-NMR(DMS0-d6, 6) 1.25(9H, s)5 2.46(3H3 s)3 5·51(2Η, s), 6.37(1Η3 d, J :7·7Ηζ), 7·18(1Η, t), 7·31(1Η, t), 7·34(2Η, d, J=8.4Hz), 7·44(1Η, d, J二8 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 548272 經浐部中央打^-^m η消费合竹衫卬^ A7 B7 五、發明説明(21i •他),7·54(1Η,d,J:8.0Hz),7·69(2Η3 d,J:8.5Hz),7·78-7·82(2Η,in)。 IR(KBr) : 1596cm1〇 Mass(FAB) : m/e 518(M+l)〇 mp : 359.5-362°C〇 &lt;實施例208;6-笨磺醯基氨基甲醯基甲基“_[‘ (二氟甲基)卞基]笨並咪ϋ坐(270)之合成&gt; 依據實施例32之方法,使用N—苯磺醯基乙醯胺 基-3-胺基苯並醯胺(0.5〇幻與4_(三氟甲基)苄基溴(〇.418幻 以得出Ν-苯磺醯基-4-乙醯胺基-3_[4_(三氟甲基)苄基胺 基]笨並醯胺(0.30g)之粗精製物,將其溶解於曱醇中,經 放置以析出結晶。藉由過濾、乾燥結晶以得出6_苯磺醯 基氨基甲醯基-2-甲基三氟甲基)苄基]苯並咪唑 (270)0.160g。 [化合物(270)的物性] ilHiMlUDMSO-dG,¢) : 2·51(3Η,s),5.66(2H,s),7·28(2Η,d,J=8.1Hz),7. 59-7.65(3H, m), 7·67-7·75(4Η, m), 7·99(2Η, d, J=7.5Hz), 8·14(1Η, d, 0Hz), 12.43(1H, s)〇 IR(KBr) : 1618, 1550CDT1。 mp ·· 278.5 —280· 0°C。 &lt;實施例209;2-苄基-6-羧基-1_甲基苯並咪唑鹽酸 鹽(271)之合成&gt; 1 將5%氫氧化鈉水溶液(28g)加入2-苄基_6_乙氧羰 基-1-曱基苯並咪唑(〇.340g)之乙醇(4ml)溶液中,加熱迴 流1.5小時。以1N鹽酸使其變成酸性,在減壓下進行濃 (讀先閱讀背面之注意事項再填寫本頁) 訂 Φ·. 548272 A7 B7 五、發明説明(2l)i 縮。將乙醇加入殘渣中以萃取出有機物,藉由減壓以餾 去乙醇,而得出2-苄基-6-羧基-1-甲基苯並咪唑鹽酸鹽 (271)0.300g。 (讀先閱讀背面之注意事項再填寫本頁) [化合物(271)的物性] H^NMR(DMS0-d63 δ) : 4.00(3H3 s), 4.62(2H, s), 7.33(1H5 m), 7.35-7.45(4 H, ‘ 7·83(1Η, d, J:8.4Hz), 8·06(1Η, d, J:8.4Hz), 8·42(1Η, s), 13.3(1H, br s)0 &lt;實施例210;5-苯磺醯基氨基曱醯基甲基苯並咪 唑(272)之合成&gt; 在60 C下攪拌N-苯磺醯基-4-乙醯胺基-3-胺基苯 並醯胺(0.50(^)、350/0鹽酸(3.9§)、甲醇(15〇11)及水(121111) 之混合物1小時。使用碳酸氫鉀水溶液以將其中和之, 藉由過濾、乾燥所析出之結晶以得出5-苯磺醯基氨基甲 酉t基-2-甲基苯並口米ϋ坐(272)0.404g。 [化合物(272)的物性] Η-fmR(DMS0-d6,5) : 2·79(3Η,s),7·64-7·68(2Η,m),7.72-7·76(1Η,m),7 ·81(1Η, d, J:8.7Hz), 7·94(1Η, dd, J=1.6 及 8·7Ηζ), 8.02-8·05(2Η, m), 8 經y部中决^.^-而0 3消货合作私卬欠 ·30(1Η, s)〇 IR(KBr) : 1701cml〇 mp : 223·0-227.5°C〇 &lt;實施例45;3-曱氧基乙醯胺基_4_硝基安息香酸乙 酯之製造&gt; 依據製造例12之方法,使用3_胺基_4_硝基安息香酸 乙酯(15.0g)、甲氧乙醯氯(15〇g)以得出弘甲氧基乙醯胺 -------- 217 本紙張尺度適州中國國家標準(CNS ) A4^i7Ti〇x297公釐)~----- 548272 A7 B7 五·、發明説明(21&gt; 基-4-硝基安息香酸乙g旨(1 8.7g)。 [化合物的物性] (翱先閱讀背面之注意事項再填寫本頁) W-醜(CDCh,6) : 1·42(3Η,t,扣7.2Hz),3.58(3H,s),4.1K2H,s),4.43 (2H, q, j:7.2Hz), 7·85(1Η, dd, J:1.6 及 8·7Ηζ), 8·27(1Η, d, J:8.7Hz), 9.44(1H, d, J=1.6Hz), 11·15(1Η, s)。 &lt;實施例211; 1-(聯苯-4-甲基)-6-乙氧羰基-2-甲氧甲 基苯並咪唑(273)之合成&gt; 依據製造例14之方法,使用3-甲氧乙醯胺基-4-硝 基安息香酸乙酯(2.OOg)與4-聯苯甲基溴(2.98g)以得出 3 - [N-(聯苯-4-甲基)甲氧基乙醯胺基]_4_石肖基安息香酸乙 酉曰之粗精製物(2·02g)。接著依據實施例24之方法,以得 出1 -(聯苯-4-甲基)-6-乙氧羰基_2_曱氧甲基苯並咪唑 (273) 之粗精製物1.44g。 〈實施例212; 1_(聯苯-4-甲基)-6-羧基-2-甲氧基甲基 苯並咪唑(274)之合成&gt; 依據實施例53之方法,使用(聯苯甲基)_6_乙 氧基.基-2-曱氧基曱基笨並味唾之粗精製物(U4g)以 得出丨_(聯笨曱基)-6-羧基-2-甲氧基曱基苯並咪唑 (274) 0.864g。 [化合物(274)的物性] Η-NMR(DMS0-d6,ό) : 3·35(3Η,s),4·77(2Η,s) 5 5,68(2H,s),7·25(2Η,d, J-8,3Hz), 7.35(1H3 t, J=7.4Hz), 7.44(2H, t, J=7.5Hz), 7.61-7.66(4H, m)5 7·74(1Η, d, J=8.6Hz), 7·83(1Η, dd, J=1.6 及 8·5Ηζ), 8.08(1H, d3 J=1.2Mass (FAB): m / e 513 (M + 1). mp: 348 — 352 ° C (decomposition of accompaniment 3). &lt; Example 207; of 6- (4-Third-butylbenzenesulfonylaminofluorenyl) _1- (2-gasobenzyl) -2-methylbenzimidyl salivary sodium salt (269) Synthesis> According to the method of Example 141, 6-carboxy-1- (2-chlorobenzyl) -2-fluorenylbenzyl rice was used. Sit (0.450g), N, N'-Weiji diwei saliva (0.486g), 2-third butylsulfonamide (0.640g), diazabicycloundecene (0.657g) to get 0.280 g of 6- (4- 3rd butylbenzenesulfonylcarbamoyl) -1-ochlorobenzyl) -2-methylbenzimidazole sodium salt (269). [Physical properties of compound (269)] 1H-NMR (DMS0-d6, 6) 1.25 (9H, s) 5 2.46 (3H3 s) 3 5.51 (2Η, s), 6.37 (1Η3 d, J: 7 · 7Ηζ ), 7 · 18 (1Η, t), 7.31 (1Η, t), 7.34 (2Η, d, J = 8.4Hz), 7.44 (1Η, d, J 2 8 China National Standard (CNS) A4 specification (210X297 mm) 548272 The central part of the warp is printed ^-^ m η Consumption Bamboo Shirt ^ A7 B7 V. Description of the invention (21i • he), 7.54 (1Η, d, J: 8.0 Hz), 7.69 (2Η3 d, J: 8.5Hz), 7.78-7 · 82 (2Η, in). IR (KBr): 1596cm1 Mass (FAB): m / e 518 (M + l) 〇mp: 359.5-362 ° C 〈Example 208; 6-Bentylsulfonylcarbamoylmethyl group “— [′ (difluoromethyl) fluorenyl] benzylimide group (270 ) Synthesis &gt; According to the method of Example 32, N-benzenesulfonylacetamidinyl-3-aminobenzofluorenamine (0.5% and 4- (trifluoromethyl) benzyl bromide (0.5%) 418 to obtain a crude product of N-benzenesulfonyl-4-acetamido-3_ [4- (trifluoromethyl) benzylamino] benzidine (0.30g), which was dissolved in In methanol, it is left to precipitate crystals. After filtering, the crystals are dried to obtain 6-benzene 0.160 g of fluorenylcarbamoyl-2-methyltrifluoromethyl) benzyl] benzimidazole (270). [Physical properties of compound (270)] ilHiMlUDMSO-dG, ¢): 2.51 (3Η, s ), 5.66 (2H, s), 7.28 (2Η, d, J = 8.1Hz), 7.59-7.65 (3H, m), 7.67-7 · 75 (4Η, m), 7.99 (2Η, d, J = 7.5Hz), 8 · 14 (1Η, d, 0Hz), 12.43 (1H, s), IR (KBr): 1618, 1550CDT1. Mp ·· 278.5 —280 · 0 ° C. & Lt Example 209; Synthesis of 2-benzyl-6-carboxy-1_methylbenzimidazole hydrochloride (271) &gt; 1 A 5% sodium hydroxide aqueous solution (28g) was added to 2-benzyl-6_ In a solution of ethoxycarbonyl-1-fluorenylbenzimidazole (0.340 g) in ethanol (4 ml), heat to reflux for 1.5 hours. Make it acidic with 1N hydrochloric acid, and concentrate under reduced pressure (read the notes on the back of the reading first) Please fill in this page for matters) Order Φ ·. 548272 A7 B7 V. Description of Invention (2l) Ethanol was added to the residue to extract organic matter, and ethanol was distilled off under reduced pressure to obtain 0.300 g of 2-benzyl-6-carboxy-1-methylbenzimidazole hydrochloride (271). (Read the precautions on the back before you fill in this page) [Physical properties of compound (271)] H ^ NMR (DMS0-d63 δ): 4.00 (3H3 s), 4.62 (2H, s), 7.33 (1H5 m), 7.35-7.45 (4 H, '7.83 (1Η, d, J: 8.4Hz), 8.06 (1Η, d, J: 8.4Hz), 8.42 (1Η, s), 13.3 (1H, br s) 0 &lt; Example 210; Synthesis of 5-benzenesulfonylaminofluorenylmethylbenzimidazole (272) &gt; Stir N-benzenesulfonyl-4-ethylamidoamine at 60 C- 3-Aminobenzofluorenamine (0.50 (^), 350/0 hydrochloric acid (3.9§), methanol (15010), and water (121111) mixture for 1 hour. Use an aqueous potassium hydrogen carbonate solution to neutralize it, The precipitated crystal was filtered and dried to obtain 0.404 g of 5-benzenesulfonylcarbamoylmethyl-2-methylbenzylpyrene (272). [Physical properties of compound (272)] Η- fmR (DMS0-d6,5): 2.79 (3Η, s), 7.64-7 · 68 (2Η, m), 7.72-7 · 76 (1Η, m), 7.81 (1Η, d, J: 8.7 Hz), 7.94 (1Η, dd, J = 1.6 and 8.7Ηζ), 8.02-8 · 05 (2Η, m), 8 determined by the Ministry of Justice ^. ^-And 0 3 Private Ownership 30 (1Η, s) 〇IR (KBr): 1701cml 〇mp: 223.0-227.5 ° C 〇 &lt; Real Example 45; Production of 3-methoxyethylamido-4_nitrobenzoate ethyl ester> According to the method of Production Example 12, 3_amino_4-nitrobenzoate ethyl ester (15.0g) was used And methoxyacetamidine (15 g) to obtain hong methoxyacetamidine -------- 217 This paper is sized to China National Standard (CNS) A4 ^ i7Ti〇297mm) ~ ----- 548272 A7 B7 V. Explanation of the invention (21 &gt; Ethyl-4-nitrobenzoate g (1 8.7g). [Physical properties of compound] (翱 Please read the precautions on the back before filling this page ) W-ugly (CDCh, 6): 1.42 (3Η, t, 7.2Hz), 3.58 (3H, s), 4.1K2H, s), 4.43 (2H, q, j: 7.2Hz), 7 · 85 (1Η, dd, J: 1.6 and 8.7Ηζ), 8.27 (1Η, d, J: 8.7Hz), 9.44 (1H, d, J = 1.6Hz), 11 · 15 (1Η, s). &lt; Example 211; Synthesis of 1- (biphenyl-4-methyl) -6-ethoxycarbonyl-2-methoxymethylbenzimidazole (273) &gt; According to the method of Production Example 14, 3- Ethyl methoxyacetamido-4-nitrobenzoate (2.OOg) and 4-biphenylmethyl bromide (2.98g) to give 3-[N- (biphenyl-4-methyl) methyl Ethoxyacetamido] _4_shishothiobenzoate Crude refined product (2.02g). Then, according to the method of Example 24, 1.44 g of a crude product of 1- (biphenyl-4-methyl) -6-ethoxycarbonyl-2-oxomethylbenzimidazole (273) was obtained. <Example 212; Synthesis of 1- (biphenyl-4-methyl) -6-carboxy-2-methoxymethylbenzimidazole (274)> According to the method of Example 53, (biphenylmethyl ) _6_ethoxy.yl-2-methoxyoxyfluorenyl crude refined product (U4g) to give 丨 _ (bibenzyl) -6-carboxy-2-methoxyfluorenyl Benzimidazole (274) 0.864 g. [Physical properties of compound (274)] Η-NMR (DMS0-d6, ό): 3.35 (3Η, s), 4.77 (2Η, s) 5 5,68 (2H, s), 7.25 ( 2Η, d, J-8, 3Hz), 7.35 (1H3 t, J = 7.4Hz), 7.44 (2H, t, J = 7.5Hz), 7.61-7.66 (4H, m) 5 7 · 74 (1Η, d , J = 8.6Hz), 7 · 83 (1Η, dd, J = 1.6 and 8. · 5Ηζ), 8.08 (1H, d3 J = 1.2

Hz), 12.83(1H, s)〇 _____218 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(21夫 &lt;實施例213; 1-(聯苯-4-甲基)-6-(1-丁磺醯基氨基甲 醯基)-2-甲氧基甲基苯並咪唑(275)之合成&gt; 依據實施例98之方法,使用1 -(聯苯-4-甲基)-6-魏 基-2-甲氧基甲基苯並味唾(〇.400g)、N,N’ -幾基二味ϋ坐 (〇.348g)、1_丁石黃酸胺基(〇.294g)、二氮二環十一稀(0.327g) 以得出1-(聯苯-4-甲基)-6-(1-丁磺醯基氨基甲醯基)-2-甲 氧基甲基苯並咪唑(275)0.429g。 [化合物(275)的物性] %-NMR(DMS0-d63 6) : 〇·84(3Η, t, J=7.4Hz), 1·35-1·42(2Η, m), 1.62-1.70( 2Η, m)3 3·33(3Η, s), 3·51(2Η, t, J=7.6Hz), 4·74(2Η, s), 5.65(2Η, s)3 7·2 6(2H, d3 J=8,3Hz), 7.35(1H, t, J=7.3Hz), 7.44(2H, t, J=7.5Hz), 7.62-7.67 (4H, m), 7·78(1Η, d3 J=8.6Hz), 7·84(1Η, dd, J二1·5 及 8·4Ηζ), 8·24(1Η, d3 J=1.5Hz)3 12.0Κ1Η, s)〇 IR(KBr) : 1684cm-即:176.0 —178.5°C〇 &lt;實施例214;l-(4·苄氧基苄基)_6_乙氧羰基曱氧 基曱基苯並咪唑(276)之合成&gt; ^沪部中决«卑而P-T消費合竹*印^ (讀先閱讀背面之注意事項再填寫本頁) 依據製造例14之方法,使用3_乙氧基乙醯基胺基 硝基芳息香酸乙酯(2.00g)與4_苄氧基苄基氣(3.3〇g) 以得出3-[N-(4-苄氧基苄基)甲氧基乙醯基胺基]硝基 安息香酸乙酯之粗精製物(2.14g)。接著依據實施例24 之方法以得出1-(4-苄氧基苄基乙氧羰基甲氧基甲 基本並米嗤(276)之粗精製物(1.66 g)。 &lt;貝施例215;1-(4-苄氧基苄基)羧基_2_曱氧基曱基 -----219 _ 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐)'一&quot;&quot;' --- 548272 A7 B7Hz), 12.83 (1H, s) 〇 _____ 218 This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (21 husband &lt; Example 213; 1- (biphenyl Synthesis of 4-methyl) -6- (1-butanesulfonylaminomethylamidino) -2-methoxymethylbenzimidazole (275) &gt; According to the method of Example 98, 1-( Biphenyl-4-methyl) -6-Weiyl-2-methoxymethylbenzoxyl salivary (0.400 g), N, N'-kisyl diisocyanine (0.348 g), 1- Butanite amine (0.294 g) and diazabicycloundecene (0.327 g) to give 1- (biphenyl-4-methyl) -6- (1-butanesulfonylcarbamidine) Group) 0.429 g of 2-methoxymethylbenzimidazole (275). [Physical properties of compound (275)]% -NMR (DMS0-d63 6): 0.84 (3Η, t, J = 7.4 Hz) , 1.35-1 · 42 (2Η, m), 1.62-1.70 (2Η, m) 3 3.33 (3Η, s), 3.51 (2Η, t, J = 7.6Hz), 4.74 ( 2Η, s), 5.65 (2Η, s) 3 7 · 2 6 (2H, d3 J = 8,3Hz), 7.35 (1H, t, J = 7.3Hz), 7.44 (2H, t, J = 7.5Hz) , 7.62-7.67 (4H, m), 7.78 (1Η, d3 J = 8.6Hz), 7.84 (1Η, dd, J 2 1.5 and 8.4Ηζ), 8.24 (1Η, d3 J = 1. 5Hz) 3 12.0K1Η, s) 〇IR (KBr): 1684cm-that is: 176.0-178.5 ° C. &lt; Example 214; 1- (4 · benzyloxybenzyl) -6-ethoxycarbonyl fluorenyloxy fluorene Synthesis of Benzylbenzimidazole (276) &gt; ^ Shanghai Ministry of Justice «Beijing and PT Consumption Hezhu * India ^ (Read the precautions on the back before filling this page) According to the method of manufacturing example 14, using Ethoxyethylaminoaminonitrobenzoate (2.00g) and 4-benzyloxybenzyl gas (3.30g) to give 3- [N- (4-benzyloxybenzyl) Crude refined product of ethyl methoxyacetamido] nitrobenzoate (2.14 g). Then according to the method of Example 24 to obtain a crude product (1.66 g) of 1- (4-benzyloxybenzylethoxycarbonylmethoxymethylbenzidine (276). &Lt; 贝 施 例 215; 1- (4-benzyloxybenzyl) carboxyl_2_ 曱 oxyfluorenyl ----- 219_ This paper is suitable for 1] Chinese National Standard (CNS) A4 specification (210X297 mm) '一 &quot; &quot; '--- 548272 A7 B7

五、發明説明(2A 苯並咪唑(277)之合成&gt; 依據貫施例53之方法,使用丨气‘苄 (讀先閱讀背面之注意事項再填寫本頁) 乙氧羰基-2-甲氧基甲基苯並咪唑之粗精製物(3 75g)以 得出1-(4-¥氧基节基)-6-幾基_2_甲氧基甲基苯並咪唑 (277)2.64g 〇 [化合物(277)的物性] !Η-NMR(DMS0-d6,ά) : 3·34(3Η,s)5 4·74(2Η,s),5·05(2Η, s),5·53(2Η, s) ,6.97(2Η, d, J=8.7Hz), 7·15(2Η3 d, J=8.7Hz), 7.31(1Η, t, J二7·2Ηζ), 7·41 (2Η,d,J^.ZHz), 7·71(1Η,d,ιϋ.^ΙΗζ),7·81(1Η, dd3 J:1.5 及 7·4Ηζ), 8·04(1Η, d, J二1·1Ηζ), 12·81(1Η, s)。 &lt;實施例216;1-(4-苄氧基苄基)_6_(1_丁磺醯基氨基 甲醯基)-2-曱氧基甲基苯並咪唑(278)之合成&gt; άψ. 依據實施例I55之方法,使用1-(4_苄氧基节基)-6-魏基-2-曱氧基曱基苯並咪α坐(〇.4〇〇g)、n,N,-幾基二味。坐 (〇.322g)、1-丁磺醯胺(〇.272g)、二氮二環十一烯(0.302g) 以得出1-(4_苄氧基苄基)-6_(l-丁磺醯基氨基甲醯基)_2-甲氧基曱基苯並咪唑(278)0.32lg。 [化合物(278)的物性] ^-NMRiDMSO-dp, δ) : 0.86(3H3 t3 J=7.4Hz)3 1.37-1.44(2H, m),1.65-1.71(2 H,in), 3·32(3Η,s),3·52(2Η,t,J二7·6Ηζ),4·71(2Η,s),5.05(2H,s),5.51 (2H,s),6·98(2Η,d,J:3.7Hz),7·15(2Η,d,J=8.3Hz),7·31(1Η,t,J二7·2Ηζ ),7·37(2Η, t, J=7.2Hz), 7·41(2Η, d, J=7.1Hz), 7·74(1Η, d3 J=8.5Hz), 7.8 2(1H,dd,J=1.5 及 8.5Hz),8·21(1Η,s),1L98(1H, s)。 IR(KBr) : 1685CHT1。 mp : 72.0—74.0°C。 ______220 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明( &lt;貫施例217;1-(2,4-二氯代苄基)-6_乙氧羰基·2•甲 氧基甲基苯並咪唑(279)之合成&gt; 依據製造例14之方法,使用3_乙氧基乙醯基胺基 硝基安息香酸乙酯(2.00g)與2,扣二氣苄基氯(2 〇8幻以 得出3-[N-(2,4-二氯代苄基)甲氧基乙醯基胺基]_4_硝基 安息香酸乙酯之粗精製物。接著依據實施例24之方法 以得出1-(2,4-二氣代苄基)-6-乙氧羰基_2_甲氧基甲基苯 並咪唑(2乃)之粗精製物3.15g。 &lt;實施例218;6-羧基-1-(2,4_二氯代苄基)-2_甲氧基 曱基苯並咪唑(280)之合成&gt; 依據貫施例53之方法,使用丨_(2,4_二氯代苄基)_ 6-乙氧基羰基-2-曱氧基曱基苯並咪唑之粗精製物(315g) 以得出6-羧基-1-(2,4-二氯代苄基)_2_曱氧基曱基苯並咪 唑(280)1.46g。 [化合物(280)的物性] 4〜NMR(DMS0-d6,ά) : 3·23(3Η,s),4·70(2Η,s),5·68(2Η, s),6.54UH,d, J=8.5Hz),7·31(1Η,dd,J:2.2 及 8·5Ηζ),7·73(1Η,d,J:2.1liz),7·76(1Η ,d, J二8·5Ηζ), 7·86(1Η, dd, J二1·5 及 8·5Ηζ), 8·0〇(1Η, d, 12· ^牙,部中央&quot;-率^只3消費合竹私印^ (讀先閱讀背面之注意事項再填寫本頁) MW. 85(1Η, s)〇 ^ &lt;實施例219;6-(1·丁磺醯基氨基甲醯基卜丨-^仁二 氯代卡基)-2-甲氧基甲基苯並味唾(2 81)之合成&gt; 依據實施例98之方法,使用6_羧基_1-(2,4-二氯代 苄基)-2-甲氧基甲基苯並咪唑(〇.4〇〇g)、N,N,-羰基二咪唑 (0.355g)、1-丁 磺醯胺(〇.3〇〇g)、二氮二環十一烯(〇 333g) 尺度適用中國國家標準(CNS ) A4規格(210/29¾1 羡) 548272 A7 B7 五、發明説明( 以得出6-(1-丁磺醯基氨基甲醯基)-i-(2,4-二氯代节基)_ 2-甲氧基甲基苯並咪唑(281)0.430g。 (讀先閱讀背面之注意事項再填寫本頁) [化合物(281)的物性] 2H? m), 3.21(3H, s), 3.51(2H, t3 J=7.6Hz)3 4.68(2H, s), 5.65(2H, s), fi.4 6(1H, d, J二8·5Ηζ), 7·31(1Η, dd, J二2.0 及 8·4Ηζ), 7·75(1Η, d3 J:2.1Hz), 7·80(1Η,d,J:8.5Hz),7·86(1Η,dd,J:1.7 及 8·6Ηζ),8·14(1Η,d,J二 1·2V. Description of the invention (2A Synthesis of benzimidazole (277) &gt; According to the method of Example 53, using Benzene (read the precautions on the back before filling this page) ethoxycarbonyl-2-methoxy Crude refined product of methyl benzimidazole (3 75 g) to give 1- (4- ¥ oxybenzyl) -6-isopropyl-2-methoxymethyl benzimidazole (277) 2.64 g. [Physical properties of compound (277)]! -NMR (DMS0-d6, ά): 3.34 (3Η, s) 5 4.74 (2Η, s), 5.05 (2Η, s), 5.53 (2Η, s), 6.97 (2Η, d, J = 8.7Hz), 7.15 (2Η3 d, J = 8.7Hz), 7.31 (1Η, t, J = 7.2 · 2Ηζ), 7.41 (2Η, d, J ^ .ZHz), 7.71 (1Η, d, ιϋ. ^ ΙΗζ), 7.81 (1Η, dd3 J: 1.5 and 7. · 4Ηζ), 8.04 (1Η, d, J2 · 1 · 1Ηζ), 12 · 81 (1Η, s). &Lt; Example 216; 1- (4-benzyloxybenzyl) -6- (1-butanesulfonylcarbamoyl) -2-fluorenyloxymethyl Synthesis of benzimidazole (278) &gt; According to the method of Example I55, 1- (4-benzyloxybenzyl) -6-weiyl-2-fluorenylbenzyl benzimidyl α was used ( 0.400 g), n, N, -kisyl di-taste. Sit (〇.322 g), 1-butanesulfonamide (0.272 g), diazabicyclo Undecene (0.302g) to give 1- (4-benzyloxybenzyl) -6_ (l-butanesulfonylaminomethylamidino) _2-methoxyfluorenylbenzimidazole (278) 0.32lg [Physical properties of compound (278)] ^ -NMRiDMSO-dp, δ): 0.86 (3H3 t3 J = 7.4Hz) 3 1.37-1.44 (2H, m), 1.65-1.71 (2 H, in), 3.32 (3Η, s), 3.52 (2Η, t, J 2 7.6Ηζ), 4.71 (2Η, s), 5.05 (2H, s), 5.51 (2H, s), 6.98 (2Η, d, J: 3.7 Hz), 7.15 (2Η, d, J = 8.3Hz), 7.31 (1Η, t, J 2 7.2Ηζ), 7.37 (2Η, t, J = 7.2Hz) , 7.41 (2Η, d, J = 7.1Hz), 7.74 (1Η, d3 J = 8.5Hz), 7.8 2 (1H, dd, J = 1.5 and 8.5Hz), 8.21 (1Η, s ), 1L98 (1H, s). IR (KBr): 1685CHT1. mp: 72.0-74.0 ° C. ______220 _ This paper size is in accordance with China National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (&lt; Example 217; 1- (2,4-dichlorobenzyl) -6_ Synthesis of ethoxycarbonyl · 2 · methoxymethylbenzimidazole (279) &gt; According to the method of Production Example 14, 3-ethoxyethylamidoaminonitrobenzoate (2.00 g) and 2, deaminium benzyl chloride (2.08 to obtain 3- [N- (2,4-dichlorobenzyl) methoxyethylamidoamino] _4-nitrobenzoate ethyl ester The crude product was purified according to the method of Example 24 to obtain the crude product of 1- (2,4-dioxobenzyl) -6-ethoxycarbonyl-2-methoxymethylbenzimidazole (2) 3.15 g of purified product. &Lt; Example 218; Synthesis of 6-carboxy-1- (2,4-dichlorobenzyl) -2-methoxymethoxybenzimidazole (280) &gt; Method 53, using 丨 _ (2,4_dichlorobenzyl) _ 6-ethoxycarbonyl-2-methoxyoxybenzyl benzimidazole crude product (315g) to obtain 6-carboxyl- 1- (2,4-dichlorobenzyl) _2_methoxyoxybenzyl benzimidazole (280) 1.46 g. [Physical properties of compound (280)] 4 ~ NMR (DMS0-d6, ά): 3 · 23 (3Η, s), 4.70 (2Η, s), 5.68 (2Η, s), 6.54UH, d, J = 8.5Hz), 7.31 (1Η, dd, J: 2.2 and 8 · 5Ηζ), 7.73 (1Η, d, J: 2.1liz), 7.76 (1Η, d, J 2: 8.5Ηζ), 7.86 (1Η, dd, J 2: 1.5, and 8.5Ηζ ), 8 · 〇〇 (1Η, d, 12 · ^ tooth, central part &quot;-rate ^ only 3 consumer Hezhu private seal ^ (read the precautions on the back before filling in this page) MW. 85 (1Η, s) ○ Example 219; 6- (1. Butanesulfonylaminocarbamyl phenyl ^ -rendichlorocarbyl) -2-methoxymethyl benzo saliva (2 81) Synthesis> According to the method of Example 98, 6-carboxy_1- (2,4-dichlorobenzyl) -2-methoxymethylbenzimidazole (0.400 g), N , N, -carbonyldiimidazole (0.355g), 1-butanesulfonamide (0.300g), diazabicycloundecene (〇333g) The scale is applicable to China National Standard (CNS) A4 specifications (210 / 29¾1 Xian) 548272 A7 B7 V. Description of the invention (to get 6- (1-butanesulfonylaminomethylamidino) -i- (2,4-dichlorobenzyl) _ 2-methoxymethyl Benzimidazole (281) 0.430 g. (Read the precautions on the back before filling this page) [Chemicals (Physical properties of (281)] 2H? M), 3.21 (3H, s), 3.51 (2H, t3 J = 7.6Hz) 3 4.68 (2H, s), 5.65 (2H, s), fi.4 6 (1H, d, J 2: 8.5Ηζ), 7.31 (1Η, dd, J2 2.0 and 8.4Ηζ), 7.75 (1Η, d3 J: 2.1Hz), 7.80 (1Η, d, J: 8.5 Hz), 7.86 (1Η, dd, J: 1.7 and 8.6Ηζ), 8.14 (1Η, d, J 2: 1.2

Hz), 12.00(1Η3 s)〇 IR(KBr) : 1694cm—1。 mp : 168.5 —170.5°C。 &lt;實施例220;l-(2-氯代苄基)-2-甲基-6-(1-丁磺醯基 氨基甲醯基)苯並咪唑(282)之合成&gt; 依據實施例98之方法,使用6-羧基-1-(2-氯代节 基)-2-甲基苯並味唾(0.400g)、N,N’- I炭基二味唾 (0.431g)、1-丁磺醯胺(0.328g)、二氮二環十一烯(〇.4〇4g) 以得出1 -(2-氯代卞基)-2-甲基-6-( 1 - 丁石黃酿基氨基甲酷 基)苯並咪唑(282)0.459§。 [化合物(282)的物性] 經滂部中央榀枣而β,τ消贽合竹衫印繁 ^-NMRCDMSO-dG, 6) : 0.98(3H, t, J=7.4Hz), 1.67-1.75(2H5 m) 5 2.50(3H, s ),3·49(2Η, t, J=7.7Hz), 5·61(2Η5 s), 6·45(1Η, d,扣7.0Hz), 7.24(1H, dt, J二0·8 及 7·8Ηζ), 7·35(1Η, dt, J二1.4 及 7·4Ηζ), 7·63(1Η, dd, J:〇.9 及 7·9Ηζ), 7·69(1Η, d, J=8.5Hz), 7·81(1Η, dd, J=1.6 及 8·5Ηζ), 8.12( 1H, d, J二1·6Ηζ), 11·90(1Η, s)。 IR(KBr) : 1676cm—1。 mp : 217.5—218.5〇C〇 _____—-242···.---- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明( &lt;實施例221;6-乙磺醯基氨基曱醯基氯代节 基)-2-甲基苯並咪唑(283)之合成&gt; 依據實施例98之方法,使用6-羧基-i-p-氯代节 基)-2-甲基苯並味。坐(0.400g)、N,N’-罗炭基二u米哇 (〇.431g)、乙磺醯胺(0.290g)、二氮二環十一烯((M04g) 以得出6-乙石黃醯基氨基甲酿基-1 -(2-氣代节基)_2-曱基苯 並咪唑(283)0.459g。 [化合物(283)的物性] iH-NMIUDMSO-dG,6) : 1·23(3Η,t,J:7.3Hz),2.5G(3H,s),3·50(2Η,q,J二7 ·3Ηζ),5·61(2Η,s),6·45(1Η,d,J=6.7Hz),7·24(1Η,dt,J=0.9.及 7·5Ηζ) ,7.35(1Η, dt, J=1.4 及 7·5Ηζ), 7·58(1Η, dd, J=1.0 及 8·0Ηζ), 7.69(1 Η,d,J=8.5Hz),7.81(1Η,ddv J=1.6 及 8.他),8·13(1Η,d,J:1.5Hz),11 .86(1H3 s)〇 IR(KBr) : 1673cm—1。 mp : 256.5 — 258.5°C。 &lt;實施例222;6-(丙磺内醯胺-1-羰基)-1-(2-氯代苄 基&gt;2-曱基苯並咪唑(284)之合成&gt; 經浐部中决打^-^m 5消費合作ii卬5? (誚先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用6-羧基-1-(2-氯代节 基)-2-甲基苯並咪唑(〇.400g)、N,N,-羰基二咪唑 (〇.431g)、1-(3-氣代丙)磺醯胺(0.420g)、二氮二環十一烯 (〇.404g)以得出6-(丙磺内醯胺-1_羰基)-1-(2-氣代苄基)-2-曱基笨並咪唑(284)0.323@。 [化合物(284)的物性] lH~NMR(DMS0-d6, δ) : 2.27-2·33(2Η, m), 2.52(3H, s), 3.52(2H, t, J-7.0Hz 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(22^) ),3.87(2H, t, J=6.6Hz), 5.59(2H, s), 6.57(1H, d, J=7.7Hz), 7.23(1H, t, J=7.6Hz), 7.34(1H, t5 J=6.4Hz)s 7.53-7.58(2Η, m)&gt; 7.67(1H, d, J=8.4Hz), 7.79(1H, d, J=l.lHz)〇 IR(KBr) : 1648CDT1。 mp:165.5 — 166.60C〇 &lt;實施例223;6-笨磺醯基氨基甲醯基q兴聯苯_4_甲 基)-2-環丙基苯並咪唑鉀鹽(285)之合成&gt; 依據貫施例170之方法,使用N—苯績醯基_4_胺基 -3-(聯苯-4-甲基胺基)笨並醯胺(〇4〇〇g)與環丙羰基氯 (O.lOlg)以得出N-苯磺醯基(聯笨甲基胺基)_心環 丙.基胺基笨並S&amp;fe’藉此以得出6-笨石黃酸基氨基曱醯 基-1-(聯苯-4-甲基)-2-環丙基笨並咪唑卸鹽 (285)0.196g ° [化合物(285)的物性] ilHiMIUDMSiHIG,6):1·〇〇-1.15UH,m),2·23-2·31(1Η,m),5.66(2H,s),7.2 1(2Η, m, J=9.1Hz), 7·32_7·45(7Η, m), 7·59-7·63(4Η, m), 7·78-7·83(3Η, m), 7·97(1Η, s) 〇 IR(Nujol) : 1540cm-1〇 經浐部中次榀^-而6_-1消赀合竹私印繁 (讀先閱讀背面之注意事項再填寫本頁)Hz), 12.00 (1Η3 s). IR (KBr): 1694cm-1. mp: 168.5 —170.5 ° C. &lt; Example 220; Synthesis of l- (2-chlorobenzyl) -2-methyl-6- (1-butanesulfonylcarbamoyl) benzimidazole (282) &gt; According to Example 98 Method, using 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzoxyl salivary (0.400g), N, N'-I carbon-based disulfal salivary (0.431g), 1- Butanesulfonamide (0.328g) and diazabicycloundecene (0.404g) to give 1- (2-chlorofluorenyl) -2-methyl-6- (1-butyrate yellow Benzylcarbamoyl) benzimidazole (282) 0.459 §. [Physical properties of compound (282)] β, τ digestion and bamboo shirt printing through the central part of the crotch ^ -NMRCDMSO-dG, 6): 0.98 (3H, t, J = 7.4Hz), 1.67-1.75 ( 2H5 m) 5 2.50 (3H, s), 3.49 (2Η, t, J = 7.7Hz), 5.61 (2Η5 s), 6.45 (1Η, d, 7.0Hz), 7.24 (1H, dt, J 2 0 · 8 and 7.8Ηζ), 7.35 (1Η, dt, J 2 1.4 and 7.4Ηζ), 7.63 (1Η, dd, J: 0.9 and 7.9Ηζ), 7 · 69 (1Η, d, J = 8.5Hz), 7.81 (1Η, dd, J = 1.6 and 8.5Ηζ), 8.12 (1H, d, J = 1.66Ηζ), 11 · 90 (1Η, s ). IR (KBr): 1676cm-1. mp: 217.5-218.5〇C〇 _____-- 242 ........ This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 5. Description of the invention (&lt; Examples 221; 6-Ethylsulfonylaminofluorenylchlorobenzyl) -2-methylbenzimidazole (283) Synthesis> According to the method of Example 98, 6-carboxy-ip-chlorobenzyl was used ) -2-methylbenzo. Sit (0.400g), N, N'-Carbonyl diu miwa (0.431g), ethanesulfonamide (0.290g), diazabicycloundecene ((M04g) to get 6-ethyl Permethrinyl-1-(2-Azobenzyl) _2-fluorenylbenzimidazole (283) 0.459 g. [Physical properties of compound (283)] iH-NMIUDMSO-dG, 6): 1.23 (3Η, t, J: 7.3Hz), 2.5G (3H, s), 3.50 (2Η, q, J 2 7. 3Ηζ), 5.61 (2Η, s), 6.45 (1Η, d , J = 6.7Hz), 7.24 (1Η, dt, J = 0.9. And 7.5Ηζ), 7.35 (1Η, dt, J = 1.4 and 7.5Ηζ), 7.58 (1Η, dd, J = 1.0 and 8.0Ηζ), 7.69 (1Η, d, J = 8.5Hz), 7.81 (1Η, ddv J = 1.6 and 8. he), 8.13 (1Η, d, J: 1.5Hz), 11. 86 (1H3 s) IR (KBr): 1673cm-1. mp: 256.5 — 258.5 ° C. &lt; Example 222; 6- (propanesulfonamide-1-carbonyl) -1- (2-chlorobenzyl &gt; Synthesis of 2-fluorenylbenzimidazole (284) &gt; Hit ^-^ m 5 Consumer Cooperation ii 卬 5? (诮 Please read the notes on the back before filling this page) According to the method of Example 98, use 6-carboxy-1- (2-chlorobenzyl) -2- Methyl benzimidazole (0.400 g), N, N, -carbonyldiimidazole (0.431 g), 1- (3-gasopropyl) sulfonamide (0.420 g), diazabicycloundecene ( 0.0404 g) to give 6- (propanesulfonamido-1-carbonyl) -1- (2-fluorobenzyl) -2-fluorenylbenzimidazole (284) 0.323 @. [Compound (284) Physical properties] lH ~ NMR (DMS0-d6, δ): 2.27-2 · 33 (2Η, m), 2.52 (3H, s), 3.52 (2H, t, J-7.0Hz) This paper is applicable to Chinese national standards ( CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (22 ^)), 3.87 (2H, t, J = 6.6Hz), 5.59 (2H, s), 6.57 (1H, d, J = 7.7 Hz), 7.23 (1H, t, J = 7.6Hz), 7.34 (1H, t5 J = 6.4Hz) s 7.53-7.58 (2Η, m) &gt; 7.67 (1H, d, J = 8.4Hz), 7.79 ( 1H, d, J = 1.1 Hz) IR (KBr): 1648CDT1. Mp: 165.5-166.60C &lt; Example 223; 6-Bentylsulfonylcarbamoyl group q Synthesis of biphenyl_4-methyl) -2-cyclopropylbenzimidazole potassium salt (285) &gt; According to the method of Example 170, N-phenylphenanthino-4_amino group-3- ( Biphenyl-4-methylamino) benzamidine (400 g) and cyclopropylcarbonyl chloride (0.110 g) to give N-phenylsulfonyl (bibenzylmethylamino) Cyclopropylaminobenzyl S &amp; fe 'is used to give 6-benzoflavinylaminofluorenyl-1- (biphenyl-4-methyl) -2-cyclopropylbenzimidazole Salt (285) 0.196 g ° [physical properties of compound (285)] ilHiMIUDMSiHIG, 6): 1.0--1.15 UH, m), 2.23-2 · 31 (1Η, m), 5.66 (2H, s) , 7.21 (2Η, m, J = 9.1Hz), 7.32_7 · 45 (7Η, m), 7.59-7 · 63 (4Η, m), 7.78-7 · 83 (3Η, m) , 7.97 (1Η, s) 〇IR (Nujol): 1540cm-1〇 After the middle of the 榀 ^-and 6_-1 eliminate the combination of bamboo and private printing (read the precautions on the back before filling this page )

Mass(FAB) : m/e 546(M+l)〇 - mp : 220.8—224.8〇C〇 &lt;實施例224; 1-(2-氯代苄基)-2-曱基-6-(1-戊磺醯基 氨基甲醯基)苯並咪唑(286)之合成&gt; 依據實施例98之方法,使用6-羧基-1-(2-氣代 苄基)_2·甲基苯並咪唑(〇.4〇Og)、N,N,-羰基二咪唑 _ 224______ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) 548272 A7 B7 五、發明説明(22i (讀先閱讀背面之注意事項再填寫本頁) (0.431g)、1-戊磺醯胺(〇.4〇2g)、二氮二環十一烯(〇.404g) 以付出1-(2-氣代节基)-2-甲基-6-(1-戊石黃酿基氨基甲醯 基)苯並咪唑(286)0.49lg。 [化合物(286)的物性] W-NM^DMSO-c^,d) : 〇·81(3Η,t,j=7.2Ηζ),1·23-1·28(2Η,m),1·32-1.37( 2H,in),1·65- 1.69(2H,m),3·50(2Η,t,J二7·8Ηζ),5·61(2Η,s),6·45(1Η,d, J=7.5Hz),7.24(lH3t,J:7.6Hz),7.35(lH,t,J=7.5Hz),7.57(lH,d,J=7.9 Hz),7·69(1Η,d,J:8.5Hz),7·81(1Η3 dd,J:1.7 及 8.4Hz),8.12UH,d,J 二1·2Ηζ), 12·25(1Η, s)。 IR(KBr) : 1684CDT1。 mp : 173·3-179·8ο0〇 〈實施例225;l-(2_氯代苄基)-2_甲基-6-[(3_甲基丁) 磺醯基氨基甲醯基]苯並咪唑(287)之合成&gt; 依據實施例98之方法,使用6-羧基-1-(2-氯代苄 基)-2-甲基苯並口米。坐(〇.300g)、N,N’-獄基二口米唾 (0.323g)、1-(3-甲基)丁 磺醯胺(〇.302g)、二氮二環十一烯 (0.303g)以得出1-(2-氣代苄基)-2-曱基-6_[(3-曱基丁)磺 醯基氨基曱醯基]笨並咪唑(287)0.284g。 [化合物(287)的物性] 'H-NMRlDMSO-dG, δ) : 0.84(6H, d5 J=6.5Hz), 1.52-1.59(2H, m), 1.61-1.7 0(1H, m), 3.44(2H, t, J-7.9Hz)3 5.60(2H, s), 6.45(1H, d5 J=7:8Hz)5 7.24( 1H, t, J:7.6Hz), 7·35(1Η3 t, J:7.4Hz), 7·57(1Η, d, J=7.9Hz), 7.66(1H, d, J二8.5Hz),7·81(1Η3 dd,J:1.6 及 8.6Hz),8.09UH,s),11·87(1Η,s)。 IR(KBr) : 1682CHT1。 mp : 201.0-204.1oC〇 ----- 225__ 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(22i &lt;實施例226;l-(2-氯代卡基)-6-(1-己石黃酿基氨基甲 醯基)-2-甲基苯並咪唑(288)之合成&gt; (#先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用6-羧基-1-(2-氯代节 基)-2-甲基苯並咪唑(0.300g)、N,N,-羰基二味唑 (〇.323g)、1_ 己磺醯胺(0.335g)、二氮二環十一烯(0.303g) 以得出1-(2-氣代卡基)-6-(1-己石黃酸基氨基曱酿基)_2_甲 基笨並咪唑(288)0.379g。 [化合物(288)的物性] ^-NMRiDMSO-dG, δ) : 0·81(3Η, t5 J-7.0Hz)5 L18-L28(4H, m)3 1.32-1.41( 2H, m), 1.63-1.71(2H, m), 2·53(3Η, s), 3·50(2Η, t, J=7.7Hz), 5·64(2Η, s) ,6·51(1Η, d, J:7.7Hz), 7·25(1Η, dt, J=1.2 及 7·8Ηζ), 7·36(1Η, dt, J=1 •4 及 7·7Ηζ), 7·58(1Η, dd, J:1.0 及 8·0Ηζ), 7·72(1Η, d, J:8.5Hz), 7· 84(1Η,dd,J:1.6 及 8.·5Ηζ),8·15(1Η,d,J=1.3Hz),11·87(1Η,s)。 IR(KBr) : 1682CHT1。 mp : 141.2-143.5°C〇 &lt;實施例227;6-第3 丁氧基羰基胺基-1-(2-氯代苄 基)-2-甲基苯並咪唑(289)之合成&gt; 依據實施例18之方法,使用6-羧基-1·(2-氯代苄 基)-2-甲基苯並咪唑(l.Olg)、二苯基磷醯胺(imi)、二異 丙基乙基胺(lml)及第3 丁醇(25ml)以得出6-第3 丁氧基 羰基胺基-1-(2-氯代苄基)-2-曱基苯並咪唑(289)0.760g。 [化合物(289)的物性] W-醒(CDC13,6) : 1·49(9Η,s),2·47(3Η,s),5·37(2Η,s),6·41(1Η,d3 J二7·5Ηζ), 6·55(1Η, br s), 6·93(1Η, dd, J:1.9 及 8·6Ηζ), 7·08(1Η, t, J =7.5Hz), 7.22(1H, t), 7.44(1H, d, J=8-0Hz), 7.62(2H, d, J=8,6Hz)〇 116 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(223 &lt;實施例228;6-胺基-1-(2-氯代苄基)-2-甲基苯並味 唑(290)之合成&gt; 依據貫施例22之方法,使用6-第3 丁氧基魏基胺 基-1-(2-氣代苄基)-2-甲基笨並味吐(0.760g)以得出6-胺 基_1-(2-氣代苄基)-2-曱基苯並咪唑(290)0.42(^。 [化合物(290)的物性] lH-NMR(DMS0-d6, δ) : 2.37(3H, s)3 4.83(2H, br s)5 5.32(2H? s), 6.33(1H5 d, J=1.9Hz), 6·42(1Η, d5 J=7.7Hz), 6.46(1H, dd, J二1.9 及 8·5Ηζ), 7.19 一7.24(2H, m), 7·31(1Η, t), 7·53(1Η, d3 J=7.9Hz)〇 〈實施例229;6-(l-丁磺醯基胺基)-1-(2-氣代苄基)-2-曱基苯並咪唑(291)之合成&gt; 依據實施例20之方法,使用6-胺基-1-(2-氣代苄 基)-2-甲基苯並咪唑(〇.300g)、1-丁磺醯基氯(〇.216g)、三 乙fe(0.130g)以付出6-(1-丁石黃酿基胺基)-1-(2-氯代节 基)-2-曱基苯並咪唑(291)0.230g。 [化合物(291)的物性] W-NMR(DMS0-d6,(Ϊ) : 〇·74(3Η,m),1·23(2Η,m),1·5.5(2Η,m),2·50(3Η,s) ,2·89(2Η, m), 5·47(2Η, s), 6·58(1Η, d3 J=7.4Hz) 7·02(1Η, d, J:8.5Hz), 經浐部中呔«.卑^1,;13消费合竹扣卬欠 (誚先閲讀背面之注意事項再填寫本頁) 7·10(1Η, s), 7·23(1Η, t), 7·33(1Η, t), 7·52(2Η, m), 9·55(1Η, s)。 IR(KBr) : 1629CDT1。 mp : 149.5-151.0oC〇 &lt;製造例46;2-[N-(2,4-二氯代苄基)乙醯胺基l·3·硝 基安息香酸甲酯之製造&gt; 依據製造例14之方法,使用2-乙醯胺基-3-硝基安息 _— — 227________ 本紙張尺度適中國國家標準(CNS ) A4規格(210X 297公釐) 548272 A7 _____ B7 五、發明説明(22j ~ 香酸曱酯(l.OOg)與2,4-二氯代苄基(〇.985g)以得出Ml (2,4-二氣代苄基)乙醯胺基]_3_硝基安息香酸甲酉旨 0.250g 〇 (詳先閱讀背面之注意事項再填寫本頁) [化合物的物性] π-NMR(CDC13,¢) : 1.99(3H,s),3·71(3Η,S),4·85(1Η,d,J二4·5Ηζ),4.98 (1Η, d, J:4.5Hz), 7·17-7·22(2Η, m), 7·46(1Η, d3 J:7.9Hz), 7·63(1Η, t, J二 7·9Ηζ), 7·98(1Η, d, J=8.0Hz), 8·09(1Η, d, J二7·9Ηζ)。 &lt;實施例23〇; 1 -(2,4-二氣代苄基)_7_乙氧基羰基·2-甲基苯並咪唑(292)之合成&gt; 依據實施例24之方法,使用2-[N-(2,4-二氯代节基) 乙醯胺基]-3-硝基安息香酸曱酯(6.50g)以得出1-(2,4·二 氣代卞基)-7-乙氧基幾基-2-甲基苯並味唾(292)5.15@。 [化合物(292)的物性] ^-NMRiCDCla, δ) : 2.53(3H, s), 3.70(3H, s), 5·72(2Η, s), 6.26(1H3 d3 J =8·4Ηζ), 7·04(1Η, dd, J=2,0 及 8·4Ηζ), 7·28(1Η, t, J二7·9Ηζ), 7·45(1Η, d, J=2.0Hz), 7·75(1Η, d5 J=7.8Hz), 7·93(1Η, d, J二7·9Ηζ)。 &lt;實施例231;7_羧基-l-(2,4-二氣代苄基)_2_甲基苯 並咪唑(293)之合成&gt; 依據實施例53之方法,使用1-(2,4-二氯代苄基)-7 -乙氧基魏基-2-甲基苯並味唾(2.00 g)以得出7 -魏基-1-(2,4-二氣代苄基)_2_曱基苯並咪唑(293)1.76g。 [化合物(293)的物性] lH-NMR(DMS0-d6, δ) : 2.49(3H, s), 5.81(2H, s) 3 6.09(lH5 d, J-8.4Hz)3 7. 21-7.28(2H, m), 7·62(1Η, d, J=7.8Hz), 7·67(1Η, d, J:2.2Hz), 7·83(1Η, d, J=8.〇Hz), 13-04(1H, br s)〇 ___ __—22^________—— 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 548272 A7 B7 五、發明説明(2 2 j &lt;實施例232;7-(l-丁磺醯基氨基甲醯基)-l-(2,4-二 氯代苄基)-2-甲基苯並咪唑(294)之合成&gt; (請先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用7-羧基-l-(2,4-二氯代 苄基甲基苯並咪唑(0.463g)、N,N’-羰基二咪唑 (〇.448g)、1-丁續醯胺(0.379g)、二氮二環十一稀(〇.421g) 以付出7-(1-丁石頁fc基氣基曱驢基)-1-(2,4 -二氯代节基)_ 2-甲基苯並咪唑(294)0.325§。 [化合物(294)的物性] lH~NMR(DMS0-d63 6 ) : 0.84(3H, t, J=7.3Hz), 1.33(2H3 m), 1.44(2H, m)3 2. 53(3H,s),3.16(2H,m),5.64UH,s),6.03(1H3 d,J=8.4Hz),7.25(1H,dd, J=2.1 及 8·4Ηζ), 7·30(1Η, t, J=7.8Hz), 7·44(1Η, d, J二7.4Hz), 7·68(1Η, d, J二2·1Ηζ), 7.87(1H, d, J=7.8Hz), 12·18(1Η, br s)。 IR(KBr) : 1690cm-l〇 mp : 98.5 — 102.0°C。 &lt;實施例233; 1-(2-氯代苄基)_2-曱基-6-[l-[3-(三甲 基酿基)丙]石黃醯基氨基甲酿基]苯並味吐(295)之合成&gt; 依據實施例149之方法,使用使用6-羧基-1-(2_氣 代苄基)_2_甲基苯並咪唑(〇.4〇〇g)、N,N,-羰基二咪唑 (〇.431g).、1-[3-(三乙基醯基)丙]磺醯胺(〇 52〇g)、二氮二 環十一烯(〇.4〇4g)以得出1_(2_氣代苄基)-2_曱基 (三甲基醯基)丙]磺醯基氨基甲醯基]苯並咪唑 (295)0.604g 〇 [化合物(295)的物性] 士臟⑽如-他,:七⑽⑽,s),Q 6i(2h,t,㈣愚),1 66 1 73⑽, 本紙張尺度適用中國國家標準(CNS ) A4規格- 548272 A7 B7 五、發明説明(22g m), 2·50(3Η, s), 3·51(2Η, t3 J:7.7Hz), 5·61(2Η, s), 6·46(1Η, d, J:7.8Hz) ,7·24(1Η, t3 J=7.6Hz), 7·35(1Η, t, J:7.6Hz), 7·57(1Η, dd, J=7.9 及 〇. 9Hz),7·70(1Η,d,J:8.5Hz),7·81(1Η,dd,J:1.5 及 8·5Ηζ)3 8.12UH,d,Mass (FAB): m / e 546 (M + 1) -mp: 220.8-224.8 ° C &lt; Example 224; 1- (2-chlorobenzyl) -2-fluorenyl-6- (1 -Synthesis of Pentylsulfonylcarbamyl) benzimidazole (286) &gt; According to the method of Example 98, 6-carboxy-1- (2-fluorobenzyl) _2 · methylbenzimidazole ( 〇.4.0〇g), N, N, -carbonyldiimidazole_ 224______ This paper size applies Chinese National Standard (CNS) A4 specification (210X29? Mm) 548272 A7 B7 V. Description of the invention (22i (read the first Note: Please fill in this page again) (0.431g), 1-pentanesulfonamide (0.42g), and diazabicycloundecene (0.404g) to pay 1- (2-gasoyl) -2-Methyl-6- (1-pentanite yellow aminocarbamoyl) benzimidazole (286) 0.49 lg. [Physical properties of compound (286)] W-NM ^ DMSO-c ^, d): 〇 · 81 (3Η, t, j = 7.2Ηζ), 1.23-1 · 28 (2Η, m), 1.32-1.37 (2H, in), 1.65-1.69 (2H, m), 3 · 50 (2Η, t, J = 7 · 8Ηζ), 5.61 (2Η, s), 6.45 (1Η, d, J = 7.5Hz), 7.24 (lH3t, J: 7.6Hz), 7.35 (lH , T, J = 7.5Hz), 7.57 (lH, d, J = 7.9 Hz), 7.69 (1 (, d, J: 8.5Hz), 7.81 (1Η3 dd , J: 1.7 and 8.4 Hz), 8.12 UH, d, J (1.2 2Ηζ), 12 · 25 (1Η, s). IR (KBr): 1684CDT1. mp: 173 · 3-179 · 8ο0〇 Example 225; l- (2-chlorobenzyl) -2-methyl-6-[(3-methylbutyl) sulfonamidocarbamoyl] benzene Synthesis of Benzimidazole (287) &gt; According to the method of Example 98, 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzyl rice was used. Sit (0.300g), N, N'-Geryl two-mouthed saliva (0.323g), 1- (3-methyl) butanesulfonamide (0.302g), diazabicycloundecene (0.303 g) to give 0.284 g of 1- (2-fluorobenzyl) -2-fluorenyl-6-[(3-fluorenylbutyl) sulfonamidoaminofluorenyl] benzimidazole (287). [Physical properties of compound (287)] 'H-NMRlDMSO-dG, δ): 0.84 (6H, d5 J = 6.5Hz), 1.52-1.59 (2H, m), 1.61-1.7 0 (1H, m), 3.44 ( 2H, t, J-7.9Hz) 3 5.60 (2H, s), 6.45 (1H, d5 J = 7: 8Hz) 5 7.24 (1H, t, J: 7.6Hz), 7.35 (1Η3 t, J: 7.4Hz), 7.57 (1Η, d, J = 7.9Hz), 7.66 (1H, d, J = 8.5Hz), 7.81 (1Η3 dd, J: 1.6 and 8.6Hz), 8.09UH, s) , 11.87 (1Η, s). IR (KBr): 1682CHT1. mp: 201.0-204.1oC〇 ----- 225__ This paper is suitable for China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (22i &lt; Example 226; l- (2 -Chlorocarbyl) -6- (1-Hexite yellow carbamoylcarbamyl) -2-methylbenzimidazole (288) &gt;(#Read the precautions on the back before filling this page) According to the method of Example 98, 6-carboxy-1- (2-chlorobenzyl) -2-methylbenzimidazole (0.300 g), N, N, -carbonyldizolidazole (0.323 g), 1_ Hexylsulfonamide (0.335g) and diazabicycloundecene (0.303g) to give 1- (2-gasocarbyl) -6- (1-hexoflavinylaminopyrene) _2_methylbenzimidazole (288) 0.379 g. [Physical properties of compound (288)] ^ -NMRiDMSO-dG, δ): 0.81 (3Η, t5 J-7.0Hz) 5 L18-L28 (4H, m ) 3 1.32-1.41 (2H, m), 1.63-1.71 (2H, m), 2.53 (3Η, s), 3.50 (2Η, t, J = 7.7Hz), 5.64 (2Η, s ), 6.51 (1Η, d, J: 7.7Hz), 7.25 (1Η, dt, J = 1.2 and 7.8Ηζ), 7.36 (1Η, dt, J = 1 • 4 and 7.7Ηζ ), 7.58 (1Η, dd, J: 1.0 and 8.0Ηζ), 7.72 (1Η, d, J: 8.5Hz), 7.84 (1Η, dd, J: 1.6 and 8. · 5Ηζ), 8.15 (1Η, d, J = 1.3Hz), 11.87 (1Η, s). IR (KBr): 1682CHT1. mp: 141.2-143.5 ° C. &lt; Example 227; 6-Synthesis of 3rd-butoxycarbonylamino-1- (2-chlorobenzyl) -2-methylbenzimidazole (289) &gt; According to the method of Example 18, 6-carboxy-1 · (2-chlorobenzyl) -2-methylbenzimidazole (1.0g), diphenylphosphonium amine (imi), and diisopropyl were used. Ethylamine (1ml) and 3rd Butanol (25ml) to give 6- 3rd Butoxycarbonylamino-1- (2-chlorobenzyl) -2-fluorenylbenzimidazole (289) 0.760 g. [Physical properties of compound (289)] W-Xing (CDC13, 6): 1.49 (9Η, s), 2.47 (3Η, s), 5.37 (2Η, s), 6.41 (1Η, d3 J 2: 7.5Ηζ), 6.55 (1Η, br s), 6.93 (1Η, dd, J: 1.9 and 8.6Ηζ), 7.08 (1Η, t, J = 7.5Hz), 7.22 (1H, t), 7.44 (1H, d, J = 8-0Hz), 7.62 (2H, d, J = 8,6Hz) 〇116 _ This paper size applies to China National Standard (CNS) A4 (210X297 mm) ) 548272 A7 B7 V. Description of the invention (223 &lt; Example 228; Synthesis of 6-amino-1- (2-chlorobenzyl) -2-methylbenzazole (290) &gt; The method of Example 22, using 6-th 3rd-butoxyweilylamino-1- (2-gaso-benzyl) -2-methylbenzantene (0.760g) to obtain 6-amino_1 -(2-Azobenzyl) -2-fluorenylbenzimidazole (290) 0.42 (^. [Physical properties of compound (290)] lH-NMR (DMS0-d6, δ): 2.37 (3H, s) 3 4.83 (2H, br s) 5 5.32 (2H? S), 6.33 (1H5 d, J = 1.9Hz), 6.42 (1Η, d5 J = 7.7Hz), 6.46 (1H, dd, J2 1.9 and 8 · 5Ηζ), 7.19 ~ 7.24 (2H, m), 7.31 (1Η, t), 7.53 (1Η, d3 J = 7.9Hz). <Example 229; 6- (l-Butanesulfonylamine) ) -1- (2-Azobenzyl ) Synthesis of 2-fluorenylbenzimidazole (291) &gt; According to the method of Example 20, 6-amino-1- (2-fluorobenzyl) -2-methylbenzimidazole (0.1%) was used. 300g), 1-butanesulfonyl chloride (0.216g), triethyl fe (0.130g) to pay 6- (1-butanthylamino) -1- (2-chlorobenzyl)- 0.230 g of 2-fluorenylbenzimidazole (291). [Physical properties of compound (291)] W-NMR (DMS0-d6, (Ϊ): 0.74 (3Η, m), 1.23 (2Η, m) , 1.5.5 (2Η, m), 2.50 (3Η, s), 2.89 (2Η, m), 5.47 (2Η, s), 6.58 (1Η, d3 J = 7.4Hz) 7 · 02 (1Η, d, J: 8.5Hz), 呔. 卑 ^ 1,; 13 in the consumer department (诮 Read the precautions on the back before filling this page) 7 · 10 (1Η , S), 7.23 (1Η, t), 7.33 (1Η, t), 7.52 (2Η, m), 9.55 (1Η, s). IR (KBr): 1629CDT1. mp: 149.5-151.0 ° C. &lt; Production Example 46; Production of 2- [N- (2,4-dichlorobenzyl) acetamidol · 3.nitronitrobenzoate &gt; According to Production Example The method of 14 uses 2-acetamido-3-nitrobenzyl _ — 227________ This paper is suitable for China National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 _____ B7 V. Description of the invention (22j ~ Acetate (1,000 g) and 2,4-dichlorobenzyl (.985 g) to give Ml (2,4-dioxobenzyl) acetamido] -3 -nitrobenzoic acid Formazan purpose 0.250 g 〇 (Read the precautions on the reverse side before filling in this page) [Physical properties of compounds] π-NMR (CDC13, ¢): 1.99 (3H, s), 3.71 (3Η, S), 4 85 (1Η, d, J 2 4.5 5Ηζ), 4.98 (1Η, d, J: 4.5Hz), 7.17-7 · 22 (2Η, m), 7.46 (1Η, d3 J: 7.9Hz ), 7.63 (1Η, t, J 2 7.9Ηζ), 7.98 (1Η, d, J = 8.0Hz), 8.09 (1Η, d, J 2 7.9Ηζ). &Lt; Example 23〇; Synthesis of 1- (2,4-dioxobenzyl) -7-ethoxycarbonyl · 2-methylbenzimidazole (292) &gt; According to the method of Example 24, 2- [N- (2,4-dichlorobenzyl) acetamido] -3- Benzyl nitrobenzoate (6.50 g) to give 1- (2,4 · digasofluorenyl) -7-ethoxyepi-2-methylbenzoxyl (292) 5.15 @. [ Physical properties of compound (292)] ^-NMRiCDCla, δ): 2.53 (3H, s), 3.70 (3H, s), 5.72 (2Η, s), 6.26 (1H3 d3 J = 8 · 4Ηζ), 7 · 04 (1Η, dd, J = 2, 0 and 8.4Ηζ), 7 · 28 (1Η, t, J = 7 · 9Ηζ), 7.45 (1Η, d, J = 2.0Hz), 7.75 ( 1Η, d5 J = 7.8Hz), 7.93 (1Η, d, J = 7 · 9Ηζ). &lt; Example 231; Synthesis of 7-carboxy-l- (2,4-dioxobenzyl) -2-methylbenzimidazole (293) &gt; According to the method of Example 53, 1- (2, 4-dichlorobenzyl) -7-ethoxyweilyl-2-methylbenzoxyl salivary (2.00 g) to give 7-weilyl-1- (2,4-dioxobenzyl) _2_fluorenyl benzimidazole (293) 1.76 g. [Physical properties of compound (293)] 1H-NMR (DMS0-d6, δ): 2.49 (3H, s), 5.81 (2H, s) 3 6.09 (lH5 d, J-8.4Hz) 3 7. 21-7.28 ( 2H, m), 7.62 (1Η, d, J = 7.8Hz), 7.67 (1Η, d, J: 2.2Hz), 7.83 (1Η, d, J = 8.0Hz), 13 -04 (1H, br s) 〇 ___ __— 22 ^ ________—— This paper size applies to China National Standard (CNS) A4 (21 OX 297 mm) 548272 A7 B7 V. Description of the invention (2 2 j &lt; Example 232; Synthesis of 7- (l-butanesulfonylcarbamoyl) -l- (2,4-dichlorobenzyl) -2-methylbenzimidazole (294) &gt; (Please first Read the notes on the back and fill in this page again) According to the method of Example 98, using 7-carboxyl-l- (2,4-dichlorobenzylmethylbenzimidazole (0.463g), N, N'-carbonyl Diimidazole (0.448 g), 1-butanidine (0.379 g), and diazabicycloundecene (0.421 g) to pay 7- (1-butanite fc-based gas-based donkey base)- 1- (2,4-dichlorobenzyl) _2-methylbenzimidazole (294) 0.325 § [Physical properties of compound (294)] 1H ~ NMR (DMS0-d63 6): 0.84 (3H, t , J = 7.3Hz), 1.33 (2H3 m), 1.44 (2H, m) 3 2. 53 (3H, s), 3.16 (2H, m), 5.64UH, s), 6.0 3 (1H3 d, J = 8.4Hz), 7.25 (1H, dd, J = 2.1 and 8.4Ηζ), 7.30 (1Η, t, J = 7.8Hz), 7.44 (1 (, d, J 7.4Hz), 7.68 (1Η, d, J = 2.1Ηζ), 7.87 (1H, d, J = 7.8Hz), 12.18 (1Η, br s). IR (KBr): 1690cm-1 mp: 98.5-102.0 ° C. &lt; Example 233; 1- (2-chlorobenzyl) _2-fluorenyl-6- [l- [3- (trimethyl alcohol) propanyl] carbosulfanylcarbamate Alkyl] Synthesis of Benzene (295) &gt; According to the method of Example 149, 6-carboxy-1- (2-fluorobenzyl) -2-methylbenzimidazole (0.4.00) was used. g), N, N, -carbonyldiimidazole (0.431 g), 1- [3- (triethylfluorenyl) propyl] sulfonamide (0502 g), diazabicycloundecene ( 0.44 g) to give 1- (2-fluorobenzyl) -2-fluorenyl (trimethylfluorenyl) propyl] sulfonylcarbamoyl] benzimidazole (295) 0.604 g. Physical properties of compound (295)] Shi Zang Zhi Ru-He, Qi Qi, s), Q 6i (2h, t, Qi Yu), 1 66 1 73 Ji, this paper size applies the Chinese National Standard (CNS) A4 specifications- 548272 A7 B7 V. Description of the invention (22g m), 2.50 (3Η, s), 3.51 (2Η, t3 J: 7.7Hz), 5.61 (2Η, s), 6.46 (1Η, d, J: 7.8Hz), 7.24 (1Η, t3 J = 7.6Hz), 7.35 (1Η, t, J: 7.6Hz), 7.57 (1Η, dd, J = 7.9 and 0.9Hz), 7.70 (1Η, d, J: 8.5Hz), 7.81 (1Η, dd, J: 1.5 and 8.5Ηζ ) 3 8.12UH, d,

J-1.4Hz)3 1L98(1H3 s)〇 IR(KBr) : 1688cm—、 mp : 197·0—203H &lt;實施例234;4-乙氧基羰基-2-甲基苯並咪唑(296) 之合成&gt; 將2 -乙酿基胺基-3-石肖基安息香酸甲醋(8.03g)、還 原鐵(18 · 8 g )、醋酸(20ml)、乙酵(4 0 m 1)之混合物加熱迴流 18小時。經濃縮溶媒後,將三氣甲烷與1〇%鹽酸加入殘 潰中’以進行萃取。將飽和碳酸氫納水溶液加入殘渣中 以形成驗性後,使用三氯甲燒進行萃取。經減壓顧去三 氣曱烷以得出4-乙氧基羰基-2-曱基苯並咪唑 (296)1.61g。 [化合物(296)的物性] (H-NMR(CDC133 (5) : 1·43(3Η,t),2·66(3Η,s),4·45(2Η,q),7·24-7·28(1Η, m), 7·84-7.89(2Η, m), 10·26(1Η, br s)。 經浐部中戎«.-^-^^&gt;消贽合竹扣印繁 (請先閱讀背面之注意事項再填寫本頁) 〈實·施例235; l-(2,4-二氣代苄基)-4-乙氧基羰基-2-曱基苯並咪唑(297)之合成&gt; 將4-乙氧基羰基-2-甲基苯並咪唑(1.61g)、2,4-二氣 代苄基氣(3.08g)、碘化鉀(1.51g)、碳酸鉀(l.〇5g)、N,N-二甲基甲醯胺(4ML)之混合物在80°C下攪拌16小時。加 入三氣甲烷及水以進行萃取。水洗、乾燥、濃縮三氯甲 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 五 發明説明(22) ' (讀先閱讀背面之注意事項再填寫本頁) 烧層以得出殘渣’藉由石夕勝柱色譜(溶離液··己烧/醋酸 乙酯4/8)之精製以得出丨_(2,4_二氣代苄基乙氧基羰 基-2-曱基苯並咪唑(297)0.73Og。 [化合物(297)的物性] !Η-眶(CDCh,d) : 1·47(3Η,t J:7 1H7) ? ίΠΠΗ 、 5 ί·1Ηζ)3 2.63(3Η3 s)5 4.52(2Η, q, J=7.1 Ηζ),5.39(2Η’ S),6.30(1Η,d,J=8.他),7.06(m,dd,J=21 及 8 他) 7.職t,柯划,7•戰机机〇及7 9Hz) 7 48(m ζ), 7·93(1Η, dd, J=l.〇 及 7.7Hz)。 &lt;實施例236;4-羧基-;u(2,4-二氯代苄基)_2_甲基苯 並咪唑(298)之合成〉 依據實施例53之方法,使用1-(2,4-二氯代节基)_ 4-乙氧基羰基-2-曱基苯並咪唑(〇.730g)以得出4-羧基-1_ (2,4-二氯代苄基)-2-曱基苯並咪唑(298)0.575g。 [化合物(298)的物性] W-NMR(DMS〇-d6,ά) : 2·65(3Η,s),5.67(2H,s),6·73(1Η, d,J=8.3Hz),7. 33(1H, dd, J二2·2 及 8·4Ηζ), 7·39(1Η, t, J=7.9Hz), 7·74(1Η, d, J=2.2Hz) ,7·76(1Η, d, J=8.2Hz), 7·85(1Η, d, J=7.5Hz)。 &lt;實施例237;4-(l-丁磺醯基氨基甲醯基)-;i_(2,4-二 氣代苄棊)-2_甲基苯並咪唑(299)之合成&gt; 依據實施例98之方法,使用4-羧基-1-(2,4-二氣代 苄基)-2-甲基苯並咪唑(0.35〇g)、Ν,Ν,-羰基二咪唑 (〇.339g)、1_ 丁磺醯胺(0.287g)、二氮二環十一烯(〇.318g) 以得出4-(1-丁磺醯基氨基甲醯基)-1-(2,4-二氣代苄基)_ 2-甲基苯並咪唑(299)0.275g。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 經濟部中央樣率而貞工消費合作社印製 A7 ___________B7 五、發明説明(22g [化合物(299)的物性] iH-fiMlUDMSO-d65 (5) : 〇·86(3Η5 t,J:7.3Hz),1.42(2H,m),1.73(2Η,πι),2, 61(3H5 s), 3.61(2H, m)3 5.65(2H3 s), 6.67(1H5 d3 J=8.4Hz), 7.32(1H5 dd, J二2·1 及 8.4Hz),7·39(1Η3 t,J=7.9Hz),7·73(1Η, d,J=2.1Hz),7.78UH, d, J二8·0Ηζ), 7·91(1Η, d, J:7.7Hz)3 12.66(1H, br s)。 IR(KBr) : 1699cm—1。 瓜p : 180.7 —183.6°C。 &lt;實施例238; l-(4-苄氧基苄基)_6_乙氧基羰基_2_曱 基苯並咪唑(300)之合成&gt; 依據製造例14之方法,使用%乙醯胺基_4_硝基安 息香酸乙酯(2.00g)與4_苄氧基苄基氣(36%)以得出3_ [N-(4-苄氧基苄基)乙醯胺基卜4_硝基安息香酸乙酯之粗 精製物。接著依據實施例24之方法以得出苄氧基 苄基)-6-乙氧基羰基-2-甲基苯並咪唑(3〇〇)之粗精製物 4.09g 〇 &lt;實施例239;1-(4-苄氧基苄基)_6_羧基_孓甲基苯並 咪唑(301)之合成&gt; 依據實施例53之方法,使用1_(4_苄氧基宁基)_6_ 乙氧羰棊甲基苯並咪唑(4.〇9g)以得出1_(4_苄氧基苄 基)-6-羧基-2-甲基苯並咪唑(301)0.13g。 [化合物(301)的物性]A-NMiUDMSO-dG,6) : 2·57(3Η,s),5·05(2Η,s),5·48(2Η,s),6·97(2Η d J=8.6Hz), 7·08(2Η, d, J=8.5Hz), 7·28-7·43(5Η, m), 7·60(1Η, d, J=8 3Hz) 7·78(1Η, d, J=7.5Hz), 8.07(1H, s), 12.72(1H, s)〇 232 秦紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) (請先閲讀背面之注意事項再填寫本頁) 訂 -Φ. « In HI n · 548272 A7 B7 五、發明説明(22j &lt;實施例24〇;1-(4_苄氧基苄基)_6·(1-丁磺醯基氨基 曱醯基)-2-曱基苯並咪唑(302)之合成&gt; 依據實施例149之方法,使用6-羧基-1-(4-节氧基 苄基)-2-甲基苯並咪唑(0.3〇Og)、N,N,-羰基二咪唑 (0.242g)、1-丁績醯胺(0.204g)、二氮二環十一烯(〇227g) 以得出1-(4_节氧基节基)_6_(1·丁磧酸基氨基甲醯基)_2_ 甲基苯並咪唑(302)0.206g。 [化合物(302)的物性] lH-NMR(DMS0-d6, δ) : 0.87(3H, t, J=7.3Hz), 1.38-1.43(2H, m), 1.64-1.71( 2H, m), 2·54(3Η, s), 3·49(2Η, t, J=6.8Hz), 5·05(2Η, s), 5.45(2H, s), 6.9 8(2H3 d, J=8.7Hz)3 7.10(2H, d, J=8,7Hz)5 7.31(1H, t, J=7.2Hz), 7·37(2Η, t, J=7.2Hz), 7·41(2Η, d, J:7.3Hz), 7.62(1H, d, J:8.5Hz), 7·79(1Η, dd, J= 1·5 及 8·4Ηζ), 8·23(1Η3 s), 11·93(1Η, s)。, IR(KBr) : 1684cffl-l〇 mp : 132.4—137.70C〇 &lt;實施例241;6-乙氧羰基-l-[(2,-氰基聯苯基-4-基) 甲基]-2-甲基苯並咪唑(303)之合成&gt; 經濟部中央樣率而貞工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 依據製造例14之方法,使用3-乙醯胺基-4-硝基安 息香酸么酯(l.OOg)與4,-溴代甲基-2-氰基聯苯(1.30g)以 得出3_[Ν·[(2’_氰基聯苯基_4_基)曱基;]乙醯胺基]_4_硝基 安息香酸乙酯弋粗精製物(〇.750g)。接著,依據實施例 24之方法,以得出6•乙氧羰基-1-[(2,·氰基聯苯基_4_基) 甲基]-2·甲基笨並咪唑(303)0.410g。 [化合物(303)的物性] 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) 經系部中央樣率而貞工消費合作社印繁 548272 A7 _________B7 五、發明説明(230 ~一 4-瞧(CDCI3, ά) : 1·40(3Η,t),2·63(3Η,s),4.39(2H,q),5.46(2h,s) 7.17(2H,d),7·40-7·66(5Η,m),7·73-7·78(2Η,m),8·0()(1Η,dd,J=1 5 及’ 8·5Ηζ), 8·05(1Η, d, J二1·2Ηζ)。 · &lt;實施例242;6-羧基-l-[(2,_氰基聯苯基_4_基)甲 基]-2-甲基苯並咪唑(304)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基_i_[(2,_氛 基聯苯基-4-基)曱基]-2-甲基苯並味峻(〇·41 〇g)以得出6 羧基-M(2’-氰基聯苯基-4-基)甲基]_2-甲基笨並味唾 (304)0.190g ° [化合物(304)的物性] ^-NMRCDMSO-dG, δ) : 2.59(3H, s), 5.67(2H3 s)3 7.24(2H, d, J=8.1Hz), 7 53-7,64(5H, m), 7.75(1H, t, J=7.7Hz), 7·80(1Η, d), 7.92(1H3 d, J=7 7jjz) 8·12(1Η, s)3 12.74(1H, br s)〇 &lt;實施例243;6-(l-丁磺醯基氨基甲醯基)_1-[(2,_氰 基聯苯基-4-基)甲基]-2-甲基苯並哺唾(3 05)之合成&gt; 依據實施例155之方法,使用6-羧基-1-[(2,-聯笨 基-4-基)曱基]-2-甲基苯並咪唑(0.187g)、N,N,·羰基二味 唑(0.160g)、1- 丁磺醯胺(0.135g)、二氮二環十一烯 (0.150g)j並經由矽膠柱色譜(溶離液:三氣甲烷/曱醇 =20/1)之精製以得出6·(1-丁磺醯基氨基甲醯基)-1-[(2,_ 氰基聯苯基-4-基)曱基]-2-甲基苯並哺峻(305)0.155g。 [化合物(305)的物性] 'H-NMRiDMSO-dG, δ) : 0.83(3H, t, J-7.4Hz), 1.34(2H, m), 1.60(2H, m),2· 56(3H, s), 3·27(2Η, m), 5·62(2Η, s), 7·23(2Η, d, J=8.2Hz), 7.53-7.57( _____ 234 ______ (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(23}J-1.4Hz) 3 1L98 (1H3 s) 〇IR (KBr): 1688cm-, mp: 197.0-203H &lt; Example 234; 4-ethoxycarbonyl-2-methylbenzimidazole (296) Synthesis &gt; Heat a mixture of 2-ethylethylamino-3-stone-shoky benzoate methyl vinegar (8.03g), reduced iron (18 · 8 g), acetic acid (20ml), and acetic acid (40 m 1) Reflux for 18 hours. After the solvent was concentrated, three gas methane and 10% hydrochloric acid were added to the residue 'for extraction. A saturated sodium bicarbonate aqueous solution was added to the residue to form a test, and then trichloromethane was used for extraction. Trifluoromethane was removed under reduced pressure to give 1.61 g of 4-ethoxycarbonyl-2-fluorenylbenzimidazole (296). [Physical properties of compound (296)] (H-NMR (CDC133 (5): 1.43 (3Η, t), 2.66 (3Η, s), 4.45 (2Η, q), 7.24-7 · 28 (1Η, m), 7.84-7.89 (2Η, m), 10 · 26 (1Η, br s). Zhong Rong Department of Economics «.- ^-^^ &gt; (Please read the precautions on the back before filling out this page) 〈Example 235; l- (2,4-Dioxobenzyl) -4-ethoxycarbonyl-2-fluorenylbenzimidazole (297 ) &Gt; Synthesis of 4-ethoxycarbonyl-2-methylbenzimidazole (1.61g), 2,4-digas benzyl gas (3.08g), potassium iodide (1.51g), potassium carbonate (l .05g), a mixture of N, N-dimethylformamide (4ML) was stirred at 80 ° C for 16 hours. Trichloromethane and water were added for extraction. Washing, drying, and concentration of trichloromethane paper Applicable to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 Five invention descriptions (22) '(Read the precautions on the back before filling this page) Burn the layer to get the residue' by Shi Xisheng column chromatography (Eluent ·· Hexane / Ethyl Acetate 4/8) was refined to obtain 0.73 Og of (2,4_digaso-benzylethoxycarbonyl-2-fluorenylbenzimidazole (297). [ Physical properties of compound (297)] Η-orbital (CDCh, d): 1.47 (3Η, t J: 7 1H7)? ΊΠΠΗ, 5 ί · 1Ηζ) 3 2.63 (3Η3 s) 5 4.52 (2Η, q, J = 7.1 Ηζ), 5.39 (2Η 'S), 6.30 (1Η, d, J = 8. He), 7.06 (m, dd, J = 21 and 8 others) 7. Position t, Ke Huan, 7 • Warplane Machine 0 and 7 9Hz) 7 48 (m ζ), 7.93 (1Η, dd, J = 1.0 and 7.7 Hz). &Lt; Example 236; 4-carboxy-; u (2,4-dichloro Synthesis of benzyl) -2-methylbenzimidazole (298)> According to the method of Example 53, 1- (2,4-dichlorobenzyl) _4-ethoxycarbonyl-2-fluorenyl Benzimidazole (0.730 g) to give 4-carboxyl- (2,4-dichlorobenzyl) -2-fluorenylbenzimidazole (298) 0.575 g. [Physical properties of compound (298)] W -NMR (DMS〇-d6, ά): 2.65 (3Η, s), 5.67 (2H, s), 6.73 (1Η, d, J = 8.3Hz), 7.33 (1H, dd, J 2 · 2 and 8 · 4Ηζ), 7.39 (1Η, t, J = 7.9Hz), 7.74 (1Η, d, J = 2.2Hz), 7.76 (1Η, d, J = 8.2Hz ), 7.85 (1Η, d, J = 7.5Hz). &lt; Example 237; Synthesis of 4- (l-butanesulfonylcarbamoamidinyl)-; i_ (2,4-digaso benzamidine) -2-methylbenzimidazole (299) &gt; The method of Example 98 was performed using 4-carboxy-1- (2,4-dioxobenzyl) -2-methylbenzimidazole (0.350 g), N, N, -carbonyldiimidazole (0.333 g) ), 1-butanesulfonamide (0.287g), diazabicycloundecene (0.318g) to give 4- (1-butanesulfonylcarbamoyl) -1- (2,4-di 0.275 g of 2-methylbenzimidazole (299). This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 Printed by the central sample rate of the Ministry of Economic Affairs and printed by Zhengong Consumer Cooperative B7 ___________ B7 V. Description of the invention (22g [Physical properties of compound (299)] iH-fiMlUDMSO- d65 (5): 0.86 (3Η5 t, J: 7.3Hz), 1.42 (2H, m), 1.73 (2Η, m), 2, 61 (3H5 s), 3.61 (2H, m) 3 5.65 (2H3 s), 6.67 (1H5 d3 J = 8.4Hz), 7.32 (1H5 dd, J2 2.1 and 8.4Hz), 7.39 (1Η3 t, J = 7.9Hz), 7.73 (1Η, d, J = 2.1Hz), 7.78UH, d, J = 8 · 0Ηζ), 7.91 (1Η, d, J: 7.7Hz) 3 12.66 (1H, br s). IR (KBr): 1699cm-1. Melon p: 180.7 —183.6 ° C. &lt; Example 238; Synthesis of l- (4-benzyloxybenzyl) _6_ethoxycarbonyl_2_fluorenylbenzimidazole (300) &gt; According to the method of Production Example 14,% acetamidamine was used 4-N-nitrobenzoic acid ethyl ester (2.00g) and 4-benzyloxybenzyl gas (36%) to give 3_ [N- (4-benzyloxybenzyl) acetamidoamine 4_ Crude refined product of ethyl nitrobenzoate. Then, according to the method of Example 24, a crude refined product of benzyloxybenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (300) was 4.09 g. &Lt; Example 239; 1 -(4-Benzyloxybenzyl) _6_carboxy_fluorenylmethylbenzimidazole (301) Synthesis> According to the method of Example 53, 1_ (4_benzyloxynyl) _6_ethoxycarbonylfluorene Methyl benzimidazole (4.09 g) to give 0.1- (4-benzyloxybenzyl) -6-carboxy-2-methylbenzimidazole (301). [Physical properties of compound (301)] A-NMiUDMSO-dG, 6): 2.57 (3Η, s), 5.05 (2Η, s), 5.48 (2Η, s), 6.97 (2Η d J = 8.6Hz), 7 · 08 (2Η, d, J = 8.5Hz), 7 · 28-7 · 43 (5Η, m), 7 · 60 (1Η, d, J = 8 3Hz) 7 · 78 ( 1Η, d, J = 7.5Hz), 8.07 (1H, s), 12.72 (1H, s) 〇232 Qin paper size applies to China National Standard (CNS) A4 specification (21 OX 297 mm) (Please read the back Please fill out this page again) Order-Φ. «In HI n · 548272 A7 B7 V. Description of the invention (22j &lt; Example 24〇; 1- (4-benzyloxybenzyl) _6 · (1-butanesulfonate Synthesis of fluorenylaminofluorenyl) -2-fluorenylbenzimidazole (302) &gt; According to the method of Example 149, 6-carboxy-1- (4-benzyloxybenzyl) -2-methyl was used Benzimidazole (0.300 g), N, N, -carbonyldiimidazole (0.242 g), 1-butanidine (0.204 g), and diazabicycloundecene (〇227 g) to give 1- (4_ Benzyloxy) -6_ (1.butyric acid carbamoyl) _2_methylbenzimidazole (302) 0.206 g. [Physical properties of compound (302)] lH-NMR (DMS0-d6, δ): 0.87 (3H, t, J = 7.3Hz), 1.38-1.43 (2H, m), 1.64-1.71 (2H, m), 2.54 ( 3Η, s), 3.49 (2Η, t, J = 6.8Hz), 5.05 (2Η, s), 5.45 (2H, s), 6.9 8 (2H3 d, J = 8.7Hz) 3 7.10 (2H , d, J = 8,7Hz) 5 7.31 (1H, t, J = 7.2Hz), 7.37 (2Η, t, J = 7.2Hz), 7.41 (2Η, d, J: 7.3Hz), 7.62 (1H, d, J: 8.5Hz), 7.79 (1Η, dd, J = 1.5 and 8.4Ηζ), 8.23 (1Η3 s), 11.93 (1Η, s)., IR (KBr): 1684cffl-l0mp: 132.4-137.70C0 &lt; Example 241; 6-ethoxycarbonyl-l-[(2, -cyanobiphenyl-4-yl) methyl] -2- Synthesis of methyl benzimidazole (303) & printed by the Central Laboratories of the Ministry of Economic Affairs and printed by Zhengong Consumer Cooperative (please read the precautions on the back before filling out this page) Use 3-acetamidine according to the method of manufacturing example 14 4-nitrobenzoate (1.0 g) and 4, -bromomethyl-2-cyanobiphenyl (1.30g) to give 3_ [Ν · [(2'_cyanobiphenyl (4-yl); fluorenyl;] ethylamido]-4-nitrobenzoic acid ethyl ester crude product (0.750 g). Next, according to the method of Example 24, 6 • ethoxycarbonyl-1-[(2, · cyanobiphenyl_4-yl) methyl] -2 · methylbenzimidazole (303) 0.410 was obtained. g. [Physical properties of compound (303)] This paper size applies the Chinese National Standard (CNS) A4 specification (210x297 mm). The central sample rate of the Department and the Zhengong Consumer Cooperatives Co., Ltd. printed 548272 A7 _________B7 V. Description of the invention (230 ~ 1-4 -Look (CDCI3, ά): 1.40 (3Η, t), 2.63 (3Η, s), 4.39 (2H, q), 5.46 (2h, s) 7.17 (2H, d), 7.40- 7.66 (5Η, m), 7.73-7 · 78 (2Η, m), 8.0 () (1Η, dd, J = 1 5 and '8 · 5Ηζ), 8.05 (1Η, d , J 11 · 2Ηζ). &Lt; Example 242; 6-carboxyl-l-[(2, _cyanobiphenyl_4-yl) methyl] -2-methylbenzimidazole (304) Synthesis> According to the method of Example 53, using 6-ethoxycarbonyl_i _ [(2, _aminobiphenyl-4-yl) fluorenyl] -2-methylbenzobenzoic acid (0.41 〇g) to give 6 carboxy-M (2'-cyanobiphenyl-4-yl) methyl] _2-methylbenzyl salicylic acid (304) 0.190 g ° [physical properties of compound (304)] ^ -NMRCDMSO-dG, δ): 2.59 (3H, s), 5.67 (2H3 s) 3 7.24 (2H, d, J = 8.1Hz), 7 53-7, 64 (5H, m), 7.75 (1H, t , J = 7.7Hz), 7.80 (1Η, d), 7.92 (1H3 d, J = 7 7jjz) 8.12 (1Η, s) 3 12.74 (1H, br s) 〇 Example 243; 6 -(l-Butanesulfonyl Synthesis of carbamate) _1-[(2, _cyanobiphenyl-4-yl) methyl] -2-methylbenzoxazone (305) &gt; According to the method of Example 155, use 6-carboxy-1-[(2, -bibenzyl-4-yl) fluorenyl] -2-methylbenzimidazole (0.187 g), N, N, · carbonyldiisotriazole (0.160 g), 1 -Butylsulfamethoxamine (0.135g), diazabicycloundecene (0.150g) j and refined by silica gel column chromatography (eluent: trigas methane / methanol = 20/1) to get 6 · ( 1-Butylsulfonylcarbamoyl) -1-[(2, -cyanobiphenyl-4-yl) fluorenyl] -2-methylbenzoxan (305) 0.155 g. [Physical properties of compound (305)] 'H-NMRiDMSO-dG, δ): 0.83 (3H, t, J-7.4Hz), 1.34 (2H, m), 1.60 (2H, m), 2.56 (3H, s), 3.27 (2Η, m), 5.62 (2Η, s), 7.23 (2Η, d, J = 8.2Hz), 7.53-7.57 (_____ 234 ______ (Please read the notes on the back first (Fill in this page again) The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (23)

4H, m), 7.60(1H3 d, J=7.8Hz), 7·75(1Η, dt, J=1.0 及 7·8Ηζ), 7.83(1H ,dd,J=1.5 及 8·4Ηζ),7·92(1Η,d),8.13(1H,s), 11 ·92(1H,br s)。 IR(KBr) : 2223cm-1〇 mp : 115-1180C〇 * &lt;製造例47;2-氟-4’-曱基聯苯之製造&gt; 將1.6M之正丁基鋰己烷溶液(30ml)加入在氮環境 氣體下冷卻至-78°C之四氫决喃(30ml),接著加入4-溴代 甲苯(8.33g)之四氫呋喃(30ml)溶液,在-78°C下攪拌1小 時。在減壓下加熱溶融後,在-78°C下加入經脫水之氯化 鋅(6.64g)的四氫决喃(30ml)溶液,在室溫下擾拌1小時。 在室溫下將2-氟代碘通苯(7.22g)及四(三苯基膦)鈀 (0.52g)之四氫呋喃(30ml)溶液加入前述溶液中,攪拌1 天。以醋酸乙酯(300ml)稀釋反應液,加入10%鹽酸進行 萃取。以飽和食鹽水洗淨有機層,乾燥後將其濃縮。使 用矽膠柱色譜(溶離液:己烷)精製殘渣,以得出油狀的 2-氟-4’-曱基聯苯(6.05g)。 [化合物的物性] INMlUCDClh 6) : 2·39(3Η,s),7·10-7·30(5Η,m),7·39-7·49(3Η,m)。 經濟部中央標準而眞工消費合作社印製 (讀先閲讀背面之注意事項再填寫本頁) &lt;氟造例48;2_氟-4’-曱基聯苯溴之製造&gt; 將2-氟-4’·甲基聯苯(8.70g)、N-溴代丙醯胺(8.32g)、 2,2’-偶氮二異丁腈(0.10g)、四氯化碳(150ml)之混合物加 熱迴流5小時。水洗反應液,以矽膠柱色譜(溶離液: 己烷/醋酸乙酯=9/1)精製濃縮有機層所得之殘渣,以得 出2-氟-4’-甲基聯苯溴之粗精製物。使用己烷令其結 _7^^_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準而貝工消費合作相印繁 548272 A7 __________B7 五、發明説明(233 晶化以得出2-氟-4,-甲基聯苯溴(4.93g)。 [化合物的物性] lH-NMR(CDCl3,6) : 4·55(2Η,s),7.13-7·23(2Η,m),7·33(1Η,m),7·43(1Η, m)5 7.47(ZH5 d3 J-8.1HZ), 7.54(2H, d, J-8.1Hz)〇 &lt;製造例49;3-[N-[(2’-氟代聯苯基-4-基)甲基]乙醯 胺基]-4-硝基安息香酸乙酯之製造&gt; 依據製造例14之方法,使用3-乙醯胺基-4-硝基安 息香酸乙酯(1.54g)與2-氟-4,-曱基聯苯溴(2.26g)以得出 3-[N-[(2’_氟代聯苯基-4-基)甲基]乙醯胺基]-4-石肖基安息 香酸乙酯(1.90g)。 [化合物的物性] ^-NMRCCDCla, 6) : L33(3H, t3 J=7.1Hz), 1.92(3H, s)3 4.36(2Η, m)3 4·44 (1Η, d, J=4.4Hz)3 5.32C1H, d3 J=4.4Hz), 7.13(1H, m), 7.18-7.22(3H, m)3 7 • 31(1H, m),7·40(1Η,dt,J=L6 及 7·7Ηζ),7·44(2Η3 d),7·67(1Η3 d,J=1 •6Hz), 7·94(1Η, d, J=8.4Hz), 8·15(1Η, dd, J:1.8 及 8·4Ηζ)。 &lt;實施例244;6-乙氧羰基-l-[(2’·氟代聯苯基-4-基) 曱基]-2-甲基苯並咪唑(306)之合成&gt; 依據實施例24之方法,使用3-[N-[(2,_氟代聯苯基 -4-基)甲〜基]乙醯胺基]-4·硝基安息香酸乙酯(1.90g)以得 出6-乙氧羰基-1-[(2’-氟代聯苯基-4-基)甲基]-2-曱基苯 並味唾(306)1.53g。 [化合物(306)的物性] ^-NMRiCDGL·, δ) : 1.40(3H, t, J=7.1Hz)3 2.62(3H, s), 4.38(2H, q3 Jrr7 l4H, m), 7.60 (1H3 d, J = 7.8Hz), 7.75 (1Η, dt, J = 1.0 and 7. · 8Ηζ), 7.83 (1H, dd, J = 1.5 and 8. · 4Ηζ), 7. · 92 (1Η, d), 8.13 (1H, s), 11 · 92 (1H, br s). IR (KBr): 2223cm-1〇mp: 115-1180C〇 * &lt; Production Example 47; Production of 2-fluoro-4'-fluorenylbiphenyl &gt; 1.6M n-butyllithium hexane solution (30ml ) Tetrahydrodecane (30 ml) cooled to -78 ° C under a nitrogen atmosphere was added, followed by a solution of 4-bromotoluene (8.33 g) in tetrahydrofuran (30 ml), and stirred at -78 ° C for 1 hour. After heating and melting under reduced pressure, a solution of dehydrated zinc chloride (6.64 g) in tetrahydrodecane (30 ml) was added at -78 ° C, and stirred at room temperature for 1 hour. A tetrafluorofuran (30 ml) solution of 2-fluoroiodotoluene (7.22 g) and tetrakis (triphenylphosphine) palladium (0.52 g) was added to the aforementioned solution at room temperature and stirred for 1 day. The reaction solution was diluted with ethyl acetate (300 ml), and 10% hydrochloric acid was added for extraction. The organic layer was washed with saturated brine, dried, and then concentrated. The residue was purified by silica gel column chromatography (eluent: hexane) to obtain 2-fluoro-4'-fluorenylbiphenyl (6.05 g) as an oil. [Physical properties of compound] INMlUCDClh 6): 2.39 (3Η, s), 7.10-7.30 (5Η, m), 7.39-7.49 (3Η, m). Printed by the Central Standard of the Ministry of Economic Affairs and Cooperative Consumer Cooperative (read the precautions on the back before filling out this page) &lt; Example 48 of Fluoride; 2_Manufacture of Fluoro-4'-fluorenylbiphenyl bromide &gt; Will 2- Fluoro-4 '· methylbiphenyl (8.70g), N-bromopropanamide (8.32g), 2,2'-azobisisobutyronitrile (0.10g), carbon tetrachloride (150ml) The mixture was heated at reflux for 5 hours. The reaction solution was washed with water, and the residue obtained by concentrating the organic layer was purified by silica gel column chromatography (eluent: hexane / ethyl acetate = 9/1) to obtain a crude product of 2-fluoro-4'-methylbiphenyl bromide. . Use hexane to make the knot _7 ^^ _ This paper size applies the Chinese National Standard (CNS) A4 (210X297 mm) Central Standard of the Ministry of Economic Affairs and the cooperation of shellfish consumer printing 548272 A7 __________B7 V. Description of the invention (233 crystals To obtain 2-fluoro-4, -methylbiphenyl bromide (4.93g). [Physical properties of the compound] lH-NMR (CDCl3,6): 4.55 (2Η, s), 7.13-7 · 23 ( 2Η, m), 7.33 (1Η, m), 7.43 (1Η, m) 5 7.47 (ZH5 d3 J-8.1HZ), 7.54 (2H, d, J-8.1Hz) ○ Manufacturing Example 49 ; Production of 3- [N-[(2'-fluorobiphenyl-4-yl) methyl] ethylamido] -4-nitrobenzoate &gt; According to the method of Production Example 14, use 3-Ethylamido-4-nitrobenzoate ethyl ester (1.54g) and 2-fluoro-4, -fluorenylbiphenyl bromide (2.26g) to give 3- [N-[(2'_fluoro Substituted biphenyl-4-yl) methyl] acetamidinyl] -4-ethyl stilyl benzoate (1.90 g). [Physical properties of the compound] ^ -NMRCCDCla, 6): L33 (3H, t3 J = 7.1 Hz), 1.92 (3H, s) 3 4.36 (2Η, m) 3 4.44 (1Η, d, J = 4.4Hz) 3 5.32C1H, d3 J = 4.4Hz), 7.13 (1H, m), 7.18- 7.22 (3H, m) 3 7 • 31 (1H, m), 7.40 (1Η, dt, J = L6 and 7.7Ηζ), 7.44 (2Η3 d) , 7.67 (1Η3 d, J = 1 • 6Hz), 7.94 (1Η, d, J = 8.4Hz), 8.15 (1Η, dd, J: 1.8 and 8 · 4Ηζ). &lt; Example 244; Synthesis of 6-ethoxycarbonyl-l-[(2 '· fluorobiphenyl-4-yl) fluorenyl] -2-methylbenzimidazole (306) &gt; According to Examples Method 24, using 3- [N-[(2, _fluorobiphenyl-4-yl) methyl ~ yl] acetamido] -4 · nitronitrobenzoate (1.90g) to obtain 1.53 g of 6-ethoxycarbonyl-1-[(2'-fluorobiphenyl-4-yl) methyl] -2-fluorenylbenzo (306). [Physical properties of compound (306)] ^ -NMRiCDGL ·, δ): 1.40 (3H, t, J = 7.1Hz) 3 2.62 (3H, s), 4.38 (2H, q3 Jrr7 l

Hz), 5·43(2Η, s), 7·10-7·17(3Η, m), 7·19(1Η, dt, J=1.0 及 7·5Ηζ),7.3i ____ ___________ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) '~ (請先閱讀背面之注意事項再填寫本頁) ii m I mi ml ϋ— i I ϋϋ ml —ϋ m in —ϋ n —ϋ am —ϋI^i I— —Mu I m nn In —Mm— It ml —^ϋ 1^1 11 —ϋ tmmm— ^nw i m 548272 A7 B7Hz), 5.43 (2Η, s), 7.10-7 · 17 (3Η, m), 7.19 (1Η, dt, J = 1.0 and 7. · 5Ηζ), 7.3i ____ ___________ This paper size is applicable China National Standard (CNS) A4 specification (210X297 mm) '~ (Please read the precautions on the back before filling this page) ii m I mi ml ϋ— i I ϋϋ ml —ϋ m in —ϋ n —ϋ am — ϋI ^ i I— —Mu I m nn In —Mm— It ml — ^ ϋ 1 ^ 1 11 —ϋ tmmm— ^ nw im 548272 A7 B7

五、發明説明(23S (1H, m), 7·38(1Η, dt, J二1·8 及 7·8Ηζ), 7·50(2Η, dd), 7·74(1Η, d, J=8.5 Ηζ), 8·00(1Η, dd, J=1.4 及 8·4Ηζ), 8·06(1Η, s)。 〈實施例245;6-魏基-ΐ-[(2’-氟代聯苯基_4_基)甲 基]-2-甲基苯並味唾(307)之合成&gt; 依據貫施例53之方法,使用6-乙氧碳基_1__[(2,_ ι代 聯苯基-4-基)曱基]-2-甲基苯並咪唑(i.5〇g)以得出6_羧基_ 卜[(2’-氟代聯苯基-4-基)甲基]-2-甲基苯並咪唑 (307)1.24g 〇 [化合物(307)的物性] A-NMR(DMS0-d63 ό) : 2.59(3H3 s),5·63(2Η,s)3 7·19(2Η,d,J二8·1Ηζ),7· 24-7·31(2Η,m),7·39(1Η,ιη),7·46-7·53(3Η,认 7·62(1Η3 d, J=8.4Hz),7·8 0(1H, dd, J=1.3 及 8·4Ηζ), 8·10(1Η3 s)。 &lt;實施例246;6-(l-乙磺醯基氨基甲醯基卜丨七?,-氟 代聯苯基-4-基)曱基]-2-甲基苯並咪唑(308)之合成&gt; 經濟部中央標率局員工消費合作社印繁 (讀先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用6-羧基_1-[(2,-氟代聯 苯基-4-基)甲基]-2_甲基苯並咪唑(〇.455g)、Ν,Ν’-羰基二 咪唑(0.409g)、1-丁磺醯胺(〇.346g)、二氮二環十一烯 (0.384g)以得出6-(1-乙磺醯基氨基甲醯基)-1-[(2,-氟代 聯苯基-4-基)甲基]-2_曱基苯並味嗤(308)0.340g。 [化合物(308)的物性] ^-NMRiDMSO-dG, δ) : 0.84(3H, t, J=7e3Hz), 1.39(1H, m)-, 1.67(1H, m), 2. 57(3H, s), 3.5K1H, t), 5.60(2H, s), 7.21(2H, d, J=8.0Hz), 7.24-7.30(2H, in), 7.39(1H, m)3 7.48(1H, t), 7.52C2H, d, J=8.0Hz), 7.66(iH, d, J=8.5Hz ),7·80(1Η, d, J=8.5Hz), 8·25(1Η, s), 11·93(1Η, br s)。 —----22a__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央椋準而負工消費合作社印掣 548272 A7 B7 五、發明説明(23j &lt;製造例50;3-氟-4-甲基聯苯之製造&gt; 將1.6M之正丁基鋰己烷溶液(30ml)加入在氮環境 氣體下冷卻至-78°C之四氫呋喃(30ml),接著加入4-溴-2-氟代甲苯(9.21g)之四氫呋喃(30ml)溶液,在-78°C下攪 拌1小時。在減壓下加熱溶融後,在-78°C下加入經脫水 之氯化鋅(6.64g)的四氫呋喃(30ml)溶液,在室溫下攪拌1 小時。在室溫下將碘代苯(6.63g)及四(三苯基膦)鈀(0.52g) 之四氫呋喃(30ml)溶液加入前述溶液中,攪拌1天。以 醋酸乙酯(300ml)稀釋反應液,加入10%鹽酸進行萃取。 以飽和食鹽水洗淨有機層,乾燥後將其濃縮。使用矽膠 柱色譜(溶離液:己烷)精製殘渣,以得出油狀的3-氟-4-甲基聯苯(6.00g)。 [化合物的物性] lH-NMR(CDCl35 δ) : 2.31(3H, d3 J=1.8Hz), 7.2〇-7.28(3H5 m), 7.34(1H, m), 7·43(2Η, t)3 7·55(2Η, d)〇 &lt;製造例51;4-溴代甲基-3-氟代聯苯之製造&gt; 將3-氟_4_曱基聯苯(6.00g)、N-溴代丙醯胺(5.73g)、 2,2’-偶氮二異丁腈(0.075g)、四氣化碳(120ml)之混合物 加熱迴流5小時。水洗反應液,以石夕膠柱色譜(溶離液: 己烷/醋酸乙酯=9/1)精製濃縮有機層所得之殘渣,以得 出油狀的4-漠代甲基-3-氟代聯苯(8.30g)。 [化合物的物性] ^-NMRiCDCh, δ) : 4.57(2H, s), 7.30(1H, d, J=11.0Hz)3 7.34-7.40(2H, m) ,7·45(3Η, m), 7·56(2Η, d)。 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)V. Description of the invention (23S (1H, m), 7.38 (1Η, dt, J 2 1.8 and 7.8Ηζ), 7.50 (2Η, dd), 7.74 (1Η, d, J = 8.5 Ηζ), 8.00 (1Η, dd, J = 1.4 and 8.4Ηζ), 8.06 (1Η, s). 〈Example 245; 6-Weiji-ΐ-[(2'-fluorinated Synthesis of Phenyl_4-yl) methyl] -2-methylbenzosalan (307) &gt; According to the method of Example 53, 6-ethoxycarbyl_1 __ [(2, _ Biphenyl-4-yl) fluorenyl] -2-methylbenzimidazole (i.50 g) to give 6_carboxyl [[2'-fluorobiphenyl-4-yl) methyl Group] -2-methylbenzimidazole (307) 1.24 g 〇 [Physical properties of compound (307)] A-NMR (DMS0-d63): 2.59 (3H3 s), 5.63 (2Η, s) 3 7 · 19 (2Η, d, J 2: 8.1Ηζ), 7.24 ~ 7 · 31 (2Η, m), 7.39 (1Η, ιη), 7.46-7 · 53 (3Η, recognize 7.62 (1Η3 d, J = 8.4Hz), 7.80 (1H, dd, J = 1.3 and 8.4Ηζ), 8.10 (1Η3 s). &Lt; Example 246; 6- (l-ethanesulfonate) Synthesis of carbamoylcarbamidine 丨 7?,-Fluorobiphenyl-4-yl) fluorenyl] -2-methylbenzimidazole (308) &gt; Central Consumer Bureau of Ministry of Economic Affairs (Read the note on the back first Please fill in this page again.) According to the method of Example 98, 6-carboxyl 1-[(2, -fluorobiphenyl-4-yl) methyl] -2-methylbenzimidazole (0.455 g) was used. ), Ν, Ν'-carbonyldiimidazole (0.409 g), 1-butanesulfonamide (0.346 g), diazabicycloundecene (0.384 g) to give 6- (1-ethanesulfonyl Carbamidyl) -1-[(2, -fluorobiphenyl-4-yl) methyl] -2-fluorenylbenzo miso (308) 0.340 g. [Physical properties of compound (308)] ^ -NMRiDMSO-dG, δ): 0.84 (3H, t, J = 7e3Hz), 1.39 (1H, m)-, 1.67 (1H, m), 2. 57 (3H, s), 3.5K1H, t), 5.60 (2H, s), 7.21 (2H, d, J = 8.0Hz), 7.24-7.30 (2H, in), 7.39 (1H, m) 3 7.48 (1H, t), 7.52C2H, d, J = 8.0Hz ), 7.66 (iH, d, J = 8.5Hz), 7.80 (1Η, d, J = 8.5Hz), 8.25 (1Η, s), 11.93 (1Η, br s). —---- 22a__ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm). The Central Ministry of Economic Affairs and the Consumers' Cooperative Press 548272 A7 B7 V. Description of the invention (23j &lt; Manufacturing Example 50; Production of 3-fluoro-4-methylbiphenyl &gt; A 1.6M n-butyllithium hexane solution (30ml) was added to tetrahydrofuran (30ml) cooled to -78 ° C under a nitrogen atmosphere, and then 4- A solution of bromo-2-fluorotoluene (9.21g) in tetrahydrofuran (30ml) was stirred at -78 ° C for 1 hour. After heating and melting under reduced pressure, dehydrated zinc chloride (-78 ° C) was added 6.64 g) of tetrahydrofuran (30 ml) solution, stirred at room temperature for 1 hour. At room temperature, a solution of iodobenzene (6.63 g) and tetrakis (triphenylphosphine) palladium (0.52 g) in tetrahydrofuran (30 ml) was added. The solution was stirred for 1 day. The reaction solution was diluted with ethyl acetate (300 ml), and 10% hydrochloric acid was added for extraction. The organic layer was washed with saturated brine, dried, and then concentrated. Silica gel column chromatography (eluent: hexane The residue was purified to obtain 3-fluoro-4-methylbiphenyl (6.00 g) as an oil. [Physical properties of the compound] 1H-NMR (CDCl35 ): 2.31 (3H, d3 J = 1.8Hz), 7.2〇-7.28 (3H5 m), 7.34 (1H, m), 7.43 (2Η, t) 3 7.55 (2Η, d) 〇 &lt; Manufacture Example 51; Production of 4-bromomethyl-3-fluorobiphenyl &gt; 3-fluoro-4_fluorenylbiphenyl (6.00g), N-bromopropylamidamine (5.73g), 2, The mixture of 2'-azobisisobutyronitrile (0.075g) and tetragasified carbon (120ml) was heated and refluxed for 5 hours. The reaction solution was washed with water and subjected to column chromatography on silica gel (eluent: hexane / ethyl acetate = 9 / 1) The residue obtained by concentrating the organic layer was purified to obtain 4-benzylmethyl-3-fluorobiphenyl (8.30 g) as an oil. [Physical Properties of Compound] ^ -NMRiCDCh, δ): 4.57 (2H , s), 7.30 (1H, d, J = 11.0Hz) 3 7.34-7.40 (2H, m), 7.45 (3Η, m), 7.56 (2Η, d). _ This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)

、1T 548272 A7 B7 五、發明説明(239 〈製造例52;3-[N-[(3-氟代聯苯基-4-基)甲基]乙醯胺 基]-4-硝基安息香酸乙酯之製造&gt; 依據製造例14之方法,使用3-乙醯胺基_4_硝基安 息香酸乙酯(1.54g)與3-氟-4_甲基聯苯溴(2.26g)以得出 3-[N-[(3-氟代聯苯基-4_基)甲基]乙醯胺基]-4-硝基安息 香酸乙酯之粗精製物(2.68g)。 〈實施例247;6-乙氧羰基-1 _[(3_氟代聯苯基-4-基)甲 基]-2-甲基苯並咪嗤(309)之合成&gt; 依據實施例24之方法,使用3-[N-[(3-氟代聯笨基 -4-基)甲基]乙醯胺基]-4-硝基安息香酸乙酯的粗精製物 (2.68g)以得出6-乙氧羰基-l-[(3-氟代聯苯基-4·基)甲 基]-2-甲基苯並味峻(309)1.34§。 [化合物(309)的物性] 喟-NMR(CDC13,d) : 1·40(3Η,t,J=7.1Hz),2·65(3Η,s),4·39(2Η,q, J二7.1 Ηζ), 5·46(2Η, s), 6·79(1Η, t, J=8.0Hz), 7·25(1Η, m)3 7·34-7·40(2Η3 m)3 7 ·41-7·47(2Η, m), 7.50-7·54(2Η3 m), 7·74(1Η, d, J=8.5Hz), 7·99(1Η, dd, J= 1·5 及 8·4Ηζ), 8·07(1Η, d, J=1.3Hz)。 &lt;實施例248;6-羧基-1-[(3-氟代聯苯基-4-基)甲基]_ 經濟部中央樣泽趵只工消費合作社印繁 (請先閱讀背面之注意事項再填寫本頁) 2-曱基笨並咪唑(3 10)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基-1_[(3_就 代聯苯基-4-基)曱基]-2-甲基苯並味嗤(1.34g)以得出卜 羧基-l-[(3-氟代聯苯基-4-基)甲基]-2-曱基苯並咪唾 (310)1.15g。 [化合物(310)的物性] ______212_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(23》 ^-NMRiDMSO-dG, δ) : 2·59(3Η, s), 5.64(2H, s), 7.03(1H, t, J=8.0Hz), 7. 37(1H,t,J=7.3Hz·),7·42_7·48(3Η,m), 7·56-7·68(4Η,m),7.79(1H,dd,J=1 • 4 及 8.4Hz), 8·11(1Η,s)3 12·7(1Η,br s)。 &lt;實施例249;6-(l-丁磺醯基氨基甲醯基)-i_[(3_氟代 聯苯基-4-基)曱基]-2_甲基苯並咪n坐(3 π)之合成&gt; 依據實施例98之方法,使用6-羧基-l-[(3-氟代聯 苯基-4-基)甲基]-2-曱基苯並咪唑(〇.390g)、N,N,-羰基二 咪唑(0.351g)、1-丁磺醯胺(〇.297g)、二氮二環十一烯 (0.329g)以得出6-(1-丁磺醯基氨基甲醯基)-i-[(3-氟代聯 苯基-4-基)甲基]-2-甲基苯並味嗤(3 11)0.236g。 [化合物(311)的物性] ^-NMRiDMSO-dG, δ) : 0·84(3Η3 t), 1.38(2H, m), 1.65(2H, m), 2.57(3H, s) ,3··48(2Η,m),5·63(2Η,s),6.93(1H,t,J=8,lHz),7·37(1Η,m)3 7.42-7.47 (3H,m),7·60(1Η,dd,J=1.7 及 11.8Hz),7.62-7·68(3Η,m),7,80(1H,dd, J=1.5 及 8·4Ηζ), 8·21(1Η, d, J=1.3Hz), 11·90(1Η, br s)。 IR(Nujol) : 1681CBT1。 mp : 227-230°C。 經满部中央標率局貞工消費合作社印掣 (請先閱讀背面之注意事項再填寫本頁) &lt;實施例250;l-(2-氯代苄基)-6-[(2-甲氧基乙)磺醯 基氣基甲-酿基]-2-曱基苯並味ϋ坐(312)之合成&gt; 依據實施例98之方法,使用1-(聯苯基-4-甲基)-6-叛基-2_乙基笨並味嗤(〇.3〇〇g)、Ν,Ν’-幾基二口米嗤 (0.272g)、(2-乙氧基乙)確醯胺(〇.258g)、二氮二環十一 烯(0.256g)以得出1-(2-氯代苄基)-6-[(2-甲氧基乙)磺醯 基氨基甲醯基]-2-甲基笨並咪唑(312)0.149§。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 Α7 Β7 五、發明説明(23) [化合物(3 12)的物性] lH-NMR(DMS0-d6, δ) : 0.87(3H, t3 J=6.9Hz), 1.30(3H, t, J=8.0Hz), 2.89(2 H, q, J-7.6Hz), 3,25-3.35(2H, m)5 3.63~3.74(2H3 m), 5.59(2H, s)3 7.17(2H ,d3 J=8.1Hz)3 7.34(1H, t3 J-7.0Hz)3 7.44(2H, t, J=7.6Hz), 7.58-7.68(5H, m)5 7.82(1H, d5 J=8.4Hz), 8.23(1H, s), 11.88(1H, s)〇 IR(Nujol) : 1681cm-'〇 mp : 78-8rC。 &lt;實施例25l;l-(2,4-二氣代苄基)_6_(1-苯磺醯基氨 基甲醯基)苯並咪唑(313)之合成&gt; 依據實施例98之方法,使用6_羧基_1-(2,4_二氣代 节基)_2_甲基苯並咪唾(〇.3〇〇g)、N,n,-幾基二口米峻 (0.323g)、1-戊磺醯胺(0.301g)、二氮二環十一烯(〇 3〇3g) 以得出l-(2,4-二氯代苄基)-6-(1-笨磺醯基氨基甲醯基) 苯並咪唑(313)0.196g。 [化合物(313)的物性] 經淨-部中央梂率而负工消費合作社印繁 (請先閱讀背面之注意事項再填寫本頁) 6) : 0·81(3Η,t,J=7.3Hz),1·22-1·30(2Η,m)3 1·32-1·39( 2Η, m), 1.64-1.71(2Η, m)5 2.50(3Η, s), 3.50(2Η, t, J=7-8Hz), 5·59(2Η, s) ,6·45(1Η, d, J=8.4Hz), 7·33(1Η, dd, J=2.2 及 8.5Hz), 7·69(1Η, d, J=8· 5Hz),7·76(1Η,(1,J=2.1Hz),7·80(1Η,dd,J:1.6 及 8·5Ηζ),8·10(1Η,s), 1L89(1H, s)〇 IR(Nujol) : 1682cm mp : 213.2-214.6°C〇 〈實施例252; 1-(聯苯-4-甲基)-2-乙基·6-〇[3·(甲硫 基)丙]續醢基氨基甲醯基]苯並味唾(314)之合成&gt; ----244_____ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 548272 A7 B7 五、發明説明(23g 依據實施例98之方法,使用6-羧基-1-(聯苯-4-甲 基)_2-乙基苯並咪唑(0.300g)、N,N,-羰基二咪唑 (0.272g)、1-[(3-曱硫基)丙]磺醯胺(0.285g)、二氮二環十 一稀(〇_256g)以得出1-(聯笨-4-甲基)-2-乙基-6-[1-[3-(甲 硫基)丙]磺醯基氨基曱醯基]苯並咪唑(3 14)0.178g。 [化合物(314)的物性] W-NMMDMSO-d6,6) : 1.30(3H,t,J=7.5Hz),1·9Η·99(2Η,ιη),1·97(3Η,s ),2·58(2Η, t, J=7.2Hz), 2·90(2Η, q, J=7.6Hz), 3.55~3·61(2Η, m)3 5·60(2Η ,s),7·18(2Η,d,J=8.2Hz),7·35(1Η,t, Jf:7.3Hz),7.44(2H,t,.J:7.5Hz), 7·60-7·66(4Η, m), 7·69(1Η, d, J=8.5Hz), 7.82(1H, dd, J:1.8 及 8·5Ηζ), 8.24(1H, s), 11.98(1H, s)〇 I_jol) : 1671cm1。 即:89.9-91.2°C。 &lt;實施例253;1-(4-聯苯曱基)-2-乙基-6-(1-苯磺醯基 氨基曱醯基)苯並咪唑(3 15)之合成&gt; 經濟部中央標準而員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁} 依據實施例98之方法,使用6-羧基-1-(4·聯苯甲 基)-2•乙基苯並口米嗤(0.300g)、Ν,Ν’-戴基二口米唆 (0.272g)、1-戊磺醯胺(〇.254g)、二氮二環十一烯(〇.256g) 以得出J-(4-聯苯甲基)-2-乙基-6-(l_苯磺醯基氨基甲醯 基)苯並咪唑(315)0.258g。 [化合物(315)的物性] ’FHiMiUDMSO-dG,ά) : 〇·87(3Η,t,J:7.2Hz),1·22-1·39(4Η,m),1·30(3Η,t ,J=7.5Hz), 1.66-1.73(2Η, m), Ζ.90(2Η, q, J^7.4Hz), 3.51(2H, t, J=7.7Hz)1T 548272 A7 B7 V. Description of the invention (239 <Manufacturing Example 52; 3- [N-[(3-Fluorobiphenyl-4-yl) methyl] acetamido] -4-nitrobenzoic acid Production of ethyl esters> According to the method of Production Example 14, ethyl 3-acetamido-4-nitrobenzoate (1.54 g) and 3-fluoro-4-methylbiphenyl bromide (2.26 g) were used. A crude product of ethyl 3- [N-[(3-fluorobiphenyl-4-yl) methyl] acetamido] -4-nitrobenzoate (2.68 g) was obtained. 247; 6-Ethoxycarbonyl-1 — [(3-fluorobiphenyl-4-yl) methyl] -2-methylbenzimidazole (309) Synthesis> According to the method of Example 24, A crude purified product of ethyl 3- [N-[(3-fluorobibenzyl-4-yl) methyl] acetamido] -4-nitrobenzoate (2.68 g) was used to obtain 6- Ethoxycarbonyl-l-[(3-fluorobiphenyl-4 · yl) methyl] -2-methylbenzophenone (309) 1.34§. [Physical properties of compound (309)] 喟 -NMR ( CDC13, d): 1.40 (3Η, t, J = 7.1Hz), 2.65 (3Η, s), 4.39 (2Η, q, J 7.1 Ηζ), 5.46 (2Η, s) , 6.79 (1Η, t, J = 8.0Hz), 7.25 (1Η, m) 3 7.34-7 · 40 (2Η3 m) 3 7 · 41-7 · 47 (2Η, m), 7.50 -7 · 54 (2Η3 m), 7.74 (1Η, d, J = 8.5Hz), 7.99 (1Η, dd, J = 1.5 and 8.4Ηζ), 8.07 (1Η, d, J = 1.3Hz). &lt; Example 248; 6-Carboxy-1-[(3-fluorobiphenyl-4-yl) methyl] _ Central sample of the Ministry of Economic Affairs, Ze Zeyong only Consumer Cooperatives, India Fan (Please read the notes on the back first Fill out this page again) Synthesis of 2-fluorenylbenzimidazole (3 10) &gt; According to the method of Example 53, 6-ethoxycarbonyl-1 _ [(3_ is biphenyl-4-yl) 曱Methyl] -2-methylbenzobis (1,34g) to give carboxyl-l-[(3-fluorobiphenyl-4-yl) methyl] -2-fluorenylbenzyl ( 310) 1.15g. [Physical properties of compound (310)] ______212_ This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (23) 2.59 (3Η, s), 5.64 (2H, s), 7.03 (1H, t, J = 8.0Hz), 7. 37 (1H, t, J = 7.3Hz ·), 7.42_7 · 48 (3Η , M), 7.56-7 · 68 (4Η, m), 7.79 (1H, dd, J = 1 • 4 and 8.4Hz), 8 · 11 (1Η, s) 3 12 · 7 (1Η, br s ). &lt; Example 249; 6- (l-Butanesulfonylcarbamoyl) -i _ [(3-fluorobiphenyl-4-yl) fluorenyl] -2-methylbenzimidyl ( Synthesis of 3 π) &gt; According to the method of Example 98, 6-carboxyl-l-[(3-fluorobiphenyl-4-yl) methyl] -2-fluorenylbenzimidazole (0.390 g) was used. ), N, N, -carbonyldiimidazole (0.351g), 1-butanesulfonamide (0.297g), diazabicycloundecene (0.329g) to give 6- (1-butanesulfonyl Carbamate) -i-[(3-fluorobiphenyl-4-yl) methyl] -2-methylbenzobis (3 11) 0.236 g. [Physical properties of compound (311)] ^ -NMRiDMSO-dG, δ): 0.84 (3Η3 t), 1.38 (2H, m), 1.65 (2H, m), 2.57 (3H, s), 3. · 48 (2Η, m), 5.63 (2Η, s), 6.93 (1H, t, J = 8,1Hz), 7.37 (1Η, m) 3 7.42-7.47 (3H, m), 7.60 ( 1Η, dd, J = 1.7 and 11.8 Hz), 7.62-7 · 68 (3Η, m), 7,80 (1H, dd, J = 1.5 and 8. · 4Ηζ), 8 · 21 (1Η, d, J = 1.3Hz), 11 · 90 (1Η, br s). IR (Nujol): 1681CBT1. mp: 227-230 ° C. Printed by the Central Standards Bureau of Zhenggong Consumer Cooperative (please read the notes on the back before filling this page) &lt; Example 250; l- (2-chlorobenzyl) -6-[(2- 甲Synthesis of oxyethyl) sulfofluorenylmethylamino-methyl] -2-fluorenylbenzoisocyanate (312) &gt; According to the method of Example 98, 1- (biphenyl-4-methyl) was used ) -6-benzyl-2_ethylbenzyl miso (0.300 g), Ν, Ν'-Chichi two-mouth rice noodles (0.272 g), (2-ethoxyethyl) confirmation Amine (.258g), diazabicycloundecene (0.256g) to give 1- (2-chlorobenzyl) -6-[(2-methoxyethyl) sulfonamidocarbamoyl ] -2-methylbenzimidazole (312) 0.149 §. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (23) [Physical properties of compound (3 12)] lH-NMR (DMS0-d6, δ): 0.87 (3H , t3 J = 6.9Hz), 1.30 (3H, t, J = 8.0Hz), 2.89 (2 H, q, J-7.6Hz), 3,25-3.35 (2H, m) 5 3.63 ~ 3.74 (2H3 m ), 5.59 (2H, s) 3 7.17 (2H, d3 J = 8.1Hz) 3 7.34 (1H, t3 J-7.0Hz) 3 7.44 (2H, t, J = 7.6Hz), 7.58-7.68 (5H, m ) 5 7.82 (1H, d5 J = 8.4Hz), 8.23 (1H, s), 11.88 (1H, s). IR (Nujol): 1681cm-'mp: 78-8rC. &lt; Example 25l; Synthesis of l- (2,4-digaso-benzyl) -6- (1-benzenesulfonylaminocarbamyl) benzimidazole (313) &gt; According to the method of Example 98, use 6_carboxyl_1- (2,4_dikistilbyl) _2_methylbenzimidal (0.300g), N, n, -kisyldiisobutyric (0.323g), 1-pentasulfenylamine (0.301g), diazabicycloundecene (0303g) to give l- (2,4-dichlorobenzyl) -6- (1-benzylsulfonyl) Carbamidyl) Benzimidazole (313) 0.196 g. [Physical properties of compound (313)] Consumers' cooperatives printed by the Central-Ministry Central Laboratories (please read the precautions on the back before filling this page) 6): 0 · 81 (3Η, t, J = 7.3Hz ), 1.22-1 · 30 (2Η, m) 3 1.32-1 · 39 (2Η, m), 1.64-1.71 (2Η, m) 5 2.50 (3Η, s), 3.50 (2Η, t, J = 7-8Hz), 5.59 (2Η, s), 6.45 (1Η, d, J = 8.4Hz), 7.33 (1Η, dd, J = 2.2 and 8.5Hz), 7.69 ( 1Η, d, J = 8.5 Hz), 7.76 (1Η, (1, J = 2.1Hz), 7.80 (1Η, dd, J: 1.6 and 8.5Ηζ), 8.10 (1Η, s ), 1L89 (1H, s), IR (Nujol): 1682cm mp: 213.2-214.6 ° C (Example 252; 1- (biphenyl-4-methyl) -2-ethyl · 6-〇 [3 · (Methylthio) c] Synthesis of fluorenylaminocarbamyl] benzo sial (314) &gt; ---- 244_____ This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Explanation of the invention (23g according to the method of Example 98, using 6-carboxy-1- (biphenyl-4-methyl) _2-ethylbenzimidazole (0.300g), N, N, -carbonyldi Imidazole (0.272g), 1-[(3-fluorenylthio) propyl] sulfonamide (0.285g), diazabicycloundecene (0-256g) to obtain 0.178 g of 1- (biben-4-methyl) -2-ethyl-6- [1- [3- (methylthio) propyl] sulfonamidoaminofluorenyl] benzimidazole (3 14). [Physical properties of compound (314)] W-NMMDMSO-d6,6): 1.30 (3H, t, J = 7.5Hz), 1.9Η · 99 (2Η, ιη), 1.97 (3Η, s), 2 · 58 (2Η, t, J = 7.2Hz), 2.90 (2Η, q, J = 7.6Hz), 3.55 ~ 3.61 (2Η, m) 3 5 · 60 (2Η, s), 7.18 (2Η, d, J = 8.2Hz), 7.35 (1Η, t, Jf: 7.3Hz), 7.44 (2H, t, .J: 7.5Hz), 7.60-7 · 66 (4Η, m) , 7.69 (1Η, d, J = 8.5Hz), 7.82 (1H, dd, J: 1.8 and 8.5Ηζ), 8.24 (1H, s), 11.98 (1H, s) (I_jol): 1671cm1. That is: 89.9-91.2 ° C. &lt; Example 253; Synthesis of 1- (4-biphenylfluorenyl) -2-ethyl-6- (1-benzenesulfonylaminofluorenyl) benzimidazole (3 15) &gt; Central Ministry of Economic Affairs Standard and printed by employee consumer cooperatives (please read the notes on the back before filling out this page) According to the method of Example 98, 6-carboxy-1- (4 · biphenylmethyl) -2 • ethylbenzo is used Rice millet (0.300g), Ν, Ν'-Dikei rice millet (0.272g), 1-pentasulfonamide (0.254g), diazabicycloundecene (0.2256g) to obtain J- (4-biphenylmethyl) -2-ethyl-6- (l-benzenesulfonylcarbamoyl) benzimidazole (315) 0.258 g. [Physical properties of compound (315)] 'FHiMiUDMSO- dG , ά): 〇 · 87 (3Η, t, J: 7.2Hz), 1.22-1 · 39 (4Η, m), 1.30 (3Η, t, J = 7.5Hz), 1.66-1.73 ( 2Η, m), ZZ.90 (2Η, q, J ^ 7.4Hz), 3.51 (2H, t, J = 7.7Hz)

,5·60(2Η, s), 7·18(2Η, d, J=8.2Hz), 7·34(1Η, t, J=7.4Hz), 7·44(2Η, t, J _ Ύ1Ύ ____________ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(23$ =7·6Ηζ), 7·60-7·67(4Η, m), 7·71(1Η, d, J=8.4Hz), 7·81(1Η, dd, J=1.6 及 8.4Hz), 8.27(1H, d, J-l.lHz), 11.92(1H3 s)〇 IR(Nujol) : 1682CHT1。 mp : 175.3-178.4°C。 &lt;實施例254;6-(l-丁磺醯基氨基甲醯基)_1-(2,4_二 氣代卞基)-2-乙基本並味σ坐(3 16)之合成&gt; 依據實施例98之方法,使用6_羧基二氣代 苄基)_2_乙基苯並咪唑(0.3〇〇g)、N,N,-羰基二咪唑 (0.258g)、1-丁磺醯胺(0.217g)、二氮二環十一烯(〇·262§) 以得出6-(卜丁磺醯基氨基甲醯基)-1-(2,4-二氣代节基)_ 2-乙基苯並。米0坐(316)0.253g。 [化合物(316)的物性] 1臟»0成 d) : 0·85(3Η,t,J:7.4Hz),1·27(3Η, t, J=7.4Hz)3 1.35-1 •43(2H, m), 1·63-1·70(2Η, m)3 2·81(2Η, q, J=7.4Hz), 3·51(2Η, t, J:7.7Hz) ,5·59(2Η, s), 6·41(1Η3 d, J=8.4Hz)3 7.32(1H, dd3 J=2.0 及 8.4Hz), 7,7 3(1H3 d, J二8·4Ηζ), 7·76(1Η, d, J=2.0Hz), 7·81(1Η, dd3 J=1.5 及 8.5Hz), 8.12(1H, d3 J=1.6Hz), 11·87(1Η, s)。 經濟部中央椋準而負工消費合作社印繁 (請先閱讀背面之注意事項再填寫本頁), 5.60 (2Η, s), 7.18 (2Η, d, J = 8.2Hz), 7.34 (1Η, t, J = 7.4Hz), 7.44 (2Η, t, J _ Ύ1Ύ ____________ This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (23 $ = 7 · 6Ηζ), 7 · 60-7 · 67 (4Η, m), 7.71 ( 1Η, d, J = 8.4Hz), 7.81 (1Η, dd, J = 1.6 and 8.4Hz), 8.27 (1H, d, Jl.lHz), 11.92 (1H3 s), IR (Nujol): 1682CHT1. mp: 175.3-178.4 ° C. &lt; Example 254; 6- (l-butanesulfonylcarbamoamido) _1- (2,4-digasofluorenyl) -2-ethylbenzyl sigma Synthesis of (3 16) &gt; According to the method of Example 98, 6-carboxydioxobenzyl) -2-ethylbenzimidazole (0.300 g), N, N, -carbonyldiimidazole (0.258 g ), 1-butanesulfonamide (0.217g), diazabicycloundecene (0.262§) to give 6- (bubutsulfonylaminocarbamyl) -1- (2,4- Dioxoyl)-2-ethylbenzo. Mi 0 sits (316) 0.253g. [Physical properties of compound (316)] 1 dirty »0% d): 0.85 (3 (, t, J: 7.4Hz), 1.27 (3Η, t, J = 7.4Hz) 3 1.35-1 • 43 ( 2H, m), 1.63-1 · 70 (2Η, m) 3 2.81 (2Η, q, J = 7.4Hz), 3.51 (2Η, t, J: 7.7Hz), 5.59 ( 2Η, s), 6.41 (1Η3 d, J = 8.4Hz) 3 7.32 (1H, dd3 J = 2.0 and 8.4Hz), 7,7 3 (1H3 d, J 二 8 · 4Ηζ), 7.76 ( 1Η, d, J = 2.0Hz), 7.81 (1Η, dd3 J = 1.5 and 8.5Hz), 8.12 (1H, d3 J = 1.6Hz), 11 · 87 (1Η, s). The Central Ministry of Economic Affairs and the Consumers' Cooperatives, India Fanfan (Please read the precautions on the back before filling this page)

IR(Nujol) : 1694cm_1。 mp : 175.7-176.9°C &lt;實施例255;l-(4-聯苯甲基)-2-乙基甲基) 丁磺醯基氨基甲醯基]苯並咪唑(317)之合成&gt; 依據實施例98之方法,使用1-(4-聯笨甲基)_6_緩基 -2-乙基本並味嗤(0.300g)、N,N’-戴基二口米唾(〇 272g)、1_ (3-甲基)丁石κ酿胺(〇.254g)、一鼠二環十一稀(〇.256g)以 --J43__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -- 548272 A7 B7 五、發明説明(240 得出1-(4-聯苯曱基)-2-乙基-6-[l-(3-曱基)丁磺醯基氨基 甲酿基]苯並咪唾(3 17)0.273g。 (請先閱讀背面之注意事項再填寫本頁) [化合物(317)的物性] 4-NMR(DMS0-d6,ά) : G.85(6H,d5 J:6.5Hz),1J(3H,t,J:7.4Hz),1.55-1 •62(2H3 m), 1·63-1·70(1Η, m), 2·90(2Η, q3 J:7.4Hz), 3.52(2H, t, J二7.9Hz) ,5·61(2Η, s), 7·19(2Η, d, J=8.3Hz)3 7·35(1Η, t3 J=7.4Hz), 7.44(2H, t, J 二7·5Ηζ), 7·61-7.66(4Η, m), 7·71(1Η, d, J二8·5Ηζ), 7·81(1Η, dd, J:1.6 及 8·4Ηζ), 8·27(1Η, s), 11·95(1Η, s)。 IR(Nujol) : 1682cm— mp : 102·8-104.5oC〇 &lt;實施例256; l-(2,4-二氣代苄基)-5-乙氧羰基-2-曱 基苯並咪唑(318)之合成&gt; 依據製造例14之方法,使用4-乙醯胺基-3-硝基安 息香酸乙酯(1.525g)與2,4-二氣代苄基氯(1.42g)以得出 4-[N-(2,4-二氣代苄基)乙醯胺基]_3_硝基安息香酸乙 酯。再依據實施例24之方法以變換成ι_(2,4-二氯代节 基)-5 -乙氧戴基-2-甲基笨並味嗤(3l8)1.476g。 [化合物(318)的物性] 1H-NMR(CDC13j d) : 1.42(3H, t, J=7.1Hz), 2.57(3H, s)3 4.41(2H3 q3 J-7.1IR (Nujol): 1694cm_1. mp: 175.7-176.9 ° C &lt; Example 255; Synthesis of l- (4-biphenylmethyl) -2-ethylmethyl) butanesulfonylcarbamoyl] benzimidazole (317) &gt; According to the method of Example 98, 1- (4-bibenzylmethyl) -6-branzyl-2-ethylbenzo miso (0.300 g), N, N'-Dynyl saliva (〇272 g) were used. , 1_ (3-methyl) butanite kappaamine (.254g), one mouse, two ring and eleven dilute (.256g) to --J43__ This paper size applies Chinese National Standard (CNS) A4 specification (210X297) %)-548272 A7 B7 V. Description of the invention (240 gives 1- (4-biphenylfluorenyl) -2-ethyl-6- [l- (3-fluorenyl) butylsulfonylcarbamyl ] Benzimidal (3 17) 0.273 g. (Please read the precautions on the back before filling this page) [Physical properties of compound (317)] 4-NMR (DMS0-d6, ά): G.85 (6H, d5 J: 6.5Hz), 1J (3H, t, J: 7.4Hz), 1.55-1 • 62 (2H3 m), 1.63-1 · 70 (1Η, m), 2.90 (2Η, q3 J : 7.4Hz), 3.52 (2H, t, J = 7.9Hz), 5.61 (2Η, s), 7.19 (2Η, d, J = 8.3Hz) 3 7 · 35 (1Η, t3 J = 7.4 Hz), 7.44 (2H, t, J 2 7.5Ηζ), 7.61-7.66 (4Η, m), 7.71 (1Η, d, J 8 · 5Ηζ), 7.81 (1Η, dd, J: 1.6 and 8.4Ηζ), 8.27 (1Η, s), 11.95 (1Η, s). IR (Nujol): 1682cm— mp: 102 8-104.5 ° C &lt; Example 256; Synthesis of l- (2,4-dioxobenzyl) -5-ethoxycarbonyl-2-fluorenylbenzimidazole (318) &gt; According to Production Example 14 This method uses 4-ethylamido-3-nitrobenzoic acid ethyl ester (1.525 g) and 2,4-digaso-benzyl chloride (1.42 g) to obtain 4- [N- (2,4 -Digas benzyl) acetamidinyl] -3_nitrobenzoate. The method according to Example 24 was used to convert to ι_ (2,4-dichlorobenzyl) -5 -ethoxydaiyl -2-methylbenzyl miso (3l8) 1.476 g. [Physical properties of compound (318)] 1H-NMR (CDC13j d): 1.42 (3H, t, J = 7.1Hz), 2.57 (3H, s) 3 4.41 (2H3 q3 J-7.1

Hz),5·38(2Η,s),6·35(1Η,d,J:8.4Hz),7.09(1H,dd,J=2.0 及汀 8·4Ηζ), 7·16(1Η,d,J:8.9Hz),7·49(1ϋ d,J:2.0Hz),7·96(1Η,dd,J:1.5 及莎 8.5H z), 8.46(1H, s)〇 &lt;實施例257;5-羧基-1-(2,4-二氯代苄基)-2-曱基苯 並咪唑(319)之合成&gt; _ 244 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公楚) 548272 A7 B7 五、發明説明(24ί 依據實施例53之方法,使用i-(2,4-二氯代苄基)_ 5-乙氧幾基-2-曱基笨並口米。坐(1.465g)以得出5 -魏基-1一 (2,4-二氣代苄基)-2-曱基苯並咪唑(319)1.195g。 [化合物(319)的物性] lH-NMR(DMS0-d65 δ) : 2.48(3H3 s)5 5.56(2H, s) 3 6.53( 1H, d, J=8.4Hz)? 7. 32(1H, dd, J二2.1 及 8·4Ηζ), 7·44(1Η3 d, J二8·4Ηζ), 7·73(1Η, d, J二2·2Ηζ) ,7·78(1Η, dd, J二1·5 及 8·4Ηζ), 8.15(1Η, d, J=1.3Hz)。 &lt;實施例258;5-(1-丁磺醯基氨基曱醯基)_ΐ-(2,4-二 氯代苄基)_2_甲基苯並咪唑(32〇)之合成&gt; 依據實施例98之方法,使用5-羧基_1-(2,4-二氣代 苄基)-2_曱基苯並咪唑(0.565g)、Ν,Ν,-羰基二咪唑 (0.504g)、1-丁 磺醯胺(〇.427g)、二氮二環十一烯(〇.473g) 以得出5-(1-丁磺醯基氨基甲醯基)-1-(2,4-二氣代苄基)-2-甲基苯並咪唑(320)0.690邑。 [化合物(320)的物性] W-NMR(DMS(H16,6) : 0·87(3Η,t,J:7.3Hz),L41(2H,m),1·68(2Η,m),2· 49(3Η, s), 3·52(2Η, m), 5.58(2Η, s), 6.53(1Η, d, J=8.4Hz), 7·33(1Η, dd, J二2·1 及 8·4Ηζ),7·50(1Η,d,J二8·5Ηζ),7·73(1Η,d3 J二2·1Ηζ)3 7.78(1H, 好淤部中决^卑^义工消贽合作^印^ (請先閱讀背面之注意事項再填寫本頁) dd, J-1.5 及 8·5Ηζ), 8·24(1Η, s), 11·97(1Η, br s)。 IR(Nujol) : 1674cm-、 即:135.4-139.2°C。 &lt;實施例259; 1-(4-聯苯甲基)-5-乙氧羰基-2-乙基苯 並咪唑(321)之合成&gt; 依據製造例14之方法,使用4-丙醯胺基-3-硝基安息 —--- - _ 一 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 -------------------B7 五、發明説明(24i '一^ (請先閱讀背面之注意事項再填寫本頁) 香酸乙酯(1.50g)與4-溴代甲基聯苯(1.67g)以得出4_[n_ (4-聯苯曱基)丙醯胺基硝基安息香酸乙酯。再依據實 施例24之方法以變換成聯苯甲基)_5_乙氧羰基_2_ 乙基苯並咪唑(321)1.23§。 [化合物(321)的物性] ^酿⑽…,6) : 1·40(3Η,t3 J:7.1Hz),1·45(3Η,t,J:7.6Hz),2·90(2Η, 1 J:7.6Hz),4·39(2Η,q,J:7」Hz),5·顿2H,s),7·09(2Η3 d,㈣·2Ηζ), 7·27(1Η, d3 J=8.8Hz), 7.34(1H, m), 7.42(2H, t), 7.55-7.51(4H, m)3 7.97(1 H, dd, J:1.5 及 8·4Ηζ), 8·52(1Η, d, J二1·2Ηζ)。 &lt;實施例260;l-(4-聯笨曱基)-5-羧基-2-乙基笨並咪 唑(322)之合成&gt; 依據實施例53之方法,使用1-(4-聯苯曱基)_5·乙 氧幾基-2-乙基苯並味唾(l.〇〇g)以得出ι_(4-聯苯甲基)_5_ 叛基-2-乙基苯並味峻(322)0.870§。 [化合物(322)的物性] 'H-NMRiDMSO-dG, δ) : L30(3H5 t, J=7.4Hz), 2.90(2H, q, J-7.4Hz)5 5.57(2 H, s)5 7.17(2H3 d3 J=8.3Hz), 7.33(1H, m), 7.4Z(2H3 t), 7.63-7.57(5H, m)5 ?·81(1Η, dd, J二1·6 及 8·6Ηζ), 8.18(1H, d, J=1.3Hz), 12.67(1H, br s)。 經部中央«.-率乃只-T-消費合作私印^ &lt;實施例261 ;l-(4-聯笨曱基)-5-(1-丁磺醯基氨基甲 醯基)-2-乙基苯並咪唑(323)之合成&gt; 依據實施例98之方法,使用1-(4-聯苯甲基)-5-羧 基-2-乙基苯並咪唑(0.400g)、N,N、羰基二咪唑(〇.364g)、 1-丁磺醯胺(0.308g)、二氮二環十一烯(〇.342g)以得出ΙΟ-聯 苯曱基)-5-(1-丁磺醯基氨基 甲醯基)-2-乙基 笨並咪 ___ 246 _____ i紙張尺度適用中國國家標準(CNS〉A4規格(210'〆297公楚) &quot; 一 548272 Α7 Β7 五、發明説明(24) 唑(323)0.305g ° [化合物(323)的物性] (請先閱讀背面之注意事項再填寫本頁) m-NMlUDMSO-d6,ά) : 0·86(3Η,t,J二7·4Ηζ),1·30(3Η,t,J二7·5Ηζ),1·41(2 Η, m), 1·68(2Η, m), 2·91(2Η, q, J=7.4Hz), 3·52(2Η, m), 5.59(2Η, s), 7·16 (2Η,d,J二8·2Ηζ),7·34(1Η,t,J二7·4Ηζ),7.43(2Η3 t),7·59-7·65(5Η,πι),7 ·80(1Η, dd, J=1.6 及 8·6Ηζ), 8·24(1Η, d, J二1.6Ηζ), 11·97(1Η, br s)。 IR(Nujol) : 1682cm-l。 mp : 142.9-144.4°C。 &lt;實施例262;1-(4-聯苯甲基)-2-乙基-6-(2-甲氧基乙 石黃酿基氨基甲醯基)苯並咪唾(324)之合成&gt; 依據實施例98之方法,使用苯並咪唑(〇·513g)、 N,N’-羰基二咪唑(〇.464g)、2-曱氧基乙磺醯胺(0.420g)、 二氮二環十一烯(0.438g)以得出1-(4-聯苯甲基)-2-乙基· 6-(2-曱氧基乙磺醯基氨基曱醯基)苯並咪唑 (324)0.487g。 [化合物(324)的物性] 1瞧_0-d6,(5) : ΐ·30(3Η,t3 j:7.5Hz),2 9_,q,付·他),&amp; H,s),3·70-3·77(4Η,πι),5·6〇(2Η,s) 7·18(2Η,d,J二8·2Ηζ),7·35(1Η t J -7·1Ηζ),7·44&lt;2Η,t,J:7.5Hz),7·60-7·67(4Η,πι),7.70(1Η,d,J:&amp;5Hz) 7 ·80(1Η, dd, J=7.4 及 1·3Ηζ), 8·25(1Η, s), 11·97(1Η, s)。 IR(Nujol) : 1684cm—*。 mp : 94.6-97.2°C〇 &lt;實施例263;6_乙氧羰基乙基-l-[4_(4-氟代节氧 基)苄基]苯並咪唑(325)之合成&gt; _____Ύάΐ_ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 經淤部中决榀卑^h_x消贽合竹^印¾ 548272 A7 __________ B7 五、發明説明(24j — 在75 °C下攪拌4-丙醯胺-3-胺基安息香酸乙醋 (〇.534g)、碳酸鉀(〇.374g)、4-(4_氟代苄氧基)苄基 (〇.800g)、醋酸乙酯(5mi)、水(3ml)之混合物16小時。將 乙醇與36%鹽酸(〇.46g)加入濃縮有機層所得之殘渣中, 在加熱迴流下攪拌2小時。加入碳酸鉀以進行中和後, 減壓濃縮溶媒,加入醋酸乙酯與水進行萃取。在減壓下 濃縮有機層,藉由矽膠柱色譜(溶離液:己烷/酯酸乙醋 ==1八)之精製以得出6-乙氧羰基-2-乙基-1_[4气4_氟代节 氧基)苄基]苯並咪唑(325)0.228g。 [化合物(325)的物性] 'H-NMRiCDCla, δ) : 1.40(3H, J=7.1Hz), 1.42(3H, t3 J=7.5Hz), 2.86(2H, q3 J二7·5Ηζ), 4.38(2H, q, J=7.1Hz), 4.97(2H, s), 5.32(2H, s), 6.88(2H3 d, J=8.7Hz), 6·98(2Η, d, J=8.7Hz), 7·05(2Η, t, J=8.7Hz), 7·37(2Η, m), 7· 76(2H, d, J=8.4Hz), 7·98(1Η, dd, J二1·5 及 8·5Ηζ), 8·02(1Η, s)。 〈實施例264;6_叛基_2_乙基-1-[4-(4_氟代苄氧基)节 基]苯並咪唑(326)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基-2-乙基-1-[4_(4·氟代节氧基)节基]苯並味0坐(〇.225g)以得出卜魏 基_2_乙,基-1-[4-(4-氟代苄氧基)苄基]笨並咪唑 (326)0.175g。 [化合物(326)的物性] lH-NMR(DMS0-d6, δ) : 1.28(3H, t5 J=7.4Hz)3 2.89(2H, q, J-7.4Hz), 5.01(2 H,s),5.47(2H,s),6·95(2Η,d),7.03(2H,d),7·18(2Η,t),7·45(2Η,m), 7.62(1H, d3 J-8.4Hz), 7.77(1H, d, J=8.4Hz), 8.05(1H, s)〇 ;紙張尺度適/fl巾關家鮮(CNS ) A4規格(210X29^54 ) &quot; ~ 訂 線 (讀先閱讀背面之注意事項再填寫本頁) 548272 A7 五、發明説明( &lt;實施例265;6-(l-丁磺醯基氨基曱醯基)-2-乙基 [4-(4-氟代苄氧基)苄基]笨並咪唑銨鹽(327)之合成&gt; 依據實施例98之方法,使用卜羧基_2-乙基444-(4-氟代苄氧基)苄基]苯並咪唑(0171g)、N,N,-羰基二咪唑 (0.13 7g)、丁 磺醯胺(oj 16g)、二氮二環十一烯129g) 以得出油狀之6-(1-丁磺醯基氨基甲醯基)_2_乙基_〗_[‘ (4_氟代苄氧基)苄基]笨並咪唑。將其溶解於醋酸乙酯 中’並加入氨水。藉由過濾出所析出之固體,經乾燥以 得出6-(1-丁磺醯基氨基甲醯基)-2_乙基-;μ[4_(4_氟代苄 氧基)苄基]苯並咪唑銨鹽(327)0.140g。 [化合物(327)的物性] tNM^DMSO-dG,6) : 〇·83(3Η,t)3 1·25(3Η,t),1·35(2Η,ιη),1·61(2Η,m), 2·84(2Η, q), 3.27(2Η, m), 5.01(2Η3 s)3 5.42(2Η, s), 6.95(2Η, d, J-7.8Hz ),7·02(2Η, d, J=7.8Hz), 7·17(2Η, t), 7·44(2Η, m), 7·57(1Η, d, J:8.1Hz)3 7.82(1H5 d3 J-8.1Hz)3 8.12(1H3 s)〇 IR(Nujol) : 1614cm10 mp : 105-115°C〇 舒米‘部中呔i?.準^BJT消贽合竹:印^ &lt;實施例266; 1 -[4-(3,4-二氯代苄氧基)苄基]_6_乙氧 羰基-2- 基苯並咪唑(328)之合成&gt; 依據實施例263之方法,使用4-丙醯胺_3_胺基安 息香酸乙酯(l.Slg)與4_(3,4·二氯代苄氧基)苄基(3·ΐ8^ 以得出1 -[4-(3,4-二氯代苄氧基)苄基乙氧羰基乙 基苯並咪唑(328)2.Olg。 [化合物(328)的物性]Hz), 5.38 (2Η, s), 6.35 (1Η, d, J: 8.4Hz), 7.09 (1H, dd, J = 2.0 and Ting 8.4Ηζ), 7 · 16 (1Η, d, J: 8.9Hz), 7.49 (1ϋ d, J: 2.0Hz), 7.96 (1Η, dd, J: 1.5 and Sha 8.5H z), 8.46 (1H, s); &lt; Example 257; Synthesis of 5-carboxy-1- (2,4-dichlorobenzyl) -2-fluorenylbenzimidazole (319) &gt; _ 244 This paper size applies to China National Standard (CNS) A4 (210X297) ) 548272 A7 B7 V. Description of the invention (24ί According to the method of Example 53, i- (2,4-dichlorobenzyl) _5-ethoxyquinyl-2-fluorenyl was used. Sit ( 1.465 g) to obtain 1.195 g of 5-weiyl-1 ((2,4-dioxobenzyl) -2-fluorenylbenzimidazole (319). [Physical properties of compound (319)] 1H-NMR ( DMS0-d65 δ): 2.48 (3H3 s) 5 5.56 (2H, s) 3 6.53 (1H, d, J = 8.4Hz)? 7. 32 (1H, dd, J2 2.1 and 8. · 4Ηζ), 7 · 44 (1Η3 d, J 2 8.4Ηζ), 7.73 (1Η, d, J 2 2.2Ηζ), 7.78 (1Η, dd, J 2 1.5 and 8.4Ηζ), 8.15 (1Η, d, J = 1.3 Hz). &lt; Example 258; 5- (1-Butanesulfonylaminofluorenyl) _fluorene- (2,4-dichlorobenzyl) _2_methylbenzimidazole (32 〇 ) Synthesis> According to the method of Example 98, using 5-carboxyl-1- (2,4-dioxobenzyl) -2-fluorenylbenzimidazole (0.565g), N, N, -carbonyldi Imidazole (0.504 g), 1-butanesulfonamide (0.427 g), diazabicycloundecene (.473 g) to give 5- (1-butanesulfonylcarbamoyl) -1- (2,4-Dioxobenzyl) -2-methylbenzimidazole (320) 0.690 y. [Physical properties of compound (320)] W-NMR (DMS (H16, 6): 0.87 (3Η, t, J: 7.3 Hz), L41 (2H, m), 1.68 (2Η, m), 2.49 (3Η, s), 3.52 (2Η, m), 5.58 (2Η, s), 6.53 (1Η, d, J = 8.4Hz), 7.33 (1Η, dd, J 2 2.1 and 8.4Ηζ), 7.50 (1Η, d, J 2 8.5Ηζ), 7.73 (1Η , D3 J 2 2. 1Ηζ) 3 7.78 (1H, in the Ministry of Good Debris ^ humble ^ Volunteers eliminate cooperation ^ seal ^ (Please read the precautions on the back before filling out this page) dd, J-1.5 and 8. 5Ηζ ), 8 · 24 (1Η, s), 11 · 97 (1Η, br s). IR (Nujol): 1674cm-, namely: 135.4-139.2 ° C. &lt; Example 259; Synthesis of 1- (4-biphenylmethyl) -5-ethoxycarbonyl-2-ethylbenzimidazole (321) &gt; According to the method of Production Example 14, 4-propanamidin was used Benzyl-3-nitro ---- --- --- _ One paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 ----------------- --B7 V. Description of the invention (24i '一 ^ (Please read the notes on the back before filling this page) Ethyl benzoate (1.50g) and 4-bromomethylbiphenyl (1.67g) to get 4_ [n_ (4-Biphenylfluorenyl) propanamidonitronitrobenzoate. It was converted to biphenylmethyl according to the method of Example 24) _5_ethoxycarbonyl_2_ ethylbenzimidazole (321 ) 1.23§. [Physical properties of compound (321)] ^ Bake ⑽ ..., 6): 1.40 (3Η, t3 J: 7.1Hz), 1.45 (3Η, t, J: 7.6Hz), 2.90 (2Η, 1 J: 7.6 Hz), 4.39 (2Η, q, J: 7 ″ Hz), 5 · ton 2H, s), 7.09 (2Η3 d, ㈣2Ηζ), 7 · 27 (1Η, d3 J = 8.8Hz), 7.34 (1H, m), 7.42 (2H, t), 7.55-7.51 (4H, m) 3 7.97 (1 H, dd, J: 1.5 and 8.4Ηζ), 8.52 (1Η, d , J 2: 1.2Ηζ). &lt; Example 260; Synthesis of 1- (4-bibenzylidene) -5-carboxy-2-ethylbenzimidazole (322) &gt; According to the method of Example 53, 1- (4-biphenyl Fluorenyl) _5 · ethoxy-2-ethylbenzoyl salicylate (1.00 g) to give ι_ (4-biphenylmethyl) _5_ retyl-2-ethylbenzobenzoic ( 322) 0.870§. [Physical properties of compound (322)] 'H-NMRiDMSO-dG, δ): L30 (3H5 t, J = 7.4Hz), 2.90 (2H, q, J-7.4Hz) 5 5.57 (2 H, s) 5 7.17 (2H3 d3 J = 8.3Hz), 7.33 (1H, m), 7.4Z (2H3 t), 7.63-7.57 (5H, m) 5? 81 (1Η, dd, J 2 1.6 and 8.6Ηζ) , 8.18 (1H, d, J = 1.3Hz), 12.67 (1H, br s). Central Ministry of Economic Affairs «.- Rate is only -T-Consumer Cooperation Private Seal ^ &lt; Example 261; l- (4-bibenzylidene) -5- (1-butanesulfonylcarbamoyl) -2 -Synthesis of ethylbenzimidazole (323) &gt; According to the method of Example 98, using 1- (4-biphenylmethyl) -5-carboxy-2-ethylbenzimidazole (0.400 g), N, N, carbonyldiimidazole (0.364 g), 1-butanesulfonamide (0.308 g), diazabicycloundecene (0.342 g) to give 10-biphenylfluorenyl-5--5- Butylsulfonylaminocarbamyl) -2-ethylbenzimidazole ___ 246 _____ i Paper size applies to Chinese national standard (CNS> A4 specification (210'〆297 Gongchu) &quot; one 548272 Α7 Β7 V. Invention Explanation (24) azole (323) 0.305g ° [physical properties of compound (323)] (Please read the precautions on the back before filling in this page) m-NMlUDMSO-d6 , ά): 0 · 86 (3Η, t, J Two 7 · 4Ηζ), 1.30 (3Η, t, J 2 7.5Ηζ), 1.41 (2 Η, m), 1.68 (2Η, m), 2.91 (2Η, q, J = 7.4Hz), 3.52 (2Η, m), 5.59 (2Η, s), 7.16 (2Η, d, J 2 8.2Ηζ), 7.34 (1Η, t, J 2 7.4Ηζ), 7.43 (2Η3 t), 7.59-7 · 65 (5Η, π), 7.80 (1Η, dd, J = 1.6 and 8 · 6Ηζ), 8 · 24 (1Η, d, J = 1.6Ηζ), 11 · 97 (1Η, br s). IR (Nujol): 1682cm-l. mp: 142.9-144.4 ° C. &lt; Example 262; Synthesis of 1- (4-biphenylmethyl) -2-ethyl-6- (2-methoxyethylide yellow aminocarbamoyl) benzimidal (324) &gt; According to the method of Example 98, using benzimidazole (0.513 g), N, N'-carbonyldiimidazole (0.464 g), 2-methoxyethanesulfonamide (0.420 g), and diazabicyclo Undecene (0.438 g) to give 1- (4-biphenylmethyl) -2-ethyl. 6- (2-methoxyethylsulfonylaminofluorenyl) benzimidazole (324) 0.487 g. [Physical properties of compound (324)] 1-_0-d6, (5): ΐ · 30 (3Η, t3 j: 7.5Hz), 2 9_, q, Fu ·), &amp; H, s), 3 · 70-3 · 77 (4Η, π), 5.60 (2Η, s) 7.18 (2Η, d, J 2 8.28ζ), 7.35 (1Η t J -7 · 1Ηζ), 7 · 44 &lt; 2Η, t, J: 7.5Hz), 7.60-7 · 67 (4Η, π), 7.70 (1Η, d, J: & 5Hz) 7 · 80 (1Η, dd, J = 7.4 and 1 · 3Ηζ), 8 · 25 (1Η, s), 11 · 97 (1Η, s). IR (Nujol): 1684cm— *. mp: 94.6-97.2 ° C &lt; Example 263; Synthesis of 6-ethoxycarbonylethyl-l- [4- (4-fluorobenzyloxy) benzyl] benzimidazole (325) &gt; _____ Ύάΐ_ 本Paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm) ^ h_x eliminates the combination of bamboo ^ India 548 272 A7 __________ B7 V. Description of the invention (24j — Stir at 75 ° C 4-Propanamidin-3-aminobenzoic acid ethyl acetate (0.534 g), potassium carbonate (0.374 g), 4- (4-fluorobenzyloxy) benzyl (0.800 g), ethyl acetate (5mi) and water (3ml) for 16 hours. Ethanol and 36% hydrochloric acid (0.46 g) were added to the residue obtained by concentrating the organic layer, and stirred under heating and refluxing for 2 hours. After adding potassium carbonate for neutralization, The solvent was concentrated under reduced pressure, and ethyl acetate and water were added for extraction. The organic layer was concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: hexane / ethyl acetate = 1/8) to obtain 6- 0.228 g of ethoxycarbonyl-2-ethyl-1_ [4-gas 4-fluorobenzyloxy] benzyl] benzimidazole (325). [Physical properties of compound (325)] 'H-NMRiCDCla, δ): 1.40 (3H, J = 7.1Hz), 1.42 (3H, t3 J = 7.5Hz), 2.86 (2H, q3 J-27.5 · 5Ηζ), 4.38 (2H, q, J = 7.1Hz), 4.97 (2H, s), 5.32 (2H, s), 6.88 (2H3 d, J = 8.7Hz), 6.98 (2Η, d, J = 8.7Hz), 7 · 05 (2Η, t, J = 8.7Hz), 7.37 (2Η, m), 7.76 (2H, d, J = 8.4Hz), 7.98 (1Η, dd, J 2 1.5 And 8 · 5Ηζ), 8 · 02 (1Η, s). <Example 264; Synthesis of 6-tether-2-ethyl-1- [4- (4-fluorobenzyloxy) benzyl] benzimidazole (326) &gt; According to the method of Example 53, use 6-ethoxycarbonyl-2-ethyl-1- [4_ (4-fluorobenzyloxy) benzyl] benzozine (0.225g) to give buweiyl-2-ethyl, yl-1- [4- (4-fluorobenzyloxy) benzyl] benzimidazole (326) 0.175 g. [Physical properties of compound (326)] 1H-NMR (DMS0-d6, δ): 1.28 (3H, t5 J = 7.4Hz) 3 2.89 (2H, q, J-7.4Hz), 5.01 (2 H, s), 5.47 (2H, s), 6.95 (2Η, d), 7.03 (2H, d), 7.18 (2Η, t), 7.45 (2Η, m), 7.62 (1H, d3 J-8.4Hz ), 7.77 (1H, d, J = 8.4Hz), 8.05 (1H, s) 〇; Paper size is suitable / fl towel Guan Jiaxian (CNS) A4 size (210X29 ^ 54) &quot; ~ Order (read first read Note on the back, please fill out this page again) 548272 A7 V. Description of the invention (&lt; Example 265; 6- (l-Butylsulfonylaminofluorenyl) -2-ethyl [4- (4-fluorobenzyl Synthesis of oxy) benzyl] benzimidazole ammonium salt (327) &gt; According to the method of Example 98, using carboxy-2-ethyl-4-444- (4-fluorobenzyloxy) benzyl] benzimidazole (0171g), N, N, -carbonyldiimidazole (0.137g), butanesulfonamide (oj 16g), diazabicycloundecene 129g) to give 6- (1-butanesulfonyl) as an oil Carbamate) _2_ethyl _〗 _ ['(4-fluorobenzyloxy) benzyl] benzimidazole. This was dissolved in ethyl acetate 'and ammonia water was added. The precipitated solid was filtered out and dried to give 6- (1-butanesulfonylaminocarbamyl) -2_ethyl-; μ [4_ (4-fluorobenzyloxy) benzyl] benzene 0.140 g of benzimidazole ammonium salt (327). [Physical properties of compound (327)] tNM ^ DMSO-dG, 6): 0.83 (3Η, t) 3 1.25 (3Η, t), 1.35 (2Η, ιη), 1.61 (2Η, m), 2.84 (2Η, q), 3.27 (2Η, m), 5.01 (2Η3 s) 3 5.42 (2Η, s), 6.95 (2Η, d, J-7.8Hz), 7.02 (2Η, d, J = 7.8Hz), 7.17 (2Η, t), 7.44 (2Η, m), 7.57 (1Η, d, J: 8.1Hz) 3 7.82 (1H5 d3 J-8.1Hz) 3 8.12 (1H3 s) 〇IR (Nujol): 1614cm10 mp: 105-115 ° C 〇 Shumi's 呔 i ?. quasi ^ BJT elimination of bamboo: India ^ &lt; Example 266; 1-[4- Synthesis of (3,4-dichlorobenzyloxy) benzyl] -6_ethoxycarbonyl-2-ylbenzimidazole (328) &gt; According to the method of Example 263, 4-propanamidin_3_ Ethyl benzoate (l.Slg) and 4- (3,4 · dichlorobenzyloxy) benzyl (3 · ΐ8 ^ to give 1- [4- (3,4-dichlorobenzyloxy) (Benzyl) ethoxycarbonylethyl benzimidazole (328) 2.Olg. [Physical properties of compound (328)]

244L (讀先閱讀背面之注意事項再填寫本頁) 木紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7_ 五、發明説明(24^ ^-NMRiCDCh, δ) : 1.40(3H, t3 J-7.1Hz)3 1.42(3H3 t5 J-7.5Hz)3 2.86(2H3 q,J二7·5Ηζ),4·38(2Η3 q3 J=7.1Hz),4·97(2Η,s),5·33(2Η,s),6.87(2H3 in ),6.98(2H, a), 7.22(1H, dd, J二2.0 及 8·3Ηζ), 7·44(1Η, d, J二8·3Ηζ), 7· 50(1H, d, J二2·0Ηζ), 7·76(1Η, d, J:8.6Hz), 7·97(1Η, dd, J:1.6 及 8·6Ηζ) ,8·02(1Η, d3 J=1.3Hz)。 〈實施例267;6_羧基-l-[4-(3,4-二氣代苄氧基)节 基]-2-乙基苯並咪唑(329)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基-2-乙基-1 -[4-(4_ I代节氧基)节基]笨並咪η坐(2·〇 ig)以得出&amp;羧基 -1-[4_(3,4-二氯代苄氧基)苄基]·2_乙基苯並咪唑 (329)1.82g。 [化合物(329)的物性] ^-NMRiDMSO-dG, δ) : 1.28(3HS t), 2.88(2H, q), 5.05(2H, s)3 5.47(2H5 s) ,6·96(2Η, d), 7·04(2Η, d), 7·39(1Η, m), 7.68-7·59(3Η3 m)3 7·78(1Η3 d, J =8·4Ηζ), 8·06(1Η, s)。 經浐部中决榀卑而力5消費合竹私印繁 (請先閱讀背面之注意事項再填寫本頁) &lt;實施例268;6-(l-丁磺醯基氨基甲醯*h_[4_(3,4_ 一氣代苄氧基)苄基]乙基笨並咪α坐銨鹽(33〇)之合成&gt; 依據實施例98之方法,使用6_羧基_;μ[心(3,各二氯 代苄氧基)苄基]乙基笨並咪唑(〇.5〇〇g)、Ν,Ν,-幾基二味 唾(〇.356g)、丁績醯胺(0.301g)、二氮二環十一稀(〇334g) 以得出油狀之6-(1-丁磺醯基氨基甲醯基)β1_[4·(3,4_二氯 代苄氧基)苄基]乙基苯並咪唑。將其溶解於醋酸乙酯 中,並加入氨水。藉由過濾出所析出之固體,經乾燥以 得出6-(1-丁磺醯基氨基甲醯基二氯代苄氧基) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公嫠) 548272 A7 ___ B7 五、發明説明(24) 苄基]-2-乙基苯並咪唑銨鹽(330)0.5 lg。 [化合物(330)的物性] (請先閱讀背面之注意事項再填寫本頁) !H-臟(DMS0-d6,(5) : G.82(3H3 t,J=7.3Hz),1·26(3Η3 t,J=7.4Hz),1.31(2 H, m), 1·54(2Η3 m)3 2·84(2Η, q, J:7·他),3·07(2Η, m)3 5·05(2Η3 s), 5.41 (2H, s), 6·95(2Η, d, J=8.7Hz), 7·00(2Η, d, J二8·7Ηζ), 7·41(1Η3 d, J=8.2Hz ),7.46(1H,d,J二8.他),7·62(1Η,d3 J:8.2Hz),7·68(1Η,s),7·81(1Η,d, J=8.4Hz), 7.97(1H, s)〇 IR(Nujol) : 1540cm'1〇 mp : 99·5-101.5oC〇 &lt;實施例269;l-(4-聯苯甲基)-6-(正丁基氨基甲醯 基)-2-乙基苯並咪唑(331)之合成&gt; 依據實施例15之方法,使用i-(4-聯苯甲基)-6-氯 代羰基-2-乙基苯並咪唑鹽酸鹽(〇.4〇〇g)、正丁胺 (0.2338)、三乙胺(0.2158)以得出1-(4-聯苯甲基)-6-(正丁 基氨基甲醯基)-2-乙基笨並口米唾(33 1 )0.295g。 [化合物(33 1)的物性] ^-NMRiDMSO-dG, c5 ) : 0.95(3H, t5 J=7.3Hz)3 1.37-1.48(2H, m)3 1.45(3H, t, J=7.4Hz)5 1.57-1.63(2H5 m), 2.90(2H3 q3 J=7.5Hz), 3.46(2H,-q5 J-7.1Hz ),5·42(2Η, s), 6·16(1Η, br s), 7·10(2Η, d, J:8.1Hz), 7·34(1Η, t, J二7,5H z), 7.42(2H3 t, J=7.5Hz), 7.48-7.57(5H, m), 7,87(1H, d, J=8.4Hz), 7.91(1 H, s)〇 IR(Nujol) : 1621cm mp : 170.5-173.0°C。 &lt;實施例270;l-(4-聯苯曱基)-2-乙基各(癌唑_2-氨基 本紙張尺度適州中國國家標準(CNS ) A4規格(2ι〇、χ297公襲) 548272 A7 B7 五、發明説明(24^ 甲酿基)苯並咪吐(332)之合成&gt; 依據實施例15之方法,使用1-(4-聯苯甲基)-6-氣 代幾基-2-乙基苯並咪嗤鹽酸鹽(〇.4〇〇g)、2-胺基喧ϋ坐 (〇.318g)、三乙胺(〇.215g)以得出1-(4-聯苯甲基)-2-乙基 -6-(噻唑-2-氨基甲醯基)苯並咪唑(332)0.179g。 [化合物(332)的物性] lH-NMR(DMS0-d6, δ) : 1.48(3H3 t5 J=7.5Hz), 2.95(ZH, q5 J-7.5Hz), 5.41(2 H, s), 6·94(1Η, d, J二3·6Ηζ), 7.06(2H, d, J=8.1Hz), 7·26(1Η, d3 J=3.6Hz), 7.32(1H3 t3 J=7.4Hz), 7.39(2H3 t5 J=7.3Hz), 7.47-7.51(4H3 m)3 7.87(2H, s), 8·03(1Η, s), 11·15(1Η, s)〇 IR(Nujol) : 1652cm-l〇 mp ·· 225.5-227.7°C。 &lt;實施例271; 1-(4-聯苯甲基)-2-乙基-6-(2-吡啶氨基 曱醯基)苯並咪唑(333)之合成&gt; 依據實施例98之方法,使用1-(4-聯苯甲基)-6-羧 基-2-乙基苯並咪唑(〇.300g)、N,N’_羰基二咪唑(0.272g)、 2-胺基σ比咬(0· 15 8g)、二氮二環Η--稀(0.256g)以得出1- 經浐部中夹榀率而K工消费合作私印^ (請先閱讀背面之注意事項再填寫本頁) (4-聯苯曱基)-2-乙基-6-(2-。比啶氨基甲醯基)苯並咪唑 (333)0· 116g 〇 [化合物(333)的物性] 1 腿(CDCh, d) : 1·47(3Η,t3 J:7.6Hz), 2·93(2Η,q,J=7.4Hz),5.45UH, s), 7·06(1Η, dd, J=7.4 及 4·9Ηζ), 7·10(2Η, d, J:8.1Hz), 7_34(1H, t, J 二7·4Ηζ), 7·42(2Η, t, J:7.6Hz), 7·50-7·55(4Η, m), 7·75(1Η, t, J:7.9Hz), 7 •79(1H, d, J二8·4Ηζ), 7.86(1H, d, J二8·4Ηζ), 7·98(1Η, s), 8·30(1Η, d, J二6· __ 252_____ 本纸張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 548272 Α7 ___ Β7 五、發明説明(24d 2Hz), 8.38(1H, d3 J=8.4Hz), 8.62(lH)S)〇 IR(Nujol) : 1661cm'1* mp : 160.9-164.5°C。 (請先閱讀背面之注意事項再填寫本頁) &lt;實施例272;6-(正丁基氨基甲醯基)二氣代 苄基)_2_甲基苯並咪唑(334)之合成&gt; 依據實施例15之方法,使用6_氯代羰基-丨-口,4-二 氯代苄基)-2-乙基苯並咪唑鹽酸鹽(〇 3〇〇g)、三乙胺 (0.181g)、正丁胺(〇.196g)以得出6-(正丁基氨基曱醯 基)-1-(2,4-二氯代苄基)_2-甲基笨並咪唑(334)0.156邑。 [化合物(334)的物性] 'H-NMRiCDCla, δ) : 0,96(3H, t, J=7.3Hz), 1.37-1.43(2H, m), 1.55-1.62(2H ,m), 2·56(3Η, s), 3·46(2Η, q, J=7.0Hz), 5·40(2Η, s), 6·15(1Η, br s), 6. 32(1H, d, J:8.5Hz), 7·07(1Η, d, J=8.4Hz), 7·48(1Η, d3 J:2.GHz), 7·55(1Η, d3 J=8.4Hz)3 7.74(1H, d, J=8.4Hz), 7.79(lH,s)。 IR(Nujol) ·· 1636cm—1。 mp : 146.6-147.5°C。 &lt;製造例53;3-[第2(2,4-二氣代苯乙基)胺基]-4-硝 基安息香酸乙酯之製造&gt; 將3-氟-4-硝基安息香酸(〇.877g)與第2(2,4-二氯代 苯乙)胺(2.25 g)之甲苯(5ml)溶液加熱迴流15小時。餾去 溶媒後,藉由矽膠柱色譜之精製殘渣以得出3-[第2(2,4-二氯代笨乙基)胺基]-4-硝基安息香酸的粗生成物。將乙 醇(80ml)與97%硫酸(3.Og)加入其中,加熱迴流4.5小時。 在減壓下餾去乙醇後,加入三氣甲烷與飽和碳酸氫鈉水 __232______— 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 , ----------一 _____ B7 —— __ 五、發明説明(25^ 溶液以進行萃取。乾燥有機層後,藉由矽膠柱色譜(溶離 液·己烷/1旨酸乙酯=2/1)精製經減壓濃縮所得之殘渣以 得出3-[第2(2,4-二氯代笨乙基)胺基]_4_硝基安息香酸乙 酯(1.16g)。 [化合物的物性] 1 臟(CDCh,ά) : i.35(3H,t,J:7.mz),1·64(3Η,d5 J:6.6Hz),4·30(2Η, q3 J=7.1Hz)3 5.16(1H3 m)3 7.18-7.31(4H, m), 7.43(1H, d, J^Z.OHz), 8.21( 1 d,J:8.8Hz),8.34UH,d,J:5Hz)。 &lt;製造例54;4-胺基[第2(2,4_二氣代苯乙基)胺基] 安息香酸乙酯之製造&gt; 將3-[第2(2,4-二氣代苯乙基)胺基]_4_硝基安息香 酸乙酯(1.14g)、還原鐵〇 6〇g)、乙醇(1〇ml)與醋酸(5rnl) 之混合物加熱迴流3小時。過濾出固體,使用三氯甲烷 與10%鹽酸對經濃縮濾液所得之殘渣進行萃取。以飽和 碳酸氫鈉水溶液洗淨有機層,在減壓下餾去溶媒。藉由 石夕膠柱色譜(溶離液:己烷/酯酸乙酯=2/1)之精製所得之 殘渣以得出4-胺基_3_[第2(2,4-二氯代苯乙基)胺基]安息 香酸乙酯(0.920g)。 [化合物的物性] t臟(CDCh,6) : 1·31(3Η,t,J=7.1Hz),1·52(3Η,d,J二6·7Ηζ),3.56UH, br s),3·79(2Η,br s),4.23(2H,q,J:7.1Hz),4.96(1H,q,J:6.7Hz),6·68 UH,d,J=8.0Hz),7.03(1H,d3 J二 1·7Ηζ),7」5(1H,dd,J二2·1 及 8.他), 7.35(1Η, d3 J=8.4Hz), 7.39-7.43(2Η, m)〇 &lt;實施例273;1-[第2(2,4-二氯代苯乙基)]-6-乙氧碳醯 本紙張尺度適/彳]中國國家標準(CNS ) Α4規格(210X29*7公釐) (讀先閱讀背面之注意事項再填寫本頁) 、1Τ 秦· 548272 -·—_________— _B7^_____ 五、發明説明(25} &quot; 基-2-曱基苯並咪唑(335)之合成〉 在室溫下將乙醯氯(0.243g)滴入4-胺基-3-[第2(2,4-二氣代苯乙基)胺基]安息香酸乙酯(〇.90〇g)之。比啶(2.0ml) /谷液中。接著在室溫下攪摔1小時後,加入醋酸及過量 的10%鹽酸以進行萃取。以飽和碳酸氫鈉水溶液洗淨有 機層,在減壓下餾去溶媒,以得出4-4-乙醯胺基-3-[第 一(2,4-二氯代笨乙基)胺基]安息香酸乙酯之粗生成物。 馬上溶在乙醇(20ml)中,加入36%鹽酸(0.4ml)加熱迴流2 小時。加入碳酸氫鈉將其中和後,在減壓下餾去溶媒。 加入醋酸乙酯與水以對殘渣進行萃取。濃縮有機層,藉 由矽膠柱色譜(溶離液:己烷/酯酸乙酯=20/1)之精製以得 出1-[第2(2,4-二氯代苯乙基)]-6-乙氧羰基-2-甲基苯並 咪唑(335)0.700g。 [化合物(335)的物性] limiUCDCla,(5) : 1·38(3Η,t,J:7.2Hz),2·01(3Η,d5 J:7.2Hz),2·63(3Η, s),4·29-4·40(2Η,ffl),5·89(1Η,q,J=7】z),7·37(1Η,dd,J:2.2 及 8·4244L (Read the precautions on the back before you fill in this page) The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7_ V. Description of the invention (24 ^^-NMRiCDCh, δ): 1.40 ( 3H, t3 J-7.1Hz) 3 1.42 (3H3 t5 J-7.5Hz) 3 2.86 (2H3 q, J 2 7.5Ηζ), 4.38 (2Η3 q3 J = 7.1Hz), 4.97 (2Η, s ), 5.33 (2Η, s), 6.87 (2H3 in), 6.98 (2H, a), 7.22 (1H, dd, J 2.0 and 8.38ζ), 7.44 (1Η, d, J 2 8 · 3Ηζ), 7.50 (1H, d, J = 2.00Ηζ), 7.76 (1Η, d, J: 8.6Hz), 7.97 (1Η, dd, J: 1.6 and 8.6Ηζ), 8.0 (1Η, d3 J = 1.3 Hz). <Example 267; Synthesis of 6-carboxyl-l- [4- (3,4-dioxobenzyloxy) benzyl] -2-ethylbenzimidazole (329) &gt; Method according to Example 53 , Using 6-ethoxycarbonyl-2-ethyl-1-[4- (4-I-benzyloxy) benzyl] benzimidium η (2 · 〇ig) to get & carboxy-1- [ 4- (3,4-dichlorobenzyloxy) benzyl] · 2-ethylbenzimidazole (329) 1.82 g. [Physical properties of compound (329)] ^ -NMRiDMSO-dG, δ): 1.28 (3HS t), 2.88 (2H, q), 5.05 (2H, s) 3 5.47 (2H5 s), 6.96 (2Η, d ), 7 · 04 (2Η, d), 7.39 (1Η, m), 7.68-7 · 59 (3Η3 m) 3 7 · 78 (1Η3 d, J = 8 · 4Ηζ), 8 · 06 (1Η, s). In the Ministry of Economic Affairs, we must be stubborn and consume 5 Chinese characters (please read the precautions on the back before filling this page) &lt; Example 268; 6- (l-Butylsulfonylaminocarbamidine * h_ [ Synthesis of 4_ (3,4_ mono-gas benzyloxy) benzyl] ethylbenzimidamidin alpha succinic ammonium salt (33〇) &gt; According to the method of Example 98, 6-carboxyl group; μ [心 (3, Each dichlorobenzyloxy) benzyl] ethylbenzimidazole (0.500 g), N, N, -kisyl disalylamine (0.356 g), butanidine (0.301 g), diazonium Bicyclic eleven dilute (0334g) to give 6- (1-butanesulfonylaminocarbamyl) β1_ [4 · (3,4-dichlorobenzyloxy) benzyl] ethyl as an oil Benzimidazole. Dissolve it in ethyl acetate and add ammonia. The precipitated solid is filtered off and dried to give 6- (1-butanesulfonylcarbamoyldichlorobenzyloxy). This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 cm) 548272 A7 ___ B7 V. Description of the invention (24) Benzyl] -2-ethylbenzimidazole ammonium salt (330) 0.5 lg. [Compound (330) Properties] (Please read the precautions on the back before filling this page)! H-dirty (DMS0-d 6, (5): G.82 (3H3 t, J = 7.3Hz), 1.26 (3Η3 t, J = 7.4Hz), 1.31 (2 H, m), 1.54 (2Η3 m) 3 2 · 84 (2Η, q, J: 7 · he), 3.07 (2Η, m) 3 5.05 (2Η3 s), 5.41 (2H, s), 6.95 (2Η, d, J = 8.7Hz) , 7.00 (2Η, d, J 2 8.7Ηζ), 7.41 (1Η3 d, J = 8.2Hz), 7.46 (1H, d, J 2: 8. he), 7.62 (1Η, d3 J : 8.2Hz), 7.68 (1Η, s), 7.81 (1Η, d, J = 8.4Hz), 7.97 (1H, s), IR (Nujol): 1540cm'10, mp: 99 · 5- 101.5oC &lt; Example 269; Synthesis of l- (4-biphenylmethyl) -6- (n-butylaminomethyl) -2-ethylbenzimidazole (331) &gt; According to Example 15 The method uses i- (4-biphenylmethyl) -6-chlorocarbonyl-2-ethylbenzimidazole hydrochloride (0.400 g), n-butylamine (0.2338), and triethylamine. (0.2158) to give 0.295 g of 1- (4-biphenylmethyl) -6- (n-butylaminomethylmethyl) -2-ethylbenzobenzene (33 1). [Compound (33 1 ) Physical properties) ^ -NMRiDMSO-dG, c5): 0.95 (3H, t5 J = 7.3Hz) 3 1.37-1.48 (2H, m) 3 1.45 (3H, t, J = 7.4Hz) 5 1.57-1.63 (2H5 m), 2.90 (2H3 q3 J = 7.5Hz), 3.46 (2H, -q5 J-7.1Hz), 5.42 (2Η, s ), 6.16 (1Η, br s), 7.10 (2Η, d, J: 8.1Hz), 7.34 (1Η, t, J-2, 7Hz), 7.42 (2H3 t, J = 7.5 Hz), 7.48-7.57 (5H, m), 7,87 (1H, d, J = 8.4Hz), 7.91 (1 H, s). IR (Nujol): 1621cm mp: 170.5-173.0 ° C. &lt; Example 270; l- (4-biphenylfluorenyl) -2-ethyl each (canconazole_2-amino paper size, Shizhou Chinese National Standard (CNS) A4 specification (2ι〇, χ297 attack) 548272 A7 B7 V. Description of the invention Synthesis of (24 ^ methyl ethyl) benazepine (332) &gt; According to the method of Example 15, 1- (4-biphenylmethyl) -6-oxoyl 2-ethylbenzimidazole hydrochloride (0.400 g), 2-aminobenzidine (0.318 g), and triethylamine (0.215 g) to give 1- (4- Biphenylmethyl) -2-ethyl-6- (thiazole-2-carbamoyl) benzimidazole (332) 0.179 g. [Physical properties of compound (332)] lH-NMR (DMS0-d6, δ) : 1.48 (3H3 t5 J = 7.5Hz), 2.95 (ZH, q5 J-7.5Hz), 5.41 (2 H, s), 6.94 (1Η, d, J = 3.66Ηζ), 7.06 (2H, d , J = 8.1Hz), 7.26 (1Η, d3 J = 3.6Hz), 7.32 (1H3 t3 J = 7.4Hz), 7.39 (2H3 t5 J = 7.3Hz), 7.47-7.51 (4H3 m) 3 7.87 ( 2H, s), 8.03 (1Η, s), 11 · 15 (1Η, s), IR (Nujol): 1652cm-lmp, 225.5-227.7 ° C. &Lt; Example 271; 1- ( Synthesis of 4-biphenylmethyl) -2-ethyl-6- (2-pyridylaminofluorenyl) benzimidazole (333) &gt; According to Example 98 Method using 1- (4-biphenylmethyl) -6-carboxy-2-ethylbenzimidazole (0.300 g), N, N'-carbonyldiimidazole (0.272 g), and 2-amino σ ratio Bite (0 · 15 8g), diazabicyclopyrene-dilute (0.256g) to get 1-the rate of entrapment in the warp section and the private seal of K-worker cooperation ^ (Please read the notes on the back before filling This page) (4-Biphenylfluorenyl) -2-ethyl-6- (2-.pyridinylcarbamyl) benzimidazole (333) 0.116 g 〇 [Physical properties of compound (333)] 1 leg (CDCh, d): 1.47 (3Η, t3 J: 7.6Hz), 2.93 (2Η, q, J = 7.4Hz), 5.45UH, s), 7.06 (1Η, dd, J = 7.4 And 4 · 9Ηζ), 7 · 10 (2Η, d, J: 8.1Hz), 7_34 (1H, t, J 2 7.4Ηζ), 7.42 (2Η, t, J: 7.6Hz), 7.50 -7 · 55 (4Η, m), 7.75 (1Η, t, J: 7.9Hz), 7 • 79 (1H, d, J 二 8 · 4Ηζ), 7.86 (1H, d, J 二 8 · 4Ηζ ), 7 · 98 (1Η, s), 8 · 30 (1Η, d, J 2 6 · __ 252_____ This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) 548272 Α7 ___ Β7 5 Description of the invention (24d 2Hz), 8.38 (1H, d3 J = 8.4Hz), 8.62 (lH) S) 〇IR (Nujol): 1661cm'1 * mp : 160.9-164.5 ° C. (Please read the precautions on the back before filling in this page) &lt; Example 272; 6- (n-butylaminomethyl) digas benzyl) _2-methylbenzimidazole (334) Synthesis &gt; According to the method of Example 15, 6-chlorocarbonyl-b-methyl, 4-dichlorobenzyl) -2-ethylbenzimidazole hydrochloride (0.300 g), triethylamine (0.181 g) N-butylamine (0.196 g) to give 6- (n-butylaminofluorenyl) -1- (2,4-dichlorobenzyl) _2-methylbenzimidazole (334) 0.156 Yap. [Physical properties of compound (334)] 'H-NMRiCDCla, δ): 0,96 (3H, t, J = 7.3Hz), 1.37-1.43 (2H, m), 1.55-1.62 (2H, m), 2 · 56 (3Η, s), 3.46 (2Η, q, J = 7.0Hz), 5.40 (2Η, s), 6.15 (1Η, br s), 6. 32 (1H, d, J: 8.5Hz), 7.07 (1Η, d, J = 8.4Hz), 7.48 (1Η, d3 J: 2.GHz), 7.55 (1Η, d3 J = 8.4Hz) 3 7.74 (1H, d , J = 8.4Hz), 7.79 (lH, s). IR (Nujol) · 1636cm-1. mp: 146.6-147.5 ° C. &lt; Production Example 53; Production of 3- [2 (2,4-digasophenethyl) amino] -4-nitrobenzoate &gt; 3-Fluoro-4-nitrobenzoate A solution of (0.877 g) and 2 (2,4-dichlorophenylethyl) amine (2.25 g) in toluene (5 ml) was heated under reflux for 15 hours. After the solvent was distilled off, the residue was purified by silica gel column chromatography to obtain a crude product of 3- [2 (2,4-dichlorobenzylethyl) amino] -4-nitrobenzoic acid. Ethanol (80 ml) and 97% sulfuric acid (3.0 g) were added thereto, and heated under reflux for 4.5 hours. After distilling off the ethanol under reduced pressure, add three gas methane and saturated sodium bicarbonate water __232______ — This paper is suitable for China National Standard (CNS) A4 specification (210X297 mm) 548272 A7, ------- --- 一 _____ B7 —— __ 5. Description of the invention (25 ^ solution for extraction. After drying the organic layer, it is purified by silica gel column chromatography (eluent · hexane / 1 ethyl acetate = 2/1) The obtained residue was concentrated under reduced pressure to give 3- [2 (2,4-dichlorobenzylethyl) amino] -4-nitronitrobenzoate (1.16g). [Physical properties of the compound] 1 Dirty (CDCh, ά): i.35 (3H, t, J: 7.mz), 1.64 (3Η, d5 J: 6.6Hz), 4.30 (2Η, q3 J = 7.1Hz) 3 5.16 (1H3 m) 3 7.18-7.31 (4H, m), 7.43 (1H, d, J ^ Z.OHz), 8.21 (1d, J: 8.8Hz), 8.34UH, d, J: 5Hz). &lt; Production Example 54; Production of 4-amino group [2 (2,4_di-gasophenethyl) amino] ethyl benzoate &gt; 3- [2 (2,4-digasoline Phenethyl) amino] 4-nitrobenzoate (1.14 g), reduced iron (0.60 g), ethanol (10 ml) and a mixture of acetic acid (5rnl) were heated under reflux for 3 hours. The solid was filtered off, and the residue obtained by concentrating the filtrate was extracted with chloroform and 10% hydrochloric acid. The organic layer was washed with a saturated sodium bicarbonate aqueous solution, and the solvent was distilled off under reduced pressure. Residue obtained by refining on Shixi gel column chromatography (eluent: hexane / ethyl ester = 2/1) to obtain 4-amino_3_ [第 2 (2,4-dichlorophenethyl) (Amino) amino] ethyl benzoate (0.920 g). [Physical properties of compound] t dirty (CDCh, 6): 1.31 (3Η, t, J = 7.1Hz), 1.52 (3Η, d, J 2 6.7Ηζ), 3.56UH, br s), 3 79 (2Η, br s), 4.23 (2H, q, J: 7.1Hz), 4.96 (1H, q, J: 6.7Hz), 6.68 UH, d, J = 8.0Hz), 7.03 (1H, d3 J2 1.7Ηζ), 7 ″ 5 (1H, dd, J2 2.1 and 8. He), 7.35 (1Η, d3 J = 8.4Hz), 7.39-7.43 (2Η, m) 〇 &lt; Implementation Example 273; 1- [No. 2 (2,4-dichlorophenethyl)]-6-ethoxycarbamidine Paper size / 适] Chinese National Standard (CNS) A4 Specification (210X29 * 7 mm) (Read the precautions on the back before you fill in this page), 1T Qin · 548272-· ——_________— _B7 ^ _____ V. Description of the invention (25) &quot; Synthesis of 2--2-benzylbenzimidazole (335)> Acetyl chloride (0.243 g) was added dropwise at room temperature to 4-amino-3- [2 (2,4-dioxophenethyl) amino] benzoic acid ethyl ester (0.90 g) The ratio is 2.0% of pyridine (2.0ml) / cereal. After stirring at room temperature for 1 hour, acetic acid and an excess of 10% hydrochloric acid are added for extraction. The organic layer is washed with a saturated sodium bicarbonate aqueous solution and decompressed. The solvent was distilled off to obtain 4-4-acetamido-3- [ The crude product of mono (2,4-dichlorobenzylethyl) amino] ethyl benzoate. Immediately dissolved in ethanol (20ml), added 36% hydrochloric acid (0.4ml) and heated under reflux for 2 hours. Added hydrogen carbonate After neutralizing with sodium, the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to extract the residue. The organic layer was concentrated and subjected to silica gel column chromatography (eluent: hexane / ethyl ester = 20/1). ) To obtain 0.700 g of 1- [2 (2,4-dichlorophenethyl)]-6-ethoxycarbonyl-2-methylbenzimidazole (335). [Compound (335) Physical properties] limiUCDCla, (5): 1.38 (3Η, t, J: 7.2Hz), 2.01 (3Η, d5 J: 7.2Hz), 2.63 (3Η, s), 4.29-4 · 40 (2Η, ffl), 5.89 (1Η, q, J = 7) z), 7.37 (1Η, dd, J: 2.2 and 8.4

Hz), 7.40(1H, d, J=2.0Hz), 7.52(1H3 d, J=8.4Hz), 7.67(1H, d3 J=8.4Hz)3 7 •86(1H, s), 7·91(1Η, dd, J:1.4 及 8.4Hz)。 &lt;實施例274;6-羧基-1-[第2(2,4-二氣代笨乙基)l·2-曱基苯並咪唑(336)之合成&gt; 依據實施例53之方法,使用1-[第2(2,4-二氯代苯 乙基)]·6-乙氧幾基-2-甲基苯並味唾(0.690g)以得出&amp;叛 基-1-[第2(2,4-二氯代苯乙基)]-2-甲基笨並味唑 (336)0.447g ° 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) 訂 線 (請先閱讀背面之注意事項再填寫本頁) 548272 A7 B7 五、發明説明(25i [化合物(336)的物性] (讀先閱讀背面之注意事項再填寫本頁) H^(DHS0-d63 δ) : 1.88(3H, d5 J=6.8Hz), 2.57(3H, s), 6.01(1H, q)5 7. 55(1H, d)5 7.60-7.67(3H, m), 7.71(1H? d)3 7.89(1H, d)5 12.65(1H, br s) &lt;實施例275;6-(l-丁磺醯基氨基甲醯基)]_[第二 (2,‘二氣代苯乙基)]-2-甲基苯並咪唑(337)之合成&gt; 依據實施例98之方法,使用6_羧基_丨_[第2(2,4-二氯代苯乙基)]-2-曱基笨並咪唑(0.433g)、N,N,-羰基二 味唑(0.412g)、丁磺醯胺(〇.348g)、二氮二環--烯 (0.386g)以得出6-(1-丁磺醯基氨基甲醯基[第二(2,4-一氣代笨乙基)]-2 -甲基苯並味η坐(337)。 [化合物(337)的物性] 1 fiMR(DMS(H163 ¢) : 〇·84(3Η,t,J:7.3Hz),1·34(2Η,ιη),1·57(2Η,m),1· 89(3Η, d, J=7.0Hz), 2.49(3H3 s)3 3.07(ZH3 m)3 5.954(1H, q3 J=7.0Hz), 7.4 1(1H, d, J=8.7Hz), 7·56(1Η, dd, J=2,l 及 8·5Ηζ), 7.61(1H, d, J:2.1Hz), 7·74-7.79(3H, m)。 &lt;實施例276; 1-(4-聯苯甲基)_2-乙基-6-(苯基氨基甲 醯基)苯並咪唑(338)之合成&gt; 依據實施例15之方法,使用ι_(4-聯苯甲基)-6-氯 代羰基乙基苯並咪唑鹽酸鹽(〇.3〇〇g)、三乙胺 (0.243g)、苯胺(〇.224g)以得出1-(4-聯苯甲基)-2-乙基-6-(苯基氨基曱醯基)苯並咪唑(338)0.195g。 [化合物(338)的物性] lH-NMR(CDCl3, 6) : 1.47(3H, t5 J=7.5Hz), 2.93(2H, q, J-7.5Hz), 5.44(2H, s),7.1K2H,d,J二8.2Hz),7·14(1Η,t,J二7·4Ηζ),7·32-7·38(3Η,ni),7.42( 本紙張尺度適闱中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(25i 2H,t,J二7.4Hz),7.51-7·54(4Η,m),7·63(2Η,d,J二7·8Ηζ),7.69UH,dd5 J二 8·4 及 1·6Ηζ), 7·84(1Η, d, J二8·4Ηζ), 7·88(1Η, br s), 7.97(lH,d,J二1·5Ηζ )〇 IR(Nujol) : 16470111^0 mp : 171·7-172·1。。。 &lt;實施例277;l-(4-聯苯甲基)-2-乙基-6-(l,3,4-噻二 唑-2-氨基甲醯基)苯並咪唑(339)之合成&gt; 依據實施例98之方法,使用1-(4-聯苯甲基)-6-魏 基-2-乙基笨並味《坐(0.300g)、N,N’-魏基二味哇(〇,272g)、 2-胺基 _1,3,4_噻二唑(0.170g)、二氮二環十一烯(0·256§) 以得出1-(4-聯苯甲基)-2-乙基-6-(1,3,4-噻二唑-2-氨基甲 酸基)苯並味唾(339)0.234邑。 [化合物(339)的物性] ^-NMRiCDCla,^) : 1.45(3H3 t3 J-7.5Hz)3 2.90(2H, q3 J-7.5Hz), 5.53(2H,s ),7.07(2H, d3 J=8.3Hz), 7.33(1H, t, J=7.5Hz), 7.40(2H, t3 J二7.3Hz), 7.5 2(4H, d, J=8·明z), 7·89(1Η, d, J=8.5Hz), 8·08(1Η, dd, J=8.5 及 1·6Ηζ), 8·34(1Η, d, J=1.2Hz)3 7·60(1Η, s), 12·26(1Η, s)。 經浐部中次«.^-而01消費合竹私印f (讀先閱讀背面之注意事項再填寫本頁) IR(Nujol) : 1654CHT1。 mp : 230.1-233.4°C〇 &lt;實施例278; 1-(4-聯苯甲基)-2-乙基-6-(四唑-5-氨 基甲醯基)苯並咪唑(340)之合成&gt; 依據實施例98之方法,使用1-(4_聯笨甲基)-6-羧 基-2-乙基笨並咪唑(〇.300g)、N,N’_羰基二咪唑(〇.272g)、 5-胺基·&quot;四唾(〇.143g)、二氮二環十一烯(〇.256g)以得出1- 257 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(25j (4-聯苯曱基)-2-乙基-6-(四唑-5-氨基甲醯基)苯並咪唑 (340)0.135g。 [化合物(340)的物性] 4-瞧_30-(16,6) : 1·32(3Η,t,J=7.5Hz),2.93(2H,q,J:7.5Hz),5.61(2H ,s)5 7·23(2Η, d, J二8·1Ηζ)3 7·34(1Η, t, J=7.4Hz), 7·44(2Η, t, J=7.6Hz), 7.60-7.67(4H, m), 7·76(1Η, d, J:8.5Hz), 7·98(1Η, d, J=8.6Hz), 8.46(1H, s ),12·30(1Η, s)3 15.95(1H, s)。 IR(Nujol) : 1667C0T1。 即:273.1-276.0oC〇 &lt;貫施例279; 1 -(4-聯苯甲基)-2_乙基-6- (1,3,4-三〇坐_ 3-氨基曱醯基)苯並咪唑(341)之合成&gt; 依據實施例98之方法,使用1_(4_聯苯曱基)-6-羧 基-2-乙基苯並咪唑(0.300g)、N,N’_羰基二咪唑(0.272g)、 3-胺基-1,3,4-三唑(0.141g)、二氮二環十一烯(0.256g)以 得出1-(4-聯苯甲基)-2-乙基-6-(l,3,4-三唑-3-氨基甲醯基) 苯並咪唑(341)0.224g。 [化合物(341)的物性] 經浐部中成樣枣而负工消贽合竹私印^ (請先閱讀背面之注意事項再填寫本頁) 'H-NMRiDMSO-dG, c5) : 1.33(3H, t3 J-7,4Hz)3 2.93(2H3 q, J-7.4iiz)3 5.63(2H ,s), 7.17(2Hy d, J=8.3Hz), 7·35(1Η, t, J:7.4Hz), 7·44(2Η, t, J:7.5Hz), 7·60-7·65(4Η, m)3 7·78(1Η, d3 J二7·4Ηζ), 7·83(1Η, dd, J=8.4 及 1·5Ηζ), 8·17(1Η, s), 8·77(2Η, s), 12·04(1Η, s)〇 IR(Nujol) : 1675cm1。 mp : 263.4-266.20C〇 &lt;實施例280;l-(4·聯苯甲基)-2-乙基-6-(l,3,4-三唑-2- __________ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 548272 A7 B7 . 五、發明説明(25$ &quot;一~ 氨基曱醯基)苯並咪唑(342)之合成&gt; (讀先閱讀背面之注意事項再填寫本頁) 依據實施例98之方法,使用ΐ-(4·聯笨甲基)_6_魏 基-2-乙基笨並咪唑(0.300g)、N,N,-羰基二味唾(〇.272g)、 2- 胺基-1,3,4-二嗤(0.141g)、二氮二環十一烯(〇 256g)以 待出1-(4-聯苯甲基)-2 -乙基- 6-(l,3,4-三啥·2_氨基甲酸基) 笨並咪唑(342)0.215@。 [化合物(342)的物性] ^-NMRiDMSO-de, δ) : 1.31(3H5 t5 J=7.4Hz), 2.92(2H3 q3 J-7.4Hz), 5.60(2 H, s), 7·23(2Η, d5 J:7.8Hz), 7·34(1Η, t, J=7.2Hz)3 7·44(2Η, t, J:7.6Hz), 7·60-7·66(4Η, m), 7·72(1Η, d, J=8.3Hz), 7·78(1Η3 s), 7·95(1Η, d, J二8.3H z), 8·43(1Η, s), 11·85(1Η, s), 13·57(1Η, s)。 IR(Nujol) : 1659cm&quot;l〇 mp : 306.0〇C(分解)。 &lt;實施例281; 1-(4-聯苯曱基)-2-乙基-6-(3-吡啶氨基 甲醯基)苯並咪唑(343)之合成&gt; 依據實施例98之方法,使用1-(4-聯苯曱基)_6_魏 基-2-乙基苯並味唆(0.300g)、N,N’-魏基二味唾(〇.272g)、 經浐部中央柊翠而只t,消費合竹私印絮 3- 胺基17比唆(0.1588)、二氮二環十一烯(〇.2568)以得出1-(4-聯苯甲基)-2-乙基-6-(3-吐啶氨基甲醯基)苯並咪唑 (343)0.229g。 [化合物(343)的物性] ^-NMRiCDCh, δ) : 1.47(3H, t, J=7.6Hz), 2.93(2H, q3 J=7.4Hz)3 5.45(2H, s), 7.10(2H, d, J二8·1Ηζ), 7·29-7.36(2H, m), 7·42(2Η, t, J二7.4Hz), 7.53( 4H, d, J=8.0Hz), 7.71(1H, d, J=8.5Hz), 7.86(1H, d, J=8.4Hz), 7.97(1H3 s) ________ 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) 548272 Α7 Β7 五、發明説明(25g ,7·98(1Η, s), 8·27(1Η, d, J二8·4Ηζ), 8·38(1Η3 d, J=4.7Hz), 8·68(1Η, d, J 二2·5Ηζ)。 IR(Nujol) : 1644cm—1。 inp : 124.4-125.60C〇 &lt;實施例282;l-(2,4-二氯代苄基)-2-甲基-6-(2-吡啶 氨基曱醯基)苯並咪唑(344)之合成&gt; 依據實施例98之方法,使用6-羧基-l-(2,4-二氣代 苄基)_2_甲基苯並咪唑(0.3〇Og)、N,N,-羰基二咪唑 (0.290g)、2-胺基吡啶(0.168g)、二氮二環十一烯(〇.273g) 以付出1_ (2,4-二氯代卞基)-2-曱基- 6-(2-°比咬氨基甲酿基) 苯並咪唑(344)0.152邑。 [化合物(344)的物性] ^-NMRiCDCh, δ) : 2.59(3H, s), 5.43(2H, s) 3 6.33( 1H, d, J=8.4Hz), 7.06 -7.10(2H, m), 7·50(1Η, d, J二2·1Ηζ), 7·77(1Η, dt3 J二7.8 及 1·9Ηζ), 7·83 (2Η, s), 7·88(1Η, s), 8·30(1Η, d, J=3.7Hz), 8·39(1Η, d, J=8.3Hz), 8.78(1 Η, s)〇 IR(Nujol) : 1666cm 1〇 mp ·· 157.4-159.20C〇 經沪部中央«.-^-^β-τ消贽合作#卬5? (讀先閱讀背面之注意事項再填寫本頁) &lt;實施例283; 1-(4-聯苯甲基)-2-乙基-6-(4-吡啶氨基 甲醯基)苯並咪唑(345)之合成&gt; 依據實施例98之方法,使用1-(4-聯苯甲基)-6-羧 基-2-乙基苯並咪唑(〇.300g)、N,N,-羰基二咪唑(〇.272g)、 4-胺基吡啶(〇.158g)、二氮二環十一稀(〇j56g)以得出 1-(4-聯笨甲基)-2 -乙基-6-(4-。比咬氨基甲醯基)苯並口米η坐 _____ 260 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 548272 A7 B7 五、發明説明(2 5今 (345)0.153g。 [化合物(345)的物性] (請先閱讀背面之注意事項再填寫本頁) lH-NMR(CDCl3, δ) : 1.48(3H5 t5 J=7.4Hz), 2.94(2H, q5 J=7,4Hz), 5.45(2H, s), 7.10(2H, d, J=8.1Hz), 7·35(1Η, t, J:7·他),7·42(2Η, t, J:7.4Hz), 7 ·50-7·60(6Η, m), 7·691(1Η, d, J:7.8Hz), 7·86(1Η, d, J:8_3Hz), 7·95(1Η, s ),7,99(1H, br s), 8·54(2Η, dd, J二1.5 及 4·7Ηζ)。 IR(Nujol) : 1663cm-1〇 mp : 123.8-124.7°C〇 &lt;製造例55;N-(1-丁磺醯基)-4-乙醯胺基-3-硝基笨 並醯胺之製造&gt; 依據製造例28之方法,使用4-乙醯胺基-3-硝基安 息香酸(lO.Og)、N,N’_羰基二咪唑(9.40g)、1·丁磺醯胺 (7.92g)、一氮一 %十一細(8.83g)以得出N-( 1 - 丁石黃酿 基)_4_乙醯胺基-3-硝基苯並醯胺(i〇.75g)。 [化合物的物性] 'H-NMlUDMSQ-de,(5) : 〇·87(3Η,t,J:7.4Hz),1,37-1·44(2Η,m),1·64-1·71( 2Η3 m), 2.12(3Η, s), 3·52(2Η, t, J:7.7Hz), 7·83(1Η, d, J:8.6Hz), 8·21(1Η ,dd, J:8.6 及 2·1Ηζ), 8·54(1Η, d, J=2.2Hz), 10·56(1Η, s), 12·32(1Η, s )〇 一 &lt;製造例56;N-(1-丁磺醯基)-3-胺基-4-乙醯胺基笨 並醯胺之製造&gt; 依據製造例29的方法,使用N-(l-丁磺醯基)-4-乙 醯胺基-3-硝基苯並醯胺(i〇.75g)以得出Ν-(1-丁磺醯基)_ 3-胺基-4-乙醯胺基苯並酿胺(3. 〇4g)。 - 261 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 548272 A7 B7 五、發明説明(25》 [化合物的物性] (誚先閱讀背面之注意事項再填寫本頁) 4-NMR(DMS0-d6, 6) : 0·86(3Η, t3 J=7.3Hz), 1·33-1·43(2Η, m), 1·59-1·67( 2H, m), 2·07(3Η, s), 3·37-3·43(2Η, t), 5·12(2Η, br s), 7·13(1Η, dd, J=8 2 及 2·0Ηζ),7·28(1Η,d,J:1.9Hz),7.40(1H,d,Jt3Hz),9·09(1Η,s)。 &lt;製造例57;N-(1-丁磺醯基)_4-乙醯胺基_3-[4-(2_吡 °定)节基胺基]苯並酿胺之製造&gt; 依據製造例32之方法,使用Ν_(1-τ磺醯基)_3_胺 基-4-乙胺基苯並驢胺(〇4〇〇g)與2-[(4-漠代甲基)苯基] °比σ疋(0.477g)以得出N-(l-丁石黃醯基)-4-乙醯胺基_3-[4·(2_ σ比啶) 苄基 胺基] 苯並醯 胺之粗 生成物 。把 它直接 用在下 述之反應。 &lt;實施例284;6-(1-丁磺醯基氨基甲醯基 啶)苄基]_2_甲基苯並咪唑(346)之合成&gt; 依據實施例183之方法,使用上述N-(l-丁磺醯 基)-4-乙醯胺基-3-[4·(2-吡啶)苄基胺基]苯並醯胺的粗生 成物以直接得出6-(1-丁磺醯基氨基甲醯基比 啶)苄基]甲基苯並咪唑(346)0.330g。 [化合物(346)的物性] M浐部中夾榀卑而h_T消贽合作私印繁 ^-NMRiDMSO-dG, δ) : 0.82(3H, t)3 1.37-1.46(2H, m)5 1.54-1.6K2H, m), 2 •54(3H, s), 3·10(2Η, t, J=7,8Hz), 5·57(2Η, s), 7.19(2H, d, J=7.5Hz), 7.3 3(1H, t, J邛·2Ηζ), 7·49(1Η, d3 J二8·4Ηζ), 7.82-7.87(2H, m), 7.90(1H, d, J =8·0Ηζ), 8.0卜8·04(3Η, m), 8·63(1Η, d, J=4.2Hz)。 IR(Nujol) : 1722cm-l〇 mp : 292.4—298.4°C。 ___________Ζή2_ 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X297公釐) 548272 Λ7 B7 五、發明説明(25$ &lt;實施例285;5-氯代磺醯基·W24 — 一 f ^ ^ ϋ ^ (347) ^ 6. ^ „ §i ^ 基)-2-甲基苯並咪唑(348)之合成 &gt; ,—乳代卞 在冰溶下,將H2,4_二氯代节基)_2_甲 (4.〇〇g)加入氯卿0_中,在室溫下攪拌二:: 著在贼下攪拌丨·5小時。將反應液加入冰水中,、藉; 過濾出所析出之膠狀的固體’以得出5_氯代磺醯基]_ ',r-^r / 基^_2_ f基苯並㈣(347)及6_氯代續酿基 -1-(2,4-二氣代节基)_2_甲基苯並味却叫之混合物。把 它直接用在下述之反應中。 :實施例286;5-胺基磺醯基_丨_(2,4_二氣代苄基)_2_ 甲基苯並咪唑(349)及6-胺基磺醯基_丨_(2,4_二氯代苄 基)-2-甲基苯並味。坐(35〇)之合成&gt; 在至服下使用25%的氨水(i〇〇mi)處理實施例285 所侍之5-氯代磺醯基1-(2,舡二氯代苄基)·2_曱基苯並咪 唑及6-氯代磺醯基‘二氯代苄基)_2_甲基苯並咪唑 之混合物1小時。藉由過濾出固體以得出5_胺基磺醯基 -1_(2,心二氯代苄基)-2-甲基苯並咪唑(349)及6-胺基磺醯 基1 一氣代午基)-2-甲基苯並味嗤(350)之1/1的混 合物(2.68g;)。 [化合物(349)與化合物(350)的混合物之物性] NMR(CD3〇D3 (5) : 2·52(3/2Η,s),2.54(3/2H,s),5.54(2H,s),6·55(1Η, d3 J=6.9Hz), 7·17(1Η, d, J:8.GHz), 7.52(1Η, s), 7·65-7·78(2Η, m), 7·82(1 /2Η3 s), 8.11(1/2Hj s)〇 -24J- 本紙張尺度適用中國國家標準 (CNS ) A4規格(210X 297公釐 548272 kl B7 五、發明説明(26ί) (請先閱讀背面之注意事項再填寫本頁) &lt;實施例287;6-(正-祐基胺基磺醯基二氯代 苄基)-2-甲基苯並咪唑(351)及5_(正-芘基胺基磺醯基)_ 1一(2,4-&gt;一氣代卞基)-2-甲基苯並味嗤(352)之合成&gt; 將二氣甲烧(lml)、三乙胺(〇.56ml)、正祐基氯 (0.326§)加入上述5-胺基磺醯基-1-(2,4-二氯代苄基)_2_ 曱基本並味哇(349)及6-胺基績酸基-1-(2,4-二氣代节 基)-2-甲基苯並咪唑(350)之ι/丨的混合物(〇5〇〇g)中,在 室溫下攪拌48小時。加入水以停止反應。加入三氯甲 烷進行萃取。對於有機層進行乾燥、濃縮,並經由矽膠 柱色譜(溶離液:三氯甲烷/甲醇=95/5)之精製以得出6_ (正-比基胺基石頁醯基)-1-(2,4-二氯代节基)_2_甲基苯並咪 唑及5-(正-芘基胺基磺醯基‘二氯代苄基)_2•甲基 苯並咪唑之混合物(0.360g)。接著藉由中壓矽膠柱色譜 (溶離液··己烷/酯酸乙酯=1/1〜1/4)之精製以得出6_(正_ 芘基胺基磺醯基)-1 -(2,4-二氯代苄基)_2_曱基苯並咪唑 (351)(0.95§)及5-(正-祐基胺基績酿基)_1_(2,4_二氯代节 基)-2-甲基苯並咪唑(352)(0.45g)。 [化合物(351)的物性] ^-NMRiDMSO-de, ¢) : 0.74(3H, t, J=7.3Hz), l.〇9(ZH5 m)3 1.31(2H5 m), 2. 10(ZH, t, J-7.3Hz), 2.53(3H, s)3 5.63(2H, s), 6.60(1H3 d, J=8 4Hz) 3 7 32 (1H, d, J=8.3Hz), 7·67-7·77(3Η, m), 7·93(1Η, s)。 IR(KBr) : 1726cm-l〇 mp : 207,5-210.0oC〇 Mass(FD) : m/e 454(M+l)〇 _264 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 548272 A7 B7___ 五、發明说明(26! [化合物(352)的物性] (許先閱讀背面之注意事項再填寫本頁) lH-NMR(DMS0-d65 δ) : 0.75(3H3 t, J=7.3Hz), 1.11(2H, m)3 1.34(2H, m)3 2. 13(2H,t3 J=7.4Hz),2.51(3H3 s),5·59(2Η,s)3 6·57(1Η,d,J二8·5Ηζ),7.32 (1H, dd, J二2.2 及 8·4Ηζ), 7·57(1Η, d, J二8·6Ηζ), 7·67(1Η, dd, J=1.6 及 8·6Ηζ), 7·73(1Η, d, J二2·1Ηζ), 8·08(1Η, d, J二1·6Ηζ)。 IR(KBr) : 17060111^ mp : 213.0 —216.0°C。 &lt;實施例288;2,4-二曱基-6-曱氧基羰基苯並咪唑之 合成&gt; 依據 Journal of Medicinal Chemistry 1993,36,4040-4051所記載之方法,使用4-胺基-3-甲基安息香酸甲酯 以得出4-乙醯胺基-5-胺基-3-甲基安息香酸甲酯。接著 在醋酸中加熱迴流2小時以得出2,4-二甲基-6-甲氧基羰 基苯並17米11 坐。 [化合物的物性] lH-NMR(CDCl3, δ) : 2.55(3H, s), 2.62(3H3 s)3 3.91(3H5 s), 7.74(1H5 s)3 8·07(1Η, s), 10.65(1H, br s)。 &lt;實施例289; 1-(2,4-二氣代苄基)-2,4-二甲基-6-甲 氧羰基苯並咪唑(353)之合成&gt; 在80 °C攪拌2,4-二甲基-6_曱氧幾基苯並哺唾 (0.900g)、2,4-二氣代苄基氣(1.20g)、碘化鈉(0.200g)、 碳酸鉀(0.610g)、及N,N-二甲基曱醯胺(4ml)之混合物16 小時。經減壓顧去有機溶媒後,加入醋酸乙酯與水進行萃 取。濃縮有機層,加入己烷以使其結晶化。過濾出結晶, ___165___ 本紙張尺度適Jfl中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(26h 經乾燥以得出丨_(2,4_二氯代苄基)·2,4_二甲基_6_甲氧羰 基苯並咪唑(353)1.08g。 [化合物(353)的物性] (讀先閱讀背面之注意事項再填寫本頁) 'H-KMR(CDCl3, d) : 2.58(3H, s), 2.71(3H, s), 3.90(3H, s)j 5.39(2H, s) 6.30UH,d,㈣.他),7.07(1H,吡 J=8 4 及 2 〇Hz),7 49(ih,d,尺如 Z), 7.75(1H, s), 7.81(1H,S)。 &lt;貝施例29〇;6_幾基- l-(2,4_二氣代节基)·2,4-二甲 基-6-甲氧羰基苯並咪唑(354)之合成〉 依據實施例53之方法,使用卜(2,4_二氯代苄基)_ 2,4-二甲基-6-甲氧羰基苯並咪唑(〇51〇g)以得出6_羧基_ 1-(2,4·二氯代苄基)_2,4-二曱基_6_曱氧羰基苯並咪唑 (354)0.435g 〇 [化合物(354)的物性] fNMiUDMSO-d6,d) ·· 2·51(3Η,s),2·55(3Η,s),5·57(2Η,s),6·49(1Η,d, J=8.4Hz), 7·31(1Η3 dd3 J:8.4 及 2·2Ηζ), 7·62(1Η, s), 7·72(1Η, d, J二2· 0Hz), 7·78(1Η, s), 12.64(1H3 br s)。 &lt;實施例291;6-(1-丁磺醯基氨基曱醯基)_1-(2,4_二 氯代苄基)_2,4_二曱基苯並咪唾(355)之合成&gt; 依據實施例98之方法,使用6_羧基-:u(2,4-二氯代 苄基)-2,4-二甲基-6-甲氧羰基笨並咪唑(〇 435g)、N,N,_ 羰基二咪唑(0.290g)、1-丁磺醯胺(〇 246g)、二氮二環十 一烯(0.273g)以得出心(1·丁磺醯基氨基甲醯基 二氯代苄基)-2,4-二曱基苯並咪唑(355)〇 4688。 [化合物(355)的物性] ------— 266___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 548272 A7 ________________ B7 五、發明説明(26》 (謂先閱讀背面之注意事項再填寫本頁) Η-NMR(DMSQ-d6,ά) : G.84(3H, t,J=7.4Hz),L38(2H,m),1·64(2Η,m),2· 49(3H, s), 2·56(3Η3 s), 3·48(2Η, t), 5.55(2H, s), 6·40(1Η, d, J=8.5Hz), 7·31(1Η3 dd3 J=2.1 及 8·4Ηζ), 7·64(1Η, s), 7·75(1Η, d, J:2.1Hz)3 7·90( 1H3 s), 11·79(1Η, br s)。 IR(Nujol) : 16820111^0 mp : 180.0 — 181.5°C。 &lt;製造例58;4-苯氧基苄醇之製造&gt; 將硼氫化鈉(〇.48g)添加入4_笨氧基苯曱醛(4 96g) 之乙醇(20ml)溶液中,在室溫下攪拌15小時。經濃縮 後’添加第3 丁基甲基醚與水以進行萃取。濃縮有機層, 以得出4_苯氧基苄醇(4.84g)。 [化合物的物性] W-fiMIUCDCh,6) : 4··67(2Η,d,J=5,7Hz),6·99_7·01(4Η,m),7·1〇(1Η,t5 J二7.4Ηζ), 7·32-7·35(4Η,瓜)。 &lt;製造例59;4·苯氧基苄基氯之製造&gt; 將亞硫醯氯(l3.34g)加入4_苯氧基苄醇(4 06g)中, 在80 C攪拌3 ·5小時。經濃縮後,加入醋酸乙酯及水進 行萃取。濃縮有機層以得出4-苯氧基苄基氯(4.31g)。 [化合物的物性] t舰(CDC13, 6) : 4·.58(2Η,s),6·96—7·〇3(4Η,…,7_u—7 ⑷ 1H,卟 7 32-7·37(4Η, m)。 &lt;實施例292;6-乙氧羰基-2-甲基-1-(4-苯氧苄基)苯 並咪唑(356)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基安 ----- 267___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(26)ΐ 息香酸乙酯(0.56g)、碳酸鈉(〇.33g)、碘化鈉(〇.i2g)、4__ 苯氧基苄基氣(〇.66g)以得出4-乙醯胺基_3_[(4_苯氧)节 基胺基]安息香酸乙酯(0.49g)。接著將它變換成6_乙氧幾 基-2-甲基小(4-笨氧苄基)苯並咪唑(3 56)(0.44§)。 [4-乙醯胺基-3-[(4-笨氧)苄基胺基]安息香酸乙酯的物性] ^-NMRiCDCla, δ) : 1.37(3H, t3 J=7.1Hz), 2.04(3H3 s), 4.18(1H3 br s), 4 .31-4·36(4Η, m), 6.98-7.G2(4H, m), 7.09-7.12(lH, m), 7·27-7·51(8Η, m)。 [化合物(356)的物性] 屮腿⑽⑴,(Π ·· 1·40(3Η, t3 J:7.1Hz),U1(3H,s),4·39(2Η,q,J二7·1 Hz), 5.35(2H, s), 6·92-6.95(2Η, m), 6.97-7·〇〇(2Η, m), 7.02(2H, d, J=8.7Hz), 7.40 (1H, d, J = 2.0Hz), 7.52 (1H3 d, J = 8.4Hz), 7.67 (1H, d3 J = 8.4Hz) 3 7 • 86 (1H, s), 7.91 ( 1Η, dd, J: 1.4 and 8.4Hz). &lt; Example 274; 6-carboxy-1- [Synthesis of 2 (2,4-di-gas-substituted phenylethyl) l-2-fluorenylbenzimidazole (336) &gt; According to the method of Example 53, Using 1- [2 (2,4-dichlorophenethyl)] · 6-ethoxyepi-2-methylbenzoxyl salivary (0.690g) to obtain &amp; No. 2 (2,4-dichlorophenethyl)]-2-methylbenzimidazole (336) 0.447g ° This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) 548272 A7 B7 V. Description of the invention (25i [Physical properties of compound (336)] (Read the precautions on the back before filling out this page) H ^ (DHS0-d63 δ ): 1.88 (3H, d5 J = 6.8Hz), 2.57 (3H, s), 6.01 (1H, q) 5 7. 55 (1H, d) 5 7.60-7.67 (3H, m), 7.71 (1H? D ) 3 7.89 (1H, d) 5 12.65 (1H, br s) &lt; Example 275; 6- (l-Butylsulfonylaminocarbamyl)] _ [Second (2, 'digasophenethyl) )] Synthesis of 2-methylbenzimidazole (337) &gt; According to the method of Example 98, 6_carboxy_ 丨 _ [2 (2,4-dichlorophenethyl)]-2 was used -Fluorenylbenzimidazole (0.433g), N, N, -carbonyldizolidazole (0.412g), butanesulfonium Amine (.348g), diazabicyclo-ene (0.386g) to give 6- (1-butanesulfonylaminocarbamyl [second (2,4-mono-gas-substituted ethyl)]- 2-Methylbenzyl η (337). [Physical properties of compound (337)] 1 fiMR (DMS (H163 ¢): 0.84 (3Η, t, J: 7.3Hz), 1.34 (2Η, ιη), 1.57 (2Η, m), 1.89 (3Η, d, J = 7.0Hz), 2.49 (3H3 s) 3 3.07 (ZH3 m) 3 5.954 (1H, q3 J = 7.0Hz), 7.4 1 (1H, d, J = 8.7Hz), 7.56 (1Η, dd, J = 2, l and 8.5Ηζ), 7.61 (1H, d, J: 2.1Hz), 7.74-7.79 (3H M) &lt; Example 276; Synthesis of 1- (4-biphenylmethyl) _2-ethyl-6- (phenylaminomethyl) benzimidazole (338) &gt; According to Example 15 Method: ι_ (4-biphenylmethyl) -6-chlorocarbonylethylbenzimidazole hydrochloride (0.300 g), triethylamine (0.243 g), and aniline (0.224 g) were used. 0.195 g of 1- (4-biphenylmethyl) -2-ethyl-6- (phenylaminofluorenyl) benzimidazole (338) was obtained. [Physical properties of compound (338)] 1H-NMR (CDCl3, 6): 1.47 (3H, t5 J = 7.5Hz), 2.93 (2H, q, J-7.5Hz), 5.44 (2H, s), 7.1K2H, d, J = 8.2Hz), 7 · 14 (1Η, t, J 二 7 · 4Ηζ), 7.32-7 · 38 (3Η, ni), 7.42 (This paper is suitable for Chinese National Standard (CNS) A4 Specifications (210X297 mm) 548272 A7 B7 V. Description of the invention (25i 2H, t, J 2 7.4 Hz), 7.51-7 · 54 (4Η, m), 7.63 (2Η, d, J 2 7 · 8Ηζ) , 7.69UH, dd5 J 2: 8 · 4 and 1. 6Ηζ), 7.84 (1Η, d, J2 8.4Ηζ), 7.88 (1Η, br s), 7.97 (1H, d, J 2 1 5Ηζ) IR (Nujol): 16470111 ^ 0 mp: 171 · 7-172 · 1. . . &lt; Example 277; Synthesis of l- (4-biphenylmethyl) -2-ethyl-6- (l, 3,4-thiadiazole-2-aminomethylamidino) benzimidazole (339) &gt; According to the method of Example 98, 1- (4-biphenylmethyl) -6-weilyl-2-ethylbenzyl flavor was used (Sat (0.300g), N, N'-Weiji Diweiwa (〇, 272g), 2-amino-1,3,4-thiadiazole (0.170g), diazabicycloundecene (0.256§) to give 1- (4-biphenylmethyl) ) -2-Ethyl-6- (1,3,4-thiadiazole-2-carbamic acid group) benzo saliva (339) 0.234 yup. [Physical properties of compound (339)] ^ -NMRiCDCla, ^): 1.45 (3H3 t3 J-7.5Hz) 3 2.90 (2H, q3 J-7.5Hz), 5.53 (2H, s), 7.07 (2H, d3 J = 8.3Hz), 7.33 (1H, t, J = 7.5Hz), 7.40 (2H, t3 J = 7.3Hz), 7.5 2 (4H, d, J = 8 · z), 7.89 (1Η, d, J = 8.5Hz), 8 · 08 (1Η, dd, J = 8.5 and 1.6Ηζ), 8.34 (1Η, d, J = 1.2Hz) 3 7 · 60 (1Η, s), 12 · 26 ( 1Η, s). The middle section of the Ministry of Economic Affairs «. ^-And 01 Consumption Hezhu Private Seal f (Read the precautions on the back before filling this page) IR (Nujol): 1654CHT1. mp: 230.1-233.4 ° C &lt; Example 278; 1- (4-biphenylmethyl) -2-ethyl-6- (tetrazole-5-aminomethylamidino) benzimidazole (340) Synthesis> According to the method of Example 98, 1- (4-bibenzylmethyl) -6-carboxy-2-ethylbenzimidazole (0.300 g), N, N'-carbonyldiimidazole (. 272g), 5-amino group &quot; tetrasial (0.143g), diazabicycloundecene (0.256g) to get 1-257 This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 (Mm) 548272 A7 B7 5. Description of the invention (25j (4-biphenylfluorenyl) -2-ethyl-6- (tetrazole-5-aminomethylfluorenyl) benzimidazole (340) 0.135 g. [Compound (Physical properties of (340)] 4- Look_30- (16,6): 1.32 (3Η, t, J = 7.5Hz), 2.93 (2H, q, J: 7.5Hz), 5.61 (2H, s) 5 7 · 23 (2Η, d, J = 8 · 1Ηζ) 3 7 · 34 (1Η, t, J = 7.4Hz), 7.44 (2Η, t, J = 7.6Hz), 7.60-7.67 (4H, m), 7.76 (1Η, d, J: 8.5Hz), 7.98 (1Η, d, J = 8.6Hz), 8.46 (1H, s), 12.30 (1Η, s) 3 15.95 (1H , S). IR (Nujol): 1667C0T1. That is: 273.1-276.0oC. &Lt; Implementation Example 279; 1-(4-biphenylmethyl) -2-ethyl-6- (1 Synthesis of 3,4-triazolyl-3-aminofluorenyl) benzimidazole (341) &gt; According to the method of Example 98, 1- (4-biphenylfluorenyl) -6-carboxy-2- Ethylbenzimidazole (0.300g), N, N'-carbonyldiimidazole (0.272g), 3-amino-1,3,4-triazole (0.141g), diazabicycloundecene (0.256 g) to obtain 0.224 g of 1- (4-biphenylmethyl) -2-ethyl-6- (l, 3,4-triazol-3-carbamoyl) benzimidazole (341). [ Physical properties of compound (341)] After the sample was removed from the crotch, the workmanship was eliminated. (Please read the precautions on the back before filling this page) 'H-NMRiDMSO-dG, c5): 1.33 (3H , t3 J-7, 4Hz) 3 2.93 (2H3 q, J-7.4iiz) 3 5.63 (2H, s), 7.17 (2Hy d, J = 8.3Hz), 7.35 (1Η, t, J: 7.4Hz ), 7.44 (2Η, t, J: 7.5Hz), 7.60-7 · 65 (4Η, m) 3 7.78 (1Η, d3 J 2 7.4Ηζ), 7.83 (1Η, dd , J = 8.4 and 1.51ζ), 8.17 (1Η, s), 8.77 (2Η, s), 12.04 (1Η, s), IR (Nujol): 1675cm1. mp: 263.4-266.20C0 &lt; Example 280; l- (4 · biphenylmethyl) -2-ethyl-6- (l, 3,4-triazole-2- __________ This paper size applies to China Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7. 5. Description of the invention (25 $ &quot; mono ~ aminoamido) benzimidazole (342) synthesis &gt; (Read the precautions on the back before reading (Fill in this page) According to the method of Example 98, ΐ- (4 · bibenzylmethyl) _6_weiyl-2-ethylbenzimidazole (0.300 g), N, N, -carbonyl disalizol ( .272g), 2-amino-1,3,4-difluorene (0.141g), diazabicycloundecene (0256g) to be produced 1- (4-biphenylmethyl) -2-ethyl -6- (l, 3,4-tris-2-carbamic acid group) Benzimidazole (342) 0.215 @. [Physical properties of compound (342)] ^ -NMRiDMSO-de, δ): 1.31 (3H5 t5 J = 7.4Hz), 2.92 (2H3 q3 J-7.4Hz), 5.60 (2 H, s), 7.23 (2Η, d5 J: 7.8Hz), 7.34 (1Η, t, J = 7.2Hz) 3 7 · 44 (2Η, t, J: 7.6Hz), 7.60-7 · 66 (4Η, m), 7.72 (1Η, d, J = 8.3Hz), 7.78 (1Η3 s), 7.95 (1Η, d, J 8.3H z), 8.43 (1Η, s), 11.85 (1Η, s), 13.5 7 (1Η, s). IR (Nujol): 1659 cm &quot; 10 mp: 306.0 ° C (decomposed). &lt; Example 281; Synthesis of 1- (4-biphenylfluorenyl) -2-ethyl-6- (3-pyridylaminomethylfluorenyl) benzimidazole (343) &gt; According to the method of Example 98, Use 1- (4-biphenylfluorenyl) _6_Weiji-2-ethylbenzo miso (0.300g), N, N'-Weiji diwei saliva (0.272g), central part It is only green, and it consumes 3-amino 17 ratio fluorene (0.1588) and diazabicycloundecene (0.2568) to obtain 1- (4-biphenylmethyl) -2- 0.229 g of ethyl-6- (3-turidinecarbamoyl) benzimidazole (343). [Physical properties of compound (343)] ^ -NMRiCDCh, δ): 1.47 (3H, t, J = 7.6Hz), 2.93 (2H, q3 J = 7.4Hz) 3 5.45 (2H, s), 7.10 (2H, d , J 2 8.1Ηζ), 7.29-7.36 (2H, m), 7.42 (2Η, t, J 2 7.4Hz), 7.53 (4H, d, J = 8.0Hz), 7.71 (1H, d , J = 8.5Hz), 7.86 (1H, d, J = 8.4Hz), 7.97 (1H3 s) ________ This paper size applies to China National Standard (CNS) A4 specification (21〇X297 mm) 548272 Α7 Β7 V. Invention Explanation (25g, 7.98 (1Η, s), 8.27 (1Η, d, J 2 8.4Ηζ), 8.38 (1Η3 d, J = 4.7Hz), 8.68 (1Η, d, J (2 · 5Ηζ). IR (Nujol): 1644cm-1. Inp: 124.4-125.60C0 &lt; Example 282; l- (2,4-dichlorobenzyl) -2-methyl-6- ( Synthesis of 2-pyridylaminofluorenyl) benzimidazole (344) &gt; According to the method of Example 98, 6-carboxy-l- (2,4-dioxobenzyl) _2_methylbenzimidazole was used (0.300g), N, N, -carbonyldiimidazole (0.290g), 2-aminopyridine (0.168g), diazabicycloundecene (0.273g) to pay 1_ (2,4-di Chlorofluorenyl) -2-fluorenyl-6- (2- ° specific carbamate) benzimidazole (344) 0.152 yup. Physical properties of compound (344)] ^-NMRiCDCh, δ): 2.59 (3H, s), 5.43 (2H, s) 3 6.33 (1H, d, J = 8.4Hz), 7.06 -7.10 (2H, m), 7.50 (1Η, d, J 2 2.1Ηζ), 7.77 (1Η, dt3 J 2 7.8 and 1.9Ηζ), 7.83 (2Η, s), 7.88 (1Η, s), 8 · 30 (1Η, d, J = 3.7Hz), 8.39 (1Η, d, J = 8.3Hz), 8.78 (1Η, s), IR (Nujol): 1666cm 10m, · 157.4-159.20C 〇 Via the Central Committee of the Ministry of Shanghai «.- ^-^ β-τ 消 贽 Cooperation # 卬 5? (Read the precautions on the back before filling in this page) &lt; Example 283; 1- (4-Biphenylmethyl) Synthesis of 2-ethyl-6- (4-pyridylaminomethylmethyl) benzimidazole (345) &gt; According to the method of Example 98, 1- (4-biphenylmethyl) -6-carboxyl- 2-ethylbenzimidazole (0.300 g), N, N, -carbonyldiimidazole (0.272 g), 4-aminopyridine (0.158 g), diazabicycloundecene (〇j56 g) This gives 1- (4-bibenzylmethyl) -2-ethyl-6- (4-. Than biting carbamate) Benzo rice n _____ 260 This paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) 548272 A7 B7 V. Description of the invention (2 5 Today (345) 0.153g [Physical properties of compound (345)] (Please read the precautions on the back before filling this page) lH-NMR (CDCl3, δ): 1.48 (3H5 t5 J = 7.4Hz), 2.94 (2H, q5 J = 7, 4Hz), 5.45 (2H, s), 7.10 (2H, d, J = 8.1Hz), 7.35 (1Η, t, J: 7 · he), 7.42 (2Η, t, J: 7.4Hz) , 7.50-7.60 (6Η, m), 7.691 (1Η, d, J: 7.8Hz), 7.86 (1Η, d, J: 8_3Hz), 7.95 (1Η, s), 7,99 (1H, br s), 8.54 (2Η, dd, J 2 1.5, and 4.7Ηζ). IR (Nujol): 1663cm-1〇mp: 123.8-124.7 ° C. &Lt; Production Example 55; Production of N- (1-butanesulfonyl) -4-acetamidinyl-3-nitrobenzimidamine &gt; According to the method of Production Example 28, 4-acetamidinyl 3-nitrobenzoin was used Acid (lO.Og), N, N'-carbonyldiimidazole (9.40g), 1. butanesulfonamide (7.92g), one nitrogen and one percent eleven fines (8.83g) to obtain N- (1- Butyl yellow brewing group) _4_Ethylamino-3-nitrobenzofluorenamine (i.75g) [Physical properties of compound] 'H-NMlUDMSQ-de, (5): 〇87 (3Η, t, J: 7.4Hz), 1,37-1 · 44 (2Η, m), 1.64-1 · 71 (2Η3 m), 2.12 (3Η, s), 3.52 (2Η, t, J: 7.7Hz), 7.83 (1Η, d, J: 8.6Hz), 8.21 (1Η, dd, J : 8.6 and 2.1Ηζ), 8.54 (1Η, d, J = 2.2Hz), 10.56 (1Η, s), 12 · 32 (1Η, s) 〇 &lt; Production Example 56; N- ( Production of 1-butanesulfonyl) -3-amino-4-acetamidobenzylidene &gt; According to the method of Production Example 29, N- (l-butanesulfonyl) -4-acetamidine was used Amine-3-nitrobenzofluorenamine (i.75g) to give N- (1-butanesulfonyl) -3-amino-4-acetamidobenzophenamine (3. 〇 4g).-261 This paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) 548272 A7 B7 V. Description of the invention (25) [Physical properties of compound] (诮 Please read the precautions on the back before filling this page) 4-NMR (DMS0-d6, 6): 0.86 (3Η, t3 J = 7.3Hz), 1.33-1 · 43 (2Η, m), 1.59-1 · 67 (2H, m), 2 · 07 (3Η, s), 3 · 37-3 · 43 (2Η, t), 5 · 12 (2Η, br s), 7 · 13 (1Η, dd, J = 8 2 and 2 · 0Ηζ), 7 · 28 (1Η, d, J: 1.9Hz), 7.40 (1H, d, Jt3Hz), 9.09 (1Η, s). &lt; Manufacturing Example 57; Production of N- (1-butanesulfonyl) _4-acetamidoamino_3- [4- (2-pyridinyl) benzylamino] benzobenzamine &gt; According to manufacture The method of Example 32, using N_ (1-τsulfofluorenyl) _3-amino-4-ethylaminobenzodonylamine (400 g) and 2-[(4-molyl) phenyl ] ° ratio σ 疋 (0.477g) to get N- (l-butytazine) -4-ethylamidoamino_3- [4 · (2_σbipyridine) benzylamino] Crude product. Use it directly in the response below. &lt; Example 284; Synthesis of 6- (1-butanesulfonylcarbamoamidinyl) benzyl] -2-methylbenzimidazole (346) &gt; According to the method of Example 183, the above-mentioned N- ( The crude product of l-butanesulfonyl) -4-acetamidinyl-3- [4 ((2-pyridyl) benzylamino] benzobenzylamine to directly obtain 6- (1-butanesulfonyl Carbamoylpyridine) benzyl] methylbenzimidazole (346) 0.330 g. [Physical properties of compound (346)] H-T is eliminated in the M part, and h_T is eliminated. NMR-DMSO-dG, δ): 0.82 (3H, t) 3 1.37-1.46 (2H, m) 5 1.54- 1.6K2H, m), 2 • 54 (3H, s), 3.10 (2Η, t, J = 7,8Hz), 5.57 (2Η, s), 7.19 (2H, d, J = 7.5Hz) , 7.3 3 (1H, t, J 邛 · 2Ηζ), 7.49 (1Η, d3 J J2 · 4Ηζ), 7.82-7.87 (2H, m), 7.90 (1H, d, J = 8 · 0Ηζ), 8.0 Bu 8.04 (3Η, m), 8.63 (1Η, d, J = 4.2Hz). IR (Nujol): 1722cm-10 mp: 292.4-298.4 ° C. ___________ Zή2_ This paper is suitable for Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 Λ7 B7 V. Description of the invention (25 $ &lt; Example 285; 5-Chlorosulfonyl · W24 — one f ^ ^ ϋ ^ (347) ^ 6. ^ § §i ^ group) Synthesis of 2-methylbenzimidazole (348) &gt;-Milky hydrazone in ice solution, H2,4_dichlorobenzyl) _2_ A (4. 00 g) was added to Chlorine 0, and stirred at room temperature for two hours: stirring under thief for 5 hours. The reaction solution was added to ice water, and borrowed; the precipitated gelatinous Solid 'to give 5_chlorosulfofluorenyl] _', r- ^ r / radical ^ _2_f-based benzofluorene (347) and 6_chlorocontinuyl-1- (2,4-digas Benzyl)) 2-methylbenzo is called a mixture. It was directly used in the following reaction .: Example 286; 5-Aminosulfonyl_ (2,4_dioxobenzyl) ) _2_methylbenzimidazole (349) and 6-aminosulfonamido_ 丨 ((2,4_dichlorobenzyl) -2-methylbenzo). Synthesis of (35〇) & gt Treating 5-chlorosulfosulfanyl 1- (2, fluorenyldichlorobenzyl) · 2-fluorenyl with Example 25 using 25% aqueous ammonia (iomi) under hydration; A mixture of benzimidazole and 6-chlorosulfofluorenyl 'dichlorobenzyl) -2-methylbenzimidazole for 1 hour. The solid was filtered to obtain 5-aminosulfonyl-1_ (2, A 1/1 mixture of dichlorobenzyl) -2-methylbenzimidazole (349) and 6-aminosulfofluorenyl 1-methylammonium) -2-methylbenzo miso (350) ( 2.68 g;). [Physical properties of a mixture of compound (349) and compound (350)] NMR (CD3OD3 (5): 2.52 (3 / 2H, s), 2.54 (3 / 2H, s), 5.54 (2H, s), 6.55 (1Η, d3 J = 6.9Hz), 7.17 (1Η, d, J: 8.GHz), 7.52 (1Η, s), 7.65-7 · 78 (2Η , M), 7.82 (1 / 2Η3 s), 8.11 (1 / 2Hj s) 0-24J- This paper size applies to China National Standard (CNS) A4 (210X 297 mm 548272 kl B7) V. Description of the invention ( 26ί) (Please read the precautions on the back before filling out this page) &lt; Example 287; 6- (n-Amylaminosulfonyldichlorobenzyl) -2-methylbenzimidazole (351) and 5_ (n-fluorenylaminosulfofluorenyl) _ 1- (2,4- &gt; synthetic fluorenyl) -2-methylbenzo miso (352) Synthesis &gt; Digas methylbenzene (lml ), Triethylamine (0.56ml), n-youji Chlorine (0.326§) is added to the above 5-aminosulfonyl-1- (2,4-dichlorobenzyl) _2_ hydrazone (349) and 6-aminophenoxy-1- (2 In a mixture (500 g) of 1,4-dioxobenzyl) -2-methylbenzimidazole (350), the mixture was stirred at room temperature for 48 hours. Water was added to stop the reaction. Trichloromethane was added for extraction. The organic layer was dried, concentrated, and purified by silica gel column chromatography (eluent: chloroform / methanol = 95/5) to obtain 6_ (n-pyridylaminostilbenzyl) -1- (2, A mixture of 4-dichlorobenzyl) -2-methylbenzimidazole and 5- (n-fluorenylaminosulfonyl'dichlorobenzyl) _2 • methylbenzimidazole (0.360 g). Then, it is purified by medium pressure silica gel column chromatography (eluent ·· hexane / ethyl ester = 1/1 ~ 1/4) to obtain 6_ (n-fluorenylaminosulfonyl) -1-( 2,4-dichlorobenzyl) _2_fluorenylbenzimidazole (351) (0.95§) and 5- (n-benzylaminomethyl) _1_ (2,4_dichlorobenzyl)- 2-methylbenzimidazole (352) (0.45 g). [Physical properties of compound (351)] ^ -NMRiDMSO-de, ¢): 0.74 (3H, t, J = 7.3Hz), 1.09 (ZH5 m) 3 1.31 (2H5 m), 2. 10 (ZH, t, J-7.3Hz), 2.53 (3H, s) 3 5.63 (2H, s), 6.60 (1H3 d, J = 8 4Hz) 3 7 32 (1H, d, J = 8.3Hz), 7.67- 7.77 (3Η, m), 7.93 (1Η, s). IR (KBr): 1726cm-l0mp: 207,5-210.0oC〇Mass (FD): m / e 454 (M + l) 〇_264 This paper size applies to China National Standard (CNS) A4 specification (21 OX 297 mm) 548272 A7 B7___ V. Description of the invention (26! [Physical properties of compound (352)] (You may read the precautions on the back before filling in this page) lH-NMR (DMS0-d65 δ): 0.75 (3H3 t, J = 7.3Hz), 1.11 (2H, m) 3 1.34 (2H, m) 3 2. 13 (2H, t3 J = 7.4Hz), 2.51 (3H3 s), 5.59 (2Η, s) 3 6 · 57 (1Η, d, J 2: 8.5Ηζ), 7.32 (1H, dd, J 2.2 and 8.4Ηζ), 7.57 (1Η, d, J 2: 8.6Ηζ), 7.67 (1Η, dd , J = 1.6 and 8. · 6Ηζ), 7.73 (1Η, d, J = 2 · 1Ηζ), 8.08 (1Η, d, J · 2 · 6Ηζ). IR (KBr): 17060111 ^ mp: 213.0 —216.0 ° C. &Lt; Example 288; Synthesis of 2,4-difluorenyl-6-fluorenyloxybenzimidazole &gt; According to the method described in Journal of Medicinal Chemistry 1993, 36, 4040-4051, use 4-Amino-3-methylbenzoic acid methyl ester to give 4-acetamido-5-amino-3-methylbenzoic acid methyl ester. Then heated under reflux in acetic acid for 2 hours to give 2, 4-dimethyl-6-methoxycarbonyl Benzo at 17 m 11. [Physical properties of compounds] lH-NMR (CDCl3, δ): 2.55 (3H, s), 2.62 (3H3 s) 3 3.91 (3H5 s), 7.74 (1H5 s) 3 8 · 07 ( 1Η, s), 10.65 (1H, br s). &Lt; Example 289; 1- (2,4-dioxobenzyl) -2,4-dimethyl-6-methoxycarbonylbenzimidazole ( Synthesis of 353) &gt; Stir 2,4-dimethyl-6-oxobenzoylbenzoxazone (0.900g), 2,4-dioxobenzyl gas (1.20g), iodine at 80 ° C A mixture of sodium chloride (0.200g), potassium carbonate (0.610g), and N, N-dimethylamidamine (4ml) for 16 hours. After removing the organic solvent under reduced pressure, ethyl acetate and water were added for extraction. Concentrate the organic layer, add hexane to crystallize it. Filter out the crystals, ___165___ This paper is suitable for Jfl Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (26h after drying to obtain 1.08 g of (2,4_dichlorobenzyl) · 2,4_dimethyl-6_methoxycarbonylbenzimidazole (353). [Physical properties of compound (353)] (Read the precautions on the back before filling this page) 'H-KMR (CDCl3, d): 2.58 (3H, s), 2.71 (3H, s), 3.90 (3H, s ) j 5.39 (2H, s) 6.30UH, d, ㈣, he), 7.07 (1H, pyr J = 8 4 and 20 Hz), 7 49 (ih, d, ruler such as Z), 7.75 (1H, s ), 7.81 (1H, S). &lt; Bex Example 29〇; 6-Ikisyl-l- (2,4-dioxobenzyl) · 2,4-dimethyl-6-methoxycarbonylbenzimidazole (354) Synthesis> Basis The method of Example 53 uses di (2,4-dichlorobenzyl) -2,4-dimethyl-6-methoxycarbonylbenzimidazole (0501 g) to obtain 6-carboxyl-1 -(2,4 · Dichlorobenzyl) _2,4-difluorenyl-6-fluorenyloxycarbonylbenzimidazole (354) 0.435 g 〇 [Physical properties of compound (354)] fNMiUDMSO-d6, d) ·· 2.51 (3Η, s), 2.55 (3Η, s), 5.57 (2Η, s), 6.49 (1Η, d, J = 8.4Hz), 7.31 (1Η3 dd3 J: 8.4 And 2 · 2Ηζ), 7.62 (1Η, s), 7.72 (1Η, d, J = 2.0Hz), 7.78 (1Η, s), 12.64 (1H3 br s). &lt; Example 291; Synthesis of 6- (1-butanesulfonylaminofluorenyl) _1- (2,4_dichlorobenzyl) _2,4_difluorenylbenzimidal (355) &gt; According to the method of Example 98, using 6-carboxy-: u (2,4-dichlorobenzyl) -2,4-dimethyl-6-methoxycarbonylbenzimidazole (0435g), N, N, _ carbonyldiimidazole (0.290g), 1-butanesulfonamide (0246g), diazabicycloundecene (0.273g) to give the heart (1 · butanesulfonylcarbamoamidinyl dichloride Benzyl) -2,4-difluorenylbenzimidazole (355) 04688. [Physical properties of compound (355)] ------— 266___ This paper size applies to Chinese National Standard (CNS) A4 specification (210X297). 548272 A7 ________________ B7 V. Description of the invention (26) Please fill in this page again for attention) Η-NMR (DMSQ-d6, ά): G.84 (3H, t, J = 7.4Hz), L38 (2H, m), 1.64 (2Η, m), 2 · 49 (3H, s), 2.56 (3Η3 s), 3.48 (2Η, t), 5.55 (2H, s), 6.40 (1Η, d, J = 8.5Hz), 7.31 (1Η3 dd3 J = 2.1 and 8 · 4Ηζ), 7.64 (1Η, s), 7.75 (1Η, d, J: 2.1Hz) 3 7 · 90 (1H3 s), 11 · 79 (1Η, br s) IR (Nujol): 16820111 ^ 0 mp: 180.0-181.5 ° C. &Lt; Production Example 58; Production of 4-phenoxybenzyl alcohol &gt; Sodium borohydride (0.48 g) was added to 4-benzyloxy In a solution of benzoxaldehyde (4 96 g) in ethanol (20 ml), stir at room temperature for 15 hours. After concentration, '3 butyl methyl ether and water are added for extraction. The organic layer is concentrated to give 4-phenoxy Benzyl alcohol (4.84 g). [Physical properties of the compound] W-fiMIUCDCh, 6): 4 ·· 67 (2Η, d, J = 5, 7Hz), 6.99_7 · 01 (4Η, m), 7 · 1 〇 (1Η, t5 J 2 7.4Ηζ ), 7.32-7.35 (4Η, melon). &lt; Production Example 59; Production of 4 · phenoxybenzyl chloride &gt; Thionyl chloride (13.34 g) was added to 4-phenoxybenzyl alcohol (4 06 g), and the mixture was stirred at 80 C for 3.5 hours. . After concentration, ethyl acetate and water were added for extraction. The organic layer was concentrated to give 4-phenoxybenzyl chloride (4.31 g). [Physical properties of the compound] T-boat (CDC13, 6): 4. · 58 (2Η, s), 6.96-7 · 03 (4Η,…, 7_u-77 1H, porphyrin 7 32-7 · 37 ( 4Η, m) &lt; Example 292; Synthesis of 6-ethoxycarbonyl-2-methyl-1- (4-phenoxybenzyl) benzimidazole (356) &gt; According to the method of Example 263, use 4-Ethylamido-3-aminoamino ----- 267___ This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (26) 乙酯 Ethyl benzoate (0.56g), sodium carbonate (0.33g), sodium iodide (0.12g), 4-phenoxybenzyl gas (0.66g) to give 4-acetamido-3 _ [(4-benzene Oxygen) benzylamino] ethyl benzoate (0.49g). Then convert it to 6-ethoxyquinyl-2-methyl small (4-benzyloxybenzyl) benzimidazole (3 56) (0.44 §). [Physical properties of 4-ethylamidoamino-3-[(4-benzyloxy) benzylamino] ethyl benzoate] ^ -NMRiCDCla, δ): 1.37 (3H, t3 J = 7.1Hz), 2.04 (3H3 s), 4.18 (1H3 br s), 4.3.1-4 · 36 (4Η, m), 6.98-7.G2 (4H, m), 7.09-7.12 (lH, m), 7.27- 7.51 (8Η, m). [Physical properties of compound (356)] 屮 leg ⑽⑴, (Π ·· 1 · 40 (3Η, t3 J: 7.1Hz), U1 (3H, s), 4 · 39 (2Η, q, J 2 7.1 Hz ), 5.35 (2H, s), 6.92-6.95 (2Η, m), 6.97-7 · 〇〇 (2Η, m), 7.02 (2H, d, J = 8.7

Hz), 7.09-7.13(1H3 a), 7.31-7.34(2H, m)3 7.72(1H, d3 J-8.6Hz)5 7.98(1H3 dd, J=1.5 及 8·4Ηζ), 8·04(1Η, d, J二1.2Hz)。 &lt;實施例293;6-羧基-2-甲基-l-(4_苯氧苄基)苯並咪 唑(357)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基甲基_ 1-(4-苯氧)苄基笨並咪唑(〇44§)以得出6_羧基_2_曱基_1_ (4-笨氧苄基)苯並咪唑(357)0.37g。 [化合物(357)的物性] 'H-NMR(DMS0-d6) ,) ; 2.57(3H) s)&gt; 5.54(^ ^ ? ^ .13⑽,π),7,33_7.37⑽,7 6〇(iH,d,j=8 4Hz),'π⑽,^,㈣他) ,8·〇7(1Η,s),12·72(1Η,br s)。 &lt;貫施例294;6-(1-丁石黃醯基氨基曱醯基)_2_甲基-卜 (4-笨氧苄基)苯並咪唑(358)之合成&gt; 依據貫施例98的方法,使用6_羧基甲基_丨_(4_苯 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 548272 Α7 Β7 五、發明説明( 氧苄基)苯並咪唑(0.36g)、N,N,-羰基二咪唑(0.24g)、1-丁磺醯胺(〇.21g)、二氮二環十一烯(〇.23g)以得出6_(1_ 丁磺醯基氨基甲醯基)-2-甲基-1-(4-苯氧苄基)苯並咪唑 (358)0.19g。 [化合物(358)的物性] lH-NMR(DMS0-d63 δ) : 0.85(3H, t, J二7·4Ηζ), 1·40(2Η, m), 1·68(2Η, m), 2·54(3Η,s),3.52(2Η,t,J二7·8Ηζ), 5.51UH,s),6·96-6·98(4Η,m),7.11(1 Η, t, J二7·4Ηζ), 7.17(2Η, d, J二8·6Ηζ), 7·34-7·37(2Η, m), 7·64(1Η, d, J二8· 5Ηζ), 7·79(1Η, dd, J=1.5 及 8·5Ηζ), 8·24(1Η, s), 11·92(1Η, br s)。 m(Nujol) : 1632CDT1。 mp : 183.4 — 184.4°C。 &lt;實施例295;6-乙氧羰基-2-甲基-1-(2-吡啶甲基)苯 並咪唑(359)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙醋(0.600g)、碳酸妈(〇.45〇g)、硬化納(〇」22g) 及2-氯代曱基吡啶(0.413g)以得出6-乙氧羰基-2-甲基-1-(2-叶b唆甲基)苯並味唾(3 5 9)0.65 6g。將它直接用在下述 之反應中。 經浐部中决樣準而力工消贽合作私印^ (讀先閱讀背面之注意事項再填寫本頁) 〈實-施例296;6-羧基-2-甲基-1-(2-吡啶甲基)苯並咪 峻(360)之合成〉 依據貫施例53的方法,使用6-乙氧魏基_2_甲基_ 1-(2-α比啶甲基)苯並咪唑(〇 656g)以得出6_羧基_2_甲基_ 1-(2-°比咬甲基)苯並口米唾(360)0.532g。 [化合物(360)的物性] 本紙張尺度適Λ中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(2以 lH~NHR(DMS0-d6, δ) : 2.56(3H, s), 5.56(2H, s)3 7.22(1H, d, J=7.9Hz), 7. 28(1H, dd3 J=5.0 及 7.1Hz), 7·45(1Η3 d3 J:8.3Hz), 7·74-7·79(2Η, m), 7· 95(1H, s), 8·48(1Η, d, J=8.5Hz)· &lt;實施例297;1-(丁磺醯基氨基甲醯基)_2-甲基-1_(2- 吡啶甲基)苯並咪唑(361)之合成&gt; 依據實施例98之方法,使用6-羧基-2-甲基-1-(2-17比啶曱基)苯並咪唑(0.500g)、n,N,-羰基二味唑 (〇.394g)、1-丁磺醯胺(0.334g)、二氮二環十一烯(〇 37〇g) 以得出1 -(丁石黃醯基氨基甲酷基)-2-曱基-1 -(2-σ比咬甲基) 笨並咪唑(361)0.142g。 [化合物(361)的物性] lH-NMR(DMS0-d6, δ) : 0·83(3Η, t, J=7.3Hz), 1.28-L36(2H3 m)3 1.52-1.58( 2H, m), 2·55(3Η,s)3 3·06(2Η,t,&lt;Ι=7·9Ηζ)3 5·56(2Η,s),7.17(1H, d, J二7 •8Hz), 7.29(1H, dd, J=4.2 及 7·3Ηζ), 7·43(1Η, d5 J二8·4Ηζ), 7·77(1Η, dt ,J=1.8 及 7·7Ηζ), 7·81(1Η, dd3 J=1.4 及 8·4Ηζ), 7·96(1Η, s), 8.50(1 Η, d3 扣4.7Hz) m(Nujol) : 1674cm-1. πιρ ·· 139°C(分解)· 〈實.施例298;6-乙氧羰基-2-甲基-1-(4-硝基节基)笨 並咪唑(362)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(〇.67g)、碳酸鈣(〇.39g)、碘化鈉(〇.14g)及 4-硝基苄基溴(〇.78g)以得出6-乙氧羰基-2-甲基-:1-(4-硝 基苄基)苯並咪唑(362)0.5 lg。 ____ 3 钟---- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------f (讀先閱讀背面之注意事項再填寫本頁)Hz), 7.09-7.13 (1H3 a), 7.31-7.34 (2H, m) 3 7.72 (1H, d3 J-8.6Hz) 5 7.98 (1H3 dd, J = 1.5 and 8.4Ηζ), 8.04 (1Η , D, J 1.2Hz). &lt; Example 293; Synthesis of 6-carboxy-2-methyl-l- (4-phenoxybenzyl) benzimidazole (357) &gt; According to the method of Example 53, 6-ethoxycarbonylmethyl was used _ 1- (4-phenoxy) benzylbenzimidazole (〇44§) to give 6_carboxy_2_fluorenyl_1_ (4-benzyloxybenzyl) benzimidazole (357) 0.37 g. [Physical properties of compound (357)] 'H-NMR (DMS0-d6),); 2.57 (3H) s) &gt; 5.54 (^^? ^. 13⑽, π), 7,33_7.37⑽, 7 6〇 ( iH, d, j = 8 4 Hz), 'π⑽, ^, sunda), 8.07 (1Η, s), 12.72 (1Η, br s). &lt; Synthesis Example 294; Synthesis of 6- (1-butanxanthenylaminofluorenyl) _2_methyl-bu (4-benzyloxybenzyl) benzimidazole (358) &gt; Method, using 6_carboxymethyl_ 丨 _ (4_benzene paper size applicable to Chinese National Standard (CNS) A4 specification (210X 297 mm) 548272 A7 B7 5. Description of the invention (oxybenzyl) benzimidazole (0.36 g), N, N, -carbonyldiimidazole (0.24 g), 1-butanesulfonamide (0.21 g), diazabicycloundecene (0.23 g) to give 6- (1_ butanesulfonyl Carbamate) -2-methyl-1- (4-phenoxybenzyl) benzimidazole (358) 0.19 g. [Physical properties of compound (358)] 1H-NMR (DMS0-d63 δ): 0.85 ( 3H, t, J 2 7. 4Ηζ), 1.40 (2Η, m), 1.68 (2Η, m), 2.54 (3Η, s), 3.52 (2Η, t, J 2 7 · 87ζ) , 5.51UH, s), 6.96-6 · 98 (4Η, m), 7.11 (1Η, t, J 2 7.4Ηζ), 7.17 (2Η, d, J 2 8.6Ηζ), 7.34 -7 · 37 (2Η, m), 7.64 (1Η, d, J = 8.5Ηζ), 7.79 (1Η, dd, J = 1.5 and 8.5Ηζ), 8.24 (1Η, s) , 11 · 92 (1Η, br s). m (Nujol): 1632CDT1. mp: 183.4 — 184.4 ° C. &lt; Example 295; Synthesis of 6-ethoxycarbonyl-2-methyl-1- (2-pyridylmethyl) benzimidazole (359) &gt; According to the method of Example 263, 4-acetamidoamino group was used Ethyl-3-aminobenzoate (0.600 g), sodium carbonate (0.445 g), hardened sodium (22 g) and 2-chloropyridylpyridine (0.413 g) to give 6-ethoxy Carbonyl-2-methyl-1- (2-leaf b-methyl) benzo-flavin (3 5 9) 0.65 6 g. It was used directly in the reaction described below. The Ministry of Economic Affairs has worked hard to eliminate the cooperation private seal ^ (Read the precautions on the back before filling this page) 〈例-例 296; 6-carboxy-2-methyl-1- (2- Synthesis of pyridylmethyl) benzimidazole (360)> According to the method of Example 53, 6-ethoxyweilyl_2_methyl_1- (2-αbipyridylmethyl) benzimidazole ( 〇656g) to obtain 6_carboxy_2_methyl_1- (2- ° specific bite methyl) benzoacetone (360) 0.532g. [Physical properties of compound (360)] This paper is suitable for Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (2 to 1H ~ NHR (DMS0-d6, δ): 2.56 (3H , s), 5.56 (2H, s) 3 7.22 (1H, d, J = 7.9Hz), 7. 28 (1H, dd3 J = 5.0 and 7.1Hz), 7.45 (1Η3 d3 J: 8.3Hz), 7.74-7.79 (2Η, m), 7.95 (1H, s), 8.48 (1Η, d, J = 8.5Hz) &lt; Example 297; 1- (butylsulfonylamino) Synthesis of methylmethyl) -2-methyl-1_ (2-pyridylmethyl) benzimidazole (361) &gt; According to the method of Example 98, 6-carboxy-2-methyl-1- (2-17 Pyridinyl) benzimidazole (0.500 g), n, N, -carbonyldizolidazole (0.394 g), 1-butanesulfonamide (0.334 g), diazabicycloundecene (〇37. g) 0.142 g of 1- (butytazinemethylcarbamoyl) -2-amidino-1-(2-σ specific methyl) benzimidazole (361). [Physical properties of compound (361)] lH-NMR (DMS0-d6, δ): 0.83 (3Η, t, J = 7.3Hz), 1.28-L36 (2H3 m) 3 1.52-1.58 (2H, m), 2.55 (3Η, s) 3 3 · 06 (2Η, t, &lt; I = 7 · 9Ηζ) 3 5 · 56 (2Η, s), 7.17 (1H, d, J 2 7 • 8Hz), 7.29 (1H, dd, J = 4.2 and7 · 3Ηζ), 7 · 43 (1Η, d5 J, 2 · 4Ηζ), 7.77 (1Η, dt, J = 1.8 and 7.7Ηζ), 7.81 (1Η, dd3 J = 1.4, and 8.48ζ ), 7.96 (1Η, s), 8.50 (1Η, d3, 4.7Hz) m (Nujol): 1674cm-1. Πιρ ·· 139 ° C (decomposed) · <Solution. Example 298; 6-B Synthesis of oxycarbonyl-2-methyl-1- (4-nitrobenzyl) benzimidazole (362) &gt; According to the method of Example 263, 4-ethylamidoamino-3-aminobenzoic acid ethyl Ester (0.67 g), calcium carbonate (0.39 g), sodium iodide (0.14 g), and 4-nitrobenzyl bromide (0.78 g) to give 6-ethoxycarbonyl-2-methyl- : 1- (4-nitrobenzyl) benzimidazole (362) 0.5 lg. ____ 3 minutes ---- This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) ------ --- f (Read the precautions on the back before filling in this page)

、1T 548272 A7 --___________________________ B7_ 五、發明説明(26) [化合物(362)的物性]1T 548272 A7 --___________________________ B7_ V. Description of the invention (26) [Physical properties of compound (362)]

lH-NMR(CDCl33 δ) : L39(3H5 t, J=7.1Hz), 2.59(3H, s), 4.38(2H, q3 J=7.1H (誚先閱讀背面之注意事項再填寫本頁) z)3 5·49(2Η, s), 7.2G(2H3 d, J:8.6Hz), 7·76(1Η, d, J:8.5Hz), 7·94(1Η, d, JHHz),8·01(1Η,dd3 J:1.4 及 8.5Hz),8·20(2Η5 d5 J:8.6Hz)·)物性 3lH-NMR (CDCl33 δ): L39 (3H5 t, J = 7.1Hz), 2.59 (3H, s), 4.38 (2H, q3 J = 7.1H (诮 Please read the precautions on the back before filling this page) z) 3 5.49 (2Η, s), 7.2G (2H3 d, J: 8.6Hz), 7.76 (1Η, d, J: 8.5Hz), 7.94 (1Η, d, JHHz), 8.01 (1Η, dd3 J: 1.4 and 8.5Hz), 8.20 (2Η5 d5 J: 8.6Hz) ·) Physical properties 3

'H'NMRiCDCL·, δ) : 1.39(3H5 t, J-7.1Hz), 2.59(3H, s), 4-38(2H5 q, J=7.1H z), 5·49(2Η, s), 7·20(2Η, d, J二8·6Ηζ), 7·76(1Η, d3 J=8.5Hz), 7·94(1Η, d, J=l.lHz),8·01(1Η,dd,J:1.4 及 8·5Ηζ),8·20(2Η,d,J:8.6Hz)·)物性] lH-_(CDC13,(5) : 1·39(3Η3 t,J=7.1Hz),2.59(3H,s),4·38(2Η,q,J二7.1H z)3 5.49(2H3 s)3 7.20(2H, d, J=8.6Hz)3 7.76(1H, d3 J-8.5Hz), 7.94(1H3 d3 J=l.lHz), 8·01(1Η, dd, J:1.4 及 8.5Hz), 8.20(2H, d, J:8.6Hz)· &lt;實施例299;1-(4-胺基苄基)-6-乙氧羰基-2-甲基苯 並&quot;7米峻(363)之合成&gt; 將乙醇(6ml)、醋酸(〇.8ml)加入1-(4-硝基节基)_6_ 乙氧1^厌基-2-甲基本並味σ坐(〇.50g)、遷原鐵(〇.47g)中迴流 4 · 5小時。加入水、醋酸乙g旨以進行萃取。對有機層進 行水洗、乾燥後,在減壓下濃縮以得出1 -(4-胺基节基)_6-乙氧羰基-2-曱基苯並咪唑(363)0.46g。 經沪部中央榀羋而力工消费合作杉印^ [化合物(363)的物性] ΐ-醜(CDCL·,(5) : 1·40(3Η,t, J:7.2Hz),2·59(3Η,s), 4.38(2H,q3 J:7.2H z), 5·25(2Η, s), 6·61(2Η, d, J二8·6Ηζ), 6·87(2Η, d,扣8·6Ηζ), 7·71(ιη, d, J=8.3Hz),7.96(1Η3 dd5 J二1·5 及 8·他),8·05(1Η,d,J:i.3Hz). &lt;實施例300;l-[(4-苯醯胺)苄基]-6-乙氧幾基甲 基苯並咪唑(364)之合成&gt; -------2J4--_____ 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) ' 548272 A7 B7 五、發明説明(26g ' 一 (讀先閱讀背面之注意事項再填寫本頁) 將苯醯氯(〇.25g)之三氯甲烷(4ml)溶液加入1-(4-胺 基苄基)-6-乙氧羰基-2-甲基苯並咪唑(〇.45g)、a比啶(〇.15g) 之三氯甲烷(8ml)溶液中,在室溫下攪拌16小時。添加 水、三氯甲烷以進行萃取。在減壓下濃縮有機層,以得 出1-[(4-苯醯胺)苄基]-6-乙氧羰基-2-曱基苯並咪唑 (364)0.33g 〇 [化合物(364)的物性] ^NMRiCDCL·, δ) : L40(3H, t, J-7.1Hz)3 2.59(3H, s), 4.38(2H3 q3 J-7.1H z), 5.37(2H, s), 7.06(2H3 d3 J=8.5Hz), 7.46-7.50(2H, m), 7.53-7.57(1H, m ),7·61(2Η,d,J=8.5Hz),7·72(1Η,d,J:8]Hz),7·84-7·86(2Η,m),7.89(1 H,br s),7·98(1Η,dd,J=1.5 及 8·5Ηζ),8.03(1H,s)· &lt;實施例301; l-[(4·苯醯胺)苄基]-6-羧基-2-甲基苯 並咪唑(365)之合成&gt; 依據實施例53的方法,使用1-[(4-苯醯胺)苄基]-6-乙氧羰基-2-甲基苯並咪唑(0.31 g)以得出1-[(4-苯醯胺) 卞基]-6-魏基-2-甲基苯並味唾(365)0.28g。 [化合物(365)的物性] Ή-NMR(DMS0-d6,6) : 2·58(3Η,s),5·52(2Η, s)3 7·12(2Η,d,J:8,5Hz),7· 48-7·52(2Η,m),7·54-7·58(1Η,m),7·61(1Η,d,J=8·他),7.73UH,d,J二8. 6Hz), 7·79(1Η3 dd,J=1.5 &amp;8·4Ηζ)57·90-7·92(2Η,ιη),8·07(1Η,(13ΐΜ· 2Hz;, 10·26(1Η, s), 12·73(1Η3 br s)· &lt;實施例302;l-[(4-苯醯胺基)苄基]-6-(1-丁磺醯基 氨基曱醯基)-2-甲基苯並咪唑(366)之合成&gt; 依據實施例98之方法,使用1-[(4-笨醯胺)苄基]-6- ----------Ύ1Ύ___________ 本紙張尺度適用中國國家標準(CNS〉A4規格(210X297公釐) A7 548272 B7 五、發明説明(26$ 魏基-2-甲基本並味嗤(0.26g)、N,N’_罗炭基二味唾(〇」7g)、 (讀先閱讀背面之注意事項再填寫本頁) 卜丁磺醯胺(0.14g)、二氮二環十一烯(0.16g)以得出卜[(4-苯醯胺基)苄基]-6-(1-丁磺醯基氨基甲醯基)-2-甲基苯並 口米唆(366)0· 14g。 [化合物(366)的物性] Ή-NMR(DMS0-d6,d) : 〇·85(3Η, t,J二7·4Ηζ),1·40(2Η5 m), 1·68(2Η, in),2 ·56(3Η3 s)3 3·52(2Η, t3 J:7.8Hz)3 5·50(2Η, s), 7·15(2Η, d, J:8.6Hz), 7·5'H'NMRiCDCL ·, δ): 1.39 (3H5 t, J-7.1Hz), 2.59 (3H, s), 4-38 (2H5 q, J = 7.1H z), 5.49 (2Η, s), 7 · 20 (2Η, d, J = 8 · 6Ηζ), 7.76 (1Η, d3 J = 8.5Hz), 7.94 (1Η, d, J = l.lHz), 8.01 (1Η, dd , J: 1.4 and 8. · 5Ηζ), 8.20 (2Η, d, J: 8.6Hz) ·) Physical properties] lH -_ (CDC13, (5): 1.39 (3Η3 t, J = 7.1Hz), 2.59 (3H, s), 4.38 (2Η, q, J = 7.1H z) 3 5.49 (2H3 s) 3 7.20 (2H, d, J = 8.6Hz) 3 7.76 (1H, d3 J-8.5Hz) , 7.94 (1H3 d3 J = 1.1 Hz), 8.01 (1Η, dd, J: 1.4 and 8.5Hz), 8.20 (2H, d, J: 8.6Hz) &lt; Example 299; 1- (4 -Aminobenzyl) -6-ethoxycarbonyl-2-methylbenzo &quot; Synthesis of 7-million (363) &gt; ethanol (6ml) and acetic acid (0.8ml) were added to 1- (4-nitro Base group) _6_ ethoxy 1 ^ analyl-2-methylbenzyl sigma (0.50 g), reflow iron (0.57 g), reflux for 4.5 hours. Add water, ethyl acetate for the purpose Extraction. The organic layer was washed with water, dried, and concentrated under reduced pressure to obtain 0.46 g of 1- (4-aminobenzyl) -6-ethoxycarbonyl-2-fluorenylbenzimidazole (363). Central Ministry of Foreign Affairs and Consumer Cooperation Sugiyin ^ [Physical properties of compound (363)] ΐ-ugly (CDCL ·, (5): 1.40 (3Η, t, J: 7.2Hz), 2.59 (3Η, s), 4.38 (2H, q3 J: 7.2 H z), 5.25 (2Η, s), 6.61 (2Η, d, J 2 8.6Ηζ), 6.87 (2Η, d, buckle 8.6Ηζ), 7.71 (ιη, d, J = 8.3Hz), 7.96 (1Η3 dd5 J 2 1.5 and 8 · He), 8.05 (1Η, d, J: i. 3Hz). &Lt; Example 300; l-[(4-Benzene Amine) benzyl] Synthesis of 6-ethoxyquinylmethyl benzimidazole (364) &gt; ------- 2J4 --_____ The paper size is in accordance with China National Standard (CNS) A4 size (210X297 (Mm) 548272 A7 B7 V. Description of the invention (26g) (Read the precautions on the reverse side and fill in this page) Add a solution of phenylhydrazine (0.25g) in chloroform (4ml) to 1- (4 -Aminobenzyl) -6-ethoxycarbonyl-2-methylbenzimidazole (0.45 g) and a pyridine (0.155 g) in a solution of trichloromethane (8 ml), and stirred at room temperature for 16 hour. Water and chloroform were added for extraction. The organic layer was concentrated under reduced pressure to give 1-[(4-benzylamine) benzyl] -6-ethoxycarbonyl-2-fluorenylbenzimidazole (364) 0.33 g of [Compound (364) Physical properties) ^ NMRiCDCL ·, δ): L40 (3H, t, J-7.1Hz) 3 2.59 (3H, s), 4.38 (2H3 q3 J-7.1H z), 5.37 (2H, s), 7.06 (2H3 d3 J = 8.5Hz), 7.46-7.50 (2H, m), 7.53-7.57 (1H, m), 7.61 (2Η, d, J = 8.5Hz), 7.72 (1Η, d, J: 8) Hz), 7.84-7 · 86 (2Η, m), 7.89 (1 H, br s), 7.98 (1Η, dd, J = 1.5 and 8. · 5 · ζ), 8.03 (1H, s) · & lt Example 301; Synthesis of l-[(4 · Benzamidine) benzyl] -6-carboxy-2-methylbenzimidazole (365) &gt; According to the method of Example 53, 1-[(4 -Benzylamine) benzyl] -6-ethoxycarbonyl-2-methylbenzimidazole (0.31 g) to give 1-[(4-benzylamine) fluorenyl] -6-weiyl-2- 0.28 g of methyl benzo saliva (365). [Physical properties of compound (365)] Ή-NMR (DMS0-d6,6): 2.58 (3Η, s), 5.52 (2Η, s) 3 7 · 12 (2Η, d, J: 8,5Hz ), 7.48-7.52 (2Η, m), 7.54-7 · 58 (1Η, m), 7.61 (1Η, d, J = 8 · he), 7.73UH, d, J 8. 6Hz), 7.79 (1Η3 dd, J = 1.5 & 8.4Ηζ) 57 · 90-7 · 92 (2Η, ιη), 8.07 (1Η, (13ΐM · 2Hz ;, 10 · 26 ( 1Η, s), 12 · 73 (1Η3 br s) · &lt; Example 302; l-[(4-phenylamidino) benzyl] -6- (1-butanesulfonylaminofluorenyl)- Synthesis of 2-methylbenzimidazole (366) &gt; According to the method of Example 98, using 1-[(4-benzylamine) benzyl] -6- ---------- Ύ1Ύ ___________ Paper size applies to Chinese national standard (CNS> A4 specification (210X297 mm) A7 548272 B7 V. Description of the invention (26 $ Weiji-2-methyl Benzo miso (0.26g), N, N'_ 罗 炭 基 二Taste saliva (〇 ”7g), (Read the precautions on the back before filling in this page) Pubusulfonamide (0.14g), diazabicycloundecene (0.16g) to get the [[4- Phenylamino) benzyl] -6- (1-butanesulfonylcarbamoyl) -2-methylbenzopyrene (366) 0.14 g. [Compound (366) Properties] Ή-NMR (DMS0-d6, d): 0.85 (3Η, t, J 二 7.4Ηζ), 1.40 (2Η5 m), 1.68 (2Η, in), 2.56 (3Η3 s) 3 3 · 52 (2Η, t3 J: 7.8Hz) 3 5 · 50 (2Η, s), 7 · 15 (2Η, d, J: 8.6Hz), 7 · 5

0(2H3 t3 J-7.5Hz), 7.55-7,59(1H3 m), 7.64(1H, d3 J=8,5Hz)3 7.74(2H3 d3 J 二8·6Ηζ)3 7·79(1Η, dd, J:1.6 及 8.5Hz), 7.90-7·92(2Η, m), 8·24(1Η, d, J 二1·3Ηζ), 10·27(1Η, s), 11.92(1H3 br s)· IR(Nujol) : 1693cm-1. mp : 267.5-268.1°C. 〈貫施例203;6-乙氧戴基-2-甲基- l- [4-(2 -苯乙稀基) 苄基]苯並咪唑(367)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(〇.405g)、碳酸鈣(0.253g)、碘化鈉(〇.〇82g) 及4-氯代曱基芪(0.500g)以得出6-乙氧羰基-2-甲基-1-[4-(2-苯乙烯基)苄基]笨並咪唑(367)0.32〇g。 [化合物(367)的物性] ^NMRiCDCL·, δ) : 1.40(3H3 t, J=7.2HJz), 2.6(3H, s), 4.38(2H, q, J=7.1H z), ό·38(2Η, s), 7·(Π-7·09(4Η3 m), 7.26(1H, t, J二7·4Ηζ), 7·35(2Η, t, J二7 •5Hz), 7.45(2H, d, J=8.2Hz), 7·49(2Η, d3 J二7·5Ηζ), 7·73(1Η, d, J=8.5Hz)3 7·99(1Η, dd, J=1.5 及 8·4Ηζ), 8·30(1Η, d, J=1.2Hz)· &lt;實施例304;6-乙氧羰基-2-曱基-l-[4-(2-苯乙基) _____273___ 本紙張尺度通J1]中國國家標準(CNS ) A4規格(21 OX 297公釐) 548272 經沪部中央i?:^-^h.T-消贽合作妇印¾ A7 五、發明説明(27j ~- 苄基]笨並咪唑(368)之合成〉 在氮%境氣體下將5%鈀_碳加入6_乙氧羰基甲 基1-[4-(2_苯乙烯基)苄基]苯並咪唑(〇 32〇g)之乙醇 (l〇ml)洛液中,在氫環境氣體下攪拌23小時。過濾出固 2,濃縮濾液以得出6-乙氧羰基-2-甲基苯乙基) 苄基]笨並咪唑(368)。將它直接用在下述的反應中。 &lt;貝施例305;6-敌基曱基_1-[4-(2_笨乙基)苄基] 笨並咪唾(369)之合成〉 依據實施例53之方法,使用6_乙氧羰基_2_甲基_ 1·[4-(2-苯乙基)苄基]苯並咪唑(〇 283g)以得出6_羧基-2_ 曱基-1-[4-(2_苯乙基)苄基]苯並咪唾(369)〇 242g。 [化合物(369)的物性] HNMR(DMS0 d6,(5) : 2·56(3Η,s),2·82(4Η,s),5·51(2Η3 s),7·02(2Η,d, J 8·1Ηζ), 7.1卜7·27(7Η, m)3 7·61(1Η, d, J=8.4Hz), 7·78(1Η, dd, J=1.5 及 8·〇4(1Η, s), 12·72(1Η, s). 〈實施例306;6-(l-丁磺醯基氨基甲醯基)-2-甲基-[4-(2_苯乙基)苄基]苯並咪唑(37〇)之合成&gt; 依據實施例98之方法,使用6-羧基-2-曱基-l-[4-(2-笨乙基 &gt; 苄基]苯並咪唑(〇.225g)、N,N,·幾基二味唑 (1.214g)、1-丁磺醯胺(〇el67g)、二氮二環十一烯(〇 185g) 以得出6-(1-丁磺醯基氨基甲醯基)_2_甲基-[4-(2-苯乙基) 苄基]笨並咪唑(370)0.249g。 [化合物(370)的物性] II-NMR(DMS0-d6,&lt;5) ·· 0·86(3Η, t,J=7.4Hz),1·35-1·42(2Η,m),1·63-1·71( 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) (讀先閱讀背面之注意事項再填寫本頁)0 (2H3 t3 J-7.5Hz), 7.55-7,59 (1H3 m), 7.64 (1H, d3 J = 8,5Hz) 3 7.74 (2H3 d3 J two 8.6Ηζ) 3 7.79 (1Η, dd , J: 1.6 and 8.5 Hz), 7.90-7 · 92 (2Η, m), 8 · 24 (1Η, d, J = 1.3Ηζ), 10 · 27 (1Η, s), 11.92 (1H3 br s) IR (Nujol): 1693cm-1. Mp: 267.5-268.1 ° C. <Cut Example 203; 6-ethoxydienyl-2-methyl-l- [4- (2-phenylethenyl) benzyl Synthesis of benzimidazole (367) &gt; According to the method of Example 263, 4-ethylamidoamino-3-aminobenzoic acid ethyl ester (0.405 g), calcium carbonate (0.253 g), and iodination were used. Sodium (0.082g) and 4-chlorofluorenylstilbene (0.500g) to give 6-ethoxycarbonyl-2-methyl-1- [4- (2-styryl) benzyl] benzyl Imidazole (367) 0.32 g. [Physical properties of compound (367)] NMRiCDCL ·, δ): 1.40 (3H3 t, J = 7.2HJz), 2.6 (3H, s), 4.38 (2H, q, J = 7.1H z), ό · 38 ( 2Η, s), 7 · (Π-7 · 09 (4Η3 m), 7.26 (1H, t, J 2 7.4Ηζ), 7.35 (2Η, t, J 2 7 • 5Hz), 7.45 (2H, d, J = 8.2Hz), 7 · 49 (2Η, d3 J = 7 · 5Ηζ), 7 · 73 (1Η, d, J = 8.5Hz) 3 7 · 99 (1Η, dd, J = 1.5 and 8 · 4Ηζ), 8 · 30 (1Η, d, J = 1.2Hz) &lt; Example 304; 6-ethoxycarbonyl-2-fluorenyl-l- [4- (2-phenethyl) _____273___ Paper size Tong J1] Chinese National Standard (CNS) A4 specification (21 OX 297 mm) 548272 Passed by the central ministry of Shanghai Ministry i?: ^-^ HT-elimination cooperation cooperation printed ¾ A7 5. Description of the invention (27j ~-benzyl) Synthesis of benzimidazole (368)> Add 5% palladium-carbon to 6-ethoxycarbonylmethyl 1- [4- (2-styryl) benzyl] benzimidazole (0,32) under nitrogen atmosphere. g) in ethanol (10 ml), and stirred under a hydrogen atmosphere for 23 hours. The solid 2 was filtered off, and the filtrate was concentrated to give 6-ethoxycarbonyl-2-methylphenethyl) benzyl] benzyl. Benzimidazole (368). It was used directly in the following reaction. &Lt; Besch Example 305; 6-Diene Synthesis of fluorenyl_1- [4- (2_benzylethyl) benzyl] benzimidazole (369)> According to the method of Example 53, 6_ethoxycarbonyl_2_methyl_1 · [ 4- (2-phenethyl) benzyl] benzimidazole (〇283g) to give 6-carboxy-2_fluorenyl-1- [4- (2-phenethyl) benzyl] benzimidazole ( 369) 0242 g. [Physical properties of compound (369)] HNMR (DMS0 d6, (5): 2.56 (3Η, s), 2.82 (4Η, s), 5.51 (2Η3 s), 7. · 02 (2Η, d, J 8 · 1Ηζ), 7.1, 7.27 (7Η, m) 3 7 · 61 (1Η, d, J = 8.4Hz), 7 · 78 (1Η, dd, J = 1.5 and 8 · 〇4 (1Η, s), 12.72 (1Η, s). <Example 306; 6- (l-butanesulfonylcarbamoamido) -2-methyl- [4- (2-benzene Ethyl) benzyl] Synthesis of benzimidazole (37〇) &gt; According to the method of Example 98, 6-carboxy-2-fluorenyl-l- [4- (2-benzylethyl) &gt; Benzimidazole (0.225 g), N, N ,. jidizodiazole (1.214 g), 1-butanesulfonamide (〇el67 g), diazabicycloundecene (〇185 g) to give 6 -(1-butanesulfonylcarbamoyl) -2-methyl- [4- (2-phenethyl) benzyl] benzimidazole (370) 0.249 g. [Physical properties of compound (370)] II-NMR (DMS0-d6, &lt; 5) ·· 86 · (3Η, t, J = 7.4Hz), 1.35-1 · 42 (2Η, m), 1 · 63-1 · 71 (The paper size is suitable / 1) Chinese National Standard (CNS) A4 size (210X297mm) (Read the precautions on the back before filling this page)

、1T 548272 A7 B7 五、發明説明(27i 2H, m)3 2.53(3H, s)3 2.83(4H3 s)3 3.52(2H, t3 J-7.7Hz), 5.49(2H, s), 7. 04(2H, d, J-8.0Hz), 7.12-7.25(7H3 m)3 7.64(1H3 d, J=8.4Hz), 7.79(1H3 dd, (讀先閱讀背面之注意事項再填寫本頁) J=1.7 及 8·5Ηζ), 8·22(1Η, d3 J:l.3Hz), 11·92(1Η, s)· IR(Nujol) : 1682cm-l. mp : 95.4—99.0°C. &lt;製造例6〇;4_苯醯苄基溴之製造&gt; 依據製造例48之方法,使用4_甲基苯醯苯 (3.92g)、N-溴代丙醯胺(4.28g)及2,2,-偶氮二異丁腈 (0.4〇g)以得出4-苯醯苄基溴(5.28g)。 [化合物的物性] ’H-NMIUCDCL·,ά) ·· 4·54(2Η,s),7·47-7·52(4Η,in),7·58_7·62(1Η,m)3 7.77 -7·82(4Η, m). &lt;實施例307;1_[(4-苯醯基)苄基]-6-乙氧羰基-2-甲 基苯並咪唑(371)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(0.56g)、碳酸鈉(〇.33g)、碘化鈉(O.llg)及 4_苯醯苄基溴(0.83g)以得出1-[(4-苯醯基)苄基]-6-乙氧 羰基-2-曱基苯並咪唑(371)(0.70g)。 [化合物C371)的物性] Ή-NMR(CDCl·,(5) : 1·40(3Η3 t,J=7.2Hz),2·61(3Η3 s),4·39(2Η3 q,J=7.2H ζ), 5·47(2Η, s), 7·14(2Η, d, J:8.2Hz), 7·45-7·48(2Η, m), 7.5fi-7.60(lh, m), 7.74-7·77(5Η, m), 7·99-8·02(2Η, m)· &lt;實施例308; l-[(4-苯醯)苄基]-6-羧基-2-甲基苯並 咪唑(372)之合成&gt; 275_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公董) 548272 經浐部中决榀^-^h_T消赀合作杉卬象 A7 B7 五、發明説明(27$ 依據實施例53之方法,使用^[(4—苯醯基)苄基卜 6-乙氧羰基-2-曱基笨並咪唑(〇.68g)以得出卜[(4-苯醯)苄 基]-6-羧基-2-曱基苯並咪唾(372)(0.55g)。 [化合物(372)的物性] Η-NMR(DMSGU) ·· 2·57(3Η,s),5·71(2Η,s),7·25(2Η,d,J:8.2Hz),7 •52(2H,t,J=7.7Hz)3 7·62-7·66(2Η,m)3 7·68-7·72(4Η,m),7·80(1Η,dd,J二 1·3 及 8·4Ηζ), 8·08(1Η,d,J:l]Hz),12,72(1H,br s)· &lt;實施例309;l-[(4-苯醯)苄基]-6-(1-丁磺醯基氨基 甲醯基)-2-甲基苯並咪唑(373)之合成&gt; 依據實施例98之方法,使用1-[(4_苯醯)苄基]_6_ 羧基·2-曱基苯並口米嗤(0.52g)、N,N’-魏基二咪ϋ坐(〇.34g)、 1-丁磺醯胺(〇.29g)、二氮二環十一烯(〇.32g)以得出i-[(4-苯醯)苄基]-6-(1-丁磺醯基氨基甲醯基)-2-甲基苯並咪唑 (373)0.13g。 [化合物(373)的物性] lH-NMR(DMS0-d6, δ) : 0.84(3H, t5 J-7.4Hz)3 1.38(2H, m)3 1.66(2H, m)3 2 •54(3H, s), 3·48(2Η, t, J二7.7Hz), 5.67(2H, s), 7·27(2Η, d, J二8.2Hz), 7.5 1-7·55(2Η,瓜),7·63-7·73(6Η3 m), 7·81(1Η3 dd, J二1.6 及 8·5Ηζ), 8·21(1Η ,d, J=1.4Hz)· IR(Nujol) : 1660cm-l. mp : 111.0-112.4°C.1T 548272 A7 B7 V. Description of the invention (27i 2H, m) 3 2.53 (3H, s) 3 2.83 (4H3 s) 3 3.52 (2H, t3 J-7.7Hz), 5.49 (2H, s), 7. 04 (2H, d, J-8.0Hz), 7.12-7.25 (7H3 m) 3 7.64 (1H3 d, J = 8.4Hz), 7.79 (1H3 dd, (Read the precautions on the back before filling this page) J = 1.7 and 8. · 5Ηζ), 8.22 (1Η, d3 J: 1.3 Hz), 11.92 (1Η, s) · IR (Nujol): 1682cm-l. Mp: 95.4-99.0 ° C. &Lt; Manufacturing Example 6; Production of 4-benzylbenzyl bromide &gt; According to the method of Production Example 48, 4-methylbenzylbenzene (3.92 g), N-bromopropylamidamine (4.28 g) and 2,2 were used. , -Azobisisobutyronitrile (0.40 g) to give 4-phenylhydrazone benzyl bromide (5.28 g). [Physical properties of compound] 'H-NMIUCDCL · , ά) ··· 54 (2Η, s), 7.47-7 · 52 (4Η, in), 7.58_7 · 62 (1Η, m) 3 7.77- 7.82 (4Η, m). &Lt; Example 307; Synthesis of 1 _ [(4-phenylfluorenyl) benzyl] -6-ethoxycarbonyl-2-methylbenzimidazole (371) &gt; The method of Example 263 uses ethyl 4-acetamido-3-aminobenzoate (0.56 g), sodium carbonate (0.33 g), sodium iodide (0.11 g), and 4-benzylbenzyl bromide. (0.83 g) to give 1-[(4-phenylfluorenyl) benzyl] -6-ethoxycarbonyl-2-fluorenylbenzimidazole (371) (0.70 g). [Physical properties of compound C371] Ή-NMR (CDCl ·, (5): 1.40 (3Η3 t, J = 7.2Hz), 2.61 (3Η3 s), 4.39 (2Η3 q, J = 7.2H ζ), 5.47 (2Η, s), 7.14 (2Η, d, J: 8.2Hz), 7.45-7 · 48 (2Η, m), 7.5fi-7.60 (lh, m), 7.74 -7 · 77 (5Η, m), 7.99-8 · 02 (2Η, m) · &lt; Example 308; l-[(4-phenylhydrazone) benzyl] -6-carboxy-2-methyl Synthesis of benzimidazole (372) &gt; 275_ This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 public directors) 548272 Ministry of Economic Affairs ^-^ h_T Elimination cooperation Sugihara A7 B7 V. Description of the invention (27 $ According to the method of Example 53, ^ [(4-phenylfluorenyl) benzyl 6-ethoxycarbonyl-2-fluorenylbenzimidazole (0.68 g) was used to obtain [[4 -Phenylhydrazone) benzyl] -6-carboxy-2-fluorenylbenzilide (372) (0.55g). [Physical properties of compound (372)] Η-NMR (DMSGU) ····· 57 (3Η, s), 5.71 (2Η, s), 7.25 (2Η, d, J: 8.2Hz), 7 • 52 (2H, t, J = 7.7Hz) 3 7 · 62-7 · 66 (2Η, m) 3 7 · 68-7 · 72 (4Η, m), 7 · 80 (1Η, dd, J 2 1.3 and 8.4Ηζ), 8 · 08 (1Η, d, J: l) Hz), 12,72 (1H, br s) &lt; Example 309; l- [ (4-Benzamidine) benzyl] -6- (1-butanesulfonylcarbamoyl) -2-methylbenzimidazole (373) &gt; According to the method of Example 98, 1- [ (4-Phenylhydrazine) benzyl] -6-carboxy · 2-fluorenylbenzofluorene (0.52g), N, N'-Weiyldiimidofluorene (0.34g), 1-butanesulfonamide ( 0.29 g), and diazabicycloundecene (0.32 g) to give i-[(4-phenylhydrazone) benzyl] -6- (1-butanesulfonylaminocarbamyl) -2- 0.13 g of methyl benzimidazole (373). [Physical properties of compound (373)] 1H-NMR (DMS0-d6, δ): 0.84 (3H, t5 J-7.4Hz) 3 1.38 (2H, m) 3 1.66 ( 2H, m) 3 2 • 54 (3H, s), 3.48 (2Η, t, J = 7.7Hz), 5.67 (2H, s), 7.27 (2Η, d, J = 8.2Hz), 7.5 1-7 · 55 (2Η, melon), 7.63-7 · 73 (6Η3 m), 7.81 (1Η3 dd, J 1.6 and 8.5Ηζ), 8 · 21 (1Η, d, J = 1.4 Hz) IR (Nujol): 1660cm-l.mp: 111.0-112.4 ° C.

Mass(FAB) : m/e 490(M+1). &lt;實施例310;6-羧基-2-曱基-[4-(2-笨乙烯基)节基] 苯並咪唑(374)之合成&gt; __________ 276 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) '' ' (請先閱讀背面之注意事項再填寫本頁)Mass (FAB): m / e 490 (M + 1). &Lt; Example 310; Synthesis> __________ 276 This paper size applies Chinese National Standard (CNS) A4 (210X 297 mm) '' '(Please read the precautions on the back before filling this page)

、1T 548272 A7 B7 五、發明説明( 依據實施例53之方法,使用6-乙氧羰基-2-甲基- 1- [4-(2-苯乙烯基)苄基]苯並咪唑(0.500g)以得出6_竣基_ 2- 曱基-[4-(2-苯乙烯基)苄基]苯並咪唑(374)0.237g。 [化合物(374)的物性] $-NM(DMS0-d6,6) : 2.59(3H,s),5·58(2Η,s)3 7,12(2H,d,J二8.2Hz)3 7. 21(2H,s)3 7·26(1Η,t,&gt;7·4Ηζ),7·36(2Η,t,J:7.6Hz),7·57(4Η3 d3 J二8.0 Hz), 7·62(1Η, d3 J=8.4Hz), 7.79(1H, dd3 J=1.5 及 8·4Ηζ), 8·07(1Η, d, J =1·2Ηζ), 12·73(1Η, s). &lt;實施例311;6-(1-丁磺醯基氨基甲醯基)-2-甲基-[4_(2_苯乙烯基)苄基]苯並咪唑(375)之合成&gt; 依據實施例98之方法,使用6-羧基-2-甲基-[4-(2-苯乙烯基)苄基]苯並咪唑(〇.237g)、N,N’-羰基二咪唑 (0.209g)、1-丁磺醯胺(〇.176g)、二氮二環十一烯(〇.i95g) 以得出6-(1-丁磺醯基氨基甲醯基)-2-甲基-[4-(2-苯乙烯 基)苄基]苯並咪唑(375)0.239g。 [化合物(375)的物性] 經來-部中夾樣枣杓公Η消贽合作·#印繁 (請先閱讀背面之注意事項再填寫本頁) Ή-NMR(DMS0-d6, 6) : 〇·86(3Η, t, J=7.4Hz), 1·35-1·43(2Η, m), 1·63-1·70( 2Η, m)3 2·56(3Η, s), 3·52(2Η, t3 J=7.6Hz), 5.55(2Η, s), 7·15(2Η, d3 J二8 •2Hz), 7·22(2Η, s)3 7·26(1Η, t, J=7.4Hz), 7·36(2Η, t, J=7.6Hz)3 7·57(1Η, d, J二7·3Ηζ), 7·58(1Η, d, J:8.2Hz), 7·66(1Η, d, J:8.5Hz), 7·80(1Η, d, J二 8·4Ηζ), 8·24(1Η, s), 11·93(1Η3 brs). IR(Nujol) : 1680cm-l. mp : 140.3—143.4°C. &lt;實施例312;l-(二苯並呋喃-2-甲基)-6-乙氧羰基- ;_____777 _______ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 經部中央榀率而只工消费合作私印製 五、發明説明(274 2-甲基苯並咪唑(376)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(〇.480g)、碳酸鈉(〇.274g)、蛾化納(〇.〇97g) 及2-溴代甲基二苯並呋喃(〇.56g)以得出l-(二苯並α夫喃-2 -曱基)-6-乙氧戴基-2-曱基苯並口米唾(376)0.47g。 [化合物(376)的物性] ^NMRiCDCL·, δ) : 1.38(3H, t, J=7.1Hz), 2.62(3H, s)5 4.36(2H, q5 J=7.1H z), 5·54(2Η, s), 7.19(1H, dd, J=1.6 及 8·5Ηζ), 7·32(1Η, t, J=7.6Hz), 7 •43-7·59(4Η, m)3 7·76(1Η, d, J=8.4Hz), 7·85(1Η, d, J=7.1Hz), 8·00(1Η, dd ,J=1.3 及 8·4Ηζ), 8·07(1Η, d, J=1.2Hz). &lt;實施例313;6-羧基_l-(二苯並呋喃_2_曱基)-2-甲基 苯並咪唑(377)之合成&gt; 依據實施例53之方法,使用6_乙氧羰基_2_甲基苯 並咪唑(0.46g)以得出6-羧基-1-(二苯並吹喃—2-曱基)-2-曱基苯並咪唑(377)0.336g。 [化合物(377)的物性] MMIUDMSO-d6,6) : 2·63(3Η,s),5·71(2Η,s),7·27(1Η,d,J=8·5Ηζ),7· 36(1H, t5 J=7.5Hz), 7.50(1H, t), 7,61-7.68(3H, m)3 7.78(1H3 d, J=8-3Hz), 7-97(lH, s)^7.07-8-11(2H, m). &lt;實施例314;l-(二苯並。夫喃_2-甲基)-6-(1-丁石黃醯基 氨基曱醯基)-2-甲基苯並咪唑(378)之合成&gt; 依據實施例98之方法,使用6-羧基-1_(二苯並呋喃 -2-甲基)-2-甲基苯並咪唑(0.255g)、N,N,-羰基二咪唑 (0.197g)、卜 丁磺醯胺(〇.167g)、二氮二環十一烯(〇i85g)1T 548272 A7 B7 V. Description of the invention (according to the method of Example 53, 6-ethoxycarbonyl-2-methyl-1-[4- (2-styryl) benzyl] benzimidazole (0.500g ) To obtain 0.237 g of 6-endyl_ 2-fluorenyl- [4- (2-styryl) benzyl] benzimidazole (374). [Physical properties of compound (374)] $ -NM (DMS0- d6,6): 2.59 (3H, s), 5.58 (2Η, s) 3 7,12 (2H, d, J = 8.2Hz) 3 7. 21 (2H, s) 3 7 · 26 (1Η, t, &gt; 7.4Ηζ), 7.36 (2Η, t, J: 7.6Hz), 7.57 (4Η3 d3 J 2 8.0 Hz), 7.62 (1Η, d3 J = 8.4Hz), 7.79 ( 1H, dd3 J = 1.5 and 8 · 4Ηζ), 8 · 07 (1Η, d, J = 1 · 2Ηζ), 12 · 73 (1Η, s). &Lt; Example 311; 6- (1-butylsulfonium Synthesis of aminocarbamoyl) -2-methyl- [4- (2-styryl) benzyl] benzimidazole (375) &gt; According to the method of Example 98, 6-carboxy-2-methyl was used -[4- (2-styryl) benzyl] benzimidazole (0.237 g), N, N'-carbonyldiimidazole (0.209 g), 1-butanesulfonamide (0.176 g), diazonium Bicycloundecene (0.15 g) to give 6- (1-butanesulfonylcarbamoyl) -2-methyl- [4- (2-styryl) benzyl] benzimidazole ( 375) 0. 239g. [Physical properties of compound (375)] Jinglai-Jiangzhong sample-like jujube 杓 Η Η 贽 · # 印 繁 (Please read the precautions on the back before filling this page) Ή-NMR (DMS0-d6, 6 ): 〇 · 86 (3Η, t, J = 7.4Hz), 1.35-1 · 43 (2Η, m), 1.63-1 · 70 (2Η, m) 3 2 · 56 (3Η, s) , 3.52 (2Η, t3 J = 7.6Hz), 5.55 (2Η, s), 7.15 (2Η, d3 J 2 8 • 2Hz), 7.22 (2Η, s) 3 7 · 26 (1Η, t, J = 7.4Hz), 7 · 36 (2Η, t, J = 7.6Hz) 3 7 · 57 (1Η, d, J = 7 · 3Ηζ), 7 · 58 (1Η, d, J: 8.2Hz) , 7.66 (1Η, d, J: 8.5Hz), 7.80 (1Η, d, J 2 8.4Ηζ), 8.24 (1Η, s), 11 · 93 (1Η3 brs). IR (Nujol ): 1680cm-l. Mp: 140.3-143.4 ° C. &Lt; Example 312; l- (dibenzofuran-2-methyl) -6-ethoxycarbonyl-; _____777 _______ This paper size applies to Chinese national standards (CNS) A4 specification (210X297 mm) 548272 A7 B7 Printed by the Ministry of Economics and Trade and co-operation private printing V. Description of the invention (274 Synthesis of 2-methylbenzimidazole (376) &gt; According to Example 263 Method, using ethyl 4-acetamido-3-aminobenzoate (0.480 g), Sodium carbonate (0.274 g), moth sodium (0.097 g) and 2-bromomethyldibenzofuran (0.56 g) to give l- (dibenzoαfuran-2-yl) ) -6-Ethoxydiyl-2-fluorenylbenzoacetone (376) 0.47g. [Physical properties of compound (376)] NMRiCDCL ·, δ): 1.38 (3H, t, J = 7.1Hz), 2.62 (3H, s) 5 4.36 (2H, q5 J = 7.1H z), 5.54 ( 2Η, s), 7.19 (1H, dd, J = 1.6 and 8.5Ηζ), 7.32 (1Η, t, J = 7.6Hz), 7 • 43-7 · 59 (4Η, m) 3 7 · 76 (1Η, d, J = 8.4Hz), 7.85 (1Η, d, J = 7.1Hz), 8.00 (1Η, dd, J = 1.3 and 8.4Ηζ), 8.07 (1Η, d, J = 1.2Hz). &Lt; Example 313; Synthesis of 6-carboxyl- (dibenzofuran_2_fluorenyl) -2-methylbenzimidazole (377) &gt; Method according to Example 53 , 6-ethoxycarbonyl-2-methylbenzimidazole (0.46g) was used to obtain 6-carboxy-1- (dibenzopyran-2-fluorenyl) -2-fluorenylbenzimidazole (377 ) 0.336g. [Physical properties of compound (377)] MMIUDMSO-d6,6): 2.63 (3Η, s), 5.71 (2Η, s), 7.27 (1Η, d, J = 8 · 5Ηζ), 7. · 36 (1H, t5 J = 7.5Hz), 7.50 (1H, t), 7,61-7.68 (3H, m) 3 7.78 (1H3 d, J = 8-3Hz), 7-97 (lH, s) ^ 7.07-8-11 (2H, m). &Lt; Example 314; l- (dibenzo.furan_2-methyl) -6- (1-butyxanthenylaminofluorenyl) -2-methyl Of Benzobenzimidazole (378) &gt; According to the method of Example 98, 6-carboxy-1_ (dibenzofuran-2-methyl) -2-methylbenzimidazole (0.255 g), N, N, -carbonyldiimidazole (0.197g), busulfenylamine (0.167g), diazabicycloundecene (〇i85g)

2JLS 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) (讀先閱讀背面之注意事項再填寫本頁) 訂 548272 A7 B7 五、發明説明(27¾ 以得出1-(二苯並呋喃-2-甲基)-6-(1-丁磺醯基氨基甲醯 基)-2-甲基苯並咪唑(378)0.249g。 [化合物(378)的物性]2JLS The size of this paper applies Chinese National Standard (CNS) A4 (210x297 mm) (Read the precautions on the back before filling this page) Order 548272 A7 B7 V. Description of the invention (27¾ to get 1- (dibenzo Furan-2-methyl) -6- (1-butanesulfonylcarbamoyl) -2-methylbenzimidazole (378) 0.249 g. [Physical properties of compound (378)]

Ή-NMR(DMS0-d6, tf) : 0·81(3Η, t, J:7.4Hz), 1·36(2Η, m), 1·65(2Η, m), 2. 60(3H, s), 3·50(2Η, t, J:7.7HZ), 5·69(2Η, s), 7.29(1H, dd, J:1.96 及 8 •7Hz), 7·34-7·38(1Η, m), 7·48-7·52(1Η, m), 7·63-7·68(3Η, m), 7·81(1Η3 dd ,J=1.7 及 8·5Ηζ), 8·00(1Η, d, 8·94(1Η, d, J:7.1Hz), 8.28(1H ,d3 J=1.4Hz), 12.70(1H, br s). IR(Nujol) : 1682cm~l. mp : 224.1-229.8°C. &lt;製造例61 ;N-1-丁磺醯基-3-乙醯胺基-4-硝基苯並 醯胺之製造&gt; 依據製造例28之方法,使用3_乙醯胺基-4-硝基安 息香酸(5.15g)、N,N’-羰基二咪唑(5.59g)、1-丁磺醯胺 (4.73g)、二氮二環十一烯(5.25g)以得出n_1-丁磺醯基-3-乙醯胺基-4-硝基苯並醯胺(6.30g)。 [化合物的物性] 經济部中夾榀^-而只工消费合作拉印繁 (請先閱讀背面之注意事項再填寫本頁) lH-NMR(DMS0-d6, 6) : 0.87(3H, t, J=7.4Hz), 1.40(2H, m), L68(2H, m)3 Z. 07(3H, s), 3·51(2Η, t), 7.83(1H, dd, J=1.8 及 8·5Ηζ), 8·03(1Η, d, J=8· 5Hz), 8.07(1H, d, J=L8Hz), 10,43(1H, s), 12,64(1H, br s). &lt;製造例62;N-1-丁磺醯基-3-胺基-4-硝基苯並醯胺 之製造&gt; 在室溫下攪拌N-1-丁磺醯基-3-乙醯胺基_4_硝基苯 並醯胺(6.30g)、10%氫氧化納水溶液、乙醇(3〇〇mi)及水 _ 279 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五 、發明説明(27i (請先閱讀背面之注意事項再填寫本頁) (200ml)的混合物4小時,接著在50°C攪拌3小時。經餾 除約1/2體積的溶媒後,使用1〇%鹽酸調整成pH2。收 集所析出之結晶’藉由減壓乾燥以得出N-1 - 丁績醯基-3-胺基-4-硝基苯並醯胺(5.22g)。 [化合物的物性] H-NMR(DMS0-d6, δ) : 0.87(3H5 t3 J=7.4Hz), L40(2H3 m)3 1.66(2H, m), 3. 49(2H,m),6.99(1H,dd3 J=1.8 及 9·0Ηζ)3 7·49(1Η,d,cM.8Hz), 7·55(2Η ,br s), 8·04(1Η3 d, J=9.0Hz),12·28(1Η,br s)· 〈製造例63;N-1-丁磺醯基-3-(2,4-二氯代苄基胺 基)-4-硝基苯並酸胺之製造&gt; 在60°C下攪拌N-1-丁磺醯基-3-胺基-4-硝基苯並醯 胺(1.10g)、碘化鈉(0.273g)、碳酸鈣(1.54g)及2,4-二氯代 苄基氯(2.l7g)之甲醇(l〇ml)溶液24小時。接著加入2,4-一^氣代卞基氣(2.00g) ’在60°C下加熱36小時。將醋酸 乙酯與飽和碳酸氫納水溶液加入反應液中,以在水層中 萃取出N-1-丁磺醯基-3-(2,4-二氯代苄基胺基)-4-硝基笨 並醯胺。藉由濃縮有機層以得出N-1-丁磺醯基-3-(2,‘ 二氣代苄基胺基硝基苯並醯胺(〇.885g)。 [化合物的物性] Ή-NMR(DMS0-d6, 6) : 0·81(3Η, t, J=7.3Hz)3 1·29(2Η, m), 1·49(2Η, m), 2 97(2H3 m),4·66(2Η,d, J=6.0Hz),7·22(1Η,d,J=8.9Hz),727(1H,s),7·31 (1H,d,J=8.4Hz),7.37(1H,d3 J=8.3Hz),7·65(1Η,s),8·04(1Η,d5 扣8·9ΗΖ ),8·57(1Η, t)· &lt;製造例64;N-1-丁磺醯基-4-胺基-3_(2,4-二氣代苄基 ________280 ___ — 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(27&gt; 胺基)苯並醯胺之製造&gt; 在室溫下將N-1-丁磺醯基-3-(2,4-二氣代苄基胺 基)-4-硝基苯並酸胺(0.505 g)加入亞硫酸氫鈉(1.32 g)、乙 醇(1 ml)、四氫吹喃(1 ml)及水(1 ml)之混合物中。加熱迴 流40分。減壓餾去溶媒,將水加入殘渣中,收集所析 出之固體,乾燥之。接著以甲醇(l〇ml)與水(3ml)之混合 溶液洗淨,藉由乾燥以得出N-1-丁磺醯基-4-胺基-3-(2,4-一氣代卞基胺基)苯並酿胺(0.220g)。 [化合物的物性] $-臟⑽S0-d6,6) : G.93(3H,t3 J=7.4Hz), 1·45(2Η,m),1·83(2Η,m),3· 57(2Η, m), 5·45(2Η, s), 6·36(1Η, d, J=8.2Hz), 7·11(1Η, d, J=8.3Hz), 7·51 (1H, s), 7·75(1Η, d)3 7·79(1Η, d), 7·88(1Η, s)· &lt;實施例315;6-(1-丁磺醯基氨基甲醯基)_1-(2,4-二 氣代苄基)_2-羥基苯並咪唑(379)之合成&gt; 在60°C下攪拌N-1-丁磺醯基-4-胺基-3-(2,4-二氣代 苄基胺基)苯並醯胺(〇.220g)、四甲氧基甲烷(〇·3ηι1)與醋 酸(2.0ml)的混合物4小時。減壓餾去醋酸,使用三氣曱 烧與水進行萃取。濃縮三氣甲烧層以得出殘潰,將曱醇 經濟部中央樣率杓只-T消贽合竹私印f (請先閱讀背面之注意事項再填寫本頁) (4.0ml)與36%鹽酸(4滴)力α入殘渣中,在6〇。〇下攪拌2 小時。使用飽和碳酸氫鈉水溶液進行中和,水洗、乾燥 所析出之結晶以得出6-(1-丁磺醯基氨基曱醯基 二氯代苄基)_2_羥基苯並咪唑(379)0.207g。 [化合物(379)的物性] •H-NMRiDMSO-dB, δ) : 0.83(3H, t, J=7.3Hz), L36(2H, m)3 1.61(2H, m), 3. —_ ..._______ 281 本紙張尺錢财關家標準(CNS ) A4規格(210X297,1“ ) _—'&quot; 一 ----- 548272 A7 B7 經濟部中央樣卑趵负Η消費合作社印衆 五、發明説明(27¾ 40(2H, m), 5·08(2Η, s), 6·94(1Η, d5 J=8.3Hz), 7·11(1Η, d, J:8·施),7,36 (1H, dd, J:2.0 及 8·他),7.58(1H, s)3 7·68-7·73(2Η, m), 11.47(1H, br s),11.77(lH,brs). IR(Nujol) : 1689cm-l. mp : 254-256°C.Ή-NMR (DMS0-d6, tf): 0.81 (3Η, t, J: 7.4Hz), 1.36 (2Η, m), 1.65 (2Η, m), 2.60 (3H, s ), 3.50 (2Η, t, J: 7.7HZ), 5.69 (2Η, s), 7.29 (1H, dd, J: 1.96 and 8 • 7Hz), 7.34-7 · 38 (1Η, m), 7.48-7.52 (1Η, m), 7.63-7 · 68 (3Η, m), 7.81 (1Η3 dd, J = 1.7 and 8.5Ηζ), 8.00 (1Η , D, 8.94 (1Η, d, J: 7.1Hz), 8.28 (1H, d3 J = 1.4Hz), 12.70 (1H, br s). IR (Nujol): 1682cm ~ l. Mp: 224.1-229.8 ° C. &Lt; Production Example 61; Production of N-1-butanesulfonyl-3-ethylamido-4-nitrobenzopyramine &gt; According to the method of Production Example 28, 3-acetamidine was used. 4-nitrobenzoic acid (5.15g), N, N'-carbonyldiimidazole (5.59g), 1-butanesulfonamide (4.73g), diazabicycloundecene (5.25g) to obtain N_1-Butylsulfonyl-3-acetamido-4-nitrobenzopyrene (6.30g). [Physical Properties of Compounds] The Ministry of Economic Affairs is involved in 榀 ^-and only the consumer cooperation cooperates with India (please (Please read the precautions on the back before filling this page) lH-NMR (DMS0-d6, 6): 0.87 (3H, t, J = 7.4Hz), 1.40 (2H, m), L68 (2H, m) 3 Z. 07 (3H, s), 3.51 (2Η, t ), 7.83 (1H, dd, J = 1.8 and 8.5Ηζ), 8.03 (1Η, d, J = 8.5Hz), 8.07 (1H, d, J = L8Hz), 10,43 (1H, s ), 12,64 (1H, br s). &Lt; Production Example 62; Production of N-1-butanesulfonyl-3-amino-4-nitrobenzopyramine &gt; Stir N at room temperature -1-Butylsulfonyl-3-ethylamidoamino_4-nitrobenzofluorenamine (6.30g), 10% aqueous sodium hydroxide solution, ethanol (300mi), and water_ 279 Applicable to paper size Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (27i (please read the precautions on the back before filling this page) (200ml) mixture for 4 hours, then stir at 50 ° C for 3 hours After about 1/2 volume of the solvent was distilled off, it was adjusted to pH 2 using 10% hydrochloric acid. The precipitated crystals' were collected and dried under reduced pressure to obtain N-1-butanthino-3-amino-4-nitrobenzofluorenamine (5.22 g). [Physical properties of compound] H-NMR (DMS0-d6, δ): 0.87 (3H5 t3 J = 7.4Hz), L40 (2H3 m) 3 1.66 (2H, m), 3. 49 (2H, m), 6.99 ( 1H, dd3 J = 1.8 and 9 · 0Ηζ) 3 7 · 49 (1Η, d, cM.8Hz), 7.55 (2Η, br s), 8 · 04 (1Η3 d, J = 9.0Hz), 12 · 28 (1Η, br s) · <Production Example 63; Production of N-1-butanesulfonyl-3- (2,4-dichlorobenzylamino) -4-nitrobenzoate &gt; Stir N-1-butanesulfonyl-3-amino-4-nitrobenzofluorenamine (1.10g), sodium iodide (0.273g), calcium carbonate (1.54g), and 2, at 60 ° C. A solution of 4-dichlorobenzyl chloride (2.17 g) in methanol (10 ml) for 24 hours. Then, 2,4-a-gasofluorene-based gas (2.00 g) was added and heated at 60 ° C for 36 hours. Ethyl acetate and a saturated aqueous sodium bicarbonate solution were added to the reaction solution to extract N-1-butanesulfonyl-3- (2,4-dichlorobenzylamino) -4-nitrate in the aqueous layer. Benzyl benzamine. The organic layer was concentrated to obtain N-1-butanesulfonyl-3- (2, 'di-gaso benzylaminonitrobenzofluorenamine (0.885 g). [Physical properties of the compound] Ή-NMR (DMS0-d6, 6): 0 · 81 (3Η, t, J = 7.3Hz) 3 1 · 29 (2Η, m), 1 · 49 (2Η, m), 2 97 (2H3 m), 4.66 (2Η, d, J = 6.0Hz), 7.22 (1Η, d, J = 8.9Hz), 727 (1H, s), 7.31 (1H, d, J = 8.4Hz), 7.37 (1H, d3 J = 8.3Hz), 7.65 (1Η, s), 8.04 (1Η, d5, 8.9ΗZ), 8.57 (1Η, t), &lt; Production Example 64; N-1-butane Fluorenyl-4-amino-3_ (2,4-dioxobenzyl ________ 280 ___ — this paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (27 &gt; Production of Amine) Benzofluorenamine &gt; N-1-butanesulfonyl-3- (2,4-dioxobenzylamino) -4-nitrobenzoic acid amine ( 0.505 g) was added to a mixture of sodium bisulfite (1.32 g), ethanol (1 ml), tetrahydropyran (1 ml) and water (1 ml). Heated to reflux for 40 minutes. The solvent was distilled off under reduced pressure, and the water Add to the residue, collect the precipitated solid, and dry it. Then add methanol (10 ml) and water (3 ml) The mixed solution was washed, and dried to obtain N-1-butanesulfonyl-4-amino-3- (2,4-monogasofluorenylamino) benzamine (0.220 g). [ Physical properties of the compound] $ -⑽⑽S0-d6,6): G.93 (3H, t3 J = 7.4Hz), 1.45 (2Η, m), 1.83 (2Η, m), 3.57 (2Η , M), 5.45 (2Η, s), 6.36 (1Η, d, J = 8.2Hz), 7.11 (1Η, d, J = 8.3Hz), 7.51 (1H, s), 7 · 75 (1Η, d) 3 7 · 79 (1Η, d), 7 · 88 (1Η, s) · &lt; Example 315; 6- (1-Butanesulfonylcarbamoamido) _1- ( Synthesis of 2,4-dioxobenzyl) _2-hydroxybenzimidazole (379) &gt; stirred at 60 ° C for N-1-butanesulfonyl-4-amino-3- (2,4- A mixture of digas-benzylamino) benzofluorenamine (0.2220 g), tetramethoxymethane (0.31m) and acetic acid (2.0 ml) for 4 hours. The acetic acid was distilled off under reduced pressure, and tri-gas sintering was used. Extract with water. Concentrate the three-layer gas-fired layer to obtain the residue. Remove the sample from the central sample of the Ministry of Economic Affairs -T to eliminate the bamboo private seal f (Please read the precautions on the back before filling this page) ( 4.0ml) and 36% hydrochloric acid (4 drops) force α into the residue at 60. Stir for 2 hours. Neutralize with a saturated aqueous sodium bicarbonate solution, wash with water, and dry the precipitated crystals to obtain 6- (1-butanesulfonylaminofluorenyldichlorobenzyl) _2_hydroxybenzimidazole (379) 0.207g . [Physical properties of compound (379)] H-NMRiDMSO-dB, δ): 0.83 (3H, t, J = 7.3Hz), L36 (2H, m) 3 1.61 (2H, m), 3. —. .. ._______ 281 Paper Ruler (CNS) A4 Specification (210X297,1 ") _- '&quot; I ----- 548272 A7 B7 Central Ministry of Economic Affairs and Consumer Cooperatives, India. Description of the invention (27¾ 40 (2H, m), 5.08 (2Η, s), 6.94 (1Η, d5 J = 8.3Hz), 7 · 11 (1Η, d, J: 8 · Shi), 7, 36 (1H, dd, J: 2.0 and 8. he), 7.58 (1H, s) 3 7.68-7.73 (2 (, m), 11.47 (1H, br s), 11.77 (lH, brs). IR (Nujol): 1689cm-l. Mp: 254-256 ° C.

Mass(FD) ·· m/e 455(M). &lt;實施例316;6-乙氧羰基-2-甲基-1-(2-喳啉甲基)苯 並咪唑(380)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(2.22g)、碳酸鈉(1.27g)、碘化鈉(0.45g)及 2-溴代甲基喳啉(2.28g)以得出6-乙氧羰基-2-甲基-1-(2-喳啉甲基)苯並咪唑(380)0.87g。 [化合物(380)的物性] lH-NMR(DMS0-d6, δ) : 1.27(3H, t3 J=7.1Hz), 2.62(3H3 s), 4.26(2H, q? J-7 .1Hz), 5.85(2H, s), 7·35(1Η, d, J二8.5Hz), 7.58(1H, m)3 7.63(1H, d, J二8·4Mass (FD) ·· m / e 455 (M). &Lt; Example 316; Synthesis of 6-ethoxycarbonyl-2-methyl-1- (2-fluorinomethyl) benzimidazole (380) &gt; According to the method of Example 263, ethyl 4-acetamido-3-aminobenzoate was used (2.22 g), sodium carbonate (1.27 g), sodium iodide (0.45 g), and 2-bromomethyl Perylene (2.28 g) to give 0.87 g of 6-ethoxycarbonyl-2-methyl-1- (2-fluorinomethyl) benzimidazole (380). [Physical properties of compound (380)] lH-NMR (DMS0-d6, δ): 1.27 (3H, t3 J = 7.1Hz), 2.62 (3H3 s), 4.26 (2H, q? J-7 .1Hz), 5.85 (2H, s), 7.35 (1Η, d, J = 8.5Hz), 7.58 (1H, m) 3 7.63 (1H, d, J = 8.4)

Hz), 7·73(1Η, m), 7·78(1Η, dd, J=l,3 及 8·4Ηζ), 7·86(1Η, d, J二8·4Ηζ), 7·95(1Η, d, J:8.0Hz), 8·14(1Η, s), 8·36(1Η, d, J=8.5Hz). &lt;實施例317;6-羧基-2-甲基-(2-喳啉甲基)苯並咪唑 (381)之合成&gt; 依據實施例53之方法,使用6-乙氧羰基-2-甲基-1-(2-喳啉甲基)苯並咪唑(〇 85g)以得出6-羧基甲基_ (2_喳琳甲基)苯並咪唑(381)〇 46g。 [化合物(381)的物性] ,H-NMR(DMS0-d6J c^) : 2.62(3H, s), 5.83(2H, s), 7.35(1H, d3 J=8.5Hz), 7. —----—-— _ 7 只 7_______-一 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------Φ—, (謂先閱讀背面之注意事項再填寫本頁) 、1Τ -線一 548272 經浐部中夾«.^-^A工消費合作拉卬繁 A7 B7 五、發明説明(27合 57(1H, m), 7.60(1H, d, J=8.5Hz), 7.72(1H5 t, J=7.6Hz)3 7.77(1H, d3 J-8.4 Hz), 7·86(1Η, d, J二8·4Ηζ), 7·94(1Η, d, J二8.1Hz), 8·11(1Η, s), 8·35(1Η, d ,J=8.5Hz)· &lt;實施例318;6-(1-丁磺醯基氨基甲醯基)-2-甲基-i_ (2-喳啉甲基)苯並咪唑(382)之合成&gt; 依據實施例98之方法,使用6-羧基-2-甲基-(2-噎 啉甲基)苯並咪唑(〇.222g)、N,N’-羰基二咪唑(〇.i95g)、1-丁磺醯胺(〇.165g)、二氮二環十一烯(0.183g)以得出6_(1_ 丁磺醯基氨基甲醯基)-2-甲基-1-(2-喳啉甲基)苯並咪唑 (382)0.088g。 [化合物(382)的物性] Ή-ΝΜΕΧϋΜ30-(16,ά):0·82(3Η,ΐ,&lt;1:7·3Ηζ),1·36(2Η,ιη),1·64(2Η,ιη)32· 61(3H, s)3 3.48(2H, t, J=7.4Hz), 5.82(2H3s), 7.32(lH,d5 J-8.5Hz), 7.58( 1H,m),7·65(1Η,d,J=8.5Hz),7·73(1Η,t,J:7.6Hz), 7·78(1Η,m), 7.87( 1H,d,J=8.5Hz),7』5(lH,d,J=8,lHz),8·23(1Η,s),8·37(1Η,d,J=8.5Hz)5 11.86(lH5brs). IR(Nujol) : 1684cm-l. mp : 185.5-187.5°C. &lt;製造例65;4-胺基_3_(2,4-二氯代苄基胺基)安息香 酸乙酯之製造&gt; 依據製造例63之方法,使用3-(2,4-二氯代苄基胺 基)-4-硝基安息香酸乙酯(1.40g)及亞硫酸氫鈉(4.5〇g)以 得出4-胺基-3-(2,4-二氣代苄基胺基)安息香酸乙酯之粗 生成物。將它直接用在下述反應中。 __283 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -1口Hz), 7.73 (1Η, m), 7.78 (1Η, dd, J = 1, 3, and 8.4Ηζ), 7.86 (1Η, d, J = 8.4Ηζ), 7.95 ( 1Η, d, J: 8.0 Hz), 8.14 (1Η, s), 8.36 (1Η, d, J = 8.5Hz). &Lt; Example 317; 6-carboxy-2-methyl- (2 -Synthesis of fluorenylmethyl) benzimidazole (381) &gt; According to the method of Example 53, 6-ethoxycarbonyl-2-methyl-1- (2-fluorinolinemethyl) benzimidazole (. 85 g) to give 6-carboxymethyl- (2-amylmethyl) benzimidazole (381). [Physical properties of compound (381)], H-NMR (DMS0-d6J c ^): 2.62 (3H, s), 5.83 (2H, s), 7.35 (1H, d3 J = 8.5Hz), 7. --- ------ _ 7 7 _______- one paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) --------- Φ—, (Read the notes on the back before filling (This page), 1T-line one 548272 The middle of the warp «. ^-^ A Industrial and consumer cooperation cooperation A7 B7 V. Invention description (27 in 57 (1H, m), 7.60 (1H, d, J = 8.5Hz), 7.72 (1H5 t, J = 7.6Hz) 3 7.77 (1H, d3 J-8.4 Hz), 7.86 (1Η, d, J 2 8.4Ηζ), 7.94 (1Η, d, J 8.1Hz), 8.11 (1Η, s), 8.35 (1Η, d, J = 8.5Hz) &lt; Example 318; 6- (1-Butanesulfonylcarbamoamido) -2 -Methyl-i_ (2-pyridinomethyl) benzimidazole (382) Synthesis> According to the method of Example 98, 6-carboxy-2-methyl- (2-pyridinomethyl) benzo was used Imidazole (0.222 g), N, N'-carbonyldiimidazole (0.195 g), 1-butanesulfonamide (0.165 g), and diazabicycloundecene (0.183 g) to give 6_ (1_ 0.088 g of butanesulfonylcarbamoyl) -2-methyl-1- (2-fluorinomethyl) benzimidazole (382). Physical properties of matter (382)] Ή-ΝΜΕχϋΜ30- (16, ά): 0 · 82 (3Η, ΐ, &lt; 1: 7 · 3Ηζ), 1.36 (2Η, ιη), 1.64 (2Η, ιη) ) 32 · 61 (3H, s) 3 3.48 (2H, t, J = 7.4Hz), 5.82 (2H3s), 7.32 (lH, d5 J-8.5Hz), 7.58 (1H, m), 7.65 (1Η , D, J = 8.5Hz), 7.73 (1Η, t, J: 7.6Hz), 7.78 (1Η, m), 7.87 (1H, d, J = 8.5Hz), 7′5 (lH, d, J = 8, lHz), 8.23 (1Η, s), 8.37 (1Η, d, J = 8.5Hz) 5 11.86 (lH5brs). IR (Nujol): 1684cm-l. mp: 185.5- 187.5 ° C. &Lt; Production Example 65; Production of 4-amino_3_ (2,4-dichlorobenzylamino) benzoic acid ethyl ester &gt; According to the method of Production Example 63, 3- (2, 4-Dichlorobenzylamino) ethyl 4-nitrobenzoate (1.40 g) and sodium bisulfite (4.50 g) to give 4-amino-3- (2,4-digas A crude product of benzylamino) ethyl benzoate. It was used directly in the following reaction. __283 This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page) -1 mouth

I 548272 經Μ部中央樣導^负-T消費合作ii卬製 A7 B7 五、發明説明(28&amp; &lt;實施例319; 1-(2,4-二氯代苄基胺基)-2-羥基-6-乙 氧羰基苯並咪唑(3 83)之合成&gt; 依據實施例3 15之方法,使用製造例65所得出4-胺基-3-(2,4-二氣代苄基胺基)安息香酸乙酯及四曱氧基 甲烷(2.60g)以得出1-(2,4-二氯代苄基胺基)-2-羥基-6-乙 氧羰基苯並咪唑(3 83)0.40(^。 [化合物(383)的物性] Ή-ΝΜΕ(ϋΜ80-ά63 δ) : 1.27(3H, t, J=7.1Hz), 4.24(2H, q, J=7.1Hz), 5.12(2 H, s), 7·04(1Η, d, J二8·4Ηζ), 7.12(1H, d, J二8.2Hz), 7.37(1H, dd, J=2.1 及 8·4Ηζ), 7·51(1Η, s), 7.67_7·72(2Η, m), 11·37(1Η, br s) &lt;實施例320;6-乙氧羰基-2-甲基-1-[3-(4_溴代異喳 啉)甲基]苯並咪唑(384)之合成&gt; 依據實施例263之方法,使用4-乙醯胺基-3-胺基 安息香酸乙酯(0.87g)、碳酸鈉(〇.53g)、碘化鈉(0.18g)及 4-溴-3-溴代甲基異啥琳(〇 87g)以得出6-乙氧魏基-2-甲 基-1-[3-(4-溴代異咬琳)甲基]苯並咪峻(384)0.3(^。 [化合物(3 84)的物性] H-NMIUDMSO-dG,6) : 1.26(3H,t,J:7.GHz),2·59(3Η,s),4·24(2Η,q3 J=7 •ΟΗζ), 5·93(2Η, s), 7·61(1Η, d, J=8.4Hz), 7.75-7.8G(2H, m)· 7·99(1Η, m), 8·03(1Η, s), 8·13(1Η, d, J:8.1Hz), 8·23(1Η, d, J二8·5Ηζ), 9·12(1Η, s). &lt;實施例321 ;6-羧基-2-甲基-[3-(4-溴代異喳啉)甲基] 苯並咪唑(385)之合成&gt; 依據實施例53之方法,使用6-乙氧幾基曱基_ 1-[3-(4-溴代異喳啉)曱基]苯並咪唑(〇 29〇g)以得出卜緩 本紙張尺度適用中關家標準(CNS ) A4· ( 210/297¾ ) ' -- — (請先閲讀背面之注意事項再填寫本頁)I 548272 A7 B7 produced by the central sample guide of negative M-T consumer cooperation ii. Description of the invention (28 &amp; &lt; Example 319; 1- (2,4-dichlorobenzylamino) -2- Synthesis of hydroxy-6-ethoxycarbonylbenzimidazole (3 83) &gt; According to the method of Example 3 15 and using the method of Example 65, 4-Amino-3- (2,4-dioxobenzylamine) was obtained. Base) ethyl benzoate and tetramethoxymethane (2.60 g) to give 1- (2,4-dichlorobenzylamino) -2-hydroxy-6-ethoxycarbonylbenzimidazole (3 83 ) 0.40 (^. [Physical properties of compound (383)] Ν-ΝΜΕ (ϋΜ80-ά63 δ): 1.27 (3H, t, J = 7.1Hz), 4.24 (2H, q, J = 7.1Hz), 5.12 (2 H, s), 7.04 (1Η, d, J 2 8.4Ηζ), 7.12 (1H, d, J 2 8.2Hz), 7.37 (1H, dd, J = 2.1 and 8.4Ηζ), 7.51 (1Η, s), 7.67_7 · 72 (2Η, m), 11 · 37 (1Η, br s) &lt; Example 320; 6-ethoxycarbonyl-2-methyl-1- [3- (4_ Synthesis of bromoisoxoline) methyl] benzimidazole (384) &gt; According to the method of Example 263, ethyl 4-acetamido-3-aminobenzoate (0.87 g), sodium carbonate ( 0.53g), sodium iodide (0.18g), and 4-bromo-3-bromomethylisokhalin ( 87g) to give 6-ethoxyweilyl-2-methyl-1- [3- (4-bromoisomaine) methyl] benzimidazole (384) 0.3 (^. [Compound (3 84 ) Physical properties] H-NMIUDMSO-dG, 6): 1.26 (3H, t, J: 7.GHz), 2.59 (3Η, s), 4.24 (2Η, q3 J = 7 • 0Ηζ), 5 · 93 (2Η, s), 7. · 61 (1, d, J = 8.4Hz), 7.75-7.8G (2H, m) ·· 99 (1Η, m), 8.03 (1Η, s), 8 · 13 (1Η, d, J: 8.1Hz), 8 · 23 (1Η, d, J = 8.5Ηζ), 9 · 12 (1Η, s). &Lt; Example 321; 6-carboxy-2- Synthesis of methyl- [3- (4-bromoisofluorinyl) methyl] benzimidazole (385) &gt; According to the method of Example 53, 6-ethoxyamidofluorenyl_ 1- [3- (4-Bromoisopyridinyl) fluorenyl] benzimidazole (〇29〇g) to obtain the paper standard This paper applies the China Standard (CNS) A4 · (210 / 297¾) '--(Please (Read the notes on the back before filling out this page)

、1T 548272 A7 B7 五、發明説明(28Ϊ 基-2-甲基-[3-(4-漠代異喧淋)甲基]苯並17米σ坐 (385)0.1 18g。將它直接用在下述之反應中。 (請先閱讀背面之注意事項再填寫本頁) &lt;實施例322;6-(1-丁磺醯基氨基曱醯基)-2-甲基-1-[3-(4-溴代異喳啉)甲基]苯並咪唑(386)之合成&gt; 依據實施例98之方法,使用6-羧基-2-甲基-[3_(4-溴代異喳琳)曱基]苯並咪唑(0.11 lg)、N,N,-羰基二咪唑 (〇.〇97g)、1-丁磺醯胺(〇.〇82g)、二氮二環十一烯(〇.〇91g) 以得出6-(1-丁磺醯基氨基甲醯基)-2-甲基-l-[3-(4-溴代 異嗅淋)曱基]苯並。米σ坐(3 86)0.075g。 [化合物(386)的物性] H-NMR(DMS0-d6,(5) : 0·81(3Η,t3 J:7.4Hz),1·35(2Η,m),1·62(2Η,in),2. 54(3Η, s), 3·46(2Η3 t, J:7.5Hz), 5·91(2Η, s), 7·63(1Η, d, J:8.5Hz), 7.76 (1H, dd3 J=8.5 及 1·4Ηζ), 7·79(1Η, t, J=7.6Hz), 8·00(1Η, t, J=7.9Hz), 8·〇8(1Η, t, J:l.lHz), 8·13(1Η, d, J:8.2Hz), 8·24(1Η, d, J:8.5Hz), 9.11(1 H,s), 11.8K1H, brs). IR(Nujol) : 1678cm-l. mp : 258-259°C., 1T 548272 A7 B7 V. Description of the invention (28 fluorenyl-2-methyl- [3- (4-mo-isoisocyanate) methyl] benzo 17 m σ (385) 0.1 18 g. Use it directly below (Please read the precautions on the back before filling out this page) &lt; Example 322; 6- (1-Butanesulfonylaminofluorenyl) -2-methyl-1- [3- ( Synthesis of 4-bromoisoxolinoline) methyl] benzimidazole (386) &gt; According to the method of Example 98, 6-carboxy-2-methyl- [3_ (4-bromoisoxorimidine) 曱 was used Yl] benzimidazole (0.11 lg), N, N, -carbonyldiimidazole (0.097 g), 1-butanesulfonamide (0.082 g), diazabicycloundecene (0.091 g ) To give 6- (1-butanesulfonylcarbamoyl) -2-methyl-l- [3- (4-bromoisosnophyl) fluorenyl] benzo. ) 0.075 g. [Physical properties of compound (386)] H-NMR (DMS0-d6, (5): 0.81 (3Η, t3 J: 7.4Hz), 1.35 (2Η, m), 1.62 ( 2Η, in), 2. 54 (3Η, s), 3.46 (2Η3 t, J: 7.5Hz), 5.91 (2Η, s), 7.63 (1Η, d, J: 8.5Hz), 7.76 (1H, dd3 J = 8.5 and 1.41ζ), 7.79 (1Η, t, J = 7.6Hz), 8.00 (1Η, t, J = 7.9Hz), 8.08 (1Η t, J: l.lHz), 8.13 (1Η, d, J: 8.2Hz), 8.24 (1Η, d, J: 8.5Hz), 9.11 (1 H, s), 11.8K1H, brs) IR (Nujol): 1678cm-l. Mp: 258-259 ° C.

Mass(FAB) : m/e 515, 517(M+1). 由本發明之化合物中選擇代表性的化合物以進行 藥理性質的試驗。 &lt;試驗例1;3T3-L細胞(前脂肪細胞)之三酸甘油酯 (TG)蓄積促進作用&gt; 試驗化合物 6_苯磺醯基氨基甲醯基_2_環丙基_丨_(2_氟代苄基)苯並咪 --____285 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28i 口坐 使用機器 (請先閱讀背面之注意事項再填寫本頁)Mass (FAB): m / e 515, 517 (M + 1). Representative compounds are selected from the compounds of the present invention for testing of pharmacological properties. &lt; Experimental Example 1; Accumulation of triglyceride (TG) accumulation in 3T3-L cells (pre-adipocytes) &gt; Test compound 6_benzenesulfonylcarbamoamidine_2_cyclopropyl_ 丨 _ ( 2_Fluorobenzyl) Benzimid --____ 285 This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 548272 A7 B7 V. Description of the invention (28i mouth sitting machine (please read the note on the back first) (Fill in this page again)

1·離心機:TOMY LC-122 2·保溫箱:ESPECBNA-121D 3·混合機:Automatic Labo-Mixer 4·熱水槽:TAITEC PERSONAL-11 5·分光光度計:島津製紫外線可視分光光度計 UV-160A1. Centrifuge: TOMY LC-122 2. Incubator: ESPECBNA-121D 3. Mixer: Automatic Labo-Mixer 4. Hot water tank: TAITEC PERSONAL-11 5. Spectrophotometer: Shimadzu UV visible spectrophotometer UV- 160A

6· 24 孔板:岩城製 GLASS CORNING 使用試藥 1·培養基:Dulbecco’s所需最少培養基(MEM)+5% 小牛胎兒血清(FCS) 2. PBS(-):具有下述組成之溶液6. · 24-well plate: GLASS CORNING made by Iwaki. Test medium: 1. Medium: Dulbecco's minimum medium (MEM) + 5% calf fetal serum (FCS) 2. PBS (-): a solution with the following composition

NaCl 0.8g/l KC1 0.2NaCl 0.8g / l KC1 0.2

Na2HP04 1.15 KH2P〇4 0.2 3. EDTA-胰蛋白酶溶液:0.02%EDTA+0.25%胰蛋白 酶/PBS(') 4·地塞米松(dexamethasone) ·· SIGMA 製 5·ΙΒΜΧ(3-異丁基-1-甲基黃嘌呤):SIGMA製 6·胰島素:SIGMA製 7. DMSO(二曱亞颯):和光純藥製 8. TG測定用套組 本紙張尺度適用中國國家標準(CNS ) μ規格(210X297公釐) 548272 A7 B7 五、發明説明(283 三酸甘油酯-測試套組(乙醯-丙酮法):和光純藥製 9· 0.1N NaOH溶液:使用蒸餾水將IN NaOH溶液 稀釋成體積10倍 10. Bio-Rad蛋白質定量分析試藥·· BIO-RAD製 11. 牛清蛋白:SIGMA製 試驗方法 3T3-L1細胞之調製 在F75燒瓶中準備快要到達濃密狀態之3T3-L1細 胞。除去培養基,以5mlPBS(-)洗淨2次,使用EDTA-胰蛋白酶溶液剝下細胞。加入10ml培養基以形成懸濁 液。將懸濁液置入50ml離心管中,在lOOOrpm下離心5 分,令細胞沉澱,除去上液。再將細胞懸濁於20ml的 培養基中,計算細胞數。調製成6 X 104細胞/ml,1 ml、 lml的注入24孔板中。在此狀態下,在保溫箱(37°C、 5%C02)中培養2天。 地塞米松及IBMX的調製及添加 經浐部中央榀率而只工消費合作私印繁 (請先閱讀背面之注意事項再填寫本頁) 使用 DMSO以調製出ImM地塞米松+500mM IBMX。接著,使用培養基將溶液稀釋1000倍,以調製 出ΙμΜ、地塞米松+0.5mM IBMX。同時使用培養基稀釋 DMSO,以調製出0.1%DMSO溶液。 接著,自保溫箱取出其中裝有所培養的3T3-L1細胞 之24孔板,使用檢查鏡確認出細胞已形成濃稠狀態,將 培養基吸除。接著,將〇.1%DMSO溶液放入24孔板的2 孔中,將1 μΜ地塞米松+0.5mM IBMX放入其他22孔中。 _2&amp;2_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28‘ 在此狀態下,在保溫箱(37°C、5%C02)中進行培養。 被驗藥劑及胰島素的調劑與添加 以DMSO將被驗藥劑稀釋成1 X 10·2、1 X 1(T3、1 X 1〇-4Μ,再將其稀釋500倍以調製成濃度2Χ10·5、2Χ 10_6、2Χ 1(Τ7Μ。同時調製出0.2%DMSO溶液。預先調 製出ΙΟΟμΜ胰島素(0.2%牛血清清蛋白(BSA)及3mMHCl 中),在80°C保存後再自然解凍,使用培養基稀釋成 50000倍,調製出濃度2nM之胰島素。 接著,從保溫箱中取出前一天添加了地塞米松與 IBMX之24孔,使用檢查鏡以確認出細胞已基於地塞米 松與IBMX之添加而產生形態變化後,將培養基吸除。 接著,將前一天加入了 0.1 %DMSO溶液的2孔中再加入 0.2%DMSO溶液500μ1(為了要確定當時細胞的狀態)。對 於其他22孔(加入有地塞米松與IBMX之孔),將 0.2%DMSO溶液加入其中2孔、被驗藥劑500μ1加入其 中20孔,然後再將500μ1胰島素溶液加入各22孔中。 在此狀態下,在保溫箱(37°C、5%C02)中培養4〜5天。 三酸甘油酯(TG)與蛋白質之測定 經浐部中央榀聲而只工消贽合作私印繁 (請先閱讀背面之注意事項再填寫本頁)Na2HP04 1.15 KH2P〇4 0.2 3. EDTA-trypsin solution: 0.02% EDTA + 0.25% trypsin / PBS (') 4. · dexamethasone ··· IGB by Sigma (3-isobutyl-1) -Methylxanthine): SIGMA 6. Insulin: SIGMA 7. DMSO (dioxin): Made by Wako Pure Chemicals 8. Kit for TG measurement This paper applies Chinese national standard (CNS) μ specifications (210X297) 548272 A7 B7 V. Description of the invention (283 triglyceride-test kit (acetamidine-acetone method): Wako Pure Chemicals 9. · 0.1N NaOH solution: Dilute IN NaOH solution to 10 times the volume with distilled water 10. Bio-Rad protein quantitative analysis reagents ·· BIO-RAD 11. Bovine albumin: SIGMA test method 3T3-L1 cell preparation Prepare 3T3-L1 cells in a F75 flask to reach a dense state. Remove the culture medium, Wash 2 times with 5ml PBS (-), peel off the cells with EDTA-trypsin solution. Add 10ml culture medium to form a suspension. Place the suspension in a 50ml centrifuge tube and centrifuge at 1000rpm for 5 minutes to allow the cells to pellet , Remove the supernatant. Then suspend the cells in 20ml of medium, calculate the fine It was prepared at 6 X 104 cells / ml, and 1 ml and 1 ml were injected into a 24-well plate. In this state, the cells were cultured in an incubator (37 ° C, 5% C02) for 2 days. Dexamethasone and IBMX Mix and add the central rate of the ministry and work only for private consumption (please read the precautions on the back before filling this page). Use DMSO to prepare ImM Dexamethasone + 500mM IBMX. Then, dilute the solution with the medium 1000 times to prepare 1 μM, dexamethasone + 0.5 mM IBMX. At the same time, DMSO was diluted with the medium to prepare a 0.1% DMSO solution. Then, a 24-well plate containing the cultured 3T3-L1 cells was removed from the incubator. After confirming that the cells have formed a thick state using an inspection microscope, the medium was aspirated. Then, 0.1% DMSO solution was put into 2 wells of a 24-well plate, and 1 μM dexamethasone + 0.5mM IBMX was put into other 22 holes. _2 &amp; 2_ This paper size applies to Chinese National Standard (CNS) A4 (210X297mm) 548272 A7 B7 V. Description of the invention (28 'In this state, in the insulation box (37 ° C, 5% C02 ). The test agent and insulin are adjusted and added with DMSO. Test agent diluted to 1 X 10 · 2,1 X 1 (T3,1 X 1〇-4Μ, then diluted 500-fold to prepare a concentration 2Χ10 · 5,2Χ 10_6,2Χ 1 (Τ7Μ. At the same time, a 0.2% DMSO solution was prepared. 100 μM insulin (0.2% bovine serum albumin (BSA) and 3 mM HCl) was prepared in advance, stored at 80 ° C, and then thawed naturally. The medium was diluted to 50000 times to prepare 2 nM insulin. Next, the 24 wells in which dexamethasone and IBMX were added the day before were taken out of the incubator, and using an inspection mirror to confirm that the cells had undergone morphological changes based on the addition of dexamethasone and IBMX, the medium was aspirated. Next, 500 μ1 of 0.2% DMSO solution was added to 2 wells in which 0.1% DMSO solution was added the previous day (to determine the state of the cell at that time). For the other 22 wells (wells with dexamethasone and IBMX), add 0.2% DMSO solution to 2 of them, 500 μ1 of the test agent to 20 of them, and then add 500 μ1 of insulin solution to each of the 22 wells. In this state, culture in an incubator (37 ° C, 5% C02) for 4 to 5 days. Determination of triglyceride (TG) and protein After the central part of the cymbal sounds, only eliminate the cooperation private printing (Please read the precautions on the back before filling in this page)

在添加被驗藥劑與胰島素溶液4〜5天後,從保溫箱 中取出24孔板,將板傾斜以到掉培養基後,使用衛生紙 吸去殘餘的培養基以完全去除培養基。之後,使用異丙 醇進行2次萃取,使用TG測定用套組(乙醯-丙酮法)進 行TG之測定(測定波長:410nm)。接著,經異丙醇萃取 完之板在完成除去異丙醇後,對於各板孔加入O.INNaOH _ikk_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28合 (讀先閱讀背面之注意事項再填寫本頁) 溶液400μ卜在室溫下放置3〇天以使得細胞溶解。然後, 取樣50μ1溶液至各試管中。接著,將2.5ml之被蒸餾水 稀釋成5倍的Bio-Rad蛋白質定量分析試藥加入各試管 中’充分地攪拌後,使用分光光度計測定蛋白質(測定波 長:595nm) 〇 結果 把對照化合物Pi〇glitazone(lXl〇-6M)的TG蓄積促 進作用當作100%,藥劑㈠時胰島素(+)當作〇%,以求出 試驗化合物的TG蓄積促進作用(%)。結果如以下之表1 所示。 ___^1_ 濃度(M) TG蓄積促進作用(%) _lxl0·5 _38.2%_ &lt;試驗例2;使用db/db老鼠的血糖降低作用&gt; 試驗化合物 6-苯續醯基氨基甲醯基-2-環丙基-1-(2 -氟代节基)苯並咪 唑(177) 6 -本石頁酿基氛基甲醜基-1 - (2 -乳代卞基)-2 -甲基苯並味°坐 (163) ‘ 1-(聯苯-4-甲基)-6-(1-丁績醯基氨基甲醯基)-2-曱基苯並 咪唑(172) 使用動物 購自 Jackson Laboratory 之 C57BL/KsJ-dbm db+/db+、C57BL/KsJ_dbm +m/+m 之 5 週大的雌鼠,經 2〜3 ____2&amp;9___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28g 週的馴化期後供作實驗。 i物調製 (請先閲讀背面之注意事項再填寫本頁} 使用研缽混合檢體與粉末餌(CE-2,曰本CREA)。 此合比係配合老鼠的攝食量,其比例在上〇〇mg/kg時為 〇·1°/〇、30mg/kg 時為 0.03%、i〇mg/kg 時為 〇 〇1%。每週 餵餌2次,記錄給餌量與殘餌量,而由其差值算出攝辑 量。試驗程序 基於體重、血糖值、血漿中三酸甘油酯濃度將雌性 db/db老鼠分群後,進行14天之藥物混餌的給餌(實驗期 間為8週大〜10週大)。在第7天與第14天的上午,使 用經施加肝素(heparin)處理之玻璃毛細管以對眼窩靜脈 叢進行採血,對所採的血進行離心分離以得出血漿。測 疋項目為苐0天與弟14天之血糖值、血聚中三酸甘油 酯濃度、血漿胰島素濃度,第_7天之血糖值、血漿中三 酸甘油酯濃度。又,測定第〇、7、14天之體重。當完 成最終採血後,使用C02氣體令其死亡。 使用10〜15μ1之血漿,並藉由葡萄糖氧化酵素法(葡 萄糖CL1·測試套組,和光純藥)以測定血糖值。使用 1〇〜15μ1之血漿,並藉由GPO-p-氣酚法(三酸甘油酯g_ 測试套組)或GPO-DAOS法(三酸甘油g旨E-測試套組)以 測定血漿中三酸甘油酯的濃度。上述之測定是在採血後 儘速進行之。使用20μ1的血漿(可保存於_2〇°C ),藉由抗 體法(Phadeseph RIA 套組、Kabi Pharmacia)以測定之。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28) 結果 (讀先閱讀背面之注意事項再填寫本頁) 把db/db老鼠的對照群與+/+老鼠的血糖值、血漿 中三酸甘油酯濃度差當作100%,以求出被驗投藥群的 血糖值、血漿中三酸甘油酯濃度的下降率(%)。結果顯 示於以下之表2中。 表2 投藥量(mg/kg) 血糖降低作用(%) 化合物(177) 30 34.5 化合物(163) 30 72 化合物(172) 10 70 〜80 本發明提供出一種新穎的苯並咪唑衍生物或可用 來當作醫藥之該苯並咪唑衍生物的鹽類。此等化合物與 其鹽類具有血糖降低活性或PDE5抑制作用,可用來當 作耐糖能失調、糖尿病(第II型糖尿病)、糖尿病合併症 (糖尿病性腎病、糖尿病性神經失調、糖尿病性網膜症 等)、胰島素抗性症候群(胰島素受體異常症、Robson-Mendenhall 症候群、Leprechaunism 、Kobberling-Dunnigan症候群、Seip症候群、Lawrence症候群、 Cushing ‘症候群、前端巨大症等)、高月旨血症、動脈粥樣 硬化症、心血管疾病(狹心症、心不全等)、高血糖症(例 如附加上攝食失調等異常糖代謝之特徵者)、或高血壓 症、或狹心症、高血壓、肺高血壓、充血性心不全、腎 小球疾病(例如糖尿病性腎小球硬化症等)、尿細管間質 性疾病(例如基於FK506、環孢子素等所引起的腎藏病)、 -—24M--— 本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐) 548272 A7 B7 五、發明説明(28^ 腎不全、動脈粥樣硬化、血管狹窄(_ 手術後者)、末精血管疾病、腦溢血、=皮性動脈形成 坡性可逆性閉宾卜 疾病(例如支氣管炎、氣喘(慢性氣喘、過敏性氣二塞= 敏性鼻炎、蓴麻疹、青光眼、特徵為腸運動性:常之二 病(例如過敏症腸症候群)、陽萎(例如器官性陽萎、精= 性陽萎等)、糖尿病合併症(例如糖尿病壞疽、糖尿病關 節症、糖尿病性腎小球硬化症、糖尿病性皮膚異常、糖 尿病性神經異常、糖尿病性白内障、糖尿病性網膜症 等)、腎炎、惡性癌、或PCTA後的再狹窄等的治療劑使 用之。 (請先閱讀背面之注意事項再填寫本頁)After adding the test agent and insulin solution for 4 to 5 days, remove the 24-well plate from the incubator, tilt the plate to remove the medium, and then remove the remaining medium with tissue paper to completely remove the medium. Then, extraction was performed twice with isopropyl alcohol, and TG measurement was performed using a TG measurement kit (acetamidine-acetone method) (measurement wavelength: 410 nm). Next, after the isopropanol-extracted plate is removed, isopropyl alcohol is added, and O.INNaOH _ikk_ is added to each plate hole. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Invention Instructions (28 go (read the precautions on the back and then fill out this page). Solution 400μb is left at room temperature for 30 days to lyse the cells. Then, 50μ1 solution is sampled into each test tube. Then, 2.5ml of quilt Bio-Rad protein quantitative analysis reagent diluted 5 times with distilled water was added to each test tube. After sufficient stirring, the protein was measured using a spectrophotometer (measurement wavelength: 595 nm). Result The control compound PiOglitazone (1 × 10-6M) The promotion effect of TG accumulation was taken as 100%, and the insulin (+) at the time of the drug was taken as 0% to obtain the promotion effect (%) of TG accumulation of the test compound. The results are shown in Table 1 below. ___ ^ 1_ Concentration ( M) TG accumulation promoting effect (%) _lxl0 · 5 _38.2% _ &lt; Experimental Example 2; Blood glucose lowering effect in db / db mice &gt; Test compound 6-Benzofluorenylcarbamoyl-2-cyclo Propyl-1- (2-fluorobenzyl) benzimidyl (177) 6-This stone sheet is based on methyl carbamoyl-1-(2-lactofluorenyl) -2 -methylbenzoxyl ° (163) '1- (biphenyl-4-methyl ) -6- (1-Butylfluorenylcarbamoyl) -2-fluorenylbenzimidazole (172) C57BL / KsJ-dbm db + / db +, C57BL / KsJ_dbm + m / + m Female rats at the age of 5 weeks, after 2 ~ 3 ____ 2 &amp; 9 ___ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 5. Description of the invention (28g weeks for domestication for experiment. I Material preparation (please read the precautions on the back before filling out this page) Use a mortar to mix the specimen and powder bait (CE-2, CREA). This ratio is based on the food intake of rats, and the ratio is above 〇〇 0.1 ° / 〇 at mg / kg, 0.03% at 30 mg / kg, and 0.001% at img / kg. Feed bait twice a week, record the amount of bait and the amount of residual bait. The difference was used to calculate the amount of recording. The test procedure was based on body weight, blood glucose, and triglyceride concentration in plasma. Female db / db mice were grouped and fed with a drug bait for 14 days (the experimental period was 8 weeks to 10 weeks old). ). Day 7 and day 14 in the morning, so that application of heparin (heparin) process of glass capillaries for blood collection orbital venous plexus through, the blood collected was centrifuged to obtain plasma. The measurement items were blood glucose levels, triglyceride concentration in plasma, plasma insulin concentration on day 0 and 14 days, blood glucose level on day -7, and triglyceride concentration in plasma. The body weight was measured on days 0, 7, and 14. When the final blood collection was completed, he was killed using CO2 gas. Using 10 to 15 μ1 of plasma, and measuring the blood glucose level by the glucose oxidase method (glucose CL1 · test kit, Wako Pure Chemical Industries, Ltd.). Use 10 ~ 15μ1 plasma and measure GPO-p-phenol method (triglyceride g_ test kit) or GPO-DAOS method (triglyceride g-E test kit) Triglyceride concentration. The above measurement was performed as soon as possible after blood collection. 20 μ1 of plasma (can be stored at -20 ° C) was used to measure it by the antibody method (Phadeseph RIA kit, Kabi Pharmacia). This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 548272 A7 B7 V. Description of the invention (28) Results (Read the precautions on the back before filling this page) Compare the control group of db / db mice with The difference between the blood glucose level of the mouse and the triglyceride concentration in the plasma was regarded as 100%, and the reduction rate (%) of the blood glucose level and the triglyceride concentration in the plasma of the test group were determined. The results are shown in Table 2 below. Table 2 Dosage (mg / kg) Blood glucose lowering effect (%) Compound (177) 30 34.5 Compound (163) 30 72 Compound (172) 10 70 ~ 80 The present invention provides a novel benzimidazole derivative or can be used for Used as salts of the benzimidazole derivative in medicine. These compounds and their salts have blood glucose-lowering activity or PDE5 inhibitory effects, and can be used as glucose tolerance disorders, diabetes (type II diabetes), diabetic comorbidities (diabetic nephropathy, diabetic neurological disorders, diabetic omentosis, etc.) , Insulin resistance syndrome (insulin receptor abnormality, Robson-Mendenhall syndrome, Leprechaunism, Kobberling-Dunnigan syndrome, Seip syndrome, Lawrence syndrome, Cushing 'syndrome, megacephaly, etc.), high-moment bloodemia, atherosclerosis Disease, cardiovascular disease (arrhythmia, insufficiency, etc.), hyperglycemia (such as those with abnormal glucose metabolism and other characteristics), or hypertension, or autism, hypertension, pulmonary hypertension, congestion Arrhythmias, glomerular diseases (such as diabetic glomerulosclerosis, etc.), urinary tubulointerstitial diseases (such as kidney disease caused by FK506, cyclosporine, etc.), --- 24M --- This paper Standards are in accordance with Chinese National Standard (CNS) A4 specifications (210X297 mm) 548272 A7 B7 V. Description of invention (28 ^ Renal insufficiency Atherosclerosis, vascular stenosis (_ the latter), terminal seminal vascular disease, cerebral hemorrhage, = sloping arterial slope reversible occlusive disease (e.g., bronchitis, asthma (chronic asthma, allergic gas embolism = sensitive Rhinitis, measles, glaucoma, characterized by intestinal motility: two common diseases (such as allergic bowel syndrome), impotence (such as organ impotence, sperm = sexual impotence, etc.), diabetic complications (such as diabetic gangrene) , Diabetic arthritis, diabetic glomerulosclerosis, diabetic skin abnormalities, diabetic neurological abnormalities, diabetic cataracts, diabetic omentosis, etc.), nephritis, malignant cancer, or restenosis after PCTA, etc. (Please read the notes on the back before filling this page)

、1T 線 經系部中夾標牟而只5消贽合作私印緊 292 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)、 1T line The Ministry of Economics and the Ministry of Economics and the Ministry of Economic Affairs and the Ministry of Economic Affairs only print 5 papers for cooperation and private printing. 292 The paper size applies to China National Standard (CNS) A4 (210X297 mm)

Claims (1)

548272 ^ as 弟86100149號申請專利範圍修正本g 務正曰期:92.6.18 六、申請專利範圍 …· 1 · 一種苯並咪唑衍生物或醫藥上可容許之該苯並咪 唾衍生物的鹽類,該苯並咪唑衍生物為下式(IX)所代表者: 28 R 〇^〇 γ· R- 29548272 ^ as No. 86100149 Application for revision of patent scope g Proof date: 92.6.18 6. Scope of patent application ... · 1 · A benzimidazole derivative or a pharmaceutically acceptable salt of the benzimidazole derivative The benzimidazole derivative is represented by the following formula (IX): 28 R 〇 ^ 〇γ · R- 29 27 ⑽ k 經濟部智慧財產局員X.消費合作社印製 式(IX)中’ R27為氫原子、低級烧基、鹵低級烧基、 芳基磺醯基、芳基低級烷基、吡啶低級烷基、喹啉低級烷 基、_異喹啉低級烷基;該芳基低級烷基的芳香環可使用 擇自ii素原子、低級烷基、鹵低級烷基、氰芳基、胺基、 低級烷氧基、硝基、氰基、芳基、鹵芳基、芳基磺醯基低 級烧基、芳基績醯基胺基、芳基低級烷氧基'芳基低級烷 基、噻二唑基、吡啶基、芳氧基、芳基碳醯基、芳基碳醯 基胺基、或經一個或二個_素原子取代之芳基低級烧氧基 中之一個或二個取代之; R28為氫原子、低級烷基、_低級烷基、低級烷氧基 低級烷基、低級環烷基、芳基、芳基低級烷基、低級烷基 胺基、低級烷氧基、低級烷硫基、羥基、酼基、胺基或羧 基; R25為碳數到8為止之烷基、函低級烷基、三低級烷 基甲矽烷基低級烷基、低級烷氧基低級烷基、低級烷硫基 低級烧基、芳基、喹琳基、芳基低級烧基、或經基低級院 基;該芳基可使用i素原子、低級烧基、鹵低級烧基、低 293 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) A8B8C8D8 548272 六、申請專利範圍 級烧氧基或硝基取代之; R26為氫原子或低級院基;當該R25及R26皆為低級垸 基時,可互相結合而形成環; Y為碳醢基或低級烧撑基; A代表早純之結合或低級烧撐基或低級稀揮基; R29為氫原子或低級烷基; 且上述定義之中,低級烷基無特別指定之碳數為 1〜6 ;低級環烷基的碳數為3〜7 ;芳基為苯基或萘基。 2·如申請專利範圍第1項所述之苯並咪唑衍生物或醫 藥上可容許之該苯並咪唑衍生物的鹽類,其中R27係為芳 基低級烧基,該芳基低級烷基之芳香環可使用擇自_素原 子、低級烷基、i低級烷基、氰芳基、胺基、低級烷氧基、 硝基、氰基、芳基、鹵芳基、芳基績醯基低級烧基、芳基 磺醯基胺基、芳基低級烷氧基、芳基低級烷基、噻唑基、 吡啶基、芳氧基、芳基碳醯基、芳基碳醯基胺基、或經一 個或二個素原子取代之芳基低級烷氧基中之一個或二 個取代之;Y係為碳醯基;A係為單鍵。 3 ·如申請專利範圍第2項所述之苯並咪σ坐衍生物或醫 藥上可容許之該苯並咪唾衍生物的鹽類,其中R27係為芳 基低級烷基,而該芳基低級烷基之芳香環可使用ώ素原子 或芳基中之一個或二個取代之;R28係為碳數到7為止之 烧基或環烧基,R25係為碳數到8為止之烧基或芳基。 4.如申請專利範圍第1項所述之苯並咪唑衍生物或醫 藥上可容許之該苯並咪唑衍生物之鹽類,係擇自由6_苯磺 本紙張尺度適用中國國家標準(CNS)A4规柢X 9〇7八对 (請先閱讀背面之注意事項再填寫本頁} #· -線. 經濟部智慧財產局員工消費合作钍印製 294 548272 as ___ gg _ 六、申請專利範圍 酿基氨基甲醯基-叩.氯代节基)_2_甲基苯並味唾、卜(聯苯 -4-甲基)-6-(1-丁磺醯基氨基甲醯基)_2_曱基苯並咪唑、 1 (如苯-4-甲基)_6_(1_丁磺醯基氨基甲醯基&gt;2_乙基苯並咪 。坐、6_苯績醯基氨基曱醯基·2-環Θ基-1-(2-氟代节基)苯並 咪唑、6_苯績醯基氨基甲醯基小(Μ:氯代1基)·2·甲基 苯並2唑、6-苯磺醯基氨基甲醯基小(2,4_二氟代苄基)_2_ 曱基苯並咪唑、6_d-丁磺醯基氨基甲醯基)-1-[(3-氟代聯苯 -4-基)甲基]2_甲基苯並㈣、叩,二氣代〒基)_2_曱基 (戊基氣基甲酿基)苯並σ米σ坐以及1 _(4_聯苯甲 基)-2-乙基-6-(1-戊磺醯基氨基甲醯基)苯並咪唑所組成之 群體中者。 5·—種用於預防、治療耐糖能失調、糖尿病、糖尿病 合併症、胰島素抗性症候群、高脂血症、動脈粥樣硬化症、 心血官疾病或高血糖症之醫藥組合物,其係含有如申請專 利範圍第1、2、3或4項所述之化合物或醫藥上可容許之 该等鹽類以當作有效成分,並具有血糖降低活性。 (請先閱讀背面之注意事項再填寫本頁) 訂: -·線- 經濟部智慧財產局員工消費合作♦社印製 適 度 尺 張 械 (21 格 規 4 )A S) N (C 準 標 家 釐 公 9727 ⑽ k Member of the Intellectual Property Bureau of the Ministry of Economic Affairs X. Consumer Cooperative's printed formula (IX) 'R27 is a hydrogen atom, a lower alkyl group, a halogen lower alkyl group, an arylsulfonyl group, an aryl lower alkyl group, or a pyridine lower alkyl group , Quinoline lower alkyl, _isoquinoline lower alkyl; the aromatic ring of the aryl lower alkyl can be selected from the II atom, lower alkyl, halogen lower alkyl, cyanoaryl, amine, lower alkyl Oxy, nitro, cyano, aryl, haloaryl, arylsulfonyl lower alkyl, arylsulfanylamino, aryl lower alkoxy'aryl lower alkyl, thiadiazolyl , Pyridyl, aryloxy, arylcarbenyl, arylcarbenylamino, or one or two of aryl lower alkyloxy substituted with one or two _ prime atoms; R28 is Hydrogen atom, lower alkyl, lower alkyl, lower alkoxy lower alkyl, lower cycloalkyl, aryl, aryl lower alkyl, lower alkylamino, lower alkoxy, lower alkylthio, Hydroxyl, fluorenyl, amine or carboxyl; R25 is an alkyl group having up to 8 carbon atoms, a lower alkyl group, a tri-lower alkyl silyl group Alkyl, lower alkoxy lower alkyl, lower alkylthio lower alkynyl, aryl, quinolinyl, aryl lower alkynyl, or thoryl lower radical; this aryl group can use i element atom, lower alkynyl Base, halogen low-grade burning base, low 293 This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) (Please read the precautions on the back before filling this page) A8B8C8D8 548272 Oxygen or nitro substituted; R26 is a hydrogen atom or a lower radical; when R25 and R26 are lower fluorenyl groups, they can be combined with each other to form a ring; Y is a carbofluorenyl or a lower alkylene group; A represents early Pure bond or lower alkylene group or lower dilute volatile group; R29 is a hydrogen atom or a lower alkyl group; and in the above definition, the lower alkyl group has a carbon number of 1 to 6; the carbon number of the lower cycloalkyl group 3 to 7; aryl is phenyl or naphthyl. 2. The benzimidazole derivative or the pharmaceutically acceptable salt of the benzimidazole derivative as described in item 1 of the scope of the patent application, wherein R27 is an aryl lower alkyl group, and the aryl lower alkyl group is The aromatic ring can be selected from _ prime atom, lower alkyl group, i lower alkyl group, cyanoaryl group, amino group, lower alkoxy group, nitro group, cyano group, aryl group, haloaryl group, and aryl group. Alkyl, arylsulfonylamino, aryl lower alkoxy, aryl lower alkyl, thiazolyl, pyridyl, aryloxy, arylcarbamyl, arylcarbamylamino, or via One or two of the aryl lower alkoxy groups substituted with one or two prime atoms; Y is a carbofluorenyl group; and A is a single bond. 3. The benzimid sigma derivative or the salt of the benzimidal derivative as described in item 2 of the scope of patent application, wherein R27 is an aryl lower alkyl group, and the aryl group The aromatic ring of lower alkyl can be substituted by one or two of free atom or aryl group; R28 is an alkyl group having a carbon number of up to 7 or a cycloalkyl group, and R25 is an alkyl group having a carbon number of up to 8 Or aryl. 4. The benzimidazole derivative or the salt of the benzimidazole derivative as described in item 1 of the scope of the patent application is free to choose 6_benzenesulfonate. The paper size applies the Chinese National Standard (CNS) A4 Regulations X 9〇8 pairs (please read the notes on the back before filling in this page) # ·-线. Consumer Cooperation of Intellectual Property Bureau of the Ministry of Economic Affairs 钍 printed 294 548272 as ___ gg _ Aminocarbamoyl-fluorenyl. Chlorobenzyl) _2_methylbenzoxyl, benzo (biphenyl-4-methyl) -6- (1-butanesulfonylcarbamoyl) _2_ 曱Benzimidazole, 1 (such as benzene-4-methyl) _6_ (1-butanesulfonylcarbamoyl) &gt; 2-ethylbenzimidyl, 6-benzylfluorenylaminofluorenyl · 2-ring Θ group-1- (2-fluorobenzyl) benzimidazole, 6-benzylaminocarbamoyl small (M: chloro 1-yl) · 2 · methylbenzo2azole, 6 -Benzenesulfonylaminocarbamyl small (2,4-difluorobenzyl) _2_fluorenylbenzimidazole, 6_d-butanesulfonylcarbamoyl) -1-[(3-fluorobiphenyl -4-yl) methyl] 2-methylbenzofluorene, pyrene, di-gasofluorenyl) _2_fluorenyl (pentylaminomethyl) methyl σ m and σ sat groups were composed of 1 _ (4_ biphenylcarbonitrile-yl) -2-ethyl-6- (1-pentanesulfonamide acyl acyl carbamoyl) benzimidazole. 5. · A pharmaceutical composition for the prevention and treatment of glucose tolerance disorders, diabetes, diabetic comorbidities, insulin resistance syndrome, hyperlipidemia, atherosclerosis, cardiovascular disease or hyperglycemia, which contains The compounds described in the scope of patent application No. 1, 2, 3 or 4 or the pharmaceutically acceptable salts are used as active ingredients and have blood glucose lowering activity. (Please read the precautions on the back before filling out this page) Order:-· Line-Consumer Cooperation of Intellectual Property Bureau of the Ministry of Economic Affairs ♦ Society prints appropriate ruler (21 rule 4) AS) N (C quasi-standard family Male 97
TW86100149A 1996-10-08 1997-01-08 Benzimidazole derivatives TW548272B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28767696 1996-10-08

Publications (1)

Publication Number Publication Date
TW548272B true TW548272B (en) 2003-08-21

Family

ID=17720285

Family Applications (2)

Application Number Title Priority Date Filing Date
TW86100149A TW548272B (en) 1996-10-08 1997-01-08 Benzimidazole derivatives
TW92103277A TW200300758A (en) 1996-10-08 1997-01-08 Benzimdazole derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW92103277A TW200300758A (en) 1996-10-08 1997-01-08 Benzimdazole derivatives

Country Status (2)

Country Link
TW (2) TW548272B (en)
ZA (1) ZA978998B (en)

Also Published As

Publication number Publication date
ZA978998B (en) 1998-04-20
TW200300758A (en) 2003-06-16

Similar Documents

Publication Publication Date Title
JP3063162B2 (en) Benzimidazole derivatives
TW426666B (en) Sulfonamide compounds and pharmaceutical use thereof
TW383307B (en) Pyridopyrazine derivatives
US6348032B1 (en) Method of inhibiting neoplastic cells with benzimidazole derivatives
CN104487433B (en) Triazolone compound as mPGES 1 inhibitor
TW502034B (en) 2-aryl-8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
US7482373B2 (en) Bis-benzimidazoles and related compounds as potassium channel modulators
AU2010258295B2 (en) Compounds useful for treating AIDS
TWI419882B (en) Benzimidazole modulators of vr1
JP5746471B2 (en) Benzimidazole TRPV1 inhibitor
WO2001087845A2 (en) N-containing heterocyclic compounds and their use as 5-ht antagonists
EP1786773A1 (en) Isoindolin-1-one derivatives
JP2004523546A (en) Quinazolines as MMP-13 inhibitors
CA2674875A1 (en) Purine derivatives
CN110012667B (en) Crystalline hydrate
JPH04145079A (en) Indole derivative and use thereof
JP2009506127A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
JP2005509626A (en) Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
JP2009084274A (en) New 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivative
JP2024514015A (en) Alkynylphenylbenzamide compounds and their uses
JP2009511560A (en) Naphthalene-disulfonamides useful for the treatment of inflammation
TW479058B (en) 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives
TW548272B (en) Benzimidazole derivatives
HUT77734A (en) Quinoxaline derivatives, process for producing them and pharmaceutical compositions containing them
CN111875583B (en) Triazole derivative and preparation method and application thereof

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees